Citrus Sinensis ID: 036382
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 390 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.774 | 0.774 | 0.357 | 2e-58 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.689 | 0.293 | 0.313 | 1e-46 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.653 | 0.153 | 0.340 | 4e-45 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.664 | 0.491 | 0.343 | 2e-41 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.723 | 0.117 | 0.310 | 1e-40 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.661 | 0.158 | 0.347 | 2e-40 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.848 | 0.403 | 0.301 | 5e-40 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.674 | 0.204 | 0.339 | 6e-40 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.664 | 0.223 | 0.322 | 7e-40 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.666 | 0.513 | 0.334 | 7e-40 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 226 bits (577), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 118/330 (35%), Positives = 188/330 (56%), Gaps = 28/330 (8%)
Query: 43 RADKIDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY 102
R D ++ S+ ++ E +W S+ E +EEW DLS+L + N A G + +YRG Y
Sbjct: 50 RFDSMESWSMILESENVETWEASKGE----REEWTADLSQLFIGNKFASGAHSRIYRGIY 105
Query: 103 DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162
+ VAVK++ T A+ L F+ EVA+ +L HPN+ +F+ A K
Sbjct: 106 KQRAVAVKMVRIPTHKEETRAK---LEQQFKSEVALLSRLFHPNIVQFIAAC------KK 156
Query: 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSY 222
P C++ EY+ GNL+ YL + L+++ V++LALD+SRG+ Y
Sbjct: 157 PP--------------VYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEY 202
Query: 223 LHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK 282
LHS+ ++HRD+K+ N+LL+ + +K+ADFG + +E Q R+ G GT +MAPE+++ K
Sbjct: 203 LHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQC-REAKGNMGTYRWMAPEMIKEK 261
Query: 283 PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRK 342
PY R+ DVYSFGI LWE+ +P+ ++ + AV +N RP +P C +LA+++++
Sbjct: 262 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKR 321
Query: 343 CWDANAEKRPEMGEVVKMLEAIDTSKGGGM 372
CW N KRP+ +V +LE D G+
Sbjct: 322 CWSENPSKRPDFSNIVAVLEKYDECVKEGL 351
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 93/297 (31%), Positives = 167/297 (56%), Gaps = 28/297 (9%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAA 127
+ Q+ + EI S+L + + + +GT+G VY+G + VA+K + ED E
Sbjct: 647 QQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLE--- 703
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
F++E+ + +L HPN+ + A NL C + EYL
Sbjct: 704 ---EFRKELTILSRLRHPNIVLLMAACTAPPNL--------------------CFITEYL 740
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
PGG+L L +++ K+ +++ +LA+ +++G++YLH ++HRD+K+ N+LLD +K
Sbjct: 741 PGGSLYDAL-HSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVK 799
Query: 248 IADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
I DFG++++++++ +MT G+ +M+PE+L G+ Y + DVY+FGI LWE+ ++PY
Sbjct: 800 ICDFGLSKLKSKS-TEMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPY 858
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
L ++ AV ++LRP IP P L+++++ CW + KRP E++ +L I
Sbjct: 859 SGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 98/288 (34%), Positives = 160/288 (55%), Gaps = 33/288 (11%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
W I+ ++ M I G+YG VYRG + N +VA+K + + L ++E
Sbjct: 1392 WVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKF------IKQKIDENHLLG-IREE 1444
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+A +KL HPN+ VGAS+ N+ C+V EY+ GNL+
Sbjct: 1445 IAFLKKLHHPNIITMVGASLKKPNI--------------------CIVTEYMAKGNLRDA 1484
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHS--KKIVHRDVKTENMLLDSQRTLKIADFGV 253
+ R KL I++ +++++G+SYLHS I+HRD+K N+L+D +KIADFG
Sbjct: 1485 M-RTCTPKLEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGF 1543
Query: 254 ARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
AR++ +N + GT + APE+++ Y+ + DV+SFGI +WE+ C P+ +F
Sbjct: 1544 ARIKEENA--IMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFM 1601
Query: 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
++ ++ +++RP+IP+ CP A +MRKCW A + KRP M +V+ +L
Sbjct: 1602 KITMDIL-EDVRPKIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 101/294 (34%), Positives = 164/294 (55%), Gaps = 35/294 (11%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
EI +++ +++ G++G+VY+G ++VAVK+ M + L + F++EV
Sbjct: 39 EISETEITTESILGDGSFGTVYKGRCRLKDVAVKV-------MLKQVDQKTL-TDFRKEV 90
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
A+ K+ HPN+ F+GA T P K ++ L GNL+ L
Sbjct: 91 AIMSKIFHPNIVLFLGACTST-----PGK---------------LMICTELMKGNLESLL 130
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDSQRTLKIADFGVA 254
+ + KL L +++A D + G+ +LHS +HRD+KT N+L+D+ T+K+ DFG++
Sbjct: 131 L-DPMVKLPLITRMRMAKDAALGVLWLHSSNPVFIHRDLKTSNLLVDANLTVKVCDFGLS 189
Query: 255 RVE--AQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL- 310
+++ +N +D G GT +MAPEVLQG+ +N + DVYSFG+ LW+I+ +P+
Sbjct: 190 QIKQRGENLKDGQDGAKGTPLWMAPEVLQGRLFNEKADVYSFGLVLWQIFTRQELFPEFD 249
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+F +A+ + LRP IP CP SL +++KCWD N E RP +V LE I
Sbjct: 250 NFFKFVAAICEKQLRPSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSELEEI 303
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 1e-40, Method: Composition-based stats.
Identities = 103/332 (31%), Positives = 170/332 (51%), Gaps = 50/332 (15%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSF 132
+ E+EID ++L+ I +G +G V RG + +VA+K++ D T + F
Sbjct: 2105 RSEYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKII--YRDQFKTKSSLVM----F 2158
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
Q EV + KL HPNV +F+GA TA + + C+V E++ GG+L
Sbjct: 2159 QNEVGILSKLRHPNVVQFLGAC-----------TAGGEDHH-------CIVTEWMGGGSL 2200
Query: 193 KQYLIRN-RRKKLALKIVIQLALDLSRGLSYLH--SKKIVHRDVKTENMLLD-------- 241
+Q+L + + I ++LALD+++G++YLH + I+HRD+ + N+LLD
Sbjct: 2201 RQFLTDHFNLLEQNPHIRLKLALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNP 2260
Query: 242 --SQRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
S R KI+DFG++R++ + MT G + YMAPEV +G + + DVYS+G+
Sbjct: 2261 VVSSRQDIKCKISDFGLSRLKMEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMV 2320
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
L+E+ D P D+ ++ ++ RP IP S I+ +CWD+N + RP +
Sbjct: 2321 LFELLTSDEPQQDMKPMKMAHLAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQ 2380
Query: 357 VVKMLEAIDTSKGGGMIPEDQATGCFCFSPVR 388
++ L+ + EDQ F PV+
Sbjct: 2381 IIVHLKEM----------EDQGVSSFASVPVQ 2402
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 101/291 (34%), Positives = 150/291 (51%), Gaps = 33/291 (11%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
W I+ ++ + I G+YG V+ G + +VAVK +ET L F+ E
Sbjct: 1357 WIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKF-----VKQKLSETQLLE--FRAE 1409
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+A +L H N+ F+GA + N+ C+V EY+ GNL+
Sbjct: 1410 MAFLSELKHSNIVTFIGACIKKPNI--------------------CIVTEYMRMGNLRDV 1449
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDSQRTLKIADFGV 253
L +N K+ ++L + G+ YLHS IVHRD+K N+L+D +KIADFG
Sbjct: 1450 L-KNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGF 1508
Query: 254 ARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
AR++ N MT GT + APEV++G+ Y + DV+SFG+ +WE+ P+ + +F
Sbjct: 1509 ARIKEDNTT-MT-RCGTPCWTAPEVIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFM 1566
Query: 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
VS ++ RP IP CP A +++KCW A A KRP M EVV+ L I
Sbjct: 1567 KVSLDILEGG-RPIIPSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLI 1616
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (418), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 111/368 (30%), Positives = 191/368 (51%), Gaps = 37/368 (10%)
Query: 7 DDLGVVDSLRKSDNEEGSVNSKVK-GTGSLSS------KDMLFRADKIDLKSLDMQLEKH 59
DD+G R+ DN G ++ + G GSL ++M+ +++I+ ++
Sbjct: 468 DDMGFSMFHRQYDNPGGENDALAENGGGSLPPSANMPPQNMMRASNQIEAAPMNAPPISQ 527
Query: 60 LSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGM 119
+ E ++ +I L+++ I G++G+V+R + +VAVK+L +D
Sbjct: 528 PVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL-MEQDFH 586
Query: 120 ATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARA 179
A + F +EVA+ ++L HPN+ F+GA NL I
Sbjct: 587 AERV------NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI----------------- 623
Query: 180 CCVVVEYLPGGNLKQYLIRN-RRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTE 236
V EYL G+L + L ++ R++L + + +A D+++G++YLH++ IVHRD+K+
Sbjct: 624 ---VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSP 680
Query: 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
N+L+D + T+K+ DFG++R++A GT +MAPEVL+ +P N + DVYSFG+
Sbjct: 681 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 740
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
LWE+ P+ +L+ A V +AV + R EIPR +A I+ CW KRP
Sbjct: 741 LWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFAT 800
Query: 357 VVKMLEAI 364
++ +L +
Sbjct: 801 IMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 104/306 (33%), Positives = 162/306 (52%), Gaps = 43/306 (14%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
EWE+ LS++ + I +G YG V+RG++ EVAVK+L D + L S ++
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKML--FNDNV-----NLKLISDLRK 895
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
EV + KL HPN+ F+GA S + C+V EYL G+L
Sbjct: 896 EVDLLCKLRHPNIVLFMGACTEPS--------------------SPCIVTEYLSRGSLAN 935
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDSQRTLKIADFG 252
L+ + ++ + +QL D +RG++YLHS+ I+HRD+KT+N+L+D +K+ADFG
Sbjct: 936 ILL-DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFG 994
Query: 253 VARVEAQN-PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311
+A V++ + M G T G++APEVL + Y + DVYS+ I LWE+ +PY +
Sbjct: 995 LATVKSHTFAKTMCG---TTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKN 1051
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371
V ++ R P +P CP A +M +CW+ + RP E++ ++E G
Sbjct: 1052 TMQVVRSIDRGERLP-MPAWCPPKYAALMNRCWETDPTHRPSFPEILPIME--------G 1102
Query: 372 MIPEDQ 377
MI E Q
Sbjct: 1103 MISEFQ 1108
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 98/304 (32%), Positives = 157/304 (51%), Gaps = 45/304 (14%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDW-GEDGMATTAETAALRSSFQQE 135
EI+ ++LD++ +I G + V+RG YD +EVA+K+ GED M +R + QE
Sbjct: 136 EIEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKIAHQTGEDDMQR------MRDNVLQE 189
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
++ L H N+ G + T C+V+EY GG+L +
Sbjct: 190 AKLFWALKHENIAALRGVCLNTK---------------------LCLVMEYARGGSLNRI 228
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSK---KIVHRDVKTENMLLD--------SQR 244
L K+ +++ A+ ++RG++YLH++ I+HRD+K+ N+L+ Q+
Sbjct: 229 LA----GKIPPDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQK 284
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
TLKI DFG+AR E N + M+ GT +M PEV+ Y++ DV+S+G+ LWE+ +
Sbjct: 285 TLKITDFGLAR-EMYNTQRMSA-AGTYAWMPPEVISVSTYSKFSDVWSYGVLLWELITGE 342
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PY V+ V L IP+ CP + +M+ CW + KRP E++K LE+I
Sbjct: 343 TPYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESI 402
Query: 365 DTSK 368
SK
Sbjct: 403 ACSK 406
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 98/293 (33%), Positives = 153/293 (52%), Gaps = 33/293 (11%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
EI +++ LI G++G VY+G + VAVKLL AA S+F++EV
Sbjct: 18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLH-------KQNFDAATLSAFRKEV 70
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
+ K+ HPN+ F+GA +P R C +V E +P GNL + L
Sbjct: 71 HLMSKIYHPNICLFMGA-------------------CTIPGR-CVIVTELVPKGNL-ETL 109
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDSQRTLKIADFGVA 254
+ +++ +L L + +++A D + G+++LH VHRD+K+ N+L+D +KI DFG++
Sbjct: 110 LHDQKIQLPLYLRMRMARDAALGINWLHESNPVFVHRDIKSSNLLVDENMRVKICDFGLS 169
Query: 255 RVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-S 311
++ ++ +D + GT YMAPEV+ K +N DVYSFGI LWEI P+
Sbjct: 170 ALKQKHKMLKDQSSAKGTPLYMAPEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRE 229
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
AV ++ RP IP C SL ++ KCWD RP E++ L+ +
Sbjct: 230 LEKFREAVCVKHERPPIPNDCLDSLRRLIEKCWDKEPISRPSFKEIISALDHV 282
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 390 | ||||||
| 225432748 | 391 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.994 | 0.820 | 0.0 | |
| 255552091 | 393 | protein kinase atmrk1, putative [Ricinus | 0.997 | 0.989 | 0.824 | 0.0 | |
| 297737090 | 456 | unnamed protein product [Vitis vinifera] | 0.956 | 0.817 | 0.842 | 0.0 | |
| 356497440 | 387 | PREDICTED: serine/threonine-protein kina | 0.946 | 0.953 | 0.808 | 0.0 | |
| 356538188 | 385 | PREDICTED: serine/threonine-protein kina | 0.946 | 0.958 | 0.805 | 0.0 | |
| 224102095 | 351 | predicted protein [Populus trichocarpa] | 0.897 | 0.997 | 0.860 | 0.0 | |
| 224107973 | 351 | predicted protein [Populus trichocarpa] | 0.897 | 0.997 | 0.863 | 0.0 | |
| 255567520 | 444 | protein kinase atmrk1, putative [Ricinus | 0.953 | 0.837 | 0.804 | 0.0 | |
| 388514835 | 386 | unknown [Lotus japonicus] | 0.987 | 0.997 | 0.780 | 1e-180 | |
| 357480923 | 390 | Kinase-like protein [Medicago truncatula | 0.958 | 0.958 | 0.796 | 1e-178 |
| >gi|225432748|ref|XP_002283073.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/391 (82%), Positives = 357/391 (91%), Gaps = 2/391 (0%)
Query: 1 MDLTTKDDLGVVDSLRKSDNEEGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHL 60
MDL T +++G KSD +E S SKVKGTGSLS+KD +FRADKIDLKSLD+QLEKHL
Sbjct: 2 MDLKTTEEIGGAMIAEKSDCKESSTGSKVKGTGSLSNKDKIFRADKIDLKSLDIQLEKHL 61
Query: 61 SWVWSRN-ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGM 119
S VWSR+ +SQRPKEEWEIDLSKLD+++++A GTYG+VY+GTYDNQ+VAVK+LDWGEDG+
Sbjct: 62 SRVWSRSIDSQRPKEEWEIDLSKLDIKHVVAHGTYGTVYQGTYDNQDVAVKVLDWGEDGI 121
Query: 120 ATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARA 179
TTAETAALR+SF+QEVAVW KLD+PNVTKF+GAS+GTSNLK+P+++ + G+ P RA
Sbjct: 122 PTTAETAALRASFRQEVAVWHKLDNPNVTKFIGASMGTSNLKVPTQSLPLAGDR-FPTRA 180
Query: 180 CCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
CCVVVEYLPGG LKQYLIRNRRKKLA KIVIQLALDLSRGLSYLHSKKIVHRDVK+ENML
Sbjct: 181 CCVVVEYLPGGTLKQYLIRNRRKKLAFKIVIQLALDLSRGLSYLHSKKIVHRDVKSENML 240
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
LD+QRTLKIADFGVARVEAQN R+MTGETGTLGYMAPEVL GKPYNRRCDVYSFGICLWE
Sbjct: 241 LDAQRTLKIADFGVARVEAQNLREMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWE 300
Query: 300 IYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
IYCCDMPYPDLSFA+VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP+M EVVK
Sbjct: 301 IYCCDMPYPDLSFAEVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPDMNEVVK 360
Query: 360 MLEAIDTSKGGGMIPEDQATGCFCFSPVRGP 390
MLEAIDTS+GGGMIPEDQ CFCFS VRGP
Sbjct: 361 MLEAIDTSRGGGMIPEDQTPVCFCFSNVRGP 391
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552091|ref|XP_002517090.1| protein kinase atmrk1, putative [Ricinus communis] gi|223543725|gb|EEF45253.1| protein kinase atmrk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/394 (82%), Positives = 356/394 (90%), Gaps = 5/394 (1%)
Query: 1 MDLTTK-DDLGVVDSLRKSDNEEGSVNSKV--KGTGSLSSKDMLFRADKIDLKSLDMQLE 57
MD T + DD + + +KS+N +GSV SKV +GTGS+SSKDM+FRADKIDLKSLD+QLE
Sbjct: 1 MDSTRRSDDTEGIMAEKKSENTDGSVLSKVNLRGTGSVSSKDMIFRADKIDLKSLDIQLE 60
Query: 58 KHLSWVWSRN-ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGE 116
KHLS VWSRN +QRPKEEWEIDLSKLD+++ +A GT+G+VYRGTYDNQ+VAVKLLDWG+
Sbjct: 61 KHLSRVWSRNINTQRPKEEWEIDLSKLDIKHAVAHGTFGTVYRGTYDNQDVAVKLLDWGD 120
Query: 117 DGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVP 176
D A TA TAALR+SF+QEVAVW KLDHPNVT+F+GAS+GTSNLKIPSK S D + P
Sbjct: 121 DSTAATAGTAALRASFRQEVAVWHKLDHPNVTRFIGASMGTSNLKIPSKNPSED-QTSFP 179
Query: 177 ARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236
+RACCVVVEYL GG LKQYLIRNRRKKLA KIVIQLALDLSRGLSYLHSKKIVHRDVKTE
Sbjct: 180 SRACCVVVEYLAGGTLKQYLIRNRRKKLAFKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 239
Query: 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
NMLLD+ RTLKIADFGVARVEAQNP DMTGETGTLGYMAPEVL GKPYNRRCDVYSFGIC
Sbjct: 240 NMLLDAHRTLKIADFGVARVEAQNPSDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGIC 299
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
LWEIYCCDMPYPDLSF DVS+AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM E
Sbjct: 300 LWEIYCCDMPYPDLSFVDVSTAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMAE 359
Query: 357 VVKMLEAIDTSKGGGMIPEDQATGCFCFSPVRGP 390
VV+MLEAIDTSKGGGMIP+DQATGCFCF+P RGP
Sbjct: 360 VVRMLEAIDTSKGGGMIPDDQATGCFCFAPARGP 393
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737090|emb|CBI26291.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/375 (84%), Positives = 349/375 (93%), Gaps = 2/375 (0%)
Query: 17 KSDNEEGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRN-ESQRPKEE 75
KSD +E S SKVKGTGSLS+KD +FRADKIDLKSLD+QLEKHLS VWSR+ +SQRPKEE
Sbjct: 83 KSDCKESSTGSKVKGTGSLSNKDKIFRADKIDLKSLDIQLEKHLSRVWSRSIDSQRPKEE 142
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
WEIDLSKLD+++++A GTYG+VY+GTYDNQ+VAVK+LDWGEDG+ TTAETAALR+SF+QE
Sbjct: 143 WEIDLSKLDIKHVVAHGTYGTVYQGTYDNQDVAVKVLDWGEDGIPTTAETAALRASFRQE 202
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
VAVW KLD+PNVTKF+GAS+GTSNLK+P+++ + G+ P RACCVVVEYLPGG LKQY
Sbjct: 203 VAVWHKLDNPNVTKFIGASMGTSNLKVPTQSLPLAGDR-FPTRACCVVVEYLPGGTLKQY 261
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
LIRNRRKKLA KIVIQLALDLSRGLSYLHSKKIVHRDVK+ENMLLD+QRTLKIADFGVAR
Sbjct: 262 LIRNRRKKLAFKIVIQLALDLSRGLSYLHSKKIVHRDVKSENMLLDAQRTLKIADFGVAR 321
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
VEAQN R+MTGETGTLGYMAPEVL GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA+V
Sbjct: 322 VEAQNLREMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAEV 381
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPE 375
SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP+M EVVKMLEAIDTS+GGGMIPE
Sbjct: 382 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPDMNEVVKMLEAIDTSRGGGMIPE 441
Query: 376 DQATGCFCFSPVRGP 390
DQ CFCFS VRGP
Sbjct: 442 DQTPVCFCFSNVRGP 456
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497440|ref|XP_003517568.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 299/370 (80%), Positives = 339/370 (91%), Gaps = 1/370 (0%)
Query: 22 EGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRN-ESQRPKEEWEIDL 80
EG++NSK+KG G++SSKDM+FRADKIDLKSLD QLEKHLS VWSR+ E++RP+EEWEIDL
Sbjct: 18 EGALNSKMKGAGNVSSKDMIFRADKIDLKSLDAQLEKHLSRVWSRSIETKRPREEWEIDL 77
Query: 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
+KLD+R ++A G YG+VYRGTYD Q+VAVK+LDWGEDG+AT AETAALR+SF+QEVAVWQ
Sbjct: 78 AKLDLRYVVAHGAYGTVYRGTYDTQDVAVKVLDWGEDGVATAAETAALRASFRQEVAVWQ 137
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
KLDHPNVTKFVGAS+GTSNLKIP K ++P+RACCV+VE++ GG LKQYL ++R
Sbjct: 138 KLDHPNVTKFVGASMGTSNLKIPPKNPMNADEESLPSRACCVIVEFVSGGTLKQYLFKSR 197
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
R+KLA KIVIQLALDL+RGL+YLHSKKIVHRDVKTENMLLD+ R LKIADFGVARVEA N
Sbjct: 198 RRKLAYKIVIQLALDLARGLNYLHSKKIVHRDVKTENMLLDTSRNLKIADFGVARVEAMN 257
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
P DMTGETGTLGYMAPEVL GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV
Sbjct: 258 PSDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 317
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQATG 380
RQNLRP+IPRCCPS+LANIMRKCWDAN KRPEM EVV+MLEA+DTSKGGGMIPEDQ++G
Sbjct: 318 RQNLRPDIPRCCPSALANIMRKCWDANPNKRPEMEEVVRMLEALDTSKGGGMIPEDQSSG 377
Query: 381 CFCFSPVRGP 390
CFCF+P RGP
Sbjct: 378 CFCFAPTRGP 387
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538188|ref|XP_003537586.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 298/370 (80%), Positives = 337/370 (91%), Gaps = 1/370 (0%)
Query: 22 EGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRN-ESQRPKEEWEIDL 80
EG++NSK+KG G++SSKDM+FRADKIDLKSLD QLEKHLS VWSR+ E+ RPKEEWE+DL
Sbjct: 16 EGALNSKMKGAGNVSSKDMIFRADKIDLKSLDAQLEKHLSRVWSRSIETNRPKEEWEVDL 75
Query: 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
+KLD+R ++A G YG+VYRGTYD Q+VAVK+LDWGEDG+AT AETAALR+SF+QEVAVWQ
Sbjct: 76 AKLDLRYVVAHGAYGTVYRGTYDTQDVAVKVLDWGEDGVATAAETAALRASFRQEVAVWQ 135
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
KLDHPNVTKFVGAS+GTSNLKIP K ++P+RACCV+VE++ GG LKQYL ++R
Sbjct: 136 KLDHPNVTKFVGASMGTSNLKIPPKNPLNADEESLPSRACCVIVEFVSGGTLKQYLFKSR 195
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
R+KLA KIVIQLALDL+RGL+YLHSKKIVHRDVKTENMLL + R LKIADFGVARVEA N
Sbjct: 196 RRKLAYKIVIQLALDLARGLNYLHSKKIVHRDVKTENMLLSTSRNLKIADFGVARVEAMN 255
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
P DMTGETGTLGYMAPEVL GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV
Sbjct: 256 PSDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 315
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQATG 380
RQNLRP+IPRCCPS+LANIMRKCWDAN KRPEM EVV+MLEA+DTSKGGGMIPEDQ++G
Sbjct: 316 RQNLRPDIPRCCPSALANIMRKCWDANPNKRPEMEEVVRMLEALDTSKGGGMIPEDQSSG 375
Query: 381 CFCFSPVRGP 390
CFCF+P RGP
Sbjct: 376 CFCFAPTRGP 385
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102095|ref|XP_002312543.1| predicted protein [Populus trichocarpa] gi|222852363|gb|EEE89910.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/352 (86%), Positives = 325/352 (92%), Gaps = 2/352 (0%)
Query: 40 MLFRADKIDLKSLDMQLEKHLSWVWSRN-ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY 98
M FRADKIDLKSLD QLEKHLS VWSRN E QRPKEEWEID SKL++R+ +A+GT+G+VY
Sbjct: 1 MFFRADKIDLKSLDAQLEKHLSRVWSRNTEIQRPKEEWEIDSSKLEIRHEVARGTFGTVY 60
Query: 99 RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158
RGTYDNQ+VAVK+LDWGEDG+ATTAET A+R+SFQQEVAVW KLDHPNVTKFVGAS+GTS
Sbjct: 61 RGTYDNQDVAVKMLDWGEDGIATTAETTAVRASFQQEVAVWHKLDHPNVTKFVGASMGTS 120
Query: 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218
NLKIP+K S DG ++PARACCVVVEYLPGG LK YLIRN RKKLA K+VIQLALDLSR
Sbjct: 121 NLKIPAKNPS-DGYISLPARACCVVVEYLPGGTLKHYLIRNSRKKLAFKVVIQLALDLSR 179
Query: 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV 278
GLSYLHSKKIVHRDVKTENMLLDS R LKIADFGVARVEAQNP DMTGETGTLGYMAPEV
Sbjct: 180 GLSYLHSKKIVHRDVKTENMLLDSHRNLKIADFGVARVEAQNPCDMTGETGTLGYMAPEV 239
Query: 279 LQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLAN 338
L GKPYNRRCDVYSFGICLWEIYCCDMPYP+LSFADVSSAVVRQNLRPEIPRCCPSSLAN
Sbjct: 240 LDGKPYNRRCDVYSFGICLWEIYCCDMPYPNLSFADVSSAVVRQNLRPEIPRCCPSSLAN 299
Query: 339 IMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQATGCFCFSPVRGP 390
+MRKCWD NAEKRPEM EVVKMLEA+DTSKGGGMIPEDQA+ CFC +P RGP
Sbjct: 300 VMRKCWDGNAEKRPEMAEVVKMLEAVDTSKGGGMIPEDQASVCFCLTPARGP 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107973|ref|XP_002314673.1| predicted protein [Populus trichocarpa] gi|222863713|gb|EEF00844.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/352 (86%), Positives = 325/352 (92%), Gaps = 2/352 (0%)
Query: 40 MLFRADKIDLKSLDMQLEKHLSWVWSRN-ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY 98
M FRADKIDLKSLD QLEKHLS VWSR+ E QRP+EEWEIDLSKLD+R+ +A GT+G+VY
Sbjct: 1 MYFRADKIDLKSLDAQLEKHLSRVWSRDIEIQRPREEWEIDLSKLDIRHEVAHGTFGTVY 60
Query: 99 RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158
RGTYDNQ+VAVKLLDWGEDGMAT AET A+R+SFQQEVAVW KLDHPNVTKFVGAS+GT
Sbjct: 61 RGTYDNQDVAVKLLDWGEDGMATAAETMAVRASFQQEVAVWHKLDHPNVTKFVGASMGTL 120
Query: 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218
NLKIP+K S D N +PARACCVVVEYLPGG LKQYLIRN RKKLA K+VIQLALDLSR
Sbjct: 121 NLKIPAKNPS-DDNINLPARACCVVVEYLPGGTLKQYLIRNSRKKLAFKVVIQLALDLSR 179
Query: 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV 278
GLSYLHSKKIVHRDVKTENMLLDS +TLKIADFGVAR+EAQNP +MTGETGTLGYMAPEV
Sbjct: 180 GLSYLHSKKIVHRDVKTENMLLDSHKTLKIADFGVARIEAQNPCEMTGETGTLGYMAPEV 239
Query: 279 LQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLAN 338
L GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP+IPRCCPSSLAN
Sbjct: 240 LDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPDIPRCCPSSLAN 299
Query: 339 IMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQATGCFCFSPVRGP 390
+MRKCWD NAEKRPEM EVVKMLE IDTSKGGGMIPEDQ +GCFCF+PVRGP
Sbjct: 300 VMRKCWDGNAEKRPEMDEVVKMLEGIDTSKGGGMIPEDQNSGCFCFNPVRGP 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567520|ref|XP_002524739.1| protein kinase atmrk1, putative [Ricinus communis] gi|223535923|gb|EEF37582.1| protein kinase atmrk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 300/373 (80%), Positives = 337/373 (90%), Gaps = 1/373 (0%)
Query: 18 SDNEEGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRNES-QRPKEEW 76
S+ +E S++SKVK +GS+S+K+M FRADKID KS D+QLEKHLS WSRNE Q +EEW
Sbjct: 24 SNAQENSLSSKVKDSGSVSNKEMYFRADKIDFKSWDIQLEKHLSKAWSRNEEVQTKREEW 83
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
EIDLSKLDMR++IAQGTYG VYRG YD Q+VAVK+L+WGEDG+AT AE A +R+SF+QEV
Sbjct: 84 EIDLSKLDMRHVIAQGTYGIVYRGNYDGQDVAVKILNWGEDGIATAAEIATIRASFRQEV 143
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
AVW KLDHPNVTKFVGAS+GTSNLKIPS+ + P+RACCVV+EYLPGG LK++L
Sbjct: 144 AVWHKLDHPNVTKFVGASMGTSNLKIPSQNPMNGSYDSHPSRACCVVLEYLPGGTLKKFL 203
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
IRNRRKKLA KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD+ RTLKIADFGVARV
Sbjct: 204 IRNRRKKLAFKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDAHRTLKIADFGVARV 263
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316
EAQNPRDMTGETGTLGYMAPEVL GKPYNR+CDVYSFGICLWEIYCCDMPYPDLSFA+VS
Sbjct: 264 EAQNPRDMTGETGTLGYMAPEVLDGKPYNRKCDVYSFGICLWEIYCCDMPYPDLSFAEVS 323
Query: 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPED 376
S VVRQNLRPEIPRCCP+S+A+IMRKCWDAN +KRPEM EVV++LEAIDTSKGGGMIPE
Sbjct: 324 SQVVRQNLRPEIPRCCPNSVASIMRKCWDANPDKRPEMDEVVRLLEAIDTSKGGGMIPEG 383
Query: 377 QATGCFCFSPVRG 389
Q+TGCFCF+PVRG
Sbjct: 384 QSTGCFCFTPVRG 396
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388514835|gb|AFK45479.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1640), Expect = e-180, Method: Compositional matrix adjust.
Identities = 305/391 (78%), Positives = 345/391 (88%), Gaps = 6/391 (1%)
Query: 1 MDLTTKDDLGVVDSLRKSDNEEGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHL 60
MDL + D V + +K EG+ K+ G G+LSSKDM+FRAD+IDLKSLD QLEKHL
Sbjct: 1 MDLEGEGD---VRTPKKELEGEGTPR-KMGGAGTLSSKDMIFRADRIDLKSLDTQLEKHL 56
Query: 61 SWVWSRN-ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGM 119
S VWSR+ +++RPKEEWEIDL+KLD+R ++A G YG+VYRGTYDNQ+VAVK+LDWGEDG+
Sbjct: 57 SRVWSRSVDTKRPKEEWEIDLAKLDLRYVVAHGAYGTVYRGTYDNQDVAVKVLDWGEDGV 116
Query: 120 ATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARA 179
AT AETAALR+SF+QEVAVWQKLDHPNVTKF+GAS+GTSNLKIPSK S D +P+RA
Sbjct: 117 ATAAETAALRASFRQEVAVWQKLDHPNVTKFLGASMGTSNLKIPSKNPSNDAQD-LPSRA 175
Query: 180 CCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
CCV+VEYLPGG LKQ+LI+NRRKKLA K+V+QLAL+LSRGLSYLHS+KIVHRDVK+ENML
Sbjct: 176 CCVIVEYLPGGTLKQFLIKNRRKKLAYKVVVQLALELSRGLSYLHSQKIVHRDVKSENML 235
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
LD R LKIADFGVARVEA NP DMTGETGTLGYMAPEVL GKPYNRRCDVYSFGICLWE
Sbjct: 236 LDGNRNLKIADFGVARVEAMNPSDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWE 295
Query: 300 IYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
IYCCDMPYP LSFADVSSAVV QNLRPEIPRCCPS+L++IMRKCWD N KRPEM EVV+
Sbjct: 296 IYCCDMPYPYLSFADVSSAVVHQNLRPEIPRCCPSALSSIMRKCWDGNPNKRPEMDEVVR 355
Query: 360 MLEAIDTSKGGGMIPEDQATGCFCFSPVRGP 390
MLEA+DTSKGGGMIPEDQATGCFCF+P RGP
Sbjct: 356 MLEALDTSKGGGMIPEDQATGCFCFTPSRGP 386
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357480923|ref|XP_003610747.1| Kinase-like protein [Medicago truncatula] gi|355512082|gb|AES93705.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1622), Expect = e-178, Method: Compositional matrix adjust.
Identities = 302/379 (79%), Positives = 341/379 (89%), Gaps = 5/379 (1%)
Query: 17 KSDNEEGS---VNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRN--ESQR 71
K + EEG+ +NSK+KG G+ SSKDM+FRAD+IDLK+LD QLEKHLS VWSRN E++R
Sbjct: 12 KVELEEGAKSVMNSKMKGAGNQSSKDMIFRADRIDLKNLDAQLEKHLSRVWSRNTNETKR 71
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSS 131
P+EEWE++L+KLD+R ++A G YG+VYRGTYD Q+VAVK+LDWGEDG AT AETAALR+S
Sbjct: 72 PREEWEVELAKLDLRYVVAHGAYGTVYRGTYDTQDVAVKVLDWGEDGAATAAETAALRAS 131
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F+QEVAVW KLDHPNVTKFVGAS+GTSNLKIP+K +S + +P+RACCV+VE+LPGG
Sbjct: 132 FRQEVAVWHKLDHPNVTKFVGASMGTSNLKIPTKNSSTNNQENLPSRACCVIVEFLPGGT 191
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
LKQYLIRNRRKKLA +IV+QLALDLSRGLSYLHS+KIVHRDVKTENMLLD R LKIADF
Sbjct: 192 LKQYLIRNRRKKLAYRIVVQLALDLSRGLSYLHSEKIVHRDVKTENMLLDGNRNLKIADF 251
Query: 252 GVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311
GVARVEA NP DMTGETGTLGYMAPEVL GKPYNR CDVYSFGICLWEIYCCDMPYPDLS
Sbjct: 252 GVARVEALNPSDMTGETGTLGYMAPEVLDGKPYNRTCDVYSFGICLWEIYCCDMPYPDLS 311
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371
FADVSSAVVRQNLRPEIPRCCPS+LANIMRKCWDAN KRPEM +VV MLEA+DTSKGGG
Sbjct: 312 FADVSSAVVRQNLRPEIPRCCPSALANIMRKCWDANPIKRPEMKDVVIMLEALDTSKGGG 371
Query: 372 MIPEDQATGCFCFSPVRGP 390
MIPEDQ++GCFCF+P RGP
Sbjct: 372 MIPEDQSSGCFCFAPQRGP 390
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 390 | ||||||
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.928 | 0.957 | 0.758 | 4.1e-152 | |
| TAIR|locus:2130230 | 364 | AT4G14780 [Arabidopsis thalian | 0.928 | 0.994 | 0.714 | 1.8e-142 | |
| TAIR|locus:2084193 | 411 | AT3G01490 [Arabidopsis thalian | 0.817 | 0.776 | 0.715 | 8.5e-134 | |
| TAIR|locus:2170106 | 385 | AT5G50000 [Arabidopsis thalian | 0.812 | 0.823 | 0.691 | 9.9e-131 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.943 | 0.941 | 0.653 | 2.2e-130 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.464 | 0.439 | 0.439 | 1.8e-62 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.464 | 0.440 | 0.456 | 2.9e-62 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.451 | 0.370 | 0.438 | 2.9e-56 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.515 | 0.382 | 0.396 | 1.4e-54 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.502 | 0.343 | 0.373 | 3.2e-52 |
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1484 (527.5 bits), Expect = 4.1e-152, P = 4.1e-152
Identities = 279/368 (75%), Positives = 318/368 (86%)
Query: 26 NSKVKGT-GSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRN--ESQRPKEEWEIDLSK 82
N + +G G+ S KDM+FRADKIDLK+LD+QLEKHLS VWSR+ + +PKEEWEI+L+K
Sbjct: 14 NLRNRGADGNNSKKDMIFRADKIDLKNLDIQLEKHLSRVWSRSIEKHPKPKEEWEIELAK 73
Query: 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
L+MRN+IA+G YG VY+G YD Q+VAVK+LDWGEDG ATTAET+ALR+SF+QEVAVW KL
Sbjct: 74 LEMRNVIARGAYGIVYKGIYDGQDVAVKVLDWGEDGYATTAETSALRASFRQEVAVWHKL 133
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNXXXXXXXXXXXXEYLPGGNLKQYLIRNRRK 202
DHPNVT+FVGAS+GT+NLKIPS S + EY+PGG LKQYL RNRRK
Sbjct: 134 DHPNVTRFVGASMGTANLKIPS---SAETENSLPQRACCVVVEYIPGGTLKQYLFRNRRK 190
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
KLA K+V+QLALDLSRGLSYLHS++IVHRDVKTENMLLD QR LKIADFGVARVEAQNP+
Sbjct: 191 KLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLLDYQRNLKIADFGVARVEAQNPK 250
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
DMTGETGTLGYMAPEVL GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ
Sbjct: 251 DMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 310
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQATGCF 382
NLRP+IPRCCP++LA IM++CW+AN EKRPEM EVV +LEA+DT+KGGGMIPEDQ GCF
Sbjct: 311 NLRPDIPRCCPTALATIMKRCWEANPEKRPEMEEVVSLLEAVDTTKGGGMIPEDQRPGCF 370
Query: 383 CFSPVRGP 390
CF RGP
Sbjct: 371 CFVSGRGP 378
|
|
| TAIR|locus:2130230 AT4G14780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1393 (495.4 bits), Expect = 1.8e-142, P = 1.8e-142
Identities = 263/368 (71%), Positives = 302/368 (82%)
Query: 25 VNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRNESQRPK--EEWEIDLSK 82
+ K + G+ ++K+ +FRADKIDLKSLD QLEKHLS VWSRN PK EEWEIDL+K
Sbjct: 1 MEKKSEEDGNNTTKEKIFRADKIDLKSLDRQLEKHLSRVWSRNLEVNPKAKEEWEIDLAK 60
Query: 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
L+ N+IA+GTYG+VY+G YD Q+VAVK+LDW +DG TTA+TA R+ F+QEV VW KL
Sbjct: 61 LETSNVIARGTYGTVYKGIYDGQDVAVKVLDWEDDGNETTAKTATNRALFRQEVTVWHKL 120
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNXXXXXXXXXXXXEYLPGGNLKQYLIRNRRK 202
+HPNVTKFVGAS+GT+NL I S D EYLPGG LKQ+LIR++ K
Sbjct: 121 NHPNVTKFVGASMGTTNLNI----RSADSKGSLPQQACCVVVEYLPGGTLKQHLIRHKSK 176
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
KLA K VI+LALDL+RGLSYLHS+KIVHRDVKTENMLLD+Q+ LKIADFGVARVEA NP+
Sbjct: 177 KLAFKAVIKLALDLARGLSYLHSEKIVHRDVKTENMLLDAQKNLKIADFGVARVEALNPK 236
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
DMTGETGTLGYMAPEV+ GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF DVSSAVV
Sbjct: 237 DMTGETGTLGYMAPEVIDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFVDVSSAVVLH 296
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQATGCF 382
NLRPEIPRCCP++LA IM+ CWD N +KRPEM EVVKMLE +DTSKGGGMIPEDQ+ GCF
Sbjct: 297 NLRPEIPRCCPTALAGIMKTCWDGNPQKRPEMKEVVKMLEGVDTSKGGGMIPEDQSRGCF 356
Query: 383 CFSPVRGP 390
CF+P RGP
Sbjct: 357 CFAPARGP 364
|
|
| TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 8.5e-134, Sum P(2) = 8.5e-134
Identities = 231/323 (71%), Positives = 270/323 (83%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAA 127
E ++ + EWEID SKL ++++IA+GT+G+V+RG YD Q+VAVKLLDWGE+G + AE A+
Sbjct: 93 EVEKSRREWEIDPSKLIIKSVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEIAS 152
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNXXXXXXXXXXXXEYL 187
LR++F QEVAVW KLDHPNVTKF+GA++GTS + I ++ +G EY
Sbjct: 153 LRAAFTQEVAVWHKLDHPNVTKFIGAAMGTSEMSIQTE----NGQMGMPSNVCCVVVEYC 208
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
PGG LK +LI+ RR+KLA K+VIQL+LDL+RGLSYLHS+KIVHRDVKTENMLLD RTLK
Sbjct: 209 PGGALKSFLIKTRRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLK 268
Query: 248 IADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
IADFGVAR+EA NP DMTGETGTLGYMAPEVL G PYNR+CDVYSFGICLWEIYCCDMPY
Sbjct: 269 IADFGVARLEASNPNDMTGETGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPY 328
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
PDLSF++V+SAVVRQNLRPEIPRCCPSSLAN+M++CWDAN EKRPEM EVV MLEAIDTS
Sbjct: 329 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPEKRPEMEEVVAMLEAIDTS 388
Query: 368 KGGGMIPEDQATGCFCFSPVRGP 390
KGGGMIP DQ GCFCF RGP
Sbjct: 389 KGGGMIPPDQQQGCFCFRRHRGP 411
|
|
| TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1210 (431.0 bits), Expect = 9.9e-131, Sum P(2) = 9.9e-131
Identities = 222/321 (69%), Positives = 265/321 (82%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALR 129
++ + EWEID SKL ++ ++A+GT+G+V+RG YD Q+VAVKLLDWGE+G + AE +LR
Sbjct: 69 RKQRLEWEIDPSKLIIKTVLARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSEAEIVSLR 128
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNXXXXXXXXXXXXEYLPG 189
+ F QEVAVW KLDHPNVTKF+GA++G S L++ +++ G EYLPG
Sbjct: 129 ADFAQEVAVWHKLDHPNVTKFIGATMGASGLQLQTES----GPLAMPNNICCVVVEYLPG 184
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G LK YLI+NRR+KL KIV+QLALDL+RGLSYLHS+KIVHRDVKTENMLLD RT+KIA
Sbjct: 185 GALKSYLIKNRRRKLTFKIVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIA 244
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309
DFGVARVEA NP DMTGETGTLGYMAPEVL G PYNR+CDVYSFGICLWEIYCCDMPYPD
Sbjct: 245 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 304
Query: 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369
L+F++V+SAVVRQNLRP+IPRCCPS+LA +M++CWDAN +KRPEM EVV MLE+IDT+KG
Sbjct: 305 LTFSEVTSAVVRQNLRPDIPRCCPSALAAVMKRCWDANPDKRPEMDEVVPMLESIDTTKG 364
Query: 370 GGMIPEDQATGCFCFSPVRGP 390
GGMIP DQ GC CF RGP
Sbjct: 365 GGMIPNDQQQGCLCFRRKRGP 385
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 245/375 (65%), Positives = 294/375 (78%)
Query: 23 GSVNSKVKGTGSLSS-KDMLFRADKIDLKSLDMQL-EKHLSWVWSRNES-QRPK---EEW 76
G+ + K+ GTGS S+ ++ FRAD +D D+ + + S V + + S P +EW
Sbjct: 17 GTADPKIGGTGSRSAGEERYFRADTLDFSKWDLHMGQTSTSSVLTNSASTSAPAPAMQEW 76
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
EIDLSKLDM++++A GTYG+VYRG Y QEVAVK+LDWGEDG AT AET ALR+SF+QEV
Sbjct: 77 EIDLSKLDMKHVLAHGTYGTVYRGVYAGQEVAVKVLDWGEDGYATPAETTALRASFEQEV 136
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIP-SKTASVDGNXXXXXXXXXXXXEYLPGGNLKQY 195
AVWQKLDHPNVTKF+GAS+GTS+L+IP + GN EY+ GG LK++
Sbjct: 137 AVWQKLDHPNVTKFIGASMGTSDLRIPPAGDTGGRGNGAHPARACCVVVEYVAGGTLKKF 196
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
LI+ R KL +K VIQLALDL+RGLSYLHSK IVHRDVK+ENMLL +TLKIADFGVAR
Sbjct: 197 LIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLLQPNKTLKIADFGVAR 256
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
VEAQNP+DMTGETGTLGYMAPEVL+GKPYNR+CDVYSFG+CLWEIYCCDMPY D SFA++
Sbjct: 257 VEAQNPQDMTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEIYCCDMPYADCSFAEI 316
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPE 375
S AVV +NLRPEIP+CCP ++ANIM++CWD N ++RPEM EVVK+LEAIDTSKGGGMI
Sbjct: 317 SHAVVHRNLRPEIPKCCPHAVANIMKRCWDPNPDRRPEMEEVVKLLEAIDTSKGGGMIAP 376
Query: 376 DQATGCFCFSPVRGP 390
DQ GC CF RGP
Sbjct: 377 DQFQGCLCFFKPRGP 391
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 1.8e-62, Sum P(2) = 1.8e-62
Identities = 80/182 (43%), Positives = 127/182 (69%)
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
EY GG+++Q+L + + + + LK+ + ALD++RG++Y+H + +HRD+K++N+L+ + R
Sbjct: 210 EYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLISADR 269
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
++KIADFGVAR+E Q MT ETGT +MAPE++Q +PY ++ DVYSFGI LWE+
Sbjct: 270 SIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL 328
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+P+ +++ + AVV + +RP +P C L IM +CWDA+ E RP E+V +LEA
Sbjct: 329 LPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLEAA 388
Query: 365 DT 366
+T
Sbjct: 389 ET 390
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 2.9e-62, Sum P(2) = 2.9e-62
Identities = 83/182 (45%), Positives = 131/182 (71%)
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
EY GG+++Q+L R + + + LK+ ++ ALD++RG++Y+H + +HRD+K++N+L+ + +
Sbjct: 209 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADK 268
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
++KIADFGVAR+E Q MT ETGT +MAPE++Q + YN++ DVYSFGI LWE+
Sbjct: 269 SIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGL 327
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+P+ +++ + AVV + +RP +P C L++IM +CWDAN E RP EVVK+LEA
Sbjct: 328 LPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEAA 387
Query: 365 DT 366
+T
Sbjct: 388 ET 389
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 2.9e-56, Sum P(2) = 2.9e-56
Identities = 79/180 (43%), Positives = 127/180 (70%)
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
EY+P G+L+ YL + +K L L+ +I LD+++G+ Y+HS++IVH+D+K EN+L+D+
Sbjct: 239 EYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLIDNDF 298
Query: 245 TLKIADFGVARVEAQNPRDMTGET-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
LKIADFG+A E D+ G+ GT +MAPEVL+ P+ R+CDVYSFG+ LWE+
Sbjct: 299 HLKIADFGIACEEEYC--DVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWEMVAG 356
Query: 304 DMPYPDLSFAD-VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+PY ++ FA+ ++ AV+ + +RP IP CP+++ ++ +CW + +KRPE ++VK+LE
Sbjct: 357 ALPYEEMKFAEQIAYAVIYKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIVKVLE 416
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 1.4e-54, Sum P(2) = 1.4e-54
Identities = 82/207 (39%), Positives = 135/207 (65%)
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
+YLP G+L+ +L + + L LK +I+ A+D++RG+ Y+HS++I+HRD+K EN+L+D +
Sbjct: 288 QYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLIDEEF 347
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
LKIADFG+A E + + + GT +MAPE+++ KP+ R+ DVYSFG+ LWE+
Sbjct: 348 HLKIADFGIA-CEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEMVAGA 406
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE-- 362
+PY D++ + AVV +N+RP IP CP ++ ++ +CW +KRPE ++VK+LE
Sbjct: 407 IPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPEFWQIVKVLEQF 466
Query: 363 AIDTSKGGGMIPEDQATGCFCFSPVRG 389
AI + G + + ++ C P +G
Sbjct: 467 AISLEREGNL---NLSSSKICKDPRKG 490
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 3.2e-52, Sum P(2) = 3.2e-52
Identities = 74/198 (37%), Positives = 125/198 (63%)
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
E++ G++ +L +++ ++ ++++ALD+S+G++YLH I+HRD+KT N+L+D
Sbjct: 367 EFMTRGSIYDFLHKHKGV-FKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHE 425
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
+K+ADFGVARV+ ++ MT ETGT +MAPEV++ KPY+ R DV+S+ I LWE+ +
Sbjct: 426 VVKVADFGVARVQTESGV-MTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGE 484
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+PY L+ + VV++ LRP+IP+ L ++ KCW + RP E+++ML +
Sbjct: 485 LPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQL 544
Query: 365 DTSKGGGMIPEDQATGCF 382
G +D+ G F
Sbjct: 545 IREVGDDERHKDKHGGYF 562
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 390 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-72 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-72 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-71 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-53 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-47 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-45 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-44 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-42 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-41 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-41 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-40 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-39 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-39 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-39 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-36 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-36 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-36 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-35 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-35 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-34 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-33 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-32 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-32 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-31 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-31 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-30 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-30 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-30 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-29 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-29 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-29 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-28 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-28 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-28 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-28 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-28 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-28 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-28 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-27 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-27 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-27 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-26 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-25 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-25 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-24 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-24 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-23 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-22 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-22 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-22 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-21 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-21 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-19 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 5e-72
Identities = 91/287 (31%), Positives = 143/287 (49%), Gaps = 37/287 (12%)
Query: 83 LDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
L + + +G +G VY+GT EVAVK + F +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK--------TLKEDASEQQIEEFLREA 52
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
+ +KLDHPN+ K +G L +V+EY+PGG+L YL
Sbjct: 53 RIMRKLDHPNIVKLLGVCTEEEPL--------------------MIVMEYMPGGDLLDYL 92
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
+NR K+L+L ++ AL ++RG+ YL SK +HRD+ N L+ +KI+DFG++R
Sbjct: 93 RKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152
Query: 257 EAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPYPDLSFAD 314
+ + G + +MAPE L+ + + DV+SFG+ LWEI+ + PYP +S A+
Sbjct: 153 LYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
V +++ R P CP L +M +CW + E RP E+V++L
Sbjct: 213 V-LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 7e-72
Identities = 90/282 (31%), Positives = 138/282 (48%), Gaps = 39/282 (13%)
Query: 89 IAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+ +G +G VY+GT +VAVK L E R F +E ++ +KL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK--EGASE------EEREEFLEEASIMKKL 58
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
HPN+ + +G L +V EY+PGG+L +L R +
Sbjct: 59 SHPNIVRLLGVCTQGEPL--------------------YIVTEYMPGGDLLDFL-RKHGE 97
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
KL LK ++Q+AL +++G+ YL SK VHRD+ N L+ +KI+DFG++R ++
Sbjct: 98 KLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY 157
Query: 263 DMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAV 319
G L +MAPE L+ + + DV+SFG+ LWEI+ + PYP +S +V
Sbjct: 158 YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL- 216
Query: 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
+ R P CP L +M +CW + E RP E+V+ L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 223 bits (572), Expect = 2e-71
Identities = 89/283 (31%), Positives = 135/283 (47%), Gaps = 42/283 (14%)
Query: 89 IAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+ +G +G VY+G EVAVK + F +E + +KL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVK--------TLKEDASEQQIEEFLREARIMRKL 58
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
DHPNV K +G L +V+EY+ GG+L YL R R
Sbjct: 59 DHPNVVKLLGVCTEEEPL--------------------YIVMEYMEGGDLLSYL-RKNRP 97
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
KL+L ++ AL ++RG+ YL SK +HRD+ N L+ +KI+DFG++R
Sbjct: 98 KLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDD 155
Query: 263 DMTGETGTLG---YMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPYPDLSFADVSSA 318
D + G +MAPE L+ + + DV+SFG+ LWEI+ + PYP +S +V
Sbjct: 156 DYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LE 214
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
++ R P CP L ++M +CW + E RP E+V++L
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 8e-71
Identities = 94/291 (32%), Positives = 139/291 (47%), Gaps = 44/291 (15%)
Query: 87 NLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ +G +G VY+G EVAVK L A+ E R F +E V +K
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK----EDASEEE----RKDFLKEARVMKK 52
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR- 200
L HPNV + +G L +V+EY+ GG+L YL ++R
Sbjct: 53 LGHPNVVRLLGVCTEEEPL--------------------YLVLEYMEGGDLLDYLRKSRP 92
Query: 201 ------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+ L+LK ++ A+ +++G+ YL SKK VHRD+ N L+ +KI+DFG++
Sbjct: 93 VFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
Query: 255 RVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311
R + G L +MAPE L+ + + DV+SFG+ LWEI+ PYP LS
Sbjct: 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+V +R+ R P CP L +M CW + E RP E+V+ LE
Sbjct: 213 NEEVLEY-LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 2e-66
Identities = 76/281 (27%), Positives = 122/281 (43%), Gaps = 35/281 (12%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ + +G++G VY + VA+K++ + R +E+ + +K
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--------KKKIKKDRERILREIKILKK 53
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN+ + L +V+EY GG+L L +R
Sbjct: 54 LKHPNIVRLYDVFEDEDKL--------------------YLVMEYCEGGDLFDLL--KKR 91
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
+L+ + L YLHSK IVHRD+K EN+LLD +K+ADFG+AR +
Sbjct: 92 GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPG 150
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
+T GT YMAPEVL GK Y + D++S G+ L+E+ P+P +
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 322 QNLRPEIPRC--CPSSLANIMRKCWDANAEKRPEMGEVVKM 360
+ P P +++RK + EKR E ++
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 2e-62
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 66/277 (23%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
+ +G +G+VY ++VA+K++ ++++L +E+ + +KL+HPN
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK--------KEDSSSLLEELLREIEILKKLNHPN 52
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ K G ++L +V+EY GG+LK ++ KL+
Sbjct: 53 IVKLYGVFEDENHL--------------------YLVMEYCEGGSLKDL-LKENEGKLSE 91
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS-QRTLKIADFGVARVEAQNPRDMT 265
++++ L + GL YLHS I+HRD+K EN+LLDS +K+ADFG++++ + +
Sbjct: 92 DEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151
Query: 266 GETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324
GT YMAPEVL GK Y+ + D++S G+ L+E+
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187
Query: 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
L +++RK + EKRP E+++ L
Sbjct: 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-59
Identities = 82/280 (29%), Positives = 139/280 (49%), Gaps = 39/280 (13%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
+ G++G+VY+ + + VAVK+L +E + + ++E+ + ++L HPN
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILK-------KRSEKSKKDQTARREIRILRRLSHPN 59
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ + + A +L +V+EY GG+L YL R L+
Sbjct: 60 IVRLIDAFEDKDHL--------------------YLVMEYCEGGDLFDYLSRG--GPLSE 97
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
++AL + RGL YLHS I+HRD+K EN+LLD +KIADFG+A+ ++ +T
Sbjct: 98 DEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
Query: 267 ETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR 325
GT YMAPEVL G Y + DV+S G+ L+E+ P+ + D ++R+ L
Sbjct: 158 FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD-QLQLIRRILG 216
Query: 326 PEIP------RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P + ++++KC + + KRP E+++
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 6e-53
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 32/271 (11%)
Query: 87 NLIAQGTYGSVYRGTYDN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
L+ +G++GSVY + + +AVK ++ D + + ++E+ + L H
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-------SEEELEALEREIRILSSLQH 58
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ ++ G+ + N + +EY+ GG+L L + KL
Sbjct: 59 PNIVRYYGSER------------DEEKNT------LNIFLEYVSGGSLSSLL--KKFGKL 98
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
++ + + GL+YLHS IVHRD+K N+L+DS +K+ADFG A+
Sbjct: 99 PEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158
Query: 265 TGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-SFADVSSAVVR 321
+ GT +MAPEV++G+ Y R D++S G + E+ P+ +L + +
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
PEIP + +RKC + +KRP
Sbjct: 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 95/293 (32%), Positives = 142/293 (48%), Gaps = 41/293 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
W I+ +L + I +G +G V G Y Q+VAVK L +D A A F E
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK--DDSTAAQA--------FLAE 50
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+V L HPN+ + +G + + L I V EY+ G+L Y
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYI--------------------VTEYMAKGSLVDY 90
Query: 196 LIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
L R+R R + L + ALD+ G+ YL K VHRD+ N+L+ K++DFG+A
Sbjct: 91 L-RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
Query: 255 RVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-MPYPDLS 311
+ +Q ++G L + APE L+ K ++ + DV+SFGI LWEIY +PYP +
Sbjct: 150 KEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
DV V + R E P CP + +M+ CW+ + KRP ++ + L I
Sbjct: 205 LKDVVPHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 5e-47
Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 46/285 (16%)
Query: 87 NLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +G++G VY R D + +K +D + EV + +KL+H
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-------LNEVKILKKLNH 58
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK- 203
PN+ K+ + L C+V+EY GG+L I+ ++K+
Sbjct: 59 PNIIKYYESFEEKGKL--------------------CIVMEYADGGDL-SQKIKKQKKEG 97
Query: 204 ------LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
L +QL L L YLHS+KI+HRD+K +N+ L S +K+ DFG+++V
Sbjct: 98 KPFPEEQILDWFVQLCL----ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV- 152
Query: 258 AQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
+ D+ +T GT Y++PE+ Q KPYN + D++S G L+E+ P+ + ++
Sbjct: 153 LSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360
+ +++ P IP S L N++ + E+RP + ++++
Sbjct: 212 ALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 6e-46
Identities = 87/282 (30%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 88 LIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAET--AALRSSFQQEVAVWQKLDH 144
I +G +G VY+G N EVAVK T T L+ F QE + ++ DH
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK----------TCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ K +G V + I V+E +PGG+L +L R ++ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYI--------------------VMELVPGGSLLTFL-RKKKNRL 90
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+K ++Q++LD + G+ YL SK +HRD+ N L+ LKI+DFG++R E +
Sbjct: 91 TVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150
Query: 265 TGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVR 321
+ + + APE L Y DV+S+GI LWE + D PYP +S +
Sbjct: 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES 210
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
R P+ CP + +M +CW + E RP E+ L+
Sbjct: 211 -GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 42/271 (15%)
Query: 89 IAQGTYGSVYRGTYDN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G +G VY+ + +EVA+K++ E+ + E+ + +K HPN
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK---------LESKEKKEKIINEIQILKKCKHPN 58
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ K+ G+ + L I V+E+ GG+LK L+++ + L
Sbjct: 59 IVKYYGSYLKKDELWI--------------------VMEFCSGGSLKD-LLKSTNQTLTE 97
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVEAQNPRDMT 265
+ + +L +GL YLHS I+HRD+K N+LL S +K+ DFG++ ++ R+
Sbjct: 98 SQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR 325
GT +MAPEV+ GKPY+ + D++S GI E+ PY +L + + N
Sbjct: 158 --VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-MKALFKIATNGP 214
Query: 326 PEIPRCCPS----SLANIMRKCWDANAEKRP 352
P + P + ++KC N EKRP
Sbjct: 215 PGLR--NPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 85/298 (28%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQ 133
WE++ + + M++ + G YG VY G + + VAVK L ED M F
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEV--------EEFL 50
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+E AV +++ HPN+ + +G I + E++ GNL
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYI--------------------ITEFMTYGNLL 90
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
YL R+++ +++ +A +S + YL K +HRD+ N L+ +K+ADFG+
Sbjct: 91 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 150
Query: 254 ARVEAQNPRDMTGETGT--------LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM 305
+R+ MTG+T T + + APE L ++ + DV++FG+ LWEI M
Sbjct: 151 SRL-------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203
Query: 306 -PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
PYP + + V ++ + R E P CP + +MR CW N RP E+ + E
Sbjct: 204 SPYPGIDLSQVYE-LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-44
Identities = 86/288 (29%), Positives = 146/288 (50%), Gaps = 37/288 (12%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
W ++L KL + +I +G +G+V +G Y Q+VAVK + TA+ +F +E
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK-----CDVTAQ------AFLEE 49
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
AV KL H N+ + +G + +V+E + GNL +
Sbjct: 50 TAVMTKLHHKNLVRLLGV---------------------ILHNGLYIVMELMSKGNLVNF 88
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
L R +++ ++Q +LD++ G+ YL SKK+VHRD+ N+L+ K++DFG+AR
Sbjct: 89 LRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-MPYPDLSFAD 314
V + + + APE L+ K ++ + DV+S+G+ LWE++ PYP +S +
Sbjct: 149 V---GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
V V + R E P CP+ + +M CW+ +KRP ++ + LE
Sbjct: 206 VKEC-VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 90/309 (29%), Positives = 143/309 (46%), Gaps = 53/309 (17%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAAL 128
WE+ K+ + + QG++G VY G VA+K T E A++
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK----------TVNENASM 50
Query: 129 --RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
R F E +V ++ + +V + +G + S G + VV+E
Sbjct: 51 RERIEFLNEASVMKEFNCHHVVRLLG---------VVST-----GQPTL------VVMEL 90
Query: 187 LPGGNLKQYLIRNRRKK---------LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+ G+LK YL R+RR + L+ IQ+A +++ G++YL +KK VHRD+ N
Sbjct: 91 MAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149
Query: 238 MLLDSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
++ T+KI DFG+ R E R + +MAPE L+ + + DV+SFG+
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209
Query: 296 CLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354
LWE+ + PY LS +V V+ ++P CP L +MR CW N + RP
Sbjct: 210 VLWEMATLAEQPYQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTF 268
Query: 355 GEVVKMLEA 363
E+V L+
Sbjct: 269 LEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-41
Identities = 88/288 (30%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 87 NLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+I +G +G VY GT AVK L+ D E F +E + +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEV----EQFLKEGIIMKD 52
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
HPNV +G + + + VV+ Y+ G+L+ + IR+
Sbjct: 53 FSHPNVLSLLGICLPSEGSPL-------------------VVLPYMKHGDLRNF-IRSET 92
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR----VE 257
+K +I L +++G+ YL SKK VHRD+ N +LD T+K+ADFG+AR E
Sbjct: 93 HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVS 316
+ + TG + +MA E LQ + + + DV+SFG+ LWE+ PYPD+ D++
Sbjct: 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212
Query: 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
++ Q R P CP L +M CW E RP E+V +E I
Sbjct: 213 VYLL-QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 88/318 (27%), Positives = 141/318 (44%), Gaps = 54/318 (16%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---DNQE----VAVKLLDWGEDGMATTAE 124
EWE+ +L + + +G +G V + DN VAVK+L AT +
Sbjct: 3 LDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK----DDATEKD 58
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
+ L S + + + H N+ +G L VVV
Sbjct: 59 LSDLVSEMEMMKMIGK---HKNIINLLGVCTQEGPLY--------------------VVV 95
Query: 185 EYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVH 230
EY GNL+ +L R + L K ++ A ++RG+ +L SKK +H
Sbjct: 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIH 155
Query: 231 RDVKTENMLLDSQRTLKIADFGVAR-VEAQNPRDMTGETGTLGY--MAPEVLQGKPYNRR 287
RD+ N+L+ +KIADFG+AR + + T G L MAPE L + Y +
Sbjct: 156 RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN-GRLPVKWMAPEALFDRVYTHQ 214
Query: 288 CDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA 346
DV+SFG+ LWEI+ PYP + ++ ++++ R E P+ C L ++MR CW
Sbjct: 215 SDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLKEGYRMEKPQNCTQELYHLMRDCWHE 273
Query: 347 NAEKRPEMGEVVKMLEAI 364
+RP ++V+ L+ +
Sbjct: 274 VPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 40/284 (14%)
Query: 88 LIAQGTYGSVYRGTYDNQ-----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+ G++G V RG + VAVK L D ++ + F +E A+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLS------DIMDDFLKEAAIMHSL 53
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
DH N+ + G V T L + V E P G+L L ++
Sbjct: 54 DHENLIRLYGV-VLTHPLMM--------------------VTELAPLGSLLDRLRKDALG 92
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
+ + A+ ++ G+ YL SK+ +HRD+ N+LL S +KI DFG+ R QN
Sbjct: 93 HFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN-E 151
Query: 263 DMTGETGTL----GYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSS 317
D L + APE L+ + ++ DV+ FG+ LWE++ + P+ LS + +
Sbjct: 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211
Query: 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
+ ++ R E P CP + N+M +CW N RP + + L
Sbjct: 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 76/306 (24%), Positives = 142/306 (46%), Gaps = 60/306 (19%)
Query: 87 NLIAQGTYGSVYRGTYDNQ------EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
+ +G +G V YD +VAVK L+ + RS F++E+ + +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--------HSGEEQHRSDFEREIEILR 61
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
LDH N+ K+ G R+ +++EYLP G+L+ YL R+R
Sbjct: 62 TLDHENIVKYKGVCEKPGG------------------RSLRLIMEYLPSGSLRDYLQRHR 103
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV---- 256
++ LK ++ + + +G+ YL S++ +HRD+ N+L++S+ +KI+DFG+A+V
Sbjct: 104 -DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
Query: 257 ----EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI--YCCDMPYPDL 310
+ P + + + APE L+ ++ DV+SFG+ L+E+ Y P
Sbjct: 163 KDYYYVKEPGES-----PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217
Query: 311 SFADVSSAVVRQNL------------RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
F + Q + R P CP + ++M+ CW+A + RP +++
Sbjct: 218 EFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
Query: 359 KMLEAI 364
+++ +
Sbjct: 278 LIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 86/279 (30%), Positives = 136/279 (48%), Gaps = 33/279 (11%)
Query: 88 LIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
L+ +G +G V++GT D VAVK ED L+ F E + ++ DHPN
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCK--ED------LPQELKIKFLSEARILKQYDHPN 53
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ K +G + I V+E +PGG+ +L R ++ +L
Sbjct: 54 IVKLIGVCTQRQPIYI--------------------VMELVPGGDFLSFL-RKKKDELKT 92
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
K +++ ALD + G++YL SK +HRD+ N L+ LKI+DFG++R E +G
Sbjct: 93 KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152
Query: 267 -ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSSAVVRQNL 324
+ + + APE L Y+ DV+S+GI LWE + + PYP ++ V +
Sbjct: 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GY 211
Query: 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
R P+ CP + +M++CWD E RP+ E+ K L A
Sbjct: 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-39
Identities = 90/298 (30%), Positives = 141/298 (47%), Gaps = 42/298 (14%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE-----VAVKLLDWGEDGMATTAETAALRS 130
+EI + + I +G +G VY+G Y + E VAVK + ++R
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK--------TCKNCTSPSVRE 52
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
F QE + ++ DHP++ K +G V T N P +V+E P G
Sbjct: 53 KFLQEAYIMRQFDHPHIVKLIG--VITEN---PV----------------WIVMELAPLG 91
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L+ YL N+ L L +I + LS L+YL SK+ VHRD+ N+L+ S +K+ D
Sbjct: 92 ELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGD 150
Query: 251 FGVAR-VEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-P 306
FG++R +E ++ G L +MAPE + + + DV+ FG+C+WEI + P
Sbjct: 151 FGLSRYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ + DV + R +P CP +L ++M KCW + KRP E+ L I
Sbjct: 209 FQGVKNNDVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 39/289 (13%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
ID S+L + G +G V+ G + + +VA+K++ G +E F +E
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-----AMSE-----DDFIEEA 50
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V KL HPN+ + G V T R +V EY+ G L YL
Sbjct: 51 KVMMKLSHPNLVQLYG--VCTKQ------------------RPIFIVTEYMANGCLLNYL 90
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
R R+ KL + ++ + D+ + YL S +HRD+ N L+ +K++DFG+AR
Sbjct: 91 -RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149
Query: 257 EAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSF 312
+ T GT + + PEV ++ + DV+SFG+ +WE++ MPY S
Sbjct: 150 VLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207
Query: 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
++V + V R P+ P+ + IM CW E RP +++ L
Sbjct: 208 SEVVES-VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 82/275 (29%), Positives = 137/275 (49%), Gaps = 36/275 (13%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G+YGSVY+ DNQ A+K +D G + + R E+ + ++HP
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLG-------SMSQKEREDAVNEIRILASVNHP 59
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ + K A +DGN C+V+EY P G+L + + + ++K+
Sbjct: 60 NIISY--------------KEAFLDGNK------LCIVMEYAPFGDLSKAISKRKKKRKL 99
Query: 206 LK--IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ + ++ + L RGL LH +KI+HRD+K+ N+LL + +KI D G+++V +N
Sbjct: 100 IPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156
Query: 264 MT-GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
M + GT YMAPEV +G+PY+ + D++S G L+E+ P+ S D+ V R
Sbjct: 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG 216
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
P IP L N +R + RP ++
Sbjct: 217 KY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-38
Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 41/285 (14%)
Query: 89 IAQGTYGSVYRGTY---DNQE--VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD 143
+ G +GSV +G Y +E VAVK L AA + F +E +V +LD
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--------IAAGKKEFLREASVMAQLD 54
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
HP + + +G G +V+E P G L +YL + R +
Sbjct: 55 HPCIVRLIGVCKG---------------------EPLMLVMELAPLGPLLKYLKKRR--E 91
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ + + +LA ++ G++YL SK VHRD+ N+LL ++ KI+DFG++R
Sbjct: 92 IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
Query: 264 MTGETG---TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAV 319
T L + APE + ++ + DV+S+G+ LWE + PY ++ A+V A+
Sbjct: 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAM 210
Query: 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ R P CP + +IM CW E RP E+
Sbjct: 211 LESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 77/292 (26%), Positives = 143/292 (48%), Gaps = 55/292 (18%)
Query: 88 LIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
LI G++GSVY G + +AVK ++ ++ ++ + +E+A+ ++L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN----LKQY------ 195
N+ +++G+S+ +L I +EY+PGG+ L Y
Sbjct: 67 NIVQYLGSSLDADHLNI--------------------FLEYVPGGSVAALLNNYGAFEET 106
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
L+RN +++ +GL+YLH++ I+HRD+K N+L+D++ +KI+DFG+++
Sbjct: 107 LVRNFVRQIL------------KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154
Query: 256 VEAQNPRDMTGET------GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309
N G++ +MAPEV++ Y R+ D++S G + E+ P+PD
Sbjct: 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
Query: 310 LSFADVSSAVVR--QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
A+ + +N PEIP S + + K ++ + KRP E++K
Sbjct: 215 C---TQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 84/282 (29%), Positives = 130/282 (46%), Gaps = 38/282 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEI L + + G +G V+ GT++ +VAVK L G M+ A F Q
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEA--------FLQ 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + +KL H + + + I V EY+ G+L
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYI--------------------VTEYMSKGSLLD 90
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L KKL L ++ +A ++ G++YL S+ +HRD+ N+L+ KIADFG+A
Sbjct: 91 FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310
R+ + + T G + + APE + + DV+SFGI L EI +PYP +
Sbjct: 151 RLIEDD--EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ +V V R R P CP L ++M +CWD + E+RP
Sbjct: 209 TNREVLEQVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 8e-37
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 51/307 (16%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSS 131
E+ + + + G +G VY G Y D E+ V + E + S
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC------SEQDESD 55
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F E + K +H N+ + +G S +P +++E + GG+
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSF-----------------ERLPR---FILLELMAGGD 95
Query: 192 LKQYLIRNRRK-----KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS---Q 243
LK +L NR + L +K ++ A D+++G YL +HRD+ N LL
Sbjct: 96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG 155
Query: 244 RTLKIADFGVAR------VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
R KIADFG+AR + R M + +M PE + + DV+SFG+ L
Sbjct: 156 RVAKIADFGMARDIYRASYYRKGGRAML----PIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 298 WEIYCCD-MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
WEI+ MPYP + +V V R + P+ CP + IM CW E RP
Sbjct: 212 WEIFSLGYMPYPGRTNQEVMEFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270
Query: 357 VVKMLEA 363
+++ ++
Sbjct: 271 ILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 75/276 (27%), Positives = 133/276 (48%), Gaps = 38/276 (13%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ N I +G++G V++ D + A+K +D M A+ E V K
Sbjct: 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAID-----EARVLAK 55
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
LD + ++ + + L +V+EY G+L + L R
Sbjct: 56 LDSSYIIRYYESFLDKGKL--------------------NIVMEYAENGDLHKLLKMQRG 95
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
+ L V + + + GL++LHSKKI+HRD+K+ N+ LD+ +KI D GVA++ + N
Sbjct: 96 RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF-ADVSSAVV 320
GT Y++PE+ + KPYN + DV++ G+ L+E CC +P F A+ A++
Sbjct: 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTGKHP---FDANNQGALI 210
Query: 321 RQNLR---PEIPRCCPSSLANIMRKCWDANAEKRPE 353
+ +R P + + LA ++ +C + +RP+
Sbjct: 211 LKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 83/287 (28%), Positives = 126/287 (43%), Gaps = 50/287 (17%)
Query: 87 NLIAQGTYGSVYRGTYDN--------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV 138
N + G +G VY GT + VAVK L G AT E + F +E +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQE----KKEFLKEAHL 52
Query: 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR 198
+HPN+ K +G + I ++E + GG+L YL
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYI--------------------IMELMEGGDLLSYLRD 92
Query: 199 NRRKK-----LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL-----DSQRTLKI 248
R ++ L LK ++ + LD+++G YL +HRD+ N L+ D+ R +KI
Sbjct: 93 ARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152
Query: 249 ADFGVARVEAQNPRDMTGETGTLG--YMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DM 305
DFG+AR ++ G L +MAPE L + + DV+SFG+ +WEI
Sbjct: 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
PYP L+ +V V R + P CP + +M CW + +RP
Sbjct: 213 PYPALNNQEV-LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 83/282 (29%), Positives = 134/282 (47%), Gaps = 39/282 (13%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAET--AALRSSFQQEVAVWQKLDH 144
I +G +G V+ G DN VAVK + ET L++ F QE + ++ H
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK----------SCRETLPPDLKAKFLQEARILKQYSH 52
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ + +G + I V+E + GG+ +L R +L
Sbjct: 53 PNIVRLIGVCTQKQPIYI--------------------VMELVQGGDFLTFL-RTEGPRL 91
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+K +IQ+ + + G+ YL SK +HRD+ N L+ + LKI+DFG++R E
Sbjct: 92 KVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151
Query: 265 TG--ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVR 321
TG + + + APE L Y+ DV+SFGI LWE + +PY +LS A +
Sbjct: 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-IE 210
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
Q +R P CP ++ +M +CW+ + +RP V + L++
Sbjct: 211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (336), Expect = 3e-36
Identities = 71/218 (32%), Positives = 109/218 (50%), Gaps = 41/218 (18%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GTYG VY+ + VA+K LD E+G+ +TA LR E+++ ++L H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA----LR-----EISLLKELKH 57
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ K + V + K+ +V EY +LK+YL R L
Sbjct: 58 PNIVKLL--DVIHTERKL------------------YLVFEYCDM-DLKKYL-DKRPGPL 95
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+ ++ + L RGL+Y HS +I+HRD+K +N+L++ LK+ADFG+AR R
Sbjct: 96 SPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
T E TL Y APE+L G YS + +W + C
Sbjct: 156 THEVVTLWYRAPEILLG------SKHYSTAVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (336), Expect = 1e-35
Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 50/295 (16%)
Query: 88 LIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP-N 146
+ +G++G VY D + VA+K+L + F +E+ + L+HP N
Sbjct: 7 KLGEGSFGEVYLA-RDRKLVALKVLA------KKLESKSKEVERFLREIQILASLNHPPN 59
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL-IRNRRKKLA 205
+ K +L + V+EY+ GG+L+ L R+ L+
Sbjct: 60 IVKLYDFFQDEGSLYL--------------------VMEYVDGGSLEDLLKKIGRKGPLS 99
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT-LKIADFGVARV------EA 258
+ + + L YLHSK I+HRD+K EN+LLD +K+ DFG+A++ +
Sbjct: 100 ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159
Query: 259 QNPRDMTGETGTLGYMAPEVLQGK---PYNRRCDVYSFGICLWEIYCCDMPYPDLS---- 311
P + GT GYMAPEVL G + D++S GI L+E+ P+
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 312 -------FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++ + + L P P + +++++K + + R +
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 47/288 (16%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ G + S Y R +AVK + + + T++E + + ++E+ + +L+HP
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN---TSSEQEEVVEALRKEIRLMARLNHP 63
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
++ + +GA+ S+ + VE++ GG++ L ++
Sbjct: 64 HIIRMLGATCEDSHFNL--------------------FVEWMAGGSVSHLL--SKYGAFK 101
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ-RTLKIADFGVA-RVEAQNPRD 263
++I L RGLSYLH +I+HRDVK N+L+DS + L+IADFG A R+ A+
Sbjct: 102 EAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG- 160
Query: 264 MTGE-----TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD---- 314
GE GT+ +MAPEVL+G+ Y R CDV+S G + E+ P+ ++
Sbjct: 161 -AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL 219
Query: 315 ---VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++SA P IP L ++ +C + E RP E++K
Sbjct: 220 IFKIASA----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-35
Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 39/292 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
W +++ +L + I +G +G V G Y +VAVK + + A +F E
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----------KNDATAQAFLAE 49
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+V +L H N+ + +G V +V EY+ G+L Y
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKG-------------------GLYIVTEYMAKGSLVDY 90
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
L R L +++ +LD+ + YL + VHRD+ N+L+ K++DFG+ +
Sbjct: 91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
Query: 256 VEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-MPYPDLSF 312
EA + +D TG L + APE L+ K ++ + DV+SFGI LWEIY +PYP +
Sbjct: 151 -EASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205
Query: 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
DV V + + + P CP + ++M++CW +A RP ++ + LE I
Sbjct: 206 KDVVPR-VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 39/289 (13%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
I S+L + I G +G V+ G + + +VA+K T E A F +E
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIK----------TIREGAMSEEDFIEEA 50
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V KL HP + + G V T I C+V E++ G L YL
Sbjct: 51 QVMMKLSHPKLVQLYG--VCTERSPI------------------CLVFEFMEHGCLSDYL 90
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
R +R K + + ++ + LD+ G++YL S ++HRD+ N L+ + +K++DFG+ R
Sbjct: 91 -RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149
Query: 257 EAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312
+ T TGT + + +PEV Y+ + DV+SFG+ +WE++ PY + S
Sbjct: 150 VLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
Query: 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
++V + R PR S+ +M+ CW E RP ++ L
Sbjct: 208 SEVVET-INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV 138
S L+ ++ QG+ G VY+ + + A+K + D R +E+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE--------FRKQLLRELKT 52
Query: 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR 198
+ + P V K GA + +V+EY+ GG+L +
Sbjct: 53 LRSCESPYVVKCYGA---------------FYKEGEI-----SIVLEYMDGGSLAD--LL 90
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
+ K+ ++ +A + +GL YLH+K I+HRD+K N+L++S+ +KIADFG+++V
Sbjct: 91 KKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150
Query: 258 AQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL---SFA 313
D GT+ YM+PE +QG+ Y+ D++S G+ L E P+ SF
Sbjct: 151 ENT-LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209
Query: 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
++ A+ + + C + +KRP
Sbjct: 210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 52/276 (18%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G G VY+ T +EVA+K + + E+ + + HPN
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK----------ELIINEILIMKDCKHPN 76
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ + + + V VV+EY+ GG+L +I ++
Sbjct: 77 IVDYYDSYL-------------VGD-------ELWVVMEYMDGGSL-TDIITQNFVRMNE 115
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA---RVEAQNPRD 263
+ + ++ +GL YLHS+ ++HRD+K++N+LL ++K+ADFG A E
Sbjct: 116 PQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS-----FADVSSA 318
+ GT +MAPEV++ K Y + D++S GI E+ + PY F
Sbjct: 176 V---VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL----- 227
Query: 319 VVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRP 352
+ P + P + + KC + EKRP
Sbjct: 228 -ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 86/285 (30%), Positives = 131/285 (45%), Gaps = 44/285 (15%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEID + + + + G +G V+ G ++N VAVK L G T + F
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG------TMDPKD----FLA 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + +KL HP + + +V T I +V E + G+L +
Sbjct: 51 EAQIMKKLRHPKLIQLY--AVCTLEEPI------------------YIVTELMKYGSLLE 90
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
YL + L L +I +A ++ G++YL ++ +HRD+ N+L+ K+ADFG+A
Sbjct: 91 YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNR---RCDVYSFGICLWEIYC-CDMPY 307
RV ++ G + + APE YNR + DV+SFGI L EI MPY
Sbjct: 151 RVIKED--IYEAREGAKFPIKWTAPEAAL---YNRFSIKSDVWSFGILLTEIVTYGRMPY 205
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
P ++ A+V V Q R P CP L +IM CW + + RP
Sbjct: 206 PGMTNAEVLQQ-VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 55/301 (18%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRG-------TYDNQEVAVKLLDWGEDGMATTAETAALR 129
EI LS + + +G +G VY+G VA+K L + ++
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--------KVQ 52
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
F+QE + L HPN+ +G P C++ EYL
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVC-----------------TKEQPT---CMLFEYLAH 92
Query: 190 GNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
G+L ++L+RN + L + +A+ ++ G+ YL S VHRD+
Sbjct: 93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152
Query: 236 ENMLLDSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPE-VLQGKPYNRRCDVYS 292
N L+ T+KI+DFG++R A R + + +M PE +L GK + D++S
Sbjct: 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWS 211
Query: 293 FGICLWEIYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
FG+ LWEI+ + PY S +V + + L P P CP+ + +M +CW+ +R
Sbjct: 212 FGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARR 270
Query: 352 P 352
P
Sbjct: 271 P 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 39/282 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WE+ L + + G +G V+ G Y+ +VA+K L G + A F
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG------SMSPEA----FLA 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + ++L HP + + A V ++ EY+ G+L
Sbjct: 51 EANLMKQLQHPRLVRL---------------------YAVVTQEPIYIITEYMENGSLVD 89
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L KL + +I +A ++ G++++ K +HRD++ N+L+ KIADFG+A
Sbjct: 90 FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLA 149
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-MPYPDL 310
R+ N + T G + + APE + + + DV+SFGI L EI +PYP +
Sbjct: 150 RLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ +V + R R P CP L +MR CW E+RP
Sbjct: 208 TNPEVIQNLER-GYRMPRPDNCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 90/306 (29%), Positives = 149/306 (48%), Gaps = 62/306 (20%)
Query: 88 LIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ +G +GSV YD + VAVK L +TAE LR F++E+ + +
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ------HSTAEH--LRD-FEREIEILKS 61
Query: 142 LDHPNVTKF--VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
L H N+ K+ V S G NL++ V+EYLP G+L+ YL ++
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRL--------------------VMEYLPYGSLRDYLQKH 101
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
R ++L + ++ A + +G+ YL SK+ VHRD+ T N+L++S+ +KI DFG+ +V Q
Sbjct: 102 R-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160
Query: 260 NPRDMT----GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI--YC----------- 302
+ GE+ Y APE L ++ DV+SFG+ L+E+ Y
Sbjct: 161 DKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM 219
Query: 303 ----CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
D + + + +++ N R P CP+ + IM++CW+ + +RP E+
Sbjct: 220 RMMGNDKQGQMIVYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277
Query: 359 KMLEAI 364
+EAI
Sbjct: 278 LQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 38/271 (14%)
Query: 87 NLIAQGTYGSVYRG--TYDNQEVAVK---LLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+LI +G +G VY+G VA+K L E+ + S QE+ + +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL----------KSIMQEIDLLKN 55
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN+ K++G S+ TS+ + +++EY G+L+Q I +
Sbjct: 56 LKHPNIVKYIG-SIETSD-------------------SLYIILEYAENGSLRQ--IIKKF 93
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
+V + +GL+YLH + ++HRD+K N+L +K+ADFGVA
Sbjct: 94 GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
+D GT +MAPEV++ + D++S G + E+ + PY DL+ +V
Sbjct: 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV- 212
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
Q+ P +P L + + +C+ + RP
Sbjct: 213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 77/290 (26%), Positives = 135/290 (46%), Gaps = 36/290 (12%)
Query: 88 LIAQGTYGSVYRGTYDNQE-----VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
++ +G +GSV G + VAVK M T + F E A +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKT-------MKLDIHTYSEIEEFLSEAACMKDF 58
Query: 143 DHPNVTKFVGASVGTSNL-KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR- 200
DHPNV K +G S+L KIP V++ ++ G+L +L+ +R
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPM---------------VILPFMKHGDLHSFLLYSRL 103
Query: 201 ---RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
+KL L+ +++ +D++ G+ YL ++ +HRD+ N +L T+ +ADFG+++
Sbjct: 104 GGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163
Query: 258 AQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFAD 314
G + ++A E L + Y + DV++FG+ +WEI PYP + +
Sbjct: 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ +R R + P C L ++M CW A+ + RP ++ ++LE I
Sbjct: 224 IYD-YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 70/286 (24%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAAL 128
+RP+EE+ + + G +G V+ G + + VA+K+L ++
Sbjct: 2 ERPREEFT-------LERKLGSGYFGEVWEGLWKNRVRVAIKIL---------KSDDLLK 45
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+ FQ+EV ++L H + S A V ++ E +
Sbjct: 46 QQDFQKEVQALKRLRHK---------------HLISLFAVCSVGEPV-----YIITELME 85
Query: 189 GGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI 248
G+L +L + L + +I +A ++ G++YL + +HRD+ N+L+ K+
Sbjct: 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKV 145
Query: 249 ADFGVARVEAQNPRDMTGETGT-LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMP 306
ADFG+AR+ + ++ + + APE ++ + DV+SFGI L+E++ +P
Sbjct: 146 ADFGLARL-IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
YP ++ +V + R P CP + IM +CW A E RP
Sbjct: 205 YPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 38/282 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEI + + + G +G V+ G Y+N +VAVK L G M+ A F +
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQA--------FLE 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + + L H + + + I + EY+ G+L
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYI--------------------ITEYMAKGSLLD 90
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L + K+ L +I + ++ G++Y+ K +HRD++ N+L+ KIADFG+A
Sbjct: 91 FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDL 310
RV N + T G + + APE + + + DV+SFGI L+EI +PYP +
Sbjct: 151 RVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
S +DV SA+ R P CP L +IM+ CW AE+RP
Sbjct: 209 SNSDVMSALQRGYRMPR-MENCPDELYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 45/284 (15%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
L+ QG +G VY YD +E+AVK + + D T E AL + E+ + + L H
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNAL----ECEIQLLKNLQH 63
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY------LIR 198
+ ++ G L+ + +EY+PGG++K L
Sbjct: 64 ERIVQYYGC------LRDDETL--------------SIFMEYMPGGSVKDQLKAYGALTE 103
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVE 257
+K +I+ G+ YLHS IVHRD+K N+L DS +K+ DFG + R++
Sbjct: 104 TVTRKYTRQIL--------EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155
Query: 258 A--QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
+ M TGT +M+PEV+ G+ Y R+ DV+S G + E+ P+ +
Sbjct: 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ Q P++P N +R+ + NA+KRP E+++
Sbjct: 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-32
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 88 LIAQGTYGSVYRGTYD--NQEVAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKLD 143
I +G++G VY+ NQ VA+K+ L+ ED + QQE+ +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED----------IQQEIQFLSQCR 57
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
P +TK+ G+ + S L I ++EY GG+ L + K
Sbjct: 58 SPYITKYYGSFLKGSKLWI--------------------IMEYCGGGSCLDLL---KPGK 94
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR--VEAQNP 261
L + + ++ GL YLH + +HRD+K N+LL + +K+ADFGV+ +
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310
R+ GT +MAPEV++ Y+ + D++S GI E+ + P DL
Sbjct: 155 RNTF--VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 181 CVVVEYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+V+EY PGG L +L + R ++ A ++ L L YLHS I++RD+K EN+
Sbjct: 69 YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL----ALEYLHSLGIIYRDLKPENI 124
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
LLD+ +K+ DFG+A+ + GT Y+APEVL GK Y + D +S G+ L+
Sbjct: 125 LLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLY 184
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ +A+ + + L+ P +++ + KR
Sbjct: 185 EMLTGKPPF----YAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 84/297 (28%), Positives = 139/297 (46%), Gaps = 43/297 (14%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSF 132
ID+S + + +I G +G V RG VA+K L G T R F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--------TEKQRRDF 52
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
E ++ + DHPN+ G V T + R ++ E++ G L
Sbjct: 53 LSEASIMGQFDHPNIIHLEG--VVTKS------------------RPVMIITEFMENGAL 92
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
+L +N + +++V L ++ G+ YL VHRD+ N+L++S K++DFG
Sbjct: 93 DSFLRQNDGQFTVIQLVGMLR-GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 253 VARVEAQNPRDMTGETGTLG------YMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DM 305
++R + D T T +LG + APE + + + DV+S+GI +WE+ +
Sbjct: 152 LSRFLEDDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
PY D+S DV +A + Q+ R P CP++L +M CW + RP+ G++V L+
Sbjct: 211 PYWDMSNQDVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 52/286 (18%)
Query: 88 LIAQGTYGSVYRG-TYDNQE-VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
L+ G++GSVY G D+ + AVK + +DG L +QE+A+ KL HP
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQL----EQEIALLSKLQHP 62
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL-KQY--------- 195
N+ +++G NL + +E +PGG+L K
Sbjct: 63 NIVQYLGTEREEDNL--------------------YIFLELVPGGSLAKLLKKYGSFPEP 102
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
+IR +++ L GL YLH + VHRD+K N+L+D+ +K+ADFG+A+
Sbjct: 103 VIRLYTRQILL------------GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK 150
Query: 256 -VEAQNPRDMTGETGTLGYMAPEVL-QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
V G+ +MAPEV+ Q Y D++S G + E+ P+ L
Sbjct: 151 QVVEF--SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV 208
Query: 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ R P IP + + KC + RP E+++
Sbjct: 209 AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-32
Identities = 91/307 (29%), Positives = 142/307 (46%), Gaps = 51/307 (16%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAAL 128
WE+ K+ + + QG++G VY G + VAVK T E+A+L
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVK----------TVNESASL 50
Query: 129 RS--SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
R F E +V + +V + +G + SK + VV+E
Sbjct: 51 RERIEFLNEASVMKGFTCHHVVRLLG---------VVSK-----------GQPTLVVMEL 90
Query: 187 LPGGNLKQYLIRNR--------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+ G+LK YL R R L+ +IQ+A +++ G++YL++KK VHRD+ N
Sbjct: 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNC 150
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGIC 296
++ T+KI DFG+ R + G G L +MAPE L+ + D++SFG+
Sbjct: 151 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210
Query: 297 LWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355
LWEI + PY LS V V+ + P CP + ++MR CW N + RP
Sbjct: 211 LWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFL 269
Query: 356 EVVKMLE 362
E+V +L+
Sbjct: 270 EIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 83/298 (27%), Positives = 133/298 (44%), Gaps = 46/298 (15%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTY---DNQE--VAVKLLDWGEDGMATTAETAALRSSF 132
ID S + + +I G +G V RG +E VA+K L G + R F
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--------SDKQRLDF 52
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
E ++ + DHPN+ + G V T +R ++ EY+ G+L
Sbjct: 53 LTEASIMGQFDHPNIIRLEG--VVTK------------------SRPVMIITEYMENGSL 92
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
++L R K + ++ + ++ G+ YL VHRD+ N+L++S K++DFG
Sbjct: 93 DKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 253 VARVEAQNPRDMTGETGTLG------YMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DM 305
++R D T G + APE + + + DV+SFGI +WE+ +
Sbjct: 152 LSRRL----EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
PY D+S DV A V R P CPS+L +M CW + +RP ++V L+
Sbjct: 208 PYWDMSNQDVIKA-VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 74/291 (25%), Positives = 133/291 (45%), Gaps = 44/291 (15%)
Query: 88 LIAQGTYGSVYRG-------TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
+ +G +G V+ V VK L + L+S F++E+ +++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--------QKTKDENLQSEFRRELDMFR 63
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
KL H NV + +G A P +++EY G+LKQ+L +
Sbjct: 64 KLSHKNVVRLLGLC-----------------REAEPH---YMILEYTDLGDLKQFLRATK 103
Query: 201 RKK-------LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
K L+ K + L ++ G+ +L + + VHRD+ N L+ SQR +K++ +
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163
Query: 254 AR-VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLS 311
++ V + L ++APE +Q ++ + DV+SFG+ +WE++ ++P+ LS
Sbjct: 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+V + + L +P CPS L +M +CW N + RP E+V L
Sbjct: 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 78/304 (25%), Positives = 131/304 (43%), Gaps = 59/304 (19%)
Query: 89 IAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
I QG +G V++ VAVK+L E+ +A +++ FQ+E A+ +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEA------SADMQADFQREAALMAE 64
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN-- 199
DHPN+ K +G + C++ EY+ G+L ++L
Sbjct: 65 FDHPNIVKLLGV--------------------CAVGKPMCLLFEYMAYGDLNEFLRHRSP 104
Query: 200 ------------------RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
L+ + +A ++ G++YL +K VHRD+ T N L+
Sbjct: 105 RAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164
Query: 242 SQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
+KIADFG++R A + + + +M PE + Y DV+++G+ LWE
Sbjct: 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224
Query: 300 IYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
I+ M PY ++ +V V N+ P CP L N+MR CW RP +
Sbjct: 225 IFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283
Query: 359 KMLE 362
++L+
Sbjct: 284 RILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-31
Identities = 89/318 (27%), Positives = 146/318 (45%), Gaps = 58/318 (18%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRG-----TYDNQE----VAVKLLDWGEDGMATTAET 125
+WE +L + + +G +G V R + VAVK+L +D AT +
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML---KDN-ATDKDL 61
Query: 126 AALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
A L S E+ + + + H N+ +G L V+V
Sbjct: 62 ADLIS----EMELMKLIGKHKNIINLLGVCTQEGPLY--------------------VIV 97
Query: 185 EYLPGGNLKQYLIRNRR---------------KKLALKIVIQLALDLSRGLSYLHSKKIV 229
EY GNL+++L R RR ++L+ K ++ A ++RG+ YL S++ +
Sbjct: 98 EYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI 156
Query: 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRR 287
HRD+ N+L+ +KIADFG+AR G L +MAPE L + Y +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216
Query: 288 CDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA 346
DV+SFGI +WEI+ PYP + ++ ++R+ R + P C L +MR+CW A
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGIPVEELFK-LLREGHRMDKPSNCTHELYMLMRECWHA 275
Query: 347 NAEKRPEMGEVVKMLEAI 364
+RP ++V+ L+ +
Sbjct: 276 VPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 73/289 (25%), Positives = 136/289 (47%), Gaps = 34/289 (11%)
Query: 88 LIAQGTYGSVYRGTY---DN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
++ +G +GSV D Q+VAVK+L +++ F +E A ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-------ADIFSSSDIEEFLREAACMKEF 58
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
DHPNV K +G S+ + G +P V++ ++ G+L +L+ +R
Sbjct: 59 DHPNVIKLIGVSL----------RSRAKGRLPIPM----VILPFMKHGDLHTFLLMSRIG 104
Query: 203 K----LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR--V 256
+ L L+ +++ +D++ G+ YL SK +HRD+ N +L+ T+ +ADFG+++
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADV 315
R + ++A E L Y DV++FG+ +WEI PY + +++
Sbjct: 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ +++ N R + P C + +M +CW + RP + LE I
Sbjct: 225 YNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 66/296 (22%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P+E ++I + +G+YGSVY+ + Q VA+K++ ED
Sbjct: 1 PEEVFDIL-------EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----------L 42
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+E+++ ++ D P + K+ G+ ++L I V+EY
Sbjct: 43 QEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI--------------------VMEYCGA 82
Query: 190 GNLKQYLIRNRRKKLA---LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
G++ +++ K L + ++ L +GL YLHS K +HRD+K N+LL+ +
Sbjct: 83 GSVSD-IMKITNKTLTEEEIAAILYQTL---KGLEYLHSNKKIHRDIKAGNILLNEEGQA 138
Query: 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP 306
K+ADFGV+ GT +MAPEV+Q YN + D++S GI E+ P
Sbjct: 139 KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLAN----------IMRKCWDANAEKRP 352
Y D+ A+ IP P +L++ ++KC + E+RP
Sbjct: 199 YSDIH---PMRAIF------MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 85/313 (27%), Positives = 139/313 (44%), Gaps = 61/313 (19%)
Query: 82 KLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
L + + +G +G V + T VAVK+L A+++E L S F
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFN- 55
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
+ ++++HP+V K GA S DG ++VEY G+L+
Sbjct: 56 ---LLKQVNHPHVIKLYGA-------------CSQDG-------PLLLIVEYAKYGSLRS 92
Query: 195 YLIRNRR----------------------KKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232
+L +R+ + L + +I A +SRG+ YL K+VHRD
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRD 152
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDV 290
+ N+L+ R +KI+DFG++R + + G + +MA E L Y + DV
Sbjct: 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212
Query: 291 YSFGICLWEIYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAE 349
+SFG+ LWEI PYP ++ + + +++ R E P C + N+M CW +
Sbjct: 213 WSFGVLLWEIVTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPD 271
Query: 350 KRPEMGEVVKMLE 362
KRP ++ K LE
Sbjct: 272 KRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 39/219 (17%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGE-----DGMATTAETAALRSSFQQEV 136
+ + +GTY VY+ + VA+K + GE DG+ TA LR E+
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA----LR-----EI 53
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
+ Q+L HPN+ + SN+ +V E++ +L++ +
Sbjct: 54 KLLQELKHPNIIGLLDVFGHKSNI--------------------NLVFEFMET-DLEK-V 91
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
I+++ L + L RGL YLHS I+HRD+K N+L+ S LK+ADFG+AR
Sbjct: 92 IKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
R MT + T Y APE+L G + Y D++S G
Sbjct: 152 FGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 67/287 (23%), Positives = 138/287 (48%), Gaps = 40/287 (13%)
Query: 81 SKLDMRNLIAQGTYGSVYRGTY--DNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
++L+ ++ G +G+VY+G + + + VA+K+L + + A L
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL---REETSPKANKEILD----- 58
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E V +DHP+V + +G + + ++ + +P G L
Sbjct: 59 EAYVMASVDHPHVVRLLGICLSSQ---------------------VQLITQLMPLGCLLD 97
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
Y+ RN + + + ++ + +++G+SYL K++VHRD+ N+L+ + + +KI DFG+A
Sbjct: 98 YV-RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
Query: 255 RVEAQNPRDMTGETGT--LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLS 311
++ + ++ E G + +MA E + + Y + DV+S+G+ +WE+ PY +
Sbjct: 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
++ + + R P C + ++ KCW +AE RP E++
Sbjct: 217 AVEIPDLLEK-GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-30
Identities = 89/307 (28%), Positives = 143/307 (46%), Gaps = 51/307 (16%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRG-----TYDNQEVAVKLLDWGEDGMATTAETAALRS 130
WE+ K+ M + QG++G VY G D E V + T E A++R
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRV--------AIKTVNEAASMRE 52
Query: 131 --SFQQEVAVWQKLDHPNVTKFVGA-SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
F E +V ++ + +V + +G S G L V++E +
Sbjct: 53 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL---------------------VIMELM 91
Query: 188 PGGNLKQYLIRNRRKKL---------ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
G+LK YL R+ R ++ +LK +IQ+A +++ G++YL++ K VHRD+ N
Sbjct: 92 TRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNC 150
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLG--YMAPEVLQGKPYNRRCDVYSFGIC 296
++ T+KI DFG+ R + G G L +M+PE L+ + DV+SFG+
Sbjct: 151 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210
Query: 297 LWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355
LWEI + PY +S V V+ L + P CP L +MR CW N + RP
Sbjct: 211 LWEIATLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFL 269
Query: 356 EVVKMLE 362
E++ ++
Sbjct: 270 EIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 81/301 (26%), Positives = 138/301 (45%), Gaps = 41/301 (13%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETA 126
+WE + L + G +G V T +VAVK+L A ++E
Sbjct: 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK----PTAHSSERE 83
Query: 127 ALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
AL S E+ + L +H N+ +GA + V+ E
Sbjct: 84 ALMS----ELKIMSHLGNHENIVNLLGACTIGGPI--------------------LVITE 119
Query: 186 YLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245
Y G+L +L R R L L+ ++ + +++G+++L SK +HRD+ N+LL +
Sbjct: 120 YCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI 179
Query: 246 LKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+KI DFG+AR + N + + + +MAPE + Y DV+S+GI LWEI+
Sbjct: 180 VKICDFGLAR-DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
Query: 303 CDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
PYP + ++++ R P P+ + +IM+ CWDA+ KRP ++V+++
Sbjct: 239 LGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
Query: 362 E 362
Sbjct: 299 G 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 43/223 (19%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY+ + VA+K ++ ++G TA +R E+ + QKL H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA----IR-----EIKLLQKLRH 57
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP----GGNLKQYLIRNR 200
PN+ + + TS K G+ +V EY+ G L+ +
Sbjct: 58 PNIVRLKE--IVTSKGK---------GS-------IYMVFEYMDHDLTG------LLDSP 93
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-VEAQ 259
K + L GL YLHS I+HRD+K N+L+++ LK+ADFG+AR +
Sbjct: 94 EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
Query: 260 NPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301
N D T TL Y PE+L G Y D++S G L E++
Sbjct: 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 45/293 (15%)
Query: 78 IDLSKLDMRNLIAQGTYGSV----YRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQ 133
ID L + G +G V +RG YD VA+K++ E M+ F
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYD---VAIKMIK--EGSMS--------EDEFI 47
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+E V KL H + + G V T R +V EY+ G L
Sbjct: 48 EEAKVMMKLSHEKLVQLYG--VCTKQ------------------RPIYIVTEYMSNGCLL 87
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
YL R K+ ++++ D+ G++YL SK+ +HRD+ N L+D Q +K++DFG+
Sbjct: 88 NYL-REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL 146
Query: 254 ARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPD 309
+R + + T G+ + + PEVL ++ + DV++FG+ +WE+Y MPY
Sbjct: 147 SRYVLDD--EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204
Query: 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+ ++ V Q LR P + IM CW AE+RP +++ +E
Sbjct: 205 FNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 65/218 (29%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 86 RNLIAQGTYGSVYRG-TYDNQEV-AVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD 143
N I GT+G VY D E+ AVK + E+ V + L
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKE-------IRIQDNDPKTIKEIADEMKVLELLK 57
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
HPN+ K+ G V + + +EY GG L++ L+ + R
Sbjct: 58 HPNLVKYYGVEVHREKV--------------------YIFMEYCSGGTLEE-LLEHGRI- 95
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN--- 260
L ++ L L GL+YLHS IVHRD+K N+ LD +K+ DFG A N
Sbjct: 96 LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155
Query: 261 -PRDMTGETGTLGYMAPEVLQGKP---YNRRCDVYSFG 294
++ GT YMAPEV+ G + R D++S G
Sbjct: 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 45/299 (15%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQ-----EVAVKLLDWGEDGMATTAETAALRSSF 132
ID S + + +I G +G V G VA+K L G T R F
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--------TEKQRRDF 52
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
E ++ + DHPN+ G ++ +V EY+ G+L
Sbjct: 53 LSEASIMGQFDHPNIIHLEGV--------------------VTKSKPVMIVTEYMENGSL 92
Query: 193 KQYLIRNRRKKLALKIVIQLA---LDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+L RK VIQL ++ G+ YL VHRD+ N+L++S K++
Sbjct: 93 DAFL----RKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVS 148
Query: 250 DFGVARVEAQNPRDMTGETG---TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DM 305
DFG++RV +P G + + APE + + + DV+S+GI +WE+ +
Sbjct: 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PY ++S DV A + + R P CP++L +M CW + +RP+ ++V +L+ +
Sbjct: 209 PYWEMSNQDVIKA-IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 43/281 (15%)
Query: 88 LIAQGTYGSVYRG-TYDNQEV-AVKLLDW-----GEDGMATTAETAALRSSFQQEVAVWQ 140
LI +GTYG VY E+ AVK ++ G ALRS E+ +
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS----EIETLK 63
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
LDH N+ +++G L I +EY+PGG++ +R
Sbjct: 64 DLDHLNIVQYLGFETTEEYLSI--------------------FLEYVPGGSIGS-CLRTY 102
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ- 259
+ ++V + GL+YLHSK I+HRD+K +N+L+D+ KI+DFG+++
Sbjct: 103 -GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161
Query: 260 --NPRDMTGETGTLGYMAPEV--LQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
N ++M+ + G++ +MAPEV + Y+ + D++S G + E++ P+ D
Sbjct: 162 YDNDQNMSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
Query: 316 SSAVVRQNLRPEIPRCCPSSL----ANIMRKCWDANAEKRP 352
+ + P IP +L + + C+ N + RP
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
++ +G +G V+ R D + V +K + + M T R + Q E V + L HP
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQM-----TKDERLAAQNECQVLKLLSHP 59
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ ++ + L I V+EY PGG L +Y+ + L
Sbjct: 60 NIIEYYENFLEDKALMI--------------------VMEYAPGGTLAEYIQKRCNSLLD 99
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT-LKIADFGVARVEAQNPRDM 264
++ + + L ++H+K I+HRD+KT+N+LLD + +KI DFG++++ + +
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
T GT Y++PE+ +GKPYN++ D+++ G L+E+
Sbjct: 160 T-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 50/299 (16%)
Query: 89 IAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+ +G +G V YD ++VAVK L G + ++E+ + + L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--------ADLKKEIEILRNL 63
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
H N+ K+ G + DG + +++E+LP G+LK+YL RN+
Sbjct: 64 YHENIVKYKG-------------ICTEDGGNGIK-----LIMEFLPSGSLKEYLPRNK-N 104
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
K+ LK ++ A+ + +G+ YL S++ VHRD+ N+L++S+ +KI DFG+ + +
Sbjct: 105 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
Query: 263 DMTGE---TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI--YCCDMPYPDLSFADVSS 317
T + + + APE L + DV+SFG+ L+E+ YC P F +
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG 224
Query: 318 A------------VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
V+ + R P CP + +MRKCW+ KR +++ EAI
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 70/276 (25%), Positives = 127/276 (46%), Gaps = 41/276 (14%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G++G+V R D + + K +D+G M T E L S EV + ++L HPN
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGN--M-TEKEKQQLVS----EVNILRELKHPN 60
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK---K 203
+ ++ + SN + +V+EY GG+L Q LI+ +K
Sbjct: 61 IVRYYDRIIDRSNQTL------------------YIVMEYCEGGDLAQ-LIQKCKKERKY 101
Query: 204 LALKIVIQLALDLSRGLSYLH-----SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
+ + + ++ L L H ++HRD+K N+ LD+ +K+ DFG+A++
Sbjct: 102 IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM--PYPDLSFADVS 316
+ GT YM+PE L Y+ + D++S G ++E+ C + P+ + ++
Sbjct: 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL--CALSPPFTARNQLQLA 219
Query: 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
S + R IP S L +++ + + +KRP
Sbjct: 220 SKIKEGKFRR-IPYRYSSELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 77/297 (25%), Positives = 136/297 (45%), Gaps = 39/297 (13%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSS 131
EI S + + +I G +G V+RG VA+K L G T R
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--------YTEKQRQD 52
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F E ++ + H N+ + G + +K + ++ EY+ G
Sbjct: 53 FLSEASIMGQFSHHNIIRLEG---------VVTKF-----------KPAMIITEYMENGA 92
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L +YL + + + ++V L ++ G+ YL VHRD+ N+L++S K++DF
Sbjct: 93 LDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDF 151
Query: 252 GVARVEAQNPRDMTGETG---TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPY 307
G++RV +P +G + + APE + + + DV+SFGI +WE+ + PY
Sbjct: 152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
D+S +V A + R P CPS++ +M +CW + +RP ++V +L+ +
Sbjct: 212 WDMSNHEVMKA-INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 51/297 (17%)
Query: 89 IAQGTYGSVYRGTYDNQE-------VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ +G +G V+ G + E VAVK L A R F++E +
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA--------RKDFEREAELLTN 64
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
H N+ KF G +G+ + +V EY+ G+L ++L +
Sbjct: 65 FQHENIVKFYGVCT--------------EGDPPI------MVFEYMEHGDLNKFLRSHGP 104
Query: 202 ------------KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+L L ++Q+A+ ++ G+ YL S+ VHRD+ T N L+ +KI
Sbjct: 105 DAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164
Query: 250 DFGVARVEAQNPRDMTGETGTLG--YMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMP 306
DFG++R G L +M PE + + + DV+SFG+ LWEI+ P
Sbjct: 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
+ LS +V + Q + PR CPS + +IM CW + ++R + ++ + L+
Sbjct: 225 WYGLSNEEVIE-CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 82/308 (26%), Positives = 142/308 (46%), Gaps = 58/308 (18%)
Query: 83 LDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
L ++ +G +G V YD + VAVK L S +++E+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--------GQQNTSGWKKEI 57
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
+ + L H N+ K+ G S G + +++EY+P G+L+ YL
Sbjct: 58 NILKTLYHENIVKYKGC-------------CSEQGGKGLQ-----LIMEYVPLGSLRDYL 99
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
++ KL L ++ A + G++YLHS+ +HRD+ N+LLD+ R +KI DFG+A+
Sbjct: 100 PKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156
Query: 257 -----EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPY--P 308
E R+ G++ Y A E L+ ++ DV+SFG+ L+E+ CD P
Sbjct: 157 VPEGHEYYRVRE-DGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCD-SKQSP 213
Query: 309 DLSFADV------SSAVVR------QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
F ++ VVR + +R P+ CP + +M+ CW+ A+ RP
Sbjct: 214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRS 273
Query: 357 VVKMLEAI 364
++ +L+ +
Sbjct: 274 LIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 39/292 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEI L + + QG +G V+ GT++ VA+K L G M+ A F Q
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEA--------FLQ 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E V +KL H + + A V +V EY+ G+L
Sbjct: 51 EAQVMKKLRHEKLVQLY---------------------AVVSEEPIYIVTEYMSKGSLLD 89
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L K L L ++ +A ++ G++Y+ VHRD++ N+L+ K+ADFG+A
Sbjct: 90 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 149
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310
R+ N + T G + + APE + + DV+SFGI L E+ +PYP +
Sbjct: 150 RLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+V V R R P CP SL ++M +CW E+RP + LE
Sbjct: 208 VNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-28
Identities = 90/320 (28%), Positives = 148/320 (46%), Gaps = 58/320 (18%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRG---------TYDNQEVAVKLLDWGEDGMATTAET 125
+WE+ ++L + + +G +G V VAVK+L +D AT +
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DD--ATDKDL 61
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
+ L S + + + H N+ +GA L V+VE
Sbjct: 62 SDLVSEMEMMKMIGK---HKNIINLLGACTQDGPLY--------------------VLVE 98
Query: 186 YLPGGNLKQYLIRNRR---------------KKLALKIVIQLALDLSRGLSYLHSKKIVH 230
Y GNL++YL R RR ++L K ++ A ++RG+ YL S+K +H
Sbjct: 99 YASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157
Query: 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRR 287
RD+ N+L+ +KIADFG+AR + N + T + +MAPE L + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216
Query: 288 CDVYSFGICLWEIYCCD-MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA 346
DV+SFG+ LWEI+ PYP + ++ ++++ R + P C L IMR+CW A
Sbjct: 217 SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTHELYMIMRECWHA 275
Query: 347 NAEKRPEMGEVVKMLEAIDT 366
+RP ++V+ L+ + T
Sbjct: 276 VPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 67/277 (24%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 89 IAQGTYGS--VYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
+ +G +G +YR T D+ V W E + +E R E+ + L HPN
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-----WKEVNLTRLSEKE--RRDALNEIVILSLLQHPN 60
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ + + + L I +EY GG L ++R + +
Sbjct: 61 IIAYYNHFMDDNTLLIE--------------------MEYANGGTLYDKIVRQKGQLFEE 100
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
++V+ + +SY+H I+HRD+KT N+ L +K+ DFG++++
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMA 158
Query: 267 ET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324
ET GT YM+PE+ QG YN + D+++ G L+E+ + + ++ +V+ N
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218
Query: 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
P + S L +++ + EKRP EV+
Sbjct: 219 TPVVSVYS-SELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 39/274 (14%)
Query: 92 GTYGSVYRGTYDNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147
G +G V +G Y + +VA+K+L + ++R +E + +LD+P +
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYI 57
Query: 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALK 207
+ +G A A +V+E GG L ++L ++ ++ +
Sbjct: 58 VRMIGV---------------------CEAEALMLVMEMASGGPLNKFLS-GKKDEITVS 95
Query: 208 IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGE 267
V++L +S G+ YL K VHRD+ N+LL +Q KI+DFG+++ +
Sbjct: 96 NVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155
Query: 268 TG---TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQN 323
+ L + APE + + ++ R DV+S+GI +WE + PY + +V S + Q
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQG 214
Query: 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
R + P CP + +M+ CW E RP +V
Sbjct: 215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 39/292 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEI L + + G +G V+ GT++ N +VAVK L G M+ SF +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSP--------ESFLE 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + +KL H + + A V +V EY+ G+L
Sbjct: 51 EAQIMKKLRHDKLVQLY---------------------AVVSEEPIYIVTEYMSKGSLLD 89
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L + L L ++ +A ++ G++Y+ +HRD+++ N+L+ KIADFG+A
Sbjct: 90 FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310
R+ N + T G + + APE + + DV+SFGI L E+ +PYP +
Sbjct: 150 RLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+ +V V R R P+ CP SL +M +CW + E+RP + LE
Sbjct: 208 NNREVLEQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 74/301 (24%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAAL--R 129
I ++ + +L+ +GT+G ++ G + +EV VK T + A+
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVK----------TVKDHASEIQV 52
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+ QE + L H N+ + DG V+ Y+
Sbjct: 53 TLLLQESCLLYGLSHQNILPILHVC-------------IEDGEPPF------VLYPYMNW 93
Query: 190 GNLKQYLIRNR------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
GNLK +L + R + L+ + ++ +A+ ++ G+SYLH + ++H+D+ N ++D +
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE 153
Query: 244 RTLKIADFGVARVEAQNPRDMTG--ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+KI D ++R G E + +MA E L K Y+ DV+SFG+ LWE+
Sbjct: 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
Query: 302 CC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360
PY ++ ++ +A ++ R P CP L +M CW + E+RP ++V+
Sbjct: 214 TLGQTPYVEIDPFEM-AAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQC 272
Query: 361 L 361
L
Sbjct: 273 L 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEI L + + G +G V+ TY+ +VAVK + G M+ A F
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEA--------FLA 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E V + L H + K +A V ++ E++ G+L
Sbjct: 51 EANVMKTLQHDKLVKL---------------------HAVVTKEPIYIITEFMAKGSLLD 89
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L + K L +I + ++ G++++ + +HRD++ N+L+ + KIADFG+A
Sbjct: 90 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-MPYPDL 310
RV N + T G + + APE + + + DV+SFGI L EI +PYP +
Sbjct: 150 RVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
S +V A+ R R P CP L NIM +CW E+RP + +L+
Sbjct: 208 SNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 20/201 (9%)
Query: 182 VVVEYLPGGNLKQYLIRNRR---------------KKLALKIVIQLALDLSRGLSYLHSK 226
V+VEY GNL++YL R RR ++L+ K ++ A ++RG+ YL SK
Sbjct: 101 VIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK 159
Query: 227 KIVHRDVKTENMLLDSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLQGKPY 284
K +HRD+ N+L+ +KIADFG+AR + T + +MAPE L + Y
Sbjct: 160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219
Query: 285 NRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKC 343
+ DV+SFG+ LWEI+ PYP + ++ ++++ R + P C + L +MR C
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDC 278
Query: 344 WDANAEKRPEMGEVVKMLEAI 364
W A +RP ++V+ L+ I
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-28
Identities = 88/319 (27%), Positives = 144/319 (45%), Gaps = 58/319 (18%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATTAETA 126
WE KL + + +G +G V + VAVK+L +D AT + +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DD--ATEKDLS 65
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
L S + + + H N+ +GA L V+VEY
Sbjct: 66 DLVSEMEMMKMIGK---HKNIINLLGACTQDGPLY--------------------VIVEY 102
Query: 187 LPGGNLKQYLIRNRR---------------KKLALKIVIQLALDLSRGLSYLHSKKIVHR 231
GNL++YL R RR +++ K ++ ++RG+ YL S+K +HR
Sbjct: 103 ASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161
Query: 232 DVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRC 288
D+ N+L+ +KIADFG+AR + N + T + +MAPE L + Y +
Sbjct: 162 DLAARNVLVTENNVMKIADFGLAR-DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220
Query: 289 DVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
DV+SFG+ +WEI+ PYP + ++ ++++ R + P C + L +MR CW A
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAI 279
Query: 348 AEKRPEMGEVVKMLEAIDT 366
RP ++V+ L+ I T
Sbjct: 280 PSHRPTFKQLVEDLDRILT 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 75/287 (26%), Positives = 126/287 (43%), Gaps = 35/287 (12%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
I+ S+L + G +G V+ G + Q +VA+K ++ E A F +E
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN----------EGAMSEEDFIEEA 50
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V KL HP + + G L I V E++ G L YL
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKPLYI--------------------VTEFMENGCLLNYL 90
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR- 255
R R+ KL+ +++ + D+ G+ YL +HRD+ N L+ S +K++DFG+ R
Sbjct: 91 -RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314
V +G + + PEV Y+ + DV+SFG+ +WE++ MP+ S +
Sbjct: 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
V + R R P+ ++ +M CW E RP E+++ +
Sbjct: 210 VVEMISRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 72/248 (29%), Positives = 120/248 (48%), Gaps = 40/248 (16%)
Query: 121 TTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV--GTSNLKIPSKTASVDGNAAVPAR 178
TT L+ +E+ + + P + K+ GA + +S++ I
Sbjct: 35 TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI---------------- 78
Query: 179 ACCVVVEYLPGGNLKQYL--IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236
+EY GG+L ++ R ++ K++ ++A + +GLSYLHS+KI+HRD+K
Sbjct: 79 ----AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134
Query: 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
N+LL + +K+ DFGV+ E N T TGT YMAPE +QGKPY+ DV+S G+
Sbjct: 135 NILLTRKGQVKLCDFGVSG-ELVNSLAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 297 LWEIYCCDMPYP-----DLSFADVSSAVVRQNLRPEIPRCCPS-------SLANIMRKCW 344
L E+ P+P L ++ S +V PE+ P + +++C
Sbjct: 193 LLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PELKD-EPGNGIKWSEEFKDFIKQCL 250
Query: 345 DANAEKRP 352
+ + +RP
Sbjct: 251 EKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
+ +G++G+VY + E +K+L G ET QE + KLDHP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLSKLDHPA 63
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL--IRNRRKKL 204
+ KF + + C++ EY G +L L +++ K L
Sbjct: 64 IVKFHASFLERDAF--------------------CIITEYCEGRDLDCKLEELKHTGKTL 103
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+ V + + L G+ Y+H ++I+HRD+K +N+ L LKI DFGV+R+ +
Sbjct: 104 SENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA 162
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324
T TGT YM+PE L+ + Y+ + D++S G L+E+ C + +F V +V +
Sbjct: 163 TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGP 221
Query: 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P +P L +IM+ + + RP E+++
Sbjct: 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 63/278 (22%)
Query: 107 VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166
VAVK+L R F +EV + +L PN+ + +G
Sbjct: 49 VAVKVLRPDAS--------DNAREDFLKEVKILSRLSDPNIARLLGVCTVD--------- 91
Query: 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIR---------NRRKKLALKIVIQLALDLS 217
C+++EY+ G+L Q+L + K L+ ++ +A ++
Sbjct: 92 -----------PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR---------VEAQNPRDMTGET 268
G+ YL S VHRD+ T N L+ T+KIADFG++R V+ + P
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL------ 194
Query: 269 GTLGYMAPE-VLQGKPYNRRCDVYSFGICLWEIY--CCDMPYPDLSFADV---SSAVVRQ 322
+ +MA E VL GK + + DV++FG+ LWEI C + PY L+ V + R
Sbjct: 195 -PIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRD 252
Query: 323 NLRPEI---PRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+ R P CP + +M +CW + E RP E+
Sbjct: 253 DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 72/251 (28%), Positives = 114/251 (45%), Gaps = 56/251 (22%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKL--LDWGEDGMATTAETAA 127
P+E++E+ + + I GTYG VY R + VA+K+ L+ G+D
Sbjct: 1 PQEDYEL-IQR------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD---------- 43
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
QQE+++ ++ HPN+ + G+ + L I V+EY
Sbjct: 44 -FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI--------------------VMEYC 82
Query: 188 PGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245
GG+L+ R +L + V + L +GL+YLH +HRD+K N+LL
Sbjct: 83 GGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETGKIHRDIKGANILLTEDGD 139
Query: 246 LKIADFGVARVEAQNPRDMTGET---GTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWE 299
+K+ADFGV+ AQ + GT +MAPEV Y+ +CD+++ GI E
Sbjct: 140 VKLADFGVS---AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
Query: 300 IYCCDMPYPDL 310
+ P DL
Sbjct: 197 LAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 87 NLIAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
I +G YG+VY+ + VA+K + E+G+ + LR E+A+ ++L
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL----STLR-----EIALLKQL 55
Query: 143 D---HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
+ HPN+ + + G + T +V E++ +L YL +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLT---------------LVFEHVDQ-DLATYLSKC 99
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
+ L + + L L RG+ +LHS +IVHRD+K +N+L+ S +KIADFG+AR+ +
Sbjct: 100 PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+T TL Y APEVL Y D++S G E++
Sbjct: 160 EMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 84/304 (27%), Positives = 138/304 (45%), Gaps = 54/304 (17%)
Query: 85 MRNLIAQGTYGSVYRG-------TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
++ + +G +G V+ T D VAVK L T A R FQ+E
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---------KDPTLAARKDFQREAE 59
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL- 196
+ L H ++ KF G DG+ + +V EY+ G+L ++L
Sbjct: 60 LLTNLQHEHIVKFYGVCG--------------DGDPLI------MVFEYMKHGDLNKFLR 99
Query: 197 -------------IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
R + +L L ++ +A ++ G+ YL S+ VHRD+ T N L+ +
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159
Query: 244 RTLKIADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+KI DFG++R V + + + G T + +M PE + + + DV+SFG+ LWEI+
Sbjct: 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
Query: 302 CC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360
P+ LS +V + Q E PR CP + +IM CW ++R + E+ K+
Sbjct: 220 TYGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278
Query: 361 LEAI 364
L A+
Sbjct: 279 LHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 39/292 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
WEI L + + QG +G V+ GT++ +VA+K L G + +F Q
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG----------TMMPEAFLQ 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + +KL H + A V +V E++ G+L
Sbjct: 51 EAQIMKKLRHDKLVPLY---------------------AVVSEEPIYIVTEFMGKGSLLD 89
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+L K L L ++ +A ++ G++Y+ +HRD++ N+L+ KIADFG+A
Sbjct: 90 FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA 149
Query: 255 RVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310
R+ N + T G + + APE + + DV+SFGI L E+ +PYP +
Sbjct: 150 RLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+V V R R P+ CP SL +M+ CW + ++RP + LE
Sbjct: 208 VNREVLEQVER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 48/222 (21%)
Query: 89 IAQGTYGSVY----RGTYDNQEVAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
I +G +G V+ R T + VA+K L E G+ A LR E+ Q
Sbjct: 8 IGEGAHGIVFKAKDRET--GETVALKKVALRRLEGGIPNQA----LR-----EIKALQAC 56
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV-EYLPGGNLKQYLIRNRR 201
HP V K + P + V+V EY+P L + ++R+
Sbjct: 57 QHPYVVKLL---------------------DVFPHGSGFVLVMEYMPSD-LSE-VLRDEE 93
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV-EAQN 260
+ L V L +G++Y+H+ I+HRD+K N+L+ + LKIADFG+AR+ +
Sbjct: 94 RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
PR + + T Y APE+L G Y G+ LW + C
Sbjct: 154 PRLYSHQVATRWYRAPELLYGARK------YDPGVDLWAVGC 189
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 69/272 (25%), Positives = 126/272 (46%), Gaps = 39/272 (14%)
Query: 89 IAQGTYGSVYRGTYDNQE----VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ G +G+V +G Y ++ VAVK+L AL+ +E V Q+LD+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILK-------NDNNDPALKDELLREANVMQQLDN 55
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
P + + +G S + +V+E G L ++L +N+ +
Sbjct: 56 PYIVRMIGICEAESWM---------------------LVMELAELGPLNKFLQKNKH--V 92
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
K + +L +S G+ YL VHRD+ N+LL +Q KI+DFG+++ +
Sbjct: 93 TEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152
Query: 265 TGETG---TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSSAVV 320
+T + + APE + ++ + DV+SFG+ +WE + PY + +V + ++
Sbjct: 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQMI 211
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
R E P+ CP + ++M+ CW ++RP
Sbjct: 212 ESGERMECPQRCPPEMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I++G YG V+ + A+K++ + M + E + + P
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQV----DQVLTERDILSQAQSPY 54
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---RKK 203
V K + G NL +V+EYLPGG+L L+ N +
Sbjct: 55 VVKLYYSFQGKKNL--------------------YLVMEYLPGGDLAS-LLENVGSLDED 93
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+A + ++ L L YLHS I+HRD+K +N+L+DS LK+ DFG+++V +
Sbjct: 94 VARIYIAEIVL----ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149
Query: 264 MTGET--------GTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
+ GT Y+APEV+ G+ +++ D +S G L+E
Sbjct: 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 89 IAQGTYGSVYRGTYDNQE----VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +G +GSV G + + VAVK M T + F E ++ DH
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKT-------MKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 145 PNVTKFVGASV-GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
PNV + +G + + PS V++ ++ G+L +L+ +R
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPV---------------VILPFMKHGDLHSFLLYSRLGD 104
Query: 204 ----LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
L +++++ D++ G+ YL SK +HRD+ N +L+ + +ADFG+++
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164
Query: 260 NPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVS 316
G + ++A E L + Y + DV+SFG+ +WEI PYP + +++
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
Query: 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+RQ R + P C L ++M CW N + RP + LE
Sbjct: 225 D-YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 69/295 (23%), Positives = 111/295 (37%), Gaps = 67/295 (22%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLD----WGEDGMATTAETAALRSSFQQEVAVWQK 141
+I +G++ +V N+E A+K+LD E + + E V +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK----------YVKIEKEVLTR 57
Query: 142 LD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
L+ HP + K NL V+EY P G L QY+ +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYF--------------------VLEYAPNGELLQYI--RK 95
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV---- 256
L K A ++ L YLHSK I+HRD+K EN+LLD +KI DFG A+V
Sbjct: 96 YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155
Query: 257 ------------EAQNPRDMTGET----GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
GT Y++PE+L KP + D+++ G ++++
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215
Query: 301 YCCDMPYPDLSFADVSSAVVRQNLRP---EIPRCCPSSLANIMRKCWDANAEKRP 352
P F + + Q + P P +++ K + + R
Sbjct: 216 LTGKPP-----FRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 89 IAQGTYGSVYRGTYDN---QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I +GTYG VY+ D + VA+K + + + ALR E+ + ++L+HP
Sbjct: 7 IGEGTYGVVYKA-RDKLTGEIVAIKKIKLRFE--SEGIPKTALR-----EIKLLKELNHP 58
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ K + +V +L + LI++R++ L
Sbjct: 59 NIIKL---------------------LDVFRHKGDLYLVFEFMDTDLYK-LIKDRQRGLP 96
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT 265
++ L +GL++ HS I+HRD+K EN+L++++ LK+ADFG+AR R T
Sbjct: 97 ESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
T Y APE+L G YS + +W + C
Sbjct: 157 HYVVTRWYRAPELLLG------DKGYSTPVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 80/285 (28%), Positives = 139/285 (48%), Gaps = 49/285 (17%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKLD 143
LI +G YG+VYRG + + VA+K+ LD +D + S Q+EVA+ +L
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV----------SDIQREVALLSQLR 57
Query: 144 H---PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
PN+TK+ G S LK P +++EY GG+++ +
Sbjct: 58 QSQPPNITKYYG-----SYLKGPR---------------LWIIMEYAEGGSVRTLMKAGP 97
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+ + ++I+ L L Y+H ++HRD+K N+L+ + +K+ DFGVA + QN
Sbjct: 98 IAEKYISVIIREVL---VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154
Query: 261 PRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319
+ GT +MAPEV+ GK Y+ + D++S GI ++E+ + PY D+ +
Sbjct: 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214
Query: 320 VRQNLRPEIPRCCPSSLANIMRK----CWDANAEKRPEMGEVVKM 360
+ +P PR + + ++R+ C D ++R E++K
Sbjct: 215 PKS--KP--PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 89 IAQGTYGSV--YRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
+ +G+YG V R D ++ +K L+ A+ E R + +QE + +L HPN
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRE----RKAAEQEAQLLSQLKHPN 60
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ + + G L +V+ + GG+L L + K L
Sbjct: 61 IVAYRESWEGEDGL-------------------LYIVMGFCEGGDLYHKLKEQKGKLLPE 101
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
V++ + ++ L YLH K I+HRD+KT+N+ L +K+ D G+ARV +N DM
Sbjct: 102 NQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAS 160
Query: 267 E-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR--QN 323
GT YM+PE+ KPYN + DV++ G C++E+ + + D++S V R +
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF---NAKDMNSLVYRIIEG 217
Query: 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P +P+ L ++ EKRP + +++
Sbjct: 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 55/174 (31%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 183 VVEYLPGGNLKQYLIRNRR-KKLALKIVI-QLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
VV+ L GG+L+ +L + + + +K I ++ L L YLHSK I+HRD+K +N+LL
Sbjct: 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL----ALEYLHSKGIIHRDIKPDNILL 133
Query: 241 DSQRTLKIADFGVAR-VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
D Q + I DF +A V T +GT GYMAPEVL + Y+ D +S G+ +E
Sbjct: 134 DEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191
Query: 300 IYCCDMPYP--DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
PY + D A P + + + K + + +KR
Sbjct: 192 CLRGKRPYRGHSRTIRDQIRAKQETA-DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-26
Identities = 64/281 (22%), Positives = 127/281 (45%), Gaps = 31/281 (11%)
Query: 82 KLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW 139
+ ++ I +G++G +Y + D++ +K +D T + + ++EV +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-------TKMPVKEKEASKKEVILL 53
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
K+ HPN+ F + L I V+EY GG+L + + R
Sbjct: 54 AKMKHPNIVTFFASFQENGRLFI--------------------VMEYCDGGDLMKRINRQ 93
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ-RTLKIADFGVARVEA 258
R + ++ + +S GL ++H +KI+HRD+K++N+ L K+ DFG+AR
Sbjct: 94 RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
+ GT Y++PE+ Q +PYN + D++S G L+E+ P+ + +
Sbjct: 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + P P L +++ + + + RP + ++K
Sbjct: 214 ICQGYFAPISPN-FSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 37/178 (20%)
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
Q + HP + G+ SNL + V+EY+PGG L +L ++
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYL--------------------VMEYVPGGELFSHLRKS 95
Query: 200 RR------KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
R + A ++V LAL+ YLHS IV+RD+K EN+LLDS +KI DFG
Sbjct: 96 GRFPEPVARFYAAQVV--LALE------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGF 147
Query: 254 ARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311
A+ R T GT Y+APE++ K Y + D ++ GI ++E+ P+ D +
Sbjct: 148 AKRVK--GRTYT-LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 86/316 (27%), Positives = 132/316 (41%), Gaps = 66/316 (20%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRS----- 130
WE + ++I +G +G V R +DG+ A L+
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIK------------KDGLKMNAAIKMLKEFASEN 44
Query: 131 ---SFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
F E+ V KL HPN+ +GA L I +EY
Sbjct: 45 DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI--------------------AIEY 84
Query: 187 LPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232
P GNL +L ++R L + ++Q A D++ G+ YL K+ +HRD
Sbjct: 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRD 144
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYS 292
+ N+L+ KIADFG++R E + G + +MA E L Y + DV+S
Sbjct: 145 LAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWS 203
Query: 293 FGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
FG+ LWEI PY ++ A++ + Q R E PR C + +MR+CW +R
Sbjct: 204 FGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYER 262
Query: 352 PEMGEVV----KMLEA 363
P ++ +MLEA
Sbjct: 263 PPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 59/280 (21%)
Query: 107 VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166
VAVK+L + A R+ F +E+ + +L PN+ + + + + L
Sbjct: 49 VAVKMLREDANKNA--------RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL------ 94
Query: 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALK---------IVIQLALDLS 217
C++ EY+ G+L Q+L R+ ++ A K +I +A ++
Sbjct: 95 --------------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA 140
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMA 275
G+ YL S VHRD+ T N L+ T+KIADFG++R R + +M+
Sbjct: 141 SGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMS 200
Query: 276 PE-VLQGKPYNRRCDVYSFGICLWEI--YCCDMPYPDLS-----------FADVSSAVVR 321
E +L GK + DV++FG+ LWEI C + PY LS F D R
Sbjct: 201 WESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG----R 255
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
Q P+ P CP SL +M CW NA++RP E+ L
Sbjct: 256 QVYLPK-PALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 76/318 (23%), Positives = 131/318 (41%), Gaps = 67/318 (21%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLL-------DWGEDGMATTA 123
E+ LS + + + +G +Y+G Q VA+K L WGE
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE------- 53
Query: 124 ETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVV 183
FQQE ++ +L HPN+ +G + C++
Sbjct: 54 --------FQQEASLMAELHHPNIVCLLGV--------------------VTQEQPVCML 85
Query: 184 VEYLPGGNLKQYLIRNR---------------RKKLALKIVIQLALDLSRGLSYLHSKKI 228
EYL G+L ++LI + L + +A+ ++ G+ YL S
Sbjct: 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF 145
Query: 229 VHRDVKTENMLLDSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLQGKPYNR 286
VH+D+ N+L+ Q +KI+D G++R A R + +M PE + ++
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 287 RCDVYSFGICLWEIYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWD 345
D++SFG+ LWEI+ + PY S +V V ++ L P CP + ++M +CW
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQ 264
Query: 346 ANAEKRPEMGEVVKMLEA 363
+RP ++ L +
Sbjct: 265 EGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 80/289 (27%), Positives = 135/289 (46%), Gaps = 44/289 (15%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRG-TYDNQ-EVAVKLLDWGEDGMATTAETAALRSSF 132
E+E + + R ++ +GTYG VY Q +A+K E + L
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPL---- 52
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
+E+A+ L H N+ +++G+ KI +E +PGG+L
Sbjct: 53 HEEIALHSYLKHRNIVQYLGSDSENGFFKI--------------------FMEQVPGGSL 92
Query: 193 KQYLIRNRRKKLALK--IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIA 249
L+R++ L +I + GL YLH +IVHRD+K +N+L+++ +KI+
Sbjct: 93 SA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKIS 151
Query: 250 DFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLWEIYCCDMP 306
DFG + R+ NP T TGTL YMAPEV+ P Y D++S G + E+ P
Sbjct: 152 DFGTSKRLAGINPCTETF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 307 YPDLSFADVSSAVVRQNL---RPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ +L + +A+ + + PEIP + N + +C++ + +KR
Sbjct: 211 FIEL--GEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 62/304 (20%)
Query: 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRS--------SFQQEVAV 138
++I +G +G V + +DG+ A ++ F E+ V
Sbjct: 1 DVIGEGNFGQVLKARIK------------KDGLRMDAAIKRMKEYASKDDHRDFAGELEV 48
Query: 139 WQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
KL HPN+ +GA L + +EY P GNL +L
Sbjct: 49 LCKLGHHPNIINLLGACEHRGYLYL--------------------AIEYAPHGNLLDFLR 88
Query: 198 RNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
++R L+ + ++ A D++RG+ YL K+ +HRD+ N+L+
Sbjct: 89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 148
Query: 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
KIADFG++R + + G + +MA E L Y DV+S+G+ LWEI
Sbjct: 149 YVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207
Query: 304 -DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV---- 358
PY ++ A++ + Q R E P C + ++MR+CW +RP +++
Sbjct: 208 GGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266
Query: 359 KMLE 362
+MLE
Sbjct: 267 RMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 85/314 (27%), Positives = 140/314 (44%), Gaps = 72/314 (22%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P +E+ +I +GTYG VY+ + Q VA+K++D ED
Sbjct: 4 PTGIFELV-------EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EE 46
Query: 130 SSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
++E + +K +HPN+ F GA + N +V+E
Sbjct: 47 EEIKEEYNILRKYSNHPNIATFYGAFIKK--------------NPPGNDDQLWLVMELCG 92
Query: 189 GGN----LKQYLIRNRRKKLA-LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
GG+ +K + +R K + +++ L RGL+YLH K++HRD+K +N+LL
Sbjct: 93 GGSVTDLVKGLRKKGKRLKEEWIAYILRETL---RGLAYLHENKVIHRDIKGQNILLTKN 149
Query: 244 RTLKIADFGVAR-VEAQNPRDMTGETGTLGYMAPEVL--QGKP---YNRRCDVYSFGICL 297
+K+ DFGV+ +++ R T GT +MAPEV+ +P Y+ R DV+S GI
Sbjct: 150 AEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208
Query: 298 WEIYCCDMPYPDLSFADVSSAVVRQNLRP--EIPRCCPSSLA----------NIMRKCWD 345
E+ P D+ +R +IPR P +L + + +C
Sbjct: 209 IELADGKPPLCDM-----------HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLI 257
Query: 346 ANAEKRPEMGEVVK 359
N E+RP M E+++
Sbjct: 258 KNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 80 LSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
+KL+ I +G++G VY+G + VA+K++D E AE QQE+
Sbjct: 6 FTKLER---IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE------AEDEI--EDIQQEIT 54
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
V + D P +T++ G+ + + L I ++EYL GG+ L
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWI--------------------IMEYLGGGSALDLL- 93
Query: 198 RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
+ L + + ++ +GL YLHS++ +HRD+K N+LL Q +K+ADFGVA
Sbjct: 94 --KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317
GT +MAPEV++ Y+ + D++S GI E+ + P DL V
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-L 210
Query: 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++ +N P + + C + + RP E++K
Sbjct: 211 FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 50/267 (18%)
Query: 107 VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166
VAVK+L A +TA R+ F +E+ + +L +PN+ + +G V L
Sbjct: 47 VAVKML------RADVTKTA--RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL------ 92
Query: 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYL----------IRNRRKKLALKIVIQLALDL 216
C++ EY+ G+L Q+L N +++ ++ +A+ +
Sbjct: 93 --------------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI 138
Query: 217 SRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYM 274
+ G+ YL S VHRD+ T N L+ + T+KIADFG++R R + +M
Sbjct: 139 ASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWM 198
Query: 275 APE-VLQGKPYNRRCDVYSFGICLWEIY--CCDMPYPDLSFADV---SSAVVRQNLRP-- 326
A E +L GK + DV++FG+ LWE++ C + PY LS V + R R
Sbjct: 199 AWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY 257
Query: 327 -EIPRCCPSSLANIMRKCWDANAEKRP 352
CPS + +M +CW + + RP
Sbjct: 258 LSQTPLCPSPVFKLMMRCWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/171 (32%), Positives = 91/171 (53%), Gaps = 19/171 (11%)
Query: 204 LALKI--VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
LAL ++ + +++G+S+L SK +HRD+ N+LL R KI DFG+AR
Sbjct: 209 LALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR------ 262
Query: 262 RDMTGETG---------TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLS 311
D+ ++ + +MAPE + Y DV+S+GI LWEI+ PYP +
Sbjct: 263 -DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
++++ R P C PS + +IM+ CWDA+ KRP ++V+++E
Sbjct: 322 VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 59/290 (20%)
Query: 80 LSKLDMRNLIAQGTYGSVY----RGTYDNQEVAVKLLDWG--EDGMATTAETAALRSSFQ 133
LS+L+ N I G G+VY R T + A+K++ +G ED +R
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPT--GRLYALKVI-YGNHED---------TVRRQIC 120
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+E+ + + ++HPNV K D N + V++E++ GG+L+
Sbjct: 121 REIEILRDVNHPNVVKCHDM---------------FDHNGEIQ-----VLLEFMDGGSLE 160
Query: 194 QYLIRNRRKKLALKIVIQLALDLSR----GLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
I + + LA D++R G++YLH + IVHRD+K N+L++S + +KIA
Sbjct: 161 GTHIADEQ---------FLA-DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIA 210
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVL-----QGKPYNRRCDVYSFGICLWEIYCCD 304
DFGV+R+ AQ GT+ YM+PE + G D++S G+ + E Y
Sbjct: 211 DFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
Query: 305 MPYPDLSFADVSS--AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
P+ D +S + + PE P + + C KR
Sbjct: 271 FPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 61/182 (33%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 181 CVVVEYLPGGNLKQYLIRN-----RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
C V+EY GG+L ++ + R A +V+ GL YLH KIV+RD+K
Sbjct: 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL--------GLQYLHENKIVYRDLKL 129
Query: 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFG 294
+N+LLD++ +KIADFG+ + E D T GT ++APEVL Y R D + G
Sbjct: 130 DNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLG 188
Query: 295 ICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354
+ ++E+ + P+P +V ++V N PR +IMR+ N E+R
Sbjct: 189 VLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRRLLRRNPERRLGS 246
Query: 355 GE 356
GE
Sbjct: 247 GE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 52/172 (30%), Positives = 89/172 (51%), Gaps = 6/172 (3%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EY+ GG+L ++ R+ R A ++ GL +LH + I++RD+K +N+LL
Sbjct: 72 FFVMEYVNGGDLMFHIQRSGRFDEPRARF--YAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
DS+ +KIADFG+ + E T GT Y+APE+L +PY D ++ G+ L+E
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 300 IYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
+ P+ ++ +++ +R PR +I++ N EKR
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 64/286 (22%), Positives = 136/286 (47%), Gaps = 40/286 (13%)
Query: 81 SKLDMRNLIAQGTYGSVYRGTYDNQ------EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
++L ++ G +G+VY+G + + VA+K+L+ TT A + F
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN------ETTGPKANVE--FMD 58
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E + +DHP++ + +G + + +V + +P G L
Sbjct: 59 EALIMASMDHPHLVRLLGVCLSPT---------------------IQLVTQLMPHGCLLD 97
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
Y + + + ++++ + +++G+ YL +++VHRD+ N+L+ S +KI DFG+A
Sbjct: 98 Y-VHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156
Query: 255 RVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLS 311
R+ + ++ + G + +MA E + + + + DV+S+G+ +WE+ PY +
Sbjct: 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216
Query: 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
++ + + P+ P C + +M KCW +A+ RP+ E+
Sbjct: 217 TREIPDLLEKGERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 68/276 (24%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G + VY+ D + VA+K + E M A R +E+ + ++LDHPN
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFE-MMDAKA-----RQDCLKEIDLLKQLDHPN 63
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
V K++ + + + L I V+E G+L + +I++ +K+ L
Sbjct: 64 VIKYLASFIENNELNI--------------------VLELADAGDLSR-MIKHFKKQKRL 102
Query: 207 ---KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ + + + L L ++HSK+I+HRD+K N+ + + +K+ D G+ R +
Sbjct: 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP-YPD-LSFADVSSAVVR 321
GT YM+PE + YN + D++S G L+E+ P Y D ++ + + +
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+ P L +++ +C + + EKRP++ V
Sbjct: 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 41/279 (14%)
Query: 83 LDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
L+ + G G V + +AVK + + A++ +E+ +
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--------EAIQKQILRELDILH 54
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
K + P + F GA ++ I +EY+ GG+L + L +
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISI--------------------CMEYMDGGSLDKIL-KEV 93
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
+ ++ +I+ ++A+ + +GL+YLH K KI+HRDVK N+L++S+ +K+ DFGV+ +
Sbjct: 94 QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-QLV 152
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP-----DLSFAD 314
N T GT YMAPE +QG Y+ + D++S G+ L E+ PYP +
Sbjct: 153 NSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 315 VSSAVVRQNLRPEIPR-CCPSSLANIMRKCWDANAEKRP 352
+ +V + P +P + + C + +RP
Sbjct: 212 LLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 79/286 (27%), Positives = 125/286 (43%), Gaps = 46/286 (16%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I G VY +N++VA+K +D + T+ + ++EV + +HPN
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVD------ELRKEVQAMSQCNHPN 60
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKL 204
V K+ + V L + V+ YL GG+L +++ R L
Sbjct: 61 VVKYYTSFVVGDELWL--------------------VMPYLSGGSLLD-IMKSSYPRGGL 99
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
I+ + ++ +GL YLHS +HRD+K N+LL ++KIADFGV+ A D
Sbjct: 100 DEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD-GGDR 158
Query: 265 TGET-----GTLGYMAPEVL-QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
T + GT +MAPEV+ Q Y+ + D++SFGI E+ PY V
Sbjct: 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218
Query: 319 VVRQNLRPEIPRC-----CPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ QN P + S ++ C + KRP E++K
Sbjct: 219 TL-QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 3/161 (1%)
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
L L+ +I + ++RG+ +L S+K +HRD+ N+LL +KI DFG+AR ++P
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229
Query: 264 MTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSSAVV 320
+ L +MAPE + K Y + DV+SFG+ LWEI+ PYP + + +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL 289
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
++ R P + +IM CW N E RP E+V++L
Sbjct: 290 KEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-24
Identities = 85/301 (28%), Positives = 140/301 (46%), Gaps = 43/301 (14%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGTYDN---QEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
+KL+ I +G++G V++G DN Q VA+K++D E AE QQE+
Sbjct: 6 FTKLER---IGKGSFGEVFKGI-DNRTQQVVAIKIIDLEE------AEDEI--EDIQQEI 53
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V + D P VTK+ G+ + + L I ++EYL GG+ L
Sbjct: 54 TVLSQCDSPYVTKYYGSYLKGTKLWI--------------------IMEYLGGGSALDLL 93
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-- 254
+ + +++ ++ +GL YLHS+K +HRD+K N+LL Q +K+ADFGVA
Sbjct: 94 RAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150
Query: 255 RVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
+ Q R+ GT +MAPEV+Q Y+ + D++S GI E+ + P D+
Sbjct: 151 LTDTQIKRNTF--VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIP 374
V + + N P + + C + + RP E++K + +K +
Sbjct: 209 VLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLT 267
Query: 375 E 375
E
Sbjct: 268 E 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-24
Identities = 90/304 (29%), Positives = 140/304 (46%), Gaps = 53/304 (17%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYR--GTYDNQEVAVKLLDWGEDGMATTAETAALR 129
P + WEI I +GTYG V++ + + AVK+LD D +
Sbjct: 16 PSDTWEI-------IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----------ID 58
Query: 130 SSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+ E + + L DHPNV KF G + K +G+ +V+E
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYG---------MYYKKDVKNGDQ------LWLVLELCN 103
Query: 189 GGNL----KQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
GG++ K +L R R ++ + ++ AL GL +LH K +HRDVK N+LL ++
Sbjct: 104 GGSVTDLVKGFLKRGERMEEPIIAYILHEAL---MGLQHLHVNKTIHRDVKGNNILLTTE 160
Query: 244 RTLKIADFGV-ARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICL 297
+K+ DFGV A++ + R T GT +MAPEV+ Y+ RCDV+S GI
Sbjct: 161 GGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219
Query: 298 WEIYCCDMPYPDLSFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMG 355
E+ D P DL + R N P + P + + +RKC + EKRP +
Sbjct: 220 IELGDGDPPLADLHPMRALFKIPR-NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278
Query: 356 EVVK 359
++++
Sbjct: 279 DLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 8e-24
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 36/274 (13%)
Query: 89 IAQGTYGSVYRGTYDNQE---VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I +G++G V++G DN+ VA+K++D E AE QQE+ V + D P
Sbjct: 12 IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEE------AEDEI--EDIQQEITVLSQCDSP 62
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
VTK+ G+ + + L I ++EYL GG+ L +
Sbjct: 63 YVTKYYGSYLKDTKLWI--------------------IMEYLGGGSALDLLEPGPLDETQ 102
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT 265
+ +++ ++ +GL YLHS+K +HRD+K N+LL +K+ADFGVA
Sbjct: 103 IATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR 325
GT +MAPEV++ Y+ + D++S GI E+ + P+ +L V + + N
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-P 218
Query: 326 PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P + L + C + RP E++K
Sbjct: 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 40/218 (18%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY R + VA+K L+ ++G+ +TA +R E+++ ++L+H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA----IR-----EISLLKELNH 57
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ + + + L + V E+L +LK+Y+ + L
Sbjct: 58 PNIVRLLDVVHSENKLYL--------------------VFEFL-DLDLKKYMDSSPLTGL 96
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
++ L +G++Y HS +++HRD+K +N+L+D + LK+ADFG+AR R
Sbjct: 97 DPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
T E TL Y APE+L G YS + +W I C
Sbjct: 157 THEVVTLWYRAPEILLGSRQ------YSTPVDIWSIGC 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 9e-24
Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
L+ QG +G VY YD +E+AVK + + + T+ E AL E+ + + L H
Sbjct: 9 LLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLKNLLH 63
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ ++ G L+ P R + +E++PGG++K L L
Sbjct: 64 ERIVQYYGC------LRDP------------MERTLSIFMEHMPGGSIKDQL--KSYGAL 103
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR---VEAQNP 261
+ + + G+SYLHS IVHRD+K N+L DS +K+ DFG ++ +
Sbjct: 104 TENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG 163
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
M TGT +M+PEV+ G+ Y R+ D++S G + E+ P+ + +
Sbjct: 164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
Q P +P + +++ + A+ RP E+++
Sbjct: 224 QPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 59/278 (21%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 88 LIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147
LI + S+Y+G ++N+EV ++ G L + E+ +++D N+
Sbjct: 27 LIKENDQNSIYKGIFNNKEVIIRTFKKFHKG------HKVLIDITENEIKNLRRIDSNNI 80
Query: 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALK 207
K G + + +P + +++EY G L++ L ++ K L+ K
Sbjct: 81 LKIYGFIIDIVD-DLPRLS---------------LILEYCTRGYLREVL--DKEKDLSFK 122
Query: 208 IVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
+ +A+D +GL L+ ++++ + + L+ LKI G+ ++ + P
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK--- 179
Query: 267 ETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324
+ Y + ++L Y + D+YS G+ LWEI+ +P+ +L+ ++ ++ +N
Sbjct: 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239
Query: 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
++P CP + I+ C ++ KRP + E++ L
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-23
Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 57/283 (20%)
Query: 107 VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166
VAVK+L + A R+ F +EV + +L PN+ + +G V L
Sbjct: 49 VAVKIL------RPDANKNA--RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL------ 94
Query: 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK-----------------LALKIV 209
C++ EY+ G+L Q+L + ++ +
Sbjct: 95 --------------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140
Query: 210 IQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-VEAQNPRDMTGET 268
+ +AL ++ G+ YL S VHRD+ T N L+ T+KIADFG++R + A + + G
Sbjct: 141 LHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRA 200
Query: 269 G-TLGYMAPE-VLQGKPYNRRCDVYSFGICLWEIY--CCDMPYPDLSFADV---SSAVVR 321
+ +MA E +L GK + DV++FG+ LWEI C + PY +L+ V + R
Sbjct: 201 VLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFR 259
Query: 322 QNLRPEI---PRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
R P CP L +M +CW + +RP ++ L
Sbjct: 260 DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 9/171 (5%)
Query: 185 EYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
EY GG L L + A + + L YLH++ I++RD+K EN+LLDS
Sbjct: 73 EYCLGGELWTILRDRGLFDEYTARFYIACVVL----AFEYLHNRGIIYRDLKPENLLLDS 128
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+K+ DFG A+ + T GT Y+APE++ K Y+ D +S GI L+E+
Sbjct: 129 NGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT 187
Query: 303 CDMPY--PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
P+ D ++ + +++ N + E P + +++++ N E+R
Sbjct: 188 GRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-23
Identities = 66/280 (23%), Positives = 137/280 (48%), Gaps = 40/280 (14%)
Query: 88 LIAQGTYGSVYRGTYDNQ------EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ G +G+VY+G + + VA+K L A + E V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKEILDEAYVMAS 65
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+D+P+V + +G + TS +++ + + +P G L Y +R +
Sbjct: 66 VDNPHVCRLLGICL-TSTVQL--------------------ITQLMPFGCLLDY-VREHK 103
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
+ + ++ + +++G++YL +++VHRD+ N+L+ + + +KI DFG+A++ +
Sbjct: 104 DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 262 RDMTGETGT--LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSSA 318
++ E G + +MA E + + Y + DV+S+G+ +WE+ PY + +++SS
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
+ + P+ P C + IM KCW +A+ RP+ E++
Sbjct: 224 LEKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 70/261 (26%), Positives = 123/261 (47%), Gaps = 31/261 (11%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
L+ +G +G VY YD +E+AVK + + D T+ E AL E+ + + L H
Sbjct: 9 LLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQLLKNLRH 63
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ ++ G L+ P + + + VEY+PGG++K L L
Sbjct: 64 DRIVQYYGC------LRDPEE------------KKLSIFVEYMPGGSIKDQL--KAYGAL 103
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVEA--QNP 261
+ + + +G+SYLHS IVHRD+K N+L DS +K+ DFG + R++ +
Sbjct: 104 TENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG 163
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
+ TGT +M+PEV+ G+ Y R+ DV+S + E+ P+ + +
Sbjct: 164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223
Query: 322 QNLRPEIPRCCPSSLANIMRK 342
Q +P +P + + +++
Sbjct: 224 QPTKPMLPDGVSDACRDFLKQ 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 78/235 (33%), Positives = 108/235 (45%), Gaps = 41/235 (17%)
Query: 71 RPKEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETA 126
R E+E KL N I +GTYG VYR T + VA+K +D DG+ ++
Sbjct: 4 RSVTEFE----KL---NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--- 53
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
LR E+ + L HPN+ + VG + +V+EY
Sbjct: 54 -LR-----EITLLLNLRHPNIVELKEVVVGKH------------------LDSIFLVMEY 89
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+L L+ N + V L L L RGL YLH I+HRD+K N+LL + L
Sbjct: 90 CEQ-DLAS-LLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCL 147
Query: 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEI 300
KIADFG+AR + MT + TL Y APE+L G Y D+++ G L E+
Sbjct: 148 KIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 5e-23
Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 32/278 (11%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
L+ QG +G VY YD +E+A K + + + T+ E +AL E+ + + L H
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQH 63
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ ++ G + + + +EY+PGG++K L L
Sbjct: 64 ERIVQYYGCLRDRAE------------------KTLTIFMEYMPGGSVKDQL--KAYGAL 103
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR---VEAQNP 261
+ + + G+SYLHS IVHRD+K N+L DS +K+ DFG ++ +
Sbjct: 104 TESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
+ TGT +M+PEV+ G+ Y R+ DV+S G + E+ P+ + +
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT 223
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
Q P++P + + C A RP E+++
Sbjct: 224 QPTNPQLPSHISEHARDFLG-CIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 40/218 (18%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY R + VA+K LD +G+ +TA +R E+++ ++L+H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA----IR-----EISLLKELNH 58
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ K + + L + V E+L +LK+++ + +
Sbjct: 59 PNIVKLLDVIHTENKLYL--------------------VFEFL-HQDLKKFMDASPLSGI 97
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
L ++ L +GL++ HS +++HRD+K +N+L++++ +K+ADFG+AR R
Sbjct: 98 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
T E TL Y APE+L G C YS + +W + C
Sbjct: 158 THEVVTLWYRAPEILLG------CKYYSTAVDIWSLGC 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 38/215 (17%)
Query: 87 NLIAQGTYGSVYRG----TYDNQEVAVKLL--DWGEDGMATTAETAALRSSFQQEVAVWQ 140
N I +GTYG VYR T + VA+K L + ++G T+ LR E+ +
Sbjct: 11 NRIEEGTYGVVYRARDKKT--GEIVALKKLKMEKEKEGFPITS----LR-----EINILL 59
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
KL HPN+ VG++ KI +V+EY+ +LK L+
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKI------------------YMVMEYVEH-DLKS-LMETM 99
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
++ V L L L G+++LH I+HRD+KT N+LL+++ LKI DFG+AR
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 261 PRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFG 294
+ T TL Y APE+L G Y+ D++S G
Sbjct: 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 88 LIAQGTYGSVYRGTYDN--------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVA-- 137
+ G +G VY+ N +E+ V +G+D S V+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERD-------KSIGDIVSEV 59
Query: 138 --VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+ ++L HPN+ ++ + L I V++ + G L ++
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYI--------------------VMDLIEGAPLGEH 99
Query: 196 LIRNRRKKLAL------KIVIQLALDLSRGLSYLH-SKKIVHRDVKTENMLLDSQRTLKI 248
+ KK I +Q+ L L YLH K+IVHRD+ N++L + I
Sbjct: 100 FNSLKEKKQRFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155
Query: 249 ADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308
DFG+A+ + + +T GT+ Y PE+++ +PY + DV++FG L+++ P+
Sbjct: 156 TDFGLAKQKQPESK-LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
+ +++ +V P + +++ C +AE RP++ +V M+
Sbjct: 215 STNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 46/305 (15%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
++ + + +++I +G +G V + + +D M A R F E+
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRD-FAGELE 59
Query: 138 VWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V KL HPN+ +GA L + +EY P GNL +L
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYL--------------------AIEYAPHGNLLDFL 99
Query: 197 IRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
++R L+ + ++ A D++RG+ YL K+ +HRD+ N+L+
Sbjct: 100 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
KIADFG++R + + G + +MA E L Y DV+S+G+ LWEI
Sbjct: 160 NYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
Query: 303 C-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV--- 358
PY ++ A++ + Q R E P C + ++MR+CW +RP +++
Sbjct: 219 LGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
Query: 359 -KMLE 362
+MLE
Sbjct: 278 NRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
++ +G YG V R + VA+K + + ++ + +EV V ++L H
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-------KFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ A L + V EY+ L + L + L
Sbjct: 61 NIVNLKEAFRRKGRLYL--------------------VFEYVER-TLLELLEASP-GGLP 98
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-VEAQNPRDM 264
V L + ++Y HS I+HRD+K EN+L+ LK+ DFG AR + A+ +
Sbjct: 99 PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158
Query: 265 TGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEI 300
T T Y APE+L G Y + DV++ G + E+
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 55/178 (30%), Positives = 91/178 (51%), Gaps = 4/178 (2%)
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
P + LI N L+ ++ + ++ G+ +L SK VHRD+ N+L+ + +K
Sbjct: 221 PERTRRDTLI-NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 248 IADFGVARVEAQNPRDMT-GETG-TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-D 304
I DFG+AR ++ ++ G T L +MAPE + Y DV+SFGI LWEI+
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
PYP+L + +++ R P + IM+KCW+ E RP+ ++V ++
Sbjct: 340 TPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 73/302 (24%), Positives = 132/302 (43%), Gaps = 57/302 (18%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEV--AVKLLDWGEDGMATTAETAALR 129
P + WEI + +L G +G VY+ + + A K++ +
Sbjct: 3 PNDIWEI-IGEL------GDGAFGKVYKAQHKETGLFAAAKIIQIESE---------EEL 46
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
F E+ + + HPN+ A + L I ++E+ G
Sbjct: 47 EDFMVEIDILSECKHPNIVGLYEAYFYENKLWI--------------------LIEFCDG 86
Query: 190 GNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G L ++ R + ++ V + L+ L++LHS K++HRD+K N+LL +K
Sbjct: 87 GALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLHSHKVIHRDLKAGNILLTLDGDVK 143
Query: 248 IADFGVARVEAQNPRDMTGET---GTLGYMAPEVL-----QGKPYNRRCDVYSFGICLWE 299
+ADFGV+ A+N + GT +MAPEV+ + PY+ + D++S GI L E
Sbjct: 144 LADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
Query: 300 IYCCDMPYPDLSFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+ + P+ +L+ V +++ P + P SS + ++ C + + RP E+
Sbjct: 201 LAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
Query: 358 VK 359
+K
Sbjct: 260 LK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-22
Identities = 77/298 (25%), Positives = 131/298 (43%), Gaps = 53/298 (17%)
Query: 89 IAQGTYGSVYRGT-------YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ +G +G V+ D VAVK L +E+A R FQ+E +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------EASESA--RQDFQREAELLTV 63
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL----- 196
L H ++ +F G +G R +V EY+ G+L ++L
Sbjct: 64 LQHQHIVRFYGVCT--------------EG------RPLLMVFEYMRHGDLNRFLRSHGP 103
Query: 197 ---IRNRRK-----KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI 248
I + +L L ++ +A ++ G+ YL S VHRD+ T N L+ +KI
Sbjct: 104 DAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163
Query: 249 ADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DM 305
DFG++R + + + + G T + +M PE + + + D++SFG+ LWEI+
Sbjct: 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
P+ LS + + Q E PR CP + IM+ CW ++R + ++ L+A
Sbjct: 224 PWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 3/161 (1%)
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
L ++ +I + ++RG+ +L S+K +HRD+ N+LL +KI DFG+AR ++P
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 264 MTGETG--TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSSAVV 320
+ + L +MAPE + K Y + DV+SFG+ LWEI+ PYP + + +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
+ R P + IM CW + ++RP +V++L
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 5/182 (2%)
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+K L + + L ++ ++RG+ +L SK VHRD+ N+LL + +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276
Query: 247 KIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
KI DFG+AR + + + + T + +MAPE + Y DV+S+GI LWEI+
Sbjct: 277 KICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335
Query: 304 -DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
PYP + ++ R P + +IM KCW++ EKRP + ++E
Sbjct: 336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395
Query: 363 AI 364
++
Sbjct: 396 SL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD---NQE--VAVKLLDWGEDGMATTAETAALRSS 131
E+D + + ++ G +G + RG +E VA+ L G + R
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--------SDKQRRG 52
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F E + DH N+ + G + + I V EY+ G
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMI--------------------VTEYMSNGA 92
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L +L R +L ++ + L+ G+ YL VH+ + +L++S KI+ F
Sbjct: 93 LDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF 151
Query: 252 GVARVEAQNPRD--------MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
+ D M+G++ L + APE +Q ++ DV+SFGI +WE+
Sbjct: 152 R------RLQEDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204
Query: 304 -DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
+ PY D+S DV A V R PR CP+ L +M CW +RP ++ +L
Sbjct: 205 GERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 24/179 (13%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EYL GG+L ++ + A ++ GL +LH K I++RD+K +N+LLD
Sbjct: 74 VMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGET------GTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
+KIADFG+ + M GE GT Y+APE+L+G+ YN D +SFG+
Sbjct: 132 DGHIKIADFGMCKEN------MNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVL 185
Query: 297 LWEIYCCDMPY----PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
L+E+ P+ D F + N RP PR + + K ++ + KR
Sbjct: 186 LYEMLIGQSPFHGEDEDELFDSI------LNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 3/164 (1%)
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+K L L+ +I + +++G+ +L S+K +HRD+ N+LL +KI DFG+AR ++
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 261 PRDMTGETG--TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSS 317
P + L +MAPE + + Y + DV+SFG+ LWEI+ PYP + +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
+++ R P + M CW +RP E+V+ L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 49/148 (33%), Positives = 87/148 (58%), Gaps = 1/148 (0%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C+V+ + GG+LK ++ + L ++ VI + ++ G+ +LHS IV+RD+K EN+LL
Sbjct: 69 CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL 128
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
D Q +++D G+A VE ++ + +T GT GYMAPE+L+ +PY+ D ++ G ++E+
Sbjct: 129 DDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
Query: 301 YCCDMPYPDLSFADVSSAVVRQNLRPEI 328
P+ D + R+ L E+
Sbjct: 188 VAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 59/236 (25%), Positives = 111/236 (47%), Gaps = 31/236 (13%)
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
R ++EVAV + HPN+ ++ + NL I V++Y
Sbjct: 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI--------------------VMDYCE 82
Query: 189 GGNLKQYLIRNRRKKL-----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
GG+L + I +R L L +Q+ L L ++H +KI+HRD+K++N+ L
Sbjct: 83 GGDLYK-KINAQRGVLFPEDQILDWFVQICL----ALKHVHDRKILHRDIKSQNIFLTKD 137
Query: 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
T+K+ DFG+ARV GT Y++PE+ + +PYN + D+++ G L+E+
Sbjct: 138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + ++ ++R + P + L N++ + + N RP + +++
Sbjct: 198 KHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-21
Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 47/273 (17%)
Query: 89 IAQGTYGSVY------RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
I++G +GSVY G Y A+K+L + M + +++ ++ + + Q
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY----FAIKVLK--KSDMIAKNQVTNVKA--ERAIMMIQG- 54
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
+ P V K + L +V+EYL GG+ LI+
Sbjct: 55 ESPYVAKLYYSFQSKDYL--------------------YLVMEYLNGGDCAS-LIK-TLG 92
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
L Q ++ G+ LH + I+HRD+K EN+L+D LK+ DFG++R +N +
Sbjct: 93 GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY----PDLSFADVSSA 318
+ GT Y+APE + G ++ D +S G ++E P+ PD F ++ S
Sbjct: 153 FV----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
+ N E+ C +++ + + KR
Sbjct: 209 RI--NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 41/219 (18%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY+G Q VA+K L+ E+G+ +TA +E+++ ++L H
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA---------IREISLLKELQH 58
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK- 203
PN+ + S L + + E+L +LK+YL + +
Sbjct: 59 PNIVCLQDVLMQESRLYL--------------------IFEFL-SMDLKKYLDSLPKGQY 97
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ ++V + +G+ + HS++++HRD+K +N+L+D++ +K+ADFG+AR R
Sbjct: 98 MDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
T E TL Y APEVL G P YS + +W I
Sbjct: 158 YTHEVVTLWYRAPEVLLGSPR------YSTPVDIWSIGT 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 95/306 (31%), Positives = 135/306 (44%), Gaps = 54/306 (17%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALR 129
P + WEI I +GTYG VY+ T D AVK+LD D +
Sbjct: 20 PTDTWEI-------IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----------VD 62
Query: 130 SSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+ E + Q L +HPNV KF G L V G +V+E
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKL--------VGGQ-------LWLVLELCN 107
Query: 189 GGN----LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
GG+ +K LI +R A+ I L GL +LH+ +I+HRDVK N+LL ++
Sbjct: 108 GGSVTELVKGLLICGQRLDEAMISYILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEG 165
Query: 245 TLKIADFGV-ARVEAQNPRDMTGETGTLGYMAPEVLQGK-----PYNRRCDVYSFGICLW 298
+K+ DFGV A++ + R T GT +MAPEV+ + Y+ RCDV+S GI
Sbjct: 166 GVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAI 224
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGE 356
E+ D P D+ + R N P + P S + + +C + E RP
Sbjct: 225 ELGDGDPPLFDMHPVKTLFKIPR-NPPPTLLHPEKWCRSFNHFISQCLIKDFEARP---S 280
Query: 357 VVKMLE 362
V +LE
Sbjct: 281 VTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 8e-21
Identities = 70/286 (24%), Positives = 133/286 (46%), Gaps = 43/286 (15%)
Query: 87 NLIAQGTYGSVYRG-TYDNQEVAVKLLDWGEDGMATTAETAALRS--SFQQEVAVWQKLD 143
++ +G YG+VY G T Q +AVK ++ + T+ AA + Q+EV + + L
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVE-----LDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
H N+ +++G + + + I +E++PGG++ L NR
Sbjct: 61 HVNIVQYLGTCLDDNTISI--------------------FMEFVPGGSISSIL--NRFGP 98
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR------VE 257
L + + + G++YLH+ +VHRD+K N++L +K+ DFG AR +
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317
+ + GT +MAPEV+ Y R+ D++S G ++E+ P L+ D +
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK---PPLASMDRLA 215
Query: 318 AVV----RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
A+ + L P +P ++ + + C + +RP ++++
Sbjct: 216 AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 72/252 (28%), Positives = 107/252 (42%), Gaps = 48/252 (19%)
Query: 92 GTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151
G+ G V+ T Q V +L G+ G T E L Q ++HP+V +
Sbjct: 77 GSEGRVFVATKPGQPDPV-VLKIGQKG-TTLIEAMLL-----------QNVNHPSVIRM- 122
Query: 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN-RRKKLALKIVI 210
K V G C V+ Y +L YL + R + ++I
Sbjct: 123 -------------KDTLVSGAIT-----CMVLPHY--SSDLYTYLTKRSRPLPIDQALII 162
Query: 211 QLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGT 270
+ + GL YLH+++I+HRDVKTEN+ ++ + I D G A+ P + G GT
Sbjct: 163 EKQI--LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGT 219
Query: 271 LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR 330
+ APEVL YN + D++S GI L+E+ + YP F D S E +
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEM----LAYPSTIFEDPPST------PEEYVK 269
Query: 331 CCPSSLANIMRK 342
C S L I+
Sbjct: 270 SCHSHLLKIIST 281
|
Length = 357 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVK------LLDWGEDGMATTAETAALRSS 131
L+ + I +G + VYR T D VA+K L+D A R+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD------------AKARAD 48
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
+E+ + ++L+HPNV K+ + + + L I V+E G+
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNELNI--------------------VLELADAGD 88
Query: 192 LKQYL--IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
L + + + +++ + K V + + L L ++HS++++HRD+K N+ + + +K+
Sbjct: 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG 148
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP-YP 308
D G+ R + GT YM+PE + YN + D++S G L+E+ P Y
Sbjct: 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSS-LANIMRKCWDANAEKRPEMGEVVKM 360
D + Q P +P S L ++ C + + EKRP++ V +
Sbjct: 209 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 68/305 (22%), Positives = 131/305 (42%), Gaps = 53/305 (17%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALR 129
EI+LS + + + +G VY+G Q VA+K L +G LR
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--------PLR 52
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
F+ E + +L HPN+ +G L + + Y
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM--------------------IFSYCSH 92
Query: 190 GNLKQYLI--------------RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
+L ++L+ + + L + + ++ G+ +L S +VH+D+ T
Sbjct: 93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT 152
Query: 236 ENMLLDSQRTLKIADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLQGKPYNRRCDVYSF 293
N+L+ + +KI+D G+ R V A + + G + + +M+PE + ++ D++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 294 GICLWEIYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
G+ LWE++ + PY S DV + + + P P CP+ + +M +CW+ +RP
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRP 271
Query: 353 EMGEV 357
++
Sbjct: 272 RFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 75/301 (24%), Positives = 132/301 (43%), Gaps = 55/301 (18%)
Query: 85 MRNLIAQGTYGSVYRGT-------YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
++ + +G +G V+ D VAVK L D R F +E
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA---------RKDFHREAE 59
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ L H ++ KF G V +G+ + +V EY+ G+L ++L
Sbjct: 60 LLTNLQHEHIVKFYGVCV--------------EGDPLI------MVFEYMKHGDLNKFLR 99
Query: 198 R-----------NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
NR +L ++ +A ++ G+ YL S+ VHRD+ T N L+ +
Sbjct: 100 AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159
Query: 247 KIADFGVAR-VEAQNPRDMTGETG-TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC- 303
KI DFG++R V + + + G T + +M PE + + + DV+S G+ LWEI+
Sbjct: 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 219
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
P+ LS +V + + + + PR CP + ++M CW ++ P M +K + +
Sbjct: 220 KQPWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCW----QREPHMRLNIKEIHS 274
Query: 364 I 364
+
Sbjct: 275 L 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 80/284 (28%), Positives = 137/284 (48%), Gaps = 47/284 (16%)
Query: 95 GSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154
G +RG + V +L AT E + F QEV +++L+HPNV + +G
Sbjct: 14 GEAHRGMSKARVVVKELRA-----SATPDE----QLLFLQEVQPYRELNHPNVLQCLGQC 64
Query: 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQ- 211
+ ++P +V+E+ P G+LK YL NR ++A K V+Q
Sbjct: 65 I-----------------ESIPY---LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR 104
Query: 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGT- 270
+A +++ GL +LH +H D+ N L + ++KI D+G+A + +T +
Sbjct: 105 MACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 271 -LGYMAPEV-------LQGKPYNRRCDVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVR 321
L ++APE+ L K ++ +++S G+ +WE++ D PYPDLS V VVR
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224
Query: 322 -QNL---RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
Q++ +P++ +M+ CW + E RP EV ++L
Sbjct: 225 EQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 67/287 (23%), Positives = 129/287 (44%), Gaps = 32/287 (11%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
L+ + I +G + VYR T D + VA+K + E A R +E+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE------MMDAKARQDCVKEID 54
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL- 196
+ ++L+HPNV K++ + + + L I V+E G+L Q +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNI--------------------VLELADAGDLSQMIK 94
Query: 197 -IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
+ +++ + + V + + L + ++HS++++HRD+K N+ + + +K+ D G+ R
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP-YPDLSFAD 314
+ GT YM+PE + YN + D++S G L+E+ P Y D
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214
Query: 315 VSSAVVRQNLRPEIPRCCPSS-LANIMRKCWDANAEKRPEMGEVVKM 360
+ Q P +P S L ++ C + ++RP++G V ++
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
++E + K+ HPN+ F + +L I V+EY GG+L
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYI--------------------VMEYCDGGDL 85
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
Q + R K ++Q + + G+ ++H K+++HRD+K++N+ L +K+ DFG
Sbjct: 86 MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFG 145
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312
AR+ GT Y+ PE+ + PYN + D++S G L+E+ P+ S+
Sbjct: 146 SARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205
Query: 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
++ V + + +P +P L +++++ + N RP
Sbjct: 206 KNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRP 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 71/291 (24%), Positives = 137/291 (47%), Gaps = 43/291 (14%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQE----VAVKLLDWGEDGMATTAETAALRS 130
E +L K+ ++ G +G+VY+G + D + VA+K+L + + A L
Sbjct: 6 ETELKKV---KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RENTSPKANKEIL-- 57
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
E V + P V + +G + TS +++ V + +P G
Sbjct: 58 ---DEAYVMAGVGSPYVCRLLGICL-TSTVQL--------------------VTQLMPYG 93
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L Y +R + ++ + ++ + +++G+SYL ++VHRD+ N+L+ S +KI D
Sbjct: 94 CLLDY-VRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITD 152
Query: 251 FGVARVEAQNPRDMTGETGT--LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PY 307
FG+AR+ + + + G + +MA E + + + + DV+S+G+ +WE+ PY
Sbjct: 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
+ ++ + + P+ P C + IM KCW ++E RP E+V
Sbjct: 213 DGIPAREIPDLLEKGERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 89 IAQGTYGSVYRGTYDN--QEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY+ N + VA+K L+ E+G+ TA LR E+++ Q L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA----LR-----EISLLQMLSE 59
Query: 145 -PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK- 202
+ + + V+ P+ +V EYL +LK+++ N R
Sbjct: 60 SIYIVRLL-------------DVEHVEEKNGKPS--LYLVFEYL-DSDLKKFMDSNGRGP 103
Query: 203 --KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIADFGVARVEAQ 259
L K + L +G+++ H ++HRD+K +N+L+D Q+ LKIAD G+ R +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ T E TL Y APEVL G + YS + +W + C
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTH------YSTPVDIWSVGC 200
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GTY +VY+G + VA+K LD E+G +TA +R E+++ ++L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLD-AEEGTPSTA----IR-----EISLMKELKH 57
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL-IRNRRKK 203
N+ + + L + V EY+ +LK+Y+ R
Sbjct: 58 ENIVRLHDVIHTENKLML--------------------VFEYMDK-DLKKYMDTHGVRGA 96
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
L V L +G+++ H +++HRD+K +N+L++ + LK+ADFG+AR
Sbjct: 97 LDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156
Query: 264 MTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301
+ E TL Y AP+VL G + Y+ D++S G + E+
Sbjct: 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-20
Identities = 68/287 (23%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 81 SKLDMRNLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQ-- 134
++L L+ G +G+V++G + D+ ++ V + T + + R +FQ+
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAI---------KTIQDRSGRQTFQEIT 57
Query: 135 -EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+ LDH + + +G G S L++ V + P G+L
Sbjct: 58 DHMLAMGSLDHAYIVRLLGICPGAS-LQL--------------------VTQLSPLGSLL 96
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
+ +R R L + ++ + +++G+ YL ++VHR++ N+LL S ++IADFGV
Sbjct: 97 DH-VRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGV 155
Query: 254 AR-VEAQNPRDMTGETGT-LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDL 310
A + + + E T + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+V ++ + R P+ C + +M KCW + RP E+
Sbjct: 216 RPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 43/152 (28%)
Query: 183 VVEYLPGGNLKQYLIRNRR------KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236
V+EY+PGG+L LIR + ++V LALD +H +HRD+K +
Sbjct: 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELV--LALD------SVHKLGFIHRDIKPD 130
Query: 237 NMLLDSQRTLKIADFGVA------------RVEAQNPRDMTGET---------------- 268
N+L+D+ +K+ADFG+ ++ N
Sbjct: 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190
Query: 269 -GTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
GT Y+APEVL+G PY CD +S G+ L+E
Sbjct: 191 VGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 81 SKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSS--FQQEV 136
L+ + GT+G V+ R A+K++ E L+ E
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM--------AIPEVIRLKQEQHVHNEK 52
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V +++ HP + + L + ++EY+PGG L YL
Sbjct: 53 RVLKEVSHPFIIRLFWTEHDQRFLYM--------------------LMEYVPGGELFSYL 92
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
RN + + + A ++ L YLHSK+IV+RD+K EN+LLD + +K+ DFG A+
Sbjct: 93 -RNSGR-FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK- 149
Query: 257 EAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
RD T GT Y+APEV+Q K +N+ D ++ GI ++E+
Sbjct: 150 ---KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 81 SKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQ---- 134
S LD I +G+ G V T ++VAVK +D LR QQ
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------------LRK--QQRREL 62
Query: 135 ---EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
EV + + HPN+ + + + L VV+E+L GG
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDEL--------------------WVVMEFLEGGA 102
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L + R + + V L + LS+LH++ ++HRD+K++++LL S +K++DF
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
Query: 252 G-VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
G A+V + PR + GT +MAPEV+ PY D++S GI + E+ + PY
Sbjct: 160 GFCAQVSKEVPRRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEV--AVKLLDWGEDGMATTAETAA 127
P+E WEI + +L G +G VY+ V A K++D T +E
Sbjct: 1 LNPEEFWEI-IGEL------GDGAFGKVYKAQNKETGVLAAAKVID-------TKSEEEL 46
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+ E+ + DHPN+ K + A +NL I ++E+
Sbjct: 47 --EDYMVEIDILASCDHPNIVKLLDAFYYENNLWI--------------------LIEFC 84
Query: 188 PGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245
GG + ++ R + +++V + L+ L+YLH KI+HRD+K N+L
Sbjct: 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRDLKAGNILFTLDGD 141
Query: 246 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-----QGKPYNRRCDVYSFGICLWEI 300
+K+ADFGV+ + + GT +MAPEV+ + +PY+ + DV+S GI L E+
Sbjct: 142 IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
Query: 301 YCCDMPYPDLSFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKR 351
+ P+ +L+ V + + P + P S + ++KC + N + R
Sbjct: 202 AQIEPPHHELNPMRVLLKIAKSE-PPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 79 DLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQ 134
++SK + I QGT+G V+ R Q VA+K L++ ++G TA LR
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA----LR----- 60
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY----LPGG 190
E+ + Q L H NV NL +T + N + +V E+ L G
Sbjct: 61 EIKILQLLKHENVV----------NLIEICRTKATPYNRYKGS--FYLVFEFCEHDLAG- 107
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L+ N+ K L + ++ L GL Y+H KI+HRD+K N+L+ LK+AD
Sbjct: 108 -----LLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162
Query: 251 FGVARV----EAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301
FG+AR + P T TL Y PE+L G + Y D++ G + E++
Sbjct: 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 38/227 (16%)
Query: 86 RNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD 143
+ ++ G G+VY+ + + +AVK++ + T E L+ E+ + K D
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIP-----LDITVE---LQKQIMSELEILYKCD 57
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
P + F GA + + I C E++ GG+L Y +K
Sbjct: 58 SPYIIGFYGAFFVENRISI------------------CT--EFMDGGSLDVY------RK 91
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ ++ ++A+ + +GL+YL S KI+HRDVK NML++++ +K+ DFGV+ + N
Sbjct: 92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIA 150
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310
T GT YMAPE + G+ Y DV+S GI E+ PYP +
Sbjct: 151 KT-YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 15/168 (8%)
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-------- 255
L L +++ + +++G+ +L SK +HRDV N+LL R KI DFG+AR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFAD 314
V N R + +MAPE + Y + DV+S+GI LWEI+ PYP +
Sbjct: 269 VVKGNARL------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+V++ + P P + +IM+ CW+ +RP ++ ++++
Sbjct: 323 KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 47/133 (35%), Positives = 70/133 (52%), Gaps = 14/133 (10%)
Query: 181 CVVVEYLPGGNLKQYLIR------NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234
C V+EY GG L +L R +R + +IV AL YLHS +V+RD+K
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV--SALG------YLHSCDVVYRDLK 122
Query: 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294
EN++LD +KI DFG+ + + M GT Y+APEVL+ Y R D + G
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 295 ICLWEIYCCDMPY 307
+ ++E+ C +P+
Sbjct: 183 VVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 58/175 (33%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EYL GG+L ++ K L A ++ GL +LHSK IV+RD+K +N+LLD+
Sbjct: 74 VMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGET------GTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
+KIADFG+ + +M G+ GT Y+APE+L G+ YN D +SFG+
Sbjct: 132 DGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVL 185
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
L+E+ P+ ++ ++ N P PR +I+ K + E+R
Sbjct: 186 LYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 14/176 (7%)
Query: 181 CVVVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
C V+EY+ GG L +L R R R + ++ L YLHS KIV+RD+K
Sbjct: 71 CFVMEYVNGGELFFHLSRERVFSEDRTRF-------YGAEIVSALDYLHSGKIVYRDLKL 123
Query: 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
EN++LD +KI DFG+ + + M GT Y+APEVL+ Y R D + G+
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 296 CLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
++E+ C +P+ + + ++ ++++ PR + +++ + KR
Sbjct: 184 VMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 181 CVVVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
C V+EY GG L +L R R R + ++ L YLHS+ +V+RD+K
Sbjct: 71 CFVMEYANGGELFFHLSRERVFTEERARF-------YGAEIVSALEYLHSRDVVYRDIKL 123
Query: 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
EN++LD +KI DFG+ + + M GT Y+APEVL+ Y R D + G+
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 296 CLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRC----CPSSLANIMRK 342
++E+ C +P+ + + ++ + +R PR S LA +++K
Sbjct: 184 VMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKK 232
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENML 239
C+ +E++ G+L + I + + ++I+ ++A+ + GL+YL++ +I+HRD+K N+L
Sbjct: 79 CMCMEFMDCGSLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
++S+ +K+ DFGV+ E N T GT YM+PE +QG Y + DV+S GI + E
Sbjct: 137 VNSRGQIKLCDFGVSG-ELINSIADTF-VGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 300 IYCCDMPY---PDLSFADVSSA----VVRQNLRPEIPRCCPSSLANIMR----KCWDANA 348
+ P+ +++Q ++ PR S +R C +
Sbjct: 195 LALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDP 254
Query: 349 EKRPEMGEVVKMLEAIDTSK 368
+RP ++ M I +
Sbjct: 255 TERPTPQQLCAMPPFIQALR 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 56/225 (24%)
Query: 92 GTYGSVYRGTY--DNQEVAVK-----LLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D 143
GT+GSVY + VA+K W E+ M LR EV +KL +
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMN-------LR-----EVKSLRKLNE 56
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
HPN+ K L V EY+ G NL Q L+++R+ K
Sbjct: 57 HPNIVKLKEVFRENDELYF--------------------VFEYMEG-NLYQ-LMKDRKGK 94
Query: 204 L-----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-VE 257
I+ Q+ GL+++H HRD+K EN+L+ +KIADFG+AR +
Sbjct: 95 PFSESVIRSIIYQILQ----GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150
Query: 258 AQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEIY 301
++ P T T Y APE+ L+ Y+ D+++ G + E+Y
Sbjct: 151 SRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 68/234 (29%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GT+G VY+ + VA+K L+ +DG TA +E+ + +KL H
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA---------LREIKILKKLKH 66
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE-Y----LPGGNLKQYLIRN 199
PNV + +V + R +V Y L G L+ N
Sbjct: 67 PNVVPLIDMAVERP--DKSKRK-----------RGSVYMVTPYMDHDLSG------LLEN 107
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV--- 256
KL + L L G++YLH I+HRD+K N+L+D+Q LKIADFG+AR
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 257 EAQNP--------RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301
NP R T T Y PE+L G + Y D++ G E++
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 1/129 (0%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C+V+ + GG+LK ++ I A + GL +LH ++IV+RD+K EN+LL
Sbjct: 69 CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
D ++I+D G+A VE + + + G GT GYMAPEVLQG+ Y+ D ++ G L+E+
Sbjct: 129 DDHGNVRISDLGLA-VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
Query: 301 YCCDMPYPD 309
P+
Sbjct: 188 IAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 59/303 (19%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEV----AVKLLDWGEDGMATTAETAA 127
P E WEI + +L G +G VY+ N+E A K+++ T +E
Sbjct: 10 PNEVWEI-IGEL------GDGAFGKVYKA--KNKETGALAAAKVIE-------TKSEEEL 53
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+ E+ + +HP + K +GA L I ++E+
Sbjct: 54 --EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI--------------------MIEFC 91
Query: 188 PGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245
PGG + ++ R + ++++ + L+ L YLHS KI+HRD+K N+LL
Sbjct: 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIHRDLKAGNVLLTLDGD 148
Query: 246 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-----LQGKPYNRRCDVYSFGICLWEI 300
+K+ADFGV+ + + GT +MAPEV ++ PY+ + D++S GI L E+
Sbjct: 149 IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
Query: 301 YCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLA----NIMRKCWDANAEKRPEMGE 356
+ P+ +L+ V + + P + PS + + ++ D + E RP +
Sbjct: 209 AQIEPPHHELNPMRVLLKIAKSE-PPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQ 265
Query: 357 VVK 359
+++
Sbjct: 266 LLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 60/212 (28%), Positives = 108/212 (50%), Gaps = 36/212 (16%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY+ N+ +A+K L+ ++G+ +TA +E+++ +++ H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA---------IREISLLKEMQH 60
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ + V S ++ +V EYL +LK+++ +
Sbjct: 61 GNIVRL--QDVVHSEKRL------------------YLVFEYL-DLDLKKHMDSSPDFAK 99
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIADFGVARVEAQNPRD 263
+++ + RG++Y HS +++HRD+K +N+L+D + LK+ADFG+AR R
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159
Query: 264 MTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
T E TL Y APE+L G + Y+ D++S G
Sbjct: 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191
|
Length = 294 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 54/187 (28%), Positives = 104/187 (55%), Gaps = 19/187 (10%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EY+ GG+L ++ R++KL + + ++S L+YLH + I++RD+K +N+LLDS
Sbjct: 74 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+ +K+ D+G+ + E P D T GT Y+APE+L+G+ Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 302 CCDMPY--------PDLSFAD-VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR- 351
P+ PD + D + ++ + +R IPR A++++ + + ++R
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERL 248
Query: 352 ---PEMG 355
P+ G
Sbjct: 249 GCHPQTG 255
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 58/185 (31%), Positives = 95/185 (51%), Gaps = 27/185 (14%)
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
A+R+ +E+ V + + P + F GA S+ +I + +E
Sbjct: 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEI------------------SICME 79
Query: 186 YLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQR 244
++ GG+L Q L + R + I+ ++++ + RGL+YL K KI+HRDVK N+L++S+
Sbjct: 80 HMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG 137
Query: 245 TLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
+K+ DFGV+ Q M GT YM+PE LQG Y + D++S G+ L E+
Sbjct: 138 EIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
Query: 304 DMPYP 308
P P
Sbjct: 195 RYPIP 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I QG G+VY QEVA+K ++ + + E+ V ++ HPN
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKHPN 77
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ ++ + + L VV+EYL GG+L + + +
Sbjct: 78 IVNYLDSYLVGDEL--------------------WVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
V + L + L +LHS +++HRD+K++N+LL ++K+ DFG +
Sbjct: 118 AAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 267 ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA-VVRQNLR 325
GT +MAPEV+ K Y + D++S GI E+ + PY L+ + + ++ N
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGT 232
Query: 326 PEIPRCCPSSLANIMR----KCWDANAEKRPEMGEVVK 359
PE+ P L+ I R +C + + EKR E+++
Sbjct: 233 PELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVK--LLDWGEDGM--ATTAETAALRSSFQQEVAVWQKL 142
I G YG+VY R + VA+K + EDG+ +T E A L+ +
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR--------LEAF 59
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
DHPN+ + + T+ D V +V E++ +L+ YL +
Sbjct: 60 DHPNIVRLMDVCA----------TSRTDRETKV-----TLVFEHV-DQDLRTYLDKVPPP 103
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
L + + L RGL +LH+ IVHRD+K EN+L+ S +K+ADFG+AR+ +
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-M 162
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+T TL Y APEVL Y D++S G E++
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 89 IAQGTYGSVYRGTYDNQE----VAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
I +GTYG+V++ N+E VA+K LD ++G+ ++A LR E+ + ++L
Sbjct: 8 IGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSA----LR-----EICLLKEL 56
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
H N+ + L + V EY +LK+Y +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--------------------VFEYC-DQDLKKYF-DSCNG 94
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
+ +IV L +GL++ HS ++HRD+K +N+L++ LK+ADFG+AR R
Sbjct: 95 DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154
Query: 263 DMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEI 300
+ E TL Y P+VL G K Y+ D++S G E+
Sbjct: 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 39/79 (49%), Positives = 50/79 (63%), Gaps = 2/79 (2%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAP 276
RGL YLHS I+HRD+K N+L++S LKI DFG+ARVE + + MT E T Y AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 277 EVLQGKP-YNRRCDVYSFG 294
E+L G Y D++S G
Sbjct: 174 EILMGSRHYTSAVDIWSVG 192
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 74/304 (24%), Positives = 138/304 (45%), Gaps = 43/304 (14%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAET 125
++ +++ I ++ G G+V + D + AVK++D +GM +
Sbjct: 26 TAKEQAKKYWIS-------RVLGSGATGTVLCAKRVSDGEPFAVKVVDM--EGM-----S 71
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
A ++ Q EV D S +K A D +V++
Sbjct: 72 EADKNRAQAEVCCLLNCDF------------FSIVKCHEDFAKKDPRNPENVLMIALVLD 119
Query: 186 YLPGGNLKQYLIRNR-------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
Y G+L+Q I++R R+ A + IQ+ L + ++HSK ++HRD+K+ N+
Sbjct: 120 YANAGDLRQE-IKSRAKTNRTFREHEAGLLFIQVLL----AVHHVHSKHMIHRDIKSANI 174
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
LL S +K+ DFG +++ A D G T GT Y+APE+ + KPY+++ D++S G+
Sbjct: 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVL 234
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
L+E+ P+ + +V + P P P + I+ ++ ++RP +
Sbjct: 235 LYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP-EMQEIVTALLSSDPKRRPSSSK 293
Query: 357 VVKM 360
++ M
Sbjct: 294 LLNM 297
|
Length = 496 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 72/232 (31%), Positives = 112/232 (48%), Gaps = 41/232 (17%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDW---GEDGMATTAETAALR 129
K E + L KL +GTY +V++G E V L + E+G TA
Sbjct: 3 KLETYVKLDKL------GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA------ 50
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+EV++ + L H N+ T + I ++ R +V EYL
Sbjct: 51 ---IREVSLLKNLKHANIV--------TLHDIIHTE------------RCLTLVFEYLDS 87
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+LKQYL N +++ V L RGLSY H +KI+HRD+K +N+L++ + LK+A
Sbjct: 88 -DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLA 145
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEI 300
DFG+AR ++ + + E TL Y P+VL G Y+ D++ G L+E+
Sbjct: 146 DFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 71/278 (25%), Positives = 129/278 (46%), Gaps = 43/278 (15%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I QG G+V+ QEVA+K ++ + + E+ V ++L +PN
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---------LQKQPKKELIINEILVMKELKNPN 77
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ F+ + + L VV+EYL GG+L + + +
Sbjct: 78 IVNFLDSFLVGDEL--------------------FVVMEYLAGGSLTDVVTETCMDEAQI 117
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG-VARVEAQNPRDMT 265
V + L + L +LH+ +++HRD+K++N+LL ++K+ DFG A++ + + T
Sbjct: 118 AAVCRECL---QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR 325
GT +MAPEV+ K Y + D++S GI E+ + PY + + + ++ N
Sbjct: 175 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGT 232
Query: 326 PEIPRCCPSSLANIMR----KCWDANAEKRPEMGEVVK 359
PE+ P L+ I R +C + + EKR E+++
Sbjct: 233 PELQN--PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 65/250 (26%), Positives = 110/250 (44%), Gaps = 61/250 (24%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSV----YRGTYDNQEVAVKLLDWGEDGMATTAETAALR- 129
W+ LS +M + G++G V ++GT + A+K L E L+
Sbjct: 14 SWK--LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKRE----------ILKM 59
Query: 130 ---SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
QE ++ +L HP + + + + + ++E+
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF--------------------LLEF 99
Query: 187 LPGGNLKQYLIR-----NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+ GG L +L + N K ++ LA + YLHSK I++RD+K EN+LLD
Sbjct: 100 VVGGELFTHLRKAGRFPNDVAKFYHAELV-LAFE------YLHSKDIIYRDLKPENLLLD 152
Query: 242 SQRTLKIADFGVA-RVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
++ +K+ DFG A +V D T GT Y+APEV+Q K + + D ++ G+ L+E
Sbjct: 153 NKGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYE 207
Query: 300 IYCCDMPYPD 309
P+ D
Sbjct: 208 FIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 16/168 (9%)
Query: 183 VVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
V++Y+ GG L +L R R R + A +++ L YLHS I++RD+K EN
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLHSLNIIYRDLKPEN 126
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
+LLDSQ + + DFG+ + E T GT Y+APEVL+ +PY+R D + G
Sbjct: 127 ILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAV 185
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQ--NLRPEIPRCCPSSLANIMRK 342
L+E+ P+ A++ ++ + L+P I L +++K
Sbjct: 186 LYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-18
Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 27/184 (14%)
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
A+R+ +E+ V + + P + F GA + I +E+
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI--------------------CMEH 84
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRT 245
+ GG+L Q L +R + +I+ ++++ + RGL+YL K +I+HRDVK N+L++S+
Sbjct: 85 MDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE 142
Query: 246 LKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
+K+ DFGV+ Q M GT YM+PE LQG Y+ + D++S G+ L E+
Sbjct: 143 IKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
Query: 305 MPYP 308
P P
Sbjct: 200 YPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 14/167 (8%)
Query: 183 VVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
V++Y+ GG L +L R R R + A +++ L YLHS IV+RD+K EN
Sbjct: 74 VLDYINGGELFYHLQRERCFLEPRARF-------YAAEIASALGYLHSLNIVYRDLKPEN 126
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
+LLDSQ + + DFG+ + ++ + GT Y+APEVL +PY+R D + G L
Sbjct: 127 ILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 186
Query: 298 WEIYCCDMPYPDLSFADVSSAVVRQ--NLRPEIPRCCPSSLANIMRK 342
+E+ P+ + A++ ++ + L+P I L +++K
Sbjct: 187 YEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 183 VVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
V++Y+ GG L +L R R R + A +++ + YLHS I++RD+K EN
Sbjct: 74 VLDYVNGGELFFHLQRERCFLEPRARF-------YAAEVASAIGYLHSLNIIYRDLKPEN 126
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
+LLDSQ + + DFG+ + E P + T GT Y+APEVL+ +PY+R D + G
Sbjct: 127 ILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAV 185
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
L+E+ P+ + + ++ + L ++P + +++ + +R +G
Sbjct: 186 LYEMLYGLPPFYSRDVSQMYDNILHKPL--QLPGGKTVAACDLLVGLLHKDQRRR--LGA 241
Query: 357 VVKMLE 362
LE
Sbjct: 242 KADFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+E+L GG+L + I+++ + L A ++ GL +LHSK I++RD+K +N++LD
Sbjct: 74 VMEFLNGGDL-MFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+KIADFG+ + + GT Y+APE+LQG Y D +SFG+ L+E+
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 303 CDMPY----PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
P+ D F +R + P PR +I+ K ++ + +R
Sbjct: 192 GQSPFHGDDEDELFES-----IRVD-TPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 45/126 (35%), Positives = 77/126 (61%), Gaps = 4/126 (3%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EY+ GG+L Y I+ + K + A +++ GL +LHSK I++RD+K +N++LD+
Sbjct: 79 VMEYVNGGDL-MYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136
Query: 243 QRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+ +KIADFG+ + E T GT Y+APE++ +PY + D ++FG+ L+E+
Sbjct: 137 EGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
Query: 302 CCDMPY 307
P+
Sbjct: 196 AGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 45/230 (19%)
Query: 87 NLIAQGTYGSVYRG--TYDNQEVA---VKLLDWGEDGMATTAETAALRSSFQ--QEVAVW 139
+ +GTYG V + T + VA VK+++ D F +E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
++ H N+ V V + +V++ + +LK+ + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFI--------------------NLVMDIM-ASDLKK--VVD 111
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
R+ +L V + L + GL+ LH +HRD+ N+ ++S+ KIADFG+AR
Sbjct: 112 RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171
Query: 260 NP--------------RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
P +MT + TL Y APE+L G + Y+ D++S G
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 181 CVVVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKK-IVHRDVK 234
C V+EY GG L +L R R R + ++ L YLHS+K +V+RD+K
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYLHSEKNVVYRDLK 123
Query: 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294
EN++LD +KI DFG+ + ++ M GT Y+APEVL+ Y R D + G
Sbjct: 124 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 295 ICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR 330
+ ++E+ C +P+ + + ++ + +R PR
Sbjct: 184 VVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 55/184 (29%), Positives = 94/184 (51%), Gaps = 27/184 (14%)
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
A+R+ +E+ V + + P + F GA + I +E+
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI--------------------CMEH 84
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRT 245
+ GG+L Q L + ++ +I+ ++++ + +GL+YL K KI+HRDVK N+L++S+
Sbjct: 85 MDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 142
Query: 246 LKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
+K+ DFGV+ Q M GT YM+PE LQG Y+ + D++S G+ L E+
Sbjct: 143 IKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
Query: 305 MPYP 308
P P
Sbjct: 200 YPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 42/122 (34%), Positives = 71/122 (58%), Gaps = 1/122 (0%)
Query: 179 ACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
A C+V+ + GG+LK ++ + + A +++ GL LH ++IV+RD+K EN+
Sbjct: 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENI 133
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
LLD ++I+D G+A VE + G GT+GYMAPEV++ + Y D + G ++
Sbjct: 134 LLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIY 192
Query: 299 EI 300
E+
Sbjct: 193 EM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 52/151 (34%), Positives = 84/151 (55%), Gaps = 12/151 (7%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
VV+E+L GG L + R + + V L + R LSYLH++ ++HRD+K++++LL
Sbjct: 96 VVMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 242 SQRTLKIADFG-VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
S +K++DFG A+V + P+ + GT +MAPEV+ PY D++S GI + E+
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 301 YCCDMPY---PDLSFADVSSAVVRQNLRPEI 328
+ PY P L + +R NL P +
Sbjct: 212 IDGEPPYFNEPPLQ----AMRRIRDNLPPRV 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 78/277 (28%), Positives = 121/277 (43%), Gaps = 49/277 (17%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVKL--LDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ GTYG VY R + + AVK+ L+ G+D S QQE+ + ++ H
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-----------FSLIQQEIFMVKECKH 65
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ-YLIRNRRKK 203
N+ + G+ + L I +EY GG+L+ Y + +
Sbjct: 66 CNIVAYFGSYLSREKLWI--------------------CMEYCGGGSLQDIYHVTGPLSE 105
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
L + V + L +GL+YLHSK +HRD+K N+LL +K+ADFGVA
Sbjct: 106 LQIAYVCRETL---QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162
Query: 264 MTGETGTLGYMAPEVL---QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
GT +MAPEV + YN+ CD+++ GI E+ P DL +
Sbjct: 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS 222
Query: 321 RQNLRPEIPRC-----CPSSLANIMRKCWDANAEKRP 352
+ N +P P+ S+ N ++ N +KRP
Sbjct: 223 KSNFQP--PKLKDKTKWSSTFHNFVKISLTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 47/128 (36%), Positives = 81/128 (63%), Gaps = 8/128 (6%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EY+ GG+L + + R K + A +++ GL +LHSK I++RD+K +N++LDS
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136
Query: 243 QRTLKIADFGVARVEAQNPRD-MTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
+ +KIADFG+ + +N D +T +T GT Y+APE++ +PY + D ++FG+ L+E
Sbjct: 137 EGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
Query: 300 IYCCDMPY 307
+ P+
Sbjct: 194 MLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 37/90 (41%), Positives = 62/90 (68%), Gaps = 2/90 (2%)
Query: 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT-GETGTLGYMAPE 277
GL +LH ++I++RD+K EN+LLD+ ++I+D G+A VE ++ + T G GT G+MAPE
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPE 167
Query: 278 VLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
+LQG+ Y+ D ++ G+ L+E+ P+
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 50/178 (28%), Positives = 100/178 (56%), Gaps = 13/178 (7%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V+EY+ GG+L ++ R++KL + A ++ L++LH + I++RD+K +N+LLD
Sbjct: 73 LVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 242 SQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
+ +K+ D+G+ + E P D T GT Y+APE+L+G+ Y D ++ G+ ++E+
Sbjct: 131 ADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 301 YCCDMPY------PDLSFADVSSAVVRQNLRP-EIPRCCPSSLANIMRKCWDANAEKR 351
P+ PD++ D V+ + +P IPR +++++ + + ++R
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 72/233 (30%), Positives = 115/233 (49%), Gaps = 37/233 (15%)
Query: 80 LSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQE 135
+ K D+ I +GTYG VY R + VA+K LD ++G TA +E
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA---------IRE 56
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLK--IPSKTASVDGNAAVPARACCVVVEYLPG---G 190
+ + ++L+H N+ NLK + K ++D A +V EY+ G
Sbjct: 57 IKILRQLNHRNIV----------NLKEIVTDKQDALDFKK--DKGAFYLVFEYMDHDLMG 104
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L+ L+ + + QL L+ GL+Y H K +HRD+K N+LL+++ +K+AD
Sbjct: 105 LLESGLVHFSEDHIK-SFMKQL-LE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159
Query: 251 FGVARV-EAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIY 301
FG+AR+ ++ R T + TL Y PE+L G+ Y DV+S G L E++
Sbjct: 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 43/129 (33%), Positives = 72/129 (55%), Gaps = 1/129 (0%)
Query: 179 ACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
A C+V+ + GG+LK ++ + A ++ GL LH ++IV+RD+K EN+
Sbjct: 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
LLD ++I+D G+A V + + G GT+GYMAPEV++ + Y D ++ G L+
Sbjct: 134 LLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 192
Query: 299 EIYCCDMPY 307
E+ P+
Sbjct: 193 EMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 41/126 (32%), Positives = 77/126 (61%), Gaps = 4/126 (3%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+E++ GG+L ++ R R KL + + ++S L++LH + I++RD+K +N+LLD+
Sbjct: 74 VIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+ +K+ D+G+ + E P D T GT Y+APE+L+G+ Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 302 CCDMPY 307
P+
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 50/252 (19%)
Query: 77 EIDLSKL-------DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAA 127
+IDLS L ++ ++ GTYG VY+G + Q A+K++D ED
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE--------- 55
Query: 128 LRSSFQQEVAVWQKLDH-PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
+ E+ + +K H N+ + GA + S P + +V+E+
Sbjct: 56 -EEEIKLEINMLKKYSHHRNIATYYGAFIKKSP---PGHDDQL-----------WLVMEF 100
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
G++ + + L + + ++ RGL++LH+ K++HRD+K +N+LL +
Sbjct: 101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV 160
Query: 247 KIADFGVARVEAQNPRDMTGET---GTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLW 298
K+ DFGV+ AQ R + GT +MAPEV+ Y+ R D++S GI
Sbjct: 161 KLVDFGVS---AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI 217
Query: 299 EIY-----CCDM 305
E+ CDM
Sbjct: 218 EMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 56/296 (18%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKL--LDWGEDGMATTAET 125
+ P+E++E + I GTYG VY R + A+K+ L+ GED
Sbjct: 5 RNPQEDFE-------LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-------- 49
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
+ QQE+ + + H N+ + G+ + L I +E
Sbjct: 50 ---FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI--------------------CME 86
Query: 186 YLPGGNLKQ-YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
+ GG+L+ Y + + + V + L +GL YLHSK +HRD+K N+LL
Sbjct: 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETL---QGLYYLHSKGKMHRDIKGANILLTDNG 143
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL---QGKPYNRRCDVYSFGICLWEIY 301
+K+ADFGV+ GT +MAPEV + YN+ CD+++ GI E+
Sbjct: 144 HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203
Query: 302 CCDMPYPDLSFADVSSAVVRQNLRPEIPRC-----CPSSLANIMRKCWDANAEKRP 352
P DL + + N +P P+ +S + ++ N +KRP
Sbjct: 204 ELQPPMFDLHPMRALFLMTKSNFQP--PKLKDKMKWSNSFHHFVKMALTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 183 VVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
V++++ GG L +L R R R + A +++ L YLHS IV+RD+K EN
Sbjct: 74 VLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLHSINIVYRDLKPEN 126
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
+LLDSQ + + DFG+ + T GT Y+APEV++ +PY+ D + G L
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVL 186
Query: 298 WEIYCCDMPYPDLSFADVSSAVVRQ--NLRPEIPRCCPSSLANIMRK 342
+E+ P+ A++ ++ + LRP S L ++ K
Sbjct: 187 YEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 42/128 (32%), Positives = 76/128 (59%), Gaps = 8/128 (6%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EY+ GG+L ++ + K + A ++S GL +LH + I++RD+K +N++LDS
Sbjct: 79 VMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 243 QRTLKIADFGVAR---VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
+ +KIADFG+ + V+ R GT Y+APE++ +PY + D +++G+ L+E
Sbjct: 137 EGHIKIADFGMCKEHMVDGVTTRTF---CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYE 193
Query: 300 IYCCDMPY 307
+ P+
Sbjct: 194 MLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 42/222 (18%)
Query: 89 IAQGTYGSVYRG----TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY+ D +E A+K G+ T +A R E+A+ ++L H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACR-----EIALLRELKH 61
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY----LPGGNLKQYLIRNR 200
NV V + ++ + ++ +Y L + ++ + +
Sbjct: 62 ENVVSLVEVFLEHADKSV------------------YLLFDYAEHDL--WQIIKFHRQAK 101
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL----DSQRTLKIADFGVARV 256
R + +V L + G+ YLHS ++HRD+K N+L+ + +KI D G+AR+
Sbjct: 102 RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
Query: 257 EAQNPRDMTGETG---TLGYMAPEVLQG-KPYNRRCDVYSFG 294
+ + T+ Y APE+L G + Y + D+++ G
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 41/277 (14%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I QG G+VY QEVA++ ++ + + E+ V ++ +PN
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN---------LQQQPKKELIINEILVMRENKNPN 78
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ ++ + + L VV+EYL GG+L + + +
Sbjct: 79 IVNYLDSYLVGDEL--------------------WVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
V + L + L +LHS +++HRD+K++N+LL ++K+ DFG +
Sbjct: 119 AAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 267 ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP 326
GT +MAPEV+ K Y + D++S GI E+ + PY + + + ++ N P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP 234
Query: 327 EIPRCCPSSLANIMR----KCWDANAEKRPEMGEVVK 359
E+ P L+ I R +C D + EKR E+++
Sbjct: 235 ELQN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 41/232 (17%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDW---GEDGMATTAETAALR 129
K E I L KL +GTY +VY+G + V L + E+G TA
Sbjct: 4 KLETYIKLDKL------GEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA------ 51
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+EV++ + L H N+ T + I ++ ++ +V EYL
Sbjct: 52 ---IREVSLLKDLKHANIV--------TLHDIIHTE------------KSLTLVFEYL-D 87
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+LKQYL + + + V L RGL+Y H +K++HRD+K +N+L++ + LK+A
Sbjct: 88 KDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLA 146
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEI 300
DFG+AR ++ + + E TL Y P++L G Y+ + D++ G +E+
Sbjct: 147 DFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 51/140 (36%), Positives = 74/140 (52%), Gaps = 16/140 (11%)
Query: 182 VVVEYLPGGNL----KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+V+EY+PGG+L Y I + + V+ LALD +HS +HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV-LALDA------IHSMGFIHRDVKPDN 172
Query: 238 MLLDSQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQGK----PYNRRCDVYS 292
MLLD LK+ADFG +++A GT Y++PEVL+ + Y R CD +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 293 FGICLWEIYCCDMPYPDLSF 312
G+ L+E+ D P+ S
Sbjct: 233 VGVFLYEMLVGDTPFYADSL 252
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 216 LSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD----MTGETGTL 271
L RGL Y+HS ++HRD+K N+L++ L+I DFG+AR + +P + MT T
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 272 GYMAPEVLQGKP-YNRRCDVYSFGICLWE 299
Y APE+L P Y D++S G E
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 49/151 (32%), Positives = 84/151 (55%), Gaps = 12/151 (7%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
VV+E+L GG L + R + + V L + + LS LH++ ++HRD+K++++LL
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIHRDIKSDSILLT 150
Query: 242 SQRTLKIADFG-VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
+K++DFG A+V + PR + GT +MAPE++ PY D++S GI + E+
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 301 YCCDMPY---PDLSFADVSSAVVRQNLRPEI 328
+ PY P L + ++R NL P++
Sbjct: 210 VDGEPPYFNEPPLK----AMKMIRDNLPPKL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 86 RNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAA---LRSSFQQEVAVWQ 140
I G YG V ++VA+K + A LR E+ + +
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKRILR-----EIKLLR 54
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
L H N+ +G ++ P +V E + +L + +I++
Sbjct: 55 HLRHENI-------IGLLDILRPPSPEDF--------NDVYIVTELMET-DLHK-VIKSP 97
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV---E 257
+ L + + RGL YLHS ++HRD+K N+L++S LKI DFG+AR +
Sbjct: 98 QP-LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 258 AQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFG 294
+T T Y APE+ L Y + D++S G
Sbjct: 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIA 249
+Y+ + + +I+ ++A+ + L+YL + KI+HRDVK N+LLD +K+
Sbjct: 91 KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLC 150
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVL---QGKPYNRRCDVYSFGICLWEIYCCDMP 306
DFG++ + + T + G YMAPE + Y+ R DV+S GI L+E+ P
Sbjct: 151 DFGISG-QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
Query: 307 YPDL-SFADVSSAVVRQN---LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360
YP S D + VV+ + L R S N + C + KRP+ E+++
Sbjct: 210 YPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 5/172 (2%)
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTAS----VDGNAAVPARACCVVVEYLPGGNLKQY 195
+KL+ + K G ++ + +I K S A A C+V+ + GG+LK +
Sbjct: 31 KKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
+ + I A +L GL L ++IV+RD+K EN+LLD + ++I+D G+A
Sbjct: 91 IYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA- 149
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
V+ + G GT+GYMAPEV+ + Y D + G ++E+ P+
Sbjct: 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV---EAQNPRDMTGETGTLGYM 274
RGL Y+HS ++HRD+K N+LL++ LKI DFG+AR+ E + +T T Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 275 APEV-LQGKPYNRRCDVYSFGICLWEIYCC 303
APE+ L K Y + D++S G L E+
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 41/232 (17%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDW---GEDGMATTAETAALR 129
K E I L KL +GTY +V++G E V L + E+G TA
Sbjct: 4 KMETYIKLEKL------GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA------ 51
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+EV++ + L H N+ D ++ +V EYL
Sbjct: 52 ---IREVSLLKDLKHANIVTL-------------HDIVHTD-------KSLTLVFEYL-D 87
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+LKQY+ + +++ V + RGL+Y H +K++HRD+K +N+L++ + LK+A
Sbjct: 88 KDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLA 146
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEI 300
DFG+AR ++ + + E TL Y P+VL G Y+ + D++ G +E+
Sbjct: 147 DFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 42/125 (33%), Positives = 73/125 (58%), Gaps = 2/125 (1%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+E++ GG+L ++ ++RR A A +++ L +LH K I++RD+K +N+LLD
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARF--YAAEITSALMFLHDKGIIYRDLKLDNVLLDH 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ K+ADFG+ + N + + GT Y+APE+LQ Y D ++ G+ L+E+ C
Sbjct: 132 EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
Query: 303 CDMPY 307
P+
Sbjct: 192 GHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 37/236 (15%)
Query: 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
++ L+ GTYG VY+G + Q A+K++D T +QE+ + +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----------VTGDEEEEIKQEINMLK 57
Query: 141 KLDH-PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
K H N+ + GA I +D +V+E+ G++ +
Sbjct: 58 KYSHHRNIATYYGAF-------IKKNPPGMDDQ-------LWLVMEFCGAGSVTDLIKNT 103
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
+ L + + + ++ RGLS+LH K++HRD+K +N+LL +K+ DFGV+ +
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163
Query: 260 NPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIY-----CCDM 305
GT +MAPEV+ Y+ + D++S GI E+ CDM
Sbjct: 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 57/282 (20%)
Query: 91 QGTYGSVYRG------TYDN----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
QGT+ ++Y+G D QEV+V L G D + A F + ++
Sbjct: 5 QGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------FFETASLMS 56
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
+L H ++ K G V N+ +V EY+ G L +L R +
Sbjct: 57 QLSHKHLVKLYGVCVRDENI---------------------MVEEYVKFGPLDVFLHREK 95
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL--DSQRT-----LKIADFGV 253
++L + +A L+ L YL KK+VH +V +N+L+ +K++D G+
Sbjct: 96 -NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154
Query: 254 ARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRR--CDVYSFGICLWEIYC-CDMPYPDL 310
R+ E + ++APE ++ + D +SFG L EI + P L
Sbjct: 155 PI--TVLSREERVE--RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
S ++ Q+ P +P C LAN++ +CW + KRP
Sbjct: 211 SSSEKERFYQDQHRLP-MPDCAE--LANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 50/239 (20%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSV--YRGTYDNQEVAVKLLDWGEDGMATTAETAALRS 130
K WE+ + + + G YG V T ++VA+K L
Sbjct: 8 KTVWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----------------KLSR 50
Query: 131 SFQ---------QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
FQ +E+ + + +DH NV L + + +S++ V
Sbjct: 51 PFQSAIHAKRTYRELRLLKHMDHENVI---------GLLDVFTPASSLEDFQDV------ 95
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V +L G +L + + +KL+ + L + RGL Y+HS I+HRD+K N+ ++
Sbjct: 96 YLVTHLMGADLNNIV---KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152
Query: 242 SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWE 299
LKI DFG+AR +MTG T Y APE+ L YN+ D++S G + E
Sbjct: 153 EDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 5/172 (2%)
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTAS---VDGNAAVPAR-ACCVVVEYLPGGNLKQY 195
++L+ + K G S+ + +I K S V+ A + A C+V+ + GG+LK +
Sbjct: 31 KRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFH 90
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
+ + + A ++ GL LH + V+RD+K EN+LLD ++I+D G+A
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA- 149
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
V+ + G GT+GYMAPEVL + Y D + G ++E+ P+
Sbjct: 150 VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 61/253 (24%), Positives = 115/253 (45%), Gaps = 45/253 (17%)
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
++ F Q+ ++ L HPN+ + +G V A+P +V EY
Sbjct: 39 QNEFLQQGDPYRILQHPNILQCLGQCV-----------------EAIPY---LLVFEYCE 78
Query: 189 GGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
G+LK YL + R+ L ++ ++A +++ G++++H +H D+ N L S T+
Sbjct: 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTV 138
Query: 247 KIADFGVARVEAQNPRDMTGET--GTLGYMAPEVL-----------QGKPYNRRCDVYSF 293
K+ D+G+ + T + L ++APE++ Q KP N V++
Sbjct: 139 KVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSN----VWAL 194
Query: 294 GICLWEIY-CCDMPYPDLSFADVSSAVVRQN----LRPEIPRCCPSSLANIMRKCWDANA 348
G+ LWE++ PY LS +V + V++ +P++ +++ CW +
Sbjct: 195 GVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSP 253
Query: 349 EKRPEMGEVVKML 361
EKR EV ++L
Sbjct: 254 EKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 37/84 (44%), Positives = 53/84 (63%), Gaps = 4/84 (4%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 277
RGL Y+HS +VHRD+K N+L++ LKI DFG+AR+ Q+P+ MTG T Y APE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQ-MTGYVSTRYYRAPE 175
Query: 278 V-LQGKPYNRRCDVYSFGICLWEI 300
+ L + Y+ D++S G E+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 45/124 (36%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 209 VIQLALDLSR----------GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
VIQ+ LD R G+ +LHS I+HRD+K N+++ S TLKI DFG+AR A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 176
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
MT T Y APEV+ G Y D++S G + E+ + +P D +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 319 VVRQ 322
V+ Q
Sbjct: 237 VIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 66/276 (23%), Positives = 127/276 (46%), Gaps = 39/276 (14%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I QG G+VY QEVA+K ++ + + E+ V ++ +PN
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN---------LQQQPKKELIINEILVMRENKNPN 77
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ ++ + + L VV+EYL GG+L + + +
Sbjct: 78 IVNYLDSYLVGDEL--------------------WVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG-VARVEAQNPRDMT 265
V + L + L +LHS +++HRD+K++N+LL ++K+ DFG A++ + + T
Sbjct: 118 AAVCRECL---QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR 325
GT +MAPEV+ K Y + D++S GI E+ + PY + + + ++ N
Sbjct: 175 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGT 232
Query: 326 PEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
PE+ P + + + +C + + ++R E+++
Sbjct: 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 35/87 (40%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 216 LSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMA 275
L RGL Y+HS ++HRD+K N+LL++ LKI DFG+AR ++ MT T Y A
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 276 PEVLQGKPYNRRCDVYSFGICLWEIYC 302
PE+L C Y+ I +W + C
Sbjct: 177 PELLLN------CSEYTTAIDVWSVGC 197
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 52/140 (37%), Positives = 73/140 (52%), Gaps = 26/140 (18%)
Query: 182 VVVEYLPGGNL----KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+V+EY+PGG+L Y + + K V+ LALD +HS ++HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDA------IHSMGLIHRDVKPDN 172
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTG------ETGTLGYMAPEVLQGKP----YNRR 287
MLLD LK+ADFG D TG GT Y++PEVL+ + Y R
Sbjct: 173 MLLDKHGHLKLADFGTCM-----KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 288 CDVYSFGICLWEIYCCDMPY 307
CD +S G+ L+E+ D P+
Sbjct: 228 CDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 43/224 (19%)
Query: 82 KLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWG-EDGMATTAETAALRSSFQQEVAV 138
KLD + +G+Y +VY+G Q VA+K + E+G TA +R E ++
Sbjct: 9 KLDK---LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA----IR-----EASL 56
Query: 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR 198
+ L H N+ T + I +K + +V EYL +LKQY+
Sbjct: 57 LKDLKHANIV--------TLHDIIHTK------------KTLTLVFEYLDT-DLKQYMDD 95
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
L++ V L RGL+Y H ++++HRD+K +N+L+ + LK+ADFG+AR ++
Sbjct: 96 CGGG-LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ + E TL Y P+VL G YS + +W + C
Sbjct: 155 VPSKTYSNEVVTLWYRPPDVLLGS------TEYSTSLDMWGVGC 192
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLAL-DLSRGLSYLHSKKIVHRDVKTENMLL 240
+V+EY PGG+L L NR + + + Q L +L + +H VHRD+K EN+L+
Sbjct: 78 LVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 241 DSQRTLKIADFG-VARVEAQNPRDMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSF 293
D +K+ADFG AR+ A + GT Y+APEVL Y CD +S
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 294 GICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324
G+ +E+ P F + +SA N+
Sbjct: 196 GVIAYEMIYGRSP-----FHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 6e-15
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 17/131 (12%)
Query: 183 VVEYLPGGNLKQYLIRNRRK---KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
+++Y+ G+L L++ K KI+ QL L+ LH I+H D+K EN+L
Sbjct: 87 IMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLV----EALNDLHKHNIIHNDIKLENVL 141
Query: 240 LDSQRT-LKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
D + + + D+G+ ++ P D GTL Y +PE ++G Y+ D ++ G+
Sbjct: 142 YDRAKDRIYLCDYGLCKIIGT-PSCYD-----GTLDYFSPEKIKGHNYDVSFDWWAVGVL 195
Query: 297 LWEIYCCDMPY 307
+E+ P+
Sbjct: 196 TYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 40/96 (41%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 209 VIQLALDLSR----------GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
VIQ+ LD R G+ +LHS I+HRD+K N+++ S TLKI DFG+AR A
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 168
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294
MT T Y APEV+ G Y D++S G
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLA---LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+V+E+ P G+LK YL R+ +L + ++A +++ GL +LH +H D+ N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETG--TLGYMAPEVLQGKPYN-------RRCD 289
LL + T+KI D+G++ + + +T + L ++APE++ N + +
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 290 VYSFGICLWEIY-CCDMPYPDLSFADVSSAVVR-QNLRPEIPRC-CPSS--LANIMRKCW 344
V+S G+ +WE++ PY LS V + VR Q L+ PR P S +M+ CW
Sbjct: 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW 251
Query: 345 DANAEKRPEMGEV 357
E+RP EV
Sbjct: 252 -LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 40/223 (17%)
Query: 84 DMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+R I G++G+VY R N+ VA+K + + G + + +EV Q+
Sbjct: 19 DLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKW----QDIIKEVRFLQQ 71
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN ++ G + +V+EY G ++ +
Sbjct: 72 LRHPNTIEYKGCYLREHT--------------------AWLVMEYCLGS--ASDILEVHK 109
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
K L + + +GL+YLHS + +HRD+K N+LL T+K+ADFG A + +P
Sbjct: 110 KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL--VSP 167
Query: 262 RDMTGETGTLGYMAPEVL----QGKPYNRRCDVYSFGICLWEI 300
+ GT +MAPEV+ +G+ Y+ + DV+S GI E+
Sbjct: 168 ANSF--VGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 41/244 (16%)
Query: 89 IAQGTYGSV--YRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G+ G V R + ++VAVK++D R EV + + H N
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---------LRKQQRRELLFNEVVIMRDYQHQN 79
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
V + + + V++E+L GG L + + R + +
Sbjct: 80 VVEMY--------------------KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI 119
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG-VARVEAQNPRDMT 265
V + L + L YLHS+ ++HRD+K++++LL +K++DFG A++ P+ +
Sbjct: 120 ATVCESVL---QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR 325
GT +MAPEV+ PY D++S GI + E+ + PY F+D +++ LR
Sbjct: 177 -LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKR-LR 230
Query: 326 PEIP 329
P
Sbjct: 231 DSPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 48/135 (35%), Positives = 72/135 (53%), Gaps = 16/135 (11%)
Query: 182 VVVEYLPGGNL----KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+V+EY+PGG+L Y + + + V+ LALD +HS +HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV-LALD------AIHSMGFIHRDVKPDN 172
Query: 238 MLLDSQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQGKP----YNRRCDVYS 292
MLLD LK+ADFG ++ + GT Y++PEVL+ + Y R CD +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 293 FGICLWEIYCCDMPY 307
G+ L+E+ D P+
Sbjct: 233 VGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 89 IAQGTYGSVYRG---TYDNQEVAVKLL--DWGEDGM--ATTAETAALRSSFQQEVAVWQK 141
I +G YG V++ + VA+K + GE+GM +T E A LR +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--------LET 60
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+HPNV + + + T +V E++ +L YL +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLT---------------LVFEHV-DQDLTTYLDKVPE 104
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
+ + + + L RGL +LHS ++VHRD+K +N+L+ S +K+ADFG+AR+ +
Sbjct: 105 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 164
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+T TL Y APEVL Y D++S G E++
Sbjct: 165 A-LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 39/126 (30%), Positives = 71/126 (56%), Gaps = 13/126 (10%)
Query: 182 VVVEYLPGGNLKQYLI-RNRRKKLALKIVIQ---LALDLSRGLSYLHSKKIVHRDVKTEN 237
++++Y+ GG L +L R + +++ I LALD +LH I++RD+K EN
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQLGIIYRDIKLEN 135
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKP--YNRRCDVYSFG 294
+LLDS+ + + DFG+++ + GT+ YMAPEV++G +++ D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 295 ICLWEI 300
+ +E+
Sbjct: 196 VLTFEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 13/93 (13%)
Query: 216 LSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV------EAQNPRDMTGETG 269
L + L Y+HS ++HRD+K N+LL+S +K+ADFG+AR +NP +T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP-VLTDYVA 174
Query: 270 TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
T Y APE+L G Y+ G+ +W + C
Sbjct: 175 TRWYRAPEILLGSTR------YTKGVDMWSVGC 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 37/106 (34%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
LI+ R++ L K V L + L ++H I HRD+K EN+L+ LK+ADFG R
Sbjct: 89 LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK-DDILKLADFGSCR 147
Query: 256 VEAQNPRDMTGETGTLGYMAPE-VLQGKPYNRRCDVYSFGICLWEI 300
P T T Y APE +L Y + D+++ G +EI
Sbjct: 148 GIYSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 41/131 (31%), Positives = 75/131 (57%), Gaps = 12/131 (9%)
Query: 182 VVVEYLPGGNL-----KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236
+++++L GG+L K+ + K L +LAL L +LHS I++RD+K E
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELAL----ALDHLHSLGIIYRDLKPE 127
Query: 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
N+LLD + +K+ DFG+++ + + GT+ YMAPEV+ + + + D +SFG+
Sbjct: 128 NILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVL 187
Query: 297 LWEIYCCDMPY 307
++E+ +P+
Sbjct: 188 MFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 36/230 (15%)
Query: 127 ALRSSFQQEVAVWQKLDHPNVTK-----FVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
ALR E+ + ++LDH N+ K S T ++ ++ SV
Sbjct: 49 ALR-----EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSV-----------Y 92
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V EY+ +L L + L+ + L RGL Y+HS ++HRD+K N+ ++
Sbjct: 93 IVQEYMET-DLANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148
Query: 242 S-QRTLKIADFGVARV---EAQNPRDMTGETGTLGYMAPE-VLQGKPYNRRCDVYSFGIC 296
+ LKI DFG+AR+ + ++ T Y +P +L Y + D+++ G
Sbjct: 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208
Query: 297 LWEIYCCDMPYP---DLSFADV---SSAVVRQNLRPEIPRCCPSSLANIM 340
E+ + +L + S VVR+ R E+ PS + N
Sbjct: 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDG 258
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 10/107 (9%)
Query: 208 IVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM-- 264
I+ ++A+ + + L YLHSK ++HRDVK N+L++ +K+ DFG++ +
Sbjct: 104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAK 160
Query: 265 TGETGTLGYMAPEVLQG----KPYNRRCDVYSFGICLWEIYCCDMPY 307
T + G YMAPE + K Y+ + DV+S GI + E+ PY
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 40/122 (32%), Positives = 62/122 (50%), Gaps = 13/122 (10%)
Query: 185 EYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
EY+PGG+ + L + A + ++ + LH +HRD+K EN L+D+
Sbjct: 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE----AVDALHELGYIHRDLKPENFLIDA 136
Query: 243 QRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
+K+ DFG+++ V N G+ YMAPEVL+GK Y+ D +S G L+E
Sbjct: 137 SGHIKLTDFGLSKGIVTYAN-----SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEF 191
Query: 301 YC 302
C
Sbjct: 192 LC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR----VEAQNPRDMTGETGTLGY 273
GL Y+HS ++HRD+K N+L+++ LKI DFG+AR +N MT T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 274 MAPEV-LQGKPYNRRCDVYSFGICLWEIY 301
APE+ L + Y + DV+S G L E+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 36/225 (16%)
Query: 81 SKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDW-GEDGMATTAETAALRSSFQQEVA 137
S L++ L +G+Y +VY+G + Q VA+K++ E+G+ TA +E +
Sbjct: 6 SYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA---------IREAS 55
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ + L H N+ V ++ +T + V EY+ +L QY+I
Sbjct: 56 LLKGLKHANI-------VLLHDIIHTKETLTF-------------VFEYMHT-DLAQYMI 94
Query: 198 RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
++ + + L RGL+Y+H + I+HRD+K +N+L+ LK+ADFG+AR +
Sbjct: 95 QHPGGLHPYNVRL-FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAK 153
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIY 301
+ + + E TL Y P+VL G Y+ D++ G E+
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 38/120 (31%), Positives = 68/120 (56%), Gaps = 4/120 (3%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLAL-DLSRGLSYLHSKKIVHRDVKTENMLL 240
+++EYL GG L +L R+ + ++ L ++S L +LH + I++RD+K EN+LL
Sbjct: 77 LILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
D+Q +K+ DFG+ + GT+ YMAPE+L + + D +S G ++++
Sbjct: 134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDM 193
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 40/223 (17%)
Query: 84 DMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+R I G++G+VY R +++ VA+K + + + ++ +EV QK
Sbjct: 19 DLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSY------SGKQSNEKWQDIIKEVRFLQK 71
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN ++ G + TA +V+EY G L+ +
Sbjct: 72 LRHPNTIQYRGCY-------LREHTA-------------WLVMEYCLGS--ASDLLEVHK 109
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
K L + + +GL+YLHS ++HRDVK N+LL +K+ DFG A + A
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167
Query: 262 RDMTGETGTLGYMAPEVL----QGKPYNRRCDVYSFGICLWEI 300
GT +MAPEV+ +G+ Y+ + DV+S GI E+
Sbjct: 168 --ANXFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 40/125 (32%), Positives = 70/125 (56%), Gaps = 2/125 (1%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EY+ GG+L + I+ RK + A +++ L +LH +++RD+K +N+LLD+
Sbjct: 74 VMEYVNGGDL-MFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ K+ADFG+ + N T GT Y+APE+LQ Y D ++ G+ ++E+
Sbjct: 132 EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191
Query: 303 CDMPY 307
P+
Sbjct: 192 GQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 71/246 (28%), Positives = 111/246 (45%), Gaps = 34/246 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALR 129
K WE+ + + G YGSV YD Q+VAVK L + T
Sbjct: 8 KTVWEVP-ERYQNLTPVGSGAYGSVC-SAYDTRLRQKVAVKKLSRPFQSLIHARRT---- 61
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+E+ + + + H NV +G ++ P+ S++ V +V L G
Sbjct: 62 ---YRELRLLKHMKHENV-------IGLLDVFTPA--TSIENFNEV------YLVTNLMG 103
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+L + + +KL+ + V L L RGL Y+HS I+HRD+K N+ ++ L+I
Sbjct: 104 ADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308
DFG+AR Q +MTG T Y APE+ L YN+ D++S G + E+ +P
Sbjct: 161 DFGLAR---QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217
Query: 309 DLSFAD 314
+ D
Sbjct: 218 GNDYID 223
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 39/175 (22%)
Query: 178 RACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIV 229
R C+V+EY+ GG+ L K + L +D++R L YLH+ IV
Sbjct: 74 RHLCMVMEYVEGGDCATLL----------KNIGALPVDMARMYFAETVLALEYLHNYGIV 123
Query: 230 HRDVKTENMLLDSQRTLKIADFGVARV----------EAQNPRDMTGE------TGTLGY 273
HRD+K +N+L+ S +K+ DFG++++ E +D T E GT Y
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-TREFLDKQVCGTPEY 182
Query: 274 MAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEI 328
+APEV+ + Y + D ++ GI L+E +P+ F D + Q + +I
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF----FGDTPEELFGQVISDDI 233
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 66/303 (21%)
Query: 84 DMRNLIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
D+ LI +G G VY YD ++ VA+K + ED +E L+ F +E +
Sbjct: 5 DIIRLIGKGGMGEVYLA-YDPVCSRRVALKKIR--ED----LSENPLLKKRFLREAKIAA 57
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
L HP + +P + DG+ + Y+ G LK L+++
Sbjct: 58 DLIHPGI--------------VPVYSICSDGDPVY------YTMPYIEGYTLKS-LLKSV 96
Query: 201 RKKLAL----------KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
+K +L + + + + Y+HSK ++HRD+K +N+LL + I D
Sbjct: 97 WQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156
Query: 251 FGVARVEAQNPRD---------------MT--GE-TGTLGYMAPEVLQGKPYNRRCDVYS 292
+G A + D MT G+ GT YMAPE L G P + D+Y+
Sbjct: 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA 216
Query: 293 FGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP----RCCPSSLANIMRKCWDANA 348
G+ L+++ PY +S R + I R P L+ I K +
Sbjct: 217 LGVILYQMLTLSFPYRRKKGRKIS---YRDVILSPIEVAPYREIPPFLSQIAMKALAVDP 273
Query: 349 EKR 351
+R
Sbjct: 274 AER 276
|
Length = 932 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 48/141 (34%), Positives = 69/141 (48%), Gaps = 16/141 (11%)
Query: 209 VIQLALDLSR----------GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
VIQ+ LD R G+ +LHS I+HRD+K N+++ S TLKI DFG+AR A
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 169
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
MT T Y APEV+ G Y D++S G + E+ + +P + D +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 319 VVRQNLRPEIPRCCPSSLANI 339
V+ Q P CP + +
Sbjct: 230 VIEQLGTP-----CPEFMKKL 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 39/218 (17%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I G++G+VY T + N+ VAVK + + + +T +EV Q+L HPN
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSY------SGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
++ G + TA +V+EY G L+ +K L
Sbjct: 83 TIEYKGCY-------LKEHTA-------------WLVMEYCLGS--ASDLLEVHKKPLQE 120
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTG 266
+ + +GL+YLHS ++HRD+K N+LL +K+ADFG A +
Sbjct: 121 VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANS 176
Query: 267 ETGTLGYMAPEVL----QGKPYNRRCDVYSFGICLWEI 300
GT +MAPEV+ +G+ Y+ + DV+S GI E+
Sbjct: 177 FVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA---R 255
+R L L+ I + L L+YLH + I+HRDVKTEN+ LD + DFG A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
P+ G +GTL +PE+L PY + D++S G+ L+E+
Sbjct: 237 AHPDTPQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 43/220 (19%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKLLDWGED-GMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G+Y +VY+G + + VA+K++ E+ G TA +E ++ + L H
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---------IREASLLKGLKHA 63
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG----NLKQYLIRNRR 201
N+ L + + D C ++ PGG N+K +L +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTD---------LCQYMDKHPGGLHPENVKLFLFQ--- 111
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
L RGLSY+H + I+HRD+K +N+L+ LK+ADFG+AR ++
Sbjct: 112 --------------LLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRC-DVYSFGICLWEI 300
+ E TL Y P+VL G C D++ G E+
Sbjct: 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 7/146 (4%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
+V +L G +L + + +KL V L + RGL Y+HS I+HRD+K N+ ++
Sbjct: 99 LVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEIY 301
LKI DFG+AR +MTG T Y APE+ L YN+ D++S G + E+
Sbjct: 156 DCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
Query: 302 CCDMPYPDLSFADVSSAVVRQNLRPE 327
+P D ++R P
Sbjct: 213 TGRTLFPGTDHIDQLKLILRLVGTPG 238
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 58/219 (26%)
Query: 183 VVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V++Y+PGG++ LIR + LA + +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC----AIESVHKMGFIHRDIKPDNILI 134
Query: 241 DSQRTLKIADFGV------------------ARVEAQNPRDMTGE--------------- 267
D +K+ DFG+ R ++ P + E
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 268 ----------TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317
GT Y+APEVL Y + CD +S G+ L+E+ P+ + A+
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL 254
Query: 318 AVV--RQNLRPEIPRC---CPSSLANIMRKCWDANAEKR 351
V+ L IP + I+R C AE R
Sbjct: 255 KVINWETTLH--IPSQAKLSREASDLILRLC--CGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 46/181 (25%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALK--------IVIQLALDLSRGLSYLHSKKIVHRDV 233
+++EY GG+L + + + ++ L + I LALD +HS+K++HRD+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD------EVHSRKMMHRDL 195
Query: 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVY 291
K+ N+ L +K+ DFG ++ + + + GT Y+APE+ + K Y+++ D++
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 292 SFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
S G+ L+E+ P+ S ++ V+ P P +++ M+ D K
Sbjct: 256 SLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKN 310
Query: 352 P 352
P
Sbjct: 311 P 311
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 50/178 (28%), Positives = 93/178 (52%), Gaps = 14/178 (7%)
Query: 182 VVVEYLPGGNLKQYLI-RNRRKKLALKIV---IQLALDLSRGLSYLHSKKIVHRDVKTEN 237
++++Y+ GG + +L R+ + ++ I LAL+ +LH IV+RD+K EN
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE------HLHKLGIVYRDIKLEN 135
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKP-YNRRCDVYSFGI 295
+LLDS+ + + DFG+++ ++ T GT+ YMAPE+++GK + + D +S GI
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195
Query: 296 CLWEIYCCDMPYPDLSFADVSSAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKR 351
++E+ P+ + S V R+ L+ P P +++ K + +KR
Sbjct: 196 LIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 182 VVVEYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
+V +Y+ GG L +L + R + A + +L L L +LH IV+RD+K EN+L
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL----ALEHLHKYDIVYRDLKPENIL 128
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLW 298
LD+ + + DFG+++ + + GT Y+APEV L K Y + D +S G+ ++
Sbjct: 129 LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVF 188
Query: 299 EIYCCDMPY 307
E+ C P+
Sbjct: 189 EMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 32/183 (17%)
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
A R E + + ++HP++ + G T N + C++
Sbjct: 124 AGQRGGTATEAHILRAINHPSIIQLKGTF--TYN------------------KFTCLI-- 161
Query: 186 YLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245
LP Y ++ +A+ ++ + + R + YLH +I+HRD+K EN+ ++
Sbjct: 162 -LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD 220
Query: 246 LKIADFGVARVEAQNPRDMT-----GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
+ + DFG A P D+ G GT+ APE+L PY D++S GI L+E+
Sbjct: 221 VCLGDFGAACF----PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
Query: 301 YCC 303
C
Sbjct: 277 ATC 279
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 44/129 (34%), Positives = 66/129 (51%), Gaps = 7/129 (5%)
Query: 174 AVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233
V C V+ +Y +L YL R + L L V +A L + Y+H + I+HRD+
Sbjct: 230 VVGGLTCLVLPKY--RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDI 286
Query: 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMT---GETGTLGYMAPEVLQGKPYNRRCDV 290
KTEN+L++ + + DFG A A+ G GT+ APEVL G PY D+
Sbjct: 287 KTENVLVNGPEDICLGDFGAA-CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 291 YSFGICLWE 299
+S G+ ++E
Sbjct: 346 WSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 32/173 (18%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 277
RG+ + HS I+HRD+K EN+L+ +K+ DFG AR A T T Y APE
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 278 VLQGKP-YNRRCDVYSFGICLWEIYCCDMPYPDLS------------------------- 311
+L G Y R D+++ G + E+ + +P S
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230
Query: 312 ---FADVSSAVVRQ--NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
FA + V++ L P+ L ++ ++C + + RP +++
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 70/269 (26%), Positives = 114/269 (42%), Gaps = 47/269 (17%)
Query: 105 QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164
EVA+KLL D E R+ F++E A+ +L HPN+
Sbjct: 4 HEVAIKLLR--TDA----PEEEHQRARFRRETALCARLYHPNIV---------------- 41
Query: 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH 224
A +D A P V EY+PG L++ L + L +L L + L+ H
Sbjct: 42 --ALLDSGEAPPGLLF-AVFEYVPGRTLREVLAAD--GALPAGETGRLMLQVLDALACAH 96
Query: 225 SKKIVHRDVKTENMLL---DSQRTLKIADFGVAR----VEAQNPRDMTGETGTLG---YM 274
++ IVHRD+K +N+++ + K+ DFG+ V + +T T LG Y
Sbjct: 97 NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYC 156
Query: 275 APEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPS 334
APE L+G+P D+Y++G+ E C + A V+ ++ Q L P + P
Sbjct: 157 APEQLRGEPVTPNSDLYAWGLIFLE---CLTGQRVVQGASVAE-ILYQQLSP-VDVSLPP 211
Query: 335 S-----LANIMRKCWDANAEKRPEMGEVV 358
L ++RK + + +R +
Sbjct: 212 WIAGHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 84 DMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+R I G++G+VY R N+ VA+K + + + ++ +EV Q+
Sbjct: 29 DLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSY------SGKQSNEKWQDIIKEVKFLQR 81
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+ HPN ++ G + +V+EY G L+ +
Sbjct: 82 IKHPNSIEYKGCYL--------------------REHTAWLVMEYCLGS--ASDLLEVHK 119
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
K L + + +GL+YLHS ++HRD+K N+LL +K+ADFG A + +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177
Query: 262 RDMTGETGTLGYMAPEVL----QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317
GT +MAPEV+ +G+ Y+ + DV+S GI E+ P L + S
Sbjct: 178 --ANSFVGTPYWMAPEVILAMDEGQ-YDGKVDVWSLGITCIEL---AERKPPLFNMNAMS 231
Query: 318 AV--VRQNLRPEIPRCCPSS-LANIMRKCWDANAEKRPEMGEVVKML 361
A+ + QN P + S N + C + RP E++K +
Sbjct: 232 ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 41/129 (31%), Positives = 72/129 (55%), Gaps = 7/129 (5%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C +++ + GG+L +L ++ + K + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 73 CFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 241 DSQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLW 298
D ++I+D G+A + P GT GYMAPEVLQ G Y+ D +S G L+
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLF 187
Query: 299 EIYCCDMPY 307
++ P+
Sbjct: 188 KLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 1/86 (1%)
Query: 216 LSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-VEAQNPRDMTGETGTLGYM 274
L + + + H IVHRD+K EN+L+ LK+ DFG AR + + + T T Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 275 APEVLQGKPYNRRCDVYSFGICLWEI 300
+PE+L G PY + D++S G L E+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 44/245 (17%)
Query: 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQ------QEVAVWQ 140
N+I G++G VY +D T+E A++ Q +E+ + +
Sbjct: 72 NIIGNGSFGVVYEAI---------CID--------TSEKVAIKKVLQDPQYKNRELLIMK 114
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK--QYLIR 198
L+H N+ F+ T K K ++ VV+E++P K ++ R
Sbjct: 115 NLNHINII-FLKDYYYTECFKKNEKNIFLN-----------VVMEFIPQTVHKYMKHYAR 162
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ-RTLKIADFGVARVE 257
N L L +V + L R L+Y+HSK I HRD+K +N+L+D TLK+ DFG A+
Sbjct: 163 NN-HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316
R ++ Y APE++ G Y D++S G + E+ + YP S
Sbjct: 222 LAGQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI---LGYPIFSGQSSV 277
Query: 317 SAVVR 321
+VR
Sbjct: 278 DQLVR 282
|
Length = 440 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 48/302 (15%)
Query: 59 HLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE---VAVKLLDWG 115
L + ++ PK + ++ + + G++G V TY N++ VA+K +
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE-- 65
Query: 116 EDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAV 175
+ + + F E + ++HP G+ S L +
Sbjct: 66 ---KSKIIKQKQVDHVFS-ERKILNYINHPFCVNLYGSFKDESYLYL------------- 108
Query: 176 PARACCVVVEYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233
V+E++ GG +L RN+R + Q+ L YL S IV+RD+
Sbjct: 109 -------VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE----YLQSLNIVYRDL 157
Query: 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSF 293
K EN+LLD +K+ DFG A+V + GT Y+APE+L + + D ++
Sbjct: 158 KPENLLLDKDGFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVGHGKAADWWTL 214
Query: 294 GICLWEIYCCDMPY----PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAE 349
GI ++EI P+ P L + + ++ P+ ++ ++M+K +
Sbjct: 215 GIFIYEILVGCPPFYANEPLLIYQKILEGIIY------FPKFLDNNCKHLMKKLLSHDLT 268
Query: 350 KR 351
KR
Sbjct: 269 KR 270
|
Length = 340 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 40/102 (39%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 209 VIQLALDLSR----------GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
VI + LD R G+ +LHS I+HRD+K N+++ S TLKI DFG+AR
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
N MT T Y APEV+ G Y D++S G + E+
Sbjct: 175 TNFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 43/153 (28%), Positives = 85/153 (55%), Gaps = 9/153 (5%)
Query: 182 VVVEYLPGGNLKQYLI-RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
++++Y+ GG L +L R R K+ ++I ++ L +LH I++RD+K EN+LL
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSG---EIVLALEHLHKLGIIYRDIKLENILL 138
Query: 241 DSQRTLKIADFGVAR--VEAQNPRDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGIC 296
DS + + DFG+++ E + R + GT+ YMAP++++G +++ D +S G+
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197
Query: 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP 329
++E+ P+ + + + R+ L+ E P
Sbjct: 198 MYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 4/103 (3%)
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
+ +KL+ + L + +GL Y+H+ I+HRD+K N+ ++ LKI DFG+AR Q
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---Q 167
Query: 260 NPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEIY 301
+MTG T Y APEV L Y + D++S G + E+
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 220 LSYLHSKK-IVHRDVKTENMLLDSQRTLKIADFGVA--RVEAQNPRDMTGETGTLGYMAP 276
L YL K ++HRDVK N+LLD+ +K+ DFG++ V++ + T G YMAP
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KAKTRSAGCAAYMAP 183
Query: 277 EVLQGKP----YNRRCDVYSFGICLWEIYCCDMPYP--DLSFADVSSAVVRQNLRPEIPR 330
E + Y+ R DV+S GI L E+ PY F +V + ++++ P +P
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQEEP-PSLPP 241
Query: 331 CCPSS--LANIMRKCWDANAEKRPEMGEVVK 359
S + + C + KRP+ E+++
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 38/122 (31%), Positives = 68/122 (55%), Gaps = 7/122 (5%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
+++ + GG+L +L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 73 SFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 241 DSQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLW 298
D ++I+D G+A + P GT GYMAPEVLQ G Y+ D +S G L+
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187
Query: 299 EI 300
++
Sbjct: 188 KL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 41/144 (28%), Positives = 76/144 (52%), Gaps = 2/144 (1%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V+ ++ GG L +L R R L+ L + L LH +++RD+K EN+LLD
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFNVIYRDLKPENILLD 127
Query: 242 SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
Q + + DFG+ ++ ++ GT Y+APE+L G Y + D ++ G+ L+E+
Sbjct: 128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
Query: 302 CCDMPYPDLSFADVSSAVVRQNLR 325
P+ D + ++ ++++ LR
Sbjct: 188 TGLPPFYDENVNEMYRKILQEPLR 211
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V++Y GG+L L+ +L + ++ + +H VHRD+K +N+LLD
Sbjct: 78 LVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 242 SQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSFG 294
+++ADFG ++ + GT Y++PE+LQ GK Y CD +S G
Sbjct: 137 MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK-YGPECDWWSLG 195
Query: 295 ICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP 329
+C++E+ + P+ S + ++ R + P
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 223 LHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQ- 280
+H VHRD+K +N+LLD +++ADFG R+ A GT Y++PE+LQ
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 281 ---GK-PYNRRCDVYSFGICLWEIYCCDMPY 307
GK Y CD +S G+C++E+ + P+
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 48/181 (26%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 184 VEYLPGGNL-KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLD 241
+EY+ G+L K Y + + ++ ++ + +GL +L + I+HRDVK N+L++
Sbjct: 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137
Query: 242 SQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQGK------PYNRRCDVYSFG 294
+K+ DFGV+ + A + G YMAPE ++ Y + DV+S G
Sbjct: 138 GNGQVKLCDFGVSGNLVASLAKT---NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194
Query: 295 ICLWEIYCCDMPYPDLSFADVS---SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
+ + E+ PYP ++A++ SA+V + P +P + + KC + +R
Sbjct: 195 LSILEMALGRYPYPPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRR 253
Query: 352 P 352
P
Sbjct: 254 P 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 73/249 (29%), Positives = 106/249 (42%), Gaps = 41/249 (16%)
Query: 89 IAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G+YG V+ R Q VA+K ED + ALR E+ + ++L HPN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI--KKIALR-----EIRMLKQLKHPN 61
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR---KK 203
+ NL + R +V EY L + L +N R +
Sbjct: 62 LV----------NLIEVFRRK----------RKLHLVFEYCDHTVLNE-LEKNPRGVPEH 100
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
L KI+ Q +++ H +HRDVK EN+L+ Q +K+ DFG AR+ D
Sbjct: 101 LIKKIIWQTLQ----AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 264 MTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA-VVR 321
T T Y APE+L G Y DV++ G E+ +P S DV ++R
Sbjct: 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS--DVDQLYLIR 214
Query: 322 QNLRPEIPR 330
+ L IPR
Sbjct: 215 KTLGDLIPR 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 65/295 (22%), Positives = 119/295 (40%), Gaps = 62/295 (21%)
Query: 89 IAQGTYGSVYRGTYDNQ---------EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW 139
+ QGT+ +++G EV +K+LD SF + ++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD---------KSHRNYSESFFEAASMM 53
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
+L H ++ G V +V EY+ G+L YL +N
Sbjct: 54 SQLSHKHLVLNYGVCVC--------------------GDESIMVQEYVKFGSLDTYLKKN 93
Query: 200 RRK---KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT--------LKI 248
+ L++ QLA L +L K + H +V +N+LL + +K+
Sbjct: 94 KNLINISWKLEVAKQLAW----ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149
Query: 249 ADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYC-CDMP 306
+D G++ P+++ E + ++ PE ++ + + D +SFG LWEI+ D P
Sbjct: 150 SDPGIS--ITVLPKEILLE--RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
LS D + R ++P + LAN++ +C D + RP +++ L
Sbjct: 206 ---LSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 35/84 (41%), Positives = 48/84 (57%), Gaps = 4/84 (4%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 277
GL Y+HS I+HRD+K N+ ++ LKI DFG+AR +MTG T Y APE
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPE 184
Query: 278 V-LQGKPYNRRCDVYSFGICLWEI 300
V L YN+ D++S G + E+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-11
Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 35/255 (13%)
Query: 83 LDMRNLIAQGTYGSVYRGTYDNQE--VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
++ +I +G +G V N + A+K+L+ E M AETA F++E V
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETAC----FREERDVLV 56
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
D+ +T A +NL + V++Y GG+L L+
Sbjct: 57 NGDNQWITTLHYAFQDENNLYL--------------------VMDYYVGGDLLT-LLSKF 95
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVEAQ 259
+L + ++ + +H VHRD+K +N+L+D +++ADFG ++
Sbjct: 96 EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155
Query: 260 NPRDMTGETGTLGYMAPEVLQ----GK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
+ GT Y++PE+LQ GK Y CD +S G+C++E+ + P+ S +
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 315 VSSAVVRQNLRPEIP 329
++ R + P
Sbjct: 216 TYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 41/187 (21%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+++E+LPGG++ L++ + L + + + +H +HRD+K +N+LLD
Sbjct: 78 LIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135
Query: 242 SQRTLKIADFGV----------------------------------ARVEAQNPRDMTGE 267
S+ +K++DFG+ A +N R +
Sbjct: 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFS 195
Query: 268 T-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY----PDLSFADVSSAVVRQ 322
T GT Y+APEV YN+ CD +S G+ ++E+ P+ P ++ V +
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL 255
Query: 323 NLRPEIP 329
PE+P
Sbjct: 256 IFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 60/175 (34%)
Query: 183 VVEYLPGGNLKQYLIRN-------RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
++EYLPGG++ L++ R +A I LA+D +H +HRD+K
Sbjct: 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI---LAID------SIHKLGYIHRDIKP 129
Query: 236 ENMLLDSQRTLKIADFGV-----------------------ARVEAQNPRDMTGET---- 268
+N+LLD++ +K++DFG+ P +
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189
Query: 269 -----------GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI------YCCDMP 306
GT Y+APEV YN+ CD +S G+ ++E+ +C D P
Sbjct: 190 RNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 50/212 (23%)
Query: 178 RACCVVVEYLPGGNLKQYLIR-NRRKKLALKIVIQ---LALDLSRGLSYLHSKKIVHRDV 233
R +++E+LPGG++ L++ + + A + I LA+D +H +HRD+
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID------AIHQLGFIHRDI 127
Query: 234 KTENMLLDSQRTLKIADFGV----------------------------------ARVEAQ 259
K +N+LLD++ +K++DFG+ A +
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 260 NPRDMTGET-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY----PDLSFAD 314
N R + T GT Y+APEV YN+ CD +S G+ ++E+ P+ P ++
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRK 247
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA 346
V + PE+P + I+R C D+
Sbjct: 248 VMNWKETLVFPPEVP-ISEKAKDLILRFCTDS 278
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 53/174 (30%)
Query: 183 VVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V++Y+PGG++ LIR + LA + +L L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIESVHKMGFIHRDIKPDNILI 134
Query: 241 DSQRTLKIADFGVA------------------RVEAQNPRD--------------MTGE- 267
D +K+ DFG+ R ++ P D T E
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194
Query: 268 --------------TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
GT Y+APEVL K Y + CD +S G+ L+E+ P+
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 216 LSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE-AQNPRDM--TGETGTLG 272
L R L Y+H+ + HRD+K +N+L ++ LKI DFG+ARV P + T T
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 273 YMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
Y APE L G +++ Y+ I +W I C
Sbjct: 172 YRAPE-LCGSFFSK----YTPAIDIWSIGC 196
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 29/77 (37%), Positives = 51/77 (66%), Gaps = 6/77 (7%)
Query: 182 VVVEYLPGGNLKQYL--IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
+V+EYL GG++K L +++A+K + ++AL L YLH I+HRD+K +NML
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL----ALDYLHRHGIIHRDLKPDNML 136
Query: 240 LDSQRTLKIADFGVARV 256
+ ++ +K+ DFG+++V
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 28/83 (33%), Positives = 48/83 (57%), Gaps = 3/83 (3%)
Query: 220 LSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT--GETGTLGYMAPE 277
+ Y+H KK++HRD+K EN+ L+ + + DFG A + + R+ G GT+ +PE
Sbjct: 280 VEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVATNSPE 338
Query: 278 VLQGKPYNRRCDVYSFGICLWEI 300
+L G Y D++S G+ L ++
Sbjct: 339 ILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 52/236 (22%), Positives = 91/236 (38%), Gaps = 52/236 (22%)
Query: 91 QGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150
+ + N VAVK ++ D + QQE+ ++L HPN+ +
Sbjct: 12 DLMIVHLAKHKPTNTLVAVKKINL--DSCSKEDLKL-----LQQEIITSRQLQHPNILPY 64
Query: 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVI 210
V + + S L VV + G+ + L++ + ++ I
Sbjct: 65 VTSFIVDSELY--------------------VVSPLMAYGSCED-LLKTHFPEGLPELAI 103
Query: 211 QLAL-DLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV---EAQNPRDM-- 264
L D+ L Y+HSK +HR VK ++LL + ++ + + R +
Sbjct: 104 AFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 265 --TGETGTLGYMAPEVLQ----GKPYNRRCDVYSFGICLWEIYCCDM-----PYPD 309
L +++PEVLQ G YN + D+YS GI C++ P+ D
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGIT-----ACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 61/246 (24%)
Query: 88 LIAQGTYGSVY----RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD 143
L+ +G G V+ +GT + A+K+LD + M + R +QE+ LD
Sbjct: 8 LLGKGDVGRVFLVRLKGT--GKLFALKVLD--KKEMIKRNKVK--RVLTEQEIL--ATLD 59
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
HP F +P+ AS C+V++Y PGG L + L R K
Sbjct: 60 HP----F-----------LPTLYASFQ-----TETYLCLVMDYCPGGELFRLLQRQPGKC 99
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF---------GVA 254
L+ ++ A ++ L YLH IV+RD+K EN+LL + ++DF
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159
Query: 255 RVEA-------QNPRDMTGET-------------GTLGYMAPEVLQGKPYNRRCDVYSFG 294
+A + + ET GT Y+APEV+ G + D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219
Query: 295 ICLWEI 300
I L+E+
Sbjct: 220 ILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 35/198 (17%)
Query: 182 VVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
+V E++ G L L + + R +A KI + A L+ LSYL K +VH +V +N+LL
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQLASALSYLEDKNLVHGNVCAKNILL 150
Query: 241 -------DSQRTLKIADFGVA--------RVEAQNPRDMTGETGTLGYMAPEVLQ-GKPY 284
+ +K++D GV+ RVE + ++APE + G
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTALSREERVE------------RIPWIAPECVPGGNSL 198
Query: 285 NRRCDVYSFGICLWEI-YCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKC 343
+ D +SFG L EI + ++P + + ++ +++ PE P C LA ++ +C
Sbjct: 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPE-PSC--KELATLISQC 255
Query: 344 WDANAEKRPEMGEVVKML 361
+RP +++ L
Sbjct: 256 LTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 51/232 (21%)
Query: 89 IAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GTYG VY+ D +E A+K + E + S +E+A+ ++L H
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-----------EGTGISMSACREIALLRELKH 57
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PNV + S+ K+ ++ +Y + ++I+ R
Sbjct: 58 PNVIALQKVFLSHSDRKV------------------WLLFDY--AEHDLWHIIKFHRASK 97
Query: 205 ALKIVIQLALDLSR--------GLSYLHSKKIVHRDVKTENMLL----DSQRTLKIADFG 252
A K +QL + + G+ YLH+ ++HRD+K N+L+ + +KIAD G
Sbjct: 98 ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157
Query: 253 VARV--EAQNP-RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEI 300
AR+ P D+ T Y APE+L G + Y + D+++ G E+
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 51/232 (21%)
Query: 89 IAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GTYG VY+ D+++ A+K + E + S +E+A+ ++L H
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-----------EGTGISMSACREIALLRELKH 57
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PNV + ++ K+ ++ +Y + ++I+ R
Sbjct: 58 PNVISLQKVFLSHADRKV------------------WLLFDY--AEHDLWHIIKFHRASK 97
Query: 205 ALKIVIQLALDLSR--------GLSYLHSKKIVHRDVKTENMLL----DSQRTLKIADFG 252
A K +QL + + G+ YLH+ ++HRD+K N+L+ + +KIAD G
Sbjct: 98 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157
Query: 253 VARV--EAQNP-RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEI 300
AR+ P D+ T Y APE+L G + Y + D+++ G E+
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 48/213 (22%), Positives = 82/213 (38%), Gaps = 56/213 (26%)
Query: 183 VVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V++Y+PGG++ LIR + LA + +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC----AVESVHKMGFIHRDIKPDNILI 134
Query: 241 DSQRTLKIADFGVA---------------------------------------------- 254
D +K+ DFG+
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLER 194
Query: 255 RVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
R Q+ R + GT Y+APEVL Y + CD +S G+ L+E+ P+ +
Sbjct: 195 RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL 254
Query: 314 DVSSAVVRQNLRPEIP---RCCPSSLANIMRKC 343
+ V+ IP + P + I++ C
Sbjct: 255 ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 27/185 (14%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL- 240
+V E++ G L ++ R + L ++A L+ LSYL K +VH +V T+N+LL
Sbjct: 81 MVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 241 ------DSQRTLKIADFGV-----ARVEAQNPRDMTGETGTLGYMAPE-VLQGKPYNRRC 288
+ +K++D G+ +R E + ++APE V K +
Sbjct: 140 REGIDGECGPFIKLSDPGIPITVLSRQEC---------VERIPWIAPECVEDSKNLSIAA 190
Query: 289 DVYSFGICLWEI-YCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
D +SFG LWEI Y ++P D + A+ P C LA++M C + +
Sbjct: 191 DKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCMLVTPSC--KELADLMTHCMNYD 247
Query: 348 AEKRP 352
+RP
Sbjct: 248 PNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 78/335 (23%), Positives = 116/335 (34%), Gaps = 114/335 (34%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGTYDNQEV--AVKLLDWGEDGMATTAETAALRSSFQQEVA 137
LS L N+I++G G+ Y+G + VK E + S E+A
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVK-------------EINDVNSIPSSEIA 735
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
KL HPN+ K +G S + ++ EY+ G NL + L
Sbjct: 736 DMGKLQHPNIVKLIGLC--RSE------------------KGAYLIHEYIEGKNLSEVL- 774
Query: 198 RN----RRKKLALKIVIQLALDLSRGLSYLH---SKKIVHRDVKTENMLLDSQRTLKIAD 250
RN RR+K+A+ I + L +LH S +V ++ E +++D +
Sbjct: 775 RNLSWERRRKIAIGIA--------KALRFLHCRCSPAVVVGNLSPEKIIIDGK------- 819
Query: 251 FGVARVEAQNPRDMTGETGTL----------GYMAPEVLQGKPYNRRCDVYSFGICL--- 297
P G L Y+APE + K + D+Y FG+ L
Sbjct: 820 --------DEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 298 -------------------WEIYC---C--DMPYPDLSFADVSSAVVRQNLRPEIPRCCP 333
W YC C DM DVS V QN E+
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS---VNQNEIVEV----- 923
Query: 334 SSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368
N+ C + RP +V+K LE+ S
Sbjct: 924 ---MNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 65/176 (36%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIVHRDV 233
+++E+LPGG+L LI+ + D++R + +H +HRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYD----------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 234 KTENMLLDSQRTLKIADFGVA-----------------RVEAQNP--------------- 261
K +N+L+D +K++DFG++ +N
Sbjct: 128 KPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLT 187
Query: 262 --------------RDMTGET-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
R M T GT Y+APE+ + Y + CD +S G ++E
Sbjct: 188 MSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA--------RVE- 257
K++ + D+ L Y+H I H D+K EN+++D I D+G+A +E
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
++ +D+ GTL Y + G RR D+ S G C+
Sbjct: 186 SKEQKDL--HRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223
|
Length = 294 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 24/75 (32%), Positives = 34/75 (45%), Gaps = 10/75 (13%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V+EY+ G LK L R L ++ R + LH IVH D+ T N++L
Sbjct: 76 IVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILS 126
Query: 242 SQRTLKIADFGVARV 256
R I DFG+
Sbjct: 127 GGRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 21/56 (37%), Positives = 28/56 (50%), Gaps = 5/56 (8%)
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD-SQRTLKIADFGVA 254
R K+ I+ Q+ L LHS IVHRDVK +N++ + KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDG----LHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 24/83 (28%), Positives = 39/83 (46%), Gaps = 15/83 (18%)
Query: 183 VVEYLPGGNLKQYL--IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EY+ G LK + +L+ +I + LHS I+H D+ T NM+L
Sbjct: 77 VMEYIEGEPLKDLINSNGMEELELSREIGRLVGK--------LHSAGIIHGDLTTSNMIL 128
Query: 241 DSQRTLKIADFGVA----RVEAQ 259
S + + DFG+A +E +
Sbjct: 129 -SGGKIYLIDFGLAEFSKDLEDR 150
|
Length = 211 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 31/120 (25%), Positives = 54/120 (45%), Gaps = 7/120 (5%)
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V+++ GG L ++ + + + V + A ++ L LH + IV RD+ N+LLD
Sbjct: 62 LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 242 SQRTLKIADFGVAR-VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
+ +++ F VE + Y APEV CD +S G L+E+
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFEL 175
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 58/261 (22%), Positives = 118/261 (45%), Gaps = 66/261 (25%)
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+S EV V ++L H N+ +++ + +N K+ +++E+
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL------------------YILMEFCD 97
Query: 189 GGNLKQYLIRNRRK--KLALKIVIQLALDLSR----GLSYLHS-------KKIVHRDVKT 235
G+L RN +K K+ KI +D++R L+Y H+ ++++HRD+K
Sbjct: 98 AGDLS----RNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153
Query: 236 ENMLLDS-----------------QRTLKIADFGVAR---VEAQNPRDMTGETGTLGYMA 275
+N+ L + + KI DFG+++ +E+ GT Y +
Sbjct: 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWS 209
Query: 276 PEVL--QGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-SFADVSSAVVRQNLRPEIPRCC 332
PE+L + K Y+ + D+++ G ++E+ P+ +F+ + S + R P++P
Sbjct: 210 PELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG---PDLPIKG 266
Query: 333 PSSLANIM-RKCWDANAEKRP 352
S NI+ + + +A++RP
Sbjct: 267 KSKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 19/36 (52%), Positives = 23/36 (63%)
Query: 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
GL LH IVHRD+K EN+L+ +KI DFG A
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 28/105 (26%), Positives = 51/105 (48%), Gaps = 15/105 (14%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG----------VARVEAQNPRDMTGE 267
RGL+YLH +HR++K ++L+ + ++ A+V P+
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ---FS 168
Query: 268 TGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYCCDMPYPDL 310
T L +++PE+L+ YN + D+YS GI E+ +P+ D+
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 34/120 (28%), Positives = 56/120 (46%), Gaps = 18/120 (15%)
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML--LDSQRTLK--------IADFG 252
+LA+ ++Q L + L Y+H VHR VK ++L +D + L I
Sbjct: 100 ELAIAYILQGVL---KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310
RV P+ L +++PEVLQ + Y+ + D+YS GI E+ +P+ D+
Sbjct: 157 RLRVVHDFPKY---SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 13/88 (14%)
Query: 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL 271
+ L L LH + + T + LL G A + +
Sbjct: 22 VCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSV---AFKTPEQSRPDPYF 70
Query: 272 GYMAPEVLQGKPYNRRCDVYSFGICLWE 299
MAPEV+QG+ Y + D+YS GI L+E
Sbjct: 71 --MAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 21/74 (28%), Positives = 34/74 (45%), Gaps = 10/74 (13%)
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V+EY+ G LK +I +L +I + LH IVH D+ T N+++
Sbjct: 75 VMEYIEGKPLK-DVIEEGNDELLREIGRLVGK--------LHKAGIVHGDLTTSNIIVRD 125
Query: 243 QRTLKIADFGVARV 256
+ I DFG+ +
Sbjct: 126 DKLYLI-DFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 39/131 (29%), Positives = 55/131 (41%), Gaps = 27/131 (20%)
Query: 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
RT K G A VE R + GT Y+APE+L GKP+ D ++ G+CL+E
Sbjct: 523 RTPKSVRRGAAPVE--GERIL----GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTG 576
Query: 304 DMPYPDLSFADVSSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEK-RPEMGEVVKML 361
P F D + V QN L +IP W EK +++L
Sbjct: 577 IPP-----FNDETPQQVFQNILNRDIP--------------WPEGEEKLSVNAQNAIEIL 617
Query: 362 EAIDTSKGGGM 372
+D +K G+
Sbjct: 618 LTMDPTKRAGL 628
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 390 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.09 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.95 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.56 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.5 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.8 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.56 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.34 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.86 | |
| PLN02236 | 344 | choline kinase | 96.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.64 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.61 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.46 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.35 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.27 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.18 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.89 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.61 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.67 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.54 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.77 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 93.77 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 93.63 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-57 Score=429.58 Aligned_cols=289 Identities=39% Similarity=0.750 Sum_probs=252.5
Q ss_pred CCCcccccccCccccccccccCceEEEEEEECCce-EEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE-VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
....|.++.+++.+.+.||+|+||+||+|.|.|+. ||||++.....+. .....|.+|+.+|++++|||||+|
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~-------~~~~~f~~E~~il~~l~HpNIV~f 104 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD-------ESRKAFRREASLLSRLRHPNIVQF 104 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh-------HHHHHHHHHHHHHHhCCCCCeeeE
Confidence 34678999999999999999999999999999998 9999997432211 116789999999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-Cc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK-IV 229 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-ii 229 (390)
+|++.... ..+++||||+++|+|.+++.+.....++...++.++.||++||.|||+++ ||
T Consensus 105 ~G~~~~~~-------------------~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iI 165 (362)
T KOG0192|consen 105 YGACTSPP-------------------GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPII 165 (362)
T ss_pred EEEEcCCC-------------------CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Confidence 99997543 14589999999999999997644568999999999999999999999999 99
Q ss_pred ccCCCCCCEEECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 230 HRDVKTENMLLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ--GKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 230 HrDlkp~NILl~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
||||||+|||++.++ ++||+|||+++.........+...||+.|||||++. ...|+.++||||||+++|||+||..|
T Consensus 166 HrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred ecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 999999999999997 999999999987655434555678999999999999 66999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC-CCCCCCCCCCcceeec
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG-GGMIPEDQATGCFCFS 385 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~-~~~~~~~~~~~~~~~~ 385 (390)
|.+.....+...++..+.++.+|..+++.+..+|..||..||..||++.+++..|+.+.+... ....+......|.++.
T Consensus 246 f~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDSADSDSCDSPL 325 (362)
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcccccccccccccc
Confidence 999999888899999999999999999999999999999999999999999999999987554 3455544445555444
Q ss_pred C
Q 036382 386 P 386 (390)
Q Consensus 386 ~ 386 (390)
.
T Consensus 326 ~ 326 (362)
T KOG0192|consen 326 E 326 (362)
T ss_pred c
Confidence 3
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-56 Score=425.94 Aligned_cols=266 Identities=30% Similarity=0.617 Sum_probs=240.2
Q ss_pred CCcccccccCccccccccccCceEEEEEEECCc-eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
...|+++.+.+++.+.||+|.||.||.|.++++ .||+|.++.+.. ..+.|.+|+.+|++|+|+|||+++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m----------~~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM----------SPEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc----------ChhHHHHHHHHHHhCcccCeEEEE
Confidence 678999999999999999999999999999887 999999985422 135678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
|+|.... ++|||||||+.|+|.+||+...+..+...+.+.++.||++||+||+++++|||
T Consensus 268 gV~~~~~--------------------piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR 327 (468)
T KOG0197|consen 268 GVCTKQE--------------------PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR 327 (468)
T ss_pred EEEecCC--------------------ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccch
Confidence 9998543 45889999999999999987667789999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
||.++||||++++.+||+|||+|+....... ...+.--+..|.|||.+....|+.+|||||||++||||+| |+.||++
T Consensus 328 DLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 328 DLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 9999999999999999999999995444332 2333445789999999999999999999999999999998 9999999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+++.+++..+ ..++|.+.|..||+++.++|..||+.+|++||||+.+...|+++.+...
T Consensus 408 msn~ev~~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 408 MSNEEVLELL-ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCHHHHHHHH-hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 9999999765 7899999999999999999999999999999999999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-55 Score=398.39 Aligned_cols=253 Identities=28% Similarity=0.519 Sum_probs=223.8
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
..+..++++..+.||+|..|+||++.+ +++.+|+|++.. .......+++.+|+++++.++||+||.+||+
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--------~~~~~~~~Qi~rEl~il~~~~spyIV~~yga 145 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--------NIDPALQKQILRELEILRSCQSPYIVGFYGA 145 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence 446677899999999999999999988 588999999952 2234456889999999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRD 232 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrD 232 (390)
|..... ..+|+||||++|+|.+++... +++++..+..++.+|++||.|||. ++|||||
T Consensus 146 F~~~~~-------------------~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRD 204 (364)
T KOG0581|consen 146 FYSNGE-------------------EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRD 204 (364)
T ss_pred EEeCCc-------------------eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeecc
Confidence 986543 247899999999999999543 679999999999999999999995 9999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-- 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-- 310 (390)
|||+||||+..|.+||||||.+...... ...+..||..|||||.+.+..|+.++||||||++++|+.+|+.||...
T Consensus 205 IKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~ 282 (364)
T KOG0581|consen 205 IKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP 282 (364)
T ss_pred CCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC
Confidence 9999999999999999999999876654 445689999999999999999999999999999999999999999774
Q ss_pred ---ChhhHHHHHHHcCCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 ---SFADVSSAVVRQNLRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ---~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..+.+..++. +..|..|.. +++++++||..||++||.+|||+.|++++
T Consensus 283 ~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 283 PYLDIFELLCAIVD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCHHHHHHHHhc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 67777777764 456778886 99999999999999999999999999964
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-54 Score=412.48 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=228.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|+..+.||+|+|+.||.+++ +|+.||+|++.. ........++.+.+|++|.+.|+|||||+++++|.+.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk------~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPK------KLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeeh------HHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 4699999999999999999987 789999999963 22334455678889999999999999999999999887
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
++ |||+|+|..++|..+++ .++.++|..++.++.||+.||.|||+++|||||||..|+
T Consensus 92 nV--------------------YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 92 NV--------------------YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL 149 (592)
T ss_pred ce--------------------EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence 76 66999999999999996 456899999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++++.++||+|||+|...........+.||||.|.|||++.....+..+||||+||+||.||+|++||+..+..+.+..
T Consensus 150 fL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 150 FLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK 229 (592)
T ss_pred eecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence 99999999999999999888776777789999999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+. +|..++.+.++||.++|+.||.+|||+.+|+..
T Consensus 230 Ik~~~Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 230 IKLNEYS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHhcCcc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9877665 677999999999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=387.30 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=219.1
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+..++|++.++||+|+||.||.++. +++.+|+|+++.. ........+....|..||.+++||.||+++..|
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~------~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKK------KIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhh------HhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 45678999999999999999998854 7889999999732 222223456778999999999999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
++...+ |+|+||+.||.|..+|.+ ...+++..+..++.+|+.||.|||++||||||||
T Consensus 95 Qt~~kL--------------------ylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlK 152 (357)
T KOG0598|consen 95 QTEEKL--------------------YLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLK 152 (357)
T ss_pred ccCCeE--------------------EEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 977666 779999999999999965 4579999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.+|+++|+|||+++..........+.|||+.|||||++.+.+|+..+|+||||+++|||++|.+||.+.+...
T Consensus 153 PENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 153 PENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred HHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 99999999999999999999866555555666899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 352 (390)
+...+.... .+..|..++.+.+++++++|.+||++|.
T Consensus 233 ~~~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 MYDKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 998887665 3455666899999999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-53 Score=389.48 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=213.6
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.+.|.+.+.||+|+||.|-+|.. +++.||||+++......... .........+|+++|++|+|||||+++++|...
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~--~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR--AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc--cccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 35688899999999999999976 78999999997444322221 011123356999999999999999999999876
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.+. ||||||+.||+|.+.+-.+ +.+.+.....++.|++.|+.|||++||+||||||+|
T Consensus 249 ds~--------------------YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeN 306 (475)
T KOG0615|consen 249 DSS--------------------YMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPEN 306 (475)
T ss_pred Cce--------------------EEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcce
Confidence 655 7799999999999999654 458889999999999999999999999999999999
Q ss_pred EEECCC---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC---CCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 238 MLLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY---NRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 238 ILl~~~---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||+..+ ..+||+|||+|+... ....+.+.||||.|.|||++.++.+ ..++|+||+||+||-+|+|.+||.+..
T Consensus 307 ILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 307 ILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred EEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999776 789999999999765 4556778999999999999987643 347899999999999999999998876
Q ss_pred hhh-HHHHHHHcCCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FAD-VSSAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~-~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
... ...++.++.+. +.....++.+..+||.+||..||++|||+.+++++
T Consensus 386 ~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 386 TDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 555 55566555443 34556789999999999999999999999999853
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=362.74 Aligned_cols=241 Identities=28% Similarity=0.454 Sum_probs=220.1
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
..+++|++.+.||.|+||.|.+++. +|..+|+|+++. .......+.+...+|..+|+.+.||+++++++.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k------~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDK------QKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCH------HHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 5678999999999999999999876 688999999973 33555566788899999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+..++ |+||||.+||.|+.+|++ .+++++..++.++.||+.||+|||+.+|++|||||
T Consensus 115 d~~~l--------------------ymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKP 172 (355)
T KOG0616|consen 115 DNSNL--------------------YMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKP 172 (355)
T ss_pred cCCeE--------------------EEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCCh
Confidence 76666 779999999999999954 45799999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||+|.+|++||+|||+|...... ..+.||||.|+|||+++.++|..++|+||||+++|||+.|.+||.+..+..+
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 9999999999999999999876543 3458999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 351 (390)
..+++...++ +|..+++++++|+.++|++|-.+|
T Consensus 250 Y~KI~~~~v~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKVK--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 9999888665 899999999999999999999999
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=378.21 Aligned_cols=249 Identities=26% Similarity=0.458 Sum_probs=214.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|.+.+.||+|+||+||+|++ ++..||||.+... .-.....+.+..|+.+|+.++|||||++++++...
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~-------~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKK-------KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhh-------ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 46899999999999999999987 6789999998622 11344567788999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
+. +|+|||||.||+|.+|+.++ +.+++..+..++.|++.||++||+++||||||||.|
T Consensus 82 ~~--------------------i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQN 139 (429)
T KOG0595|consen 82 DF--------------------IYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQN 139 (429)
T ss_pred Ce--------------------EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcce
Confidence 54 48899999999999999654 479999999999999999999999999999999999
Q ss_pred EEECCC------CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 238 MLLDSQ------RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 238 ILl~~~------~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||++.. -.+||+|||+|+.... .....+.||++-|||||+++...|+-++|+||+|+++|+|++|+.||...+
T Consensus 140 iLLs~~~~~~~~~~LKIADFGfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 140 ILLSTTARNDTSPVLKIADFGFARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred EEeccCCCCCCCceEEecccchhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999875 4689999999997663 344456899999999999999999999999999999999999999999999
Q ss_pred hhhHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 312 FADVSSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 312 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
..+....+..... .+..+..+++.+.+++...+..+|.+|.++.+-.
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 9998887655443 3345566777888999999999999998776544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=369.12 Aligned_cols=258 Identities=24% Similarity=0.477 Sum_probs=219.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE-Ee
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA-SV 155 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-~~ 155 (390)
.+.+|++.++||+|+||.||++.. +|..||.|-++++-. .+..+.....|+.+|++|+|||||++++. |.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 456899999999999999999865 899999998874422 23345678899999999999999999984 33
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHh--CC--Cc
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHS--KK--IV 229 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~--~~--ii 229 (390)
++.. ..+|||||+..|+|...++. .....++++.+|.++.|+++||.++|+ .+ |+
T Consensus 90 ~~~e-------------------vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 90 EDNE-------------------VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred ccch-------------------hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 3222 13679999999999999964 345679999999999999999999999 45 99
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
||||||.||+++.+|.+||+|||+++............+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 99999999999999999999999999877766666678999999999999999999999999999999999999999999
Q ss_pred CChhhHHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 310 LSFADVSSAVVRQNLRPEIP-RCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
....+...++... --++.| ...+.++..||..|+..||+.||+...+++.+..
T Consensus 231 ~n~~~L~~KI~qg-d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 231 DNLLSLCKKIEQG-DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ccHHHHHHHHHcC-CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 9888877777554 444456 7789999999999999999999985545544443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=384.69 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=223.6
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 153 (390)
.....||.+++.||.|+|++|++|+. +++.||||++. ..-...+...+.+..|-++|.+| .||.|++++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~------K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLD------KRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhh------HHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 44568999999999999999999976 78899999995 12233444456778899999999 99999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
|+|...+ |+|+||+++|+|.++|.+. +.|++.-.+.++.+|+.||+|||+.|||||||
T Consensus 143 FQD~~sL--------------------YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDl 200 (604)
T KOG0592|consen 143 FQDEESL--------------------YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDL 200 (604)
T ss_pred eecccce--------------------EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccC
Confidence 9988777 6799999999999999654 57999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCC-----------CCC--CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHH
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNP-----------RDM--TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~-----------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 300 (390)
||+|||++.++++||+|||.|....... ... ..++||..|.+||++.+...++++|+|+|||+||+|
T Consensus 201 KPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQm 280 (604)
T KOG0592|consen 201 KPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQM 280 (604)
T ss_pred ChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 9999999999999999999998543221 111 457899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 301 YCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 301 l~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.|.+||.+...--+.++++... -++|..+|+.+++||+++|..||.+|+|..+|.++
T Consensus 281 laG~PPFra~NeyliFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 281 LAGQPPFRAANEYLIFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred hcCCCCCccccHHHHHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 99999999998888888887654 45899999999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=361.16 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=212.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|+.+.++|+|+||+||++++ +|+-||||.+..+ .+.....+...+|+++|++++|||+|.++.+|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-- 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-- 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--
Confidence 5788999999999999999976 7899999999633 3344556777899999999999999999999874
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.+.+++|+||++. ++.+-|.+.. ..++.+.+..+++|++.|+.|+|++++|||||||+||
T Consensus 73 ------------------krklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI 132 (396)
T KOG0593|consen 73 ------------------KRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI 132 (396)
T ss_pred ------------------cceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence 3455889999987 4445555544 4599999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||+.+|.+||||||+|+....++...+..+.|.+|.|||.+.+ .+|+.++||||+||++.||++|.+-|++.+..+.+.
T Consensus 133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 9999999999999999988877778888899999999999987 789999999999999999999999999998877666
Q ss_pred HHHHc-------------------CCCCCCCC----------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQ-------------------NLRPEIPR----------CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~-------------------~~~~~~~~----------~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+... +.+.+.|. ..+..+.+|+.+||..||.+|++-++++.
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 55421 11111111 23456889999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=382.26 Aligned_cols=303 Identities=30% Similarity=0.568 Sum_probs=256.6
Q ss_pred ceEEecCCCcCChHHHHHhhhhhccc---cc---CCCCCCCcccccccCccccccccccCceEEEEEEEC---C--ce-E
Q 036382 40 MLFRADKIDLKSLDMQLEKHLSWVWS---RN---ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---N--QE-V 107 (390)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~-v 107 (390)
.++......+.++...+.-+...... .. ..+.++..|++..++..+.++||+|+||.||+|++. + .. |
T Consensus 110 ~~~~~~~~~F~si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~V 189 (474)
T KOG0194|consen 110 LFFFEGLRKFPTISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPV 189 (474)
T ss_pred eeEEeccccCCcHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeee
Confidence 55666668888887665555433221 11 335567889999999999999999999999999772 2 23 8
Q ss_pred EEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecC
Q 036382 108 AVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187 (390)
Q Consensus 108 avK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 187 (390)
|||..+-. ..........+.+|+++|++++|||||++||++.+.. +.++|||++
T Consensus 190 AvK~~k~~------~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--------------------Pl~ivmEl~ 243 (474)
T KOG0194|consen 190 AVKTTKGS------SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--------------------PLMLVMELC 243 (474)
T ss_pred EEEeeccc------ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--------------------ccEEEEEec
Confidence 99988621 1233455678999999999999999999999998654 447799999
Q ss_pred CCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCC
Q 036382 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGE 267 (390)
Q Consensus 188 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~ 267 (390)
.||+|.++|++... .++..+...++.++++||+|||++++|||||..+|+|++.++.+||+|||+++............
T Consensus 244 ~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~ 322 (474)
T KOG0194|consen 244 NGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLK 322 (474)
T ss_pred CCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccc
Confidence 99999999976543 69999999999999999999999999999999999999999999999999998654222222223
Q ss_pred CCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhh
Q 036382 268 TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA 346 (390)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 346 (390)
..+..|+|||.+....|+.++|||||||++||+++ |..||++....++...+...+++...|...|.++..++.+||..
T Consensus 323 klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~ 402 (474)
T KOG0194|consen 323 KLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKK 402 (474)
T ss_pred cCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccC
Confidence 46789999999999999999999999999999998 88899999999999999899999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhHhcCC
Q 036382 347 NAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 347 dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+|++||||.++.+.|+++.....
T Consensus 403 ~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 403 DPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ChhhccCHHHHHHHHHHHHhccc
Confidence 99999999999999999987655
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=369.81 Aligned_cols=258 Identities=31% Similarity=0.550 Sum_probs=217.1
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
..++...+.||+|+||.||++.+. |...|||.+..... . ..+.+.+|+.+|++++|||||+++|.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-----~----~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-----P----TSESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-----h----hHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 346888899999999999999884 69999998864311 0 046688999999999999999999974432
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. ..+++.|||+++|+|.+++.+..+ ++++..+..++.||++||.|||++||||+||||+|
T Consensus 87 ~~------------------~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N 147 (313)
T KOG0198|consen 87 EN------------------DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN 147 (313)
T ss_pred cC------------------eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence 21 246899999999999999987665 79999999999999999999999999999999999
Q ss_pred EEECC-CCcEEEeecccceeccC---CCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CC
Q 036382 238 MLLDS-QRTLKIADFGVARVEAQ---NPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPD-LS 311 (390)
Q Consensus 238 ILl~~-~~~~kL~DfG~a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~-~~ 311 (390)
||++. ++.+||+|||++..... .........||+.|||||++.++ ..++++|||||||++.||+||..||.. ..
T Consensus 148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~ 227 (313)
T KOG0198|consen 148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE 227 (313)
T ss_pred EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence 99999 79999999999986552 11223346799999999999853 344699999999999999999999988 55
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
..+....+......|.+|..+|.+.++|+++|+.+||++|||+.+++++.-.-.
T Consensus 228 ~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 228 EAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred hHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 556566666666777899999999999999999999999999999998765433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=397.39 Aligned_cols=269 Identities=28% Similarity=0.533 Sum_probs=233.7
Q ss_pred CcccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 146 (390)
...++.+.+.++.+.||+|.||.||+|... ...||||.++. ........+|.+|++++..++|||
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd--------~a~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD--------KAENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc--------cccHHHHHHHHHHHHHHHhccCCC
Confidence 346788899999999999999999999763 35899999972 223335688999999999999999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------cC----CCCHHHHHHHHH
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------RK----KLALKIVIQLAL 214 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~----~l~~~~~~~i~~ 214 (390)
||+++|+|... ++.|+|+|||..|+|.++|..+. +. +++..+.+.||.
T Consensus 551 IVrLlGVC~~~--------------------~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~ 610 (774)
T KOG1026|consen 551 IVRLLGVCREG--------------------DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIAT 610 (774)
T ss_pred eEEEEEEEccC--------------------CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHH
Confidence 99999999854 55589999999999999997532 22 389999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccC-CCCCCC-CCCCCCccccccccCCCCCCCchhHHH
Q 036382 215 DLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ-NPRDMT-GETGTLGYMAPEVLQGKPYNRRCDVYS 292 (390)
Q Consensus 215 ~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~-~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwS 292 (390)
|||.||.||-++.+|||||..+|+||.++..+||+|||+++..-. +..... ...-+++||+||.+..+.|+..+||||
T Consensus 611 QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 611 QIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred HHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 999999999999999999999999999999999999999984322 222222 334678999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 293 FGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 293 lG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
|||+|||+++ |..||.+.++++++..+..+.. .+-|+.||.++++||..||+.+|.+||+|.+|-..|++...+...+
T Consensus 691 ~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred hhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 9999999998 9999999999999988876666 8899999999999999999999999999999999999987665543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=382.44 Aligned_cols=258 Identities=28% Similarity=0.629 Sum_probs=232.1
Q ss_pred CCCCCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 70 ~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
....+.|+|.++.+.-++-||.|+.|.||+|+..++.||||.++ +.-..++.-|++|+||||+.
T Consensus 113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~----------------elkETdIKHLRkLkH~NII~ 176 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR----------------ELKETDIKHLRKLKHPNIIT 176 (904)
T ss_pred hhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHh----------------hhhhhhHHHHHhccCcceee
Confidence 34457899999999999999999999999999999999999875 11236788899999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
|.|+|.. ...+|||||||..|.|..+|+. +..++...+..|..+||.||.|||.+.||
T Consensus 177 FkGVCtq--------------------sPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKII 234 (904)
T KOG4721|consen 177 FKGVCTQ--------------------SPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKII 234 (904)
T ss_pred EeeeecC--------------------CceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHh
Confidence 9999974 3456999999999999999954 56799999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|||||.-||||+.+..+||+|||-++..... .....++||..|||||++++.+.+.++|||||||+|||||||..||.+
T Consensus 235 HRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 235 HRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 9999999999999999999999999866544 455668999999999999999999999999999999999999999999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.+-.-++..+-...+..++|..||+-++=||++||+..|..||+|.+++.+|+-+..
T Consensus 314 VdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 314 VDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred cchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 887777777767778888999999999999999999999999999999999987643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=372.98 Aligned_cols=265 Identities=29% Similarity=0.580 Sum_probs=219.3
Q ss_pred cccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPN 146 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 146 (390)
.|.++.++|++.++||+|+||.||+|.+ +++.||||+++... .......+.+|+.+++.+ +|||
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~n 72 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--------TASEHKALMSELKILIHIGNHLN 72 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--------chHHHHHHHHHHHHHHHhccCcc
Confidence 3788889999999999999999999974 24679999986321 111235678999999999 8999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------------------
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------------------------- 200 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------- 200 (390)
|+++++++... ...+++||||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~-------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (338)
T cd05102 73 VVNLLGACTKP-------------------NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133 (338)
T ss_pred eeeEEeEecCC-------------------CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcc
Confidence 99999988642 234588999999999999996432
Q ss_pred ----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 201 ----------------------------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 201 ----------------------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~ 213 (338)
T cd05102 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVV 213 (338)
T ss_pred ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcE
Confidence 1347888999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcC
Q 036382 247 KIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+........+
T Consensus 214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 293 (338)
T cd05102 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293 (338)
T ss_pred EEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC
Confidence 9999999975432211 1122345678999999999999999999999999999997 999998876555454555555
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.....+..+++++.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 294 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5666778899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=359.60 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=221.8
Q ss_pred CCCCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 71 RPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 71 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
.....|.++.++|++..+||.|..++||+|+. .++.||||+++..+ .....+.+.+|+..|+.++||||+
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk--------c~~~ld~l~kE~~~msl~~HPNIv 87 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK--------CNNDLDALRKEVQTMSLIDHPNIV 87 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh--------hhhhHHHHHHHHHHhhhcCCCCcc
Confidence 34567888999999999999999999999977 68999999997432 223357889999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
+.+..|..+..+ |+||.||.+|++.++++..-...++|..+..|+.+++.||.|||.+|.
T Consensus 88 ~~~~sFvv~~~L--------------------WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~ 147 (516)
T KOG0582|consen 88 TYHCSFVVDSEL--------------------WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH 147 (516)
T ss_pred eEEEEEEeccee--------------------EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 999999866555 889999999999999988777789999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCC----CCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHh
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~ 302 (390)
||||||+.||||+.+|.+||+|||.+......+.+ +.+..||++|||||++.. ..|+.++||||||++..||.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 99999999999999999999999987654443322 245689999999999643 579999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHHcCCC--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 303 CDMPYPDLSFADVSSAVVRQNLR--------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 303 g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
|..||....+-.++..-+..... -+....++.++++++..||.+||.+|||++++++
T Consensus 228 G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 99999998888877554433221 0112335678999999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=358.67 Aligned_cols=263 Identities=22% Similarity=0.423 Sum_probs=222.8
Q ss_pred ccccccCcccc--ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMR--NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+.++.++++.. ..||+|++|.||+|.++|+.||||.++... .......+.+.+|+.+|++++||||++++|+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH------KGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccc------cccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 34455555555 679999999999999999999999986332 1122234678899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRD 232 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrD 232 (390)
+.+... .....++||||+.+|+|.+++.+. ..+++.....++.+++.||.|||+ .+++|||
T Consensus 87 ~~~~~~----------------~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrd 148 (283)
T PHA02988 87 IIDIVD----------------DLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148 (283)
T ss_pred EEeccc----------------CCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 875110 123458999999999999999653 468999999999999999999998 4999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||+|||++.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 149 lkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 149 LTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred CChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999998754332 123568899999999976 67999999999999999999999999999
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
+..+....+...+.++..|..+|+++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 226 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 226 TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 8888887777777777888789999999999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=366.74 Aligned_cols=254 Identities=23% Similarity=0.406 Sum_probs=217.7
Q ss_pred ccccccCccccccccccCceEEEEEE--ECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
..+..++|+++++||+|+||.||+|+ .+|+.+|+|+++.+ .-...........|-.+|...++|+||+++..
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS------~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS------EMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH------HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 46788999999999999999999995 48999999999732 33344556778899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
|++.+++ |+||||++||++..+|.+. ..|+++.+..++.+++.|+.-||+.|+|||||
T Consensus 210 FQD~~~L--------------------YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDI 267 (550)
T KOG0605|consen 210 FQDKEYL--------------------YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDI 267 (550)
T ss_pred ecCCCee--------------------EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccC
Confidence 9988777 6799999999999999654 57999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccC--------------------CCCC---------------------------CCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQ--------------------NPRD---------------------------MTG 266 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~--------------------~~~~---------------------------~~~ 266 (390)
||+|+|||..|++||+|||++.-... .+.. ...
T Consensus 268 KPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 268 KPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred ChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 99999999999999999999841100 0000 012
Q ss_pred CCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhh
Q 036382 267 ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCW 344 (390)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl 344 (390)
.+|||.|+|||++.+..|+..+|+||||||+||||.|.+||...++.+...+++.......+| ..++++..+||.+||
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh
Confidence 459999999999999999999999999999999999999999999999999998766434444 456799999999999
Q ss_pred hhCCCCCCC---HHHHH
Q 036382 345 DANAEKRPE---MGEVV 358 (390)
Q Consensus 345 ~~dP~~Rpt---~~~ll 358 (390)
. ||++|.. ++||-
T Consensus 428 ~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIK 443 (550)
T ss_pred c-CHHHhcCcccHHHHh
Confidence 9 9999975 55554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=375.08 Aligned_cols=249 Identities=27% Similarity=0.478 Sum_probs=216.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
...|+...+||+|+.|.||.|.. +++.||||.+....- ...+-+.+|+.+|+..+|+|||++++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---------~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---------PKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---------CchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 45688888999999999999976 678999999974322 1235678999999999999999999887654
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...|+|||||+||+|.|.+... .++|.++..|+++++.||+|||.+||+|||||.+|
T Consensus 343 --------------------deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDn 399 (550)
T KOG0578|consen 343 --------------------DELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDN 399 (550)
T ss_pred --------------------ceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccce
Confidence 3458999999999999999653 49999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.+|.+||+|||++...........+.+|||.|||||++..+.|++++||||||++++||+.|.+||-..++-..+.
T Consensus 400 ILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 400 ILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred eEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 99999999999999999876665556677899999999999999999999999999999999999999998766666555
Q ss_pred HHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+...+ .....+..+++++++|+.+||+.|+++|+++.+||++
T Consensus 480 LIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 480 LIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 553332 3445678899999999999999999999999999963
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=377.68 Aligned_cols=266 Identities=33% Similarity=0.644 Sum_probs=224.0
Q ss_pred CCCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..++|+|..+.+.+...||+|.||+||+|.|.| .||||+++.... ..+..+.|++|+.++++-+|.||+-|+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-------t~~qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-------TPEQLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCC-------CHHHHHHHHHHHHHHhhcchhhheeee
Confidence 357899999999999999999999999999998 899999985432 223678999999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
|+|+... ..||+-+|+|-+|..+|.-. ..+|.....+.|+.||++||.|||.++||||
T Consensus 455 G~~~~p~---------------------~AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHr 512 (678)
T KOG0193|consen 455 GACMNPP---------------------LAIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHR 512 (678)
T ss_pred hhhcCCc---------------------eeeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 9997543 25799999999999999643 3569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccC--CCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|||..|||+.+++.+||+|||++..... ...-.....|...|||||+++ ..+|++.+|||||||++|||++|..|
T Consensus 513 DLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lP 592 (678)
T KOG0193|consen 513 DLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELP 592 (678)
T ss_pred hccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCC
Confidence 9999999999999999999999974321 111223356889999999996 35799999999999999999999999
Q ss_pred CCCCChhhHHHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 307 YPDLSFADVSSAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|.....+.++..+-++-+.+. ....||.++++|+..||.+++++||.+.+|+..|+.+..+
T Consensus 593 ysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 593 YSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 995555555544433322332 3467899999999999999999999999999988888763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=368.00 Aligned_cols=260 Identities=25% Similarity=0.496 Sum_probs=222.2
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGAS 154 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 154 (390)
.....|.+.+.||+|+||.|+.|.+ ++..||+|+++...... .. ......+.+|+.+++.++ ||||++++.++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~---~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS---KS-QKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc---cc-cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 3456899999999999999999977 68999999886431110 11 123355668999999998 99999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
..... .++||||+.||+|.+++.+ .+++.+..+..++.|++.|++|+|++||+|||||
T Consensus 90 ~t~~~--------------------~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 90 ATPTK--------------------IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred ecCCe--------------------EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 86544 4789999999999999966 4679999999999999999999999999999999
Q ss_pred CCCEEECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 235 TENMLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YN-RRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 235 p~NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|+|||++.+ +++||+|||++...........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||.+.+
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999999 9999999999987643445567789999999999999987 86 78999999999999999999999988
Q ss_pred hhhHHHHHHHcCCCCCCCCCC-cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 312 FADVSSAVVRQNLRPEIPRCC-PSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
...+...+.... ..+|..+ +++++.|+.+||..||.+|+|+.+++ .-.-+..
T Consensus 228 ~~~l~~ki~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 228 VPNLYRKIRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHHhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 888887765543 4477777 99999999999999999999999999 5444543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=364.61 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=214.8
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..+.|+.+++||+|+||.||+|++ +|+.||+|.++....+ +.......+|+.||++|+||||+++.+...+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-------~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-------EGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-------CcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 457799999999999999999987 7889999999855422 2223455699999999999999999999876
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ....+|+|+|||+. +|.-++.. .+-+|++.++..|+.|++.||+|+|++||+|||||.+
T Consensus 188 ~------------------~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~S 247 (560)
T KOG0600|consen 188 K------------------LSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGS 247 (560)
T ss_pred c------------------CCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeecccccc
Confidence 5 23456999999987 89888843 4567999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|||||.+|.+||+|||+|+...... ..++..+.|.+|.|||++.|. .|+.++|+||.||||.||+.|++.|++.+..+
T Consensus 248 NiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 248 NILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred ceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 9999999999999999999655443 347888999999999999875 69999999999999999999999999999888
Q ss_pred HHHHHHHcCCCC--------CCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSSAVVRQNLRP--------EIP-------------------RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~~~~~~~~~~--------~~~-------------------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+..|.+-.-.| .+| ..+|++..+|+..+|..||.+|.|+.++++
T Consensus 328 Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 328 QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 877775422111 011 236788999999999999999999998875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=375.64 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=218.7
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
..+.+++|.+.++||+|+||.|+++.. +++.+|||+++.+. .-.....+....|.+|+... +||.+++++.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~------Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGD------ILQRDEVESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccc------eeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence 567889999999999999999999987 56799999998432 22222346677888998888 6999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
.|++.+++ |+||||+.||++..+. ....+++..+..|++.|+.||.|||++||||||
T Consensus 437 ~fQT~~~l--------------------~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRD 493 (694)
T KOG0694|consen 437 CFQTKEHL--------------------FFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRD 493 (694)
T ss_pred ccccCCeE--------------------EEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeee
Confidence 99976655 7899999999944332 346799999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||.+|||+|.+|++||+|||+++.....+....+.||||.|||||++.+..|+.++|+|||||+|||||.|..||++.+.
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999999998766556667789999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
+++...++.. .+.+|..++.+..+||+++|.++|++|...
T Consensus 574 ee~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 EEVFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 9999998765 556899999999999999999999999765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=351.35 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=224.9
Q ss_pred CcccccccCccccccccccCceEEEEEEECC--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
....+.+++|++++.||+|.-|+||++...+ ..+|+|++... .........+...|-+||+.++||.+..+|
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~------~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKE------SLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHH------HHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 3456778899999999999999999998855 79999999632 233344456677899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
..|..+... |++||||+||+|..+++++.+..+++..++.++.+|+.||+|||..|||+|
T Consensus 144 a~fet~~~~--------------------cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYR 203 (459)
T KOG0610|consen 144 ASFETDKYS--------------------CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYR 203 (459)
T ss_pred heeecccee--------------------EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeec
Confidence 999865544 889999999999999998888999999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccC---------------------------------C-C----------------
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQ---------------------------------N-P---------------- 261 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~---------------------------------~-~---------------- 261 (390)
||||+||||.++|++.|+||.++..... . .
T Consensus 204 DLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~ 283 (459)
T KOG0610|consen 204 DLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPEL 283 (459)
T ss_pred cCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhh
Confidence 9999999999999999999998742110 0 0
Q ss_pred ------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHH
Q 036382 262 ------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSS 335 (390)
Q Consensus 262 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (390)
.....++||.+|+|||++.+...+.++|+|+|||++|||+.|..||.+.+..+.+..++.+.+..+-...++..
T Consensus 284 ~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~ 363 (459)
T KOG0610|consen 284 VAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSA 363 (459)
T ss_pred hcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhH
Confidence 01123469999999999999999999999999999999999999999999999999999887765555577899
Q ss_pred HHHHHHHhhhhCCCCCCC----HHHHHH
Q 036382 336 LANIMRKCWDANAEKRPE----MGEVVK 359 (390)
Q Consensus 336 l~~li~~cl~~dP~~Rpt----~~~ll~ 359 (390)
+++||+++|.+||.+|.. +.+|-+
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999999999998 777754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=369.76 Aligned_cols=248 Identities=31% Similarity=0.525 Sum_probs=219.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|.+.+.||+|+||.||+|+. +.+.||+|.+.... ..+.....+.+|++|++.++|||||.++++|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-------RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 5799999999999999999965 67899999986322 12223466889999999999999999999987554
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
+.|+|+||+.| +|+.+|.. ...++++.+..++.+++.||.|||+.+|+|||+||.||
T Consensus 75 --------------------~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqni 131 (808)
T KOG0597|consen 75 --------------------HLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNI 131 (808)
T ss_pred --------------------eEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCccee
Confidence 45899999987 99999954 45799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.+|.+|+||||+|+.........+...|||-|||||++.+.+|+..+|+||+||++||+++|++||...+.......
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~ 211 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS 211 (808)
T ss_pred eecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence 99999999999999999887777677777899999999999999999999999999999999999999999888888888
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.... ...|...+..+.+|+..+|.+||..|.|..+++.+
T Consensus 212 I~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 212 ILKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 76653 34566889999999999999999999999999853
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=332.41 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=228.5
Q ss_pred CCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
...|.+ ++|++++.||+|.||.||+|+. ++.-||+|++- ...........++.+|++|-+.|+||||+++
T Consensus 16 ~~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlf------Ksqi~~~~v~~qlrREiEIqs~L~hpnilrl 87 (281)
T KOG0580|consen 16 TKTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLF------KSQILKTQVEHQLRREIEIQSHLRHPNILRL 87 (281)
T ss_pred ccccch--hhccccccccCCccccEeEeeeccCCcEEEEeeee------HHHHHHhcchhhhhheeEeecccCCccHHhh
Confidence 345554 6899999999999999999987 45689999985 2335555566889999999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
|++|.+...+ |+++||..+|+|...|......++++.....++.|++.||.|+|..+|||
T Consensus 88 Y~~fhd~~ri--------------------yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIh 147 (281)
T KOG0580|consen 88 YGYFHDSKRI--------------------YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIH 147 (281)
T ss_pred hhheecccee--------------------EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCccc
Confidence 9999976554 78999999999999998667778999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||||+|+|++..+.+||+|||.+-..+ .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...
T Consensus 148 RdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 148 RDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred CCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 9999999999999999999999986544 33445689999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
+..+.+.++.+. +..+|..++.+.+++|.+|+.++|.+|.+..|++++=
T Consensus 226 ~~~etYkrI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 226 SHSETYKRIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred hhHHHHHHHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 999999888665 4457799999999999999999999999999998763
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=392.22 Aligned_cols=265 Identities=34% Similarity=0.644 Sum_probs=229.3
Q ss_pred ccccCccccccccccCceEEEEEEEC---C----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD---N----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~---~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
++....++...||+|.||.||.|.+. + ..||||.++.. ........|.+|..+|++++|||||++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--------~~~~~~~~Fl~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--------SSEQEVSDFLKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--------CCHHHHHHHHHHHHHHhcCCCcceeeE
Confidence 56778899999999999999999872 3 25899988632 223345789999999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHS 225 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~yLH~ 225 (390)
+|++.+. ...+|++|||.+|+|..||++.+ ...++...++.++.|||+|+.||++
T Consensus 761 iGv~l~~--------------------~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~ 820 (1025)
T KOG1095|consen 761 IGVCLDS--------------------GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES 820 (1025)
T ss_pred EEeecCC--------------------CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh
Confidence 9999863 34478999999999999997541 4568999999999999999999999
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccceec-cCCCCCCCCC-CCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARVE-AQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC- 302 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~- 302 (390)
+++|||||..+|+|++....+||+|||+|+.. .......... .-+..|||||.+....|+.++|||||||++||+++
T Consensus 821 ~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifsl 900 (1025)
T KOG1095|consen 821 KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSL 900 (1025)
T ss_pred CCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhC
Confidence 99999999999999999999999999999932 2222222222 34579999999999999999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 303 CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 303 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
|..||++.++.++...++.++ |.+.|..||+.+.++|.+||+.+|++||+|..|++.+..+.+.-.+.
T Consensus 901 G~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 901 GATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred CCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 999999999999998888877 99999999999999999999999999999999999999997655544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=332.62 Aligned_cols=251 Identities=29% Similarity=0.431 Sum_probs=213.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|...+++|+|+||.||+|++ +|+.||||.++.+... ........+|+..|+.++|+||+.++++|....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-------dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-------DGINRTALREIKLLQELKHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-------cCccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence 4688899999999999999988 6899999999865321 122345679999999999999999999998766
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
++ .+|+||++. +|...++. +.-.++..++..++.+++.||+|||++.|+||||||.|+
T Consensus 75 ~l--------------------~lVfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 75 NL--------------------SLVFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred ce--------------------EEEEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 65 569999975 89998854 456799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++++|.+||+|||+|+.........+..+.|.+|.|||.+.| +.|+..+|+||.||++.||+-+.+-|++.+.-+.+.
T Consensus 133 Lis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 133 LISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred EEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 9999999999999999988877777777899999999999976 579999999999999999999999999988877776
Q ss_pred HHHHcCCCC---------------------C-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRP---------------------E-----IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~---------------------~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+...--.| . .-..++++..+|+.++|..||.+|+|+.|++++
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 665321111 0 111346778999999999999999999998864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=368.92 Aligned_cols=251 Identities=28% Similarity=0.511 Sum_probs=221.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.-|++++.||.|+.|.|-+|++ +|+.+|||++.... .........+.+|+-||+.+.|||++++|+++.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccc------ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 4578899999999999999987 89999999996331 111223356779999999999999999999988654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
++ |+|+||+++|.|++|+-++ +++++...+.++.||+.|+.|+|..+|+||||||+|+
T Consensus 86 ~l--------------------ylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl 143 (786)
T KOG0588|consen 86 HL--------------------YLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL 143 (786)
T ss_pred eE--------------------EEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence 44 7899999999999999654 5799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++..+++||+|||+|.... ++.-..+.||.|.|.|||++.|.+|+ .++||||.|||||.||+|++||.+.....++.
T Consensus 144 LLd~~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLl 222 (786)
T KOG0588|consen 144 LLDVKNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLL 222 (786)
T ss_pred hhhcccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHH
Confidence 99999999999999998654 34556678999999999999999985 78999999999999999999999988888888
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
++..+.+ ++|.++|+++++||++||..||+.|.|+++|+++-.
T Consensus 223 KV~~G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 223 KVQRGVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHcCcc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 8866654 578999999999999999999999999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=358.61 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=210.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEe
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASV 155 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 155 (390)
-.++|.++++||.|+||.||+|+. ++..||||.++.... ...+ -.-.+|+.-|++|. |||||++.+++.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~---s~ee-----~~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY---SWEE-----CMNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc---cHHH-----HHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 357899999999999999999976 788999999873321 1111 12358999999997 999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.+. ..++|||||+- +|.++++.+ +..|++..+..|+.||++||+|+|++|+.|||+||
T Consensus 80 d~~~-------------------~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKP 138 (538)
T KOG0661|consen 80 DNDR-------------------ILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKP 138 (538)
T ss_pred ccCc-------------------eEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCCh
Confidence 7652 34789999964 999999765 77899999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCcccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
+||||.....+||+|||+||..... .-++..+.|.+|.|||++ +..-|+.++|+||+||+++|+++-++-|++.+..+
T Consensus 139 ENiLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D 217 (538)
T KOG0661|consen 139 ENILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID 217 (538)
T ss_pred hheEecccceeEecccccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence 9999999999999999999965433 345667899999999987 56779999999999999999999999999998888
Q ss_pred HHHHHHHcC-----------------CCCCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQN-----------------LRPEIP-----------RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~-----------------~~~~~~-----------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+.++..-- +...+| ..++.++.++|.+||..||.+|||+.+++++
T Consensus 218 qi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 218 QIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 777765210 111111 1367889999999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=362.20 Aligned_cols=265 Identities=31% Similarity=0.561 Sum_probs=220.6
Q ss_pred CCCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-C
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D 143 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 143 (390)
....|.++.++|++.+.||+|+||.||+|++ ++..||||+++.... ......+.+|+.+++.+ +
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~Ei~il~~l~~ 97 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGN 97 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--------cHHHHHHHHHHHHHHHhcC
Confidence 4567889999999999999999999999964 345899999863221 11235678899999999 8
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-----------------------
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----------------------- 200 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------- 200 (390)
||||+++++++.+... .++||||+++|+|.+++....
T Consensus 98 HpnIv~l~~~~~~~~~--------------------~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (375)
T cd05104 98 HINIVNLLGACTVGGP--------------------TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQ 157 (375)
T ss_pred CcceeeeeeeeccCCc--------------------ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhh
Confidence 9999999999875443 478999999999999986432
Q ss_pred --------------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 201 --------------------------------------------------RKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 201 --------------------------------------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
...+++..+..++.||+.||.|||+.||+|
T Consensus 158 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 237 (375)
T cd05104 158 REMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIH 237 (375)
T ss_pred hcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 124788899999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPY 307 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf 307 (390)
|||||+|||++.++.+||+|||++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999754332211 112334667999999999999999999999999999998 89999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
...............+.++..|...|.++.+||.+||+.||++|||+.+|++.|+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 318 PGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 887666656666666767777788899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=354.73 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=218.5
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCcc-----chHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMA-----TTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
...++.|++.+.||+|.||.|-+|++ +++.||||++........ .......-.+...+|+.||++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34578899999999999999999987 688999999963221110 00111112357789999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK-LALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++.+..+...- ..|||+||+..|.+...= .... +++.+++.|+.+++.||+|||.+||
T Consensus 173 LiEvLDDP~s~------------------~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi 231 (576)
T KOG0585|consen 173 LIEVLDDPESD------------------KLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGI 231 (576)
T ss_pred EEEeecCcccC------------------ceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 99998776544 459999999999876432 2334 8999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCC-----CCCCCCCCCCCccccccccCCCC----CCCchhHHHHHHHHHH
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQN-----PRDMTGETGTLGYMAPEVLQGKP----YNRRCDVYSFGICLWE 299 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~e 299 (390)
|||||||+|+|++++|++||+|||.+...... ........|||.|+|||...++. -+.+.||||+|++||-
T Consensus 232 iHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC 311 (576)
T KOG0585|consen 232 IHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC 311 (576)
T ss_pred eccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence 99999999999999999999999998754221 12233468999999999997632 3568899999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 300 IYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
|+.|+.||-+....+...+++...+..+.......++++||.++|.+||+.|.++.+|..+...-..
T Consensus 312 llfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 312 LLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999999999999999987766654444578899999999999999999999999877765443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=361.48 Aligned_cols=265 Identities=28% Similarity=0.527 Sum_probs=220.9
Q ss_pred CCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CC
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 144 (390)
...|.++.++|++.+.||+|+||.||+|.+ ++..||||+++.... ......+.+|+.+++.+ +|
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~~h 101 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--------TDEREALMSELKILSHLGQH 101 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--------HHHHHHHHHHHHHHHhhccC
Confidence 567889999999999999999999999875 224799999863211 11245678999999999 89
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc------------------------
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR------------------------ 200 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------ 200 (390)
|||+++++++.... ..|+||||+.+|+|.+++.+..
T Consensus 102 ~nIv~~~~~~~~~~--------------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (374)
T cd05106 102 KNIVNLLGACTHGG--------------------PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161 (374)
T ss_pred CceeeEeeEecCCC--------------------CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccc
Confidence 99999999987543 4488999999999999986431
Q ss_pred --------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 201 --------------------------------------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 201 --------------------------------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
...+++..++.++.||+.||.|||++||+||||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 241 (374)
T cd05106 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR 241 (374)
T ss_pred hhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchh
Confidence 124788899999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~ 313 (390)
|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 242 Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred eEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 99999999999999999875432211 1112235668999999998899999999999999999997 99999887666
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
............+..+..+|+++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 322 SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 6555666666677777788999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=362.86 Aligned_cols=263 Identities=30% Similarity=0.614 Sum_probs=231.8
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC----Cc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD----NQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~----~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 146 (390)
..++++..+..++.+.||.|.||.||.|.++ |+ -||||..+... .....+.|..|..+|++++|||
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--------t~d~tekflqEa~iMrnfdHph 452 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--------TPDDTEKFLQEASIMRNFDHPH 452 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--------ChhhHHHHHHHHHHHHhCCCcc
Confidence 3478888889999999999999999999883 22 58999887321 1223578999999999999999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
||+++|+|. ..+.|||||.++.|.|..||+.++ ..++...+..+++||..||.|||+.
T Consensus 453 IikLIGv~~---------------------e~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk 510 (974)
T KOG4257|consen 453 IIKLIGVCV---------------------EQPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK 510 (974)
T ss_pred hhheeeeee---------------------ccceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh
Confidence 999999996 456799999999999999998654 5699999999999999999999999
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccceeccCCCCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CD 304 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~ 304 (390)
++|||||..+|||+.+...+||+|||+++........ .+...-++.|||||.++-..|+.++|||.||+++||++. |.
T Consensus 511 rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 511 RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999977654432 223345789999999999999999999999999999987 89
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.||.+..+.+++..+ ..+-|++.|.+||+.++.||.+||++||.+||++.++...|.++..
T Consensus 591 kPfqgvkNsDVI~~i-EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 591 KPFQGVKNSDVIGHI-ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CccccccccceEEEe-cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999988766 6778999999999999999999999999999999999999988865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.26 Aligned_cols=263 Identities=29% Similarity=0.609 Sum_probs=235.2
Q ss_pred CcccccccCccccccccccCceEEEEEEECC--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+.|+++..++.+.++||.|.||.||.|.|.. -.||||.++. ...-.+.|..|+.+|+.++|||+|+++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----------DtMeveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----------DTMEVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh----------cchhHHHHHHHHHHHHhhcCccHHHHh
Confidence 6899999999999999999999999999965 5899998862 223357899999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
|+|.... ++|||+|||..|+|.+||+...+..++.-.++.++.||..||+||..+++|||
T Consensus 330 GVCT~Ep--------------------PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 330 GVCTHEP--------------------PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred hhhccCC--------------------CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 9998654 44779999999999999988777889999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
||..+|+||.++..+||+|||+++........ ..+.--++.|.|||.+.-..|+.++|||+||++|||+.| |-.||++
T Consensus 390 DLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 390 DLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999976554322 222335789999999999999999999999999999998 6779999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.+...++ .++..++++..|..||+..++||+.||+.+|.+||+|.++-+.++.++.+
T Consensus 470 idlSqVY-~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 470 IDLSQVY-GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccHHHHH-HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 9988877 45689999999999999999999999999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=373.73 Aligned_cols=263 Identities=29% Similarity=0.593 Sum_probs=233.7
Q ss_pred ccccccCccccccccccCceEEEEEEEC--C---ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD--N---QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
.||+.....+.++||.|.||.|++|+.+ + ..||||.++-+. .+..+..|..|+.||-+++||||+++
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--------tekqrrdFL~EAsIMGQFdHPNIIrL 695 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--------TEKQRRDFLSEASIMGQFDHPNIIRL 695 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--------cHHHHhhhhhhhhhcccCCCCcEEEE
Confidence 4788888999999999999999999872 3 589999998432 34557889999999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
.|+.... .+.+||.|||++|+|+.+|+.+. +.++.-++..+++.|+.||+||.+.|+||
T Consensus 696 EGVVTks--------------------~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVH 754 (996)
T KOG0196|consen 696 EGVVTKS--------------------KPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVH 754 (996)
T ss_pred EEEEecC--------------------ceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchh
Confidence 9998854 44578999999999999998765 55999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCC---CCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT---GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMP 306 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~P 306 (390)
|||.++||||+.+..+|++|||+++...+.+...+ +..-+.+|.|||.+...+|+.++||||||++|||.++ |..|
T Consensus 755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred hhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 99999999999999999999999997655442222 2223689999999999999999999999999999886 9999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
|.++++.+++..+ .+++|.+.|..||..|.+||..||++|-.+||+|.||+..|+++-.+-
T Consensus 835 YWdmSNQdVIkaI-e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 835 YWDMSNQDVIKAI-EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ccccchHHHHHHH-HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999876 688999999999999999999999999999999999999999996543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=354.98 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=206.9
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
+.||+|+||.||+++. +|+.||||+++.. ..........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~------ 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKE------VIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD------ 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH------HhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC------
Confidence 3689999999999976 6789999998621 1112223456778999999999999999999987543
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~ 244 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||+|||+.||+||||||+|||++.++
T Consensus 69 --------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~ 132 (323)
T cd05571 69 --------------RLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132 (323)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC
Confidence 44889999999999999854 34689999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCC
Q 036382 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324 (390)
Q Consensus 245 ~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (390)
.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+...
T Consensus 133 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-- 210 (323)
T cd05571 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-- 210 (323)
T ss_pred CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--
Confidence 999999999875433333344567999999999999999999999999999999999999999988877766665543
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
...+|..+++++.++|.+||+.||++|| ++.+++++
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3456788999999999999999999999 79988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=354.94 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=213.1
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|++ +++.||||+++.. ..........+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR------EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH------HHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 357899999999999999999987 5789999998621 11222334668899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 90 ~~--------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~ 147 (329)
T PTZ00263 90 EN--------------------RVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147 (329)
T ss_pred CC--------------------EEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 44 34889999999999999964 346899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 148 NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 224 (329)
T PTZ00263 148 NLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224 (329)
T ss_pred HEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999999999999999999765332 22357899999999999999999999999999999999999999988877777
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
..+... ...+|..++..+.+||.+||+.||.+||+ +.+++.+
T Consensus 225 ~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 EKILAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhcC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 666544 34567778999999999999999999997 6888754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=339.53 Aligned_cols=274 Identities=29% Similarity=0.385 Sum_probs=224.3
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
+.+.|+..+.|++|+||.||+|++ +++.||+|.++...+.... --...+|+.+|.+++|||||.+-.+.+.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF-------PItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF-------PITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC-------cchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 457899999999999999999988 6789999999855432221 1234689999999999999999998875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.+ -...|+||||++. +|..++.+- .+++....+.-++.|+++|++|||.+.|+||||||+
T Consensus 147 ~~------------------~d~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~S 206 (419)
T KOG0663|consen 147 SN------------------MDKIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTS 206 (419)
T ss_pred cc------------------cceeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchh
Confidence 53 2345999999987 899998653 468999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|+|++..|.+||+|||+|+....+...++..+.|.+|.|||++.+ ..|+.++|+||+|||+.||+++.+-|++.+..+.
T Consensus 207 NLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ 286 (419)
T KOG0663|consen 207 NLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ 286 (419)
T ss_pred heeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH
Confidence 999999999999999999988888788888999999999999987 4699999999999999999999999999988777
Q ss_pred HHHHHHcC-----------------------------CCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHH
Q 036382 316 SSAVVRQN-----------------------------LRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKM--LEA 363 (390)
Q Consensus 316 ~~~~~~~~-----------------------------~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~ 363 (390)
+..+...- ++..++.. ++..-.+|+..+|..||.+|.|+.+.+++ +.+
T Consensus 287 l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 287 LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred HHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 77665311 01111111 45778899999999999999999998864 333
Q ss_pred hHhcCCCCCCCCCCCC
Q 036382 364 IDTSKGGGMIPEDQAT 379 (390)
Q Consensus 364 ~~~~~~~~~~~~~~~~ 379 (390)
.-..+.-+|.|+.+++
T Consensus 367 ~P~p~~P~~~Pt~P~k 382 (419)
T KOG0663|consen 367 TPLPIDPSMFPTWPAK 382 (419)
T ss_pred CCCCCChhhcCCCccc
Confidence 2234444555655554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=340.95 Aligned_cols=257 Identities=26% Similarity=0.517 Sum_probs=215.2
Q ss_pred ccccCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
++..+|++.+.||+|+||.||+|.+ .+..||+|.++.... ......+.+|+.++++++||||+++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 73 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------DKQRRGFLAEALTLGQFDHSNIVRLEG 73 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 5567899999999999999999975 246899999873211 122356889999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.... ..++||||+.+|+|.+++.+. ...+++..++.++.|++.||+|||++|++|||
T Consensus 74 ~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~d 132 (266)
T cd05064 74 VITRGN--------------------TMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132 (266)
T ss_pred EEecCC--------------------CcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 987543 348899999999999999654 34689999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
|||+|||++.++.++++|||.+....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.
T Consensus 133 ikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999999876432211 11112345678999999999999999999999999999775 99999988
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+..+....+ ..+...+.+..+|..+.+++.+||+.+|.+|||+.+|++.|.++
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 213 SGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 877766655 45556667888999999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=348.27 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=211.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||+|+++.. ..........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP------EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHH------HHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 4688999999999999999987 4789999998622 1112223456789999999999999999998876443
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 75 --------------------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI 132 (291)
T cd05612 75 --------------------FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132 (291)
T ss_pred --------------------eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 458899999999999999643 4689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 133 li~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~ 209 (291)
T cd05612 133 LLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209 (291)
T ss_pred EECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999998754322 2235789999999999999999999999999999999999999999888777777
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
+.... ..+|..++..+.+||.+||+.||.+||+ +.+++++
T Consensus 210 i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 ILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 65543 4567778999999999999999999995 8888866
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=354.65 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=214.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||+|+||.||+|.+ +++.||+|+++.. ..+...+.+.+|+.++.+++++||.+.||.+.....
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le--------~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE--------EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechh--------hcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 477778999999999999987 6789999999743 333345678899999999999999999999986655
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
+ |++|||+.||++.+.|+. +..+.+..+..++.+++.||.|||.++.+|||||+.|||
T Consensus 86 L--------------------wiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil 143 (467)
T KOG0201|consen 86 L--------------------WIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANIL 143 (467)
T ss_pred H--------------------HHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceeccccccccee
Confidence 5 679999999999999943 445589999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
+..+|.+||+|||.+...........++.||+.|||||++.+..|+.++||||||++++||++|.+||....+..++..+
T Consensus 144 ~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 144 LSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred EeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 99999999999999987665555557789999999999999989999999999999999999999999998875544333
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.....|.....+++.+++||..||.+||+.||++.+|++
T Consensus 224 -pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 224 -PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 344455566688999999999999999999999999885
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=337.53 Aligned_cols=258 Identities=29% Similarity=0.615 Sum_probs=220.4
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
|+++..+|++.+.||+|+||.||+|.+ .++.||+|+++.... ....+.+|+++++.++||||++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLLGV 70 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----------HHHHHHHHHHHHHhCCCCChhheEEE
Confidence 778888999999999999999999987 478999999862210 12457789999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.... ..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||
T Consensus 71 ~~~~~--------------------~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 71 CTREP--------------------PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred EcCCC--------------------CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 87543 3478999999999999997655567899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
||+|||++.++.+||+|||++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||++.+
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999999998754432211 112234668999999999999999999999999999998 999999887
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
..+....+ ...+.+..+..+|.++.+++.+||..||++|||+.++++.|+.+
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 211 LSQVYELL-EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 76665554 45667778888999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=353.31 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=217.3
Q ss_pred CCCcccccccCccccccccccCceEEEEEEEC---CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
+...+.+..++|++.+.||+|+||.||+|.+. +..||+|++... ..........+.+|+.+++.++||||+
T Consensus 21 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~Iv 94 (340)
T PTZ00426 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS------KIIKQKQVDHVFSERKILNYINHPFCV 94 (340)
T ss_pred cccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHH------HhhhhhhHHHHHHHHHHHHhCCCCCCc
Confidence 44556778899999999999999999999763 257999988521 111223345678999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.+.. ..|+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.||
T Consensus 95 ~~~~~~~~~~--------------------~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i 152 (340)
T PTZ00426 95 NLYGSFKDES--------------------YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNI 152 (340)
T ss_pred ceEEEEEeCC--------------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 9999987543 448899999999999999653 469999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
+||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|+|||||++|||++|..||.
T Consensus 153 vHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred EccCCCHHHEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 99999999999999999999999999764322 234579999999999999889999999999999999999999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
+.+.......+.... ..+|..+++.+.++|++||+.||++|+ |+++++++
T Consensus 230 ~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 230 ANEPLLIYQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 888777776665443 346778899999999999999999995 89988865
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=336.70 Aligned_cols=258 Identities=30% Similarity=0.583 Sum_probs=219.4
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|+|+.++|++.++||+|+||.||+|.. +++.||+|.+.... . ..+.+.+|+.+++.++||||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------M----SVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------h----hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 788899999999999999999999987 45789999875321 1 135678999999999999999999988
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+.. ..+++|||+.+++|.+++.+.....+++..+..++.|++.||+|||+.+++|||||
T Consensus 71 ~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~ 130 (261)
T cd05072 71 TKEE--------------------PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLR 130 (261)
T ss_pred cCCC--------------------CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 6443 34789999999999999977666678999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 131 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred hhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 9999999999999999999986543221 1122345678999999998889999999999999999998 9999988877
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.+....+. ...+.+.+..+|.++.+++.+||..+|++|||+.++++.|+++
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 211 SDVMSALQ-RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 77665553 4455556667899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=342.47 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=205.8
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|+..+.||+|+||.||++.+ +++.||||++.... .........+.+|+.++++++|+||+++++++.+..
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR------IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh------hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 77889999999999999976 68899999986221 111222345778999999999999999999987543
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
..++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 74 ------------------~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill 135 (285)
T cd05631 74 ------------------ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL 135 (285)
T ss_pred ------------------eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE
Confidence 44889999999999988865545569999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (390)
+.++.++|+|||++...... .......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (285)
T cd05631 136 DDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214 (285)
T ss_pred CCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 99999999999999764322 22334578999999999999999999999999999999999999998755432222221
Q ss_pred H--cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 321 R--QNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 321 ~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
. .......+..++.++.+|+++||+.||.+||+ +++++++
T Consensus 215 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1 22234566778999999999999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=343.46 Aligned_cols=250 Identities=25% Similarity=0.468 Sum_probs=219.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.|-+|+. .|+.||||.++.. ....+...-.+.+|++||+.|+||||+++|.+|...+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd------kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD------KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh------hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 4799999999999999999976 6899999999732 2334445567899999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.+ .|||||..+|.|.||+.. .+.+++.....+++||+.|+.|+|+++++|||||.+||
T Consensus 127 KI--------------------vivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI 184 (668)
T KOG0611|consen 127 KI--------------------VIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI 184 (668)
T ss_pred eE--------------------EEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence 44 779999999999999965 45799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+|.++++||+|||++..... ....+++||++-|.+||++++.+|. +.+|-||||++||.|+.|.+||.+.+...++.
T Consensus 185 LLD~N~NiKIADFGLSNly~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 185 LLDQNNNIKIADFGLSNLYAD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred eecCCCCeeeeccchhhhhcc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 999999999999999986543 4556779999999999999999984 78999999999999999999999999999988
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
++-.+.++.+ .-|....-||+.||..||++|.|+++|..+-.
T Consensus 264 QIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 264 QISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 8877666543 23567889999999999999999999987754
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=337.68 Aligned_cols=259 Identities=26% Similarity=0.540 Sum_probs=221.7
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|+....+|++.++||.|+||.||+|.+ .+..+|+|+++... ......+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 71 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---------LLKQQDFQKEVQALKRLRHKHLISLFAVC 71 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---------hhhHHHHHHHHHHHhcCCCcchhheeeeE
Confidence 455667899999999999999999987 46789999986321 11234577899999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+.. ..++||||+++++|.+++.+..+..+++..+..++.|++.||.|||++|++|+||+
T Consensus 72 ~~~~--------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~ 131 (261)
T cd05148 72 SVGE--------------------PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLA 131 (261)
T ss_pred ecCC--------------------CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccC
Confidence 7543 45889999999999999976556678999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFA 313 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~ 313 (390)
|+|||++.++.+||+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 132 ~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 132 ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred cceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999999765433322333456778999999998899999999999999999998 89999988877
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+....+. .+.+...+..+|+++.++|.+||..||.+|||+.++++.|+.+
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 212 EVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 7776654 5566777888999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=340.89 Aligned_cols=258 Identities=28% Similarity=0.569 Sum_probs=216.3
Q ss_pred ccccCccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
++.++|++.+.||+|+||.||+|...+ ..||+|.++... .......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~i~~~ 73 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--------EPKVQQEFRQEAELMSDLQHPNIVCL 73 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--------CHHHHHHHHHHHHHHHhcCCcccceE
Confidence 456789999999999999999997633 469999886321 12234568899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc--------------CCCCHHHHHHHHHHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--------------KKLALKIVIQLALDL 216 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i 216 (390)
++++... ...|++|||+++++|.+++..... ..+++..++.++.|+
T Consensus 74 ~~~~~~~--------------------~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 133 (283)
T cd05048 74 LGVCTKE--------------------QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133 (283)
T ss_pred EEEEcCC--------------------CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHH
Confidence 9998643 334889999999999999965421 458899999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHH
Q 036382 217 SRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294 (390)
Q Consensus 217 ~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 294 (390)
+.||.|||+.|++|+||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+||||
T Consensus 134 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG 213 (283)
T cd05048 134 AAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG 213 (283)
T ss_pred HHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHH
Confidence 999999999999999999999999999999999999987543221 112334567889999999988999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 295 ICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 295 ~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
|++|||++ |..||.+.+..+....+. ....+..+..+|+++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 99999998 999999888877766554 4445567888999999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=355.52 Aligned_cols=265 Identities=29% Similarity=0.535 Sum_probs=221.5
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-C
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-H 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 144 (390)
...|+++.++|++.++||+|+||.||+|++. +..||||+++.... ......+.+|+.+++++. |
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~Ei~~l~~l~~H 100 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--------SSEKQALMSELKIMTHLGPH 100 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCC
Confidence 3578999999999999999999999999862 23699999863211 122356889999999995 9
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc------------------------
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR------------------------ 200 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------ 200 (390)
|||+++++++.+.. ..|+||||+++|+|.+++.+..
T Consensus 101 pnIv~l~~~~~~~~--------------------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (400)
T cd05105 101 LNIVNLLGACTKSG--------------------PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD 160 (400)
T ss_pred CCeeeEEEEEccCC--------------------ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccc
Confidence 99999999987543 4488999999999999986431
Q ss_pred ----------------------------------------------------------------------cCCCCHHHHH
Q 036382 201 ----------------------------------------------------------------------RKKLALKIVI 210 (390)
Q Consensus 201 ----------------------------------------------------------------------~~~l~~~~~~ 210 (390)
...+++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~ 240 (400)
T cd05105 161 ESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLL 240 (400)
T ss_pred ccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHH
Confidence 1247888899
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCch
Q 036382 211 QLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRC 288 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 288 (390)
.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++
T Consensus 241 ~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 320 (400)
T cd05105 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS 320 (400)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchh
Confidence 9999999999999999999999999999999999999999999975432211 12223467889999999998999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 289 DVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 289 DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
|||||||++|||++ |..||......+.....+..+.++..+..+|.++.++|.+||..||++|||+.+|.+.|+.+.
T Consensus 321 DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 321 DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 99999999999997 999998876655555556666677778889999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=349.09 Aligned_cols=244 Identities=26% Similarity=0.425 Sum_probs=206.2
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
+.||+|+||.||+++. +|+.||+|+++.. ..........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------ 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKE------VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD------ 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH------HhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC------
Confidence 3689999999999986 6789999998621 1112223456678999999999999999999987543
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~ 244 (390)
..|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 69 --------------~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 132 (323)
T cd05595 69 --------------RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132 (323)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC
Confidence 448899999999999988543 4689999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCC
Q 036382 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324 (390)
Q Consensus 245 ~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (390)
.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 133 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~- 211 (323)
T cd05595 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE- 211 (323)
T ss_pred CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-
Confidence 9999999998753333333344679999999999999999999999999999999999999999888777776665443
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
..+|..+++++.++|.+||..||++|| ++.+++++
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 346778899999999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=348.51 Aligned_cols=241 Identities=21% Similarity=0.351 Sum_probs=203.4
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||+|+||.||++.+ +++.||+|+++.. ..........+.+|+.++++++||||+++++++.+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 66 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA------HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-------- 66 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--------
Confidence 69999999999987 5779999998621 1112233456778999999999999999999887543
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
..|+||||+++|+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 67 ------------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~ 132 (312)
T cd05585 67 ------------KLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHI 132 (312)
T ss_pred ------------eEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcE
Confidence 44889999999999999965 3469999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCC
Q 036382 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP 326 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 326 (390)
||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 133 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~ 210 (312)
T cd05585 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PL 210 (312)
T ss_pred EEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CC
Confidence 9999999875433333334467999999999999999999999999999999999999999988887777766544 34
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 036382 327 EIPRCCPSSLANIMRKCWDANAEKRPE---MGEVVK 359 (390)
Q Consensus 327 ~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~~ll~ 359 (390)
.+|..+++++.++|.+||..||.+||+ +.+++.
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 567788999999999999999999985 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=350.04 Aligned_cols=265 Identities=31% Similarity=0.594 Sum_probs=219.4
Q ss_pred cccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPN 146 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn 146 (390)
.|+++.++|++.+.||+|+||.||+|.. +++.||+|+++.... ......+.+|+.+++++ +|||
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~E~~~~~~l~~h~n 72 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--------ASEYKALMTELKILIHIGHHLN 72 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--------HHHHHHHHHHHHHHHhhccCcc
Confidence 3888899999999999999999999964 236899999863211 11234567899999999 8999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------------------
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------------------------- 200 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------- 200 (390)
|+++++++... ....+++|||+++++|.+++....
T Consensus 73 iv~~~~~~~~~-------------------~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 73 VVNLLGACTKP-------------------GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred hhheeeeEecC-------------------CCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 99999988643 234578999999999999986432
Q ss_pred ---------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEE
Q 036382 201 ---------------------------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247 (390)
Q Consensus 201 ---------------------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~k 247 (390)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vk 213 (337)
T cd05054 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK 213 (337)
T ss_pred ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEE
Confidence 12689999999999999999999999999999999999999999999
Q ss_pred EeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCC
Q 036382 248 IADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNL 324 (390)
Q Consensus 248 L~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 324 (390)
|+|||++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+..........
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 293 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC
Confidence 999999975432221 1122345678999999999999999999999999999998 9999988665555555555666
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
++..+..+++++.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 294 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 666777889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=349.98 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=210.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++.. ..........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHH------HHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence 3689999999999999999987 5789999998621 1122233466789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+ ...+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 75 --------------------YLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred --------------------EEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 34889999999999999954 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus 133 l~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 133 LIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred EECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 999999999999999975433 23446799999999999999999999999999999999999999998887777665
Q ss_pred HHHcCCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRPEIP------RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.........| ..+++++.++|.+||..+|.+||++.+++++
T Consensus 210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 54432222222 1458999999999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.93 Aligned_cols=255 Identities=30% Similarity=0.637 Sum_probs=219.1
Q ss_pred ccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
|-++.++|++.+.||+|+||.||++...+..||+|.++... ....+.+|+.++++++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----------hHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 66788899999999999999999999999999999985221 1246789999999999999999999865
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.. ....+++|||+++++|.+++.+.....+++..+..++.|++.||+|||++|++||||||
T Consensus 70 ~~-------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 130 (256)
T cd05082 70 EE-------------------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130 (256)
T ss_pred cC-------------------CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccch
Confidence 32 23458899999999999999765555689999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
+||+++.++.+||+|||++....... .....+..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 131 ~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05082 131 RNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred heEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999987543221 22345678999999998889999999999999999997 999998887777
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
....+ ..+..+..+..+|+.+.+++.+||..+|++|||+.++++.|+.+
T Consensus 208 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 208 VVPRV-EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHH-hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 66554 44566677788999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=342.74 Aligned_cols=257 Identities=28% Similarity=0.511 Sum_probs=206.5
Q ss_pred ccccCccccccccccCceEEEEEEEC------------------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHH
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD------------------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW 139 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 139 (390)
+..++|++.++||+|+||.||++.+. +..||+|+++... .......+.+|+.++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l 73 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--------NKNARNDFLKEVKIL 73 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--------CHHHHHHHHHHHHHH
Confidence 34568999999999999999999752 2369999986321 112345688999999
Q ss_pred HhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-----------------cC
Q 036382 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-----------------RK 202 (390)
Q Consensus 140 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~ 202 (390)
++++||||+++++++.+.. ..|+||||+.+|+|.+++.... ..
T Consensus 74 ~~l~h~niv~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 133 (304)
T cd05096 74 SRLKDPNIIRLLGVCVDED--------------------PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133 (304)
T ss_pred hhcCCCCeeEEEEEEecCC--------------------ceEEEEecCCCCcHHHHHHhccccccccccccccccccccc
Confidence 9999999999999987543 3488999999999999986432 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccC
Q 036382 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQ 280 (390)
Q Consensus 203 ~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~ 280 (390)
.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ......++..|+|||++.
T Consensus 134 ~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 134 AISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence 467888999999999999999999999999999999999999999999999875432211 112234578899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHH---c---CCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 036382 281 GKPYNRRCDVYSFGICLWEIYC--CDMPYPDLSFADVSSAVVR---Q---NLRPEIPRCCPSSLANIMRKCWDANAEKRP 352 (390)
Q Consensus 281 ~~~~~~~~DiwSlG~il~ell~--g~~Pf~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 352 (390)
+..++.++|||||||++|+|++ +..||...+..+....... . ......+..+|..+.+||.+||..||++||
T Consensus 214 ~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 214 MGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred cCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 8899999999999999999986 6688888776665543321 1 112234567899999999999999999999
Q ss_pred CHHHHHHHHH
Q 036382 353 EMGEVVKMLE 362 (390)
Q Consensus 353 t~~~ll~~L~ 362 (390)
|+.+|.+.|+
T Consensus 294 s~~~i~~~l~ 303 (304)
T cd05096 294 SFSDIHAFLT 303 (304)
T ss_pred CHHHHHHHHh
Confidence 9999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=340.98 Aligned_cols=249 Identities=34% Similarity=0.689 Sum_probs=206.7
Q ss_pred cccccccccCceEEEEEEEC------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 84 DMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
++.+.||.|.||.||+|.+. +..|+||+++... .....+.+.+|++++++++||||++++|++...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~ 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--------ccccceeeeeccccccccccccccccccccccc
Confidence 45678999999999999886 5789999995311 112256788999999999999999999999843
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++|+||+++|+|.++|.......+++..+..|+.||+.||.|||+++++|++|+++|
T Consensus 74 ~--------------------~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~n 133 (259)
T PF07714_consen 74 E--------------------PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSN 133 (259)
T ss_dssp S--------------------SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred c--------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3 35889999999999999987655679999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
||++.++.+||+|||++...... ............|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+
T Consensus 134 ill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 134 ILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp EEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999765221 111233456788999999988889999999999999999999 789999998888
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
....+ ..+.++..+..+|..+.++|.+||..||++|||+.+|++.|
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 IIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 77776 66667778889999999999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=352.83 Aligned_cols=254 Identities=24% Similarity=0.469 Sum_probs=225.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|..++++|+|+||.++..+. +++.+++|.+...... ...+....+|+.++++++|||||.+.+.|.++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-------~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-------EPERRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-------chhhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 46899999999999999987654 6789999999744321 11234667999999999999999999998865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. ..||||+|++||+|.+.+.+.++..++++.++.|+.|++.|+.|||+++|+|||||+.|
T Consensus 76 ~~-------------------~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~N 136 (426)
T KOG0589|consen 76 GQ-------------------LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCAN 136 (426)
T ss_pred Cc-------------------eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhh
Confidence 43 14889999999999999988777889999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.++|+|||+|+..........+..||+.||+||++.+.+|+.++|||||||++|||++-+++|...+....+.
T Consensus 137 ifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ 216 (426)
T KOG0589|consen 137 IFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL 216 (426)
T ss_pred hhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH
Confidence 99999999999999999977655434455789999999999999999999999999999999999999999999999998
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
++.... -.+.|...+.+++.+|..||..+|+.||++.+|+..
T Consensus 217 ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 KINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 887665 456788899999999999999999999999999976
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=348.75 Aligned_cols=244 Identities=26% Similarity=0.426 Sum_probs=205.9
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
+.||+|+||.||++.. +++.||||+++... .........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV------IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD------ 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC------
Confidence 3689999999999976 57899999986221 112223456778999999999999999999987543
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~ 244 (390)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 69 --------------~~~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 132 (328)
T cd05593 69 --------------RLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132 (328)
T ss_pred --------------EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC
Confidence 44889999999999998854 34699999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCC
Q 036382 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324 (390)
Q Consensus 245 ~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (390)
.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-- 210 (328)
T cd05593 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-- 210 (328)
T ss_pred cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--
Confidence 999999999875333333334467999999999999999999999999999999999999999888777766555433
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
...+|..+++++.++|.+||..||++|| ++.+++++
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3456778899999999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=332.10 Aligned_cols=257 Identities=29% Similarity=0.582 Sum_probs=219.2
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|+|..++|++.++||+|+||.||+|.. +++.||+|.+..... ....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----------SPEAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----------cHHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 678889999999999999999999987 568999999863221 124577899999999999999999886
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ...+++|||+.+++|.+++....+..+++..+..++.|++.||+|||+.|++|||||
T Consensus 71 ~~---------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~ 129 (260)
T cd05067 71 TQ---------------------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR 129 (260)
T ss_pred cc---------------------CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 32 234899999999999999976666679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus 130 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred HHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 999999999999999999987544221 11223345678999999998889999999999999999999 9999998877
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.+....+ ....+.+.+..+|.++.+++.+||..+|++|||++++++.|+.+
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 210 PEVIQNL-ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 6665554 45566677888899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=335.07 Aligned_cols=265 Identities=24% Similarity=0.340 Sum_probs=211.8
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|++. ..|...+.||+|+||.|..+.+ +|+.||||.+. .........+...+|+.+|+.++|+||+.+.+
T Consensus 17 ~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-------~~F~~~~~akRtlRElklLr~~~HeNIi~l~d 88 (359)
T KOG0660|consen 17 LFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-------NPFENQIDAKRTLRELKLLRHLRHENIIGLLD 88 (359)
T ss_pred EEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhh-------hhhhchHHHHHHHHHHHHHHHhcCCCcceEEe
Confidence 34443 3566688999999999999977 68999999875 12233334566779999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.... ...-+..|+|+|+| +.+|...++. ++.++.+.+..+++|+++||+|+|+.+|+|||
T Consensus 89 i~~p~~---------------~~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRD 150 (359)
T KOG0660|consen 89 IFRPPS---------------RDKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRD 150 (359)
T ss_pred eccccc---------------ccccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccc
Confidence 986411 12345679999999 4599999944 45599999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccC--CCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|||.|+|++.+..+||+|||+|+.... ....++..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|++
T Consensus 151 LKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 151 LKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred cchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 999999999999999999999997643 334567788999999999884 46799999999999999999999999998
Q ss_pred CChhhHHHHHHH------------------------cCCCCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 310 LSFADVSSAVVR------------------------QNLRPEIP-----RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 310 ~~~~~~~~~~~~------------------------~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+..+.+..++. ....+..| ...++...+|+.+||..||.+|+|++|.+++
T Consensus 231 ~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 231 KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 765554443321 11111111 2467889999999999999999999999864
Q ss_pred --HHHhH
Q 036382 361 --LEAID 365 (390)
Q Consensus 361 --L~~~~ 365 (390)
|..++
T Consensus 311 PYl~~~h 317 (359)
T KOG0660|consen 311 PYLAPYH 317 (359)
T ss_pred hhhhhhc
Confidence 44444
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=350.61 Aligned_cols=265 Identities=28% Similarity=0.545 Sum_probs=222.8
Q ss_pred CCcccccccCccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-C
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-H 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 144 (390)
...|+++.++|.+.+.||+|+||.||+|++.+ ..||||+++.... ......+.+|+.++..+. |
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~E~~~l~~l~~H 100 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--------SSEKQALMSELKIMSHLGPH 100 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--------hhHHHHHHHHHHHHHhcCCC
Confidence 45699999999999999999999999998633 5799999963211 112346789999999997 9
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-----------------------
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR----------------------- 201 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------- 201 (390)
|||+++++++.... ..++||||+.+|+|.+++.+...
T Consensus 101 ~niv~~~~~~~~~~--------------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (401)
T cd05107 101 LNIVNLLGACTKGG--------------------PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTP 160 (401)
T ss_pred CCeEEEEEEEccCC--------------------CcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccc
Confidence 99999999987543 34889999999999999965321
Q ss_pred -------------------------------------------------------------------------CCCCHHH
Q 036382 202 -------------------------------------------------------------------------KKLALKI 208 (390)
Q Consensus 202 -------------------------------------------------------------------------~~l~~~~ 208 (390)
..+++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 240 (401)
T cd05107 161 LSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMD 240 (401)
T ss_pred ccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHH
Confidence 2367778
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCC
Q 036382 209 VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNR 286 (390)
Q Consensus 209 ~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 286 (390)
++.++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++...... .......++..|+|||.+.+..++.
T Consensus 241 ~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 320 (401)
T cd05107 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320 (401)
T ss_pred HHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence 89999999999999999999999999999999999999999999997543221 1122345678899999999888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 287 RCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 287 ~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
++|+|||||++|||++ |..||......+.....+..+.++..|..++.++.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus 321 ~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 321 LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 9999999999999998 899998877767666666677777788889999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=329.83 Aligned_cols=258 Identities=31% Similarity=0.561 Sum_probs=218.3
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|+++.++|++.+.||+|+||.||+|.+ .++.||+|.++.... ....+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----------DPKDFLAEAQIMKKLRHPKLIQLYAVC 70 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----------cHHHHHHHHHHHHHCCCCCccceeEEE
Confidence 678889999999999999999999987 456899999863321 124577899999999999999999988
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
... +..|+||||+.+++|.+++....+..+++..+..++.|++.||.|||+.|++|+|||
T Consensus 71 ~~~--------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 130 (261)
T cd05068 71 TLE--------------------EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130 (261)
T ss_pred ecC--------------------CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 644 344889999999999999976555578999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||++......... ..+...+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 131 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred cceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999999865422111 112223467999999998899999999999999999999 9999998887
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
......+ ........+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 211 AEVLQQV-DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 7766555 34455566777899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=328.68 Aligned_cols=255 Identities=34% Similarity=0.662 Sum_probs=219.9
Q ss_pred ccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
|.++.++|++.+.||.|+||.||+|...|+.||+|.++... . ....+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~-------~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS-------T---AAQAFLAEASVMTTLRHPNLVQLLGVVL 70 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccch-------h---HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence 56678899999999999999999999999999999986321 1 3466889999999999999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+. ...++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||
T Consensus 71 ~~--------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p 130 (256)
T cd05039 71 QG--------------------NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAA 130 (256)
T ss_pred CC--------------------CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhccc
Confidence 43 3458899999999999999765545799999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
+||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 131 ~Nili~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 131 RNVLVSEDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred ceEEEeCCCCEEEccccccccccccc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999997653221 13345678999999988889999999999999999997 999998887776
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
....+ ..+.+...+..+|+.+.++|.+||..+|++|||+.+++++|+.+
T Consensus 208 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 VVPHV-EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHH-hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 65544 44556667788899999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=344.15 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=205.2
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHH---HhcCCCccceEEEEEecc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW---QKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~ 157 (390)
|++.+.||+|+||.||+|.+ +++.||||+++... .........+.+|.+++ +.++||||+++++++.+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD------IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 67789999999999999987 57899999986321 11112234556666554 566899999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 75 ~--------------------~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~N 131 (324)
T cd05589 75 D--------------------HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131 (324)
T ss_pred C--------------------EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHH
Confidence 3 44889999999999988743 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||++.............+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~ 211 (324)
T cd05589 132 LLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211 (324)
T ss_pred eEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999998754333333445679999999999999999999999999999999999999999988888777
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
.+.... ...|..++.++.++|.+||..||.+|| ++.+++++
T Consensus 212 ~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 765543 346778899999999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=344.39 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=206.0
Q ss_pred ccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
+.||+|+||.||+++. .++.||||+++... ..........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--- 73 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT-----IVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--- 73 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHH-----HHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC---
Confidence 5799999999999875 56789999986211 1111223355778999999999999999999987543
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
..|+||||+.+++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 74 -----------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 134 (323)
T cd05584 74 -----------------KLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134 (323)
T ss_pred -----------------eEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 44889999999999999854 34688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 036382 242 SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (390)
.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 135 AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987543333333445799999999999998899999999999999999999999998887777766654
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 322 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
. ....|..+++++.++|.+||+.||++|| ++.+++++
T Consensus 215 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 215 G--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 4 3456778899999999999999999999 88888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=340.24 Aligned_cols=262 Identities=23% Similarity=0.544 Sum_probs=216.9
Q ss_pred cccCccccccccccCceEEEEEEE--CCc----eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...+|++.+.||+|+||.||+|++ +++ .||+|+++... .......+.+|+.+++.++||||++++|
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 346799999999999999999986 333 48999986221 1222456788999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++... ..++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+.||+|||
T Consensus 77 ~~~~~---------------------~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~d 134 (316)
T cd05108 77 ICLTS---------------------TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRD 134 (316)
T ss_pred EEcCC---------------------CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 98632 236899999999999999654 34588999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
|||+|||++.++.+||+|||+++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 135 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 135 LAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999865432221 122334678999999999999999999999999999997 9999988
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
....+.. .+...+.....+..++.++.+++.+||..+|.+|||+.+++..|.++......+
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 215 IPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred CCHHHHH-HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 7766644 444555666667788999999999999999999999999999999997655444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=334.56 Aligned_cols=259 Identities=30% Similarity=0.552 Sum_probs=213.2
Q ss_pred ccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
|++..++|++.+.||+|+||.||+|.+. +..||||.++... .......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~iv 72 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCee
Confidence 6778889999999999999999998763 3579999875211 111234578999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------RKKLALKIVIQLALDLSRGL 220 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L 220 (390)
++++++... ...++||||+++++|.+++.+.. ...+++..+..++.|++.||
T Consensus 73 ~~~~~~~~~--------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 73 RLLGVVSQG--------------------QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred eEEEEEcCC--------------------CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 999998643 34488999999999999996532 12367888999999999999
Q ss_pred HHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHH
Q 036382 221 SYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298 (390)
Q Consensus 221 ~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 298 (390)
.|||+.|++|+||||+|||++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+|||||++|
T Consensus 133 ~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212 (277)
T ss_pred HHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHH
Confidence 999999999999999999999999999999999874332111 111234577899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 299 EIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 299 ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
||++ |..||.+....+....+... ..+..+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 213 EIATLAEQPYQGMSNEQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 9999 78999988877766655443 3345677889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=348.38 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=207.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||||+++.. ..........+.+|+.++++++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA------DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH------HHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4789999999999999999977 5789999998621 1122333466788999999999999999999987544
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 75 --------------------NLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred --------------------eEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 34889999999999999965 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC-----------------------------------CCCCCCCCCccccccccCCCC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR-----------------------------------DMTGETGTLGYMAPEVLQGKP 283 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~ 283 (390)
|++.++.+||+|||+++....... .....+||+.|+|||++.+..
T Consensus 133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 212 (363)
T cd05628 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212 (363)
T ss_pred EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC
Confidence 999999999999999864321100 012357999999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhh--hCCCCCCCHHHHHH
Q 036382 284 YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWD--ANAEKRPEMGEVVK 359 (390)
Q Consensus 284 ~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~--~dP~~Rpt~~~ll~ 359 (390)
++.++|||||||++|||++|..||.+.+..+....+........+|. .+++++.++|.+++. .++..||++++|++
T Consensus 213 ~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 99999999999999999999999999888887777765433333443 367899999998664 23335689999998
Q ss_pred H
Q 036382 360 M 360 (390)
Q Consensus 360 ~ 360 (390)
+
T Consensus 293 h 293 (363)
T cd05628 293 N 293 (363)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=329.56 Aligned_cols=258 Identities=31% Similarity=0.538 Sum_probs=216.4
Q ss_pred ccccccCccccccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|++..++|++.++||+|+||.||+|++.+ ..||+|+++.... ....+.+|+++++.++||||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----------~~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----------CHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 67888899999999999999999998743 5799999863211 124578899999999999999999876
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ...++||||+.+|+|.+++.+.....+++..+..++.|++.||.|||+.+++|||||
T Consensus 71 ~~---------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (262)
T cd05071 71 SE---------------------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129 (262)
T ss_pred CC---------------------CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 32 234799999999999999976555568999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+|||||++|+|++ |..||.+...
T Consensus 130 p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred cccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 99999999999999999999754332211 122345678999999988889999999999999999999 8889988877
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
.+....+. .......+..+|..+.+++.+||+.||++|||+.++++.|+...
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 210 REVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 77665543 34444556678999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=342.44 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=206.5
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+..++|++.+.||+|+||.||++++ ++..||+|+++... .......+.+|++++++++||||+++++++.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 4567899999999999999999988 47889999986321 1223467889999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVK 234 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiHrDlk 234 (390)
+.. ..++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. +|+|||||
T Consensus 74 ~~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlk 131 (331)
T cd06649 74 SDG--------------------EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVK 131 (331)
T ss_pred ECC--------------------EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCC
Confidence 543 347899999999999999543 4689999999999999999999986 69999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.++.+||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 132 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred hhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998754322 2234568999999999999999999999999999999999999997765544
Q ss_pred HHHHHH---------------------------------------------HcCCCCCC-CCCCcHHHHHHHHHhhhhCC
Q 036382 315 VSSAVV---------------------------------------------RQNLRPEI-PRCCPSSLANIMRKCWDANA 348 (390)
Q Consensus 315 ~~~~~~---------------------------------------------~~~~~~~~-~~~~~~~l~~li~~cl~~dP 348 (390)
....+. ....++.. ...+++++.+||.+||..||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P 289 (331)
T cd06649 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNP 289 (331)
T ss_pred HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence 322111 01111111 12467899999999999999
Q ss_pred CCCCCHHHHHHHH
Q 036382 349 EKRPEMGEVVKML 361 (390)
Q Consensus 349 ~~Rpt~~~ll~~L 361 (390)
++|||+.+|+++-
T Consensus 290 ~~Rpt~~ell~h~ 302 (331)
T cd06649 290 AERADLKMLMNHT 302 (331)
T ss_pred ccCCCHHHHhcCh
Confidence 9999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=350.90 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=211.3
Q ss_pred cCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+. ++.||||+++.. ..........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS------DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHH------HHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence 36899999999999999999884 889999998621 1112233466789999999999999999999887543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 75 --------------------HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred --------------------eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 448899999999999999654 5699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC-----------------------------CCCCCCCCCCccccccccCCCCCCCchh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP-----------------------------RDMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
|++.++.+||+|||++....... .......||+.|+|||++.+..++.++|
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 212 (350)
T cd05573 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD 212 (350)
T ss_pred EECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCcee
Confidence 99999999999999987543322 1233456899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH--cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHHH
Q 036382 290 VYSFGICLWEIYCCDMPYPDLSFADVSSAVVR--QNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-MGEVVKM 360 (390)
Q Consensus 290 iwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~~ 360 (390)
||||||++|+|++|..||...+..+....+.. .....+....+++++.+||.+||. ||.+||+ +.+++++
T Consensus 213 iwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 213 WWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred eEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99999999999999999998887777777665 333333333469999999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=328.76 Aligned_cols=256 Identities=30% Similarity=0.564 Sum_probs=217.0
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|++..++|++.+.||+|+||.||+|.. .+..||+|.++.... . ...+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~-------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---S-------PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---C-------HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 778889999999999999999999987 456899999863221 0 24578999999999999999999886
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ...+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.+++|||||
T Consensus 71 ~~---------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 129 (260)
T cd05070 71 SE---------------------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129 (260)
T ss_pred CC---------------------CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 32 224789999999999999976555568999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus 130 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999976443221 1122335668999999988889999999999999999999 8999998887
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
.+....+. .+...+.+..++.++.+|+.+||..+|.+|||+.++.+.|+.
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 210 REVLEQVE-RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 77666553 455666778889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=333.71 Aligned_cols=259 Identities=31% Similarity=0.573 Sum_probs=217.0
Q ss_pred ccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
|+++.++|++.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~ 72 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--------SMRERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--------CHHHHHHHHHHHHHHHhCCCCcee
Confidence 6788899999999999999999999763 2679999985221 112235677899999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------RKKLALKIVIQLALDLSRGL 220 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L 220 (390)
++++++.... ..++||||+++|+|.+++.... ...+++..+..++.|++.||
T Consensus 73 ~~~~~~~~~~--------------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 73 RLLGVVSTGQ--------------------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred EEEEEEcCCC--------------------CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 9999987543 3488999999999999996532 22478889999999999999
Q ss_pred HHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHH
Q 036382 221 SYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298 (390)
Q Consensus 221 ~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 298 (390)
.|||+.+++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|
T Consensus 133 ~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred HHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 999999999999999999999999999999999875432211 122334678899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 299 EIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 299 ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
|+++ |..||...+..+....+. .+.....|..++.++.+++.+||+.+|++|||+.++++.|++
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 9998 999999888777766554 555566788889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=350.02 Aligned_cols=251 Identities=21% Similarity=0.361 Sum_probs=208.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +++.||||+++.. ..........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS------EMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 4789999999999999999987 5789999998621 1112233456788999999999999999999988554
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 75 --------------------YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred --------------------eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 348899999999999999653 4699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC--------------------------------------CCCCCCCCCccccccccC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR--------------------------------------DMTGETGTLGYMAPEVLQ 280 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~ 280 (390)
|++.++.++|+|||++........ .....+||+.|+|||++.
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (364)
T cd05599 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212 (364)
T ss_pred EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence 999999999999999864321100 011246899999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HH
Q 036382 281 GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAEKRPE---MG 355 (390)
Q Consensus 281 ~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt---~~ 355 (390)
+..++.++|||||||++|||++|..||...+..+....+.........|. .+++++.++|.+||. +|.+|++ +.
T Consensus 213 ~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 213 QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 99999999999999999999999999999888777766655443333333 468999999999997 9999998 88
Q ss_pred HHHHH
Q 036382 356 EVVKM 360 (390)
Q Consensus 356 ~ll~~ 360 (390)
+++++
T Consensus 292 ~ll~h 296 (364)
T cd05599 292 EIKSH 296 (364)
T ss_pred HHhcC
Confidence 88763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=343.26 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=207.2
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCC-ccceEEEEEeccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP-NVTKFVGASVGTS 158 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~ 158 (390)
+|++.+.||+|+||.||+|++ +++.||||+++... .........+..|.++++.+.|+ +|+++++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV------IIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence 588999999999999999987 45789999986211 11122345677899999999765 6888888887543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 132 (324)
T cd05587 75 --------------------RLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (324)
T ss_pred --------------------EEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 44889999999999999854 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred EEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987433333333446799999999999999999999999999999999999999999888887777
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM-----GEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~~ 360 (390)
+... ....|..++.++.+++.+||..||.+|++. .+++++
T Consensus 213 i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 213 IMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 6543 445677889999999999999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=338.06 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=203.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||.|+||.||+|.. +++.||+|+++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--------APCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--------cchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 56899999999999999999977 57899999986432111 123466899999999999999999998644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+ +|.+++... +..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 76 ~--------------------~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 133 (288)
T cd07871 76 R--------------------CLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133 (288)
T ss_pred C--------------------eEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3 44789999975 999988643 3458899999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.+||+|||+++.............+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+..
T Consensus 134 il~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 134 LLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred EEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999765433333445678999999999865 56899999999999999999999999887766655
Q ss_pred HHHHHcCCC--------------------CC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLR--------------------PE--------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~--------------------~~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+...... +. ....++.++.+||.+||..||.+|||+.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 443321000 00 012357889999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=329.60 Aligned_cols=256 Identities=30% Similarity=0.601 Sum_probs=215.0
Q ss_pred cccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+.++|++.+.||+|+||.||+|.+. ...||||+++... .......+.+|+.++++++||||+++++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--------SDKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--------ChHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 4578999999999999999999873 3479999886321 12234567889999999999999999998
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+... ...++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||
T Consensus 74 ~~~~--------------------~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di 132 (266)
T cd05033 74 VTKS--------------------RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132 (266)
T ss_pred EecC--------------------CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 8643 33488999999999999996543 46899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
||+|||++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999986542111 1122345678999999998899999999999999999998 99999888
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+..+....+. .....+.+..+|..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 213 SNQDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7777665553 4455566778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=349.73 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=213.3
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.+.+..++|++.+.||+|+||.||+++. +++.||+|+++.. ..........+.+|+.+++.++||||+++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF------EMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH------HhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4556778999999999999999999987 5789999998621 1111222345778999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+|||
T Consensus 111 ~~~~~~--------------------~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (370)
T cd05596 111 AFQDDK--------------------YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (370)
T ss_pred EEecCC--------------------EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 987543 34889999999999999854 3589999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK----PYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||+|||++.++.+||+|||++....... .......||+.|+|||++.+. .++.++|+|||||++|||++|..||
T Consensus 168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 99999999999999999999997543322 122346799999999998653 4789999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
.+.+.......+........+|. .++.++.+||.+||..+|.+ |+|+.+++++
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 248 YADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 99888777777765443444444 57899999999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=335.98 Aligned_cols=264 Identities=29% Similarity=0.551 Sum_probs=221.0
Q ss_pred CCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CC
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 144 (390)
...|.+..++|.+.+.||+|+||.||++.+ .+..||||+++.... ......+.+|+.+++++ +|
T Consensus 27 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h 98 (302)
T cd05055 27 DLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--------SSEREALMSELKIMSHLGNH 98 (302)
T ss_pred cccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--------hHHHHHHHHHHHHHHhccCC
Confidence 346788889999999999999999999975 234799998863211 12245688999999999 89
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH 224 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH 224 (390)
|||+++++++.... ..++||||+.+|+|.+++.+.....+++..+..++.|++.||.|||
T Consensus 99 ~~iv~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH 158 (302)
T cd05055 99 ENIVNLLGACTIGG--------------------PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158 (302)
T ss_pred CCcceEEEEEecCC--------------------ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999987543 3488999999999999997644445899999999999999999999
Q ss_pred hCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 036382 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 225 ~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 302 (390)
+++|+|+||||+|||++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 159 ~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred HCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999875433211 1112345778999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 303 -CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 303 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
|..||......+........+.++..+...+.++.+++.+||..+|++|||+.+|++.|+++
T Consensus 239 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 239 LGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 99999887766666566666666666777899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=342.74 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=201.0
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|++ +++.||||+++.. ..........+..|..+++.+ +||||+++++++.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----- 69 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKD------VILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----- 69 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHH------HHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----
Confidence 3689999999999987 5789999998621 111122345567888888877 7999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~ 132 (320)
T cd05590 70 ---------------RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE 132 (320)
T ss_pred ---------------EEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 448899999999999988543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~- 211 (320)
T cd05590 133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND- 211 (320)
T ss_pred CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999999875433333344567999999999999999999999999999999999999999998888877766543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
....|..++.++.++|.+||+.||.+||++
T Consensus 212 -~~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 212 -EVVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 344667789999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.58 Aligned_cols=244 Identities=25% Similarity=0.422 Sum_probs=205.1
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
+.||+|+||.||++.+ +++.||+|+++... .........+.+|+++++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~------ 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV------IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD------ 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC------
Confidence 3689999999999986 67899999986211 111223355678999999999999999999887543
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 69 --------------~~~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~ 132 (325)
T cd05594 69 --------------RLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132 (325)
T ss_pred --------------EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC
Confidence 45889999999999998854 3468999999999999999999997 799999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~- 211 (325)
T cd05594 133 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME- 211 (325)
T ss_pred CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999999875433333334467999999999999999999999999999999999999999988877766655433
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
...+|..+++++.++|.+||+.||++|+ ++.+++++
T Consensus 212 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 -EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3456778899999999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=349.75 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=204.6
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|++++.||+|+||.||+|++ +++.||||+++.. ..........+.+|+.++++++||||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~------~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK------DVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH------HhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-
Confidence 588999999999999999987 5789999998621 1122333467889999999999999999999997544
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 75 -------------------~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil 133 (381)
T cd05626 75 -------------------NLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133 (381)
T ss_pred -------------------EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence 348899999999999999653 46899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCC-----------------------------------------------CCCCCCCCCCc
Q 036382 240 LDSQRTLKIADFGVARVEAQNP-----------------------------------------------RDMTGETGTLG 272 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~-----------------------------------------------~~~~~~~gt~~ 272 (390)
++.++++||+|||++....... ......+||+.
T Consensus 134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred ECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence 9999999999999875321000 00123469999
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhh--hhCC
Q 036382 273 YMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCW--DANA 348 (390)
Q Consensus 273 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl--~~dP 348 (390)
|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........| ..+++++.+||.+++ ..+|
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999999999999999999999999999998887766665555433233333 357899999999954 5566
Q ss_pred CCCCCHHHHHHH
Q 036382 349 EKRPEMGEVVKM 360 (390)
Q Consensus 349 ~~Rpt~~~ll~~ 360 (390)
..||++.+++++
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 669999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=342.10 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=205.5
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|++ +++.||||+++.. ..........+..|.++++.+ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----- 69 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKD------VILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----- 69 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHH------HhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----
Confidence 3699999999999987 4679999998621 111222345567888888876 8999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~ 132 (321)
T cd05591 70 ---------------RLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132 (321)
T ss_pred ---------------eEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 458899999999999998543 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred CCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998754433333445679999999999999999999999999999999999999999988888877776543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCC-------CHHHHHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRP-------EMGEVVKM 360 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-------t~~~ll~~ 360 (390)
...|..++.++.+++.+||..||++|| ++.+++++
T Consensus 213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 345667899999999999999999999 78888755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.96 Aligned_cols=252 Identities=27% Similarity=0.561 Sum_probs=211.2
Q ss_pred ccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
++.++|++.+.||+|+||.||++.+. +..+|+|.+..... ....+.+|++++++++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----------cHHHHHHHHHHHHHCCCCCceeEEEEEcc
Confidence 35678999999999999999999884 45899998763211 12457789999999999999999999864
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ...++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.||+||||+|+
T Consensus 71 ~--------------------~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ 129 (256)
T cd05114 71 Q--------------------KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129 (256)
T ss_pred C--------------------CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcc
Confidence 4 33488999999999999986533 46899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
||+++.++.+||+|||.++....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 130 ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred eEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999999875432211 1122345678999999998889999999999999999999 899999888777
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
....+.. +.++..|...+.++.+++.+||+.+|.+|||+.++++.|
T Consensus 210 ~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 210 VVEMISR-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 7766643 445556777889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=340.43 Aligned_cols=243 Identities=26% Similarity=0.427 Sum_probs=200.9
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|++ +++.||||+++... .........+..|..++..+ +||||+++++++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----- 69 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDV------VLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----- 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----
Confidence 3689999999999987 46789999986321 11112233445667777654 8999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~ 132 (316)
T cd05592 70 ---------------HLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132 (316)
T ss_pred ---------------EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC
Confidence 448899999999999998543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 133 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-- 210 (316)
T cd05592 133 GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-- 210 (316)
T ss_pred CCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--
Confidence 999999999997543333334456799999999999999999999999999999999999999999888777766543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMG-EVVK 359 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll~ 359 (390)
..+.+|..++.++.++|.+||..||.+||++. ++++
T Consensus 211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 35567788999999999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=341.82 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=204.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEeccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTS 158 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 158 (390)
+|++.+.||+|+||.||+|.+ +++.||||+++... .........+..|..++..+ +||+|+++++++.+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV------VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence 588899999999999999987 46799999986321 11122234566788888877 6899999999887543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Ni 132 (323)
T cd05616 75 --------------------RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (323)
T ss_pred --------------------EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHe
Confidence 347899999999999998543 4689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+....
T Consensus 133 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 133 MLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred EECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999997543333334456799999999999999999999999999999999999999999888887777
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
+.... ..+|..++.++.+++.+||+.||.+|++.
T Consensus 213 i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 66543 44677889999999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=342.82 Aligned_cols=265 Identities=29% Similarity=0.560 Sum_probs=217.3
Q ss_pred ccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCcc
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNV 147 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI 147 (390)
|+++.++|++.+.||+|+||.||+|.+ +++.||||+++.... ......+.+|+.++.++ +||||
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~ni 73 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHHLNV 73 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--------hHHHHHHHHHHHHHHhccCCccH
Confidence 788889999999999999999999974 457899999863211 11235677899999999 78999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---------------------------
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------------------- 200 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------- 200 (390)
+++++++... ....++||||+.+|+|.+++....
T Consensus 74 v~~~~~~~~~-------------------~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (343)
T cd05103 74 VNLLGACTKP-------------------GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134 (343)
T ss_pred hhhcceeecC-------------------CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhh
Confidence 9999987543 234588999999999999986431
Q ss_pred --------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 201 --------------------------------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 201 --------------------------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 214 (343)
T cd05103 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 214 (343)
T ss_pred hhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC
Confidence 123678889999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 036382 243 QRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAV 319 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (390)
++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||............
T Consensus 215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 99999999999875432211 1112335678999999998899999999999999999997 99999876655444455
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
...+.+...|..+++++.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 555566667777889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=336.52 Aligned_cols=269 Identities=31% Similarity=0.566 Sum_probs=221.9
Q ss_pred CcccccccCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-C
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D 143 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 143 (390)
..|++..++|.+.+.||+|+||.||++.+. ...+|+|+++... .......+.+|+++++.+ +
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~~ 82 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--------TEKDLSDLISEMEMMKMIGK 82 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--------ChHHHHHHHHHHHHHHHhcC
Confidence 468888899999999999999999999752 2469999986321 011235577899999999 8
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc--------------CCCCHHHH
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--------------KKLALKIV 209 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~ 209 (390)
||||+++++++.... ..|+||||+.+|+|.+++.+... ..+++..+
T Consensus 83 h~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 142 (307)
T cd05098 83 HKNIINLLGACTQDG--------------------PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142 (307)
T ss_pred CCCEeeEEEEEecCC--------------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHH
Confidence 999999999987543 34889999999999999975421 34889999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCc
Q 036382 210 IQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRR 287 (390)
Q Consensus 210 ~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 287 (390)
+.++.|++.||+|||+.|++||||||+|||++.++.++|+|||++........ ......+++.|+|||.+.+..++.+
T Consensus 143 ~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 222 (307)
T cd05098 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 222 (307)
T ss_pred HHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH
Confidence 99999999999999999999999999999999999999999999875432111 1112234578999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 288 CDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 288 ~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+|+|||||++|+|++ |..||...+..+....+ ....+...+..++.++.+++.+||..+|.+|||+.++++.|+++.+
T Consensus 223 ~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 223 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 999999999999998 88999887766655443 4555667788899999999999999999999999999999999987
Q ss_pred cCCCC
Q 036382 367 SKGGG 371 (390)
Q Consensus 367 ~~~~~ 371 (390)
.....
T Consensus 302 ~~~~~ 306 (307)
T cd05098 302 LTSNQ 306 (307)
T ss_pred HhhcC
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=331.80 Aligned_cols=262 Identities=27% Similarity=0.514 Sum_probs=217.5
Q ss_pred ccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
|...+|.+.+.||+|+||.||++.. ++..+|+|.++.. .......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---------SDNARKDFHREAELLTNLQHEHIVKF 72 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---------CHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 4456899999999999999999974 2356899988521 11234568899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-----------cCCCCHHHHHHHHHHHHHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-----------RKKLALKIVIQLALDLSRG 219 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~ 219 (390)
++++.... ..++||||+.+++|.+++.... ...+++..+..++.|++.|
T Consensus 73 ~~~~~~~~--------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~a 132 (288)
T cd05093 73 YGVCVEGD--------------------PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132 (288)
T ss_pred EEEEecCC--------------------ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 99987543 3488999999999999996432 2358999999999999999
Q ss_pred HHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 036382 220 LSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297 (390)
Q Consensus 220 L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 297 (390)
|.|||++|++||||||+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+|||||++
T Consensus 133 L~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred HHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 999999999999999999999999999999999987443221 112223457789999999998999999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 298 WEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 298 ~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|+|++ |..||......+....+.. +.....+..++.++.+|+.+||+.||.+|||+.++++.|+++.+...
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 99998 9999988887777766644 33445667789999999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=335.53 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=202.9
Q ss_pred cCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGAS 154 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~ 154 (390)
.+|++.+.||+|+||.||+|++ .++.||||+++....... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~hpniv~~~~~~ 73 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-------MPLSTIREVAVLRHLETFEHPNVVRLFDVC 73 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-------chHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence 3689999999999999999986 357899999864322111 112344677766655 699999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
..... ......++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+|||||
T Consensus 74 ~~~~~---------------~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 74 TVSRT---------------DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred ecccC---------------CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 53211 12345689999996 599999976555668999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 99999999999999999999754432 23344568999999999998899999999999999999999999999887777
Q ss_pred HHHHHHHcCCCC-------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSSAVVRQNLRP-------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+..+......+ .....++..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 666654321100 011235778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.80 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=216.1
Q ss_pred ccccccCccccccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|++..++|++...||+|+||.||++.+.+ ..+|+|.+..... ....+.+|+++++.++|||++++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----------MPEAFLQEAQIMKKLRHDKLVPLYAVV 70 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----------cHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 67778889999999999999999998754 5799998763211 124577899999999999999999886
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ...+++|||+.+++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+
T Consensus 71 ~~---------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~ 129 (260)
T cd05069 71 SE---------------------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129 (260)
T ss_pred cC---------------------CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccC
Confidence 32 224799999999999999976555568999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+...
T Consensus 130 ~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred cceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999975433221 1122345678999999988889999999999999999999 9999998877
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.+....+ .....+..+...|..+.+++.+||..||++||++.+|++.|+++
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 210 REVLEQV-ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHHH-HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 7666554 34555666778899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=336.60 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=200.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++++ +++.||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-------NEEVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-------cccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 3689999999999999999988 467999999864321 1122356778999999999999999999886543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.++.|..+.. ....+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 74 --------------------~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 74 --------------------KLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred --------------------EEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4588999999877665442 235699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++.++.+||+|||++....... .......+++.|+|||++.+..++.++|+|||||++|+|++|+.||+..+..+...
T Consensus 132 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 132 LISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred EEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999997643221 22233568999999999999889999999999999999999999998876554433
Q ss_pred HHHHcC-------------------CCC-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQN-------------------LRP-----------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~-------------------~~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+.... ... .....++.++.+||.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 222100 000 011236788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=344.96 Aligned_cols=264 Identities=31% Similarity=0.564 Sum_probs=206.0
Q ss_pred ccccccCccccccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.....++|.-.+.||+|+||.||+|...+ ..||||.+...... . ...|.+|+.++.+++|||+|+++|+|
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~-------~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ-------G--EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc-------c--hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 33345778888999999999999999865 89999987632210 0 23499999999999999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---Cccc
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK---IVHR 231 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---iiHr 231 (390)
.+... ..++|+||+++|+|.++|.......++|..+.+||.++|+||+|||... ||||
T Consensus 141 ~e~~~-------------------~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr 201 (361)
T KOG1187|consen 141 LEGGE-------------------HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHR 201 (361)
T ss_pred ecCCc-------------------eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence 86542 3488999999999999996543327899999999999999999999864 9999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCC-CCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||||+|||+|++.++||+|||+|+............ .||.+|+|||.+..+..+.++||||||++|.||++|+.|....
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999999999999999999999997554311111112 7999999999999999999999999999999999999887643
Q ss_pred C------hhhHHHHHHHcC-----CCCCCC-CCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 311 S------FADVSSAVVRQN-----LRPEIP-RCCP-----SSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 311 ~------~~~~~~~~~~~~-----~~~~~~-~~~~-----~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
. ..+-.......+ ..+.+. ...+ ..+..+...|++.+|.+||++.+|++.|+.+...
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2 111111122211 122222 2222 2367888999999999999999999999766543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.48 Aligned_cols=257 Identities=27% Similarity=0.533 Sum_probs=212.4
Q ss_pred ccccCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+++++|++.+.||+|+||.||+|.+ .+..||+|.++... .......+.+|+++++.++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~ 73 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--------NPQQWGEFQQEASLMAELHHPNIVCLL 73 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--------CHHHHHHHHHHHHHHhhCCCCCeeeEE
Confidence 4567899999999999999999975 44689999886211 112235678899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---------------cCCCCHHHHHHHHHHH
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---------------RKKLALKIVIQLALDL 216 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~i 216 (390)
+++... ...|+||||+.+++|.+++.... ...+++..+..++.|+
T Consensus 74 ~~~~~~--------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 133 (283)
T cd05090 74 GVVTQE--------------------QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133 (283)
T ss_pred EEEecC--------------------CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHH
Confidence 998743 34588999999999999985322 2347899999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHH
Q 036382 217 SRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294 (390)
Q Consensus 217 ~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 294 (390)
+.||.|||++|++||||||+|||++.++.+||+|||++....... .......++..|+|||.+.+..++.++|+||||
T Consensus 134 ~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05090 134 AAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG 213 (283)
T ss_pred HHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHH
Confidence 999999999999999999999999999999999999997543221 112234456789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 295 ICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 295 ~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
|++|||++ |..||.+....+....+. .......+..+++.+.+++.+||+.||.+||++.+|++.|.+
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 214 VVLWEIFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 99999998 999998877666655443 444556778899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.06 Aligned_cols=268 Identities=31% Similarity=0.567 Sum_probs=223.0
Q ss_pred CcccccccCccccccccccCceEEEEEEE---------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-C
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D 143 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 143 (390)
..|++..++|++.+.||+|+||.||+|++ ++..||+|+++.. ........+.+|+.+++.+ +
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--------ATEKDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--------cchHHHHHHHHHHHHHHhhcc
Confidence 35888899999999999999999999974 2347999988521 1112235678999999999 8
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHH
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIV 209 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~ 209 (390)
||||+++++++.... ..++||||+.+|+|.+++.+.. ...+++..+
T Consensus 80 h~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05101 80 HKNIINLLGACTQDG--------------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139 (304)
T ss_pred CCCchheeEEEecCC--------------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHH
Confidence 999999999987543 3478999999999999997532 235788899
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCc
Q 036382 210 IQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRR 287 (390)
Q Consensus 210 ~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~ 287 (390)
..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.+
T Consensus 140 ~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 219 (304)
T cd05101 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219 (304)
T ss_pred HHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence 999999999999999999999999999999999999999999999755432211 222345678999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 288 CDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 288 ~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+||||||+++|+|++ |..||...+..+....+ ....+...+..++.++.+++.+||..+|.+|||+.++++.|+++.+
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 999999999999998 88999888877766655 4455566778899999999999999999999999999999999987
Q ss_pred cCCC
Q 036382 367 SKGG 370 (390)
Q Consensus 367 ~~~~ 370 (390)
..++
T Consensus 299 ~~~~ 302 (304)
T cd05101 299 LTTN 302 (304)
T ss_pred hhhc
Confidence 6654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.83 Aligned_cols=246 Identities=29% Similarity=0.564 Sum_probs=206.8
Q ss_pred cccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccC
Q 036382 88 LIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
.||+|+||.||+|.+ +++.+|+|+++... ......+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 67 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-------NDPALKDELLREANVMQQLDNPYIVRMIGICEA------- 67 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-------
Confidence 689999999999965 46789999986332 112345678899999999999999999998742
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..+++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||.|||++.+
T Consensus 68 --------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~ 131 (257)
T cd05116 68 --------------ESWMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131 (257)
T ss_pred --------------CCcEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC
Confidence 2347899999999999999543 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 036382 244 RTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAV 319 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (390)
+.+||+|||++......... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||......+....+
T Consensus 132 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 132 HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred CeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998754332211 122334678999999988889999999999999999998 99999888776666554
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
..+..++.|..+|+++.++|.+||+.||++||++.+|.+.|+.+
T Consensus 212 -~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 212 -ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 45556678888999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=325.96 Aligned_cols=258 Identities=31% Similarity=0.579 Sum_probs=218.9
Q ss_pred ccccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|+++.++|++.+.||+|+||.||+|... +..||||.+..... ....+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----------SPEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----------CHHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 7888999999999999999999999874 46899998863221 124578899999999999999999987
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
... ...++||||+++++|.+++.......+++..+..++.+++.||.|||++|++|+||+
T Consensus 71 ~~~--------------------~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~ 130 (261)
T cd05034 71 SEE--------------------EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA 130 (261)
T ss_pred ecC--------------------CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 643 334889999999999999976555679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.++|+|||++....... ........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987543211 11112334578999999998889999999999999999998 9999988887
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
......+. .++....+..+|.++.+++.+||..+|.+||++.++++.|+.+
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 211 REVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 77776654 4556666777899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.09 Aligned_cols=271 Identities=28% Similarity=0.553 Sum_probs=223.1
Q ss_pred CCcccccccCccccccccccCceEEEEEEE---------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL- 142 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 142 (390)
+..|.+..++|.+.+.||+|+||.||+++. ....||+|+++.... ......+.+|+++++.+
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~ 75 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--------DKDLADLISEMELMKLIG 75 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcc
Confidence 457888899999999999999999999975 234799998863211 11235577899999999
Q ss_pred CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHH
Q 036382 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKI 208 (390)
Q Consensus 143 ~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~ 208 (390)
+||||+++++++.+. ...|++|||+.+|+|.+++.... ...+++..
T Consensus 76 ~h~~iv~~~~~~~~~--------------------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (314)
T cd05099 76 KHKNIINLLGVCTQE--------------------GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135 (314)
T ss_pred CCCCeeeEEEEEccC--------------------CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHH
Confidence 699999999998643 33488999999999999996532 23588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCC
Q 036382 209 VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNR 286 (390)
Q Consensus 209 ~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 286 (390)
+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.
T Consensus 136 ~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (314)
T cd05099 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215 (314)
T ss_pred HHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence 9999999999999999999999999999999999999999999999754322111 11223456799999999889999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 287 RCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 287 ~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
++|||||||++|+|++ |..||...+..+....+. .+.....+..++.++.+++.+||..+|++|||+.++++.|+++.
T Consensus 216 ~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 216 QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred cchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999 899998887777665553 44455677888999999999999999999999999999999998
Q ss_pred hcCCCCC
Q 036382 366 TSKGGGM 372 (390)
Q Consensus 366 ~~~~~~~ 372 (390)
....+.+
T Consensus 295 ~~~~~~~ 301 (314)
T cd05099 295 AAVSEEY 301 (314)
T ss_pred HHhcCCc
Confidence 6555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.99 Aligned_cols=257 Identities=28% Similarity=0.538 Sum_probs=213.8
Q ss_pred ccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
+..++|.+.+.||+|+||.||+|... +..||||+++.... ......+.+|+++++.++||||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~ 73 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--------NDARKDFEREAELLTNFQHENIVKF 73 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--------HHHHHHHHHHHHHHHhcCCCCchhe
Confidence 34568999999999999999999752 36899999863211 1134678899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc------------cCCCCHHHHHHHHHHHHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR------------RKKLALKIVIQLALDLSR 218 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~ 218 (390)
++++... ...++||||+++++|.+++.... ...+++..+..++.|++.
T Consensus 74 ~~~~~~~--------------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 133 (280)
T cd05049 74 YGVCTEG--------------------DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIAS 133 (280)
T ss_pred eeEEecC--------------------CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHH
Confidence 9998754 34488999999999999996532 245789999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHH
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 296 (390)
||.|||++|++||||||+|||++.++.++|+|||++....... .......+++.|+|||++.+..++.++|||||||+
T Consensus 134 ~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05049 134 GMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213 (280)
T ss_pred HHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHH
Confidence 9999999999999999999999999999999999987532211 11123345788999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 297 LWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 297 l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
+|+|++ |..||...+..+....+. .+.....+..+|..+.+++.+||..||++|||+.++++.|++
T Consensus 214 l~e~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 214 LWEIFTYGKQPWYGLSNEEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 999998 999998888777666654 444445667789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.58 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=206.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||||++... ..........+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS------EMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH------HHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 3689999999999999999977 6789999998521 1122334466789999999999999999999997544
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI 132 (377)
T cd05629 75 --------------------YLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132 (377)
T ss_pred --------------------eeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 34889999999999999964 35689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC-------------C----------------------------------CCCCCCCCC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP-------------R----------------------------------DMTGETGTL 271 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~-------------~----------------------------------~~~~~~gt~ 271 (390)
|++.++.+||+|||+++...... . .....+||+
T Consensus 133 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (377)
T cd05629 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP 212 (377)
T ss_pred EECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCc
Confidence 99999999999999985221100 0 001246899
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCC
Q 036382 272 GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAE 349 (390)
Q Consensus 272 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~ 349 (390)
.|+|||++.+..++.++|||||||++|||++|..||...+..+....+........+|. .++.++.+||.+||. +|.
T Consensus 213 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 213 DYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred cccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 99999999999999999999999999999999999998887777766654333333443 478999999999997 777
Q ss_pred CC---CCHHHHHHH
Q 036382 350 KR---PEMGEVVKM 360 (390)
Q Consensus 350 ~R---pt~~~ll~~ 360 (390)
+| +|+.+++.+
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.65 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=204.9
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||++.+ +++.||||+++.. ..........+..|.++++.+ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----- 69 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKD------VILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----- 69 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH------HHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----
Confidence 3699999999999987 5679999998621 111222345567888999888 7999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 132 (318)
T cd05570 70 ---------------RLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE 132 (318)
T ss_pred ---------------EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC
Confidence 458899999999999988543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++.............++|+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~- 211 (318)
T cd05570 133 GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED- 211 (318)
T ss_pred CcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999999875333333334457899999999999999999999999999999999999999988877776666543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEM-----GEVVKM 360 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~~ 360 (390)
....|..++.++.+||.+||..||.+|||+ .++++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 345677889999999999999999999999 877754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.17 Aligned_cols=264 Identities=31% Similarity=0.581 Sum_probs=220.6
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CC
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 144 (390)
...|+++.++|++.+.||+|+||.||++... ...+|+|+++... .......+.+|+.+++++ +|
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~~h 75 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIGKH 75 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--------CHHHHHHHHHHHHHHHhhcCC
Confidence 4578999999999999999999999999763 2579999886321 111234578899999999 89
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--------------ccCCCCHHHHH
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--------------RRKKLALKIVI 210 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~ 210 (390)
|||+++++++... ...+++|||+++|+|.+++... ....+++..+.
T Consensus 76 ~~i~~~~~~~~~~--------------------~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 135 (293)
T cd05053 76 KNIINLLGVCTQE--------------------GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135 (293)
T ss_pred CCeeeEEEEEcCC--------------------CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence 9999999998643 3458899999999999999642 23568999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCch
Q 036382 211 QLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRC 288 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 288 (390)
.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++
T Consensus 136 ~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (293)
T cd05053 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS 215 (293)
T ss_pred HHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccc
Confidence 9999999999999999999999999999999999999999999975433211 11223356789999999988999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 289 DVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 289 DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
|||||||++|||++ |..||......+....+ ..+.....+..++.++.+|+.+||..||++|||+.++++.|+++.
T Consensus 216 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99999999999997 99999988777766554 455566677788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.88 Aligned_cols=261 Identities=31% Similarity=0.543 Sum_probs=215.1
Q ss_pred ccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
|+++.++|++.+.||+|+||.||+|... +..||+|.++.... ......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~ 72 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--------LRERIEFLNEASVMKGFTCHHVV 72 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence 8889999999999999999999998652 34799998763211 11124567899999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------RKKLALKIVIQLALDLSRGL 220 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L 220 (390)
++++++.+.. ..|+||||+.+|+|.+++.+.. ...++...+..++.|++.||
T Consensus 73 ~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 73 RLLGVVSKGQ--------------------PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred eEEEEEcCCC--------------------CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 9999986443 3488999999999999996532 23456788999999999999
Q ss_pred HHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCchhHHHHHHHHH
Q 036382 221 SYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298 (390)
Q Consensus 221 ~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 298 (390)
.|||+++|+||||||+|||++.++.++|+|||+++........ .....++..|+|||.+.+..++.++|+|||||++|
T Consensus 133 ~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~ 212 (288)
T cd05061 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212 (288)
T ss_pred HHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHH
Confidence 9999999999999999999999999999999998754322111 11234567899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 299 EIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 299 ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
||++ |..||.+.+..+....+... .....+..+++.+.+++.+||+.||++|||+.++++.|++..
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 213 EITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 9998 78999988887766655443 344567778999999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=337.00 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=198.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|+. +++.||||+++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--------GTPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--------ccchhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 36799999999999999999987 5789999998633211 1123456899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+. ++|.+++.+. ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 76 ~--------------------~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~N 133 (303)
T cd07869 76 E--------------------TLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133 (303)
T ss_pred C--------------------eEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3 3488999995 6888888653 3568999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF-ADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~~ 315 (390)
||++.++.+||+|||++..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+.
T Consensus 134 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 134 LLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred EEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 99999999999999998754433334445678999999999865 4588999999999999999999999987533 222
Q ss_pred HHHHHHcC----------------CCC-----CCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQN----------------LRP-----EIP---------RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~----------------~~~-----~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+..+.... +.+ ..+ ...++++.+|+.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 22221100 000 001 123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.63 Aligned_cols=259 Identities=23% Similarity=0.447 Sum_probs=211.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|+. +++.||||.++.... ........+.+|+++++.++||||+++++++.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM------MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc------CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 5799999999999999999987 678999998763211 11223456788999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..++++||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+
T Consensus 76 --------------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ 135 (267)
T cd08228 76 --------------------ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA 135 (267)
T ss_pred --------------------eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHH
Confidence 347899999999999988532 2345899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--FAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~~~ 314 (390)
|||++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+
T Consensus 136 nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 215 (267)
T cd08228 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215 (267)
T ss_pred HEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence 999999999999999998765433322334568889999999988889999999999999999999999996543 234
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
....+......+..+..++..+.++|.+||..+|++|||+.++++.|+.+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 444333333333334567889999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=348.14 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=205.3
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|++.+.||+|+||.||+|.. +++.||+|++... ..........+.+|+.++++++||||+++++.+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~------~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK------DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH------HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-
Confidence 588999999999999999987 6789999998621 1222334567889999999999999999999998554
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 75 -------------------~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL 133 (382)
T cd05625 75 -------------------NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133 (382)
T ss_pred -------------------EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 348899999999999999653 46899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCC-----------------------------------------------CCCCCCCCCCCc
Q 036382 240 LDSQRTLKIADFGVARVEAQN-----------------------------------------------PRDMTGETGTLG 272 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~-----------------------------------------------~~~~~~~~gt~~ 272 (390)
++.++.+||+|||++...... .......+||+.
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 999999999999997421100 000112468999
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCC
Q 036382 273 YMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEK 350 (390)
Q Consensus 273 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~ 350 (390)
|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........| ..+++++.++|.+++ .+|++
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred cCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999999999999999999999999999888777766665433333333 457899999999976 59999
Q ss_pred CCC---HHHHHHH
Q 036382 351 RPE---MGEVVKM 360 (390)
Q Consensus 351 Rpt---~~~ll~~ 360 (390)
|++ +.+++++
T Consensus 293 R~~~~~~~ei~~h 305 (382)
T cd05625 293 RLGKNGADEIKAH 305 (382)
T ss_pred cCCCCCHHHHhcC
Confidence 997 8887753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=331.68 Aligned_cols=258 Identities=25% Similarity=0.503 Sum_probs=213.9
Q ss_pred cccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
+++..+|++.+.||+|+||.||+|.+. +..||+|+++... .......+.+|+.+++.++||||++
T Consensus 1 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~h~~iv~ 72 (283)
T cd05091 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--------EGPLREEFKHEAMMRSRLQHPNIVC 72 (283)
T ss_pred CCCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--------CHHHHHHHHHHHHHHhcCCCCCcCe
Confidence 356778999999999999999999763 3689999986321 1123466889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHHHHH
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALD 215 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ 215 (390)
+++++.+.. ..++++||+.+++|.+++.... ...+++..+..++.|
T Consensus 73 ~~~~~~~~~--------------------~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 132 (283)
T cd05091 73 LLGVVTKEQ--------------------PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132 (283)
T ss_pred EEEEEcCCC--------------------ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence 999987543 3478999999999999985321 235788899999999
Q ss_pred HHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHH
Q 036382 216 LSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSF 293 (390)
Q Consensus 216 i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 293 (390)
++.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||
T Consensus 133 l~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred HHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 9999999999999999999999999999999999999987543221 11223345778999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 294 GICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 294 G~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
||++|||++ |..||.+....+....+... .....+..+|..+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 213 G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 999999998 88899888877776665443 3445678899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=323.30 Aligned_cols=251 Identities=27% Similarity=0.490 Sum_probs=214.0
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||+|.. +++.|++|.+..... .......+.+|+++++.++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-------NRREREEAIDEARVLAKLDSSYIIRYYESFLDK-- 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-------CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--
Confidence 478889999999999999987 678999999863221 122345678999999999999999999998744
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...|+||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus 72 ------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nil 133 (256)
T cd08529 72 ------------------GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLF 133 (256)
T ss_pred ------------------CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 34588999999999999997765567999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+
T Consensus 134 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 134 LDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred EeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999886544433334456889999999999999999999999999999999999999888776666555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.. +..+..+..++.++.+++.+||+.+|++||++.++++.
T Consensus 214 ~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 214 IR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred Hc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 43 44455666789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.90 Aligned_cols=259 Identities=23% Similarity=0.443 Sum_probs=213.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||||.+.... .........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD------LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh------hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 5789999999999999999986 68899999875321 112233467889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..+++|||+.+++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+
T Consensus 76 --------------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 135 (267)
T cd08229 76 --------------------ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135 (267)
T ss_pred --------------------eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 347899999999999998642 2356899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF--AD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~--~~ 314 (390)
||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08229 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred HEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence 9999999999999999987654433333345688999999999988899999999999999999999999965432 23
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
....+......+..+..++..+.+++.+||..||.+|||+.+|++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 216 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 333333333333344568899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=348.95 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=205.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+++. +++.||||++... ..........+.+|+++++.++||||+++++.+.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~------~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA------DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH------HHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 3699999999999999999987 5789999998521 1112233466789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 75 --------------------NLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred --------------------EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 45889999999999999955 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCC-------------------------------------------CCCCCCCCCCCcccc
Q 036382 239 LLDSQRTLKIADFGVARVEAQN-------------------------------------------PRDMTGETGTLGYMA 275 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~-------------------------------------------~~~~~~~~gt~~y~a 275 (390)
|++.++.+||+|||+|...... .......+||+.|+|
T Consensus 133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 212 (376)
T cd05598 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212 (376)
T ss_pred EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence 9999999999999997421100 000123469999999
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCC-
Q 036382 276 PEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRP- 352 (390)
Q Consensus 276 PE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rp- 352 (390)
||++.+..++.++|||||||++|||++|..||.+.+..+....+......... ...+++++.++|.+|+ .+|.+|+
T Consensus 213 PE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 213 PEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred HHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999999999999999999999999999988877766555433222222 3457899999999976 5999999
Q ss_pred --CHHHHHHH
Q 036382 353 --EMGEVVKM 360 (390)
Q Consensus 353 --t~~~ll~~ 360 (390)
|+.+++++
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 89999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=338.36 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=200.6
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|.+ +++.||+|+++... .........+..|..++..+ +||||+++++++.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----- 69 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDV------VLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----- 69 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----
Confidence 4699999999999987 57899999986321 11112234556788888765 8999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~ 132 (316)
T cd05620 70 ---------------HLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132 (316)
T ss_pred ---------------EEEEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 44889999999999999854 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.++|+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~- 211 (316)
T cd05620 133 GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD- 211 (316)
T ss_pred CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999999874332223344567899999999999999999999999999999999999999988877766655432
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMG-EVV 358 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll 358 (390)
.+..|..++.+++++|.+||..||++||++. +++
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 4556777899999999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=331.69 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=206.9
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|++.++||+|+||.||++.+ +++.||||++.... .........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR------IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh------hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-
Confidence 378889999999999999987 57899999985211 112223355678999999999999999999886543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+.+|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus 74 -------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (285)
T cd05605 74 -------------------ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134 (285)
T ss_pred -------------------eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEE
Confidence 4588999999999999886654557999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
+++++.++|+|||++...... .......+++.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 135 LDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred ECCCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 999999999999998754322 2223457899999999999889999999999999999999999999876543332222
Q ss_pred HH--cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 320 VR--QNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 320 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
.. .......+..++..+.+||.+||..||.+|| ++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11 1233446667899999999999999999999 88898764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=341.77 Aligned_cols=239 Identities=24% Similarity=0.411 Sum_probs=202.0
Q ss_pred ccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
+.||+|+||.||+++. +|+.||+|+++.. .........+.+|++++++++||||+++++++.+..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 71 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-------TLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--- 71 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHH-------HhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC---
Confidence 5799999999998864 5789999999621 111122345678999999999999999999987543
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 72 -----------------~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 132 (318)
T cd05582 72 -----------------KLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD 132 (318)
T ss_pred -----------------EEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC
Confidence 45889999999999999854 34689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 036382 242 SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (390)
.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..
T Consensus 133 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~ 212 (318)
T cd05582 133 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212 (318)
T ss_pred CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 99999999999987554333334456789999999999998899999999999999999999999998888777766654
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 322 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
.. ..+|..+++++.++|++||+.||++|||+.+
T Consensus 213 ~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 33 3467788999999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=354.10 Aligned_cols=250 Identities=20% Similarity=0.345 Sum_probs=210.5
Q ss_pred ccCccccccccccCceEEEEEEE--C-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--D-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
...|.+.+.||+|+||.||+|.. + ++.||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---------ERQAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 34599999999999999999976 3 5688998764211 1223456789999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+|||||
T Consensus 137 ~~--------------------~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk 196 (478)
T PTZ00267 137 DD--------------------KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196 (478)
T ss_pred CC--------------------EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC
Confidence 43 458899999999999988542 24468999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999998643321 123345699999999999999999999999999999999999999998888
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+....+..... .+.|..++.++.++|.+||..||++||++.+++.
T Consensus 277 ~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 REIMQQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 877777665443 3466778999999999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=340.00 Aligned_cols=248 Identities=22% Similarity=0.432 Sum_probs=219.4
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
=|.+.+.||+|.|++|-+|++ +|+.||||++...+.+. .....+.+|++.|+.++|||||++|.+...
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-------~st~hlfqEVRCMKLVQHpNiVRLYEViDT--- 88 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-------LSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--- 88 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-------hhhhHHHHHHHHHHHhcCcCeeeeeehhcc---
Confidence 488899999999999999875 99999999997544322 234678899999999999999999998764
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
+...|+|+|.-++|+|+|||.++. ..+.++...+++.||+.|+.|+|+..+|||||||+||.
T Consensus 89 -----------------QTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVV 150 (864)
T KOG4717|consen 89 -----------------QTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVV 150 (864)
T ss_pred -----------------cceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeE
Confidence 344588999999999999998765 56999999999999999999999999999999999987
Q ss_pred ECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 240 LDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 240 l~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
+-+ -|-+||+|||++..+. ++...++.||...|-|||++.+..|+ +++||||||+|||.++||++||+.....+.+-
T Consensus 151 FFEKlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT 229 (864)
T KOG4717|consen 151 FFEKLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT 229 (864)
T ss_pred EeeecCceEeeeccccccCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh
Confidence 654 5999999999997543 45677889999999999999999997 58999999999999999999999998899888
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.++..++. +|..++.++++||..||..||.+|.+.++|...
T Consensus 230 mImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 230 MIMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 88877665 889999999999999999999999999999853
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.04 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=198.6
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.++||+|+||.||+|.+ +++.||||.++.... .......+.+|+++++.++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 488899999999999999987 578999999863211 11122457789999999999999999998764321
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
. .....|+||||+. ++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 74 ~---------------~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 135 (338)
T cd07859 74 R---------------EFKDIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNIL 135 (338)
T ss_pred C---------------CCceEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 1 1234689999995 689998854 346999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 240 LDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
++.++.+||+|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 136 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 136 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred ECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 9999999999999997532211 12234578999999999866 678999999999999999999999998765433
Q ss_pred HHHHHHH----------------------cCCCCCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVR----------------------QNLRPEI-------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~----------------------~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+.. ....... ...+++++.++|.+||..||++|||+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 2211100 0000000 12357889999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.27 Aligned_cols=243 Identities=28% Similarity=0.427 Sum_probs=200.6
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|++ +++.||||+++... .........+..|..+++.+ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----- 69 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDV------VLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----- 69 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----
Confidence 3689999999999987 46789999986321 11112234456677888765 9999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~ 132 (316)
T cd05619 70 ---------------NLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132 (316)
T ss_pred ---------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC
Confidence 347899999999999998543 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~- 211 (316)
T cd05619 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD- 211 (316)
T ss_pred CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999999875332222334457899999999999999999999999999999999999999988877777665433
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMG-EVVK 359 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll~ 359 (390)
.+..|..++.++.+++.+||+.||.+||++. ++++
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 -NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 3446677889999999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=344.25 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=202.0
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
....++|+..+.||+|+||.||+|++ +++.||||++.... .......+.+|+++++.++|+||+++++++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 141 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--------EDTVRRQICREIEILRDVNHPNVVKCHDMF 141 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--------cHHHHHHHHHHHHHHHhCCCCCcceeeeEe
Confidence 34567899999999999999999987 57899999985321 122346788999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+.. ..++||||+.+|+|.+.. ..++..+..++.||+.||.|||++||+|||||
T Consensus 142 ~~~~--------------------~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 195 (353)
T PLN00034 142 DHNG--------------------EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIK 195 (353)
T ss_pred ccCC--------------------eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 7543 447899999999986532 35678889999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|+|||++.++.+||+|||++..............||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 196 p~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred HHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865433333344678999999998843 2345689999999999999999999974
Q ss_pred CChhh---HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 310 LSFAD---VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 310 ~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+ ....+ .....+..+..++.++.+||.+||..||++|||+.+++++
T Consensus 276 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 276 GRQGDWASLMCAI-CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccHHHHHHHH-hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33222 22222 2334555677889999999999999999999999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=319.42 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=214.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.++||+|.|+.|+++.. +|+.+|+|+++....... ..+.+.+|++|.+.|+||||+++........
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-------DFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-------cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 5689999999999999998855 789999999974332211 3467889999999999999999998766443
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+|+|++.|++|..-+-++ .-.++..+-.++.||+++|.|+|.+||||||+||+|+
T Consensus 84 --------------------~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nl 141 (355)
T KOG0033|consen 84 --------------------FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENL 141 (355)
T ss_pred --------------------eeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 347899999999997666433 4588999999999999999999999999999999999
Q ss_pred EECCC---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|+-+. --+||+|||+|.... .+..+.+..|||.|||||++...+|+..+|||+.|++||-++.|.+||.+.+...+
T Consensus 142 lLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl 220 (355)
T KOG0033|consen 142 LLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 220 (355)
T ss_pred eeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH
Confidence 99543 468999999998766 66677789999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 316 SSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
...+....+.. +....++++.++|+++||..||.+|.|+.+.+
T Consensus 221 ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 221 YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 99988776544 35578899999999999999999999998765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=323.61 Aligned_cols=251 Identities=29% Similarity=0.573 Sum_probs=210.6
Q ss_pred cccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+..+|++.+.||+|+||.||++.+. +..+|+|+++.... ....+.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 4567999999999999999999874 45899999863211 123567899999999999999999988644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+++++|.+++.++. ..+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 72 ~--------------------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05059 72 R--------------------PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130 (256)
T ss_pred C--------------------ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhh
Confidence 3 3488999999999999996543 368999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~ 315 (390)
|+++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 131 i~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred EEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 99999999999999998754322111 112234567999999998899999999999999999999 8999988877776
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
...+ ....+...+..+|.++.+++.+||..+|++|||+.++++.|
T Consensus 211 ~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 211 VESV-SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHH-HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 6554 45566677888999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.41 Aligned_cols=264 Identities=22% Similarity=0.362 Sum_probs=216.8
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
+...++|++.+.||+|+||.||+|.+ +++.||||+++.... .......+.+|+.++..++|+||++++..+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-------SEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-------CHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 34457999999999999999999976 688999999864321 112235577899999999999999998876
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
....... .......++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+.||+|||
T Consensus 101 ~~~~~~~------------~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD 168 (496)
T PTZ00283 101 AKKDPRN------------PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168 (496)
T ss_pred ecccccC------------cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 5332110 011223579999999999999996432 34689999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||+|||++.++.+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 169 LKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred CCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999754322 11223457999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..+....+.... ..+.|..+++++.+++.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 249 NMEEVMHKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 8877776665443 345678899999999999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=329.40 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=198.6
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||+|+||+||++.+ +++.||+|.+.... .........+..|+++++.++||||+++++++...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--------- 65 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR------LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--------- 65 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH------HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC---------
Confidence 69999999999976 67899999985221 11222335667899999999999999999988644
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~ 244 (390)
...|+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 66 -----------~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 134 (280)
T cd05608 66 -----------TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG 134 (280)
T ss_pred -----------CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 3458899999999999887532 345689999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHc--
Q 036382 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ-- 322 (390)
Q Consensus 245 ~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~-- 322 (390)
.++|+|||++..............+|+.|+|||++.+..++.++|+|||||++|+|++|+.||...........+...
T Consensus 135 ~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 214 (280)
T cd05608 135 NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214 (280)
T ss_pred CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc
Confidence 999999999976544333334457899999999999999999999999999999999999999765432221111111
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 323 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
......+..++..+.+++.+||+.||++|| |+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 122345677899999999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=345.69 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=211.4
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...+..++|++.+.||+|+||.||++++ +++.||+|++... ..........+.+|+.+++.++||||+++++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF------EMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH------HhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3455667899999999999999999987 5789999998521 1111223355778999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+|||
T Consensus 111 ~~~~~~--------------------~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrD 167 (370)
T cd05621 111 AFQDDK--------------------YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167 (370)
T ss_pred EEEcCC--------------------EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 987543 44889999999999999854 3589999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCC----CCCchhHHHHHHHHHHHHhCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKP----YNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||
T Consensus 168 LKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 99999999999999999999997653322 1233567999999999997543 788999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
...+.......+........+|. .++..+.+++.+||..++.+ |+|+.+++++
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 248 YADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 98888777777766554444554 46899999999999855543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=324.40 Aligned_cols=250 Identities=23% Similarity=0.449 Sum_probs=212.9
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||++.+ +++.||+|.++... .....+.+.+|+.+++.++||||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-
Confidence 578899999999999999977 57899999986321 1122356778999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|++|||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+
T Consensus 72 -------------------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nil 132 (255)
T cd08219 72 -------------------HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132 (255)
T ss_pred -------------------EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 4488999999999999987655567899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||.+..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 133 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 212 (255)
T cd08219 133 LTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212 (255)
T ss_pred ECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence 99999999999999976544333334456889999999999888999999999999999999999999888777766555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.. +.....+..++..+.++|.+||+.||++|||+.+|+..
T Consensus 213 ~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQ-GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hc-CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 43 33445677789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.30 Aligned_cols=245 Identities=22% Similarity=0.390 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||++++ +++.||||+++... .........+..|..+++.+ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----- 69 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL------VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----- 69 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----
Confidence 3689999999999987 57899999996321 11222345677899999998 7999999999987544
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~ 132 (329)
T cd05588 70 ---------------RLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132 (329)
T ss_pred ---------------EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 348899999999999988543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--------hhhH
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--------FADV 315 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--------~~~~ 315 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.... ..+.
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 133 GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred CCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence 99999999998743333333445679999999999999999999999999999999999999996321 1122
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE------MGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt------~~~ll~~ 360 (390)
....... ....+|..++.++.++|.+||+.||.+|+| +.+++++
T Consensus 213 ~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 213 LFQVILE-KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHc-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2222222 234567788999999999999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=326.15 Aligned_cols=262 Identities=23% Similarity=0.457 Sum_probs=214.5
Q ss_pred cccCccccccccccCceEEEEEEE--CCc----eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
..++|++.+.||+|+||.||+|.+ +++ .|++|.+... ........+..|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 346789999999999999999987 444 4777776421 11122345678888999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.. ...++++||+++|+|.+++... ...+++..+..++.||+.||.|||++|++|||
T Consensus 77 ~~~~---------------------~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~d 134 (279)
T cd05111 77 ICPG---------------------ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRN 134 (279)
T ss_pred EECC---------------------CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccc
Confidence 8742 2246899999999999999653 34689999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
|||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 135 lkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 135 LAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999975432221 2223456778999999998899999999999999999998 9999988
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
....... .+...+.++..+..++.++.+++.+||..||++|||+.++++.|..+......+
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 215 MRPHEVP-DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred CCHHHHH-HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 7766544 344556666677788999999999999999999999999999999987655443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=329.47 Aligned_cols=259 Identities=30% Similarity=0.547 Sum_probs=215.5
Q ss_pred cccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
...+|.+.+.||+|+||.||+++. ++..+++|.++.. .......+.+|++++++++||||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---------TLAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---------cHHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 456789999999999999999974 2346888987521 112235678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHHHHHHH
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLS 217 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~ 217 (390)
+++... ...++||||+++++|.+++..+. ...+++..++.++.||+
T Consensus 74 ~~~~~~--------------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 133 (291)
T cd05094 74 GVCGDG--------------------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133 (291)
T ss_pred EEEccC--------------------CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHH
Confidence 998743 33488999999999999996532 23489999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHH
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 295 (390)
.||.|||++||+||||||+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||
T Consensus 134 ~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 213 (291)
T cd05094 134 SGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213 (291)
T ss_pred HHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHH
Confidence 99999999999999999999999999999999999987543221 1122344678899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 296 CLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 296 il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
++|+|++ |..||...+..+....+ ..+..+..+..+|..+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus 214 il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 214 ILWEIFTYGKQPWFQLSNTEVIECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 9999998 99999888777766554 44445556777899999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=324.27 Aligned_cols=252 Identities=33% Similarity=0.684 Sum_probs=216.3
Q ss_pred ccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
|-++..+|++.+.||+|+||.||++..+++.||+|.++... ....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----------TAQAFLEETAVMTKLHHKNLVRLLGVIL 69 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----------hHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 45667889999999999999999999999999999985211 1246788999999999999999999875
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.. ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||
T Consensus 70 ~~---------------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p 128 (254)
T cd05083 70 HN---------------------GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128 (254)
T ss_pred CC---------------------CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCc
Confidence 32 247899999999999999765555689999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
+||+++.++.++|+|||++...... ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 129 ~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 129 RNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ceEEEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 9999999999999999998754321 122344678999999998899999999999999999997 999999888777
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
....+ ..+.++..+..+|.++.+++.+||+.+|.+|||+.+|++.|++
T Consensus 206 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 VKECV-EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHH-hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 66544 4556666677889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=337.65 Aligned_cols=251 Identities=25% Similarity=0.462 Sum_probs=203.4
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+..++|++.+.||+|+||.||++.+ ++..+|+|+++... .......+.+|+++++.++||||+++++++.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 4567899999999999999999988 57789999886321 1123456889999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVK 234 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiHrDlk 234 (390)
+.. ..|+||||+.+|+|.+++.+ ...+++..+..++.+++.||.|||+. +|+|||||
T Consensus 74 ~~~--------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlk 131 (333)
T cd06650 74 SDG--------------------EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 131 (333)
T ss_pred ECC--------------------EEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCC
Confidence 543 44889999999999999964 34689999999999999999999975 79999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.++.+||+|||++...... ......++..|+|||++.+..++.++|+|||||++|+|++|..||......+
T Consensus 132 p~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 132 PSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred hhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 99999999999999999998744322 1233568999999999999889999999999999999999999997654433
Q ss_pred HHHHH-------------------------------------------HHcCCCCCCC-CCCcHHHHHHHHHhhhhCCCC
Q 036382 315 VSSAV-------------------------------------------VRQNLRPEIP-RCCPSSLANIMRKCWDANAEK 350 (390)
Q Consensus 315 ~~~~~-------------------------------------------~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~ 350 (390)
....+ ......+..+ ...+.++.+||.+||+.||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCccc
Confidence 22111 0111111222 235788999999999999999
Q ss_pred CCCHHHHHHH
Q 036382 351 RPEMGEVVKM 360 (390)
Q Consensus 351 Rpt~~~ll~~ 360 (390)
|||+.+++..
T Consensus 290 Rpt~~ell~h 299 (333)
T cd06650 290 RADLKQLMVH 299 (333)
T ss_pred CcCHHHHhhC
Confidence 9999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=325.25 Aligned_cols=252 Identities=29% Similarity=0.564 Sum_probs=211.1
Q ss_pred cccCccccccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+.++|++.+.||+|+||.||.|.+.+ ..+|||.++.... ..+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----------cHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45689999999999999999998855 4699998863211 124578899999999999999999998643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+|
T Consensus 72 ~--------------------~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05113 72 R--------------------PIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130 (256)
T ss_pred C--------------------CcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcce
Confidence 3 3488999999999999996543 368999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~ 315 (390)
||++.++.+||+|||.++....... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+.
T Consensus 131 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred EEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 9999999999999999875433221 1122345678999999998889999999999999999998 9999988777666
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
...+. .+.+...+...+..+.+++.+||..+|.+|||+.+|++.|+
T Consensus 211 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 211 VEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 65554 44555667778999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=326.28 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=217.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc-cceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN-VTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~ 156 (390)
...|+..++||+|+||+||+|+. +|+.||+|.++...+. +.......+|+-+++.|+|+| |+++++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-------EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-------EGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-------cCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 56788889999999999999976 7899999999855432 112244568999999999999 9999999987
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+. ......+++|+||++. +|.+|+..... ..++...+..++.||+.||+|||+++|+|||||
T Consensus 83 ~~~--------------~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLK 147 (323)
T KOG0594|consen 83 SNN--------------HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLK 147 (323)
T ss_pred ccc--------------ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCC
Confidence 653 1134466899999965 99999976543 368889999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|.||||+++|.+||+|||+|+....+....+...+|.+|.|||++.+. .|+..+||||+|||++||++++.-|++.+..
T Consensus 148 PQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 148 PQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred cceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence 999999999999999999999777667778889999999999999876 7999999999999999999999999999887
Q ss_pred hHHHHHHHcC----------------CCCCCC-----CC-------CcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHH
Q 036382 314 DVSSAVVRQN----------------LRPEIP-----RC-------CPSSLANIMRKCWDANAEKRPEMGEVVKM--LEA 363 (390)
Q Consensus 314 ~~~~~~~~~~----------------~~~~~~-----~~-------~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~ 363 (390)
+.+..+...- +...++ .. ..++..+++.+||+.+|.+|.|+...+++ +..
T Consensus 228 ~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 228 DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 7777665321 111111 11 12478899999999999999999999876 544
Q ss_pred h
Q 036382 364 I 364 (390)
Q Consensus 364 ~ 364 (390)
+
T Consensus 308 ~ 308 (323)
T KOG0594|consen 308 L 308 (323)
T ss_pred c
Confidence 4
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=329.49 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=203.2
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|.-.+++|+|+||.||+|.. +++.||||....... .-.+|+++|+.++|||||++.-+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------------~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------------YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------------cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 477788999999999999977 568999998753221 12379999999999999999988864321
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
- ..-...+||||++. +|.++++. +.+.+++.-.+.-++.||++||.|||+.||+||||||.|
T Consensus 92 ~---------------d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqN 155 (364)
T KOG0658|consen 92 S---------------DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQN 155 (364)
T ss_pred C---------------chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChhe
Confidence 1 12345789999986 99999863 235679999999999999999999999999999999999
Q ss_pred EEECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|+|.+ |.+||||||.|+........ .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|++.+..+.
T Consensus 156 lLvD~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ 234 (364)
T KOG0658|consen 156 LLVDPDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ 234 (364)
T ss_pred EEEcCCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH
Confidence 999987 99999999999976654443 44567899999999976 5799999999999999999999999999887776
Q ss_pred HHHHHHcC----------CCC-----------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQN----------LRP-----------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~----------~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+..+++-- ..+ -+....++++.+|+.++|..+|.+|.++.+++.
T Consensus 235 L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 235 LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 66554210 000 023457899999999999999999999999884
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=335.08 Aligned_cols=267 Identities=31% Similarity=0.573 Sum_probs=221.8
Q ss_pred CcccccccCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-C
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D 143 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 143 (390)
.+|++...+|++.+.||+|+||.||++.+. +..||+|+++... .......+.+|+.+++++ +
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~ 76 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--------TDKDLSDLVSEMEMMKMIGK 76 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--------CHHHHHHHHHHHHHHHhhcC
Confidence 579999999999999999999999999752 2368999886211 112245678999999999 8
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHH
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIV 209 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~ 209 (390)
||||+++++++.... ..+++|||+.+|+|.+++.+.. ...+++..+
T Consensus 77 h~~iv~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (334)
T cd05100 77 HKNIINLLGACTQDG--------------------PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136 (334)
T ss_pred CCCeeeeeEEEccCC--------------------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHH
Confidence 999999999987543 3478999999999999996532 234788899
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCc
Q 036382 210 IQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRR 287 (390)
Q Consensus 210 ~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~ 287 (390)
..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.+
T Consensus 137 ~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 216 (334)
T cd05100 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216 (334)
T ss_pred HHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch
Confidence 999999999999999999999999999999999999999999999754332111 122334567999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 288 CDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 288 ~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+|||||||++|||++ |..||...+..+....+ ........+..++.++.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 217 ~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 217 SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 999999999999998 89999988877766555 4455666777889999999999999999999999999999999986
Q ss_pred cCC
Q 036382 367 SKG 369 (390)
Q Consensus 367 ~~~ 369 (390)
...
T Consensus 296 ~~~ 298 (334)
T cd05100 296 VTS 298 (334)
T ss_pred hcC
Confidence 553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=323.67 Aligned_cols=260 Identities=26% Similarity=0.501 Sum_probs=209.3
Q ss_pred ccccccccccCceEEEEEEECC--c--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDN--Q--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
|.+.+.||+|+||.||+|.+.. . .||+|.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 3567899999999999998743 2 689998864311 1122466788999999999999999999875332
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN----RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ......+++|||+.+|+|.+++... ....+++..+..++.|++.||.|||+++|+|||||
T Consensus 74 ~~--------------~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 139 (272)
T cd05075 74 ES--------------EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA 139 (272)
T ss_pred cc--------------cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 11 0123458999999999999988532 23458999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
|+|||++.++.+||+|||++........ ......+++.|++||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 140 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 140 ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred hhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999975433221 1122345678999999999999999999999999999999 899998877
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
..+....+. .+.....+..++..+.++|.+||+.||++|||+.+|++.|+.+
T Consensus 220 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 220 NSEIYDYLR-QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 766665543 4444456678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=322.07 Aligned_cols=254 Identities=28% Similarity=0.501 Sum_probs=214.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|++|.||++.. +++.||+|.++..... .........+.+|++++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS----PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 4688899999999999999976 6789999998643221 112223456889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 78 --------------------~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 78 --------------------TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred --------------------eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 448899999999999998653 4589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....
T Consensus 136 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 136 LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred EEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 9999999999999998754321111 1234578899999999998899999999999999999999999988777666
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.............+..++..+.++|.+||..+|.+|||+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 666666666677888899999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=339.55 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=221.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 156 (390)
...|++.+.||+|.||.||+++. +|+.+|+|+++....... .....+.+|+.+|+++. |||||.++++|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~------~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK------EDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc------ccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 35689999999999999999987 588999999974332211 13467889999999997 9999999999987
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
...+ ++|||++.||.|.+.+.+. .+++..+..++.||+.+++|||+.||+||||||+
T Consensus 108 ~~~~--------------------~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE 164 (382)
T KOG0032|consen 108 PDSV--------------------YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE 164 (382)
T ss_pred CCeE--------------------EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence 6544 7799999999999999765 3999999999999999999999999999999999
Q ss_pred CEEECCC----CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 237 NMLLDSQ----RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 237 NILl~~~----~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+|+... +.+|++|||++..... .......+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.+.+.
T Consensus 165 N~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 165 NLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred HeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 9999644 4799999999987765 6667788999999999999999999999999999999999999999999998
Q ss_pred hhHHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
......+....+.. +....++..+.++|+.||..||..|+|+.+++++
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 88888888776533 3456678999999999999999999999999996
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=336.25 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=203.2
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEeccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTS 158 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 158 (390)
+|++.+.||+|+||.||+|.. +++.||+|+++.. ..........+..|..+++.+. |++|+++++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD------VVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 478889999999999999987 5789999998621 1111223355678888998885 577888988877543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 75 --------------------~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Ni 132 (323)
T cd05615 75 --------------------RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132 (323)
T ss_pred --------------------EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 348899999999999998543 4699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......
T Consensus 133 ll~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 133 MLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred EECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987543333333445689999999999999999999999999999999999999999888777777
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
+.... ...|..++.++.+++.+||+.+|.+|++.
T Consensus 213 i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 66543 35677889999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=339.21 Aligned_cols=239 Identities=25% Similarity=0.387 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHH-HHHhcCCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA-VWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|.+ +++.||+|++.... .........+..|.. +++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----- 69 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA------ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----- 69 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----
Confidence 3689999999999988 67899999986211 111112233444544 567899999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~ 132 (323)
T cd05575 70 ---------------KLYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ 132 (323)
T ss_pred ---------------EEEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 44889999999999999854 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 133 GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred CcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998754333333445679999999999999999999999999999999999999999988877777665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 355 (390)
...+..++.++.++|.+||+.||.+||++.
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 335566799999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=327.44 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=221.0
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.-.+.+++|+++++||+|+||.|.+++. +++.+|+|+++..- .........-..|-++|+..+||.+..+--
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev------iiakdEVAHTlTE~RVL~~~~HPFLt~LKY 235 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV------IIAKDEVAHTLTENRVLQNCRHPFLTSLKY 235 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh------eeehHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence 3456788999999999999999998866 78999999997321 111222344568999999999999998876
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
.|+. +...|+||||..||.|+-+|.+. ..+++...+.+..+|+.||.|||+++||+||
T Consensus 236 sFQt--------------------~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRD 293 (516)
T KOG0690|consen 236 SFQT--------------------QDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRD 293 (516)
T ss_pred hhcc--------------------CceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeee
Confidence 6653 45569999999999999999654 4699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||.+|+|+|.+|++||+|||+++.....+....+.||||.|+|||++....|+.++|+|.+|+++|||+||++||...+.
T Consensus 294 lKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 294 LKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred chhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 99999999999999999999998777777778889999999999999999999999999999999999999999999988
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC--CHHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP--EMGEVVKML 361 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp--t~~~ll~~L 361 (390)
.....-++...+ .+|..++++.+.|+..+|.+||.+|. ...++.+..
T Consensus 374 ~kLFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~ 422 (516)
T KOG0690|consen 374 EKLFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM 422 (516)
T ss_pred hHHHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence 888877776654 48999999999999999999999995 344444443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.81 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=202.7
Q ss_pred CccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
+|++.+.||+|+||.||+++. +++.||+|+++... ........+.+..|+.+++.+ +||||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA-----LVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence 488899999999999999865 57899999986211 112223345678899999999 6999999999887
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... ..++||||+.+|+|.+++.+ +..+++..+..++.||+.||.|||++||+||||||
T Consensus 76 ~~~--------------------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 133 (332)
T cd05614 76 TEA--------------------KLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL 133 (332)
T ss_pred cCC--------------------EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH
Confidence 543 44789999999999999954 34699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC--
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLS-- 311 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~-- 311 (390)
+|||++.++.+||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus 134 ~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred HHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 99999999999999999987543222 222345799999999999875 47889999999999999999999996432
Q ss_pred --hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 312 --FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 312 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
.......+. ...+.++..+++.+.+++.+||+.||++|| ++.+++++
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 214 NTQSEVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 222222322 234567778899999999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=322.33 Aligned_cols=257 Identities=30% Similarity=0.576 Sum_probs=217.4
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
|++..++|++.+.||+|+||.||++.+ .+..+|+|.+.... .....+.+|+++++.++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----------MSVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----------hHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 788999999999999999999999986 45689999886321 1135678899999999999999999987
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ...+++|||+.+++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+
T Consensus 71 ~~---------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (260)
T cd05073 71 TK---------------------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129 (260)
T ss_pred cC---------------------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 53 234889999999999999976555678999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~ 312 (390)
|+||+++.++.+||+|||.+........ ......++..|+|||.+.+..++.++|+|||||++|++++ |..||...+.
T Consensus 130 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred cceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999875432211 1122345677999999998889999999999999999998 9999998877
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
......+ ......+.+...+.++.+++.+||..+|++||++.++++.|+.+
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 210 PEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHH-hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 6666544 45555566778899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=340.66 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=208.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||+|+++.. ..........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS------VLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 3689999999999999999987 6789999999622 1112234566788999999999999999999887543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 75 --------------------NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred --------------------eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 348899999999999999654 34699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|++.++.+||+|||++........ ......+|+.|+|||++. ...++.++|||||||++|+|++|..||...+
T Consensus 134 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred EECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 999999999999999975443221 223346899999999986 4567899999999999999999999998887
Q ss_pred hhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.......+........+| ..+++++.+|+.+||. +|.+|||+.+++++
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 777766665443333333 3578999999999998 99999999999854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=316.57 Aligned_cols=270 Identities=23% Similarity=0.388 Sum_probs=229.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 157 (390)
..|.-.+.||+|..++|-++.. +++.+|+|++........... ....++.-.+|+.||+++ .||+|+++.+++..+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-PYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4677788999999999998855 688999999976554433333 556677788999999998 899999999999866
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..+ ++|+|.|+.|.|+|||.. ...++++....|+.|++.|++|||.++|+||||||+|
T Consensus 96 sF~--------------------FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpEN 153 (411)
T KOG0599|consen 96 AFV--------------------FLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPEN 153 (411)
T ss_pred chh--------------------hhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhh
Confidence 555 669999999999999954 4579999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||++++.++||+|||+|+... .+......||||+|+|||.+. ...|+..+|+|++|+++|.++.|.+||....
T Consensus 154 ILlddn~~i~isDFGFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 154 ILLDDNMNIKISDFGFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred eeeccccceEEeccceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 999999999999999999654 456677899999999999984 3468889999999999999999999998877
Q ss_pred hhhHHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhHhcCCCCCCC
Q 036382 312 FADVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAIDTSKGGGMIP 374 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~~~~~~~~~~ 374 (390)
.--+++.++.+++.. +.....+...++||.+||+.||.+|.|+++++++ +.-+.......|.|
T Consensus 233 QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 233 QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 777777887777554 3446788999999999999999999999999964 44455555666666
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=325.05 Aligned_cols=260 Identities=25% Similarity=0.543 Sum_probs=214.4
Q ss_pred ccccCccccccccccCceEEEEEEE--CCc----eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+..++|++.+.||+|+||.||+|++ +++ .||+|+++... .......+.+|+.+++.++||||++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 3456899999999999999999986 444 48999886321 112235678899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++... ..++++||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||
T Consensus 76 ~~~~~~---------------------~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~ 133 (279)
T cd05109 76 GICLTS---------------------TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133 (279)
T ss_pred EEEcCC---------------------CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 998632 236899999999999998643 3468999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
||||+|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 134 dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999865432221 122345678999999998899999999999999999998 899998
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
......... ....+...+.+..++.++.+++.+||..||++||++.++++.|+++...-
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 214 GIPAREIPD-LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCCHHHHHH-HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 877666554 34455566667788999999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=342.39 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=210.8
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.+.+..++|++.+.||+|+||.||++.+ +++.||+|++... ..........+.+|..+++.++||||+++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~------~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF------EMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH------HhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4566778999999999999999999987 5789999998521 1112223455778999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+|||
T Consensus 111 ~~~~~~--------------------~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (371)
T cd05622 111 AFQDDR--------------------YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (371)
T ss_pred EEEcCC--------------------EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 987543 45889999999999999854 3489999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK----PYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||+|||++.++.+||+|||++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus 168 Lkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 99999999999999999999997653322 123346799999999998654 3788999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEK--RPEMGEVVKML 361 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~L 361 (390)
...+.......+........+| ..++.+++++|.+||..++.+ |+++.+++++.
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 248 YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 9888877777776544333333 368899999999999844433 78999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=321.91 Aligned_cols=247 Identities=28% Similarity=0.581 Sum_probs=206.1
Q ss_pred cccccCceEEEEEEEC----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccC
Q 036382 88 LIAQGTYGSVYRGTYD----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------- 66 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------- 66 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-------
Confidence 4899999999999763 3469999986321 12234568899999999999999999998742
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
...++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.+
T Consensus 67 --------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~ 131 (257)
T cd05115 67 --------------EALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ 131 (257)
T ss_pred --------------CCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC
Confidence 2348999999999999998643 3568999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 036382 244 RTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAV 319 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (390)
+.+||+|||++........ ......++..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+
T Consensus 132 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05115 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211 (257)
T ss_pred CcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 9999999999874432211 1122234578999999988889999999999999999996 99999988877766544
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
..+.++..+..+++++.++|.+||..+|++||++.+|.+.|+.+.
T Consensus 212 -~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 212 -EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 555667788889999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.03 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=197.5
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHH-HHHHhcCCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV-AVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||++++ +++.||+|++... ..........+..|. .+++.++||||+++++++....
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----- 69 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKK------AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----- 69 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH------HHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----
Confidence 3699999999999987 5678999998621 111111122333444 4567889999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~ 132 (325)
T cd05602 70 ---------------KLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 132 (325)
T ss_pred ---------------eEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 44889999999999999954 3468899999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 133 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 133 GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred CCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999998754333333445679999999999999999999999999999999999999999888887776665443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
...+..++..+.+++.+||+.||.+||++.+.
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 213 --LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred --cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 33556789999999999999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=356.66 Aligned_cols=267 Identities=20% Similarity=0.407 Sum_probs=220.2
Q ss_pred CcccccccCccccccccccCceEEEEEEEC-C-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-N-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKF 150 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~ 150 (390)
..++|...++++.+.|.+|||+.||.|++. + ..||+|.+-. ..+.....+.+|+++|++|+ |+|||.+
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---------~de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---------NDEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---------CCHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 456777788999999999999999999883 3 7999998742 13445678899999999995 9999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--I 228 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--i 228 (390)
++...... ......-++.|+||||.||.|-|++.++....|++..+++|+.|+++|+.+||... |
T Consensus 101 idss~~~~-------------~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPi 167 (738)
T KOG1989|consen 101 IDSSAINR-------------SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPI 167 (738)
T ss_pred eccccccc-------------cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence 98422111 01112346789999999999999998766677999999999999999999999998 9
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCCC---------CCCCCCCcccccccc---CCCCCCCchhHHHHHHH
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM---------TGETGTLGYMAPEVL---QGKPYNRRCDVYSFGIC 296 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~i 296 (390)
||||||-+||||+.+|++||||||.|+......... ....-|+.|.|||++ .+.+.+.|+|||+|||+
T Consensus 168 IHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGcl 247 (738)
T KOG1989|consen 168 IHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCL 247 (738)
T ss_pred chhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHH
Confidence 999999999999999999999999997543332111 112368999999987 67889999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 297 l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
||-|+...+||...... +|+..++..+.....+..|.+||+.||+.||.+||++-||+..+-++..
T Consensus 248 LYkLCy~t~PFe~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 248 LYKLCYFTTPFEESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHHHHHhCCCcCcCcce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 99999999999765322 3556666665556789999999999999999999999999999988864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.46 Aligned_cols=260 Identities=28% Similarity=0.551 Sum_probs=213.5
Q ss_pred ccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
|++.+.||+|+||.||+|... +..||||.++.... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence 567889999999999999762 36799999863211 112235678999999999999999999987654
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
.... .....+++|||+++|+|..++.... ...+++..+..++.|++.||.|||+.+++||||
T Consensus 74 ~~~~--------------~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 139 (273)
T cd05035 74 SSLQ--------------KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDL 139 (273)
T ss_pred Cccc--------------cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 3321 1234589999999999999985432 246899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
||+||++++++.+||+|||+++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 140 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 140 AARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred chheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865432211 112235678999999988899999999999999999999 89999888
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
...+....+. .+.....+..++.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 220 ENHEIYDYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CHHHHHHHHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8777665554 4445667888999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.00 Aligned_cols=251 Identities=20% Similarity=0.344 Sum_probs=206.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||||+++.. ..........+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA------DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH------HHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4689999999999999999987 5789999998621 1122334567788999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++|+|.+++.+ ...+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI 132 (360)
T cd05627 75 --------------------NLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132 (360)
T ss_pred --------------------EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 44889999999999999954 34699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC-----------------------------------CCCCCCCCCCccccccccCCCC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP-----------------------------------RDMTGETGTLGYMAPEVLQGKP 283 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~ 283 (390)
|++.++.++|+|||++....... ......+||+.|+|||++.+..
T Consensus 133 li~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 212 (360)
T cd05627 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 212 (360)
T ss_pred EECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC
Confidence 99999999999999986432110 0012346999999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHH
Q 036382 284 YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAEKRPE---MGEVV 358 (390)
Q Consensus 284 ~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt---~~~ll 358 (390)
++.++|||||||++|||++|..||...+..+....+........+|. .+++++.++|.+++ .||.+|++ +.+++
T Consensus 213 ~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 99999999999999999999999999888887777664333333443 36889999999977 49999985 66666
Q ss_pred HH
Q 036382 359 KM 360 (390)
Q Consensus 359 ~~ 360 (390)
++
T Consensus 292 ~h 293 (360)
T cd05627 292 SH 293 (360)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=325.61 Aligned_cols=263 Identities=26% Similarity=0.494 Sum_probs=218.0
Q ss_pred cccccCccccccccccCceEEEEEEEC------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
.++.++|++.+.||+|+||.||+|.+. +..|++|.+.... .......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~ 73 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--------SEIQVTLLLQESCLLYGLSHQNILPI 73 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--------CHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 356788999999999999999999874 4789999875211 12234667889999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR------KKLALKIVIQLALDLSRGLSYLH 224 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~yLH 224 (390)
++++... ....+++++|+.+++|.+++..... ..+++..++.++.|++.||.|||
T Consensus 74 ~~~~~~~-------------------~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 134 (280)
T cd05043 74 LHVCIED-------------------GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134 (280)
T ss_pred EEEEecC-------------------CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9987643 2334789999999999999965422 45899999999999999999999
Q ss_pred hCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 036382 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 225 ~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 302 (390)
+.+++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++||+++
T Consensus 135 ~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~ 214 (280)
T cd05043 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214 (280)
T ss_pred HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhc
Confidence 99999999999999999999999999999975432211 1122345678999999998889999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 303 -CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 303 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|..||...+..+.... .....+...+..+|+++.+++.+||..||++|||+.++++.|+++.+.
T Consensus 215 ~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 215 LGQTPYVEIDPFEMAAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCcCcCCHHHHHHH-HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 9999988776665443 345566666777899999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=325.87 Aligned_cols=256 Identities=28% Similarity=0.523 Sum_probs=211.6
Q ss_pred ccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
++..+|++.++||+|+||.||++.. ++..+|+|.+... .......+.+|+++++.++||||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---------SESARQDFQREAELLTVLQHQHIVRF 72 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---------CHHHHHHHHHHHHHHhcCCCCCCceE
Confidence 3456889999999999999999863 3458899987521 11224578899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-------------CCCCHHHHHHHHHHHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-------------KKLALKIVIQLALDLS 217 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~ 217 (390)
++++.+.. ..+++|||+.+++|.+++.+... ..+++..+..++.|++
T Consensus 73 ~~~~~~~~--------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 132 (280)
T cd05092 73 YGVCTEGR--------------------PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132 (280)
T ss_pred EEEEecCC--------------------ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHH
Confidence 99987543 34889999999999999965421 3588999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHH
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 295 (390)
.||+|||+.|++||||||+|||++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+|||||
T Consensus 133 ~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred HHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 99999999999999999999999999999999999987543221 1112233567899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 296 CLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 296 il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
++|+|++ |..||......+....+. .+.....+..+|+.+.+|+.+||+.||.+||++.+|++.|++
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 9999998 999998877777665554 334456677899999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=319.87 Aligned_cols=246 Identities=31% Similarity=0.606 Sum_probs=203.8
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
+.||+|+||.||+|++ +++.||+|.+.... .......+.+|++++++++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 66 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ------ 66 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC------
Confidence 3689999999999987 68899999875211 1223456789999999999999999999987543
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~ 244 (390)
..++||||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.|++||||||+|||++.++
T Consensus 67 --------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~ 131 (252)
T cd05084 67 --------------PIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN 131 (252)
T ss_pred --------------CeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC
Confidence 348899999999999998643 34689999999999999999999999999999999999999999
Q ss_pred cEEEeecccceeccCCCCCC--CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHH
Q 036382 245 TLKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVR 321 (390)
Q Consensus 245 ~~kL~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~ 321 (390)
.+||+|||++.......... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+ .
T Consensus 132 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-~ 210 (252)
T cd05084 132 VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-E 210 (252)
T ss_pred cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-H
Confidence 99999999987533221111 11123457999999999899999999999999999998 89999887766655444 3
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 322 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
...+...+..+|..+.+++.+||..+|++|||+.+|++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 45566678888999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=330.55 Aligned_cols=263 Identities=28% Similarity=0.541 Sum_probs=213.8
Q ss_pred ccccCccccccccccCceEEEEEEE--CCc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
+..++|++.+.||+|+||.||+|.+ ++. .+|+|.++... .......+.+|++++.++ +||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~ 75 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLG 75 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--------CHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence 3456899999999999999999986 344 45666654211 112345678899999999 8999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHHHHHHHH
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSR 218 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~ 218 (390)
++.+.. ..|+||||+++++|.+++.+.. ...+++..++.++.|++.
T Consensus 76 ~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 135 (303)
T cd05088 76 ACEHRG--------------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 135 (303)
T ss_pred EECCCC--------------------CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHH
Confidence 987543 3478999999999999996532 235789999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHH
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 298 (390)
||+|||++|++||||||+|||++.++.+||+|||++...... ........+..|+|||.+.+..++.++|||||||++|
T Consensus 136 al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 136 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 999999999999999999999999999999999998632211 1111223467899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 299 EIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 299 ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
+|++ |..||...+..+....+ ........+..+++++.+|+.+||+.+|++||++.++++.|+.+...+..
T Consensus 215 ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 215 EIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHHhcCCCCcccCChHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 9998 99999887776665544 44555666777899999999999999999999999999999988665543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=323.90 Aligned_cols=256 Identities=28% Similarity=0.598 Sum_probs=213.0
Q ss_pred cccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+..+|++.+.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4568999999999999999999762 23799998863211 1224577889999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.... ..|+||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.|++||||
T Consensus 74 ~~~~~--------------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dl 132 (267)
T cd05066 74 VTKSK--------------------PVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 132 (267)
T ss_pred EecCC--------------------ccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhh
Confidence 86443 348899999999999999654 346899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
||+|||++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||..
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred chhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 999999999999999999998754432211 112233568999999998889999999999999999886 9999988
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.+..+....+. ...+.+.+..+|+++.+++.+||+.+|.+||++.++++.|+++
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 213 MSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 87776665553 4456666777899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.21 Aligned_cols=258 Identities=24% Similarity=0.470 Sum_probs=213.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.. +++.||+|.++.... ........+.+|++++++++|+||+++++++.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM------MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc------cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 5799999999999999999987 588999998863221 11123466889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..++||||+++++|.+++... ....+++..+..++.+++.||.|||+.|++|+||+|+
T Consensus 76 --------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 135 (267)
T cd08224 76 --------------------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135 (267)
T ss_pred --------------------eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence 347899999999999998642 2355899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--FAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~~~ 314 (390)
||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+
T Consensus 136 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08224 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred hEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH
Confidence 999999999999999998755443333344568889999999998889999999999999999999999996543 233
Q ss_pred HHHHHHHcCCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 315 VSSAVVRQNLRPEIPR-CCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
....+. .+..++.|. .++..+.++|.+||..+|.+|||+.+|++.|+.++
T Consensus 216 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 LCKKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHhhhh-cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 333332 233344444 78889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=341.26 Aligned_cols=262 Identities=29% Similarity=0.539 Sum_probs=221.5
Q ss_pred cccccccCccccccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
-.+++.+.+.+.++||+|.||.|+++...+ ..||||+++. ......+..|.+|+++|.+|+||||++++|+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~--------~a~~~~r~~F~kEIkiLsqLkhPNIveLvGV 603 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRP--------DATKNARNDFLKEIKILSRLKHPNIVELLGV 603 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCc--------ccchhHHHHHHHHHHHHhccCCCCeeEEEee
Confidence 346778889999999999999999998876 8999999973 2334446889999999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
|..++. +|+|+||+++|+|.+++.++......-.....|+.||+.||+||.+.++|||||
T Consensus 604 C~~DeP--------------------icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~ 663 (807)
T KOG1094|consen 604 CVQDDP--------------------LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDL 663 (807)
T ss_pred eecCCc--------------------hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccc
Confidence 986554 488999999999999998775444566778889999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCC-C-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHH--hCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNP-R-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY--CCDMPYPD 309 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~-~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--~g~~Pf~~ 309 (390)
.++|+|++.++++||+|||+++..-... . ......-+++|||||.+..++++.++|+|+||+++||++ |...||..
T Consensus 664 a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 664 ATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred cccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 9999999999999999999998432221 1 112234678999999999999999999999999999987 47889999
Q ss_pred CChhhHHHHHHH---cC---CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 310 LSFADVSSAVVR---QN---LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 310 ~~~~~~~~~~~~---~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.+.+++...... .+ ..+..|..||..+.++|.+||..|-++||+|++|...|++.
T Consensus 744 lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 744 LTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 988887755431 11 12346788999999999999999999999999999998865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.56 Aligned_cols=255 Identities=28% Similarity=0.545 Sum_probs=222.7
Q ss_pred cccccCccccccccccCceEEEEEEEC---C--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD---N--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
-|..+++++.++||+|+||+|++|.|+ | -.||||+++...... ....|.+|+.+|.+|+|||++++|
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--------~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--------IMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--------hHHHHHHHHHHHHhccCcceeEEe
Confidence 356678899999999999999999984 3 379999998544321 357899999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
|+..+ ....+|+|.++.|+|.+.|.+.....|....+..|+.||+.||.||.++++|||
T Consensus 178 GvVl~---------------------qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHR 236 (1039)
T KOG0199|consen 178 GVVLD---------------------QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHR 236 (1039)
T ss_pred eeecc---------------------chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 99864 344689999999999999987667789999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCC--CC-CCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MT-GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPY 307 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf 307 (390)
||..+|+|+-....+||+|||+.+........ +. .......|+|||.++...|+.++|+|+|||++|||++ |..||
T Consensus 237 DLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 237 DLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred hhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 99999999999999999999999865543222 21 1235678999999999999999999999999999998 78999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
.+.....++..+. .+-+.+.|+.||.+++++|.+||..+|.+||||..|.+.+
T Consensus 317 ~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 317 VGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999998876 7778889999999999999999999999999999997433
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.09 Aligned_cols=254 Identities=27% Similarity=0.517 Sum_probs=204.6
Q ss_pred ccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 83 LDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
|++.+.||+|+||+||++.+ ++..||+|+++.... ......+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--------QQNTSGWKKEINILKTLYHENIVKYKGCCSE 77 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 48889999999999988653 467899999863211 1223567789999999999999999998764
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ....+++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 78 ~~------------------~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~ 136 (283)
T cd05080 78 QG------------------GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAAR 136 (283)
T ss_pred CC------------------CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChh
Confidence 32 2335899999999999999854 35999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 137 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 216 (283)
T cd05080 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216 (283)
T ss_pred eEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence 999999999999999998754332211 11234566799999999888999999999999999999999998653211
Q ss_pred --------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 314 --------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 314 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
.............+.+..+|.++.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111122233444557778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=336.93 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||++.+ +++.||+|+++... .........+.+|+.++.++ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----- 69 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL------VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----- 69 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH------hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----
Confidence 3699999999999987 56799999996321 11122345577888888877 8999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~ 132 (329)
T cd05618 70 ---------------RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132 (329)
T ss_pred ---------------EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 448899999999999988543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------Chhh-
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL--------SFAD- 314 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~--------~~~~- 314 (390)
+.+||+|||+++.............||+.|+|||++.+..++.++|+|||||++|+|++|..||... ...+
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05618 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212 (329)
T ss_pred CCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH
Confidence 9999999999875333333334467899999999999999999999999999999999999999531 1111
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE------MGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt------~~~ll~~ 360 (390)
....+. .....+|..++..+.++|.+||+.||++||| +.+++++
T Consensus 213 ~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 213 LFQVIL--EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHh--cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 222222 2244578888999999999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=323.15 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=209.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 157 (390)
+.|++.+.||+|+||.||+|.. +++.||+|++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 4688899999999999999987 578999999863221 124567899999998 799999999998753
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... .....+|++|||+.+++|.+++.......+++..+..++.|++.||.|||+++|+|+||+|+|
T Consensus 76 ~~~--------------~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~n 141 (272)
T cd06637 76 NPP--------------GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141 (272)
T ss_pred CCC--------------CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 211 123457899999999999999976555678999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+++.++.++|+|||++..............++..|+|||++. +..++.++|+|||||++|+|++|..||...+.
T Consensus 142 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~ 221 (272)
T cd06637 142 VLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221 (272)
T ss_pred EEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9999999999999999976543333344467899999999986 34688899999999999999999999987766
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
............+...+..++.++.+||.+||..+|.+|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 55554444444444445668899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.02 Aligned_cols=259 Identities=30% Similarity=0.544 Sum_probs=213.0
Q ss_pred cCccccccccccCceEEEEEEEC--Cc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD--NQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
++|++.+.||+|+||.||+|... +. .+++|.++... .......+.+|+.+++++ +||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--------SENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 57999999999999999999763 32 47888875211 111235678899999999 7999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHHHHHHHHHHH
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLS 221 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~ 221 (390)
... ..|++|||+++++|.+++.+.. ...+++..++.++.|++.||+
T Consensus 74 ~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~ 133 (297)
T cd05089 74 NRG--------------------YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQ 133 (297)
T ss_pred cCC--------------------cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHH
Confidence 543 3478999999999999996532 134889999999999999999
Q ss_pred HHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHH
Q 036382 222 YLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 222 yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 301 (390)
|||++||+||||||+|||++.++.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||+
T Consensus 134 ~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 134 YLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred HHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999986432211 111123356799999999888999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 302 C-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 302 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+ |..||...+..+....+. .+..+..+..++.++.+|+.+||..+|.+|||+.++++.|+.+.....
T Consensus 213 t~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 7 999999888877766553 455666778899999999999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=345.30 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=202.9
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
...+|++.+.||+|+||.||+|.. +++.||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 346799999999999999999987 67899999875211 123479999999999999999998754
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.... ........++||||+++ +|.+++.. .....+++..++.++.||+.||.|||++||+|||||
T Consensus 131 ~~~~------------~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLK 197 (440)
T PTZ00036 131 ECFK------------KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197 (440)
T ss_pred cccc------------cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcC
Confidence 3210 00112345789999975 78777753 234579999999999999999999999999999999
Q ss_pred CCCEEECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 235 TENMLLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+|||++.++ .+||+|||+|+..... .......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.
T Consensus 198 p~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 198 PQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred HHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999998765 7999999999854332 223345789999999998764 689999999999999999999999988776
Q ss_pred hhHHHHHHHcC---------------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHH
Q 036382 313 ADVSSAVVRQN---------------------------LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK--MLEA 363 (390)
Q Consensus 313 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~ 363 (390)
.+.+..+.... +...+|...|+++.+||.+||..||.+|||+.++++ .++.
T Consensus 277 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 277 VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 65554443210 011134457889999999999999999999999994 4555
Q ss_pred hH
Q 036382 364 ID 365 (390)
Q Consensus 364 ~~ 365 (390)
+.
T Consensus 357 ~~ 358 (440)
T PTZ00036 357 LR 358 (440)
T ss_pred hh
Confidence 44
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.46 Aligned_cols=240 Identities=25% Similarity=0.374 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHH-HHHhcCCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA-VWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||+|.. +|+.||+|++.... .........+..|.. +++.++||||+++++++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----- 69 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI------VLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----- 69 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----
Confidence 4689999999999987 67899999986211 111122234445554 567789999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~ 132 (325)
T cd05604 70 ---------------KLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ 132 (325)
T ss_pred ---------------EEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 44789999999999998854 3569999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 133 GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred CCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998754333333445679999999999999999999999999999999999999999888887777665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
...+...+.++.++|.+||..+|.+||++.+
T Consensus 213 --~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 --LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2344567899999999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.35 Aligned_cols=256 Identities=30% Similarity=0.554 Sum_probs=212.1
Q ss_pred CccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
+|++.+.||+|+||.||+|.... ..+|+|.+..... ......+.+|+.+++.++||||+++++.+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--------SSELRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--------HHHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 47888999999999999997632 4689998863211 11235678999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----------------------cCCCCHHHHHHH
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----------------------RKKLALKIVIQL 212 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i 212 (390)
.... ..++++||+.+++|.+++.... ...+++..++.+
T Consensus 73 ~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 132 (290)
T cd05045 73 SQDG--------------------PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132 (290)
T ss_pred ecCC--------------------CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHH
Confidence 7543 3478999999999999986421 134789999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhH
Q 036382 213 ALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDV 290 (390)
Q Consensus 213 ~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di 290 (390)
+.|++.||.|||+.+++||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||
T Consensus 133 ~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 212 (290)
T cd05045 133 AWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212 (290)
T ss_pred HHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHH
Confidence 99999999999999999999999999999999999999999875432211 1222345678999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 291 YSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 291 wSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
||||+++|+|++ |..||.+....+... ..........+..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 213 ~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 213 WSFGVLLWEIVTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 999999999998 999998887766554 445556667788899999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=325.17 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=203.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|+. +++.||+|+++.... .....+.+|+.++++++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---------DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---------chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 45799999999999999999987 678999999863211 1123567899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.||+||||+|+|
T Consensus 79 ~--------------------~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~n 136 (267)
T cd06646 79 E--------------------KLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGAN 136 (267)
T ss_pred C--------------------EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 3 34789999999999999854 3468999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+++.++.++|+|||++..............++..|+|||.+. ...++.++|+|||||++|+|++|..||......+
T Consensus 137 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 137 ILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred EEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 9999999999999999986543322233456889999999884 3457889999999999999999999997665444
Q ss_pred HHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 315 VSSAVVRQNLRPEI---PRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 315 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
....+....+.+.. +..++.++.++|++||..+|++|||++++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 33332222222222 234678999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=325.51 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=195.8
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||+|+||.||++.. +|+.||+|.+.... .........+..|++++++++||||+++++++.+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-------- 66 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR------LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-------- 66 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHH------hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--------
Confidence 69999999999976 58899999985211 111112234567999999999999999999987543
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.+
T Consensus 67 ------------~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 134 (277)
T cd05607 67 ------------HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC 134 (277)
T ss_pred ------------eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCE
Confidence 44889999999999998866555568999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hhHHHHHHHc
Q 036382 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF----ADVSSAVVRQ 322 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~----~~~~~~~~~~ 322 (390)
+|+|||++...... .......++..|+|||++.+..++.++|+|||||++|+|++|..||..... .+........
T Consensus 135 ~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 213 (277)
T cd05607 135 RLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED 213 (277)
T ss_pred EEeeceeeeecCCC-ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc
Confidence 99999998754332 223345689999999999998899999999999999999999999976432 2222222222
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 323 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
.. ......+++++.+||.+||+.||++||++.++++.+
T Consensus 214 ~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 214 EV-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cc-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 21 112245789999999999999999999997765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=334.46 Aligned_cols=239 Identities=24% Similarity=0.385 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHH-HHHHhcCCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV-AVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
++||+|+||.||+|++ +++.||+|++... ..........+..|. .+++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----- 69 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKK------TILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----- 69 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH------HHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----
Confidence 3699999999999987 5789999998621 111122233444554 4678899999999999887543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 132 (321)
T cd05603 70 ---------------KLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ 132 (321)
T ss_pred ---------------EEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 44889999999999998854 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~- 211 (321)
T cd05603 133 GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK- 211 (321)
T ss_pred CCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999999875333333334467899999999999999999999999999999999999999988877776666543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 355 (390)
....|...+.++.+++.+||+.||.+||++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3456677889999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.22 Aligned_cols=254 Identities=26% Similarity=0.328 Sum_probs=200.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 46899999999999999999977 578999999863211 112235567899999999999999999998654
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..+. .....|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 93 ~~~~--------------~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 153 (359)
T cd07876 93 KSLE--------------EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153 (359)
T ss_pred CCcc--------------ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3221 22346899999975 6776663 248899999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 154 Il~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 154 IVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred EEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999753322 22334578999999999999999999999999999999999999998766544332
Q ss_pred HHHHcCC--------------------CC--------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNL--------------------RP--------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~--------------------~~--------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+..... .+ ......++++++||.+||..||++|||+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 2211100 00 0112245789999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+++
T Consensus 313 l~h 315 (359)
T cd07876 313 LRH 315 (359)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=323.13 Aligned_cols=255 Identities=30% Similarity=0.572 Sum_probs=208.9
Q ss_pred cccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..++|++.+.||+|+||.||+|.+. +..||+|.++... .......+.+|+.+++.++|+||++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4467999999999999999999874 3678899875221 111235678899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-----KKLALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
+++.+.. ..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++
T Consensus 76 ~~~~~~~--------------------~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 135 (277)
T cd05036 76 GVSFERL--------------------PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135 (277)
T ss_pred EEEccCC--------------------CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9887543 33789999999999999965431 2589999999999999999999999
Q ss_pred CCcccCCCCCCEEECCCC---cEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHH
Q 036382 227 KIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~---~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 301 (390)
+++||||||+|||++.++ .+||+|||+++....... .......+..|+|||++.+..++.++|||||||++|+|+
T Consensus 136 ~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 999999999999998754 699999999975422111 111223356899999999889999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 302 C-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 302 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
+ |..||...+..+....+ ....+...|..+|..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 216 ~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFV-TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 7 99999988777765544 444556677889999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=332.95 Aligned_cols=239 Identities=23% Similarity=0.393 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||+|+||.||++.. +++.||+|+++.. ..........+.+|+.++.++ +||||+++++++.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----- 69 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE------LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----- 69 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----
Confidence 3699999999999987 5689999999621 112223345678899999888 7999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~ 132 (327)
T cd05617 70 ---------------RLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132 (327)
T ss_pred ---------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC
Confidence 348899999999999988543 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------ChhhHHH
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL------SFADVSS 317 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~------~~~~~~~ 317 (390)
+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred CCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH
Confidence 9999999999875333333344567999999999999999999999999999999999999999532 2222222
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
..... .....|..++..+.+++.+||..||++|+++
T Consensus 213 ~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 213 QVILE-KPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22222 2345777889999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.15 Aligned_cols=244 Identities=23% Similarity=0.430 Sum_probs=194.4
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+...+|++.+.||+|+||.||++.+ +++.||+|... ...+.+|++++++++||||+++++++.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------------~~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------------RGGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------------hhhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 4556899999999999999999987 57899999653 133568999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... ..|+|||++. ++|..++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 154 ~~~--------------------~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP 210 (391)
T PHA03212 154 YNK--------------------FTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210 (391)
T ss_pred ECC--------------------eeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 543 3478999995 6899888543 4689999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCC-CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--- 311 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--- 311 (390)
+|||++.++.+||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 211 ~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 211 ENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred HhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 9999999999999999999743221 122334679999999999999999999999999999999999998864321
Q ss_pred ----hhhHHHHHHH--------------------------cCCC-C-CCC-----CCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 312 ----FADVSSAVVR--------------------------QNLR-P-EIP-----RCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 312 ----~~~~~~~~~~--------------------------~~~~-~-~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
....+..+.. .... + ..+ ..+|.++.+||.+||+.||++|||+
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 1111111110 0000 0 000 1246789999999999999999999
Q ss_pred HHHHH
Q 036382 355 GEVVK 359 (390)
Q Consensus 355 ~~ll~ 359 (390)
.++++
T Consensus 371 ~elL~ 375 (391)
T PHA03212 371 EALLD 375 (391)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=319.27 Aligned_cols=259 Identities=32% Similarity=0.598 Sum_probs=215.1
Q ss_pred cccccCccccccccccCceEEEEEEECC-----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+++.++|++.+.||+|+||.||+|.+.. ..||||....... ....+.+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~ 73 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--------PSVREKFLQEAYIMRQFDHPHIVKLI 73 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCchhcee
Confidence 4566789999999999999999998632 3689998763211 22345788999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+ ...++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+.|++|+
T Consensus 74 ~~~~~---------------------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~ 131 (270)
T cd05056 74 GVITE---------------------NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHR 131 (270)
T ss_pred EEEcC---------------------CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 98753 22478999999999999996543 358999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
||||+|||++.++.++|+|||++........ ......++..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999875433211 1112234568999999988889999999999999999986 9999988
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.+..+....+ ..+.+...+..+|.++.++|.+||..+|.+|||+.++++.|+.+..
T Consensus 212 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 212 VKNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 8877766554 3445556778899999999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=319.57 Aligned_cols=257 Identities=28% Similarity=0.592 Sum_probs=212.7
Q ss_pred ccccCccccccccccCceEEEEEEEC--C---ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD--N---QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
|..++|+..+.||+|+||.||+|... + ..+|+|.++... .......+.+|++++++++||||+++++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--------TEKQRQDFLSEASIMGQFSHHNIIRLEG 73 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--------CHHHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence 45568999999999999999999863 3 379999886321 1122356789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..++||||+.+++|.+++..+ ...+++..+..++.|++.||.|||+.|++|+|
T Consensus 74 ~~~~~~--------------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 132 (268)
T cd05063 74 VVTKFK--------------------PAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRD 132 (268)
T ss_pred EEccCC--------------------CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 987543 347899999999999998653 35689999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCC---CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDM---TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
|||+||+++.++.++|+|||++.......... .....+..|+|||.+.+..++.++|+|||||++|||++ |..||.
T Consensus 133 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987543322111 11223457999999998889999999999999999997 999998
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
..+..+....+. .....+.+..++.++.+++.+||..+|.+||++.+|++.|+++
T Consensus 213 ~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 213 DMSNHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred cCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 887777666654 3445556667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=317.95 Aligned_cols=255 Identities=28% Similarity=0.543 Sum_probs=212.1
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|.+...||.|+||.||+|.+ +++.||+|.+.................+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 367788999999999999976 56899999887544333323334445578889999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 80 -------------------~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil 138 (267)
T cd06628 80 -------------------HLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138 (267)
T ss_pred -------------------ccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE
Confidence 347899999999999999553 46899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCC------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 240 LDSQRTLKIADFGVARVEAQNP------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred EcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 9999999999999987543211 1112245788999999999888999999999999999999999999887665
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.....+. ....+..+..++..+.++|.+||+.||.+||++.++++
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 5544433 34566778889999999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=316.95 Aligned_cols=247 Identities=32% Similarity=0.571 Sum_probs=206.0
Q ss_pred ccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
++||+|+||.||+|.+. +..||+|.++.... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 67 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--------AAGKKEFLREASVMAQLDHPCIVRLIGVCKG----- 67 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----
Confidence 47999999999999762 25799999863221 1234567889999999999999999998642
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
...++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||..+++|+||||+|||++
T Consensus 68 ----------------~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~ 129 (257)
T cd05060 68 ----------------EPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129 (257)
T ss_pred ----------------CceEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc
Confidence 2347899999999999999654 3689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCC---CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 036382 242 SQRTLKIADFGVARVEAQNPRDM---TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSS 317 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (390)
.++.+||+|||+++......... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+...
T Consensus 130 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05060 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209 (257)
T ss_pred CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 99999999999997553322211 11223567999999998899999999999999999998 999998887766655
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
.+ ........+..++..+.++|.+||..+|++|||+.+|++.|+++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 210 ML-ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HH-HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 54 445556677889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.13 Aligned_cols=252 Identities=25% Similarity=0.479 Sum_probs=211.6
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|++.+.||+|+||.||++.. +++.||+|.+.... ......+.+.+|++++++++|||++++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-- 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC--
Confidence 488999999999999999977 56789999986321 1122345678899999999999999999876432
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
....|++|||+++++|.+++.......+++..++.++.+++.||.|||+.|++|+||+|+||+
T Consensus 72 -----------------~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil 134 (257)
T cd08223 72 -----------------DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134 (257)
T ss_pred -----------------CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEE
Confidence 223589999999999999997655567999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+
T Consensus 135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred EecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999976544333334456889999999999999999999999999999999999999887776665555
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.. +..+..+...++++.+++.+||+.||++|||+.+++.+
T Consensus 215 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 215 IE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred Hh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 43 33445667789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.10 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=205.9
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|+..+.||+|+||.||+|.+ +++.||+|++... ..........+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--- 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK------RIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--- 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehh------hhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC---
Confidence 67778999999999999987 5789999998521 111222235567899999999999999999988644
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 73 -----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili 135 (285)
T cd05632 73 -----------------DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL 135 (285)
T ss_pred -----------------CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 345889999999999998866555579999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (390)
+.++.++|+|||++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~ 214 (285)
T cd05632 136 DDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214 (285)
T ss_pred CCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999998754322 22234578999999999998899999999999999999999999998766544333332
Q ss_pred H--cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 321 R--QNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 321 ~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
. .......+..++.++.+|+.+||..||++||| +.+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 RRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 2 12233456678899999999999999999999 7787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=323.47 Aligned_cols=257 Identities=29% Similarity=0.555 Sum_probs=212.1
Q ss_pred ccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
++.++|++.+.||+|+||.||++.+ ++..||+|+++... .......+.+|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~ei~~l~~l~h~~iv~~ 73 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDHPNIVKL 73 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--------CHHHHHHHHHHHHHHHhcCCCchheE
Confidence 4567899999999999999999976 35789999986321 11223568889999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------------cCCCCHHHHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------------RKKLALKIVI 210 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~ 210 (390)
++++.+.. ..|+||||+.+|+|.+++.... ...+++..++
T Consensus 74 ~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 133 (288)
T cd05050 74 LGVCAVGK--------------------PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133 (288)
T ss_pred EEEEcCCC--------------------ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHH
Confidence 99987543 3488999999999999996432 1247888999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCch
Q 036382 211 QLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRC 288 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 288 (390)
.++.|++.||.|||+++++||||||+|||++.++.++|+|||++....... ........+..|+|||.+.+..++.++
T Consensus 134 ~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (288)
T cd05050 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES 213 (288)
T ss_pred HHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchh
Confidence 999999999999999999999999999999999999999999987432211 111223356779999999988999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 289 DVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 289 DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
|+|||||++|+|++ |..||.+....+....+.... ....+..+|.++.+||.+||+.+|.+|||+.+|++.|++
T Consensus 214 Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 99999999999997 888998888877776654333 334567789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=320.22 Aligned_cols=256 Identities=30% Similarity=0.609 Sum_probs=212.1
Q ss_pred cccCccccccccccCceEEEEEEEC--C---ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD--N---QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+..+|++.+.||+|+||.||+|... + ..||||+++... .......|..|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 73 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--------TEKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 4567899999999999999999873 3 369999986321 12234678899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+. ...++||||+.+++|.+++... ...+++..++.++.|++.||.|||++|++|+||
T Consensus 74 ~~~~--------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl 132 (269)
T cd05065 74 VTKS--------------------RPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132 (269)
T ss_pred ECCC--------------------CceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 8644 3447899999999999998654 346899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCC--CCC---CCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRD--MTG---ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPY 307 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf 307 (390)
||+||+++.++.++|+|||++......... ... ...+..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 999999999999999999998754322111 111 112457999999999999999999999999999886 99999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
...+..+....+ ....+.+.+..+|..+.+++.+||..+|.+||++.+|++.|+++
T Consensus 213 ~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 213 WDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 888777766655 44556666778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=316.28 Aligned_cols=247 Identities=37% Similarity=0.701 Sum_probs=211.2
Q ss_pred ccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
+.||+|+||.||+|... +..||+|+++.... ......+.+|+++++.++|+||+++++++.+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 68 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE---- 68 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--------hhHHHHHHHHHHHHhhcCCCChheeeeeecCC----
Confidence 46999999999999874 77999999873321 11346788999999999999999999998753
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
...++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+
T Consensus 69 ----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 132 (262)
T cd00192 69 ----------------EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132 (262)
T ss_pred ----------------CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccC
Confidence 34488999999999999996542 3679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+
T Consensus 133 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 133 ARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred cceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999998654332 22334567889999999988889999999999999999999 699999988
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
..+....+.. +.+...+..+|.++.+++.+||..+|.+|||+.++++.|+
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 213 NEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7777766643 5566778888999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=324.26 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=204.5
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||+|+||.||++.+ +++.||||.+.... .........+.+|+.+++.++|+||+++++.+.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR------IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh------ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-
Confidence 367788999999999999987 57899999885321 111222345678999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus 74 -------------------~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil 134 (285)
T cd05630 74 -------------------ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134 (285)
T ss_pred -------------------EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEE
Confidence 4488999999999999986655556999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh---hHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA---DVS 316 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---~~~ 316 (390)
++.++.++|+|||++...... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... +..
T Consensus 135 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~ 213 (285)
T cd05630 135 LDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213 (285)
T ss_pred ECCCCCEEEeeccceeecCCC-ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 999999999999998754322 2223457899999999999999999999999999999999999999765322 222
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVK 359 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~ 359 (390)
.... .......+..+++++.+|+.+||+.||++||| +.++++
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 214 ERLV-KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Hhhh-hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2221 22233456778999999999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=323.11 Aligned_cols=256 Identities=29% Similarity=0.533 Sum_probs=208.4
Q ss_pred cccCccccccccccCceEEEEEEECC------------------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHH
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYDN------------------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 140 (390)
...+|++.+.||+|+||.||++.+.+ ..||+|.+..... ......+.+|+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~ 74 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--------DNAREDFLKEVKILS 74 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--------HHHHHHHHHHHHHHH
Confidence 45689999999999999999987632 4589998863211 133467889999999
Q ss_pred hcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---------cCCCCHHHHHH
Q 036382 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---------RKKLALKIVIQ 211 (390)
Q Consensus 141 ~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~ 211 (390)
+++||||+++++++.... ..+++|||+.+++|.+++.+.. ...+++..++.
T Consensus 75 ~l~~~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (296)
T cd05051 75 RLSDPNIARLLGVCTVDP--------------------PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY 134 (296)
T ss_pred hcCCCCEeEEEEEEecCC--------------------CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHH
Confidence 999999999999987543 3488999999999999996543 12689999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchh
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|
T Consensus 135 ~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 214 (296)
T cd05051 135 MATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214 (296)
T ss_pred HHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccch
Confidence 99999999999999999999999999999999999999999987543221 1112234677899999998888999999
Q ss_pred HHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHHc------CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 290 VYSFGICLWEIYC--CDMPYPDLSFADVSSAVVRQ------NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 290 iwSlG~il~ell~--g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
||||||++|||++ +..||...+..+.+...... ......+..+|.++.+++.+||+.||.+|||+.+|++.|
T Consensus 215 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred hhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 9999999999998 77899877766665554322 112234556789999999999999999999999999988
Q ss_pred H
Q 036382 362 E 362 (390)
Q Consensus 362 ~ 362 (390)
+
T Consensus 295 ~ 295 (296)
T cd05051 295 Q 295 (296)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.83 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=205.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +++.||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--------APCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--------cchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 46799999999999999999977 57789999987432211 123456899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+ +|.+++... +..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 77 ~--------------------~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~N 134 (309)
T cd07872 77 K--------------------SLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134 (309)
T ss_pred C--------------------eEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3 44889999975 898888543 3458999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.+||+|||++..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 135 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 135 LLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred EEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999754433333444568999999999865 46889999999999999999999999887765554
Q ss_pred HHHHHcC---------------------CCCC-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHh
Q 036382 317 SAVVRQN---------------------LRPE-------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK--MLEAIDT 366 (390)
Q Consensus 317 ~~~~~~~---------------------~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~ 366 (390)
..+.... .... ....++.++.++|.+||..||.+|||+.++++ .++.+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 4332210 0000 11246788999999999999999999999997 4444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=315.49 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=213.8
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||.++. +++.+++|.+..... .......+.+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-------SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-
Confidence 488999999999999887765 678999998863221 1122356779999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..+++|||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 73 -------------------~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~ 133 (256)
T cd08221 73 -------------------TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133 (256)
T ss_pred -------------------eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEE
Confidence 3478999999999999997655567899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.+||+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 134 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 134 LTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred EeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999999986544433334467899999999998888999999999999999999999999888777777666
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
....+. ..+..++.++.+++.+||..+|.+||++.++++.+
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 214 VQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 554443 34567889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.26 Aligned_cols=253 Identities=22% Similarity=0.379 Sum_probs=205.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+++. +++.||+|+++.. ..........+.+|..+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW------EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH------HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4799999999999999999987 5789999998621 1222233456788999999999999999999987544
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 --------------------~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (331)
T cd05597 75 --------------------NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133 (331)
T ss_pred --------------------eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence 348899999999999999643 35689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|++.++.+||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 134 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred EECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 999999999999999875433221 2223468999999999863 4578899999999999999999999998887
Q ss_pred hhHHHHHHHcCCCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIP---RCCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
.+....+........++ ..++.+++++|++||..++.+ |+++.+++++
T Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 77766665433222222 347899999999988654433 7899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=320.24 Aligned_cols=256 Identities=30% Similarity=0.563 Sum_probs=205.3
Q ss_pred cCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+|++.+.||+|+||.||++.. ++..||+|.++... ......+.+|+++++.++||||+++++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 4688999999999999999874 46789999986321 12235678999999999999999999987
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.... ....++||||+++++|.+++.+. ...+++..+..++.|++.||.|||++||+|||||
T Consensus 75 ~~~~------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlk 135 (284)
T cd05081 75 YSAG------------------RRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLA 135 (284)
T ss_pred ccCC------------------CCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 5322 23458999999999999999643 3468999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCC---CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDM---TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|+|||++.++.++|+|||++.......... ....++..|+|||.+.+..++.++|+|||||++|||++|..|+....
T Consensus 136 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 136 TRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred HhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 999999999999999999998654322111 11223456999999998899999999999999999999877754332
Q ss_pred hh---------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 312 FA---------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 312 ~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.. .............+.+..++.++.+|+.+||..+|++|||+.+|++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11 011123344445556677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.65 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=201.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ .++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-------ChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 57899999999999999999976 578999999863211 112235567899999999999999999998644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.... .....|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 89 ~~~~--------------~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 149 (355)
T cd07874 89 KSLE--------------EFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_pred cccc--------------ccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 3221 23456899999965 67777632 48899999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 150 ill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 150 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred EEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999754322 22334578999999999999999999999999999999999999998776544333
Q ss_pred HHHHcCC----------------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNL----------------------------------------RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+...-. ....+...+.++++||.+||..||++|||+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 2221100 000112235678999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+++
T Consensus 309 l~h 311 (355)
T cd07874 309 LQH 311 (355)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.20 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=204.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.... .....+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 35799999999999999999987 578999999863321 1124567899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus 79 ~--------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n 136 (267)
T cd06645 79 D--------------------KLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGAN 136 (267)
T ss_pred C--------------------EEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3 34789999999999999854 3469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+++.++.++|+|||++..............++..|+|||++. ...++.++|+|||||++|+|++|..||.......
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~ 216 (267)
T cd06645 137 ILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred EEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh
Confidence 9999999999999999875543333334457899999999974 4568899999999999999999999997665444
Q ss_pred HHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEI---PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...........+.. ...++..+.++|.+||..+|++|||+.+|++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 217 ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 44333333332221 12467889999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=321.30 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=209.0
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
..+.|++.+.||.|+||.||+|.+ +++.||+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----------DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----------HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 446789999999999999999987 57899999985221 1124567899999998 7999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.... .......|++|||+.+|+|.+++.......+++..+..++.||+.||.|||+.||+|+||+|
T Consensus 84 ~~~~--------------~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~ 149 (282)
T cd06636 84 KKSP--------------PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKG 149 (282)
T ss_pred cccc--------------cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 4211 11345679999999999999999766566789999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
+||+++.++.++|+|||++..............+++.|+|||.+. +..++.++|+|||||++|+|++|..||...
T Consensus 150 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 150 QNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred HHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 999999999999999999875433222334456889999999985 346888999999999999999999999877
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
........+.........+..++.++.+||.+||..||.+|||+.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 6555544443333333344568899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=321.25 Aligned_cols=254 Identities=28% Similarity=0.378 Sum_probs=199.5
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEEEec
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGASVG 156 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~ 156 (390)
+|++.+.||+|+||.||+|.+ +++.||+|.++....... ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-------LPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-------CchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 488899999999999999987 578999999874321111 012234566666554 79999999998764
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... ......++||||+.+ +|.+++.+.....+++..+..++.|++.||.|||+.||+||||||+
T Consensus 74 ~~~---------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~ 137 (288)
T cd07863 74 SRT---------------DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137 (288)
T ss_pred ccC---------------CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 321 123456899999975 8999987655556999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|||++.++.+||+|||++...... .......+|..|+|||++.+..++.++|||||||++|+|++|.+||......+..
T Consensus 138 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~ 216 (288)
T cd07863 138 NILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216 (288)
T ss_pred HEEECCCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH
Confidence 999999999999999999754322 2233456889999999999889999999999999999999999999887666555
Q ss_pred HHHHHcC------------------CCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQN------------------LRP-------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~------------------~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..+.... +.+ .....++..+.+++.+||+.||++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 217 GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 4443210 000 011246778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=333.45 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=202.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-------CchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 46899999999999999999987 578999999863211 112234567899999999999999999987644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... ......|+||||+.+ +|.+++.. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 96 ~~~--------------~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 156 (364)
T cd07875 96 KSL--------------EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156 (364)
T ss_pred ccc--------------cccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 322 123456999999965 78877732 48899999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 157 Ill~~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 157 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred EEECCCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999754322 22344578999999999999999999999999999999999999998877666554
Q ss_pred HHHHcCCC--------------------C--------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNLR--------------------P--------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~~--------------------~--------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.++..-.. + ......+.++++||.+||+.||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 44321100 0 0011124578999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+++
T Consensus 316 L~h 318 (364)
T cd07875 316 LQH 318 (364)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=329.82 Aligned_cols=253 Identities=21% Similarity=0.387 Sum_probs=207.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++++ +++.||+|++... ..........+.+|..++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW------EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH------HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4789999999999999999987 4678999998511 1122223455788999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.+. ...+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 75 --------------------~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni 133 (332)
T cd05623 75 --------------------NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133 (332)
T ss_pred --------------------EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 348899999999999999653 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|++.++.+||+|||++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.
T Consensus 134 li~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred EECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999987543222 1223357999999999986 34688999999999999999999999999888
Q ss_pred hhHHHHHHHcCCCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIP---RCCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
.+....+.....+..+| ..++.++.+||++||..++.+ |+++.+++++
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 88887776554444343 357899999999999665444 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=334.87 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=201.8
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||++.+ +++.||||.+.... ........+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 478889999999999999986 68899999885221 111123567789999999999999999999865431
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
- .....|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 74 ~---------------~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil 135 (372)
T cd07853 74 D---------------PFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL 135 (372)
T ss_pred c---------------ccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEE
Confidence 1 1135689999996 588888743 356999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
++.++.+||+|||+++...... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...
T Consensus 136 i~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 215 (372)
T cd07853 136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215 (372)
T ss_pred ECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999999999999998543221 223345678999999999774 47899999999999999999999998877655444
Q ss_pred HHHH-----------------------cCCCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVR-----------------------QNLRP-------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~-----------------------~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+.. ....+ ......++++.+||.+||+.||++|||+.+++++
T Consensus 216 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 3321 11111 1223457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=318.39 Aligned_cols=256 Identities=28% Similarity=0.539 Sum_probs=212.8
Q ss_pred cccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+.++|++...||+|+||.||+|+. ..+.|++|.+.... .......+.+|++++++++||||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--------DENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--------chHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 446899999999999999999985 24579999875321 122345688999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHH
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-------KKLALKIVIQLALDLSRGLSYLH 224 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~yLH 224 (390)
+++.+.. ..|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||
T Consensus 75 ~~~~~~~--------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 75 GLCREAE--------------------PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred EEECCCC--------------------cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 9886433 34889999999999999965431 25899999999999999999999
Q ss_pred hCCCcccCCCCCCEEECCCCcEEEeecccceeccCC-CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-
Q 036382 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC- 302 (390)
Q Consensus 225 ~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~- 302 (390)
+.+|+||||||+|||++.++.++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 135 ~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~ 214 (275)
T cd05046 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214 (275)
T ss_pred hcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998643221 112233456778999999988889999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 303 CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 303 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
|..||.....................+..+|..+.+++.+||..+|.+|||+.++++.|.
T Consensus 215 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 215 GELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 889998877777666665555555567788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.32 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=206.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+++. +++.||+|+++.. ..........+.+|..+++.++|+||+++++++.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW------EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH------HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4799999999999999999987 5678999998521 1122223455788999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.+. ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 75 --------------------~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 75 --------------------YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred --------------------EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 448899999999999999653 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|++.++.+||+|||++........ ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.
T Consensus 134 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred EEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 999999999999999875433221 1223569999999999875 4678899999999999999999999998887
Q ss_pred hhHHHHHHHcCCCCCCCC---CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPR---CCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
.+....+.....+..+|. .++.++.+++.+||..++.+ |+++++++++
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 777777665544444443 36899999999999876544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=321.95 Aligned_cols=257 Identities=28% Similarity=0.524 Sum_probs=205.2
Q ss_pred cccCccccccccccCceEEEEEEEC------------------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHH
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD------------------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 140 (390)
..++|++.+.||+|+||.||++.+. +..||+|+++... .......+.+|+.+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~~E~~~l~ 74 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--------NKNARNDFLKEIKIMS 74 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--------CHHHHHHHHHHHHHHH
Confidence 3457999999999999999988542 2368999886321 1223457889999999
Q ss_pred hcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc---------CCCCHHHHHH
Q 036382 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR---------KKLALKIVIQ 211 (390)
Q Consensus 141 ~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~ 211 (390)
.++||||+++++++.... ..++||||+.+++|.+++.+... ..+++..+..
T Consensus 75 ~l~~~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (296)
T cd05095 75 RLKDPNIIRLLAVCITSD--------------------PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIF 134 (296)
T ss_pred hCCCCCcceEEEEEecCC--------------------ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHH
Confidence 999999999999987543 34889999999999999965321 2467889999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC-C-CCCCCCCCccccccccCCCCCCCchh
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR-D-MTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
++.|++.||+|||+.|++|+||||+|||++.++.++|+|||++........ . .....+++.|++||...+..++.++|
T Consensus 135 ~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D 214 (296)
T cd05095 135 MATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASD 214 (296)
T ss_pred HHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhh
Confidence 999999999999999999999999999999999999999999875432211 1 11223467899999988888999999
Q ss_pred HHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHH------cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 290 VYSFGICLWEIYC--CDMPYPDLSFADVSSAVVR------QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 290 iwSlG~il~ell~--g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
+|||||++|||++ |..||...+..+....... .....+.+..+|+.+.+|+.+||+.||.+|||+.+|++.|
T Consensus 215 iwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 215 VWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred hhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 9999999999998 7789987766655433211 1112234567889999999999999999999999999998
Q ss_pred HH
Q 036382 362 EA 363 (390)
Q Consensus 362 ~~ 363 (390)
+.
T Consensus 295 ~~ 296 (296)
T cd05095 295 LE 296 (296)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=314.16 Aligned_cols=247 Identities=29% Similarity=0.575 Sum_probs=208.8
Q ss_pred ccccccCceEEEEEEEC---Cc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTYD---NQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
+.||+|+||.||+|.+. ++ .||||.+..... . .....+.+|+.++++++||||+++++.+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~------~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 67 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL------S--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT----- 67 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc------H--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-----
Confidence 46899999999999863 22 689999863221 0 445778899999999999999999998764
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
...++||||+++++|.+++.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 68 ----------------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~ 131 (257)
T cd05040 68 ----------------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131 (257)
T ss_pred ----------------CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe
Confidence 3348899999999999999765435689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 036382 242 SQRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSS 317 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (390)
.++.+||+|||++......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+...
T Consensus 132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 211 (257)
T cd05040 132 SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211 (257)
T ss_pred cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998755332111 112446788999999998899999999999999999998 999998888888777
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
.+.........+..+|..+.+++.+||..+|++|||+.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 766555555667788999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.20 Aligned_cols=246 Identities=33% Similarity=0.647 Sum_probs=204.9
Q ss_pred ccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCc
Q 036382 87 NLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSK 165 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 165 (390)
++||+|+||.||+|.. +++.||+|+++.... ......+.+|+++++.++||||+++++++....
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 65 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ------- 65 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-------
Confidence 3689999999999976 567899998863211 122346788999999999999999999987543
Q ss_pred ccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCc
Q 036382 166 TASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245 (390)
Q Consensus 166 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~ 245 (390)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 66 -------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~ 131 (250)
T cd05085 66 -------------PIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV 131 (250)
T ss_pred -------------ccEEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe
Confidence 348899999999999998653 345899999999999999999999999999999999999999999
Q ss_pred EEEeecccceeccCCCCCC-CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcC
Q 036382 246 LKIADFGVARVEAQNPRDM-TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 246 ~kL~DfG~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
++|+|||++.......... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||...........+ ...
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~~ 210 (250)
T cd05085 132 LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKG 210 (250)
T ss_pred EEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcC
Confidence 9999999987533221111 11234567999999998889999999999999999998 99999888777665554 455
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 324 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
.+...+..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 666777889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=333.13 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=195.5
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEEEecccccccC
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~~~ 163 (390)
||+|+||.||+|++ +++.||||++... ..........+..|..++..+ +||||+++++++.+..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----- 69 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK------EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----- 69 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHH------HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----
Confidence 69999999999987 5789999998521 111112223445666777655 7999999999987544
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 70 ---------------~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~ 132 (330)
T cd05586 70 ---------------DLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132 (330)
T ss_pred ---------------eEEEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 34789999999999999854 3569999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHc
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (390)
+.++|+|||++.............+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 133 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 133 GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 999999999987543333334456799999999998764 4899999999999999999999999988877777666544
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 036382 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRP----EMGEVVK 359 (390)
Q Consensus 323 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~~ll~ 359 (390)
..+.. ...+++++.+++.+||..||.+|| ++.++++
T Consensus 213 ~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 43322 234789999999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.42 Aligned_cols=251 Identities=29% Similarity=0.594 Sum_probs=210.4
Q ss_pred cccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+..+|++.+.||.|+||.||++.+. +..+|+|+++.... . ...+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---S-------EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---C-------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 4568999999999999999999874 78999998863221 0 23577899999999999999999998643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...|+||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+|
T Consensus 72 --------------------~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~n 130 (256)
T cd05112 72 --------------------SPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130 (256)
T ss_pred --------------------CceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccce
Confidence 34588999999999999986533 458999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~ 315 (390)
|+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|||++ |..||......+.
T Consensus 131 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred EEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 9999999999999999875433211 1223345678999999998889999999999999999998 9999988777766
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
...+ ..+.+...+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 211 ~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 211 VETI-NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHH-hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6554 34445556777899999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=321.17 Aligned_cols=257 Identities=26% Similarity=0.522 Sum_probs=205.5
Q ss_pred ccccCccccccccccCceEEEEEEECC----------------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHh
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYDN----------------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 141 (390)
+..++|++.+.||+|+||.||++...+ ..||+|.++.... ......+.+|++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~ei~~l~~ 73 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--------KTARNDFLKEIKIMSR 73 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--------HHHHHHHHHHHHHHHh
Confidence 344689999999999999999986532 2589998863211 1224568899999999
Q ss_pred cCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----------cCCCCHHHHHH
Q 036382 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----------RKKLALKIVIQ 211 (390)
Q Consensus 142 l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~ 211 (390)
++||||+++++++.... ..++||||+.+++|.+++.... ...+++..+..
T Consensus 74 l~h~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (295)
T cd05097 74 LKNPNIIRLLGVCVSDD--------------------PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLY 133 (295)
T ss_pred CCCCCcCeEEEEEcCCC--------------------ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHH
Confidence 99999999999987543 3488999999999999985432 12468899999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchh
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
++.|++.||.|||+.|++|+||||+|||++.++.+||+|||++........ ......++..|+|||.+.+..++.++|
T Consensus 134 i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 134 MAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred HHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhh
Confidence 999999999999999999999999999999999999999999875432211 111233567899999999888999999
Q ss_pred HHHHHHHHHHHHh--CCCCCCCCChhhHHHHHHH------cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 290 VYSFGICLWEIYC--CDMPYPDLSFADVSSAVVR------QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 290 iwSlG~il~ell~--g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
+|||||++|+|++ +..||...+..+....... .......+..+|+.+.+|+.+||..||++|||+.+|++.|
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999998 6788988776665544322 1112234556789999999999999999999999999988
Q ss_pred H
Q 036382 362 E 362 (390)
Q Consensus 362 ~ 362 (390)
+
T Consensus 294 ~ 294 (295)
T cd05097 294 R 294 (295)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.80 Aligned_cols=253 Identities=25% Similarity=0.474 Sum_probs=209.0
Q ss_pred CccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
+|++.+.||+|+||.||+|.. +++.+|||.++..... ..........+.+|+++++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN---VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--- 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc---hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC---
Confidence 477889999999999999977 6788999998643221 122223346688999999999999999999998754
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+|+|+||+|+||++
T Consensus 75 -----------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 135 (265)
T cd06631 75 -----------------NTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML 135 (265)
T ss_pred -----------------CeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE
Confidence 3448899999999999999543 468999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCC------CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 241 DSQRTLKIADFGVARVEAQN------PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
+.++.++|+|||++...... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+...
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 99999999999998743211 111223468899999999999889999999999999999999999998766555
Q ss_pred HHHHHHHc-CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSSAVVRQ-NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
....+... ...+..+..++.++.++|++||..+|.+|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44333332 3455677888999999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.16 Aligned_cols=251 Identities=33% Similarity=0.588 Sum_probs=203.0
Q ss_pred ccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 68 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS---- 68 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----
Confidence 36899999999999762 3479999874211 112235677899999999999999999987532
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
.+..++||||+.+|+|.+++.+. ...+++..+..++.|++.||.|||+.+++||||||+|||++
T Consensus 69 ---------------~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~ 132 (262)
T cd05058 69 ---------------EGSPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD 132 (262)
T ss_pred ---------------CCCcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc
Confidence 22347899999999999999653 23467888899999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHH
Q 036382 242 SQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVS 316 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~ 316 (390)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+..
T Consensus 133 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 212 (262)
T cd05058 133 ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212 (262)
T ss_pred CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999987432211 11123345778999999988889999999999999999999 56778877766655
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
..+ ..+..+..+..+|..+.+++.+||..+|++||++.+|++.|+.+..
T Consensus 213 ~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 213 VYL-LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHH-hcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 544 3444555677789999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.10 Aligned_cols=254 Identities=27% Similarity=0.486 Sum_probs=209.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|+..+.||+|+||.||+|.. ++..||+|.++..... .........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES----PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC----chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 3688899999999999999986 5789999988643321 112233466889999999999999999999876432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
....++++||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+|+|+||+|+||
T Consensus 78 ------------------~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni 137 (266)
T cd06651 78 ------------------EKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI 137 (266)
T ss_pred ------------------CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 23447899999999999999543 4589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCC---CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQN---PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+++.++.++|+|||++...... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus 138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 9999999999999998754321 1112234578899999999988899999999999999999999999988776666
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..........+.++..+++.+.+++ +||..+|++|||+.+|++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 6665555556677777889999999 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=319.13 Aligned_cols=251 Identities=24% Similarity=0.435 Sum_probs=206.6
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
.-+.|++.+.||.|+||.||+|+. +++.||+|++... .......+.+|+.+++.++||||+++++.+..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 346799999999999999999987 5689999998632 12234567889999999999999999999864
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ..+|+||||+.+++|..++.+. ...+++..+..++.|++.||.|||+.|++||||||+
T Consensus 81 ~--------------------~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ 139 (292)
T cd06644 81 D--------------------GKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139 (292)
T ss_pred C--------------------CeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcc
Confidence 3 3458899999999999887543 346899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||+++.++.++|+|||++..............++..|+|||.+. ...++.++|+|||||++|+|++|..||...+
T Consensus 140 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred eEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 99999999999999999875433333334456888999999984 3457889999999999999999999998877
Q ss_pred hhhHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 312 FADVSSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 312 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.......+..... ....+..++.++.++|.+||..||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 6655544433221 22345667889999999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=318.80 Aligned_cols=251 Identities=24% Similarity=0.436 Sum_probs=208.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||.|+||.||++.+ ++..||+|+++... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---------EEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---------HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 35799999999999999999987 57899999986321 12235678899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.||+|+||+|+|
T Consensus 75 ~--------------------~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n 133 (280)
T cd06611 75 N--------------------KLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN 133 (280)
T ss_pred C--------------------eEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence 3 448899999999999998653 3469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+++.++.++|+|||++..............+++.|+|||.+. ...++.++|+|||||++|+|++|..||...+.
T Consensus 134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred EEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 9999999999999999875443333334456899999999974 34578899999999999999999999988877
Q ss_pred hhHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
......+..... ....+..++.++.++|.+||..+|.+||++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 666655543321 123456788999999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.39 Aligned_cols=249 Identities=29% Similarity=0.548 Sum_probs=203.3
Q ss_pred ccccccCceEEEEEEEC--Cc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTYD--NQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 161 (390)
+.||+|+||.||+|.+. +. .+|+|.++... .......+.+|+++++++ +||||+++++++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--- 69 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--- 69 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC---
Confidence 36899999999999873 33 46888775211 112235678899999999 8999999999987543
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.|
T Consensus 70 -----------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ 132 (270)
T cd05047 70 -----------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 132 (270)
T ss_pred -----------------CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3478999999999999996532 134789999999999999999999999
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMP 306 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~P 306 (390)
++||||||+|||++.++.+||+|||++....... .......+..|+|||.+.+..++.++|+|||||++|||++ |..|
T Consensus 133 i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred EeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999986322111 1112234567999999988889999999999999999997 9999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
|.+.+..+....+ ..+.+.+.+..++.++.+++.+||..||.+|||+.+++..|+.+.
T Consensus 212 f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 212 YCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ccccCHHHHHHHH-hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9888777766555 344566677778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.85 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=208.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.++||+|+||.||+|.+ +++.||||+++... .........+.+|++++++++||||+++++++.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l------~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL------SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc------ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 5799999999999999999987 57899999986321 112234567889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---------RKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
..|+||||++||+|.+++.+.. ...++...+..++.||+.||.|||++||+
T Consensus 76 --------------------~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII 135 (932)
T PRK13184 76 --------------------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135 (932)
T ss_pred --------------------EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4488999999999999986421 23456778899999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC------------------CCCCCCCCCCccccccccCCCCCCCchhHH
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP------------------RDMTGETGTLGYMAPEVLQGKPYNRRCDVY 291 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 291 (390)
||||||+|||++.++.++|+|||++....... .......||+.|+|||++.+..++.++|||
T Consensus 136 HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIW 215 (932)
T PRK13184 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIY 215 (932)
T ss_pred ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHH
Confidence 99999999999999999999999997541110 011124689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHH-cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHhcCC
Q 036382 292 SFGICLWEIYCCDMPYPDLSFADVSSAVVR-QNLRPEIPRCCPSSLANIMRKCWDANAEKRP-EMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 292 SlG~il~ell~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~~~~~ 369 (390)
||||++|||++|..||...+.......... ..........+|+.+.+++.+||..||++|| +++++++.|+.+.....
T Consensus 216 SLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 216 ALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 999999999999999987654443322111 1111111246789999999999999999995 67788888888765433
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.50 Aligned_cols=248 Identities=28% Similarity=0.460 Sum_probs=209.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||.|+||.||+|.+ +++.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence 3688999999999999999987 57899999986321 1112355778999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+|+||+.+++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 73 --------------------~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 129 (274)
T cd06609 73 --------------------KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129 (274)
T ss_pred --------------------eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 348899999999999998543 689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 130 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~ 209 (274)
T cd06609 130 LLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209 (274)
T ss_pred EECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 99999999999999998665443334456788899999999988899999999999999999999999987766655544
Q ss_pred HHHcCCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+. ....+..+.. ++.++.+++.+||..+|++|||++++++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 210 IP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hh-hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 43 3344455555 88999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=314.69 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=208.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||.|+||.||+|.. +++.+|+|++..... .....+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---------DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---------hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 5789999999999999999987 567899999863321 13467789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 74 --------------------~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 132 (262)
T cd06613 74 --------------------KLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132 (262)
T ss_pred --------------------EEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhE
Confidence 448899999999999998653 25699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK---PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+++.++.++|+|||++..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+....
T Consensus 133 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 133 LLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred EECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999987554333233445688899999999776 889999999999999999999999988776665
Q ss_pred HHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+....+.+. .+...+.++.+++.+||..+|.+|||+.+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 555544433322 23345788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.81 Aligned_cols=256 Identities=28% Similarity=0.504 Sum_probs=205.4
Q ss_pred CccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
-|++.+.||+|+||.||++++ ++..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 478899999999999999874 46789999986321 1122356889999999999999999999886
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ....++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||++|++||||||
T Consensus 77 ~~~------------------~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp 137 (284)
T cd05079 77 EDG------------------GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA 137 (284)
T ss_pred cCC------------------CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccch
Confidence 532 233589999999999999986542 3589999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS- 311 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 311 (390)
+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|+++..|+....
T Consensus 138 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 138 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred heEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 999999999999999999875433221 1123446778999999988889999999999999999999876642210
Q ss_pred -------------hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 312 -------------FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 312 -------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
...........+.+.+.+..++..+.+|+.+||+.+|.+|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111222334445556777899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.91 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=204.5
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.+.||.|+||.||+|.+ ++..+++|.+.... ......+.+|+++++.++||||+++++++...
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--- 74 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---------EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--- 74 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC---
Confidence 67888999999999999988 45688999885221 12235678899999999999999999998753
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...++||||+.+++|..++.+. ...+++..+..++.|++.||.|||+.|++||||||+|||+
T Consensus 75 -----------------~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili 136 (282)
T cd06643 75 -----------------NNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF 136 (282)
T ss_pred -----------------CEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE
Confidence 3458899999999999987543 3468999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+.++.++|+|||++..............++..|+|||++. +..++.++|+|||||++|+|++|..||...+..+.
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 137 TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 9999999999999875443333334456899999999984 45578899999999999999999999988776666
Q ss_pred HHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+.... .....+..++.++.++|.+||..||.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 55554322 2233566788999999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=317.92 Aligned_cols=248 Identities=33% Similarity=0.602 Sum_probs=201.3
Q ss_pred ccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.+.||+|+||.||+++.. ++.||+|++... ...........+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~-------~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKS-------EIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEEST-------THHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccc-------cccccccchhhhhhhccccccccccccccccccccc--
Confidence 678899999999999999984 457999999732 222222333456999999999999999999987643
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
..++||||+.+++|.+++. ....+++..+..++.|++.||.+||+.||+|+||||+|||+
T Consensus 72 ------------------~~~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~ 131 (260)
T PF00069_consen 72 ------------------YLYIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL 131 (260)
T ss_dssp ------------------EEEEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE
T ss_pred ------------------ccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc
Confidence 4478999999999999996 34568999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh---HH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD---VS 316 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~---~~ 316 (390)
+.++.++|+|||.+..............++..|+|||++. +..++.++|+||||+++|+|++|..||......+ ..
T Consensus 132 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~ 211 (260)
T PF00069_consen 132 DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII 211 (260)
T ss_dssp STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 9999999999999875333334455577899999999998 8889999999999999999999999998873222 33
Q ss_pred HHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
........... .....+..+.++|.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 212 EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222111111 11223489999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=314.17 Aligned_cols=259 Identities=24% Similarity=0.567 Sum_probs=215.7
Q ss_pred ccccCccccccccccCceEEEEEEE--CCc----eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+...+|++.+.||+|+||.||+|.+ +++ .||+|.++.... ......+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3456899999999999999999976 332 589998763221 23346678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.. ...++||||+.+|+|.+++.+. ...+++..+..++.||+.||+|||+.|++||
T Consensus 76 ~~~~~---------------------~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~ 133 (279)
T cd05057 76 GICLS---------------------SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133 (279)
T ss_pred EEEec---------------------CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence 99863 2348899999999999999654 3458999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCC--CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
||||+|||++.++.+||+|||+++......... ....++..|+|||.+.+..++.++|+|||||++||+++ |..||.
T Consensus 134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999997544322111 12234568999999988889999999999999999998 999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.....+....+. .+.....+..++..+.+++.+||..+|.+|||+.++++.|+++...
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 214 GIPAVEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 888777665554 4445566777889999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=328.97 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=203.1
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|++ .++|++.+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+++.++||||+++++
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-------QSLIHARRTYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-------hhhHHHHHHHHHHHHHHhcCCCchhhhhh
Confidence 3555 47899999999999999999976 56799999986321 11122345678999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++...... ......|++++++ +++|.+++.. ..+++..+..++.||+.||.|||++||+|||
T Consensus 82 ~~~~~~~~--------------~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrd 143 (343)
T cd07878 82 VFTPATSI--------------ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRD 143 (343)
T ss_pred hhcccccc--------------cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 87643221 1234568999988 7799888742 4599999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+
T Consensus 144 ikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 144 LKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CChhhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999985433 2344578999999999877 568999999999999999999999998766
Q ss_pred hhhHHHHHHHcCC---------------------CCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQNL---------------------RPEI--------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~---------------------~~~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+....+..... .+.. ....++.+.+||.+||..||.+|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 5544433321100 0001 12345678999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.91 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=209.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+|.+ ++..||||.+....... ........+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP----ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc----ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 5788999999999999999986 57899999886332111 11223467889999999999999999999876432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
....+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++|+||+|+||
T Consensus 78 ------------------~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 137 (265)
T cd06652 78 ------------------ERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI 137 (265)
T ss_pred ------------------CceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 22347899999999999998643 4588999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCC---CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQN---PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|++.++.++|+|||++...... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus 138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 9999999999999998743321 1122334688899999999888899999999999999999999999988766666
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..........+..|...+..+.+++.+||. +|++||++++|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 655555555566777788889999999995 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.75 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=206.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~- 89 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---------PKKELIINEILVMRENKNPNIVNYLDSYLVG- 89 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---------chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-
Confidence 5799999999999999999986 678999998863221 1125577899999999999999999998753
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 90 -------------------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Ni 147 (296)
T cd06654 90 -------------------DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (296)
T ss_pred -------------------CEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 345889999999999999853 3589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.++|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...........
T Consensus 148 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred EEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 99999999999999987543332233445788999999999988899999999999999999999999987766554433
Q ss_pred HHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...... ....+..++..+.++|.+||..+|++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 332221 223456678899999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.04 Aligned_cols=249 Identities=18% Similarity=0.340 Sum_probs=195.3
Q ss_pred cccccccc--CceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 85 MRNLIAQG--TYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 85 ~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
+.++||+| +|++||++.. +|+.||+|.++... ........+.+|+++++.++||||+++++++....
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-- 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA-------CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-- 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh-------ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--
Confidence 56789999 7889999976 67899999986321 11223456778999999999999999999997543
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
..|+||||+++|+|.+++..+....+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 73 ------------------~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~ 134 (327)
T cd08227 73 ------------------ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134 (327)
T ss_pred ------------------EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE
Confidence 34889999999999999976555569999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCC-------CCCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 241 DSQRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
+.++.++++||+.+........ ......++..|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999999999986543211111 0112346778999999976 468999999999999999999999998765
Q ss_pred hhhHHHHHHHcCCC--------------------------------------------CCCCCCCcHHHHHHHHHhhhhC
Q 036382 312 FADVSSAVVRQNLR--------------------------------------------PEIPRCCPSSLANIMRKCWDAN 347 (390)
Q Consensus 312 ~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~l~~li~~cl~~d 347 (390)
.............. .+....+++++.+|+.+||+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 294 (327)
T cd08227 215 ATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294 (327)
T ss_pred hhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC
Confidence 44433222211100 0011234678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 036382 348 AEKRPEMGEVVKM 360 (390)
Q Consensus 348 P~~Rpt~~~ll~~ 360 (390)
|++|||+.+|++.
T Consensus 295 P~~Rpt~~ell~~ 307 (327)
T cd08227 295 PDARPSASTLLNH 307 (327)
T ss_pred chhcCCHHHHhcC
Confidence 9999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=312.07 Aligned_cols=251 Identities=23% Similarity=0.445 Sum_probs=212.2
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||.+.. +++.||+|.+..... .......+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-------SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-- 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--
Confidence 588899999999999999876 678999999863211 112235678999999999999999999998643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+|||
T Consensus 72 ------------------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil 133 (256)
T cd08218 72 ------------------GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133 (256)
T ss_pred ------------------CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 34588999999999999997655556899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||......+....+
T Consensus 134 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred EcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 99999999999999975543322223345788999999999888999999999999999999999999888777776666
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
... ..+..+..++.++.++|.+||+.+|.+||++.+|+++
T Consensus 214 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 214 IRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred hcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 543 3455677889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.42 Aligned_cols=253 Identities=25% Similarity=0.490 Sum_probs=212.4
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||++.+ +++.||+|+++.... .......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS- 72 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC-
Confidence 478889999999999999976 678999999864321 1122356788999999999999999999876432
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCcccC
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLH-----SKKIVHRD 232 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~iiHrD 232 (390)
....+++|||+++++|.+++.+. ....+++..++.++.|++.||.||| +.+++|+|
T Consensus 73 -----------------~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 73 -----------------NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred -----------------CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 33458999999999999999653 2457899999999999999999999 88999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+|+||+++.++.+||+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 136 l~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 215 (265)
T cd08217 136 LKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215 (265)
T ss_pred CCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH
Confidence 99999999999999999999988654433323445789999999999988899999999999999999999999998876
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+ ..+..+..+..++..+.+++.+||..+|.+|||+.+|++.
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 LQLASKI-KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHH-hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 6655554 3444456777889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.27 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=199.8
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||+|+. +++.||||.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-------EGVPSTAIREISLLKELQHPNIVCLQDVLMQES- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-------CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-
Confidence 578889999999999999987 5789999998643211 112245678999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+. ++|.+++.... +..+++..++.++.|++.||.|||+.||+|+||+|+||
T Consensus 73 -------------------~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni 132 (285)
T cd07861 73 -------------------RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNL 132 (285)
T ss_pred -------------------eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 4488999997 68998886533 35689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+...
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~ 212 (285)
T cd07861 133 LIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212 (285)
T ss_pred EEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999987554333333445678999999988654 57889999999999999999999998765443332
Q ss_pred HHHHcC----------------CC-----------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQN----------------LR-----------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~----------------~~-----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+.... +. ......+++++.++|.+||..||.+|||+.+|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 213 RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 221100 00 0112346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.44 Aligned_cols=258 Identities=19% Similarity=0.360 Sum_probs=205.6
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
..+...++|++.+.||+|+||.||++.+ ++..||+|++..... .......+..|+.++++++|||||++++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-------~e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-------KEREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-------CHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 3455667999999999999999999987 567899999863321 1122456788999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSK---- 226 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~---- 226 (390)
+|.+.. ...+|+||||+.+|+|.++|.... ...+++..++.|+.||+.||.|||+.
T Consensus 80 ~f~de~------------------~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~ 141 (1021)
T PTZ00266 80 RFLNKA------------------NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGP 141 (1021)
T ss_pred EEEecC------------------CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhccccc
Confidence 986432 234589999999999999996532 35699999999999999999999984
Q ss_pred ---CCcccCCCCCCEEECC-----------------CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC--CCC
Q 036382 227 ---KIVHRDVKTENMLLDS-----------------QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--KPY 284 (390)
Q Consensus 227 ---~iiHrDlkp~NILl~~-----------------~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~ 284 (390)
+||||||||+||||+. .+.+||+|||++....... ......+|+.|+|||++.+ ..+
T Consensus 142 ~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~ 220 (1021)
T PTZ00266 142 NGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSY 220 (1021)
T ss_pred ccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCC
Confidence 4999999999999964 2358999999997543221 2234578999999999854 458
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 285 NRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 285 ~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+.++|||||||+||+|++|..||........+...+......+ ....+.++.+||..||..+|.+|||+.+++.
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 8999999999999999999999987654444433333332221 2346899999999999999999999999984
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=313.23 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=193.1
Q ss_pred ccccccCceEEEEEEEC----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 87 NLIAQGTYGSVYRGTYD----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
+.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 68 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT---- 68 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC----
Confidence 36899999999999763 35789998763211 112246788999999999999999999986543
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+++||||||+||+
T Consensus 69 ----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil 132 (269)
T cd05087 69 ----------------PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCL 132 (269)
T ss_pred ----------------CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 3478999999999999996532 224677888899999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 240 LDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGK-------PYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
++.++.++|+|||++........ ......++..|+|||++.+. .++.++|+||||+++|||++ |..||..
T Consensus 133 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 133 LTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred EcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999874332211 12234567889999998642 35789999999999999996 9999988
Q ss_pred CChhhHHHHHHHcC-CC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 310 LSFADVSSAVVRQN-LR---PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 310 ~~~~~~~~~~~~~~-~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
....+......... .+ +.....++..+.++|.+|| .+|++|||+.+|+..|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 77666544433221 11 1223356788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.36 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=209.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.+ +++.||+|+++.. ..........+.+|+++++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA------KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 3689999999999999999987 5789999998622 1112233467889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 75 --------------------~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 75 --------------------NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred --------------------eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 447899999999999999654 5699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 133 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 209 (290)
T cd05580 133 LLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK 209 (290)
T ss_pred EECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999998754433 2345688999999999888899999999999999999999999988876666655
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
+.. ....+|..++..+.+++.+||..||.+|+ ++.++++.
T Consensus 210 ~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 ILE--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred Hhc--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 543 24456777899999999999999999999 77777743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.13 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=207.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||.|+||.||+|.+ +++.||+|.+..... .....+.+|+.+++.++||||+++++.+....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---------PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---------chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 4699999999999999999976 678999998863211 12345778999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+|+||+.+++|.+++.+ ..+++..+..++.+++.||.|||+.|++|+||+|+||
T Consensus 90 --------------------~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Ni 146 (296)
T cd06655 90 --------------------ELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV 146 (296)
T ss_pred --------------------eEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 45889999999999998854 3589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
+++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 147 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred EECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999987543332223345688999999999988899999999999999999999999988776655544
Q ss_pred HHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 319 VVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 319 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+..... ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 433221 22356678899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=318.69 Aligned_cols=258 Identities=24% Similarity=0.579 Sum_probs=211.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCc----eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
..+|+..+.||+|+||.||+|.+ ++. .||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--------GPKANVEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 45788899999999999999986 443 57888875221 11222457889999999999999999998
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+... ..++++||+++|+|.+++..+ ...+++..+..++.|++.||.|||++||+||||
T Consensus 78 ~~~~---------------------~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~di 135 (303)
T cd05110 78 CLSP---------------------TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDL 135 (303)
T ss_pred EcCC---------------------CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeecccc
Confidence 8532 125799999999999998654 345899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 136 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999975433221 1223345778999999998999999999999999999997 99999887
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
...+.. .+...+.....+..++..+.+++.+||..+|++||++.+|++.|+++....
T Consensus 216 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 216 PTREIP-DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 655544 344555556666778899999999999999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=302.56 Aligned_cols=268 Identities=19% Similarity=0.307 Sum_probs=214.7
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
....|+-.+|++.+.||+|||+.||+++. +++.+|+|.+.-.. ....+...+|++..++++|||+++++
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---------~~~~e~~~rEid~~rkf~s~~vl~l~ 84 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---------QEDIEEALREIDNHRKFNSPNVLRLV 84 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---------hHHHHHHHHHHHHHHhhCCcchHHHH
Confidence 44567888999999999999999999875 78899999886321 22345677999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKK-- 227 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~-- 227 (390)
++...... ......|++++|...|+|.+.+.... +..+++.+++.|+.+|++||++||...
T Consensus 85 dh~l~~~~---------------D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~ 149 (302)
T KOG2345|consen 85 DHQLREEK---------------DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPP 149 (302)
T ss_pred HHHHHhhc---------------cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCc
Confidence 88654321 02345799999999999999997543 456999999999999999999999998
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCCC---------CCCCCCCCCCccccccccCC---CCCCCchhHHHHHH
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP---------RDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGI 295 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~---------~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~ 295 (390)
+.||||||.|||+++++.++|.|||.++...-.. .++.....|..|.|||.+.- ...+.++|||||||
T Consensus 150 yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC 229 (302)
T KOG2345|consen 150 YAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC 229 (302)
T ss_pred ccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence 9999999999999999999999999987432111 22344567999999999854 45788999999999
Q ss_pred HHHHHHhCCCCCCCC--ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 296 CLWEIYCCDMPYPDL--SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 296 il~ell~g~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
+||+|+.|..||... ....+..++....+..+.....|..+.++|+.||+.||.+||++.+|+..++++.
T Consensus 230 tLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 230 TLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999999999999542 1111222333334444444458999999999999999999999999999999874
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=312.59 Aligned_cols=245 Identities=30% Similarity=0.546 Sum_probs=193.3
Q ss_pred cccccCceEEEEEEE-C---CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccC
Q 036382 88 LIAQGTYGSVYRGTY-D---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
.||+|+||.||+|.. . ...+|+|.+.... .......+.+|+.+++.++||||+++++.+.+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~------ 67 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES------ 67 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC------
Confidence 689999999999965 2 3467888764211 112235678899999999999999999998744
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR---KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...|+||||+.+|+|.+++.+... ...++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 68 --------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill 133 (269)
T cd05042 68 --------------IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL 133 (269)
T ss_pred --------------CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe
Confidence 345889999999999999976432 235678889999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 241 DSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQG-------KPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
+.++.+||+|||++....... .......+++.|+|||++.. ..++.++|||||||++|||++ |..||...
T Consensus 134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 134 TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 999999999999986432211 11123345678999998743 456889999999999999999 88999888
Q ss_pred ChhhHHHHHHHcCC----CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 311 SFADVSSAVVRQNL----RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 311 ~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
...+.......... .+..+..++..+.+++..|| .||++|||+.+|++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 77766655544332 12334567889999999999 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=320.20 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=210.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||+|.+.... .........+.+|+++++.++||||+++++.+.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE------MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE- 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc------cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-
Confidence 3688999999999999999987 47899999986332 11122346688999999999999999999998643
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+||||+.+++|.+++.+..+..+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 74 -------------------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 134 (316)
T cd05574 74 -------------------TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134 (316)
T ss_pred -------------------CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence 3458899999999999999765556799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC-----------------------------CCCCCCCCCCccccccccCCCCCCCchh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP-----------------------------RDMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 214 (316)
T cd05574 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214 (316)
T ss_pred EEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHH
Confidence 99999999999999986432111 0111235788999999999988999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHHHHHH
Q 036382 290 VYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE----MGEVVKM 360 (390)
Q Consensus 290 iwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~~ll~~ 360 (390)
|||||+++|+|++|..||...+.......+.............+..+.++|.+||..||++||| +++++..
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999999999999999999888777776665444433333346899999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.54 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=207.5
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
+....++|++.+.||+|+||.||++.. +++.+|+|+++... .....+.+|+.+++.+ +||||+++++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----------DIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----------chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 344567899999999999999999977 57899999875211 1124567899999999 7999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++..... ..+...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++|
T Consensus 83 ~~~~~~~---------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 147 (286)
T cd06638 83 MYYKKDV---------------KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH 147 (286)
T ss_pred eeeeccc---------------CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 8753211 1234569999999999999988532 2356899999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
|||||+||+++.++.++|+|||++..............+++.|+|||++.. ..++.++|+|||||++|+|++|..
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred cCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 999999999999999999999998765433333344568999999999853 457889999999999999999999
Q ss_pred CCCCCChhhHHHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 306 PYPDLSFADVSSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
||................ .....+..++..+.++|.+||+.||++|||+.+|++.+
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 228 PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 998776544443332221 11223555788999999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=308.04 Aligned_cols=247 Identities=34% Similarity=0.657 Sum_probs=204.9
Q ss_pred ccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCc
Q 036382 87 NLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSK 165 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 165 (390)
++||.|+||.||++.+. ++.||+|++..... ......+.+|++++++++||||+++++++.+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 65 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ------- 65 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-------
Confidence 46899999999999875 78999998863211 123467889999999999999999999987543
Q ss_pred ccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCc
Q 036382 166 TASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245 (390)
Q Consensus 166 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~ 245 (390)
..++||||+.+++|.+++.+. ...+++..+..++.+++.||.|||+++++||||+|+|||++.++.
T Consensus 66 -------------~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~ 131 (251)
T cd05041 66 -------------PIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV 131 (251)
T ss_pred -------------CeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc
Confidence 347899999999999999653 346889999999999999999999999999999999999999999
Q ss_pred EEEeecccceeccCCCCCC--CCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHc
Q 036382 246 LKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQ 322 (390)
Q Consensus 246 ~kL~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~ 322 (390)
++|+|||++.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+ ..
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~ 210 (251)
T cd05041 132 LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ES 210 (251)
T ss_pred EEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hc
Confidence 9999999987543211111 11234567999999988889999999999999999999 88999887765555444 44
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 323 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
......+..+|.++.+++.+||..+|.+|||+.+|++.|++
T Consensus 211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 45566777889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.01 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=202.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||.||+|++ +++.||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--------APCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--------chhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 46899999999999999999987 57899999986432211 123456899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+. ++|.+++.+. ...+++..+..++.||+.||.|||+.||+|+||||+|
T Consensus 77 ~--------------------~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~N 134 (301)
T cd07873 77 K--------------------SLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134 (301)
T ss_pred C--------------------eEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHH
Confidence 3 4588999997 5899988653 3468999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.++|+|||++..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+..
T Consensus 135 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 135 LLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred EEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998754433333344567899999999865 45788999999999999999999999887765544
Q ss_pred HHHHHcCC-----------------C---C--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQNL-----------------R---P--------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~~-----------------~---~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..+..... . + .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 33321100 0 0 011346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.82 Aligned_cols=245 Identities=27% Similarity=0.484 Sum_probs=198.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.++||+|+||.||+|.+ +++.||+|++.... .......+.+|++++++++||||+++++.+....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 3688899999999999999986 67899999986321 1122356889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+||
T Consensus 73 --------------------~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 73 --------------------RISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred --------------------EEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 347899999999997642 478899999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF------ 312 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~------ 312 (390)
|++.++.++|+|||++...... ......+|..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 127 ll~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 204 (279)
T cd06619 127 LVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204 (279)
T ss_pred EECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence 9999999999999998754322 23345789999999999998999999999999999999999999965321
Q ss_pred -hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 313 -ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 313 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
......+.............++++.++|.+||+.+|++||++.++++.-
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred hHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1222222211111112334678999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.12 Aligned_cols=247 Identities=29% Similarity=0.486 Sum_probs=207.1
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||+|+||.||+|.+ +++.||+|+++... .......+.+|+.+++.++||||+++++.+....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-
Confidence 477888999999999999987 56799999886321 1123467889999999999999999999886443
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 76 -------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~ 133 (277)
T cd06642 76 -------------------KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVL 133 (277)
T ss_pred -------------------ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEE
Confidence 44889999999999998843 45899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+
T Consensus 134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred EeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 99999999999999875443322223346788999999999988999999999999999999999999876655554433
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.....+..+..++.++.+++.+||..+|.+|||+.++++.
T Consensus 214 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 214 -PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3344555666788999999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=308.77 Aligned_cols=250 Identities=36% Similarity=0.693 Sum_probs=209.4
Q ss_pred ccccccccccCceEEEEEEECC------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
+++.+.||.|+||.||++.+.. ..||+|+++.... ......+..|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--------EQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--------hHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 4677899999999999998853 7899999863321 1134678899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. +..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus 73 ~--------------------~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ 132 (258)
T smart00219 73 E--------------------EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAAR 132 (258)
T ss_pred C--------------------CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccc
Confidence 4 34488999999999999996644333899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCC-CCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMT-GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
||+++.++.++|+|||++........... ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 133 NCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred eEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999975543311111 2336789999999988889999999999999999998 889998877777
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
....+. .......+..+|.++.+++.+||..||++|||+.++++.|
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 VLEYLK-KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHh-cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 766554 4445666777899999999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.30 Aligned_cols=248 Identities=31% Similarity=0.617 Sum_probs=202.8
Q ss_pred ccccccCceEEEEEEECC--------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 87 NLIAQGTYGSVYRGTYDN--------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.||+|+||.||+|++.. ..+|+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE 72 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC
Confidence 368999999999997632 579999875221 1122356788999999999999999999986443
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
..++||||+++++|.+++.+.. ...+++..+..++.|++.||.|||+.+++|+||
T Consensus 73 --------------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 132 (269)
T cd05044 73 --------------------PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL 132 (269)
T ss_pred --------------------CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 3488999999999999996532 234788999999999999999999999999999
Q ss_pred CCCCEEECCCC-----cEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 036382 234 KTENMLLDSQR-----TLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDM 305 (390)
Q Consensus 234 kp~NILl~~~~-----~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 305 (390)
+|+||+++.++ .++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred ChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCC
Confidence 99999999887 89999999987443211 11112345678999999999999999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
||...+..+....+ ..+.....+..+|..+.++|.+||..+|.+||++.+|++.|++
T Consensus 213 p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 213 PYPALNNQEVLQHV-TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcccCHHHHHHHH-hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 99887776655544 3444556777889999999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=314.01 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=208.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||.|+||.||+|.+ ++..||+|+++... .......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT- 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 578889999999999999987 57899999986321 1122467889999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 76 -------------------~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil 133 (277)
T cd06640 76 -------------------KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVL 133 (277)
T ss_pred -------------------EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEE
Confidence 34889999999999999853 35899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+
T Consensus 134 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 134 LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred EcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 99999999999999976543332233346788999999999888999999999999999999999999887766555433
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.....+..+..++..+.+++.+||..+|++||++.+++..
T Consensus 214 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3344556666788999999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=311.06 Aligned_cols=260 Identities=22% Similarity=0.480 Sum_probs=212.7
Q ss_pred CccccccccccCceEEEEEEEC---CceEEEEEeccCCCCccc-hHHHHHHHHHHHHHHHHHHh-cCCCccceEEEEEec
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMAT-TAETAALRSSFQQEVAVWQK-LDHPNVTKFVGASVG 156 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 156 (390)
.|++.+.||+|+||.||+|.+. ++.+|+|.+......... ..........+.+|+.++++ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999874 478999988643322111 11222334566788888875 699999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDV 233 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDl 233 (390)
. ...+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+++|+||
T Consensus 81 ~--------------------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl 140 (269)
T cd08528 81 N--------------------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDL 140 (269)
T ss_pred C--------------------CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCC
Confidence 4 345889999999999998854 234568999999999999999999996 78999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
+|+|||++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 9999999999999999999997644332 334566889999999999888999999999999999999999999887777
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
.....+......+.....+++++.++|.+||+.||++||++.++.+.|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 6666665555444444467899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=313.37 Aligned_cols=257 Identities=28% Similarity=0.610 Sum_probs=209.9
Q ss_pred cCccccccccccCceEEEEEEEC------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
++|++.+.||+|+||.||++.++ +..||||+++..... .....+.+|+++++.++||||+++++++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------QHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 56888999999999999999863 578999998633211 3346788999999999999999999988
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.... ....+++|||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.|++|+|||
T Consensus 76 ~~~~------------------~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 136 (284)
T cd05038 76 EKPG------------------GRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLA 136 (284)
T ss_pred ecCC------------------CCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 6532 234589999999999999996543 359999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 137 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 137 ARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred HHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 99999999999999999999865422111 112234567999999988899999999999999999999999986532
Q ss_pred hh--------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 312 FA--------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 312 ~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.. ......+....+...+..+|.++.+++.+||..+|.+|||+.+|++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 21 112233344555566778899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=319.42 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=201.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.+ ++..+|+|.++... .......+.+|++++++++||||+++++++.+..
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3689999999999999999987 56789999886321 1223456788999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVKTEN 237 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlkp~N 237 (390)
..|+||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||||+|
T Consensus 73 --------------------~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 73 --------------------EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred --------------------EEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 448899999999999999653 568999999999999999999997 599999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+......
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 208 (308)
T cd06615 131 ILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208 (308)
T ss_pred EEEecCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence 99999999999999998754322 1234578899999999988889999999999999999999999997554333221
Q ss_pred HHH-----------------------------------HcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 318 AVV-----------------------------------RQNLRPEIP-RCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 318 ~~~-----------------------------------~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
.+. .....+..| ..++.++.+||.+||..+|++|||+.+|++.-
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111 011111222 13678899999999999999999999999874
Q ss_pred H
Q 036382 362 E 362 (390)
Q Consensus 362 ~ 362 (390)
-
T Consensus 289 ~ 289 (308)
T cd06615 289 F 289 (308)
T ss_pred h
Confidence 3
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=306.99 Aligned_cols=251 Identities=27% Similarity=0.496 Sum_probs=209.9
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|+..+.||+|+||.||+|.. +++.|++|.+....... ........+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-- 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ----TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-- 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc----cchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--
Confidence 467778999999999999987 57899999986432211 1222346688999999999999999999988644
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..+++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 75 ------------------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~ 134 (258)
T cd06632 75 ------------------DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134 (258)
T ss_pred ------------------CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 3458899999999999999653 45899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.++.+||+|||++....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||......+....
T Consensus 135 ~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~ 213 (258)
T cd06632 135 VDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213 (258)
T ss_pred ECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence 9999999999999987544322 233456889999999997766 89999999999999999999999987766555555
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.......+.++..++.++.+++.+||..+|.+|||+.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 214 IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 54444556677788999999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=310.42 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=204.2
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.+++.+.+.....||+|+||.||+|.+ ++..||+|.+.... ......+.+|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 73 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---------SRYVQPLHEEIALHSYLKHRNIVQYLGS 73 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---------HHHHHHHHHHHHHHHhcCCCCeeeeeee
Confidence 455666777778999999999999986 46789999876321 1123567899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCC--CHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL--ALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+... ...++|+||+.+++|.+++.... ..+ ++..+..++.||+.||.|||+.||+||
T Consensus 74 ~~~~--------------------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~ 132 (268)
T cd06624 74 DSEN--------------------GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132 (268)
T ss_pred eccC--------------------CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 8754 34478999999999999996542 234 888899999999999999999999999
Q ss_pred CCCCCCEEECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 232 DVKTENMLLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
||||+||+++. ++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus 133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred CCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999976 6799999999987543322223334578999999998654 37889999999999999999999997
Q ss_pred CCChhh-HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 309 DLSFAD-VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 309 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...... ...........+.+|..+++++.+++.+||..+|.+|||+.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 213 ELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 643322 2222222234456778889999999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=310.15 Aligned_cols=260 Identities=26% Similarity=0.519 Sum_probs=207.8
Q ss_pred ccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
|++.+.||+|+||.||+|.+ ++..||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-------FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-------CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 56788999999999999975 35789999986321 1112245678899999999999999999988643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
.... .....++++||+.+|+|.+++.... ...+++..+..++.|++.||+|||+.||+||||
T Consensus 74 ~~~~--------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~di 139 (273)
T cd05074 74 RAKG--------------RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDL 139 (273)
T ss_pred CCCC--------------cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 2110 1123478999999999998875321 224789999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
||+||+++.++.+||+|||+++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 140 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 140 AARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred chhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999875432211 1122335678999999998889999999999999999999 89999887
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+..+....+.. ......+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 220 ENSEIYNYLIK-GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 77666555443 334445567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=307.65 Aligned_cols=250 Identities=25% Similarity=0.478 Sum_probs=209.5
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||++.. +++.+|||.+..... .......+.+|+++++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-------TKDERLAAQNECQVLKLLSHPNIIEYYENFLED-- 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-------ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--
Confidence 488899999999999999876 678999999863321 112246688999999999999999999987643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++||||+++++|.+++.......+++..+..++.+++.||.|||++|++|+||+|+||+
T Consensus 72 ------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 133 (256)
T cd08220 72 ------------------KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133 (256)
T ss_pred ------------------CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 34588999999999999997665566899999999999999999999999999999999999
Q ss_pred ECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.+ +.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 212 (256)
T cd08220 134 LDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212 (256)
T ss_pred EcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 9865 468999999997654322 22235678899999999988899999999999999999999999988777666655
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+... .....+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 213 ~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 IMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 5443 3345667789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=315.70 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=208.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.. +++.||+|.++.. ..........+.+|+++++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ------NLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehh------hhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence 3688999999999999999987 5679999988632 1112233456778999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 75 --------------------~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 75 --------------------HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred --------------------EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 448899999999999999543 4689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC---------------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP---------------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 303 (390)
+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 133 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g 212 (305)
T cd05609 133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212 (305)
T ss_pred EECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999886321100 001123578899999999888899999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHcCCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 304 DMPYPDLSFADVSSAVVRQNLR-PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 304 ~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
..||.+.+..+........... +..+..+|.++.++|.+||+.||++||+...+.+.|+.
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 213 CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 9999988888777766554432 22233678999999999999999999997666666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.10 Aligned_cols=257 Identities=29% Similarity=0.428 Sum_probs=207.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
..++|++.+.||+|+||.||++.. +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----------DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 357899999999999999999987 57899999985321 1124566889999998 8999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
..+.. .....|+||||+.+++|.+++... ....+++..++.++.|++.||.|||+.|++|+||
T Consensus 90 ~~~~~---------------~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl 154 (291)
T cd06639 90 KADKL---------------VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDV 154 (291)
T ss_pred ecccc---------------CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 54321 234568999999999999988542 3456899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-----PYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
||+||+++.++.++|+|||++..............++..|+|||.+... .++.++|+|||||++|+|++|+.||.
T Consensus 155 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 155 KGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred CHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999987544333233345688999999998543 36889999999999999999999998
Q ss_pred CCChhhHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 309 DLSFADVSSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..........+..... ....+..++.++.++|.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 235 DMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 8776555544433221 122345677889999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.30 Aligned_cols=247 Identities=24% Similarity=0.432 Sum_probs=205.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||.|+||.||++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---------chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 5799999999999999999986 688999999863321 11245778999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 90 --------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Ni 146 (297)
T cd06656 90 --------------------ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI 146 (297)
T ss_pred --------------------EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 45889999999999999854 3589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.++|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 147 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred EECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 99999999999999987544333333345688999999999998899999999999999999999999977655443322
Q ss_pred HHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 319 VVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 319 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+...+ .....+..++..+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222 122345678899999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.75 Aligned_cols=262 Identities=31% Similarity=0.607 Sum_probs=225.1
Q ss_pred cccccccCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CC
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 144 (390)
.|+++.+++.+.+.||+|.||.|++|... ...||||.++.... ....+.+..|+++|+.+ .|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--------~~~~~~~~~El~~m~~~g~H 361 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--------SSEKKDLMSELNVLKELGKH 361 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--------cHHHHHHHHHHHHHHHhcCC
Confidence 79999999999999999999999998642 34799999873221 13457889999999999 79
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc------------c--CCCCHHHHH
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR------------R--KKLALKIVI 210 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~ 210 (390)
|||+.++|+|... +..++|+||+..|+|..+|+.++ . ..++...++
T Consensus 362 ~niv~llG~~t~~--------------------~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLl 421 (609)
T KOG0200|consen 362 PNIVNLLGACTQD--------------------GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLL 421 (609)
T ss_pred cchhhheeeeccC--------------------CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHH
Confidence 9999999999853 34478999999999999997654 0 238999999
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCC-CCCC--CCCccccccccCCCCCCCc
Q 036382 211 QLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM-TGET--GTLGYMAPEVLQGKPYNRR 287 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~ 287 (390)
.++.||+.||+||++.++|||||..+|||+..+..+||+|||+|+......... .... -+..|||||.+....|+.+
T Consensus 422 sfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 422 SFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred HHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc
Confidence 999999999999999999999999999999999999999999998543322211 2222 3566999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCC-hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 288 CDVYSFGICLWEIYC-CDMPYPDLS-FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 288 ~DiwSlG~il~ell~-g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
+||||||++||||++ |..||++.. ..++ ...++.+.+.+.|..|+++++++|+.||+.+|++||++.++.+.|+..-
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 999999999999998 889999976 5555 4578999999999999999999999999999999999999999999953
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=309.60 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=208.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|.. +++.+++|++..... ....+.+|+.+++++ .||||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 36899999999999999999987 567899999863211 125678999999999 79999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.... ......++||||+.+++|.+++.... +..+++..+..++.|++.||.|||+.|++|+||+
T Consensus 75 ~~~~--------------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~ 140 (275)
T cd06608 75 KNPP--------------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140 (275)
T ss_pred cCCC--------------CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 4321 12455789999999999999986533 4679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|+||+++.++.++|+|||++..............++..|+|||++.. ..++.++|+|||||++|+|++|..||..
T Consensus 141 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred HHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 99999999999999999998755443333344568899999998753 3467899999999999999999999987
Q ss_pred CChhhHHHHHHHcCCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 310 LSFADVSSAVVRQNLR-PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.........+...... ...+..++.++.+||.+||..||++|||+.+|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 221 MHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 6655555444332211 1123346789999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=315.44 Aligned_cols=255 Identities=25% Similarity=0.474 Sum_probs=207.2
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+..++|++.+.||+|+||.||++.+ +++.||+|++.... .......+.+|+++++.++||||+++++++.
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--------KSSVRKQILRELQIMHECRSPYIVSFYGAFL 73 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--------cchHHHHHHHHHHHHHHcCCCCcceEeeeEe
Confidence 3457899999999999999999987 47899999886321 1223467889999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVK 234 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlk 234 (390)
.. ...++||||+++++|.+++.+ .+.+++..+..++.+++.||.|||+ .+++||||+
T Consensus 74 ~~--------------------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~ 131 (284)
T cd06620 74 NE--------------------NNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIK 131 (284)
T ss_pred cC--------------------CEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCC
Confidence 54 345889999999999999854 3468999999999999999999997 689999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh-
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA- 313 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 313 (390)
|+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 132 p~nil~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 209 (284)
T cd06620 132 PSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209 (284)
T ss_pred HHHEEECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence 999999999999999999986432221 12356899999999998888999999999999999999999999765432
Q ss_pred ----------hHHHHHHHcCCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 314 ----------DVSSAVVRQNLRPEIPR-CCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 314 ----------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
+....+... ..+..+. .++.++.+|+.+||..||.+|||+.++++...-+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 210 DGQDDPMGILDLLQQIVQE-PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhHHHHHHHHHhhc-cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 222233222 2222333 37889999999999999999999999998754444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=313.91 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=200.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-------PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-------ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 4688999999999999999987 5789999988632211 112245678999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 74 --------------------~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 74 --------------------KLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred --------------------EEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 34789999999888877643 34699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+...
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~ 211 (286)
T cd07847 132 LITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211 (286)
T ss_pred EEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999865443323334567889999999876 557899999999999999999999998876655443
Q ss_pred HHHHcC-------------------CCCCC----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQN-------------------LRPEI----------PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~-------------------~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+.... ...+. -...+..+.+|+.+||..+|++|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 332100 00000 1235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=310.89 Aligned_cols=237 Identities=24% Similarity=0.408 Sum_probs=189.8
Q ss_pred cccccCceEEEEEEEC--------------------------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHh
Q 036382 88 LIAQGTYGSVYRGTYD--------------------------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 141 (390)
+||+|+||.||+|... ...||+|+++. ........+.+|+.+++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~---------~~~~~~~~~~~~~~~~~~ 72 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP---------SHRDIALAFFETASLMSQ 72 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh---------HHHHHHHHHHHHHHHHhc
Confidence 6999999999998641 13588998852 122234567889999999
Q ss_pred cCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Q 036382 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLS 221 (390)
Q Consensus 142 l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~ 221 (390)
++||||+++++++.... ..++||||+++|+|..++.+. ...+++..+..++.||+.||+
T Consensus 73 l~h~niv~~~~~~~~~~--------------------~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~ 131 (274)
T cd05076 73 VSHIHLAFVHGVCVRGS--------------------ENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALS 131 (274)
T ss_pred CCCCCeeeEEEEEEeCC--------------------ceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence 99999999999987543 347899999999999988643 356899999999999999999
Q ss_pred HHHhCCCcccCCCCCCEEECCCC-------cEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHH
Q 036382 222 YLHSKKIVHRDVKTENMLLDSQR-------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSF 293 (390)
Q Consensus 222 yLH~~~iiHrDlkp~NILl~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl 293 (390)
|||++||+||||||+|||++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|+|||
T Consensus 132 ~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 132 YLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred HHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 99999999999999999997643 4899999987643221 22357788999998865 568999999999
Q ss_pred HHHHHHHH-hCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 294 GICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 294 G~il~ell-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
||++|||+ +|..||......+..... ... ...+...++.+.++|.+||+.+|++|||+.+|++.|
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKERFY-EKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHHH-Hhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99999995 699999887665544322 222 223444567899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.11 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=206.2
Q ss_pred cCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||.|+||.||+|... ++.|++|.++.. .. ...+.+|+++++.++||||+++++.+.+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~- 70 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------ED----LQEIIKEISILKQCDSPYIVKYYGSYFKN- 70 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC-
Confidence 57999999999999999999873 689999998521 11 46788999999999999999999998754
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+++||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 71 -------------------~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 130 (256)
T cd06612 71 -------------------TDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI 130 (256)
T ss_pred -------------------CcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 3458899999999999998643 35689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
+++.++.++|+|||++..............++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~ 210 (256)
T cd06612 131 LLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210 (256)
T ss_pred EECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence 99999999999999987654433233345578899999999998999999999999999999999999987766554433
Q ss_pred HHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 319 VVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 319 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+.... .....+..++.++.++|.+||+.||.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 32211 111234457789999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.72 Aligned_cols=238 Identities=24% Similarity=0.420 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEEC--------------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 87 NLIAQGTYGSVYRGTYD--------------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
+.||+|+||.||+|+.. ...|++|++... .......+.+|+.+++.++||||+++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~l~~l~hp~iv~~~~ 71 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---------HRDISLAFFETASMMRQVSHKHIVLLYG 71 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---------hhhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 36899999999999752 225888987521 1223456788999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.... ..++||||+++|+|..++.+. ...+++..++.++.||+.||+|||+++|+|||
T Consensus 72 ~~~~~~--------------------~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 130 (262)
T cd05077 72 VCVRDV--------------------ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGN 130 (262)
T ss_pred EEecCC--------------------CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCC
Confidence 987543 337899999999999888543 34689999999999999999999999999999
Q ss_pred CCCCCEEECCCCc-------EEEeecccceeccCCCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHH-hC
Q 036382 233 VKTENMLLDSQRT-------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIY-CC 303 (390)
Q Consensus 233 lkp~NILl~~~~~-------~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-~g 303 (390)
|||+|||++.++. ++++|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|
T Consensus 131 lkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 131 VCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCcccEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9999999987664 89999999864322 12345788899999886 567899999999999999998 58
Q ss_pred CCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 304 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
..||......+... ....... .....+.++.+||.+||+.||.+||++.+|++.|
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 88988766544432 2222222 2333467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.07 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=204.8
Q ss_pred ccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||.|+||.||++++. ++.||+|++.... .........+.+|+.+++.++||||+++++.+.+...
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------- 67 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY------- 67 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc-------
Confidence 689999999999985 7899999986321 1122234678899999999999999999999875443
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
.+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 68 -------------~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~ 132 (262)
T cd05572 68 -------------IYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132 (262)
T ss_pred -------------cEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCE
Confidence 47899999999999999553 458999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhhHHHHHHHcCC
Q 036382 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--FADVSSAVVRQNL 324 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~~~~~~~~~~~~~ 324 (390)
+|+|||++....... ......+++.|++||.+.+..++.++|+||||+++|+|++|..||.... ..+....+.....
T Consensus 133 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 211 (262)
T cd05572 133 KLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211 (262)
T ss_pred EEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC
Confidence 999999987654332 2233467889999999988889999999999999999999999998776 5566666655455
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVK 359 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~ 359 (390)
....|..+++++.++|.+||..+|++||+ +.++++
T Consensus 212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 66777778999999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.45 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=211.7
Q ss_pred ccccccCccccccccccCceEEEEE--EECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+.+..+.|+..++||+|+||.||-+ +.+|+-+|.|.+.. .............+|..||.+++.+.||.+-.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K------KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK------KRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHH------HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 4566678999999999999999966 45899999998852 122223334556789999999999999999888
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
|.+.+.+ |+||..|.||+|.-+|.+..+..+++..++.++.+|++||++||+.+||+|||
T Consensus 254 feTkd~L--------------------ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDL 313 (591)
T KOG0986|consen 254 FETKDAL--------------------CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDL 313 (591)
T ss_pred ecCCCce--------------------EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccC
Confidence 8765444 99999999999999998877778999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS-- 311 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-- 311 (390)
||+|||+|+.|+++|+|+|+|...... ....+.+||.+|||||++.+..|+.+.|+|||||++|||+.|+.||....
T Consensus 314 KPeNILLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 314 KPENILLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred ChhheeeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 999999999999999999999866543 34455699999999999999999999999999999999999999996643
Q ss_pred --hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 036382 312 --FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355 (390)
Q Consensus 312 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 355 (390)
.+++-+.+.. ...+++..+++++++|.+.+|++||++|....
T Consensus 393 vk~eEvdrr~~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 393 VKREEVDRRTLE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhHHHHHHHHhc--chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3344333332 34467889999999999999999999997543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.11 Aligned_cols=246 Identities=25% Similarity=0.499 Sum_probs=192.9
Q ss_pred cccccCceEEEEEEE-CCc---eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccC
Q 036382 88 LIAQGTYGSVYRGTY-DNQ---EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
.||+|+||.||+|.. ++. .+++|.++... .......+.+|+.+++.++||||+++++.+.+..
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----- 68 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----- 68 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----
Confidence 689999999999965 332 45566654211 1122467889999999999999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
..|+||||+++|+|.+++.+.. ...+++..+..++.||+.||.|||+.+++||||||+|||++
T Consensus 69 ---------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~ 133 (268)
T cd05086 69 ---------------PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133 (268)
T ss_pred ---------------ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc
Confidence 3488999999999999996542 23467778889999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 242 SQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQG-------KPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
.++.++|+|||++...... ........++..|+|||++.. ..++.++|||||||++|||++ |..||...+
T Consensus 134 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 134 SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999998632211 112234567889999999753 245789999999999999997 577998877
Q ss_pred hhhHHHHHHHcC----CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 312 FADVSSAVVRQN----LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 312 ~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
..+....+.... .++..+..+++.+.+++..|| .+|.+|||+.+|++.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 777666654433 233445567889999999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=335.86 Aligned_cols=254 Identities=19% Similarity=0.316 Sum_probs=194.4
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC------Cccc
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH------PNVT 148 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv 148 (390)
.+..++|++.++||+|+||.||+|.+ +++.||||+++... .....+..|+.+++.++| ++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----------KYTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----------hhHHHHHHHHHHHHHHhhcCcccCccee
Confidence 34457899999999999999999987 57789999986211 112334557777776654 4588
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KK 227 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~ 227 (390)
++++++... ....|+|||++ +++|.+++.+. ..+++..+..++.||+.||.|||+ .|
T Consensus 195 ~i~~~~~~~-------------------~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g 252 (467)
T PTZ00284 195 KIQRYFQNE-------------------TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH 252 (467)
T ss_pred eeEEEEEcC-------------------CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 888887642 23468999988 77899988653 469999999999999999999998 59
Q ss_pred CcccCCCCCCEEECCCC----------------cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHH
Q 036382 228 IVHRDVKTENMLLDSQR----------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVY 291 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~----------------~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 291 (390)
||||||||+|||++.++ .+||+|||.+.... ......+||+.|+|||++.+..|+.++|||
T Consensus 253 IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 99999999999998765 49999999886432 223456799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCC-------------------------CCCC-C--------------CC
Q 036382 292 SFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL-------------------------RPEI-P--------------RC 331 (390)
Q Consensus 292 SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------------------~~~~-~--------------~~ 331 (390)
||||++|||++|+.||...+..+.+..+..... .+.. + ..
T Consensus 330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 999999999999999988766554433221100 0000 0 00
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 036382 332 CPSSLANIMRKCWDANAEKRPEMGEVVK--MLEAID 365 (390)
Q Consensus 332 ~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~ 365 (390)
..+.+.+||.+||..||.+|||+.|+++ .+....
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 1345779999999999999999999997 444433
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=305.06 Aligned_cols=249 Identities=30% Similarity=0.520 Sum_probs=204.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||+|.. +++.||+|+++..... ......+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-- 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-- 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-------hHHHHHHHHHHHHHHhCCCCChhheeeeEecC--
Confidence 478889999999999999986 5789999998743221 33457788999999999999999999987643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++|+||+.+++|.+++.+ +..+++..+..++.+++.||.|||+.|++|+||+|+||+
T Consensus 72 ------------------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil 131 (264)
T cd06626 72 ------------------EKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131 (264)
T ss_pred ------------------CEEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 345889999999999999954 345889999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCC----CCCCCCCccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDM----TGETGTLGYMAPEVLQGKP---YNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
++.++.+||+|||++.......... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.
T Consensus 132 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred ECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 9999999999999987654322211 1346788999999998766 88999999999999999999999977643
Q ss_pred hhHHHHHHHcCCCCCCCCCC--cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCC--PSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.............+..|... +..+.+++.+||+.+|.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 212 EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 33333333334444555544 899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=306.30 Aligned_cols=255 Identities=25% Similarity=0.472 Sum_probs=212.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+|.+ +++.||+|++...... .........+.+|++++++++||||+++++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS----QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc----chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 4789999999999999999986 5789999987532211 112233467889999999999999999999886432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
....++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 78 ------------------~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni 137 (264)
T cd06653 78 ------------------EKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI 137 (264)
T ss_pred ------------------CCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 23457899999999999998543 4588999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCC---CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQN---PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+++.++.++|+|||+++..... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||........
T Consensus 138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 9999999999999998754321 1112234688999999999988899999999999999999999999988776666
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..++.....++.+|..+++.+.+++.+||. +|..|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 218 IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 666666666677888899999999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=313.31 Aligned_cols=251 Identities=26% Similarity=0.430 Sum_probs=201.3
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|+..+.||.|+||.||+|.+ +++.||||.++.... .......+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-------ccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-
Confidence 478889999999999999987 578999998863321 1112346778999999999999999999886443
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++||||+. ++|..++.......+++..+..++.|++.||+|||+.+++|+||+|+||+
T Consensus 73 -------------------~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nil 132 (284)
T cd07860 73 -------------------KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132 (284)
T ss_pred -------------------cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 3488999996 68999987655667999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.++.++|+|||++..............+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....
T Consensus 133 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 133 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred ECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99999999999999875443333334456788999999887644 68899999999999999999999987665544433
Q ss_pred HHHcCCCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRP---------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+......+ .....++.+++++|.+||+.||.+|||+.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 32211000 0112467889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.77 Aligned_cols=251 Identities=28% Similarity=0.472 Sum_probs=206.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||.|+||.||+|.. ++..+|+|++..... ......+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG- 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--------chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-
Confidence 4789999999999999999976 678999999863211 11346688999999999999999999988654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++|||++.+++|.+++.+... ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 72 -------------------~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 72 -------------------DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred -------------------CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 345889999999999999976433 568999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCC----CCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|++++++.++|+|||++......... .....++..|+|||++... .++.++|+|||||++|+|++|..||...+.
T Consensus 133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 99999999999999998754432211 1234588999999998776 789999999999999999999999988776
Q ss_pred hhHHHHHHHcCCCCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIP-----RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
........... .+..+ ..+++.+.+++.+||..||++|||+.+|+++
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 213 MKVLMLTLQND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred hhhHHHHhcCC-CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 66555554332 11111 3567899999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.45 Aligned_cols=244 Identities=28% Similarity=0.496 Sum_probs=202.5
Q ss_pred cccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccC
Q 036382 86 RNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
.-+||+|+||+||.|++ +..++|||-+..... ....-+..|+.+-++|+|.|||+.+|.+..+.
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---------r~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----- 645 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---------REVQPLHEEIALHSTLRHKNIVRYLGSVSENG----- 645 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccc---------hhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----
Confidence 34799999999999987 445789998863322 12355778999999999999999999976544
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL--ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
..-|.||..+||+|.++|+... +++ ++..+-.+..||++||.|||.+.|||||||-+||||+
T Consensus 646 ---------------f~kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN 709 (1226)
T KOG4279|consen 646 ---------------FFKIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN 709 (1226)
T ss_pred ---------------eEEEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe
Confidence 3456999999999999997655 346 8889999999999999999999999999999999996
Q ss_pred C-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChhh-HHH
Q 036382 242 S-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD-VSS 317 (390)
Q Consensus 242 ~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-~~~ 317 (390)
. .|.+||+|||-+++...-.....++.||..|||||++..+ .|+.++|||||||++.||.||++||....... ...
T Consensus 710 TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF 789 (1226)
T KOG4279|consen 710 TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF 789 (1226)
T ss_pred eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh
Confidence 5 6999999999988765544455568899999999999764 58999999999999999999999997653332 222
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
++-.-+..|++|..++.+.+.||.+|+..||.+||++.++++
T Consensus 790 kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 790 KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 333334567899999999999999999999999999999984
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.84 Aligned_cols=250 Identities=23% Similarity=0.458 Sum_probs=203.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.+ +++.||+|.++... .......+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE- 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-
Confidence 4689999999999999999988 47899999886321 111235678899999999999999999988754
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlkp~ 236 (390)
+..++||||+++++|..++.... ...+++..+..++.|++.||.|||+ .+|+||||||+
T Consensus 72 -------------------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 132 (286)
T cd06622 72 -------------------GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132 (286)
T ss_pred -------------------CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence 34578999999999999885431 2368999999999999999999997 59999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK------PYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||+++.++.++|+|||++...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...
T Consensus 133 nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 133 NVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred HEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 999999999999999998754322 22335678899999998553 3578999999999999999999999776
Q ss_pred ChhhHHHHH--HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SFADVSSAV--VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
........+ ...+..+..+..++.++.+||.+||..+|.+||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 211 TYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred chhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 554433222 12334455677789999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.26 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=197.2
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||+|.+ +|+.||+|.++..... ......+.+|+++++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLLKELKHKNIVRLYDVLHSDK- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-------ccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-
Confidence 478889999999999999987 6789999998643211 112245678999999999999999999886543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++|+||+. ++|.+++.+. +..+++..++.++.||+.||.|||+.||+||||||+||+
T Consensus 73 -------------------~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil 131 (284)
T cd07839 73 -------------------KLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLL 131 (284)
T ss_pred -------------------ceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 4588999997 5888887543 356999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCC-CCCChhhHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPY-PDLSFADVSS 317 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf-~~~~~~~~~~ 317 (390)
++.++.++|+|||++..............++..|+|||.+.+. .++.++|||||||++|+|++|..|| .+.+..+...
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 132 INKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred EcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 9999999999999987544333334445678999999998764 4789999999999999999998885 4444433333
Q ss_pred HHHHcC------------------CCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQN------------------LRP---------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~------------------~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+.... ..+ .....+++++.++|.+||+.||.+|||+++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 221100 000 0112467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=309.66 Aligned_cols=239 Identities=25% Similarity=0.442 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 87 NLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+.||+|+||.||+|... ...||+|.+.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~---------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 71 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---------SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG 71 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc---------hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence 36899999999999762 23488887641 1223345678899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. .++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 72 ~~--------------------~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~n 130 (258)
T cd05078 72 DE--------------------SIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN 130 (258)
T ss_pred CC--------------------cEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 33 378999999999999996543 368999999999999999999999999999999999
Q ss_pred EEECCCCc--------EEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhC-CCCC
Q 036382 238 MLLDSQRT--------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCC-DMPY 307 (390)
Q Consensus 238 ILl~~~~~--------~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g-~~Pf 307 (390)
||++.++. ++++|||++..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++| ..||
T Consensus 131 ili~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 131 VLLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred EEEecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 99987764 69999998864332 123467889999999986 4578999999999999999998 4677
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
...+........ .. +...|...+.++.++|.+||+.||++|||+.++++.|+
T Consensus 207 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 207 SALDSQKKLQFY-ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred hhccHHHHHHHH-Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 666555443322 22 34566667789999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.97 Aligned_cols=251 Identities=24% Similarity=0.475 Sum_probs=208.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||++.. ++..||+|.+...... ....+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-- 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-------VKEKEASKKEVILLAKMKHPNIVTFFASFQEN-- 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-------chhhHHHHHHHHHHHhCCCCChhhhhheeccC--
Confidence 478889999999999999987 5789999998632111 11235677899999999999999999988643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++|+||+.+++|.+++.+.....+++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 72 ------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil 133 (257)
T cd08225 72 ------------------GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIF 133 (257)
T ss_pred ------------------CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEE
Confidence 34588999999999999997655556899999999999999999999999999999999999
Q ss_pred ECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.++ .++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 134 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 134 LSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred EcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 98886 46999999987654333223334688899999999888899999999999999999999999988777666655
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
... ....+.+..++.++.++|.+||..+|++|||+.++++.
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 214 ICQ-GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred Hhc-ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 543 33444556678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=315.00 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=211.6
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
-|.+.++||+|+||.||+|.+ +|+.+|+|.+.... ....+.+|+.||++++.|++|++||.+.....
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 488899999999999999865 79999999886322 14667899999999999999999998765444
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
.|+|||||..|+..+.++. ++++++++.+..++...+.||+|||...=||||||.-|||
T Consensus 103 --------------------LWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNIL 161 (502)
T KOG0574|consen 103 --------------------LWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNIL 161 (502)
T ss_pred --------------------eEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEE
Confidence 4889999999999998864 4578999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.+|+.||+|||.|...........+..|||.|||||++..-.|+.++||||||++..||..|++||.+..+-..+..+
T Consensus 162 LNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 162 LNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred EcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 99999999999999986555444556678999999999999999999999999999999999999999987765544333
Q ss_pred HHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
- .+..| ..|+.+++++.+|+++||.++|++|-|+.+|+++
T Consensus 242 P-T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 242 P-TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred c-CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2 22222 2467789999999999999999999999998864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=306.74 Aligned_cols=257 Identities=26% Similarity=0.480 Sum_probs=205.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCcc-chHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMA-TTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+|.+.+.||.|+||.||+|.. +++.||+|.++....... .........+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999976 678999998863221111 11222334567889999999999999999999986543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+++|+||+|+||
T Consensus 82 --------------------~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni 139 (272)
T cd06629 82 --------------------YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139 (272)
T ss_pred --------------------ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence 347899999999999999654 5689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
+++.++.++|+|||++....... .......++..|+|||.+.+.. ++.++|+||||+++|++++|..||...+..+
T Consensus 140 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 219 (272)
T cd06629 140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219 (272)
T ss_pred EEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence 99999999999999987543211 1123346788999999987654 8899999999999999999999997766555
Q ss_pred HHHHHHHcCCCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIP----RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+........++ ..++.++.++|.+||..+|.+|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 444443333333333 3468899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=314.66 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=185.3
Q ss_pred cccccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 86 RNLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
..+||+|+||.||+|.. +++.||+|.++.... ...+.+|+.++++++||||+++++++....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 71 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFLSHA--- 71 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------cHHHHHHHHHHHhcCCCCCcceeeeEecCC---
Confidence 45899999999999985 347899998863211 123568999999999999999999886432
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
....|++|||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+|||||
T Consensus 72 ---------------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlk 135 (317)
T cd07868 72 ---------------DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 135 (317)
T ss_pred ---------------CcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCC
Confidence 234589999986 58988875321 2358999999999999999999999999999999
Q ss_pred CCCEEE----CCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 235 TENMLL----DSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 235 p~NILl----~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|+|||+ +..+.+||+|||+++...... .......+|+.|+|||++.+ ..++.++|+||+||++|+|++|..|
T Consensus 136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred HHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 456799999999997643321 12334578999999999976 4589999999999999999999999
Q ss_pred CCCCChh---------hHHHHHHHc-C----------------------CCC-------------CCCCCCcHHHHHHHH
Q 036382 307 YPDLSFA---------DVSSAVVRQ-N----------------------LRP-------------EIPRCCPSSLANIMR 341 (390)
Q Consensus 307 f~~~~~~---------~~~~~~~~~-~----------------------~~~-------------~~~~~~~~~l~~li~ 341 (390)
|...... +....+... + +.. ......+.++.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 9643211 111111100 0 000 000112456889999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 036382 342 KCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 342 ~cl~~dP~~Rpt~~~ll~ 359 (390)
+||+.||.+|||++++++
T Consensus 296 ~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 296 KLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHhccCcccCCCHHHHhc
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.48 Aligned_cols=237 Identities=26% Similarity=0.462 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEECCc------------eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 87 NLIAQGTYGSVYRGTYDNQ------------EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
+.||+|+||.||+|.+.+. .|++|++.... .. ...+.+|+.+++.++||||+++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~-~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---------RD-SLAFFETASLMSQLSHKHLVKLYGVC 70 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---------hh-HHHHHHHHHHHHcCCCcchhheeeEE
Confidence 4689999999999988432 37788765221 11 46778899999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. . ..++||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus 71 ~~-~--------------------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlk 128 (259)
T cd05037 71 VR-D--------------------ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVC 128 (259)
T ss_pred ec-C--------------------CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCc
Confidence 64 2 2378999999999999996543 268999999999999999999999999999999
Q ss_pred CCCEEECCCC-------cEEEeecccceeccCCCCCCCCCCCCCccccccccCCC--CCCCchhHHHHHHHHHHHHh-CC
Q 036382 235 TENMLLDSQR-------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYC-CD 304 (390)
Q Consensus 235 p~NILl~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~-g~ 304 (390)
|+|||++.++ .+||+|||++..... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |.
T Consensus 129 p~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 129 GKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred cceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 9999999887 899999999875433 1224567789999999876 78999999999999999999 58
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
.||...+..+...... .... .+......+.++|.+||..+|.+|||+.++++.|+
T Consensus 205 ~p~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 205 EPLSTLSSSEKERFYQ-DQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCcccCCchhHHHHHh-cCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 8887776544433332 2212 22222478999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=325.61 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=192.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
...|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|++++++++||||+++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 45799999999999999999988 467899996431 2345899999999999999999998643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...|+|||++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 233 --------------------~~~~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~N 290 (461)
T PHA03211 233 --------------------GLTCLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTEN 290 (461)
T ss_pred --------------------CEEEEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHH
Confidence 34478999995 6899988653 3469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL----- 310 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~----- 310 (390)
||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+-..
T Consensus 291 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 291 VLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred EEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 9999999999999999975432211 122456999999999999999999999999999999999987654221
Q ss_pred ---ChhhHHHHHHHcCCC-CCCC-------------------------------CCCcHHHHHHHHHhhhhCCCCCCCHH
Q 036382 311 ---SFADVSSAVVRQNLR-PEIP-------------------------------RCCPSSLANIMRKCWDANAEKRPEMG 355 (390)
Q Consensus 311 ---~~~~~~~~~~~~~~~-~~~~-------------------------------~~~~~~l~~li~~cl~~dP~~Rpt~~ 355 (390)
....+...+...... ..++ ...+.++.+||.+||+.||.+|||+.
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~ 450 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA 450 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH
Confidence 112222221111110 0000 02345789999999999999999999
Q ss_pred HHHHH
Q 036382 356 EVVKM 360 (390)
Q Consensus 356 ~ll~~ 360 (390)
|++++
T Consensus 451 elL~h 455 (461)
T PHA03211 451 ELLRL 455 (461)
T ss_pred HHhhC
Confidence 99874
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=307.88 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=208.0
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
-|++.+.||.|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-
Confidence 377888999999999999976 57899999875321 1123456889999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..|+||||+.+++|.+++.+ ..+++..+..++.+++.|+.|||+.|++|+||+|+||+
T Consensus 76 -------------------~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~ 133 (277)
T cd06641 76 -------------------KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL 133 (277)
T ss_pred -------------------eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEE
Confidence 34889999999999999853 35899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+
T Consensus 134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (277)
T cd06641 134 LSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213 (277)
T ss_pred ECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence 99999999999999875543322233356788999999998888999999999999999999999999877665555444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.....+..+..++.++.+++.+||..+|.+||++.+++++
T Consensus 214 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 -PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3344555667789999999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=328.03 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=204.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-C-----CccceEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-H-----PNVTKFVG 152 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~ 152 (390)
.+|.+.+.||+|+||.|.+|.+ +++.||||+++... ....+...|+.+|..|+ | -|+|++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 4789999999999999999987 67899999997432 12344567999999986 3 49999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
+|...+++ |||+|.+. -+|.++|+.++-..++...++.|+.||+.||.+||..||||.|
T Consensus 256 ~F~fr~Hl--------------------ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcD 314 (586)
T KOG0667|consen 256 YFYFRNHL--------------------CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCD 314 (586)
T ss_pred ccccccce--------------------eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99866555 88999995 4999999988888899999999999999999999999999999
Q ss_pred CCCCCEEECCC--CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 233 VKTENMLLDSQ--RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 233 lkp~NILl~~~--~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||+|||+... ..+||+|||.|+...... .....+..|.|||++.+.+|+.+.|+||||||++||++|.+.|++.
T Consensus 315 LKPENILL~~~~r~~vKVIDFGSSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 315 LKPENILLKDPKRSRIKVIDFGSSCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CChhheeeccCCcCceeEEecccccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 99999999765 479999999998665432 2567889999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHHH---------------------c-C----------------------------CCCCCC-C---------
Q 036382 311 SFADVSSAVVR---------------------Q-N----------------------------LRPEIP-R--------- 330 (390)
Q Consensus 311 ~~~~~~~~~~~---------------------~-~----------------------------~~~~~~-~--------- 330 (390)
+..+.+..++. . . .....| .
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 88887766642 0 0 000011 0
Q ss_pred -CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 331 -CCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 331 -~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.--..+.+||++||..||.+|+|+.+.+++
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 011357899999999999999999998864
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.43 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=202.8
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|.....||+|+||.||++.. ++..||||.+... .....+.+.+|+.+++.++||||+++++.+...
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-- 91 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-- 91 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--
Confidence 455567899999999999976 5789999988521 112345678999999999999999999987643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 92 ------------------~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 150 (292)
T cd06658 92 ------------------DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSIL 150 (292)
T ss_pred ------------------CeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 345889999999999998843 35899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|||++|..||...+.......+
T Consensus 151 l~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 151 LTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred EcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999875433333333456889999999999888999999999999999999999999887766655443
Q ss_pred HHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
. ....... ....+..+.+++.+||..||.+|||+.++++.
T Consensus 231 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 R-DNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred H-hcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2 2222222 23467889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.36 Aligned_cols=254 Identities=29% Similarity=0.418 Sum_probs=203.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||.|+||.||+|++ +++.+|+|.++..... ......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-------EGFPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 45799999999999999999988 4789999998743221 11234566899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ....|+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|+|
T Consensus 77 ~------------------~~~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~n 136 (293)
T cd07843 77 N------------------LDKIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN 136 (293)
T ss_pred C------------------CCcEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 2 2345899999974 9999886543 368999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+..
T Consensus 137 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~ 216 (293)
T cd07843 137 LLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216 (293)
T ss_pred EEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999988655443334445678899999998764 4688999999999999999999999877655544
Q ss_pred HHHHHcC-----------------------------CCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQN-----------------------------LRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~-----------------------------~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+.... +...++.. +++.+.++|.+||+.||++|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 4332110 11122333 57889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.27 Aligned_cols=253 Identities=30% Similarity=0.547 Sum_probs=206.6
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|+..+.||+|+||.||++.. +++.||+|+++.... ...........+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN---TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccC---CchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-
Confidence 377788999999999999976 678999999864322 11223345578889999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 77 -------------------~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil 135 (268)
T cd06630 77 -------------------HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLL 135 (268)
T ss_pred -------------------eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 447899999999999999643 46899999999999999999999999999999999999
Q ss_pred ECCCC-cEEEeecccceeccCCCCC----CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh-
Q 036382 240 LDSQR-TLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA- 313 (390)
Q Consensus 240 l~~~~-~~kL~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 313 (390)
++.++ .++|+|||.+......... .....++..|+|||.+.+..++.++|+||+||++|+|++|..||......
T Consensus 136 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 136 IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred EcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 98776 5999999998754332111 12245788999999998888999999999999999999999999754432
Q ss_pred --hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 --DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
............+..+..+++++.+++.+||..+|.+|||+.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2233333344556677788999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.90 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=205.5
Q ss_pred CcccccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 151 (390)
+.+.|....|++.++||+||.+.||++... .+.+|+|.+.. ..........|.+|+..|.+| .|.+||+++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~-------~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVL-------LEADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHH-------hhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 345778889999999999999999999874 45777776642 233344567899999999999 689999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+|-+.+.. .||||||-+ -+|...|.++......+ .+..+..|++.|+.++|.+||||.
T Consensus 427 DYEv~d~~--------------------lYmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gIVHS 484 (677)
T KOG0596|consen 427 DYEVTDGY--------------------LYMVMECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGIVHS 484 (677)
T ss_pred eeeccCce--------------------EEEEeeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhceeec
Confidence 99775444 478999985 49999997765443334 889999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCC-----------CCCchhHHHHHHHHH
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKP-----------YNRRCDVYSFGICLW 298 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~ 298 (390)
||||.|+|+ -.|.+||+|||+|......... ....+||+.||+||.+.... .+.++||||||||||
T Consensus 485 DLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILY 563 (677)
T KOG0596|consen 485 DLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILY 563 (677)
T ss_pred CCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHH
Confidence 999999999 6899999999999865544322 34578999999999986432 457899999999999
Q ss_pred HHHhCCCCCCCCC-hhhHHHHHHHcCCCCCCCCCCcH-HHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 299 EIYCCDMPYPDLS-FADVSSAVVRQNLRPEIPRCCPS-SLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 299 ell~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+|+.|++||.... ....+..+...+-..++|..-+. ++.++|+.||+.||.+|||+.+||+.
T Consensus 564 qMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 564 QMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 9999999998765 33344455444444456654433 49999999999999999999999863
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.25 Aligned_cols=248 Identities=27% Similarity=0.506 Sum_probs=204.6
Q ss_pred cCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||.|+||.||++.+. ++.||+|.+..... ......+.+|+++++.++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--------EAIQKQILRELDILHKCNSPYIVGFYGAFYNN- 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--------hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-
Confidence 36888999999999999999884 78999999863321 12346678899999999999999999998643
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVKTEN 237 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlkp~N 237 (390)
..+++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+|
T Consensus 72 -------------------~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~n 131 (265)
T cd06605 72 -------------------GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131 (265)
T ss_pred -------------------CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHH
Confidence 44588999999999999996543 578999999999999999999999 999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----Ch
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-----SF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-----~~ 312 (390)
|+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++|+||||+++|+|++|..||... ..
T Consensus 132 i~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 132 ILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred EEECCCCCEEEeecccchhhHHHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 9999999999999999864432211 1266888999999999999999999999999999999999999664 22
Q ss_pred hhHHHHHHHcCCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+. ....+..+.. ++.++.++|.+||..||++|||+.+++..
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 210 FELLQYIV-NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 23333332 3334444444 78899999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.24 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=201.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+++++.++||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK- 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-------cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-
Confidence 3688999999999999999988 478999998853221 112345677899999999999999999998643
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+||||+.+++|.++... ...+++..+..++.||+.||.|||+.|++|+||+|+||
T Consensus 73 -------------------~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 73 -------------------KRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred -------------------CeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 345889999999888887643 34589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
+++.++.++|+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+...
T Consensus 132 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~ 211 (286)
T cd07846 132 LVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211 (286)
T ss_pred EECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 9999999999999998765444444445568899999999875 447889999999999999999999998766544333
Q ss_pred HHHHcC--------------------CCCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQN--------------------LRPE---------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~--------------------~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+.... ..+. ....++..+.+++.+||..+|++|||+.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 322100 0000 123567889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=330.52 Aligned_cols=248 Identities=23% Similarity=0.446 Sum_probs=209.5
Q ss_pred ccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
+.++..||-|+||.||+|... +-..|.|++... ...-.+.|.-|++||..++||+||+++++|...+.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---------seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk- 103 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK- 103 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-
Confidence 456778999999999999764 445677887521 12234677889999999999999999998865444
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
.||+.|||.||-....+-.- +..+++.++..+++|++.||.|||+++|||||||+.|||+
T Consensus 104 -------------------LwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~ 163 (1187)
T KOG0579|consen 104 -------------------LWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL 163 (1187)
T ss_pred -------------------eEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE
Confidence 48899999999988877543 4579999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+-+|.++|+|||.+............+.|||.|||||++. +.+|++++||||||++|.||..+.+|-....+-.+
T Consensus 164 TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV 243 (1187)
T KOG0579|consen 164 TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 243 (1187)
T ss_pred EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH
Confidence 9999999999999865444344455688999999999874 56899999999999999999999999999988888
Q ss_pred HHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRP-EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.++.+...+. -.|..++..+.+|+.+||.+||+.||++.+|+++
T Consensus 244 llKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 244 LLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 88776554222 3588899999999999999999999999999853
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=308.21 Aligned_cols=245 Identities=25% Similarity=0.430 Sum_probs=203.4
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|...+.||+|++|.||++.. +++.+++|.++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-- 88 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-- 88 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--
Confidence 455667999999999999976 56899999885221 11234577899999999999999999988743
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...|+++||+.+++|.+++.. .++++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 89 ------------------~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil 147 (285)
T cd06648 89 ------------------DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147 (285)
T ss_pred ------------------CeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEE
Confidence 345889999999999999854 45899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 148 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~ 227 (285)
T cd06648 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227 (285)
T ss_pred EcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 99999999999998875443332333456889999999999888999999999999999999999999887766666554
Q ss_pred HHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 320 VRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 320 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
... ..+.. +..++..+.++|.+||..+|++|||+.++++
T Consensus 228 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 228 RDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Hhc-CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 433 22222 3347889999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=307.77 Aligned_cols=247 Identities=28% Similarity=0.505 Sum_probs=202.4
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC---CCccceEEEEEec
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD---HPNVTKFVGASVG 156 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~ 156 (390)
.|++.+.||+|+||.||+|.+ +++.||+|+++.... ......+.+|+.+++.++ |||++++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 477889999999999999987 678999999863211 112345678999999986 9999999999874
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ...|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+
T Consensus 74 ~--------------------~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ 130 (277)
T cd06917 74 G--------------------PRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAA 130 (277)
T ss_pred C--------------------CEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHH
Confidence 3 344889999999999999854 26899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+....
T Consensus 131 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 210 (277)
T cd06917 131 NILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210 (277)
T ss_pred HEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 999999999999999999866544433444578899999999865 4578999999999999999999999987765554
Q ss_pred HHHHHHcCCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPR-CCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+.. ...+..+. .++.++.+++.+||..||++|||+.+++..
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 211 MMLIPK-SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hhcccc-CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 433222 22233333 378899999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=301.55 Aligned_cols=248 Identities=28% Similarity=0.531 Sum_probs=209.3
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|++|.||+|+. +++.|+||++...... .....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--------EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-- 71 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--
Confidence 688899999999999999987 4789999998643211 3346788999999999999999999998754
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVKTENM 238 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlkp~NI 238 (390)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||
T Consensus 72 ------------------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni 131 (264)
T cd06623 72 ------------------GEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNL 131 (264)
T ss_pred ------------------CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHE
Confidence 3458899999999999999653 569999999999999999999999 9999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL---SFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~---~~~~~ 315 (390)
+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+.
T Consensus 132 ~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 132 LINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred EECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 999999999999999886544333333456788999999999989999999999999999999999999776 44444
Q ss_pred HHHHHHcCCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+. ....+..+.. ++..+.++|.+||..+|++|||+.++++.
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 212 MQAIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 44443 3344455555 88999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.51 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=189.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
..+|++.+.||+|+||.||+|.+ +++.||+|+... .....|+.++++++||||+++++++...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 129 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------------GTTLIEAMLLQNVNHPSVIRMKDTLVSG 129 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---------------cccHHHHHHHHhCCCCCCcChhheEEeC
Confidence 34799999999999999999988 456899997541 1224689999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+. ++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 130 ~--------------------~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 187 (357)
T PHA03209 130 A--------------------ITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187 (357)
T ss_pred C--------------------eeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3 3478999995 5899888653 3569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChh---
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP-YPDLSFA--- 313 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P-f~~~~~~--- 313 (390)
||++.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||+++..| |......
T Consensus 188 ill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~ 266 (357)
T PHA03209 188 IFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266 (357)
T ss_pred EEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHH
Confidence 99999999999999998743322 223446789999999999999999999999999999999986554 4332110
Q ss_pred ------hHHHHHHH-cCCC-CCCC------------------------------CCCcHHHHHHHHHhhhhCCCCCCCHH
Q 036382 314 ------DVSSAVVR-QNLR-PEIP------------------------------RCCPSSLANIMRKCWDANAEKRPEMG 355 (390)
Q Consensus 314 ------~~~~~~~~-~~~~-~~~~------------------------------~~~~~~l~~li~~cl~~dP~~Rpt~~ 355 (390)
..+..+.. .+.. ..++ ..++.++.+||.+||+.||.+|||+.
T Consensus 267 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~ 346 (357)
T PHA03209 267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE 346 (357)
T ss_pred HHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence 01111111 0100 0011 13466778899999999999999999
Q ss_pred HHHHH
Q 036382 356 EVVKM 360 (390)
Q Consensus 356 ~ll~~ 360 (390)
+|+++
T Consensus 347 e~l~h 351 (357)
T PHA03209 347 EILNY 351 (357)
T ss_pred HHhcC
Confidence 99864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=310.86 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=204.3
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
+.++|++.+.||+|+||.||+|.+ +|+.||+|.++...... .....+.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-------GIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-------CCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 457899999999999999999987 57899999986432211 111234579999999999999999999864
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ....++||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+
T Consensus 78 ~~------------------~~~~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 137 (309)
T cd07845 78 KH------------------LDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137 (309)
T ss_pred CC------------------CCeEEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 32 2345899999964 899888653 356899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||+++.++.+||+|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+.
T Consensus 138 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~ 217 (309)
T cd07845 138 NLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217 (309)
T ss_pred HEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999865443333334456788999999865 5688999999999999999999999998887776
Q ss_pred HHHHHHcCCCC-----------------CCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRP-----------------EIP-----------RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~-----------------~~~-----------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+......+ ..+ ...++++.++|.+||..||++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 218 LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 65554311000 000 1247789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=312.17 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=204.0
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|.....||+|+||.||++.. +++.||+|+++.... .....+.+|+.+++.++||||+++++.+...
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-- 90 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-- 90 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---------chHHHHHHHHHHHHhCCCCchhhhhhheeeC--
Confidence 355566899999999999976 578999999863221 1134577899999999999999999988754
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+
T Consensus 91 ------------------~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nil 149 (297)
T cd06659 91 ------------------EELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSIL 149 (297)
T ss_pred ------------------CeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeE
Confidence 345889999999999998743 35899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|||++|..||...+..+....+
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 150 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred EccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999865433333334456899999999999888999999999999999999999999877766655544
Q ss_pred HHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..... ....+..++..+.++|.+||+.+|.+||++.+|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred hccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 32211 112344578899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=300.57 Aligned_cols=251 Identities=28% Similarity=0.538 Sum_probs=213.3
Q ss_pred CccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||++.+. ++.||+|++..... .......+.+|+++++.++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-- 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-------SEKEREDALNEVKILKKLNHPNIIKYYESFEEK-- 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--
Confidence 4788899999999999999885 78999999864321 122345677899999999999999999988644
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++|+||+++++|.+++.+.. ...+++..+..++.+++.||.|||+.|++|+||+|+|
T Consensus 72 ------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n 133 (258)
T cd08215 72 ------------------GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133 (258)
T ss_pred ------------------CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence 34588999999999999997643 4679999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+...
T Consensus 134 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 213 (258)
T cd08215 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213 (258)
T ss_pred eEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence 99999999999999999765443322333568889999999998889999999999999999999999998887777666
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..... .....+..++..+.+++.+||..+|++|||+.++++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 KILKG-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 66543 3556677889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.13 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=204.9
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||++.+ +++.||+|++.... .......+.+.+|++++++++||||+++++.+.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK------CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh------hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-
Confidence 478899999999999999987 47899999986321 111223567889999999999999999998876443
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++|+||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 74 -------------------~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 132 (258)
T cd05578 74 -------------------NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132 (258)
T ss_pred -------------------eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 458899999999999999654 57999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hhHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF---ADVS 316 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~---~~~~ 316 (390)
++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ....
T Consensus 133 ~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (258)
T cd05578 133 LDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211 (258)
T ss_pred EcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 9999999999999987543322 23345688899999999888899999999999999999999999987763 3332
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM--GEVV 358 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~--~~ll 358 (390)
..... .....|..+|..+.++|.+||..||.+||++ .+++
T Consensus 212 -~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 -AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22221 4556777889999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=323.42 Aligned_cols=245 Identities=26% Similarity=0.418 Sum_probs=195.0
Q ss_pred cccCccccccccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
...+|++.+.||+|+||.||++.. .+..||||.+... ....+|++++++++||||+++++++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 345799999999999999999875 3467999987521 1235799999999999999999988
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
... ...|+|||++. ++|.+++. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 156 ~~~--------------------~~~~lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk 212 (392)
T PHA03207 156 RWK--------------------STVCMVMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212 (392)
T ss_pred eeC--------------------CEEEEEehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 643 34488999995 68999883 34569999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+|||++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999987543322 122345689999999999999999999999999999999999999976432
Q ss_pred h---hHHHHHHH-------------------------cCCCCCC--C-----CCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 313 A---DVSSAVVR-------------------------QNLRPEI--P-----RCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 313 ~---~~~~~~~~-------------------------~~~~~~~--~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
. ..+..+.. ...++.. + ...+.++.++|.+||..||++|||+.++
T Consensus 293 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~ 372 (392)
T PHA03207 293 KSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372 (392)
T ss_pred CCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence 1 11111111 0011111 1 1346678999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+.+
T Consensus 373 l~~ 375 (392)
T PHA03207 373 LSL 375 (392)
T ss_pred hhC
Confidence 875
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=305.78 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=197.6
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||+|+||.||++.. +|+.||+|++.... .........+.+|+++++.++||||+++++++...
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 65 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR------LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--------- 65 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh------hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC---------
Confidence 68999999999976 57899999986321 11122345567899999999999999999998643
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
...|+||||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+
T Consensus 66 -----------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~ 134 (277)
T cd05577 66 -----------DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134 (277)
T ss_pred -----------CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 345899999999999999976555579999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH--cCC
Q 036382 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR--QNL 324 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~--~~~ 324 (390)
+|+|||.+..... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.. ...
T Consensus 135 ~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 213 (277)
T cd05577 135 RISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213 (277)
T ss_pred EEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc
Confidence 9999999875432 2223345678899999999888899999999999999999999999977543211111111 123
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVK 359 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~ 359 (390)
....+..+++.+.++|.+||+.||.+|| ++.+++.
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 4456677899999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.50 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=204.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---------QPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---------chHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 36799999999999999999976 67899999985321 11235678899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 89 ~--------------------~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~N 145 (293)
T cd06647 89 D--------------------ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 145 (293)
T ss_pred C--------------------cEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHH
Confidence 3 44889999999999999854 348899999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|++++|..||...+..+...
T Consensus 146 ili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred EEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 99999999999999998755443333344568889999999988889999999999999999999999998766544433
Q ss_pred HHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+..... ....+..++..+.++|.+||..+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3222211 112344567889999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=306.36 Aligned_cols=248 Identities=25% Similarity=0.457 Sum_probs=195.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHH-HHhcCCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV-WQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~ 157 (390)
++|++.+.||+|+||.||++.+ +|+.||+|.++.... ... ...+..|+.+ ++.++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQE-----QKRLLMDLDISMRSVDCPYTVTFYGALFRE 72 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence 4789999999999999999987 578999999863211 111 1234445554 6667999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVK 234 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiHrDlk 234 (390)
. ..|++|||++ |+|.+++... ....+++..++.++.||+.||.|||++ +++|||||
T Consensus 73 ~--------------------~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk 131 (283)
T cd06617 73 G--------------------DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK 131 (283)
T ss_pred C--------------------cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence 3 3478999996 6898888542 235689999999999999999999997 99999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG----KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|+|||++.++.+||+|||++...... ...+...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 132 p~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 132 PSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred HHHEEECCCCCEEEeecccccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 99999999999999999998754322 12233568889999998864 45788999999999999999999999753
Q ss_pred C-hhhHHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 311 S-FADVSSAVVRQNLRPEIP-RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 311 ~-~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
. ..+....... ...+..+ ..+|.++.++|.+||..+|.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 211 KTPFQQLKQVVE-EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ccCHHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2 2233333332 3333333 457899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.65 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=202.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|+..+.||.|++|.||++.+ +++.||+|++..... ......+.+|+++++.++||||+++++++.+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--------PDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 3688899999999999999987 578999999863211 123466789999999999999999999986432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
....|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus 73 ------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~ 134 (287)
T cd06621 73 ------------------SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134 (287)
T ss_pred ------------------CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 23458999999999999987542 3456899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----C
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-----S 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-----~ 311 (390)
||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||... .
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (287)
T cd06621 135 NILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212 (287)
T ss_pred HEEEecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC
Confidence 9999999999999999986443221 12345788999999999999999999999999999999999999765 2
Q ss_pred hhhHHHHHHHcCCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEIP------RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+....+.. ...+..+ ...++++.++|.+||..+|.+|||+.+++..
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 213 PIELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hHHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2333333322 1122221 2356789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=308.03 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=201.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++.... .......+.+|+++++.++|+||+++++++.+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 3689999999999999999987 578999998863211 1223467789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.++.|..++.+ ...+++..+..++.||+.||.|||+.+++|+||+|+||
T Consensus 74 --------------------~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 74 --------------------RLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred --------------------EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 34889999998766665532 34589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
+++.++.++|+|||++........ ......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+..
T Consensus 132 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 132 LVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred EECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999876543322 33345678899999999887 8899999999999999999999999876554433
Q ss_pred HHHHHcC----------------CC--------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQN----------------LR--------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~----------------~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..+.... +. ...+..++.++.+||++||..+|++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 3221100 00 0123345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=306.26 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=202.0
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||+|++ +|+.||||++..... .......+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-------EGGIPNQALREIKALQACQHPYVVKLLDVFPHG-- 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-------cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--
Confidence 488899999999999999987 578999999864321 112235678999999999999999999998753
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+
T Consensus 72 ------------------~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (286)
T cd07832 72 ------------------SGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131 (286)
T ss_pred ------------------CeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEE
Confidence 3458899999 999999986543 56999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||+||++|+|++|.+||...+..+...
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred EcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 9999999999999987654332 123445689999999998654 46899999999999999999988887766555444
Q ss_pred HHHHcCCCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRP----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+......+ ......+.++.+++.+||..+|++|||+++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 333211000 0112456889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=309.42 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=201.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||+|.+ +++.||||.++..... .........+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-- 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERK----EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-- 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccc----cccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--
Confidence 478888999999999999987 5789999999743221 01122345667899999999999999999998753
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+|||
T Consensus 75 ------------------~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 134 (298)
T cd07841 75 ------------------SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134 (298)
T ss_pred ------------------CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE
Confidence 3448899999 899999996432 36999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.++.++|+|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+..+....
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 135 IASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred EcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 999999999999999865544333444567889999998854 4678999999999999999999888887665554443
Q ss_pred HHHcCCC---------------------CC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 319 VVRQNLR---------------------PE-----IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 319 ~~~~~~~---------------------~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+...... +. .....+.++.++|.+||..||++|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 215 IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 3221000 00 11335688999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=353.55 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=216.0
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
++-..+||.|.||.||.|.. +|...|+|-++..... ......+.+|..++..++|||+|+.||+=.+.+.+
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-------cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 45567899999999999976 7889999988765443 22235677899999999999999999998776665
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
+|.||||.+|+|.+++.. +.-.++.....+..|++.|+.|||++|||||||||.|||+
T Consensus 1310 --------------------~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L 1367 (1509)
T KOG4645|consen 1310 --------------------YIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL 1367 (1509)
T ss_pred --------------------HHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee
Confidence 459999999999999943 4457888889999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCC----CCCCCCCCccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 241 DSQRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQGK---PYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
+.+|.+|++|||.|.....+..+ .....||+-|||||++.+. ....++|||||||++.||+||+.||...+..
T Consensus 1368 d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1368 DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 99999999999999876554322 3346799999999999763 4567999999999999999999999999999
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
-.+...+.-+-.|.+|..++++-++||..||..||+.|+++.||++.
T Consensus 1448 ~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 WAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 98888888889999999999999999999999999999999887764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.89 Aligned_cols=250 Identities=26% Similarity=0.468 Sum_probs=208.5
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.+.|++.+.||+|+||.||+|.+. +..|++|+++.... ....+.+|+++++.++|+||+++++.+...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----------NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----------hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 346888999999999999999884 78999999863221 245678899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...|+|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 88 --------------------~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~n 146 (286)
T cd06614 88 --------------------DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146 (286)
T ss_pred --------------------CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhh
Confidence 34588999999999999997643 369999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+++.++.++|+|||++..............++..|++||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 147 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~ 226 (286)
T cd06614 147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF 226 (286)
T ss_pred EEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999988654433222334457889999999998889999999999999999999999998877665555
Q ss_pred HHHHcCCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRP-EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....... ..+..++.++.++|.+||+.+|.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 227 LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 444333222 2233478999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.54 Aligned_cols=267 Identities=27% Similarity=0.445 Sum_probs=226.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
...|.+.+.||+|.|+.|.+|++ ++..||+|+++....+ ...+..+.+|+++|+.+.|||||+++.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-------PSKRQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-------hHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 45689999999999999999977 7899999999744322 22234488999999999999999999998765
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..+ |+||||+.+|.+++|+.++ +.+.+..+..++.|+++|++|||+++|+|||||++|
T Consensus 128 ~~l--------------------ylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 128 ATL--------------------YLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred cee--------------------EEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 555 7799999999999999665 457779999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.+.++||+|||++.... ......+.||++.|.|||++.+..|+ +.+|+||+|+++|.|++|.+||.+....+..
T Consensus 186 ilL~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr 264 (596)
T KOG0586|consen 186 ILLDENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR 264 (596)
T ss_pred cccccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc
Confidence 999999999999999998665 44556678999999999999998874 7899999999999999999999999888888
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCCCCCCCCC
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPEDQA 378 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~~~~~~ 378 (390)
...+..+++ +|..++.++.++|+++|..+|.+|++..++.+.-..-.....+.+.|..+.
T Consensus 265 ~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~ 324 (596)
T KOG0586|consen 265 PRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIER 324 (596)
T ss_pred chheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhccccc
Confidence 888877777 445556799999999999999999999999876555444333444444433
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=306.71 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=200.3
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.+.||.|++|.||+|.+ +|+.||+|++...... ......+.+|+++++.++||||+++++++.+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--- 70 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-------EGVPSTAIREISLLKELNHPNIVRLLDVVHSE--- 70 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-------ccchhHHHHHHHHHHhcCCCCccCHhheeccC---
Confidence 56788999999999999987 6889999998643211 11224567899999999999999999998744
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...|++|||+. ++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||++
T Consensus 71 -----------------~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~ 132 (283)
T cd07835 71 -----------------NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132 (283)
T ss_pred -----------------CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE
Confidence 34588999995 699999866544579999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
+.++.++|+|||++..............++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+
T Consensus 133 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 133 DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999987544333333445678899999988654 5788999999999999999999999877655443333
Q ss_pred HHcCCC---------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLR---------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...... ......++.++.++|.+||+.||.+|||+.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 221000 01123467889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=293.67 Aligned_cols=255 Identities=24% Similarity=0.451 Sum_probs=208.1
Q ss_pred CCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccce
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTK 149 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 149 (390)
.+.+..++++++++..||.|+-|+|+++++ +|...|||.+.... .....+.+...+.++.+. ++|.||+
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--------Nkee~kRILmDldvv~~s~dcpyIV~ 155 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--------NKEENKRILMDLDVVLKSHDCPYIVQ 155 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--------CHHHHHHHHHhhhHHhhccCCCeeee
Confidence 345667788999999999999999999987 56899999987332 222346677788887777 5999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKI 228 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~i 228 (390)
++|+|..+..+.+ .||.|. .-+..++++ ..++++|..+-.+...++.||.||.. ++|
T Consensus 156 c~GyFi~n~dV~I--------------------cMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~v 213 (391)
T KOG0983|consen 156 CFGYFITNTDVFI--------------------CMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGV 213 (391)
T ss_pred eeeEEeeCchHHH--------------------HHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcce
Confidence 9999998777744 888883 245555543 45679999999999999999999985 689
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
||||+||+|||+|+.|++||||||++...... ...+...|-+.|||||.+. ...|+.++||||||++++|+.||+.
T Consensus 214 iHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y 292 (391)
T KOG0983|consen 214 IHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY 292 (391)
T ss_pred eecccCccceEEccCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence 99999999999999999999999999866543 2334467889999999995 3469999999999999999999999
Q ss_pred CCCCC-ChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 306 PYPDL-SFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 306 Pf~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
||++. +..+++.+++. ...|..+. .+++.+.+|+..||.+|+.+||.+.+|++
T Consensus 293 Py~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 293 PYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99985 45666666665 44454443 47999999999999999999999999885
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.04 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=202.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
..|++.+.||+|+||.||+|.. +++.||+|.+...... .......+.+|+++++.++||||+++++++.+..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC------cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 4588899999999999999987 5789999988633211 1222356789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+|+||+|+||
T Consensus 89 --------------------~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI 146 (307)
T cd06607 89 --------------------TAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI 146 (307)
T ss_pred --------------------eEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence 3478999997 5888877543 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+++.++.++|+|||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|..||...+....
T Consensus 147 l~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 147 LLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred EECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 9999999999999998754322 2346788999999874 45688999999999999999999999988776665
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+.........+..++.++.++|.+||..+|.+||++.+|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 554433322222344578899999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=307.64 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=195.7
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.. +++.||||.+....... ....+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--------APFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--------CchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 46799999999999999999987 57899999986432111 113356899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+ +|.+++.+.. ..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 76 ~--------------------~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~n 133 (291)
T cd07844 76 K--------------------TLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133 (291)
T ss_pred C--------------------eEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHH
Confidence 3 44889999975 9999886543 368999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS-FADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~ 315 (390)
||++.++.+||+|||+++.............++..|+|||++.+ ..++.++||||+|+++|+|++|..||.... ..+.
T Consensus 134 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 213 (291)
T cd07844 134 LLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213 (291)
T ss_pred EEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 99999999999999998754333333334457889999999875 458899999999999999999999997654 2222
Q ss_pred HHHHHHcC---------------------CCCC-------CCCCCc--HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQN---------------------LRPE-------IPRCCP--SSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~---------------------~~~~-------~~~~~~--~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+...- .... ....++ ..+.+++.+||+.+|++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 22111100 0000 001123 77889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=307.01 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=200.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||.|++|.||+|.+ +++.||+|.++.... .......+.+|+++++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-------cccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 5799999999999999999987 578999998863221 1122356778999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+. ++|.+++.......+++..+..++.||+.||.|||+++++|+||+|+||
T Consensus 75 --------------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni 133 (294)
T PLN00009 75 --------------------RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133 (294)
T ss_pred --------------------eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence 4588999996 5888888655444578899999999999999999999999999999999
Q ss_pred EECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 239 LLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 239 Ll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
+++. ++.+||+|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+..
T Consensus 134 ll~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~ 213 (294)
T PLN00009 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213 (294)
T ss_pred EEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9985 467999999999754433333344567889999998866 45789999999999999999999999877665555
Q ss_pred HHHHHcCC-----------------------CCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQNL-----------------------RPE----IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~~-----------------------~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..+....- +.. .....++++.+++.+||+.+|++||++.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 214 FKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 44322100 000 11346788999999999999999999999986
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=325.82 Aligned_cols=247 Identities=27% Similarity=0.550 Sum_probs=201.9
Q ss_pred ccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
.++..+||+|+|-+||+|.+. |-.||--.++. ......+...+.|..|+.+|+.|+|||||++|..+.+..+.
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~-----~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI-----RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhH-----HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 477789999999999999874 44444322221 12233344568899999999999999999999999877654
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENM 238 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrDlkp~NI 238 (390)
.+ .+|+|.+..|+|..|+++.+ .++.+.+..|++||+.||.|||++. |||||||.+||
T Consensus 117 ~i------------------n~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 117 TI------------------NFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNI 176 (632)
T ss_pred ee------------------eeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceE
Confidence 33 78999999999999997654 6899999999999999999999985 99999999999
Q ss_pred EECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhhHH
Q 036382 239 LLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS-FADVS 316 (390)
Q Consensus 239 Ll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~ 316 (390)
||+.+ |.+||+|+|+|....... .....|||.|||||+.. ..|+..+||||||++++||.|+..||.... +..++
T Consensus 177 FinG~~G~VKIGDLGLAtl~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY 253 (632)
T KOG0584|consen 177 FVNGNLGEVKIGDLGLATLLRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY 253 (632)
T ss_pred EEcCCcCceeecchhHHHHhhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH
Confidence 99876 999999999998665432 23368999999999997 779999999999999999999999997754 55555
Q ss_pred HHHHHcCCCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQNLRPE-IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.++ ..+..|. +.+--.+++++||.+||.. .++|||+.+||.
T Consensus 254 KKV-~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 254 KKV-TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHH-HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 555 4554443 3333468899999999999 999999999874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.73 Aligned_cols=248 Identities=27% Similarity=0.508 Sum_probs=210.9
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|++|.||++.. +++.||+|.+...... ......+.+|++++++++|||++++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-- 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--
Confidence 478889999999999999977 5679999998643211 22346788999999999999999999998643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...+++|||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||+|+||+
T Consensus 72 ------------------~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (254)
T cd06627 72 ------------------DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131 (254)
T ss_pred ------------------CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence 3458899999999999999654 56999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||++..............++..|+|||...+..++.++|+||+|+++|+|++|..||...+........
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (254)
T cd06627 132 TTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211 (254)
T ss_pred ECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 99999999999999986654443334456889999999998888899999999999999999999999887765555444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
. ....+..+..++..+.+++.+||..+|++|||+.+++.
T Consensus 212 ~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3 34445677788999999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.14 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=200.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 157 (390)
++|++.+.||+|+||.||+|.+ +++.||||.++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-------ccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 3688999999999999999987 578999998864221 111234567899999999 569999999988654
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
... .....|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||+
T Consensus 74 ~~~---------------~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~ 137 (295)
T cd07837 74 EKN---------------GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137 (295)
T ss_pred CCC---------------CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 321 12236899999985 8999886533 2468999999999999999999999999999999
Q ss_pred CCCEEECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 235 TENMLLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 235 p~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|+||+++. ++.+||+|||++..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.
T Consensus 138 ~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred hHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999998 899999999998754433333344567889999998865 4578999999999999999999999987765
Q ss_pred hhHHHHHHHcCCCC--------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVSSAVVRQNLRP--------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+....+...-..+ .....++.++.++|.+||..||.+|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 218 LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 55444332210000 001246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.99 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=200.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
..+|++.+.||+|+||.||+|.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 36799999999999999999987 678999998852211 111234566899999999999999999988644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... ......|+||||+. ++|.+++.. .+++..+..++.|++.||+|||+.||+||||||+|
T Consensus 88 ~~~--------------~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 88 KSL--------------EEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred CCc--------------cccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 321 12234689999996 588888743 28999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 149 il~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 149 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred EEECCCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999999864332 22334567899999999999999999999999999999999999998766444333
Q ss_pred HHHHcCCC--------------------C---------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 318 AVVRQNLR--------------------P---------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 318 ~~~~~~~~--------------------~---------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
.+...-.. + ..+...++.+.++|.+||+.||++|||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 32210000 0 001234667899999999999999999999
Q ss_pred HHHH
Q 036382 357 VVKM 360 (390)
Q Consensus 357 ll~~ 360 (390)
++..
T Consensus 308 iL~~ 311 (353)
T cd07850 308 ALQH 311 (353)
T ss_pred HhcC
Confidence 9964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=322.61 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=227.1
Q ss_pred cccccCccccccccccCceEEEEEEECCce--EEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQE--VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+.+.+++.+..||-|+||.|=+.+.+++. +|+|+++. .........+.+..|-+||.+++.|.||++|..|
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK------~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKK------KHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhH------hhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 456788899999999999999999887665 89999872 2333445567888999999999999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.++.++ |++||-|-||.|+..|.. ++.+++.....++.-+++|++|||++|||+||||
T Consensus 490 rd~kyv--------------------YmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLK 547 (732)
T KOG0614|consen 490 RDSKYV--------------------YMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLK 547 (732)
T ss_pred ccchhh--------------------hhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCC
Confidence 887766 569999999999999954 5679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|++++.+|-+||.|||+|+........+ ++||||.|.|||++.++..+.++|.||||+++||+++|.+||.+.++-.
T Consensus 548 PENllLd~~Gy~KLVDFGFAKki~~g~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 548 PENLLLDNRGYLKLVDFGFAKKIGSGRKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred hhheeeccCCceEEeehhhHHHhccCCcee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 999999999999999999999877655554 4899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
.+..++++--...+|+.++....++|++++..+|.+|.. +.+|..+
T Consensus 627 tYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 627 TYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 999998887778899999999999999999999999976 5566554
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=321.53 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=206.8
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|.-++.||+|+||.||-|++ +.+.||||.+.++.... ...-..+.+|+..|+++.|||+|.+-|+|..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs------~EKWqDIlKEVrFL~~l~HPntieYkgCyLr---- 97 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDILKEVRFLRQLRHPNTIEYKGCYLR---- 97 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccccccc------HHHHHHHHHHHHHHHhccCCCcccccceeec----
Confidence 56677899999999999987 67899999998654322 1223567899999999999999999999863
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...+|+|||||- |+-.|++.-++ +++-+..+..|+.+.+.||+|||+.+.||||||.-|||+
T Consensus 98 ----------------e~TaWLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 98 ----------------EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred ----------------cchHHHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 456689999995 58888886543 579999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
++.|.+||+|||.|....+ ...++|||.|||||++. .+.|+-++||||||++..|+...++|+-++..-..+.
T Consensus 160 se~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 160 SEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred cCCCeeeeccccchhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 9999999999999976543 24578999999999985 3679999999999999999999999998887766666
Q ss_pred HHHHcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIP-RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+ .++-.|..+ ..++..+++|+..||++-|.+|||.++++.+
T Consensus 236 HI-AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 236 HI-AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HH-HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 65 445455544 4588999999999999999999999988753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=307.64 Aligned_cols=278 Identities=32% Similarity=0.563 Sum_probs=225.1
Q ss_pred cccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHh--cCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK--LDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~ 156 (390)
++..+++.+++|+|.||.||+|+++++.||||++... ....|.+|-+|++. ++|+||++|+++-..
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ------------EKQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHH------------HHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 4567889999999999999999999999999999732 24668888888875 589999999988543
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---------C
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK---------K 227 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---------~ 227 (390)
... ....+++|++|.+.|+|.+||+.+ .++|....+|+..+++||+|||+. .
T Consensus 276 ~t~----------------~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~ 336 (534)
T KOG3653|consen 276 GTA----------------DRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPP 336 (534)
T ss_pred CCc----------------cccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCc
Confidence 221 245679999999999999999654 599999999999999999999964 5
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCC-CCC-----CchhHHHHHHHHHH
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGK-PYN-----RRCDVYSFGICLWE 299 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwSlG~il~e 299 (390)
|+|||||.+||||.+|+++.|+|||+|...... ..+..+.+||.+|||||++.+. .+. .+.||||+|.+|||
T Consensus 337 IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWE 416 (534)
T KOG3653|consen 337 IAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWE 416 (534)
T ss_pred cccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999865432 2344568899999999999653 122 47899999999999
Q ss_pred HHhC------------CCCCC-----CCChhhHHHHHHHcCCCCCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 300 IYCC------------DMPYP-----DLSFADVSSAVVRQNLRPEIPRCC-----PSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 300 ll~g------------~~Pf~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
|++. ++||. ..+.+++...++..+.||.+|..+ ...+++.+..||..||+.|.|+.=+
T Consensus 417 i~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 417 IASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 9962 24453 356777878888888899888653 4678999999999999999999988
Q ss_pred HHHHHHhHhcC---CCCCCCCCCCCcceeecCC
Q 036382 358 VKMLEAIDTSK---GGGMIPEDQATGCFCFSPV 387 (390)
Q Consensus 358 l~~L~~~~~~~---~~~~~~~~~~~~~~~~~~~ 387 (390)
-+.+..+.... .+.-.+..-.+.++|.+++
T Consensus 497 ~eR~~~l~~~~~~~~~~s~~~~~~~~~~~~~~~ 529 (534)
T KOG3653|consen 497 EERMAELMMLWEDSSGESSSSLVTPVDVVTAPP 529 (534)
T ss_pred HHHHHHHhccCCccCCccccccCCCCccccCCC
Confidence 88888887655 4455555566666665543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.53 Aligned_cols=264 Identities=19% Similarity=0.288 Sum_probs=193.3
Q ss_pred cccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHH--HHHHHHHHHHHHHHHhcCCCccce
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAET--AALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
++...+|++.+.||+|+||.||+|... +..+|+|+.............. .........+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 345578999999999999999999873 3467777655333221111100 000112233445566779999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++...... ....+++++++.. ++.+.+... ...++..+..++.|++.||.|||+.+|+
T Consensus 88 ~~~~~~~~~~~----------------~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ii 148 (294)
T PHA02882 88 YYGCGSFKRCR----------------MYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGIS 148 (294)
T ss_pred EEEeeeEecCC----------------ceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99876543211 1123678888743 677776432 3467888999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC-------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 302 (390)
||||||+|||++.++.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 149 HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 149 HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999997543221 11123469999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-hhHH--------HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 303 CDMPYPDLSF-ADVS--------SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 303 g~~Pf~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
|..||.+... .... ..+.... .....+|..+.+++..||..+|++||++.+|++.|+
T Consensus 229 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 229 IKLPWKGFGHNGNLIHAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCCCCccccchHHHHHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999987632 2222 1111111 123456899999999999999999999999998763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.58 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=217.8
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...+..++|+++++||+|+||.|..++. +++.||+|+++.-. + -.......|..|-.+|...+.+-|++++-
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e--M----lKr~~tA~F~EERDimv~~ns~Wiv~Lhy 142 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE--M----LKRAETACFREERDIMVFGNSEWIVQLHY 142 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH--H----hhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence 3456789999999999999999999877 67899999986110 0 01122356778889999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
+|+|..++ |+||||++||+|..++.+.. +++++.+++|+..|+.||.-||+.|+||||
T Consensus 143 AFQD~~~L--------------------YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRD 200 (1317)
T KOG0612|consen 143 AFQDERYL--------------------YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRD 200 (1317)
T ss_pred HhcCccce--------------------EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceecc
Confidence 99988777 67999999999999996653 799999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceecc-CCCCCCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEA-QNPRDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~-~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|||+|||+|..|++||+|||.+-... +..-.....+|||.|.+||+++. +.|++.+|+||+||++|||++|..|
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 99999999999999999999876554 33444566789999999999952 5689999999999999999999999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPE---MGEVVKM 360 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt---~~~ll~~ 360 (390)
|...+..+.+.+|+.-.-...+| ..+|.+.++||.+.+.. |+.|.. ++++..+
T Consensus 281 FYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 281 FYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNH 338 (1317)
T ss_pred chHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhC
Confidence 99999999999998765555566 55899999999998874 788887 8777653
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=306.26 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=208.5
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||+|+||.||+++. ++..||+|++...... .......+.+|+++++.++|||++++++++.+..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 98 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ------SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH- 98 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC------chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence 477888999999999999987 5789999998643211 1123356788999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++||||+. |+|.+++... ...+++..+..++.+++.||.|||+.||+||||+|+||+
T Consensus 99 -------------------~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil 157 (317)
T cd06635 99 -------------------TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL 157 (317)
T ss_pred -------------------eEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEE
Confidence 3478999997 4888877543 356899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
++.++.++|+|||++..... .....+++.|+|||.+. +..++.++|+|||||++|+|++|..||.........
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 233 (317)
T cd06635 158 LTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233 (317)
T ss_pred ECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 99999999999998864332 22356888999999973 456889999999999999999999999887777766
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
..+.........+..+++.+.++|.+||+.+|.+|||+.++++.+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 6666555555555678899999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=295.06 Aligned_cols=252 Identities=29% Similarity=0.524 Sum_probs=210.8
Q ss_pred CccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|+..+.||+|++|.||+|... ++.|++|+++..... ....+.+.+|+.++++++||||+++++.+.+..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-------EEELEALEREIRILSSLQHPNIVRYYGSERDEE- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC-
Confidence 4777889999999999999884 789999998643211 234567889999999999999999999987541
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
....++++||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus 73 -----------------~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~ 133 (260)
T cd06606 73 -----------------KNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL 133 (260)
T ss_pred -----------------CCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 134588999999999999996543 7999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhhHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS-FADVS 316 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~ 316 (390)
++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .....
T Consensus 134 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (260)
T cd06606 134 VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213 (260)
T ss_pred EcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence 99999999999999986554332 1334568899999999988889999999999999999999999998765 23333
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+......+..+..++..+.+++.+||..+|.+||++.+++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 33333345566778889999999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=297.95 Aligned_cols=249 Identities=31% Similarity=0.556 Sum_probs=209.7
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|+||.||+++. +++.+|+|.+..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-------SQKEREDAVNEIRILASVNHPNIISYKEAFLDG-- 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--
Confidence 478899999999999999977 578999999863221 122245667899999999999999999887643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++||||+++++|.+++.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 72 ------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~n 133 (256)
T cd08530 72 ------------------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSAN 133 (256)
T ss_pred ------------------CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence 44588999999999999986522 3568999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+++.++.+||+|||++...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+...
T Consensus 134 i~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~ 211 (256)
T cd08530 134 ILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211 (256)
T ss_pred EEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999765443 2233568889999999999999999999999999999999999999888776665
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+. ....+..+..++.++.+++.+||..+|++|||+.++++.
T Consensus 212 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 212 KVQ-RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHh-cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 554 344445666789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.11 Aligned_cols=257 Identities=33% Similarity=0.592 Sum_probs=213.5
Q ss_pred ccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHh--cCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK--LDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~ 157 (390)
..+.++.+.||+|.||.||+|.|.|+.||||++.- .+ ...+.+|.+|++. |+|+||+.|+++-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s-------rd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~- 276 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSS-------RD-----ERSWFRETEIYQTVMLRHENILGFIAADNK- 276 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecc-------cc-----hhhhhhHHHHHHHHHhccchhhhhhhcccc-
Confidence 46789999999999999999999999999999952 11 2557789999886 499999999988543
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCc
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK--------KIV 229 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~ii 229 (390)
..+.....|+|.+|.+.|||+|||.+ ..++.+..++++..++.||++||.. .|.
T Consensus 277 ---------------~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIA 338 (513)
T KOG2052|consen 277 ---------------DNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIA 338 (513)
T ss_pred ---------------CCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhh
Confidence 33456788999999999999999965 4699999999999999999999963 499
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCC----CC--CCchhHHHHHHHHHH
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGK----PY--NRRCDVYSFGICLWE 299 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~--~~~~DiwSlG~il~e 299 (390)
|||||..||||..+|.+.|+|+|+|-...... ......+||-+|||||++... -| -..+||||||.++||
T Consensus 339 HRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWE 418 (513)
T KOG2052|consen 339 HRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWE 418 (513)
T ss_pred ccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHH
Confidence 99999999999999999999999997654432 224457899999999998543 12 246899999999999
Q ss_pred HHh----------CCCCCCC-----CChhhHHHHHHHcCCCCCCCCCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 300 IYC----------CDMPYPD-----LSFADVSSAVVRQNLRPEIPRCCP-----SSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 300 ll~----------g~~Pf~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+.. -++||.+ ++.+++..-+..+.++|.+|..+. ..+.++|+.||..+|..|.|+-.+..
T Consensus 419 iarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 419 IARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 985 2588854 466777766777888998887653 45789999999999999999999999
Q ss_pred HHHHhHhc
Q 036382 360 MLEAIDTS 367 (390)
Q Consensus 360 ~L~~~~~~ 367 (390)
.|.++..+
T Consensus 499 tl~~l~~~ 506 (513)
T KOG2052|consen 499 TLAKLSNS 506 (513)
T ss_pred HHHHHhcC
Confidence 99998753
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=310.42 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=183.8
Q ss_pred ccccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 87 NLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
.+||+|+||.||+|+. ++..||+|.++.... ...+.+|+.++++++||||+++++++....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 71 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------SMSACREIALLRELKHPNVIALQKVFLSHS---- 71 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccC----
Confidence 5799999999999986 346899998863211 124568999999999999999999986432
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN-------RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
....|+||||+.+ +|.+++... ....+++..+..++.||+.||.|||+.||+||||||
T Consensus 72 --------------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp 136 (317)
T cd07867 72 --------------DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKP 136 (317)
T ss_pred --------------CCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCH
Confidence 3345899999864 888887532 123588999999999999999999999999999999
Q ss_pred CCEEE----CCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 236 ENMLL----DSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 236 ~NILl----~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
+|||+ +.++.+||+|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 137 ~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred HHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 99999 556799999999998543322 12234568999999999876 45899999999999999999999999
Q ss_pred CCCChh---------hHHHHHHHc-C----------------------C-C------------CCCCCCCcHHHHHHHHH
Q 036382 308 PDLSFA---------DVSSAVVRQ-N----------------------L-R------------PEIPRCCPSSLANIMRK 342 (390)
Q Consensus 308 ~~~~~~---------~~~~~~~~~-~----------------------~-~------------~~~~~~~~~~l~~li~~ 342 (390)
...... .....+... + . . .......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 643211 000000000 0 0 0 00011234568899999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 036382 343 CWDANAEKRPEMGEVVK 359 (390)
Q Consensus 343 cl~~dP~~Rpt~~~ll~ 359 (390)
||..||.+|||+.|+++
T Consensus 297 ~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 297 LLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhccCcccccCHHHHhc
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.96 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=201.9
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||.|+||.||++.+ +++.||+|++.... .........+.+|+++++.++||||+++++.+...
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------- 65 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD------MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--------- 65 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh------hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC---------
Confidence 68999999999988 48899999986321 22234456788999999999999999999887643
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
...|++|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+
T Consensus 66 -----------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~ 132 (265)
T cd05579 66 -----------KNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132 (265)
T ss_pred -----------cEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE
Confidence 3458899999999999999653 368999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCC--------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 247 KIADFGVARVEAQNPR--------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
+|+|||++........ ......++..|++||...+..++.++|+||||+++|+|++|..||......+....
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN 212 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999875433211 22334578899999999888899999999999999999999999998888877766
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
+.............+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 213 ILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 65543332222224899999999999999999999955555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.04 Aligned_cols=275 Identities=25% Similarity=0.323 Sum_probs=210.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|.+.+.||+|+||.||+|.. +++.||||.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-------ccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 4699999999999999999987 578999998863211 1111244568999999999999999999876432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.. .....|+|+||+. ++|.+++.+ ...+++..+..++.|++.||.|||+++++||||||+||
T Consensus 78 ~~---------------~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Ni 139 (337)
T cd07858 78 RE---------------AFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNL 139 (337)
T ss_pred cc---------------ccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 11 1134689999996 689998854 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
+++.++.+||+|||++..............++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus 140 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 219 (337)
T cd07858 140 LLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK 219 (337)
T ss_pred EEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 9999999999999999865433233344567889999998865 468899999999999999999999998765433222
Q ss_pred HHHH-----------------------c-CC--CC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhHh
Q 036382 318 AVVR-----------------------Q-NL--RP---EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAIDT 366 (390)
Q Consensus 318 ~~~~-----------------------~-~~--~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~~ 366 (390)
.+.. . .. ++ .....+++++.++|++||+.+|++|||+.+++++ +..+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 220 LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 1110 0 00 00 1123578889999999999999999999999987 777654
Q ss_pred cCCCCCCCCCCCCccee
Q 036382 367 SKGGGMIPEDQATGCFC 383 (390)
Q Consensus 367 ~~~~~~~~~~~~~~~~~ 383 (390)
... .|..|.+--+|
T Consensus 300 ~~~---~~~~~~~~~~~ 313 (337)
T cd07858 300 PSD---EPVCQTPFSFD 313 (337)
T ss_pred ccc---CccCCCccchh
Confidence 443 34445444444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=297.77 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHH-HhcCCCccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW-QKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
+.||.|+||.||+|.. +++.||||+++... .........+..|..++ +..+||||+++++++....
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----- 70 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSD------MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----- 70 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchh------hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----
Confidence 5689999999999987 67899999986321 11111123344555444 4558999999999987543
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
..|+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+
T Consensus 71 ---------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~ 133 (260)
T cd05611 71 ---------------YLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133 (260)
T ss_pred ---------------eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 348899999999999999543 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC
Q 036382 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323 (390)
Q Consensus 244 ~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (390)
+.++|+|||++..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 134 ~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 134 GHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred CcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 9999999999875432 223467889999999988889999999999999999999999998887777666554433
Q ss_pred C--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 324 L--RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 324 ~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
. ....+..++..+.++|.+||..+|++|||+.++.+.|
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 2 2234456899999999999999999999775554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.90 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=195.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 156 (390)
.++|+..+.||+|+||.||++.+ +++.||+|.+..... ......+.+|+.++.++. ||||+++++++..
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 45788889999999999999987 578999998863221 123456788999999995 9999999998864
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHH---HhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL---IRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRD 232 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiHrD 232 (390)
. ...+++|||+.. +|.++. .......+++..+..++.+++.||+|||+. +++|||
T Consensus 75 ~--------------------~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 133 (288)
T cd06616 75 E--------------------GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133 (288)
T ss_pred C--------------------CcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccC
Confidence 3 334789999864 665543 223346799999999999999999999975 999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK---PYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|||+|||++.++.++|+|||++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 134 lkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 134 VKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred CCHHHEEEccCCcEEEeecchhHHhccC-CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 9999999999999999999998754322 122334688999999999766 689999999999999999999999976
Q ss_pred CCh-hhHHHHHHHcC---CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 310 LSF-ADVSSAVVRQN---LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 310 ~~~-~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
... .+....+.... +....+..++.++.+||.+||..+|++|||+.+|+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 213 WNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 542 22222222111 1112223578999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=301.67 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=193.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+|.. +++.||+|++....... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~- 75 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--------VPFTAIREASLLKGLKHANIVLLHDIIHTK- 75 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--------CcHHHHHHHHHHHhcCCCCEeEEEEEEecC-
Confidence 5799999999999999999976 57899999986432111 113456899999999999999999998743
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+||
T Consensus 76 -------------------~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 134 (291)
T cd07870 76 -------------------ETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134 (291)
T ss_pred -------------------CeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 34488999995 6887777543 34578888999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChh-hHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFA-DVS 316 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~ 316 (390)
|++.++.++|+|||+++.............+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.. +.+
T Consensus 135 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~ 214 (291)
T cd07870 135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214 (291)
T ss_pred EEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH
Confidence 99999999999999987544333333445678999999998754 5788999999999999999999999765432 221
Q ss_pred HHHHH----------------cCCCCC-----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVR----------------QNLRPE-----IP---------RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~----------------~~~~~~-----~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..... ..+... .+ ...+.++.+++.+||..||++|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 11110 000000 00 112568999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.08 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=201.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +|+.||||.++... .......+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 5799999999999999999976 67899999985211 1122345678999999999999999999876433
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.. .....|+|+||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 77 ~~---------------~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Ni 137 (336)
T cd07849 77 FE---------------SFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNL 137 (336)
T ss_pred cc---------------ccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 21 22356899999964 88887743 4699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|++.++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 138 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred EECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999875432211 1223467899999998754 568999999999999999999999998765433
Q ss_pred HHHHHHHc------------------------CCCCCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHH
Q 036382 315 VSSAVVRQ------------------------NLRPEI-----PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEA 363 (390)
Q Consensus 315 ~~~~~~~~------------------------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~ 363 (390)
....+... ...... ....++++.++|.+||+.||++|||+.+++++ ++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 22221110 000000 12346789999999999999999999999987 665
Q ss_pred hHh
Q 036382 364 IDT 366 (390)
Q Consensus 364 ~~~ 366 (390)
+..
T Consensus 298 ~~~ 300 (336)
T cd07849 298 YHD 300 (336)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=293.78 Aligned_cols=247 Identities=30% Similarity=0.549 Sum_probs=206.2
Q ss_pred CccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||+|++|.||++.+. ++.+++|+++.... .....+.+|+++++.++||||+++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 69 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---------EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-- 69 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 4788899999999999999884 78999999863221 2346788999999999999999999998754
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++++||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 70 ------------------~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~ 130 (253)
T cd05122 70 ------------------DELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130 (253)
T ss_pred ------------------CeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEE
Confidence 34588999999999999986542 46899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.++|+|||.+........ .....++..|++||.+.+..++.++|+||||+++|+|++|..||...+........
T Consensus 131 i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 131 LTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred EccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 99999999999999875543321 33456889999999998888999999999999999999999999887655555444
Q ss_pred HHcCCCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLRPEIPRC--CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.. ...+..+.. ++..+.+++.+||..||.+|||+.+++++
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 210 AT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Hh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33 222333333 38899999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=302.76 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=200.6
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|++|.||+|++ +++.||||+++...... ....+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--------TPSTAIREISLMKELKHENIVRLHDVIHTEN- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--------chHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-
Confidence 488899999999999999987 57899999987432211 1244568999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus 72 -------------------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni 131 (284)
T cd07836 72 -------------------KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNL 131 (284)
T ss_pred -------------------cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 34789999985 8988886533 24689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
+++.++.++|+|||++..............++..|++||.+.+. .++.++|+|||||++|+|++|..||.+.+..+...
T Consensus 132 ~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 211 (284)
T cd07836 132 LINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211 (284)
T ss_pred EECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999997544333333445678899999988654 57889999999999999999999998877665544
Q ss_pred HHHHcC----------------CCCCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQN----------------LRPEI-----------PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~----------------~~~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+.... +.... ...+++.+.+++.+||+.||.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 433211 00111 1235778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=301.28 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=189.5
Q ss_pred cccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHH---HhcCCCccceEEEEEeccccccc
Q 036382 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW---QKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
.||+|+||.||++.. +++.||+|+++........ ....+.+|..++ ...+||||+.+++++....
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 70 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ------GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD---- 70 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch------HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC----
Confidence 489999999999987 5789999998633221111 112223344333 3457999999999887543
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
..++||||+.+++|.+++..+ ..+++..+..++.|++.||.|||+.+|+||||||+|||++.
T Consensus 71 ----------------~~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~ 132 (279)
T cd05633 71 ----------------KLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132 (279)
T ss_pred ----------------eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC
Confidence 447899999999999998543 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh--HHHHH
Q 036382 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD--VSSAV 319 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~--~~~~~ 319 (390)
++.++|+|||++...... ......++..|+|||.+. +..++.++|+|||||++|+|++|..||....... .....
T Consensus 133 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 210 (279)
T cd05633 133 HGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (279)
T ss_pred CCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH
Confidence 999999999998754322 223356899999999986 4568999999999999999999999997543221 11111
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
........+..+++++.++|.+||..||.+|| |+.+++++
T Consensus 211 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 -TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22344567778899999999999999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=297.25 Aligned_cols=252 Identities=22% Similarity=0.377 Sum_probs=207.7
Q ss_pred ccCcccc-ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 80 LSKLDMR-NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 80 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
.++|.+. .+||-|-.|.|..+.. +++.+|+|++.-. ...++|+++--.. .|||||.+++++.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------------~KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------------PKARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------------HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence 3566653 5799999999998865 7899999998521 3345788875544 8999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
..- .......+|||.|+||.|+..+..+....+++..+..|+.||..|+.|||+.+|.||||||
T Consensus 126 Ns~----------------~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKp 189 (400)
T KOG0604|consen 126 NSY----------------QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKP 189 (400)
T ss_pred hhc----------------cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCCh
Confidence 332 1245567899999999999999888878899999999999999999999999999999999
Q ss_pred CCEEECCC---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 236 ENMLLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 236 ~NILl~~~---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
+|+|.+.. ..+||+|||+|+.... .....+.|-||.|.|||++....|+.++|+||+|+++|-|+||.+||.....
T Consensus 190 ENLLyt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 190 ENLLYTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred hheeeecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 99999654 5799999999985443 4566778999999999999999999999999999999999999999976532
Q ss_pred ----hhHHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 313 ----ADVSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 313 ----~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
..+..++..+.+..+ -+.+++.+.+++|+++|..+|.+|.|+.++++.=.
T Consensus 269 ~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 269 LAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 334455555554433 33578899999999999999999999999987543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=309.89 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=211.5
Q ss_pred cccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 153 (390)
.|...+|.++.+||+|+||.|.+|... .+.+|||+++..- ... ....+--..|-++|... +-|.+++++..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV---iiQ---dDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV---IIQ---DDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccce---eee---cCcccceehhhhheecCCCCchHHHHHHH
Confidence 566789999999999999999999774 4689999997321 000 11112223567777766 56799999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
|+..+.+ |+||||+.||+|--.+++- +++-+..+..++.+|+-||-+||++|||+|||
T Consensus 419 FQTmDRL--------------------yFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDL 476 (683)
T KOG0696|consen 419 FQTMDRL--------------------YFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL 476 (683)
T ss_pred hhhhhhe--------------------eeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence 8866555 7799999999999888543 56889999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|.+|||++.+|++||+|||++...........+.||||.|+|||++.-.+|+.++|+||+|++||||+.|++||.+.+.+
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999986655666667799999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE 353 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 353 (390)
++.+.+...+ ..+|..++.+..+++...|.+.|.+|..
T Consensus 557 elF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 ELFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 9999987664 4589999999999999999999999953
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=302.08 Aligned_cols=270 Identities=26% Similarity=0.455 Sum_probs=232.2
Q ss_pred CcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 146 (390)
.+..+...++++..++-+|+||.||+|.| +.+.|-||.++. ...+.....+..|.-++..+.|||
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--------~AS~iQv~~~L~es~lly~~sH~n 348 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--------HASQIQVNLLLQESMLLYGASHPN 348 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--------cccHHHHHHHHHHHHHHhcCcCCC
Confidence 45566677889999999999999999965 235778887762 222344677889999999999999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh------hccCCCCHHHHHHHHHHHHHHH
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR------NRRKKLALKIVIQLALDLSRGL 220 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~i~~~L 220 (390)
+..+.+++..+ ....++++.++.-|+|..+|.. ...+.++..++..++.|++.|+
T Consensus 349 ll~V~~V~ie~-------------------~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am 409 (563)
T KOG1024|consen 349 LLSVLGVSIED-------------------YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAM 409 (563)
T ss_pred ccceeEEEeec-------------------cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHH
Confidence 99999998753 3445789999999999999972 2235678889999999999999
Q ss_pred HHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCC--CCCCCCccccccccCCCCCCCchhHHHHHHHHH
Q 036382 221 SYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT--GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298 (390)
Q Consensus 221 ~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 298 (390)
+|||++||||.||..+|.+|++..++||+|=.+++...+...... +...+..||+||.+.+..|+.++|+||||++||
T Consensus 410 ~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW 489 (563)
T KOG1024|consen 410 EHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW 489 (563)
T ss_pred HHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence 999999999999999999999999999999999987655444333 244678999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 299 EIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 299 ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
||+| |+.||...++.|+.. +++.++|...|.+||+++..+|..||+..|++||+++|++..|.+++++.+.+
T Consensus 490 ELmtlg~~PyaeIDPfEm~~-ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y 562 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDPFEMEH-YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRY 562 (563)
T ss_pred HHHhcCCCCccccCHHHHHH-HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence 9998 999999999999875 55789999999999999999999999999999999999999999999877644
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.04 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=192.9
Q ss_pred cccccc--CceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 87 NLIAQG--TYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 87 ~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
..||+| +||+||++++ +++.||+|+++.... .....+.+.+|+.+++.++||||++++++|....
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~---- 72 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS---- 72 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC----
Confidence 456666 9999999987 789999999864321 1123467889999999999999999999997543
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
..|+||||+.+++|.+++.+.....+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 73 ----------------~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~ 136 (328)
T cd08226 73 ----------------WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG 136 (328)
T ss_pred ----------------ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC
Confidence 3488999999999999997665556999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCCC-------CCCCCCCCccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 243 QRTLKIADFGVARVEAQNPRD-------MTGETGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
++.++++||+.+......... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||......
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 216 (328)
T cd08226 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216 (328)
T ss_pred CCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH
Confidence 999999999865422111100 0112345679999999764 4789999999999999999999999876654
Q ss_pred hHHHHHHHcC---------------------------------------------CCCCCCCCCcHHHHHHHHHhhhhCC
Q 036382 314 DVSSAVVRQN---------------------------------------------LRPEIPRCCPSSLANIMRKCWDANA 348 (390)
Q Consensus 314 ~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP 348 (390)
.......... .+...+..+++.+.+||++||+.||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 296 (328)
T cd08226 217 QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296 (328)
T ss_pred HHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCc
Confidence 4433222111 0111123456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 036382 349 EKRPEMGEVVKM 360 (390)
Q Consensus 349 ~~Rpt~~~ll~~ 360 (390)
++|||+.++++.
T Consensus 297 ~~Rpta~e~l~~ 308 (328)
T cd08226 297 EKRPSASSLLSH 308 (328)
T ss_pred ccCCCHHHHhhC
Confidence 999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.94 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=207.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 157 (390)
++|.+.+.||+|+||.||++.. +++.||+|++.... .........+.+|..++++++ ||||+++++++.+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ------LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh------ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 3688999999999999999987 68899999986321 111222356788999999998 99999999987644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 75 ~--------------------~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~n 132 (280)
T cd05581 75 E--------------------NLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132 (280)
T ss_pred c--------------------eEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 3 448899999999999999653 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCC--------------------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNP--------------------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 297 (390)
|+++.++.++|+|||++....... .......++..|+|||...+..++.++|+||||+++
T Consensus 133 i~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 212 (280)
T cd05581 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212 (280)
T ss_pred eEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHH
Confidence 999999999999999987543322 112234578899999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 036382 298 WEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM----GEVVK 359 (390)
Q Consensus 298 ~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~~ll~ 359 (390)
|++++|..||...+.......+. ......+..++..+.+++.+||..+|.+|||+ .++++
T Consensus 213 ~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 213 YQMLTGKPPFRGSNEYLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhCCCCCCCccHHHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 99999999998877655555544 23445677889999999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.76 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=202.7
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccce
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTK 149 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 149 (390)
...|.++.++|++.+.||.|+||.||+|.+. ++.||||.++.... ......+..|+.++.++ .||||++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~i~~ 78 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--------KEENKRILMDLDVVLKSHDCPYIVK 78 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--------hHHHHHHHHHHHHHHhccCCCchHh
Confidence 3567788899999999999999999999885 88999999863211 11223455677766666 5999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKI 228 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~i 228 (390)
+++++.+... .|++|||+. ++|.+++... ...+++..+..++.|++.||.|||+ .||
T Consensus 79 ~~~~~~~~~~--------------------~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i 136 (296)
T cd06618 79 CYGYFITDSD--------------------VFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGV 136 (296)
T ss_pred hheeeecCCe--------------------EEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 9999875443 478999985 4788777543 3478999999999999999999997 599
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC----CCCchhHHHHHHHHHHHHhCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP----YNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~ 304 (390)
+||||+|+||+++.++.+||+|||++...... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|.
T Consensus 137 ~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 215 (296)
T cd06618 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215 (296)
T ss_pred ecCCCcHHHEEEcCCCCEEECccccchhccCC-CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998754322 2223345788999999987553 788999999999999999999
Q ss_pred CCCCCCCh-hhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 305 MPYPDLSF-ADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 305 ~Pf~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
.||..... .+....+.... .+.. ...++.++.+|+.+||..||.+|||+.+++.+-
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 216 FPYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 99976432 34444443332 2222 234789999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=301.16 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=201.8
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|+...+||+|+||.||++.. +++.||||.+.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 90 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-- 90 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--
Confidence 34456899999999999977 67899999875221 122456888999999999999999999987543
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus 91 ------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv 149 (292)
T cd06657 91 ------------------ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149 (292)
T ss_pred ------------------EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 44889999999999998743 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (390)
+.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 150 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~- 228 (292)
T cd06657 150 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI- 228 (292)
T ss_pred CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 9999999999999875443322333456889999999998888999999999999999999999999887666555443
Q ss_pred HcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 321 RQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 321 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....... ....++..+.+++.+||..+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 2232222 234578899999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=304.99 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=196.8
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
+.+.+.+|.|+++.|+++..+++.||||+++.... .......+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~----- 71 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD----- 71 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-------chhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----
Confidence 44566677778888888888899999999863211 112346688999999999999999999998754
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
...+++|||+.+|+|.+++.+.....+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 72 ---------------~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~ 136 (314)
T cd08216 72 ---------------SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG 136 (314)
T ss_pred ---------------CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec
Confidence 34588999999999999997665567999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCC-------CCCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 243 QRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
++.++|+|||.+........ ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..
T Consensus 137 ~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred CCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999998864332111 1123446778999999866 35889999999999999999999999876544
Q ss_pred hHHHHHHHcCCC--------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLR--------------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
............ ...+..++.++.+|+.+||..||++|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 217 QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 433222211100 00111234678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.63 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=194.0
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSN 159 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 159 (390)
|++.+.||+|+||.||+|.. +++.||+|.++..... .. .....+|+.+++++ +||||+++++++.+..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~- 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LE-----QVNNLREIQALRRLSPHPNILRLIEVLFDRK- 71 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---ch-----hhhHHHHHHHHhhcCCCCCccceEEEEecCC-
Confidence 57788999999999999987 6789999998632211 11 12234788889988 5999999999987541
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
.+..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 72 -----------------~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~ 132 (282)
T cd07831 72 -----------------TGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL 132 (282)
T ss_pred -----------------CCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence 234589999997 5888888543 246899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++. +.+||+|||++...... .......++..|+|||.+. +..++.++|+|||||++|||++|..||...+..+....
T Consensus 133 l~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 133 IKD-DILKLADFGSCRGIYSK-PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred EcC-CCeEEEecccccccccC-CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 999 99999999999754332 2223346788999999764 45578899999999999999999999988766554433
Q ss_pred HHHcC----------------CCCCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQN----------------LRPEI-----------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~----------------~~~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.... ..... ...++.++.++|.+||.++|++|||+.++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 32100 00011 12467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=296.43 Aligned_cols=253 Identities=29% Similarity=0.496 Sum_probs=203.9
Q ss_pred CccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|.+.+.||+|+||.||++.+. +..+++|+++....... .......+..|+.++++++||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL----NPNETVQANQEAQLLSKLDHPAIVKFHASFLER-- 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc----CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--
Confidence 4788899999999999999874 45677777653221100 011123456789999999999999999887643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++||||+.+++|.+++.. .....+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 75 ------------------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n 136 (260)
T cd08222 75 ------------------DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN 136 (260)
T ss_pred ------------------CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence 334889999999999998864 234569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+++. +.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+......
T Consensus 137 ili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~ 215 (260)
T cd08222 137 IFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215 (260)
T ss_pred eEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 99964 67999999998765443333334567889999999988889999999999999999999999998776666555
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+. .+..+..+..++.++.++|.+||..+|++||++.++++.
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 RIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 543 344555677889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=307.69 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=203.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|.+ +++.||||.+..... .......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-------NATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-------cchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 35799999999999999999987 578999998852111 011124566899999999 99999999998764
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ....|+||||+. ++|..++... .+++..+..++.||+.||.|||+.||+||||+|+
T Consensus 79 ~~------------------~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ 136 (337)
T cd07852 79 EN------------------DKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPS 136 (337)
T ss_pred CC------------------CceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 32 234589999997 5999988542 6889999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC-----CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP-----RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||++.++.+||+|||++....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.
T Consensus 137 nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 137 NILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred HEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987543221 12233457889999998754 56788999999999999999999999876
Q ss_pred ChhhHHHHHHHcCCC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH-
Q 036382 311 SFADVSSAVVRQNLR-----------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM- 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~- 360 (390)
+..+....+...... ......++.++.++|.+||+.||.+|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 655443332211100 01112368899999999999999999999999975
Q ss_pred -HHHhHhcCC
Q 036382 361 -LEAIDTSKG 369 (390)
Q Consensus 361 -L~~~~~~~~ 369 (390)
+..+.+...
T Consensus 297 ~~~~~~~~~~ 306 (337)
T cd07852 297 YVAQFHNPSD 306 (337)
T ss_pred hhhhhccCCC
Confidence 666655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=302.95 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=204.2
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
...++|++.+.||.|+||.||+|.. +++.||+|+++..... ......+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~ 76 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-------EGFPITAIREIKILRQLNHRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-------cCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence 4457899999999999999999987 5789999998743211 111245668999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+..... .........|+|+||+.+ +|.+++.+. ...+++..+..++.||+.||.|||+.||+|+||+|
T Consensus 77 ~~~~~~----------~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p 144 (302)
T cd07864 77 DKQDAL----------DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144 (302)
T ss_pred Ccchhh----------hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 543110 001123467999999976 787777543 34689999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
+||+++.++.+||+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 145 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999987544322 12223456788999998865 35788999999999999999999999876655
Q ss_pred hHHHHHHHcCCCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRP----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+......+ .....+|..+.+++.+||..||.+|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 5444333211000 0122468899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=304.46 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=195.0
Q ss_pred CccccccccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+|++.+.||+|+||.||+|.. .++.||+|++..... ........+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE------QYTGISQSACREIALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc------cccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence 478889999999999999987 568999999974321 1111224567899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
. ....|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.+|+|||||
T Consensus 75 ~------------------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk 135 (316)
T cd07842 75 A------------------DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK 135 (316)
T ss_pred C------------------CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 2 2345899999975 7877775332 2368999999999999999999999999999999
Q ss_pred CCCEEECC----CCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 235 TENMLLDS----QRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 235 p~NILl~~----~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|+|||++. ++.+||+|||++........ ......++..|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus 136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred HHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 99999999 89999999999875433221 2233467889999998866 4588999999999999999999999
Q ss_pred CCCCChhh---------HHHHHHH------------------------cCCCCCCC-----------CCCcHHHHHHHHH
Q 036382 307 YPDLSFAD---------VSSAVVR------------------------QNLRPEIP-----------RCCPSSLANIMRK 342 (390)
Q Consensus 307 f~~~~~~~---------~~~~~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~ 342 (390)
|.+..... ....++. .......+ ...+.++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97654322 0111000 00011111 1456789999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 036382 343 CWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 343 cl~~dP~~Rpt~~~ll~~ 360 (390)
||..||++|||+.+++++
T Consensus 296 ~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 296 LLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhcCCcccCcCHHHHhcC
Confidence 999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.28 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=203.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
..|+..+.||+|+||.||+|+. +++.||+|.+...... .......+.+|+++++.++|||++++++++...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE- 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc------ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-
Confidence 3477888999999999999987 5788999988632111 112234577899999999999999999998754
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||
T Consensus 88 -------------------~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 88 -------------------HTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred -------------------CeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 33478999996 5888877543 34689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|++.++.++|+|||++...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+.
T Consensus 147 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 147 LLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred EECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 9999999999999998754322 2356788999999974 35678899999999999999999999988776665
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
...+.........+..++..+.+||.+||..+|++||++.+++..-.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 55554443333344568889999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.89 Aligned_cols=238 Identities=25% Similarity=0.392 Sum_probs=200.9
Q ss_pred ccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||.|+||.||++.. +++.||+|+++... .........+.+|+.++++++||||+++++.+...
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 65 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK------IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--------- 65 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh------hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC---------
Confidence 68999999999987 47899999986322 11122345678899999999999999999887643
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
...|+||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 66 -----------~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~ 132 (250)
T cd05123 66 -----------EKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132 (250)
T ss_pred -----------CeeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcE
Confidence 3458899999999999999653 368999999999999999999999999999999999999999999
Q ss_pred EEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCC
Q 036382 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP 326 (390)
Q Consensus 247 kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 326 (390)
+|+|||++..............++..|++||...+..++.++|+||||+++|+|++|..||...+.......+.. ...
T Consensus 133 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~ 210 (250)
T cd05123 133 KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL 210 (250)
T ss_pred EEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC
Confidence 999999987654432334456688899999999888899999999999999999999999988776666555544 345
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 327 EIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 327 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
.++...+..+.+++.+||..||++|||+.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 677888999999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=308.70 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=199.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.. +++.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-------ccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 5789999999999999999976 5889999998632211 112355678999999999999999998875332
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
......++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 78 ----------------~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 78 ----------------ADFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred ----------------CCCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 12345689999995 689998854 34599999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC----CCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..
T Consensus 139 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 218 (334)
T cd07855 139 LVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218 (334)
T ss_pred EEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH
Confidence 999999999999999875432211 1223468899999999865 46889999999999999999999999876544
Q ss_pred hHHHHHHHc------------------------CCCCCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQ------------------------NLRPEI-----PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~------------------------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.....+... ...... ....+.++.++|.+||+.+|++|||+.+++..
T Consensus 219 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 333222110 001111 13468899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.29 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=206.9
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|.+ .++|++.+.||+|+||.||++.. +++.||||+++... ........+.+|+.+++.++||||+++++
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-------cchHHHHHHHHHHHHHHhcCCCCccceee
Confidence 3554 46799999999999999999976 57899999885321 11223356778999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.....+. .....++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+|||
T Consensus 82 ~~~~~~~~~--------------~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~d 143 (343)
T cd07880 82 VFTPDLSLD--------------RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143 (343)
T ss_pred eecCCcccc--------------ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 987544321 123458999998 7799988743 4689999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||+||+++.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+
T Consensus 144 lkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 144 LKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred CCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998754322 233467889999999876 458899999999999999999999998766
Q ss_pred hhhHHHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH--HH
Q 036382 312 FADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVV--KM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll--~~ 360 (390)
.......+....... .....+++++.++|.+||+.||.+|||+.+++ ..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 221 HLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 544443332211100 11235678899999999999999999999999 45
Q ss_pred HHHhHh
Q 036382 361 LEAIDT 366 (390)
Q Consensus 361 L~~~~~ 366 (390)
++.+..
T Consensus 301 ~~~~~~ 306 (343)
T cd07880 301 FEEFHD 306 (343)
T ss_pred HhhhcC
Confidence 555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=305.79 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=208.8
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|++.+.||.|+||.||+|+. +++.||||.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-------ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 588899999999999999987 47899999886321 112234567889999999999999999998865431
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
......|++|||+. ++|.+++.+ +..+++..++.++.|++.||.|||+.||+|+||||.|||
T Consensus 74 ---------------~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nil 135 (330)
T cd07834 74 ---------------EDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL 135 (330)
T ss_pred ---------------ccccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 12235689999997 489998854 347999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 240 LDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.
T Consensus 136 i~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~ 215 (330)
T cd07834 136 VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215 (330)
T ss_pred EcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 9999999999999998654432 123345678899999999887 789999999999999999999999988776665
Q ss_pred HHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 036382 316 SSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAI 364 (390)
Q Consensus 316 ~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~ 364 (390)
...+....-.+ .....++.++.++|.+||+.+|++|||+.+++.. ++.+
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 54443211100 0112367889999999999999999999999985 6665
Q ss_pred Hh
Q 036382 365 DT 366 (390)
Q Consensus 365 ~~ 366 (390)
..
T Consensus 296 ~~ 297 (330)
T cd07834 296 HD 297 (330)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=294.95 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=190.3
Q ss_pred cccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHH---HHHHHhcCCCccceEEEEEeccccccc
Q 036382 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQE---VAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
.||+|+||.||++.. +++.||+|++........ .. ...+..| ...++...||||+++++++....
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QG---ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD---- 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc---hh---HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----
Confidence 489999999999876 578999999864321111 11 1112233 34455568999999999887543
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
..|+||||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.+|+||||||+||+++.
T Consensus 71 ----------------~~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~ 132 (278)
T cd05606 71 ----------------KLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 132 (278)
T ss_pred ----------------EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC
Confidence 34789999999999998854 346999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhhHHHH
Q 036382 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLS---FADVSSA 318 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~---~~~~~~~ 318 (390)
++.++|+|||++...... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||.... .......
T Consensus 133 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~ 210 (278)
T cd05606 133 HGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (278)
T ss_pred CCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence 999999999998744322 22345789999999999754 68999999999999999999999997763 2222211
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
........|..++.++.+++.+||..+|.+|| ++.++++.
T Consensus 211 --~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 211 --TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 22334567777899999999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.53 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=199.7
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
+.++|++.+.||+|+||.||+|.. +++.||||.+...... ......+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-------EGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-------CCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 457899999999999999999987 5789999988632211 1112345679999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..... .......++||||+.+ +|.+++.+. ...+++..++.++.||+.||.|||++|++|+||+|+
T Consensus 83 ~~~~~------------~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~ 148 (310)
T cd07865 83 KATPY------------NRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAA 148 (310)
T ss_pred ccccc------------cCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 43221 1134567999999964 888887543 346899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCC----CCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+
T Consensus 149 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred HEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999875432211 12334578899999988664 47889999999999999999999998766
Q ss_pred hhhHHHHHHH--cCCCCC---------------C-------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVR--QNLRPE---------------I-------------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~--~~~~~~---------------~-------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.......+.. ....+. . +...+..+.+||.+||..||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 229 EQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 5443322211 000000 0 11235678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=298.33 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=203.7
Q ss_pred CccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
+|++.+.||+|+||.||++.. +++.||||+++... ..........+.+|+.+++++ +||||+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~-----~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT-----IVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHH-----HHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence 478889999999999999874 46789999986211 112223345678999999999 6999999998876
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.. ...|+||||+.+|+|.+++.+ ...+++..+..++.|++.||.|||+.+++|+||+|
T Consensus 76 ~~--------------------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p 133 (288)
T cd05583 76 TD--------------------TKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133 (288)
T ss_pred cC--------------------CEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 43 344789999999999999854 34689999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLWEIYCCDMPYPDLS- 311 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~Pf~~~~- 311 (390)
+||+++.++.++|+|||+++....... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||....
T Consensus 134 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 213 (288)
T cd05583 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213 (288)
T ss_pred HHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence 999999999999999999875433221 122345789999999987654 7889999999999999999999996432
Q ss_pred ---hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 312 ---FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 312 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
..+....+.. ..+..+..++..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 214 QNSQSEISRRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cchHHHHHHHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 2233333222 23456777889999999999999999999998888877765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=298.94 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=200.7
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|...+.||+|+||.||+|+. +++.||+|++...... .......+.+|+++++.++|||++++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ------TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC------chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--
Confidence 66677899999999999987 6789999998643211 1122346778999999999999999999987543
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
..|+||||+. |+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 95 ------------------~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili 154 (313)
T cd06633 95 ------------------TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154 (313)
T ss_pred ------------------EEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE
Confidence 3478999996 5888887543 3468999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
+.++.++|+|||++.... ......++..|+|||.+. ...++.++|+|||||++|+|++|..||...+......
T Consensus 155 ~~~~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 155 TEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred CCCCCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999999999986422 223456888999999984 4568889999999999999999999998877666555
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+............++..+.+|+.+||+.+|.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5544433333344577889999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=297.78 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=200.9
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.+.||.|++|.||++.. +++.+++|.++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 70 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-------SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--- 70 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-------cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC---
Confidence 56778999999999999987 578999999863321 112345677899999999999999999987644
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...++|+||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||++
T Consensus 71 -----------------~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 131 (283)
T cd05118 71 -----------------GDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI 131 (283)
T ss_pred -----------------CCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE
Confidence 345889999975 8888886543 578999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
+.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+..+..+....+
T Consensus 132 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 132 NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999997655433233345678899999998776 7899999999999999999999999887766554444
Q ss_pred HHcCCCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 320 VRQNLRP----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 320 ~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
......+ .....++.++.++|.+||..||.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 3211000 011236788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.19 Aligned_cols=258 Identities=25% Similarity=0.533 Sum_probs=221.6
Q ss_pred ccccccccccCceEEEEEEE--CC----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DN----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
++..++||.|+||+||+|.| .| -+||+|++... ........+..|+.+|..++|||+++++|+++.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--------t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--------TSPKASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--------CCchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 45567899999999999987 33 48999998522 122234678899999999999999999999986
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
+. +.||++|++.|+|.||++.+ +..+..+..+.|..||+.||.|||.++++||||..+
T Consensus 770 s~---------------------~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaR 827 (1177)
T KOG1025|consen 770 ST---------------------LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAAR 827 (1177)
T ss_pred ch---------------------HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhh
Confidence 53 35799999999999999765 457899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCC--CCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTG--ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~ 313 (390)
||||.+-.++||.|||+|+........... ....+.|||-|.+....|+.++|||||||++||++| |..||.+...+
T Consensus 828 NVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 828 NVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred heeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 999999999999999999976655444333 334688999999999999999999999999999998 99999999888
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
++. .+++.+.|.+.|..|+-++..+|.+||..|+..||+|+++...+.++-..-..+
T Consensus 908 eI~-dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 908 EIP-DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred Hhh-HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 865 556788889999999999999999999999999999999999999886544433
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=303.11 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=197.5
Q ss_pred Ccc-ccccccccCceEEEEEEE--CCceEEEEEeccCCCCccch-----HHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 82 KLD-MRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATT-----AETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 82 ~~~-~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+|. +.+.||.|+||.||+|.+ +++.||||+++......... .........+.+|+++++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 567899999999999986 57899999986432211000 0000011246789999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+... ...|+||||+. |+|.+++.. ...+++..+..++.|++.||+|||+.||+|+||
T Consensus 89 ~~~~--------------------~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl 145 (335)
T PTZ00024 89 YVEG--------------------DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDL 145 (335)
T ss_pred EecC--------------------CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 8744 34488999996 599999854 346899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceecc--------------CCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHH
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEA--------------QNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLW 298 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ 298 (390)
+|+|||++.++.++|+|||++.... ..........+++.|+|||.+.+. .++.++|+|||||++|
T Consensus 146 ~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 225 (335)
T PTZ00024 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225 (335)
T ss_pred cHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHH
Confidence 9999999999999999999987544 111222334568899999998764 4789999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHcCCCC--------------------------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 036382 299 EIYCCDMPYPDLSFADVSSAVVRQNLRP--------------------------EIPRCCPSSLANIMRKCWDANAEKRP 352 (390)
Q Consensus 299 ell~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~Rp 352 (390)
+|++|..||...+..+....+......+ .....++.++.++|.+||..+|++||
T Consensus 226 el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 305 (335)
T PTZ00024 226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305 (335)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence 9999999998877666554443211000 01124578899999999999999999
Q ss_pred CHHHHHH
Q 036382 353 EMGEVVK 359 (390)
Q Consensus 353 t~~~ll~ 359 (390)
|+.+++.
T Consensus 306 s~~~~l~ 312 (335)
T PTZ00024 306 SAKEALK 312 (335)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=323.53 Aligned_cols=260 Identities=19% Similarity=0.303 Sum_probs=186.6
Q ss_pred ccCccccccccccCceEEEEEEEC---CceEEEEEeccCCCCc--------cchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGM--------ATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~--------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
.++|++.+.||+|+||.||++... +..+++|.+....... ............+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998652 2222333111000000 00011112345678999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR---RKKLALKIVIQLALDLSRGLSYLHS 225 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~yLH~ 225 (390)
++++++.+... .|+|++++. ++|.+++.... ........+..++.||+.||.|||+
T Consensus 227 ~l~~~~~~~~~--------------------~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 227 KIEEILRSEAN--------------------TYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred cEeEEEEECCe--------------------eEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 99999875443 377999985 57888775322 2234466788899999999999999
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
+||+||||||+|||++.++.+||+|||++....... .......||..|+|||++.+..++.++|||||||++|||++|.
T Consensus 286 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999998654322 1223457999999999999999999999999999999999987
Q ss_pred CC-CCCC--ChhhHHHHHHHcC------C---------------CCCC---------CCCCcHHHHHHHHHhhhhCCCCC
Q 036382 305 MP-YPDL--SFADVSSAVVRQN------L---------------RPEI---------PRCCPSSLANIMRKCWDANAEKR 351 (390)
Q Consensus 305 ~P-f~~~--~~~~~~~~~~~~~------~---------------~~~~---------~~~~~~~l~~li~~cl~~dP~~R 351 (390)
.| |... .....+..++... + .... ...++.++.++|.+||+.||.+|
T Consensus 366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence 54 4322 1112222211100 0 0000 11346678889999999999999
Q ss_pred CCHHHHHHH
Q 036382 352 PEMGEVVKM 360 (390)
Q Consensus 352 pt~~~ll~~ 360 (390)
||+.+++++
T Consensus 446 psa~elL~h 454 (501)
T PHA03210 446 PGAAELLAL 454 (501)
T ss_pred cCHHHHhhC
Confidence 999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.74 Aligned_cols=250 Identities=22% Similarity=0.383 Sum_probs=199.0
Q ss_pred CccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
+|++.+.||.|+||.||++.. +|+.||+|+++... ........+.+.+|+.+++++ +|+||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKAT-----IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhh-----hhhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence 478889999999999999876 67899999986321 111223346677899999999 6999999998886
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.. ...|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|
T Consensus 76 ~~--------------------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 133 (290)
T cd05613 76 TD--------------------TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133 (290)
T ss_pred cC--------------------CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 43 3447899999999999999653 4689999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYCCDMPYPDLS- 311 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 311 (390)
+|||++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....
T Consensus 134 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred HHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 99999999999999999987543221 122235688999999998653 46789999999999999999999996432
Q ss_pred ---hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 312 ---FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 312 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
..+....+.. ..++.+..+++.+.+++.+||..||++|| ++.+++..
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 214 KNSQAEISRRILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cccHHHHHHHhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2222222222 23456777899999999999999999997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=295.76 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=199.7
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEEEecc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGASVGT 157 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~ 157 (390)
|++.+.||+|+||.||+|.+ +++.||+|+++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 57788999999999999988 478999999974322 111223455677777666 699999999998765
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... .....+++|||+.+ +|.+++.+.....+++..++.++.|++.||.|||+.+++|+||+|+|
T Consensus 74 ~~~---------------~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n 137 (287)
T cd07838 74 RTD---------------RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137 (287)
T ss_pred cCC---------------CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 431 12235899999975 89998876544569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+...
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~ 216 (287)
T cd07838 138 ILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216 (287)
T ss_pred EEEccCCCEEEeccCcceeccCC-cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH
Confidence 99999999999999998764332 12233457889999999999899999999999999999999999998887766665
Q ss_pred HHHHcCCC------------------CCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQNLR------------------PEI-------PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~~~------------------~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+...... ... ....+..+.++|.+||+.||.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 55431100 000 0123567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.91 Aligned_cols=262 Identities=23% Similarity=0.389 Sum_probs=204.7
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|++. ++|.+.+.||+|+||.||+|.+ +++.||||.++.... .......+.+|+.+++.++||||+++++
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-------SEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-------cccchhHHHHHHHHHHhcCCCCccchhh
Confidence 46663 5799999999999999999986 578999998863211 1112345678999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++....... .....|+|+||+.. +|..++ +..+++..+..++.|++.||.|||+.|++|||
T Consensus 82 ~~~~~~~~~--------------~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~d 142 (342)
T cd07879 82 VFTSAVSGD--------------EFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142 (342)
T ss_pred eecccccCC--------------CCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 986543221 22446899999964 777665 23589999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||+|||++.++.++|+|||++..... ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.+.+
T Consensus 143 lkp~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 143 LKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875432 2234567889999999876 468899999999999999999999998876
Q ss_pred hhhHHHHHHHcCC---------------------CCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--
Q 036382 312 FADVSSAVVRQNL---------------------RPEI--------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM-- 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~---------------------~~~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~-- 360 (390)
.......+..... .+.. ....+.++.+||.+||+.||++|||+.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 5444433322100 0000 12356789999999999999999999999955
Q ss_pred HHHhHh
Q 036382 361 LEAIDT 366 (390)
Q Consensus 361 L~~~~~ 366 (390)
++.+..
T Consensus 300 f~~~~~ 305 (342)
T cd07879 300 FDSFRD 305 (342)
T ss_pred hhhccc
Confidence 777654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=302.39 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=198.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||+|+++... ........+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-------hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 36899999999999999999976 67899999886321 1112234577899999999999999999987643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.... .....|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 89 ~~~~--------------~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 150 (345)
T cd07877 89 RSLE--------------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 150 (345)
T ss_pred cccc--------------ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence 3221 123457788876 7899888743 358999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|+++.++.++|+|||++..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.....
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred EEEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999875432 2234567889999999866 56889999999999999999999999876654443
Q ss_pred HHHHHcCC------------------------CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNL------------------------RPE-----IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~------------------------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+..... .+. .....++++.++|.+||+.||.+|||+.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 33221100 000 011357789999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=290.56 Aligned_cols=239 Identities=21% Similarity=0.370 Sum_probs=189.4
Q ss_pred cCccccccc--cccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 81 SKLDMRNLI--AQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 81 ~~~~~~~~l--g~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
++|++.+.+ |.|+||.||++.. ++..+|+|++...... ..|+.....+ +||||+++++.+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------------~~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------------AIEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------------hhhHHHHHHhhcCCCEEEEEEEEe
Confidence 356666665 9999999999976 6789999998632110 0122222222 7999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... ..|+||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|
T Consensus 80 ~~~--------------------~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 137 (267)
T PHA03390 80 TLK--------------------GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137 (267)
T ss_pred cCC--------------------eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 543 348899999999999999654 3799999999999999999999999999999999
Q ss_pred CCEEECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 236 ENMLLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 236 ~NILl~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
+||+++.++ .++|+|||++...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||......+
T Consensus 138 ~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 138 ENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred HHEEEeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 999999998 9999999998754322 23468899999999999899999999999999999999999998654433
Q ss_pred HHHHHH--HcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 036382 315 VSSAVV--RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-MGEVVK 359 (390)
Q Consensus 315 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~ 359 (390)
...... ........+..+++.+.++|.+||+.+|.+||+ ++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 211111 112233455678999999999999999999996 688874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=292.57 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=199.2
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.+.||.|+||.||+|.. +++.+|+|.++... ........+.+|+++++.++|||++++++++.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG-- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence 56788999999999999987 46899999997432 11222355778999999999999999999987541
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
....++||||+.+ +|.+++.+. ...+++..++.++.||+.||+|||+.|++|+||+|+||++
T Consensus 72 ----------------~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~ 133 (287)
T cd07840 72 ----------------KGSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133 (287)
T ss_pred ----------------CCcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 2445899999975 899888543 2469999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
+.++.++|+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 134 NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999999999997554332 12334567888999998765 4578999999999999999999999987765554444
Q ss_pred HHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+......+ .....++.++.+++.+||..+|.+|||+.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 33211000 0111237889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=291.63 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=195.7
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSN 159 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 159 (390)
|++.+.||.|+||.||+|.. +++.||||.+...... .......+|+..+++++ ||||+++++++.+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-- 70 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--------WEECMNLREVKSLRKLNEHPNIVKLKEVFREN-- 70 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--
Confidence 57788999999999999988 5678999988632110 11123457899999998 99999999988643
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
...++||||+ +|+|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+
T Consensus 71 ------------------~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~ 131 (283)
T cd07830 71 ------------------DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL 131 (283)
T ss_pred ------------------CcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 3458899999 789999987655457899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.++.++|+|||++...... .......++..|+|||++. +..++.++|+||||+++|+|++|..||+.....+....
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 132 VSGPEVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred EcCCCCEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 999999999999999754332 2223356788999999874 45578999999999999999999999987765544433
Q ss_pred HHHcC-----------------CCCC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQN-----------------LRPE-----------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~-----------------~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.... .... .....+..+.+++++||+.+|++|||+.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 22110 0000 011225789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=291.50 Aligned_cols=248 Identities=30% Similarity=0.457 Sum_probs=199.2
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.+.||+|+||.||+|+. +++.||+|+++... ........+.+|+.+++.++|+||+++++++.+.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 70 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--- 70 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC---
Confidence 56678899999999999987 47899999997432 1112234567899999999999999999988754
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...++||||+. ++|.+++.+.. ..+++..+..++.|++.||.|||+.||+|+||+|+||++
T Consensus 71 -----------------~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~ 131 (282)
T cd07829 71 -----------------RKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131 (282)
T ss_pred -----------------CceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE
Confidence 34588999997 59999996542 469999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
+.++.++|+|||++..............++..|+|||.+.+. .++.++|+|||||++|||++|..||...+..+....+
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 132 NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 999999999999987654433334445667889999998776 7899999999999999999999999887655544433
Q ss_pred HHcC----------------CCCC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 320 VRQN----------------LRPE-----------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 320 ~~~~----------------~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.... .... .....+..+.++|.+||..||++||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 2210 0000 01123678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=313.05 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=201.9
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
+...+.||+|+||.||+|++ +|+.||||.++... ....++...+|+++|++++|||||+++++=.+...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~- 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL- 85 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--------ccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc-
Confidence 34456899999999999986 79999999987322 22234677899999999999999999987544332
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR-NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
+. ......+|||||.||||..+|.+ .+...+++..++.++.++..||.|||.+||+||||||.||+
T Consensus 86 ~~-------------~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIv 152 (732)
T KOG4250|consen 86 GL-------------VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIV 152 (732)
T ss_pred Cc-------------ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Confidence 11 34556899999999999999964 23456999999999999999999999999999999999999
Q ss_pred EC--CCC--cEEEeecccceeccCCCCCCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q 036382 240 LD--SQR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--- 311 (390)
Q Consensus 240 l~--~~~--~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--- 311 (390)
+- ++| ..||+|||.|+...++. .++...||+.|.+||++. ++.|+..+|.|||||++|+..||..||-...
T Consensus 153 l~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 153 LQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred EeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 82 333 57999999999766543 677789999999999998 5889999999999999999999999995432
Q ss_pred -hhhHHHHHHHcCC-------------------CCCCCCCCcH----HHHHHHHHhhhhCCCCCC--CHHHHHHHHHHhH
Q 036382 312 -FADVSSAVVRQNL-------------------RPEIPRCCPS----SLANIMRKCWDANAEKRP--EMGEVVKMLEAID 365 (390)
Q Consensus 312 -~~~~~~~~~~~~~-------------------~~~~~~~~~~----~l~~li~~cl~~dP~~Rp--t~~~ll~~L~~~~ 365 (390)
+.++...+..++. ..++|-..++ .+-..+..+|..+|++|. .+.+....+.++-
T Consensus 232 ~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 232 NNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 2233333332211 1122323333 355677888899999998 7777777777764
Q ss_pred h
Q 036382 366 T 366 (390)
Q Consensus 366 ~ 366 (390)
.
T Consensus 312 ~ 312 (732)
T KOG4250|consen 312 N 312 (732)
T ss_pred h
Confidence 3
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.95 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=198.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||.|+||.||+|.+ +++.||||++........ ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-------FPITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-------cchhHHHHHHHHHhcCCCCccchhhheecc
Confidence 47899999999999999999987 578999998863321110 112456899999999999999999987654
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.... .......++||||+.+ +|...+... ...+++..+..++.|++.||.|||++||+|+||||+|
T Consensus 80 ~~~~------------~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~n 145 (311)
T cd07866 80 PDKS------------KRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAAN 145 (311)
T ss_pred cccc------------cccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3220 1134456899999965 777777542 3569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCC-----------CCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCC
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPR-----------DMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
||++.++.++|+|||++........ ..+...+++.|+|||.+.+ ..++.++|+|||||++|+|++|..
T Consensus 146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 9999999999999999875432211 1122356788999998865 458899999999999999999999
Q ss_pred CCCCCChhhHHHHHHHcCCCC---------------------CCC-------CCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 306 PYPDLSFADVSSAVVRQNLRP---------------------EIP-------RCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~---------------------~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
||.+.+.......+......+ ..+ ...+..+.++|.+||..||++|||+.++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 998776655444333211000 000 1234678999999999999999999998
Q ss_pred HH
Q 036382 358 VK 359 (390)
Q Consensus 358 l~ 359 (390)
+.
T Consensus 306 l~ 307 (311)
T cd07866 306 LE 307 (311)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=301.05 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=197.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||.|+||.||+|.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---------chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 5799999999999999999987 578999999864322 12355778999999999999999998765432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.... .+..........|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 76 ~~~~------~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Ni 145 (342)
T cd07854 76 SDLT------EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145 (342)
T ss_pred cccc------cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 1100 00011112345789999997 589888743 3589999999999999999999999999999999999
Q ss_pred EECC-CCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 239 LLDS-QRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 239 Ll~~-~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
+++. ++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9974 56789999999875432111 1122357889999998754 56888999999999999999999999876654
Q ss_pred hHHHHHHHcC-----------------------CCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQN-----------------------LRPE-----IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~-----------------------~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+......... .... ....++.++.+||.+||..||++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 4433332110 0000 11246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=296.08 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=195.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||.|+||.||++.. +++.||||.+..... .......+.+|+++++.++||||+++++++...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-------TPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 35799999999999999999976 578999998753211 111235577899999999999999999988642
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
....|+++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+|
T Consensus 82 -------------------~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~N 138 (328)
T cd07856 82 -------------------LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSN 138 (328)
T ss_pred -------------------CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 23458899998 5689888743 358889999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.........
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 139 ILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred EeECCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999874322 2233467889999998765 56899999999999999999999999876543322
Q ss_pred HHHHH------------------------cCCCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVR------------------------QNLRPE-----IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~------------------------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+.. ...... ....++.++.++|.+||+.+|++|||+.+++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110 000011 112467899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.47 Aligned_cols=148 Identities=24% Similarity=0.442 Sum_probs=127.8
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.++||+|+||.||+|.+. ++.||||+++.... ........+..|+.+++.++||||+++++++...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM------INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc------cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 468999999999999999999885 78999999863221 1123346678899999999999999999888644
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 77 ~--------------------~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~N 134 (669)
T cd05610 77 N--------------------NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134 (669)
T ss_pred C--------------------EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHH
Confidence 3 458899999999999999543 458999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccce
Q 036382 238 MLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~ 255 (390)
||++.++.+||+|||+++
T Consensus 135 ILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 135 MLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEcCCCCEEEEeCCCCc
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=301.39 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=202.7
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|++ .++|++.+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.++++++||||+++++
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-------QSAIHAKRTYRELRLLKHMDHENVIGLLD 81 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-------chhhHHHHHHHHHHHHHhccCCCHHHHHH
Confidence 4455 45799999999999999999988 57899999885321 11122345678999999999999999988
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++...... ......++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+|||
T Consensus 82 ~~~~~~~~--------------~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (343)
T cd07851 82 VFTPASSL--------------EDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143 (343)
T ss_pred Hhhccccc--------------cccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 76543221 1223468999998 6699998853 4699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 144 LKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred CCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998754322 334567889999999865 467899999999999999999999998776
Q ss_pred hhhHHHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+....+......+ .....++.++.++|.+||..||.+|||+.+|+++
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 221 HIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 655544433211000 0112357889999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=295.75 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=194.6
Q ss_pred CccccccccccCceEEEEEEEC----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
+|++.+.||+|+||.||++.+. +..||+|.+.... ........+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-------SKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-------ccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 4788899999999999999874 5689999885221 1112235567899999999 69999999987542
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ......+++++|+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+
T Consensus 74 ~~----------------~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~ 134 (332)
T cd07857 74 FP----------------GNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPG 134 (332)
T ss_pred cc----------------ccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 21 01234578899885 689998854 456999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+
T Consensus 135 Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred HeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9999999999999999997543221 11223468899999998765 568999999999999999999999998765
Q ss_pred hhhHHHHHHHcC--------------------------CCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQN--------------------------LRP---EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~--------------------------~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.......+...- ... .....++..+.+++.+||+.||++|||+.+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 444333222100 000 0112357889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=312.63 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=215.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.+.|++.++||.|++|.||+++. +++.+||||+....+. .+.+..|.+|++.+ .|||++.++|++..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----------deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----------EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----------cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 35577888999999999998755 7899999999743321 13455688888887 89999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... ..++.+|+|||||.+||..|+++...+..+.|..+..|++.++.||.+||...+||||||-.
T Consensus 88 ~~~---------------~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~ 152 (953)
T KOG0587|consen 88 KDP---------------GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQ 152 (953)
T ss_pred ecC---------------CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCc
Confidence 433 35788999999999999999998877889999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||++.++.+||+|||++......-....+..|||.|||||++.. ..|+..+|+||||++..||--|.+|+.++.
T Consensus 153 NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 153 NVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred eEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 999999999999999999876655555667889999999999943 357889999999999999999999999988
Q ss_pred hhhHHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 312 FADVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+.-.+..+.+ +.+| ..|..++.++.++|..||.+|-++||+..++++
T Consensus 233 PmraLF~IpR-NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 PMRALFLIPR-NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhhhhccCCC-CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 7776655432 2222 236778999999999999999999999998874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.34 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=200.7
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.+.|++...+|.|+|+.|..+.. +++..+||++..... ...+|+.++... +||||+++.+++.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------------~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------------DNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------------ccccccchhhhhcCCCcceeecceecC
Confidence 56788888899999999998866 678999999964311 123577666666 89999999999986
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..+. |+|||.+.|+-|.+.+.+.. .....+..|+.+|+.|+.|||++|+|||||||+
T Consensus 388 ~~~~--------------------~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~ 444 (612)
T KOG0603|consen 388 GKEI--------------------YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPG 444 (612)
T ss_pred Ccee--------------------eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChh
Confidence 6555 77999999999988875432 333677789999999999999999999999999
Q ss_pred CEEE-CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLL-DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl-~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|||+ ++.++++|+|||+++..... ..+.+-|..|.|||++....|+.++||||||++||+||+|..||........
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 9999 68899999999999865433 4556889999999999999999999999999999999999999987766622
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~ 363 (390)
+ ...-..+.+...++.+.++|+.+||+.||.+||++.++..+=..
T Consensus 522 i---~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 I---HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred H---HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 2 22223444558899999999999999999999999999876444
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=322.34 Aligned_cols=268 Identities=28% Similarity=0.454 Sum_probs=197.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
..+|+.+.+||+||||.||+++. +|+.||||.+... . .......+.+|+..+.+|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~-------~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK-------A-SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc-------h-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 35788899999999999999976 8999999998632 2 344557788999999999999999998875543
Q ss_pred ccccc------------------------------------------------CC-------ccc---------------
Q 036382 158 SNLKI------------------------------------------------PS-------KTA--------------- 167 (390)
Q Consensus 158 ~~~~~------------------------------------------------~~-------~~~--------------- 167 (390)
..-.. ++ ...
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 21111 00 000
Q ss_pred -cc--------------------CCCCCCCC--------CceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHH
Q 036382 168 -SV--------------------DGNAAVPA--------RACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 168 -~~--------------------~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~ 218 (390)
.. ..+..... ...||=||||+..+|.+++.++.... .....++++++|++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILE 708 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHH
Confidence 00 00000111 45789999999988888775543111 47789999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceecc------------------CCCCCCCCCCCCCccccccccC
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA------------------QNPRDMTGETGTLGYMAPEVLQ 280 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~ 280 (390)
||.|+|++|||||||||.|||+++++.+||+|||+|+... ....+.++..||.-|+|||++.
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999999999999999999999999999999999997511 1122456788999999999997
Q ss_pred CCC---CCCchhHHHHHHHHHHHHhCCCCCCC-CChhhHHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 281 GKP---YNRRCDVYSFGICLWEIYCCDMPYPD-LSFADVSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 281 ~~~---~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
+.. |+.++|+||||++|+||+ +||.- +....++..+.+..++.+ +...--+.-.++|+.+++.||.+|||+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 654 999999999999999997 45643 344444444432222222 011112456789999999999999999
Q ss_pred HHHHH
Q 036382 355 GEVVK 359 (390)
Q Consensus 355 ~~ll~ 359 (390)
.+|+.
T Consensus 866 ~eLL~ 870 (1351)
T KOG1035|consen 866 TELLN 870 (1351)
T ss_pred HHHhh
Confidence 99984
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=261.12 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=206.3
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|.-.++||+|+||+||+|+. +++-||+|.++...++-. ......+|+.+++.++|.|||+++++...+..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-------vpssalreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-------CcHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 566778999999999999976 678999999986544322 23456799999999999999999999886655
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
+ -+|+||+.. +|..|...- ++.++.+.+..++.|+++||.++|++++.||||||.|+|
T Consensus 76 l--------------------tlvfe~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnll 133 (292)
T KOG0662|consen 76 L--------------------TLVFEFCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLL 133 (292)
T ss_pred e--------------------EEeHHHhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEE
Confidence 5 569999965 898888654 467999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSS 317 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (390)
|+.+|.+||+|||+++...-+-+-+.....|.+|.+|.++.+. -|+.+.|+||.||++.|+.. |++.|++.+..+.+.
T Consensus 134 in~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred eccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 9999999999999999777666666677899999999999774 58999999999999999986 777799999888887
Q ss_pred HHHHcCCCC------------------CCCC---------CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRP------------------EIPR---------CCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~------------------~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+...--.+ .+|. .+...-+++++++|.-+|..|.+++..++.
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 775421111 0010 122346899999999999999999987753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=284.19 Aligned_cols=241 Identities=25% Similarity=0.436 Sum_probs=196.3
Q ss_pred cccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEeccccccc
Q 036382 86 RNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 162 (390)
.+.||+|+|+.|-.+.. ++..+|||++.... ...+....+|++++.++ .|+||++++++|.++...
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F-- 151 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF-- 151 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE--
Confidence 35799999999998754 88999999997432 22356788999999999 799999999999876544
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
|+|||-|.||+|...|.++ ..+++..+..+..+|+.||.+||.+||.||||||+|||...
T Consensus 152 ------------------YLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 152 ------------------YLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred ------------------EEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 7799999999999999654 57999999999999999999999999999999999999976
Q ss_pred CC---cEEEeecccceecc-------CCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 243 QR---TLKIADFGVARVEA-------QNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 243 ~~---~~kL~DfG~a~~~~-------~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
.. -+||+||.++.-.. .......+.+|+..|||||+.. ..-|+.++|.||||+++|-||+|.+||
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 54 48999999875321 1233456678999999999873 346899999999999999999999999
Q ss_pred CCC-------Ch--------hhHHHHHHHcCCCCCCCC----CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 308 PDL-------SF--------ADVSSAVVRQNLRPEIPR----CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 308 ~~~-------~~--------~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+. +. ..+...+..+.+ ++|. .++.+.++++..+|..|+..|.++.+++.
T Consensus 292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCccCCcCCccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 764 11 112333333333 3443 47889999999999999999999999887
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=285.31 Aligned_cols=251 Identities=23% Similarity=0.417 Sum_probs=208.1
Q ss_pred CCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccce
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTK 149 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 149 (390)
+..|.+.+.+|+++.+||+|+|+.|.+++. +.+-+|+|+++..-. . .....+-...|-.+..+. +||.+|-
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~---n---ddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV---N---DDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc---C---CcccchhHHhhHHHHHhccCCCeEEe
Confidence 356889999999999999999999999877 567899999872211 1 111123445677777766 8999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
++.+|+....+ ++|.||.+||+|--.+.+. .+++++.++.+..+|..||.|||++|||
T Consensus 316 lhscfqtesrl--------------------ffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgii 373 (593)
T KOG0695|consen 316 LHSCFQTESRL--------------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGII 373 (593)
T ss_pred hhhhhcccceE--------------------EEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCee
Confidence 99998866554 7899999999998888543 4699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP- 308 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~- 308 (390)
+||||.+|||++..|++||+|+|+++....++....+.||||.|.|||++++..|+.++|+|+||++++||+.|+.||.
T Consensus 374 yrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 374 YRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999999999999999999999876666667778999999999999999999999999999999999999999994
Q ss_pred ------CCChhhHH-HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 036382 309 ------DLSFADVS-SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE 353 (390)
Q Consensus 309 ------~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt 353 (390)
+...++.+ +-++...+ .+|..++-....+++..|.+||.+|..
T Consensus 454 vgm~n~d~ntedylfqvilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 22333333 33344433 477888888889999999999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=282.26 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=204.6
Q ss_pred CCCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHH-HhcCCCccc
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW-QKLDHPNVT 148 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv 148 (390)
....|++..++++-...||.|+||+|++..+ .|+..|||.++... ......++..|.+.. +.-++||||
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--------~~keq~rll~e~d~~mks~~cp~IV 126 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--------IEKEQKRLLMEHDTVMKSSNCPNIV 126 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--------chHHHHHHHHHHHHHHhhcCCcHHH
Confidence 3456888889999999999999999998876 68999999997322 122345667777754 445899999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHH---hhccCCCCHHHHHHHHHHHHHHHHHHHh
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI---RNRRKKLALKIVIQLALDLSRGLSYLHS 225 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~---~~~~~~l~~~~~~~i~~~i~~~L~yLH~ 225 (390)
++||++. .++.+|+.||.|+ -||..+.+ .-....++|..+..|+.-.+.||.||..
T Consensus 127 kfyGa~F--------------------~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~ 185 (361)
T KOG1006|consen 127 KFYGALF--------------------SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE 185 (361)
T ss_pred HHhhhhh--------------------cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH
Confidence 9999875 4677899999995 47766543 2335679999999999999999999985
Q ss_pred -CCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC--CCCCCCchhHHHHHHHHHHHHh
Q 036382 226 -KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ--GKPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 226 -~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~ 302 (390)
..|||||+||+|||++..|.+||||||.+..... ....+...|-..|||||.+. +..|+.++|+||||++|||+.|
T Consensus 186 ~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt 264 (361)
T KOG1006|consen 186 ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT 264 (361)
T ss_pred HhhhhhccCChhheEEecCCCEeeecccchHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeec
Confidence 5899999999999999999999999999875443 23345567888999999994 3469999999999999999999
Q ss_pred CCCCCCCCC-hhhHHHHHHHcCCCC-CCCC---CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 303 CDMPYPDLS-FADVSSAVVRQNLRP-EIPR---CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 303 g~~Pf~~~~-~~~~~~~~~~~~~~~-~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
|..||...+ ..+.+..++.+..+. ..+. ..+..+..+|..||.+|-+.||.+.+|..
T Consensus 265 G~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 265 GNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 999997753 444455554433221 1222 36789999999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.60 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=209.4
Q ss_pred cccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccC
Q 036382 86 RNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 163 (390)
.++||.|.||+||-|++ +|+.||||++..-. +... ..+.+.+|+.||+++.||.||.+...|...+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlr--Fp~k-----qesqlR~EVaILq~l~HPGiV~le~M~ET~er---- 637 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLR--FPTK-----QESQLRNEVAILQNLHHPGIVNLECMFETPER---- 637 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeeccc--CCCc-----hHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----
Confidence 46899999999999876 79999999996322 2111 23678899999999999999999988876544
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
.++|||-+.|.-|.-.|. ...+++++.....++.||+.||+|||-++|+|.||||+|||+.+.
T Consensus 638 ----------------vFVVMEKl~GDMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~ 700 (888)
T KOG4236|consen 638 ----------------VFVVMEKLHGDMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA 700 (888)
T ss_pred ----------------EEEEehhhcchHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC
Confidence 478999997655555554 445689999999999999999999999999999999999999665
Q ss_pred ---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 036382 244 ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320 (390)
Q Consensus 244 ---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (390)
-++||||||+|+...+... .....|||.|+|||+++++.|..+-|+||.|+|+|--+.|..||... +++..++.
T Consensus 701 ~~FPQvKlCDFGfARiIgEksF-RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQ 777 (888)
T KOG4236|consen 701 SPFPQVKLCDFGFARIIGEKSF-RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQ 777 (888)
T ss_pred CCCCceeeccccceeecchhhh-hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhh
Confidence 4799999999998765432 34478999999999999999999999999999999999999999542 23333332
Q ss_pred Hc--CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH-----------HHHHhHhcCCCCCCCCC
Q 036382 321 RQ--NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK-----------MLEAIDTSKGGGMIPED 376 (390)
Q Consensus 321 ~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~-----------~L~~~~~~~~~~~~~~~ 376 (390)
+. -+.+..++.+++...+||..+|+..-++|.|..+-++ -|+++....++-++-+.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThe 846 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHE 846 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCc
Confidence 22 2455566788999999999999999999999887654 46667666666555444
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=278.93 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=194.8
Q ss_pred cccCccccccccccCceEEEEEEEC------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
++..|+..+.||+|+||.||+|..+ ...+|+|.++-.++.... -....+|+.++++++|||++.+..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-------S~SAcREiaL~REl~h~nvi~Lv~ 94 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-------SMSACREIALLRELKHPNVISLVK 94 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-------CHHHHHHHHHHHHhcCCcchhHHH
Confidence 3567999999999999999999542 237899998754432221 234568999999999999999998
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN---RRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+|... +...++++||.+. +|...+.-+ ....++...+..|+.||+.|+.|||++-|+
T Consensus 95 Vfl~~-------------------d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvl 154 (438)
T KOG0666|consen 95 VFLSH-------------------DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVL 154 (438)
T ss_pred HHhcc-------------------CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhee
Confidence 87642 3456899999987 899888532 234689999999999999999999999999
Q ss_pred ccCCCCCCEEECCC----CcEEEeecccceeccCCCCC---CCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHH
Q 036382 230 HRDVKTENMLLDSQ----RTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 230 HrDlkp~NILl~~~----~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell 301 (390)
||||||.||||..+ |.+||+|||+++........ ....+.|.+|.|||.+.+ ..|+.+.|+||+|||+.||+
T Consensus 155 HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 155 HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 99999999999888 99999999999976554332 334568999999999987 46999999999999999999
Q ss_pred hCCCCCCCCCh---------hhHHHHHHH-----------------------cCCCCCCCC------------CCcHHHH
Q 036382 302 CCDMPYPDLSF---------ADVSSAVVR-----------------------QNLRPEIPR------------CCPSSLA 337 (390)
Q Consensus 302 ~g~~Pf~~~~~---------~~~~~~~~~-----------------------~~~~~~~~~------------~~~~~l~ 337 (390)
+-.+-|.+... .+.+..+.. ..++..... .-++...
T Consensus 235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~ 314 (438)
T KOG0666|consen 235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSAL 314 (438)
T ss_pred ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHH
Confidence 98777754210 011111110 000000111 1245588
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 036382 338 NIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 338 ~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+|+.++|..||-+|.|+++.++.
T Consensus 315 ~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 315 DLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHhccCchhhccHHHHhcc
Confidence 99999999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.80 Aligned_cols=218 Identities=20% Similarity=0.231 Sum_probs=178.0
Q ss_pred cCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCccccc
Q 036382 92 GTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASV 169 (390)
Q Consensus 92 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~ 169 (390)
|.||.||++.+ +++.||+|.++... .+.+|...+....||||+++++++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------------~~~~~~~~~~~~~~~~i~~~~~~~~~~------------ 57 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------------EYSRERLTIIPHCVPNMVCLHKYIVSE------------ 57 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------------hhhhHHHHHHhcCCCceeehhhheecC------------
Confidence 89999999987 67899999986321 123455555566799999999988744
Q ss_pred CCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEe
Q 036382 170 DGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249 (390)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~ 249 (390)
...|+||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+
T Consensus 58 --------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 127 (237)
T cd05576 58 --------DSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLT 127 (237)
T ss_pred --------CeEEEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3458899999999999999654 358999999999999999999999999999999999999999999999
Q ss_pred ecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCC
Q 036382 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP 329 (390)
Q Consensus 250 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 329 (390)
|||.+...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .........|
T Consensus 128 df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~ 198 (237)
T cd05576 128 YFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIP 198 (237)
T ss_pred cccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCc
Confidence 99987644322 23345677899999998888999999999999999999999887543211 1112233466
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 330 RCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 330 ~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
..+++.++++|.+||+.||++|||+
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 7788999999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.93 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=190.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
..+...+.||+|+||.||+|++ ++..||||.++.... ....|++++++++|||||+++|++.+..
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------------IPSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------------ccHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 3456677899999999999986 678999998862211 1124688899999999999999997543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCcccCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH---SKKIVHRDVKT 235 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH---~~~iiHrDlkp 235 (390)
..|+||||+++|+|.+++. .+++..+..++.||+.||+||| +.+|+||||||
T Consensus 757 --------------------~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 757 --------------------GAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred --------------------CCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 3478999999999999993 3889999999999999999999 66999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF-AD 314 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-~~ 314 (390)
+||+++.++..++. ||.+..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred HhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 99999998888775 665543221 1223678999999999999999999999999999999999999853211 00
Q ss_pred HHHHHHHc---------CCCCCC------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 315 VSSAVVRQ---------NLRPEI------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 315 ~~~~~~~~---------~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
........ ...+.. +.....++.+++.+||+.||++|||+.++++.|+++.......
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 958 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccc
Confidence 01000000 001111 1112345788999999999999999999999999997655433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.13 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=206.4
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
-.....|+-..+||+|+||.||+|+. +|+.||+|++-.. .+.........+|+.+|..|+|+|++.++..|
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-------neKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-------NEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 34456788889999999999999865 6778999866421 22222234456899999999999999999988
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.....-. .......|+|+.+++. +|.-+|.. ...+++...+..++.++..||.|+|+..|+|||+|
T Consensus 86 ~tk~Tp~------------~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 86 RTKATPT------------NRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred hhccCCc------------ccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 6543222 2245568999999976 89988843 34679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCC----CCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQN----PRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|.|+||+.+|.+||+|||+++..... ....+..+.|.+|.+||.+.+ ..|+++.|+|..||++.||+++.+-|++
T Consensus 152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 99999999999999999999754322 234666778999999999876 5799999999999999999999999998
Q ss_pred CChhhHHHHHH--HcCCCCCC------------------CCC-------------CcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 310 LSFADVSSAVV--RQNLRPEI------------------PRC-------------CPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 310 ~~~~~~~~~~~--~~~~~~~~------------------~~~-------------~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
.+....+..+. .+...++. |.. -.++..+|+.++|..||.+|+++.+
T Consensus 232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 87776554432 11111111 110 1246789999999999999999998
Q ss_pred HHHH
Q 036382 357 VVKM 360 (390)
Q Consensus 357 ll~~ 360 (390)
++.+
T Consensus 312 alnh 315 (376)
T KOG0669|consen 312 ALNH 315 (376)
T ss_pred hhch
Confidence 8754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=291.23 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=199.6
Q ss_pred ccccCccccccccccCceEEEEEE--ECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
.+-.-|..++.||-|+||.|.++. ++...+|.|.++. ...-..........|-.||...+.+-||++|-.|+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK------aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK------ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHH------HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 445567888899999999999884 4677999999862 22334455667788999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.+++ |+||+|++||++-.+|.+. +.|.|..+++++.++++|+++.|+.|+|||||||
T Consensus 700 DkdnL--------------------YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKP 757 (1034)
T KOG0608|consen 700 DKDNL--------------------YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 757 (1034)
T ss_pred cCCce--------------------EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCc
Confidence 88777 6799999999999999764 4699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceec---------cCC--C--------C-----------------------CCCCCCCCCcc
Q 036382 236 ENMLLDSQRTLKIADFGVARVE---------AQN--P--------R-----------------------DMTGETGTLGY 273 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~---------~~~--~--------~-----------------------~~~~~~gt~~y 273 (390)
+|||||.+|++||+|||++.-. ... . . .....+||+.|
T Consensus 758 DNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~ny 837 (1034)
T KOG0608|consen 758 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNY 837 (1034)
T ss_pred cceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcc
Confidence 9999999999999999998511 000 0 0 00123599999
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcC--CCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 036382 274 MAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN--LRPEIPRCCPSSLANIMRKCWDANAEKR 351 (390)
Q Consensus 274 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~R 351 (390)
+|||++....|+..+|+||.|+|||||+.|+.||...++.+...++.... +......+++.++.++|.+++. +++.|
T Consensus 838 iapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~R 916 (1034)
T KOG0608|consen 838 IAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSR 916 (1034)
T ss_pred cChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhh
Confidence 99999999999999999999999999999999998888777666554433 2233345678999999887654 34555
Q ss_pred C
Q 036382 352 P 352 (390)
Q Consensus 352 p 352 (390)
.
T Consensus 917 L 917 (1034)
T KOG0608|consen 917 L 917 (1034)
T ss_pred h
Confidence 4
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.84 Aligned_cols=246 Identities=24% Similarity=0.434 Sum_probs=195.6
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC--C----ccceEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH--P----NVTKFV 151 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv~~~ 151 (390)
..+|.+...+|+|+||.|-.+.+ .+..||||+++ .....+++..-|+++++++.+ | -++++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik----------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK----------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH----------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 57899999999999999999876 46799999986 123345666789999999932 2 355666
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
++|. -.++.|+|+|.+ |-|+.++|..++-.+++...++.|+.|++.++++||+.+++|-
T Consensus 158 ~wFd--------------------yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HT 216 (415)
T KOG0671|consen 158 DWFD--------------------YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHT 216 (415)
T ss_pred hhhh--------------------ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeec
Confidence 6664 356779999999 5599999988777789999999999999999999999999999
Q ss_pred CCCCCCEEECC--------------------CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHH
Q 036382 232 DVKTENMLLDS--------------------QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVY 291 (390)
Q Consensus 232 Dlkp~NILl~~--------------------~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 291 (390)
||||+|||+.+ +..++|+|||.|+...+. ....+.|..|.|||++.+-+++.++|||
T Consensus 217 DLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvW 293 (415)
T KOG0671|consen 217 DLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVW 293 (415)
T ss_pred CCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCce
Confidence 99999999932 235899999999864433 2456789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHH---HHHHH-----------------cCCCCCCCC-------------C-------
Q 036382 292 SFGICLWEIYCCDMPYPDLSFADVS---SAVVR-----------------QNLRPEIPR-------------C------- 331 (390)
Q Consensus 292 SlG~il~ell~g~~Pf~~~~~~~~~---~~~~~-----------------~~~~~~~~~-------------~------- 331 (390)
|+||||+|+++|..-|+..++.|-+ ..++. .+ +...+. .
T Consensus 294 SiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~ 372 (415)
T KOG0671|consen 294 SIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYM 372 (415)
T ss_pred eeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHh
Confidence 9999999999999999887766633 22210 00 111000 0
Q ss_pred -----CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 332 -----CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 332 -----~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+|.+||++||.+||.+|+|+.|++++
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 01358999999999999999999998863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=262.84 Aligned_cols=236 Identities=31% Similarity=0.462 Sum_probs=193.3
Q ss_pred CceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccC
Q 036382 93 TYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVD 170 (390)
Q Consensus 93 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~ 170 (390)
+||.||+|.+. ++.+|+|++....... ....+.+|++.+++++|+||+++++.+...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------------- 59 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--------KRERILREISILKKLKHPNIVRLYDVFEDE------------- 59 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--------HHHHHHHHHHHHHhCCCCcHHHHHhheeeC-------------
Confidence 58999999884 6899999987432210 046788999999999999999999988643
Q ss_pred CCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEee
Q 036382 171 GNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250 (390)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~D 250 (390)
...++++||+.+++|.+++.... .+++..++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|
T Consensus 60 -------~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d 130 (244)
T smart00220 60 -------DKLYLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLAD 130 (244)
T ss_pred -------CEEEEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEcc
Confidence 34588999999999999986533 389999999999999999999999999999999999999999999999
Q ss_pred cccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCC
Q 036382 251 FGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR 330 (390)
Q Consensus 251 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 330 (390)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||......+..............+.
T Consensus 131 ~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 209 (244)
T smart00220 131 FGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP 209 (244)
T ss_pred ccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc
Confidence 99998654332 33446688899999999988899999999999999999999999987333333333333332222222
Q ss_pred C--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 331 C--CPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 331 ~--~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
. ++.++.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 2 8899999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=279.22 Aligned_cols=258 Identities=22% Similarity=0.409 Sum_probs=202.4
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
.--++|-++++||+|+|+.||+|.+ .++.||||+-...+. =..+..+...+...+|.+|-+.|+||.||++|++|.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~--WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKN--WRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccc--hhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 3346789999999999999999976 567999998753321 122334456677889999999999999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK--KIVHRDV 233 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--~iiHrDl 233 (390)
.+. ..+|-|+||++|.+|.-||+.+ ..++++.+..|+.||+.||.||... .|||-||
T Consensus 538 lDt-------------------dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDL 596 (775)
T KOG1151|consen 538 LDT-------------------DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDL 596 (775)
T ss_pred ecc-------------------ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeecc
Confidence 543 3358999999999999999654 4699999999999999999999976 4999999
Q ss_pred CCCCEEECC---CCcEEEeecccceeccCCCCC-------CCCCCCCCccccccccC-C---CCCCCchhHHHHHHHHHH
Q 036382 234 KTENMLLDS---QRTLKIADFGVARVEAQNPRD-------MTGETGTLGYMAPEVLQ-G---KPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 234 kp~NILl~~---~~~~kL~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~-~---~~~~~~~DiwSlG~il~e 299 (390)
||.|||+-. -|.+||+|||++......... .....||.+|++||.+. + ...+.++||||+|+|+|.
T Consensus 597 KPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 597 KPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred CCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 999999944 378999999999976654333 12356999999999874 2 347889999999999999
Q ss_pred HHhCCCCCCCC-ChhhHHHHHHHcC-CCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 300 IYCCDMPYPDL-SFADVSSAVVRQN-LRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 300 ll~g~~Pf~~~-~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
.+.|+.||-.. +..+++.....-+ -...+| ..++++..+||++||++.-++|.+..+|.
T Consensus 677 ClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 99999999654 3333332211100 111223 34789999999999999999999888775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=270.96 Aligned_cols=278 Identities=24% Similarity=0.354 Sum_probs=215.8
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
.+-.+.||-|+||+||..++ +|+.||+|.+. .....-...+.+.+|+.+|.-.+|.|++..+++..-..--
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p-------nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP-------NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcc-------hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 33446899999999999987 78999999875 2223333456788999999999999999888775432211
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
+ -++.|+++|.|.. +|...+- ..+.++.+.+.-+++||++||+|||+.+|.||||||.|+|+
T Consensus 128 f---------------FqEiYV~TELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV 189 (449)
T KOG0664|consen 128 F---------------FQELYVLTELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV 189 (449)
T ss_pred H---------------HHHHHHHHHHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe
Confidence 1 1345778888865 8888773 45679999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccC-CCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 241 DSQRTLKIADFGVARVEAQ-NPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
+++..+||||||+|+.... ....++....|-.|.|||++.+. .|+.++||||.||++.|++..+..|+...+.+.+..
T Consensus 190 NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 190 NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM 269 (449)
T ss_pred ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence 9999999999999996543 34556677889999999999874 699999999999999999998888877666554443
Q ss_pred HH-----------------------HcCCCCC-CC--------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 319 VV-----------------------RQNLRPE-IP--------RCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 319 ~~-----------------------~~~~~~~-~~--------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+. +...+++ .+ ..-..+...++.++|..||++|.+.++.+..+
T Consensus 270 ItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~----- 344 (449)
T KOG0664|consen 270 IIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR----- 344 (449)
T ss_pred HHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc-----
Confidence 32 1121111 11 11124567888999999999999988776654
Q ss_pred cCCCCCCCCCCCCcceeecCCCCC
Q 036382 367 SKGGGMIPEDQATGCFCFSPVRGP 390 (390)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~ 390 (390)
-.+++-.-...|.-|+|+.-+|++
T Consensus 345 ~~~e~R~r~~sCmC~~~~tt~~~~ 368 (449)
T KOG0664|consen 345 YLEEGRLRFHSCMCSCCYTKPNMP 368 (449)
T ss_pred cccccceeeeeeeEeeeccCCCcc
Confidence 456666778899999999988874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=253.84 Aligned_cols=246 Identities=21% Similarity=0.391 Sum_probs=197.5
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEe
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASV 155 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 155 (390)
..++|++.+++|+|.|+.||.|.. +++.++||++++-+ .+.+.+|+.||..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------------kkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------------KKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------------HHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 467999999999999999999974 78899999997322 367889999999995 999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+..+ ..+.+|+||+.+.+...+. +.++...+..++.+++.||.|+|+.||+|||+||
T Consensus 104 Dp~S------------------ktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKP 160 (338)
T KOG0668|consen 104 DPES------------------KTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKP 160 (338)
T ss_pred Cccc------------------cCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCc
Confidence 6643 3446899999998887765 3488889999999999999999999999999999
Q ss_pred CCEEECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCC-CCCCh
Q 036382 236 ENMLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPY-PDLSF 312 (390)
Q Consensus 236 ~NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf-~~~~~ 312 (390)
.|++|+.. ..++|+|||+|...- ++........+..|..||.+.+ ..|+.+-|+|||||++..|+..+.|| .+.++
T Consensus 161 hNvmIdh~~rkLrlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 161 HNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred ceeeechhhceeeeeecchHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 99999876 579999999997543 2334444567778899999976 46899999999999999999998886 55555
Q ss_pred hhHHHHHHH-----------c----CCCC--------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 313 ADVSSAVVR-----------Q----NLRP--------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 313 ~~~~~~~~~-----------~----~~~~--------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+.+-++.+ . .+.+ +.....+++..+|+.++|..|-.+|+|+.+.
T Consensus 240 ~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 240 YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 554333221 0 0111 1111246899999999999999999999998
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+.+
T Consensus 320 m~H 322 (338)
T KOG0668|consen 320 MAH 322 (338)
T ss_pred hcC
Confidence 753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=282.83 Aligned_cols=272 Identities=18% Similarity=0.254 Sum_probs=188.4
Q ss_pred cccccCccccccccccCceEEEEEEE------------------CCceEEEEEeccCCCCccchHH-----HHHHHHHHH
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY------------------DNQEVAVKLLDWGEDGMATTAE-----TAALRSSFQ 133 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~ 133 (390)
..+.++|++.++||+|+||.||+|.+ .++.||||.++........... .....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 44678999999999999999999963 3457999998633211100000 001123344
Q ss_pred HHHHHHHhcCCCcc-----ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------
Q 036382 134 QEVAVWQKLDHPNV-----TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------- 200 (390)
Q Consensus 134 ~E~~~l~~l~hpnI-----v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------- 200 (390)
.|+.++.+++|.++ ++++++|..... ......+..|+||||+.+++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~------------~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~ 288 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTA------------DGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLE 288 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccc------------cccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHH
Confidence 57777888876654 667777653210 11113455799999999999999986421
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC-CCC
Q 036382 201 --------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR-DMT 265 (390)
Q Consensus 201 --------------~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~ 265 (390)
...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 289 e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 368 (507)
T PLN03224 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL 368 (507)
T ss_pred HHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCcc
Confidence 12346778899999999999999999999999999999999999999999999965432211 111
Q ss_pred CCCCCCccccccccCCCC--------------------CC--CchhHHHHHHHHHHHHhCCC-CCCCCChhhH-------
Q 036382 266 GETGTLGYMAPEVLQGKP--------------------YN--RRCDVYSFGICLWEIYCCDM-PYPDLSFADV------- 315 (390)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwSlG~il~ell~g~~-Pf~~~~~~~~------- 315 (390)
...+|+.|+|||.+.... ++ ...|+||+||++|+|++|.. ||.+......
T Consensus 369 ~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~ 448 (507)
T PLN03224 369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN 448 (507)
T ss_pred ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc
Confidence 234578999999985422 11 24799999999999999886 7754321111
Q ss_pred ----HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCC---CCCCCHHHHHHH
Q 036382 316 ----SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANA---EKRPEMGEVVKM 360 (390)
Q Consensus 316 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~~ll~~ 360 (390)
...+....+.......+++...+|+.++|..+| .+|+|+.+++++
T Consensus 449 ~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 449 DLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111223333345678899999999999876 689999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=291.68 Aligned_cols=257 Identities=16% Similarity=0.182 Sum_probs=169.8
Q ss_pred ccccccCccccccccccCceEEEEEEE--C----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--D----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
.....++|++.+.||+|+||.||+|++ + +..||||.+..... . +....+ .++...+.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~------e~~~~e--~l~~~~~~~~~~ 193 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----V------EIWMNE--RVRRACPNSCAD 193 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----h------HHHHHH--HHHhhchhhHHH
Confidence 445678999999999999999999987 3 67999998752110 0 011111 122222333333
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc------------------CCCCHHHHHH
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR------------------KKLALKIVIQ 211 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~ 211 (390)
++..+..... .......++|+||+.+++|.+++..... ....+..+..
T Consensus 194 ~~~~~~~~~~--------------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~ 259 (566)
T PLN03225 194 FVYGFLEPVS--------------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQT 259 (566)
T ss_pred HHHhhhcccc--------------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHH
Confidence 3222211100 1235567999999999999999864321 0112345678
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCcEEEeecccceeccCC-CCCCCCCCCCCccccccccCCC-------
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDS-QRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLQGK------- 282 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~-~~~~kL~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------- 282 (390)
++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+..... ........+++.|+|||.+...
T Consensus 260 i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~ 339 (566)
T PLN03225 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAP 339 (566)
T ss_pred HHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCc
Confidence 9999999999999999999999999999986 589999999999754322 1223345789999999976322
Q ss_pred ---------------CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCC---------CCCC----------
Q 036382 283 ---------------PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL---------RPEI---------- 328 (390)
Q Consensus 283 ---------------~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~---------~~~~---------- 328 (390)
.++.++|||||||++|||+++..|+... .......+...+. ....
T Consensus 340 ~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (566)
T PLN03225 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEV 418 (566)
T ss_pred cccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhh
Confidence 2344679999999999999977665331 1111111111000 0000
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 329 PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 329 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.........+||.+||++||++|||+.+++++
T Consensus 419 ~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 419 LDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred ccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 01122345689999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=247.12 Aligned_cols=219 Identities=24% Similarity=0.406 Sum_probs=176.9
Q ss_pred CcccccccCccccccccccCceEEEE--EEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYR--GTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKF 150 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~ 150 (390)
..+++..+++.-+..||+|+||.|-+ -..+|+..|+|.++..- .......+.+|+.+..+. .+|.+|.|
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--------n~q~q~r~L~dldi~~r~~~CPf~V~F 110 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--------NSQEQKRLLMDLDIIMRTVDCPFTVHF 110 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--------ChHHHHHHHHhhhhhccCCCCCeEEEe
Confidence 34778888899999999999998854 45589999999986221 122345667888876665 89999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSK-K 227 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~ 227 (390)
||...+ .+..|+.||.|.- ||..+.++ ..++.++|..+-+|+..|+.||.|||++ .
T Consensus 111 yGa~~r--------------------egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~ 169 (282)
T KOG0984|consen 111 YGALFR--------------------EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS 169 (282)
T ss_pred ehhhhc--------------------cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh
Confidence 998664 3445889999954 88776543 3567899999999999999999999976 7
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC----CCCCCCchhHHHHHHHHHHHHhC
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ----GKPYNRRCDVYSFGICLWEIYCC 303 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g 303 (390)
+||||+||.||||+.+|++|+||||.+....++- ..+-..|--.|||||.+. +..|+.++||||||+++.||.++
T Consensus 170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred hhhccCCcceEEEccCCcEEEcccccceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence 9999999999999999999999999998655432 223356777899999984 34799999999999999999999
Q ss_pred CCCCCC-CChhhHHHHHHHc
Q 036382 304 DMPYPD-LSFADVSSAVVRQ 322 (390)
Q Consensus 304 ~~Pf~~-~~~~~~~~~~~~~ 322 (390)
+.||+. .++.+.+.+++..
T Consensus 249 r~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 249 RFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccccccCCHHHHHHHHhcC
Confidence 999976 5778888777654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=260.08 Aligned_cols=135 Identities=23% Similarity=0.391 Sum_probs=115.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-----C---Cccc
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-----H---PNVT 148 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv 148 (390)
...+|.+.++||.|.|++||++.+ ..+.||+|+.+- .....+....|+.+|++++ | ..||
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 446899999999999999999988 457999999962 2334566778999999883 3 4799
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-K 227 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~ 227 (390)
++++.|... .+.+.+.|||+|++ |.+|..+|++..-..++...+..|+.||+.||.|||++ |
T Consensus 146 ~LlD~Fkhs----------------GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 146 QLLDHFKHS----------------GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred eeeccceec----------------CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 999998743 34678899999999 67999999887777899999999999999999999975 8
Q ss_pred CcccCCCCCCEEE
Q 036382 228 IVHRDVKTENMLL 240 (390)
Q Consensus 228 iiHrDlkp~NILl 240 (390)
|||-||||+|||+
T Consensus 209 IIHTDlKPENvLl 221 (590)
T KOG1290|consen 209 IIHTDLKPENVLL 221 (590)
T ss_pred ccccCCCcceeee
Confidence 9999999999999
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=283.75 Aligned_cols=241 Identities=24% Similarity=0.410 Sum_probs=186.1
Q ss_pred ccccccccccCceE-EEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGS-VYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 160 (390)
|.-.+.+|.|+-|+ ||+|.+.|+.||||.+-. .......+|+..|+.. .|||||++|+.-.+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--- 575 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDR--- 575 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh------------HhHHHHHHHHHHHHhccCCCceEEEEeeccCC---
Confidence 34456789999985 699999999999997741 1234567999999999 799999999886644
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
+..||..|.|. .+|.+++... ......-...+..+.|++.||++||+.+||||||||.||
T Consensus 576 -----------------qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNI 637 (903)
T KOG1027|consen 576 -----------------QFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNI 637 (903)
T ss_pred -----------------ceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceE
Confidence 44477999995 5999999763 111111134578899999999999999999999999999
Q ss_pred EECC---C--CcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCC
Q 036382 239 LLDS---Q--RTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPD 309 (390)
Q Consensus 239 Ll~~---~--~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~ 309 (390)
||+. + .+++|+|||+++...... ....+..||.+|+|||++....-+.++|||||||++|+.++| .+||.+
T Consensus 638 LI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 638 LISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred EEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 9976 2 478999999998654432 234557799999999999988888899999999999999995 899977
Q ss_pred CChhhHHHHHHHcCCCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 310 LSFADVSSAVVRQNLRPEI-PRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
.-..+. .++..+..... ...-..+..+||.+|+..+|..||++.+|+
T Consensus 718 ~~~R~~--NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 718 SLERQA--NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHHhhh--hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 554443 23333322211 111111889999999999999999999997
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=250.18 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=198.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
..+|.-...+|.|.- .|..+.+ .+++||+|.+-..... ....+...+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-------~~~akra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-------QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-------CccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 346777788999988 6666654 6889999976422111 11124566899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..+. .-...|+|||+|. .+|...+. -.++-+.+..+..|+++|++|||+.||+||||||+|
T Consensus 88 ~~l~--------------~~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsn 148 (369)
T KOG0665|consen 88 KTLE--------------EFQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSN 148 (369)
T ss_pred ccHH--------------HHHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccc
Confidence 4332 2455689999996 48998885 247788899999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++..++.+||.|||+|+..... -..+....|..|.|||++.+..|...+||||+||++.||++|..-|++.+..+...
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred ceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 99999999999999999865433 35666788999999999999999999999999999999999999998876555444
Q ss_pred HHHHcCC--------------------CC-----C----CCC-----------CCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNL--------------------RP-----E----IPR-----------CCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~--------------------~~-----~----~~~-----------~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
++...-. ++ . +|. .-...+++++.+||..||++|.++.++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 3331100 00 0 111 113458899999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+.+
T Consensus 308 L~H 310 (369)
T KOG0665|consen 308 LRH 310 (369)
T ss_pred hcC
Confidence 864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=267.95 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=197.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC------CccceEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH------PNVTKFV 151 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~ 151 (390)
-.+|.+....|+|-||+|.+|.+ .|+.||||+++... ...+.=..|++||++|.. -++++++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----------VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----------HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 35788888999999999999987 57799999997321 112333579999999952 4788888
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
..|... +++|+|+|-+. -+|.++|++.. +..|....+..|+.|++.||..|...||+|
T Consensus 501 r~F~hk--------------------nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlH 559 (752)
T KOG0670|consen 501 RHFKHK--------------------NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLH 559 (752)
T ss_pred HHhhhc--------------------ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeee
Confidence 777644 45599999995 49999998643 456888999999999999999999999999
Q ss_pred cCCCCCCEEECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 231 RDVKTENMLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 231 rDlkp~NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
.||||+||||++. ..+||||||.|.....+ ..+....+..|.|||++.|.+|+...|+||.||+|||++||+..|++
T Consensus 560 aDIKPDNiLVNE~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 560 ADIKPDNILVNESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccCccceEeccCcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 9999999999887 56899999999765443 23334567789999999999999999999999999999999999999
Q ss_pred CChhhHHHHHHHcCCCC----------------------------------------CCC-C----------CCc-----
Q 036382 310 LSFADVSSAVVRQNLRP----------------------------------------EIP-R----------CCP----- 333 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~----------------------------------------~~~-~----------~~~----- 333 (390)
.++..++...+...-.. ..| . .+|
T Consensus 638 ~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~ 717 (752)
T KOG0670|consen 638 RTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPK 717 (752)
T ss_pred CCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHH
Confidence 98888776443210000 000 0 011
Q ss_pred --HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 334 --SSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 334 --~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+++|+.+||..||++|.|..+.|.+
T Consensus 718 ~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 718 IVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 358899999999999999999988753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=276.48 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=212.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++...+|.|+||.||++++ +++..|||+++....+. ...+.+|+-+++.++||||+.++|.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---------~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---------FSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---------ccccccceeeeecCCCcChHHHHhhhhhh
Confidence 36799999999999999999987 68899999998554322 24456899999999999999999988755
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..+ |+.|||+.+|+|.+.. +..+++++.++..++++.+.||+|||+.|=+|||||-.|
T Consensus 85 dkl--------------------wicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGan 142 (829)
T KOG0576|consen 85 DKL--------------------WICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGAN 142 (829)
T ss_pred cCc--------------------EEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccc
Confidence 444 8899999999999976 456789999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCcccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL---QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||+++.|.+|++|||.+............+.||+.|||||+. +.+.|...+|+|++|++..|+-..++|.-+..+-.
T Consensus 143 illtd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr 222 (829)
T KOG0576|consen 143 ILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR 222 (829)
T ss_pred eeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH
Confidence 999999999999999987555444445568899999999986 45679999999999999999999999987777777
Q ss_pred HHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSSAVVRQNLRPEI---PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+.-..+.++.++. +..+++.+.+|++.||.++|++|||++.++.
T Consensus 223 ~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 223 ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 77666666666543 4457889999999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-31 Score=233.37 Aligned_cols=211 Identities=36% Similarity=0.665 Sum_probs=181.0
Q ss_pred ccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
||+|++|.||++... ++.+++|++....... ....+.+|++.++.++|++|+++++++...
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--------- 63 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------LLEELLREIEILKKLNHPNIVKLYGVFEDE--------- 63 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------HHHHHHHHHHHHHhcCCCCeeeEeeeeecC---------
Confidence 689999999999986 8999999997432211 346788999999999999999999998743
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-CCc
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS-QRT 245 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~-~~~ 245 (390)
...++++||+.+++|.+++.... ..+++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.
T Consensus 64 -----------~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~ 131 (215)
T cd00180 64 -----------NHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131 (215)
T ss_pred -----------CeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc
Confidence 34588999999999999986532 46899999999999999999999999999999999999999 899
Q ss_pred EEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCC
Q 036382 246 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324 (390)
Q Consensus 246 ~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (390)
++|+|||.+..............+...|++||..... .++.+.|+|++|+++++|
T Consensus 132 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 132 VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred EEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 9999999997654432223345678899999999877 788999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 325 RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 325 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
..+.+++.+|+..+|.+||++.++++.+
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5799999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=257.91 Aligned_cols=204 Identities=26% Similarity=0.410 Sum_probs=166.7
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccch-HHHHHHHHHHHHHHHHHHhcC---CCccceEEEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATT-AETAALRSSFQQEVAVWQKLD---HPNVTKFVGA 153 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~ 153 (390)
..+|...+.+|.|+||.|++|.++ ...|+||.+.... +-.. -......-....|+.||..++ |+||++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR--IL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER--ILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhh--hhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 457899999999999999999884 4688999875211 0000 000001123456999999996 9999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecC-CCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL-PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
|.++++. |++||-. ++-+|++++..+ ..++|.....|+.||+.|+++||++||||||
T Consensus 638 FEddd~y--------------------yl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrd 695 (772)
T KOG1152|consen 638 FEDDDYY--------------------YLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRD 695 (772)
T ss_pred eecCCee--------------------EEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecc
Confidence 9876555 6688865 456899999654 5699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
||-+||.++.+|.+||+|||.|......+ +..+.||..|.|||++.+.+| +..-|||++|++||.++....||.+
T Consensus 696 ikdenvivd~~g~~klidfgsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 696 IKDENVIVDSNGFVKLIDFGSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cccccEEEecCCeEEEeeccchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999998665443 456789999999999999887 5678999999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=227.12 Aligned_cols=212 Identities=33% Similarity=0.532 Sum_probs=173.1
Q ss_pred ccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|.+.+.||.|++|.||++... ++.+|+|.+...... .....+.+|++.++.++|+|++++++.+...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--- 69 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFEDP--- 69 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeecC---
Confidence 567789999999999999884 589999998743221 2346788999999999999999999987643
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
...++++||+.+++|.+++..... .+++..+..++.+++.++.+||+.+++|+||+|.||++
T Consensus 70 -----------------~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v 131 (225)
T smart00221 70 -----------------EPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL 131 (225)
T ss_pred -----------------CceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 345789999999999999965332 28999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCC-CCCCCCCCCCcccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChhhHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVL-QGKPYNRRCDVYSFGICLWEIYCCDMPYPD-LSFADVSS 317 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~-~~~~~~~~ 317 (390)
+.++.++|+|||.+....... .......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ........
T Consensus 132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 132 GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 999999999999988654332 122335678889999998 667788899999999999999999999977 45553444
Q ss_pred HHHHcC
Q 036382 318 AVVRQN 323 (390)
Q Consensus 318 ~~~~~~ 323 (390)
.....+
T Consensus 212 ~~~~~~ 217 (225)
T smart00221 212 DVWSFG 217 (225)
T ss_pred HHHhcC
Confidence 443333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=217.73 Aligned_cols=163 Identities=24% Similarity=0.366 Sum_probs=132.0
Q ss_pred CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCC
Q 036382 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETG 269 (390)
Q Consensus 190 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~g 269 (390)
|+|.+++..+ +..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...+
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g 66 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV 66 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence 6899999653 356999999999999999999999999 999999999999999 9998765432 2368
Q ss_pred CCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh-hHHHHHHHcCCCCC------CCCCCcH--HHHHHH
Q 036382 270 TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA-DVSSAVVRQNLRPE------IPRCCPS--SLANIM 340 (390)
Q Consensus 270 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~------~~~~~~~--~l~~li 340 (390)
|+.|+|||++.+..++.++|||||||++|||++|..||...... .....+... .... .+..++. ++.++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hccCCccccccHHHHHhhhhHHHHH
Confidence 89999999999999999999999999999999999999765432 223333222 1111 1122333 699999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 341 RKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 341 ~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.+||..+|.+|||+.++++++..+...
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999888654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=268.99 Aligned_cols=203 Identities=20% Similarity=0.241 Sum_probs=145.1
Q ss_pred HhcCC-CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHH
Q 036382 140 QKLDH-PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 140 ~~l~h-pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~ 218 (390)
+.++| +||++++++|.... .....+...+.++||+ +++|.++|... ...+++..+..++.||+.
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~ 91 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGN-------------LDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVE 91 (793)
T ss_pred chhhHHHHHHHhhcccCCcc-------------ccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHH
Confidence 34556 68888888863221 0111234567788887 56999999642 346999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCC-------------------CcEEEeecccceeccCCC----------------CC
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQ-------------------RTLKIADFGVARVEAQNP----------------RD 263 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~-------------------~~~kL~DfG~a~~~~~~~----------------~~ 263 (390)
||.|||++||+||||||+||||+.. +.+||+|||+++...... ..
T Consensus 92 al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (793)
T PLN00181 92 IVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMK 171 (793)
T ss_pred HHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccc
Confidence 9999999999999999999999653 455666666665321100 00
Q ss_pred CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHh
Q 036382 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKC 343 (390)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 343 (390)
.....+|+.|||||++.+..++.++|||||||+||||++|..|+.... .....+......+... ...+...+++.+|
T Consensus 172 ~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (793)
T PLN00181 172 QILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQIL-LNWPKEASFCLWL 248 (793)
T ss_pred ccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhh-hcCHHHHHHHHHh
Confidence 112457889999999999999999999999999999999988875422 1222222222222111 2245577899999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 036382 344 WDANAEKRPEMGEVVKM 360 (390)
Q Consensus 344 l~~dP~~Rpt~~~ll~~ 360 (390)
|..+|.+|||+.+++++
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=231.88 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=186.1
Q ss_pred cCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGAS 154 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 154 (390)
..|...++||.|+|++||++.+ .++.||+|.+..... ...+.+|+++|..+ .+.||+++.+++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----------p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----------PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----------chHHHHHHHHHHHhccchhhhcchhhh
Confidence 4688999999999999999865 457999998864322 24578999999999 789999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
...+.. ++||||++.....+++. .++...+..+++.++.||.++|++||||||||
T Consensus 105 rnnd~v--------------------~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiK 159 (418)
T KOG1167|consen 105 RNNDQV--------------------AIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIK 159 (418)
T ss_pred ccCCee--------------------EEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCC
Confidence 755444 78999999999999883 37788999999999999999999999999999
Q ss_pred CCCEEECCC-CcEEEeecccceecc-----------------C-CC--------------------------CCCCCCCC
Q 036382 235 TENMLLDSQ-RTLKIADFGVARVEA-----------------Q-NP--------------------------RDMTGETG 269 (390)
Q Consensus 235 p~NILl~~~-~~~kL~DfG~a~~~~-----------------~-~~--------------------------~~~~~~~g 269 (390)
|.|+|.+.. +.-.|+|||+|.... . .+ .......|
T Consensus 160 psNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAG 239 (418)
T KOG1167|consen 160 PSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAG 239 (418)
T ss_pred ccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCC
Confidence 999999765 788999999986100 0 00 00012348
Q ss_pred CCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChhhHHHHHHH--------------cC----------
Q 036382 270 TLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL-SFADVSSAVVR--------------QN---------- 323 (390)
Q Consensus 270 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~~~~~~~~--------------~~---------- 323 (390)
|++|.|||++.. ...+.++||||.|+++..+++++.||-.. +..+.+..+.. +.
T Consensus 240 T~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~ 319 (418)
T KOG1167|consen 240 TPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIP 319 (418)
T ss_pred CCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccccc
Confidence 999999999865 45788999999999999999999998321 11111111100 00
Q ss_pred -----------C-------------CCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 324 -----------L-------------RPE-IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 324 -----------~-------------~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
. ... ..+..|..+.+|+.+||..||.+|.|+++.|.
T Consensus 320 ~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 320 TIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 000 11234568999999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=219.78 Aligned_cols=240 Identities=20% Similarity=0.330 Sum_probs=180.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 157 (390)
+.|.+.+.||+|.||.+.++.+ +++.+++|.++... .....|.+|...--.| .|.||+.-|++....
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----------hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 5699999999999999999988 46799999886221 1236688888877677 689999888764332
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.+.+++++||++.|+|..-+.. ..+.+.....++.|++.|+.|+|++++||||||.+|
T Consensus 94 -------------------~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eN 151 (378)
T KOG1345|consen 94 -------------------SDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAEN 151 (378)
T ss_pred -------------------CceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccce
Confidence 2345789999999999987743 458899999999999999999999999999999999
Q ss_pred EEECC--CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC---C--CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 238 MLLDS--QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG---K--PYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 238 ILl~~--~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||-. .-++||||||..+..+.. ....-.+..|.+||.... + ...+.+|+|.||+++|.+++|..||+..
T Consensus 152 iLif~~df~rvKlcDFG~t~k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 152 ILIFDADFYRVKLCDFGLTRKVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred EEEecCCccEEEeeecccccccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 99932 358999999998743321 111234667999997632 2 3567899999999999999999999743
Q ss_pred ChhhH----HHHHHHcCCCCCCCCC---CcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 311 SFADV----SSAVVRQNLRPEIPRC---CPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 311 ~~~~~----~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
...+. ..+. .++..+..|.. +++.+..+.++-|..+|++|--..+
T Consensus 229 ~~~d~~Y~~~~~w-~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 229 SIMDKPYWEWEQW-LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred hccCchHHHHHHH-hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 22111 1111 23334445543 5788889999999999999943333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=218.82 Aligned_cols=256 Identities=28% Similarity=0.529 Sum_probs=216.3
Q ss_pred ccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
-.|+..++.+.-+|.+...|..|+|+|.|..+++|+++... ........|..|.-.|+-+.||||+.++|+|.
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~-------~t~risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVRE-------VTARISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhh-------cchhhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 35777888889999999999999999999999999997432 22333467888888999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDV 233 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrDl 233 (390)
...++ .++..||+.|+|..+|....+...+..++.+++.+|++|++|||+.. |.---|
T Consensus 258 sppnl--------------------v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~l 317 (448)
T KOG0195|consen 258 SPPNL--------------------VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYL 317 (448)
T ss_pred CCCCc--------------------eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhc
Confidence 66555 56999999999999997666666788999999999999999999975 334468
Q ss_pred CCCCEEECCCCcEEEe--ecccceeccCCCCCCCCCCCCCccccccccCCCCCC---CchhHHHHHHHHHHHHhCCCCCC
Q 036382 234 KTENMLLDSQRTLKIA--DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN---RRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 234 kp~NILl~~~~~~kL~--DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
....|+||++.+.+|+ |--++.. ..+..-.|.||+||.++.++-+ .++|+|||++++||+.|...||.
T Consensus 318 ns~hvmidedltarismad~kfsfq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 318 NSKHVMIDEDLTARISMADTKFSFQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred ccceEEecchhhhheecccceeeee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence 9999999999877763 3222221 1234557899999999877644 47999999999999999999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
+.++-+.-.++.-.+++..+|...+..+..||.-|+..||.+||.+..++-.|+++.
T Consensus 391 dlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 391 DLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999888888899999999999999999999999999999999999999998863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-27 Score=221.73 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=201.5
Q ss_pred CccccccccccCceEEEEEEECC---ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC----CccceEEEEE
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYDN---QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH----PNVTKFVGAS 154 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~ 154 (390)
+|++.+.||+|+||.||.+.... ..+|+|+-....... ...+..|..++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---------~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---------PSVLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---------CccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 79999999999999999998744 368999876322111 0145678888888862 5788888775
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. .....|+||+.+ |.+|.++........++...+..++.|++.+|++||+.|++|||||
T Consensus 90 ~~-------------------~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiK 149 (322)
T KOG1164|consen 90 RS-------------------TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIK 149 (322)
T ss_pred cC-------------------CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcC
Confidence 30 233458899988 7799998866656789999999999999999999999999999999
Q ss_pred CCCEEECCC-----CcEEEeecccce--ecc-CC------CCC-CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHH
Q 036382 235 TENMLLDSQ-----RTLKIADFGVAR--VEA-QN------PRD-MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 235 p~NILl~~~-----~~~kL~DfG~a~--~~~-~~------~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 299 (390)
|.|+++... ..+.|.|||+++ ... .. .+. .....||..|+++.+..+...+.+.|+||++.++.+
T Consensus 150 p~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~e 229 (322)
T KOG1164|consen 150 PENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLE 229 (322)
T ss_pred HHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHH
Confidence 999999765 469999999998 321 11 111 234559999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHcC---CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 300 IYCCDMPYPDLSFADVSSAVVRQN---LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
++.|..||...........+.... .........|.++.+++..+-..+...+|....+...|+......+
T Consensus 230 l~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 230 LLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred HhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 999999998766433333322211 1111345567889999998888999999999999999998887663
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=203.35 Aligned_cols=258 Identities=19% Similarity=0.335 Sum_probs=207.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.-.|+++++||+|+||+++.|+. ++++||||.=....+ ..++..|.+.++.| ..++|...|-+-..
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----------APQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----------APQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC-----------cchHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 45799999999999999999976 899999997542211 24677899999988 67899888866543
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ..-.+|+|.+ |.||.|+..- .+.+|+.+.+..+|.|++.-++|+|++.+|+|||||+
T Consensus 96 G--------------------~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPd 153 (449)
T KOG1165|consen 96 G--------------------KYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPD 153 (449)
T ss_pred c--------------------chhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 3 2336799999 7789888754 4567999999999999999999999999999999999
Q ss_pred CEEECCC-----CcEEEeecccceeccCCC-------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 036382 237 NMLLDSQ-----RTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 237 NILl~~~-----~~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
|+||... ..+-|+|||+|+...++. +......||.+||+--...+...+.+.|+-|||-++.+.|-|.
T Consensus 154 NFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 154 NFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred ceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence 9999654 468999999998544321 2234567999999999999999999999999999999999999
Q ss_pred CCCCCCChh---hHHHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 305 MPYPDLSFA---DVSSAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 305 ~Pf~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
+||++.... +...+|-..+...+ ....+|.++..-|+..-..+-.+-|+.+-+...+.++....++
T Consensus 234 LPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 234 LPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred CccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 999986544 44444433322222 2356799999999999999999999999999999998766554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=196.13 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=203.8
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC-CccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-PNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~ 153 (390)
.|-..+|.++++||.|+||.+|.|.. +|+.||||+=.... ....+.-|..+++.|++ ..|..+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----------~hpqL~yEskvY~iL~~g~GiP~i~~y 79 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----------KHPQLLYESKVYRILQGGVGIPHIRHY 79 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----------CCcchhHHHHHHHHhccCCCCchhhhh
Confidence 35567899999999999999999976 78999999854211 12456789999999965 455554444
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
..+. ..-.+||+.+ |.+|.+++.= ....++.+.++..+-|++.-++|+|.+++|||||
T Consensus 80 ~~e~--------------------~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDI 137 (341)
T KOG1163|consen 80 GTEK--------------------DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDI 137 (341)
T ss_pred cccc--------------------ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccC
Confidence 4332 3336899999 7799887742 3456999999999999999999999999999999
Q ss_pred CCCCEEECCC---CcEEEeecccceeccCC-------CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 036382 234 KTENMLLDSQ---RTLKIADFGVARVEAQN-------PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303 (390)
Q Consensus 234 kp~NILl~~~---~~~kL~DfG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 303 (390)
||+|+|..-+ ..+.|+|||+|+...+. .+.-....||.+|.+--...+...+.+.|+-|+|.+|..+.-|
T Consensus 138 KPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG 217 (341)
T KOG1163|consen 138 KPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRG 217 (341)
T ss_pred CccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecC
Confidence 9999999654 56899999999753321 1223445799999998888888889999999999999999999
Q ss_pred CCCCCCCChhhHH---HHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 304 DMPYPDLSFADVS---SAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 304 ~~Pf~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
..||++....... .++...+...+ ....+|.++.-.+..|-..--++-|+..-+.+.+..+..+..-
T Consensus 218 ~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 218 SLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred CCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 9999997554433 33333333332 3456799999999999999999999999999998888765543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-24 Score=201.88 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=198.5
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCC-ccceEEEEEecccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP-NVTKFVGASVGTSNLK 161 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~ 161 (390)
|.+...||.|+||.||++.+. ..+++|.+....... ......+.+|+.+++.+.|+ +|+++.+.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESK------SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccc------hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE--
Confidence 677889999999999999888 889999986332211 12456788999999999888 79999999853322
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
.+++++++.+++|.+++..... ..++......++.|++.++.|+|+.+++|||+||+||++
T Consensus 73 ------------------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~ 134 (384)
T COG0515 73 ------------------LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL 134 (384)
T ss_pred ------------------EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 5889999999999977744321 268999999999999999999999999999999999999
Q ss_pred CCCC-cEEEeecccceeccCCCC------CCCCCCCCCccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 241 DSQR-TLKIADFGVARVEAQNPR------DMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 241 ~~~~-~~kL~DfG~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
+..+ .++++|||.+........ ......++..|++||.+.+ ..+....|+||+|++++++++|..||...
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9988 799999999975443321 2356789999999999987 57889999999999999999999998776
Q ss_pred Ch----hhHHHHHHHcCCC---CCCCCCC----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SF----ADVSSAVVRQNLR---PEIPRCC----PSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~----~~~~~~~~~~~~~---~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.. ......+...... ....... ...+.+++..|+..+|..|.+..+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 215 KNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 63 3444333333221 1112222 1578999999999999999998887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=213.03 Aligned_cols=172 Identities=17% Similarity=0.146 Sum_probs=127.9
Q ss_pred CcccccccCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
.....-.++|++.+.||+|+||+||+|.+ +++.||||++...... .........+.+|+++|++++|+||+..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~----~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW----WSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc----cccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 33445567899999999999999999976 4677899987421000 0011234568899999999999999853
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
+..+ +..|+||||++|++|.. + .. .. ...++.+++.||.|||++||+|
T Consensus 87 l~~~-----------------------~~~~LVmE~~~G~~L~~-~--~~---~~---~~~~~~~i~~aL~~lH~~gIiH 134 (365)
T PRK09188 87 LLAT-----------------------GKDGLVRGWTEGVPLHL-A--RP---HG---DPAWFRSAHRALRDLHRAGITH 134 (365)
T ss_pred EEEc-----------------------CCcEEEEEccCCCCHHH-h--Cc---cc---hHHHHHHHHHHHHHHHHCCCee
Confidence 3221 12389999999999963 2 11 11 1467889999999999999999
Q ss_pred cCC-CCCCEEECCCCcEEEeecccceeccCCC--------CCCCCCCCCCccccccccCC
Q 036382 231 RDV-KTENMLLDSQRTLKIADFGVARVEAQNP--------RDMTGETGTLGYMAPEVLQG 281 (390)
Q Consensus 231 rDl-kp~NILl~~~~~~kL~DfG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 281 (390)
||| ||+|||++.++.+||+|||+|+...... ...++..+++.|+|||.+..
T Consensus 135 rDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 135 NDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999 9999999999999999999998654322 11234567888999999854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=200.57 Aligned_cols=216 Identities=20% Similarity=0.326 Sum_probs=158.5
Q ss_pred CCCccceEEEEEecccccccCCcc-------cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHH
Q 036382 143 DHPNVTKFVGASVGTSNLKIPSKT-------ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALD 215 (390)
Q Consensus 143 ~hpnIv~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 215 (390)
+|||||++.++|.++-.+.-...+ ........+.....|+||--... +|..|+-. ...+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence 599999999999876543321111 11122334456778999998865 99999954 34777788889999
Q ss_pred HHHHHHHHHhCCCcccCCCCCCEEEC--CC--CcEEEeecccceeccCCC------CCCCCCCCCCccccccccCCCCC-
Q 036382 216 LSRGLSYLHSKKIVHRDVKTENMLLD--SQ--RTLKIADFGVARVEAQNP------RDMTGETGTLGYMAPEVLQGKPY- 284 (390)
Q Consensus 216 i~~~L~yLH~~~iiHrDlkp~NILl~--~~--~~~kL~DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~- 284 (390)
+++|+.|||++||.|||+|.+|||+. +| -.+.|+|||++-.....+ .+....-|.-..||||+....+-
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999994 33 368899999875433221 12223447778999999865432
Q ss_pred -----CCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 285 -----NRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 285 -----~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
-.++|.|+.|.+.||++....||..............+..-|..|+.||+.+++++...|+.||++|++..-...
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 247999999999999999999997732221111112334456789999999999999999999999998765555
Q ss_pred HHH
Q 036382 360 MLE 362 (390)
Q Consensus 360 ~L~ 362 (390)
.|.
T Consensus 510 vl~ 512 (598)
T KOG4158|consen 510 VLN 512 (598)
T ss_pred HHH
Confidence 544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-25 Score=214.97 Aligned_cols=234 Identities=24% Similarity=0.372 Sum_probs=190.5
Q ss_pred cccccCceEEEEE-----EECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecccccc
Q 036382 88 LIAQGTYGSVYRG-----TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 88 ~lg~G~~g~Vy~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 161 (390)
++|+|+||.|++. .+.++.+|+|+++......... .....|..++..++ ||.+|+++-.+..+..+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-------~~t~~er~il~~~~~~~f~v~lhyafqt~~kl- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-------THTKQERIILAFVHNTPFLVKLHYAFQTDGKL- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-------cccccHHHHHhhccCCCceeeeeeeeccccch-
Confidence 4799999999954 4467899999987433221111 14456788888885 99999999998876666
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
+++++|..+|.|...+.+ ...+++.....+...++-+++++|+.+|+|||+|++||+++
T Consensus 73 -------------------~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld 131 (612)
T KOG0603|consen 73 -------------------YLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL 131 (612)
T ss_pred -------------------hHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec
Confidence 559999999999988843 45688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 036382 242 SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (390)
.+|++++.|||+++....... .|||..|||||+++ ....++|+||||++++||++|..||.. ++...+.+
T Consensus 132 ~~Ghi~~tdfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 132 LEGHIKLTDFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred ccCccccCCchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 999999999999985443322 29999999999998 578899999999999999999999987 55555554
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHHHHHH
Q 036382 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM--GEVVKMLE 362 (390)
Q Consensus 322 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~--~~ll~~L~ 362 (390)
. ...+|...+..+++++.+++..+|..|... ..+.+..+
T Consensus 202 ~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 202 A--ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred h--ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 3 345788889999999999999999999765 34444433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-25 Score=222.26 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=185.7
Q ss_pred cccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
.....+|.|++|.|+.... ..+.++.|..+.. .. ...........+..|+.+-..+.|||++..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~--~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK--PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC--CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-
Confidence 4567899999998877654 3344445443311 00 1112222223377788888899999998776655433222
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
.-+|||+++ +|+.++.+. ..++...+..++.|++.|+.|+|+.||.|||+|++|+++.
T Consensus 397 -------------------~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~ 454 (601)
T KOG0590|consen 397 -------------------LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT 454 (601)
T ss_pred -------------------hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence 224999999 999999553 4688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 242 SQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGKPYNR-RCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
.+|.+||+|||.+....... ....+.+|+-.|+|||++.+..|++ ..||||.|+++..|.+|+.||......+..
T Consensus 455 ~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 455 ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 99999999999987544332 2345678999999999999999987 579999999999999999999766544432
Q ss_pred H-HHH-HcCCCC-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 S-AVV-RQNLRP-----EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~-~~~-~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
. ... ...... .+...+|.+.+.+|.++|+.||.+|.|+.+|++
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1 111 001110 122346888999999999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=190.07 Aligned_cols=186 Identities=12% Similarity=0.148 Sum_probs=136.7
Q ss_pred ccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
-.+|+..+++|.|+||.||+...++..+|||+++................+.+.+|+..+.++.||+|..+.+++.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 46899999999999999999877888999999974432211111111112347899999999999999999888664321
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
-.. ...+..++||||++|.+|.++. .+++. ...+++.+|..+|+.|++|||++|.||+
T Consensus 110 ~~~------------~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nil 167 (232)
T PRK10359 110 KTL------------RYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFI 167 (232)
T ss_pred ccc------------cccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEE
Confidence 110 1234578999999999998874 13332 4568999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 300 (390)
++.+| ++|+|||.......... ....+....|+.++|+||||+++...
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EeCCC-EEEEECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHH
Confidence 99988 99999998764321110 01133445677899999999998755
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=182.35 Aligned_cols=147 Identities=17% Similarity=0.211 Sum_probs=109.2
Q ss_pred cccccccCceEEEEEEE-CCceEEEEEeccCCCCccchH-----------------HHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 86 RNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTA-----------------ETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
...||+|+||.||+|.. +|+.||||+++.+........ ...........|.+++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999987 689999999975432111100 000112334569999999988776
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH-HhC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYL-HSK 226 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~ 226 (390)
.....+.. ...++||||+.+++|.....+ ...+++..+..++.|++.+|.|+ |+.
T Consensus 82 ~~p~~~~~----------------------~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~ 137 (190)
T cd05147 82 PCPEPILL----------------------KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC 137 (190)
T ss_pred CCCcEEEe----------------------cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 43322211 112789999999877655422 34689999999999999999999 799
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
||+||||||+|||++ ++.++|+|||+|...
T Consensus 138 giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 138 RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999999998 588999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=188.76 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=149.1
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC----------CCccce
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD----------HPNVTK 149 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------hpnIv~ 149 (390)
.+.....||.|+++.||.+++ +|+.+|||++........ ...+.+.+|.-....+. |-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~------~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA------NEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT------THHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch------HHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 467788999999999999998 569999999975542211 12344445543333322 222333
Q ss_pred EEEEEeccc-ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh---hcc--CCCCHHHHHHHHHHHHHHHHHH
Q 036382 150 FVGASVGTS-NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR---NRR--KKLALKIVIQLALDLSRGLSYL 223 (390)
Q Consensus 150 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~i~~~L~yL 223 (390)
.++...... .... ....+ .....--..+++|+-+. ++|.+++.- ... ..+.......+..|+++.+++|
T Consensus 87 P~d~~~i~~~~~~~---~~~~~-~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L 161 (288)
T PF14531_consen 87 PLDLLRIPGKPPFF---ERGPG-QSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL 161 (288)
T ss_dssp -SEEEEETTS-SEE---EECET-TEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEcCCCcce---ecCCC-Cccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH
Confidence 333322111 0000 00000 00000012367888884 589888642 111 1233444566678999999999
Q ss_pred HhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC--------CCCCCchhHHHHHH
Q 036382 224 HSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--------KPYNRRCDVYSFGI 295 (390)
Q Consensus 224 H~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~ 295 (390)
|+.|++|+||+|+|+|++.+|.++|+||+.......... ....+..|.+||.... -.++.+.|.|+||+
T Consensus 162 h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 162 HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred hhcceEecccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999999998765443211 1344577999997633 25788999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 036382 296 CLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351 (390)
Q Consensus 296 il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 351 (390)
++|.|+|+..||...+....... ........|+.++.||..+|+.||++|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999976543322111 111223678999999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=210.43 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=183.7
Q ss_pred CCCcccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHH----HHHhcC---
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA----VWQKLD--- 143 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~----~l~~l~--- 143 (390)
+..+.++..++|.+.+.||+|+||.||+|.. +|+.||||+-+.... +|+. ++.+|+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----------------WEfYI~~q~~~RLk~~~ 752 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----------------WEFYICLQVMERLKPQM 752 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----------------eeeeehHHHHHhhchhh
Confidence 4566788889999999999999999999976 688999998764321 3332 333444
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYL 223 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yL 223 (390)
-+-|+.+..+++ -.+..++|+||.+.|+|.+++. ..+.+++..+..+..|++..+++|
T Consensus 753 ~~~~~~~~~a~~--------------------~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~l 810 (974)
T KOG1166|consen 753 LPSIMHISSAHV--------------------FQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHL 810 (974)
T ss_pred hcchHHHHHHHc--------------------cCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHH
Confidence 123333333222 3455689999999999999995 556799999999999999999999
Q ss_pred HhCCCcccCCCCCCEEECC-------CCcEEEeecccceec--cCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHH
Q 036382 224 HSKKIVHRDVKTENMLLDS-------QRTLKIADFGVARVE--AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294 (390)
Q Consensus 224 H~~~iiHrDlkp~NILl~~-------~~~~kL~DfG~a~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 294 (390)
|..+|||+||||+|+||.. .-.++|+|||.+... ......+...++|-.+-++|+..|+++++.+|.|.|+
T Consensus 811 H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlA 890 (974)
T KOG1166|consen 811 HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLA 890 (974)
T ss_pred HhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHH
Confidence 9999999999999999943 346999999998743 2334456778899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCC----CCCCCc-HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 295 ICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPE----IPRCCP-SSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 295 ~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.+++-||.|+.- + +..+..-. +++.+- +.+.+|...+|..|-..=|...+|...|+.+..
T Consensus 891 a~~h~mLFG~y~-------q-----~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 891 ATVHVMLFGKYM-------E-----VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHHHHHHHHH-------H-----hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 999999999732 1 11111111 222222 235678888888555555888888888877653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=212.79 Aligned_cols=242 Identities=22% Similarity=0.298 Sum_probs=174.8
Q ss_pred CccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
++...+.||.+.|=.|.+|++++..|+||++-...+...-. .. .+...|++ ...++|||.+++.-+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~----~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t----- 92 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLR----PF-KQRLEEIK-FALMKAPNCLPFQKVLVT----- 92 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCch----HH-HHHHHHHH-HHhhcCCcccchHHHHHh-----
Confidence 67888999999999999999987779999996554433211 11 11123333 455699999988765432
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
....|+|-+|..+ +|.|.|.. +.-+..-...+|+.|++.||..+|+.||+|+|||.+||||+
T Consensus 93 ---------------~kAAylvRqyvkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT 154 (1431)
T KOG1240|consen 93 ---------------DKAAYLVRQYVKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT 154 (1431)
T ss_pred ---------------hHHHHHHHHHHhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence 2334667788865 89998843 34467778889999999999999999999999999999999
Q ss_pred CCCcEEEeecccce---eccCCCCCCC----CCCCCCccccccccCCC----------C-CCCchhHHHHHHHHHHHHh-
Q 036382 242 SQRTLKIADFGVAR---VEAQNPRDMT----GETGTLGYMAPEVLQGK----------P-YNRRCDVYSFGICLWEIYC- 302 (390)
Q Consensus 242 ~~~~~kL~DfG~a~---~~~~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ell~- 302 (390)
+.+.+.|+||..-+ ...+++.+++ +...-.+|.|||.+... + .+++.||||+||+++|+++
T Consensus 155 SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E 234 (1431)
T KOG1240|consen 155 SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE 234 (1431)
T ss_pred eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence 99999999998543 1112222322 22344689999987531 2 6789999999999999998
Q ss_pred CCCCCCCCCh-------hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 303 CDMPYPDLSF-------ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 303 g~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
|++||.-... ......++.+ .-...++++|..|++.||++|.++++.++.
T Consensus 235 g~PlF~LSQL~aYr~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 235 GRPLFTLSQLLAYRSGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CCCcccHHHHHhHhccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 7888832100 1111111111 112479999999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=175.03 Aligned_cols=148 Identities=17% Similarity=0.150 Sum_probs=111.5
Q ss_pred cccccccCceEEEEEEE-CCceEEEEEeccCCCCccchH-----------------HHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 86 RNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTA-----------------ETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
.+.||+|+||.||+|.+ +|+.||||+++.......... ........+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 599999999986532211100 011112345689999999999987
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-K 226 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~ 226 (390)
.....+... ..++||||+.|+++...... ...++...+..++.|++.++.++|+ .
T Consensus 82 ~~p~~~~~~----------------------~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ 137 (190)
T cd05145 82 PVPEPILLK----------------------KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA 137 (190)
T ss_pred CCceEEEec----------------------CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 544433221 12789999998865443222 2457888999999999999999999 9
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccceecc
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~ 258 (390)
||+||||||+|||++ ++.++|+|||++....
T Consensus 138 givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 138 GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999999998 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=170.09 Aligned_cols=187 Identities=16% Similarity=0.106 Sum_probs=137.4
Q ss_pred cccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEeccccccc
Q 036382 84 DMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 162 (390)
.+...|++|+||+||.+...+.+++.+.+.... ..........+.+|+++|++|. |++|.+++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~-----~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-------- 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAP-----WWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-------- 71 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccch-----hhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------
Confidence 345689999999999888888899887775211 1111111235789999999994 57899998752
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCCEEEC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV-KTENMLLD 241 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl-kp~NILl~ 241 (390)
..+++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||.|||++
T Consensus 72 ----------------~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~ 126 (218)
T PRK12274 72 ----------------GRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ 126 (218)
T ss_pred ----------------CEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc
Confidence 13789999999998764311 1 1357789999999999999999999 79999999
Q ss_pred CCCcEEEeecccceeccCCCCCC-------------CCCCCCCccccccccCCC-CCC-CchhHHHHHHHHHHHHhCCCC
Q 036382 242 SQRTLKIADFGVARVEAQNPRDM-------------TGETGTLGYMAPEVLQGK-PYN-RRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~~~-------------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~ell~g~~P 306 (390)
.++.++|+|||+|.......... .-...++.|++|+...-. ..+ .+.++++.|+-+|.++|+..|
T Consensus 127 ~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 127 EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 99999999999998544332110 001256778888754322 233 577889999999999999988
Q ss_pred CC
Q 036382 307 YP 308 (390)
Q Consensus 307 f~ 308 (390)
+.
T Consensus 207 ~~ 208 (218)
T PRK12274 207 HW 208 (218)
T ss_pred cc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=200.19 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=155.0
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
-.+|+.++.|..|+||.||..+++ .+++|+|+-+. --|++ ||..+.+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---------------------~lilR-----nilt~a~n---- 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---------------------NLILR-----NILTFAGN---- 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc---------------------chhhh-----ccccccCC----
Confidence 367999999999999999999774 78999976531 01111 23333221
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.++| |+-...++. -++++.+. +.+++|||+.||+|||+||+|
T Consensus 132 ----------------------pfvv------gDc~tllk~--~g~lPvdm--------vla~Eylh~ygivhrdlkpdn 173 (1205)
T KOG0606|consen 132 ----------------------PFVV------GDCATLLKN--IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDN 173 (1205)
T ss_pred ----------------------ccee------chhhhhccc--CCCCcchh--------hHHhHhhccCCeecCCCCCCc
Confidence 1223 444444422 22344322 679999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCC-------------CC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQN-------------PR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~-------------~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 302 (390)
+||+.-|++|++|||++....-. .. .....+||+.|.|||++.-..|+..+|+|++|+|+||.+.
T Consensus 174 llIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV 253 (1205)
T KOG0606|consen 174 LLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 253 (1205)
T ss_pred ceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe
Confidence 99999999999999998632110 00 0123589999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 036382 303 CDMPYPDLSFADVSSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRP 352 (390)
Q Consensus 303 g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 352 (390)
|..||.+.+++++...++... ..++-....+++.++++.++|+.+|..|.
T Consensus 254 gcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 254 GCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred eeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 999999999999988776543 33444556789999999999999999995
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=186.00 Aligned_cols=209 Identities=32% Similarity=0.560 Sum_probs=166.7
Q ss_pred HHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHH
Q 036382 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 139 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~ 218 (390)
|+.+.|.|+.+|+|.+.+.. ..++|-+|+.-|+|.|.+.. ....+++.....++.+|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------------------~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~ 59 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------------------EMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISK 59 (484)
T ss_pred CcccchhhhhhheeeEecCC--------------------ceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHH
Confidence 45789999999999998653 34789999999999999965 3467999999999999999
Q ss_pred HHHHHHhCCC-cccCCCCCCEEECCCCcEEEeecccceeccC--CCCCCCCCCCCCccccccccCCC-------CCCCch
Q 036382 219 GLSYLHSKKI-VHRDVKTENMLLDSQRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLQGK-------PYNRRC 288 (390)
Q Consensus 219 ~L~yLH~~~i-iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~ 288 (390)
||.|||+..| .|+.+++.|.+++....+||+|||+...... .........-..-|.|||.+.+. ..+.+.
T Consensus 60 Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~g 139 (484)
T KOG1023|consen 60 GLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKG 139 (484)
T ss_pred HHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccC
Confidence 9999998876 9999999999999999999999999875532 11111112244578999999763 146779
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC----ChhhHHHHHHHcC---CCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 289 DVYSFGICLWEIYCCDMPYPDL----SFADVSSAVVRQN---LRPEIPR--CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 289 DiwSlG~il~ell~g~~Pf~~~----~~~~~~~~~~~~~---~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
|+||||++++|+++-..||... ++.+++..+...+ ++|.+.. .+++++..++++||..+|+.||++.++..
T Consensus 140 diYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 140 DIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9999999999999999999652 3345555544312 3443331 45668999999999999999999999999
Q ss_pred HHHHhHhcC
Q 036382 360 MLEAIDTSK 368 (390)
Q Consensus 360 ~L~~~~~~~ 368 (390)
.++.+.+..
T Consensus 220 ~~~~~~~~~ 228 (484)
T KOG1023|consen 220 KLLTINKGG 228 (484)
T ss_pred hhhhhcccc
Confidence 999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-19 Score=161.41 Aligned_cols=142 Identities=23% Similarity=0.340 Sum_probs=112.8
Q ss_pred ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
+.||+|++|.||+|.+.|..|+||+......... ..........+.+|++++..+.|++|.....++.+.
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--------- 71 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHP-ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--------- 71 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcCh-HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC---------
Confidence 5789999999999999999999998753221111 112222345678899999999999987766665433
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
...++||||++|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.|||++ ++.+
T Consensus 72 -----------~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~ 133 (211)
T PRK14879 72 -----------ENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKI 133 (211)
T ss_pred -----------CCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCE
Confidence 23478999999999999985421 2 7889999999999999999999999999999998 8899
Q ss_pred EEeeccccee
Q 036382 247 KIADFGVARV 256 (390)
Q Consensus 247 kL~DfG~a~~ 256 (390)
+|+|||.+..
T Consensus 134 ~liDf~~a~~ 143 (211)
T PRK14879 134 YLIDFGLAEF 143 (211)
T ss_pred EEEECCcccC
Confidence 9999998863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=165.62 Aligned_cols=140 Identities=16% Similarity=0.270 Sum_probs=103.8
Q ss_pred cccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-----CCCccceEEEEEeccc
Q 036382 84 DMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-----DHPNVTKFVGASVGTS 158 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~ 158 (390)
.-..+||+|+||.||....++.. +||++..... ...+.+.+|+.+++.+ +||||++++|++.++.
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~---------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~ 74 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGD---------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC 74 (210)
T ss_pred CCcceecCCCceEEEECCCCcCe-EEEEEecccc---------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence 34568999999999973334444 6888764321 1235678999999999 5799999999997642
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEec--CCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEY--LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGL-SYLHSKKIVHRDVKT 235 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~iiHrDlkp 235 (390)
. .+..+.+|+|| ..+|+|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||
T Consensus 75 g----------------~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp 133 (210)
T PRK10345 75 G----------------TGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP 133 (210)
T ss_pred C----------------CeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 1 11123478999 5579999999542 36666 35677888777 999999999999999
Q ss_pred CCEEECC----CCcEEEeecccc
Q 036382 236 ENMLLDS----QRTLKIADFGVA 254 (390)
Q Consensus 236 ~NILl~~----~~~~kL~DfG~a 254 (390)
+|||++. ++.++|+||+.+
T Consensus 134 ~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 134 QNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHEEEeccCCCCCcEEEEECCCC
Confidence 9999974 348999995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=163.93 Aligned_cols=149 Identities=19% Similarity=0.224 Sum_probs=111.6
Q ss_pred CccccccccccCceEEEEEE-E--CCceEEEEEeccCCCCccch---------------HHHHHHHHHHHHHHHHHHhcC
Q 036382 82 KLDMRNLIAQGTYGSVYRGT-Y--DNQEVAVKLLDWGEDGMATT---------------AETAALRSSFQQEVAVWQKLD 143 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~-~--~~~~vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l~ 143 (390)
-|.+.+.||+|+||.||+|. . +|+.||||+++......... .........+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 2 78999999997543211110 011112345678999999997
Q ss_pred CCc--cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Q 036382 144 HPN--VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLS 221 (390)
Q Consensus 144 hpn--Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~ 221 (390)
+.+ +.++++.. ..++||||+.+++|...... ...+....+..++.||+.+|.
T Consensus 109 ~~~i~~p~~~~~~------------------------~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~ 162 (237)
T smart00090 109 EAGVPVPKPIAWR------------------------RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMR 162 (237)
T ss_pred hcCCCCCeeeEec------------------------CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHH
Confidence 533 33333321 12789999999888765422 234666677899999999999
Q ss_pred HHHhCC-CcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 222 YLHSKK-IVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 222 yLH~~~-iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
+||+.| |+||||||+||+++ ++.++|+|||.+...
T Consensus 163 ~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 163 KLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred HHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999 99999999999998 889999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=157.64 Aligned_cols=138 Identities=23% Similarity=0.324 Sum_probs=106.9
Q ss_pred cccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCccc
Q 036382 88 LIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTA 167 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 167 (390)
.||+|+||.||+|.+++..|++|+........ ...+.......+.+|+++++.+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~---------- 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRH-PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP---------- 69 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcC-chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC----------
Confidence 48999999999999999999999865322111 1122233346778999999999888765444443322
Q ss_pred ccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEE
Q 036382 168 SVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247 (390)
Q Consensus 168 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~k 247 (390)
...++||||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++
T Consensus 70 ----------~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~ 129 (199)
T TIGR03724 70 ----------DNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLY 129 (199)
T ss_pred ----------CCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEE
Confidence 22378999999999999874321 1 7889999999999999999999999999998 89999
Q ss_pred Eeeccccee
Q 036382 248 IADFGVARV 256 (390)
Q Consensus 248 L~DfG~a~~ 256 (390)
++|||++..
T Consensus 130 liDfg~a~~ 138 (199)
T TIGR03724 130 LIDFGLGKY 138 (199)
T ss_pred EEECCCCcC
Confidence 999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=177.33 Aligned_cols=142 Identities=21% Similarity=0.259 Sum_probs=112.0
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
|...+.||+|+||.||+|.+.+..+++|+........ ...........+.+|+++++.++|++++....++.+..
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~---- 409 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRH-PELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE---- 409 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccc-hhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC----
Confidence 4557899999999999999988777777543211111 11122233466889999999999999988776655432
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
..++||||+++++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .
T Consensus 410 ----------------~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~ 462 (535)
T PRK09605 410 ----------------EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-R 462 (535)
T ss_pred ----------------CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-E
Confidence 2378999999999999884 246789999999999999999999999999999 6
Q ss_pred CCcEEEeeccccee
Q 036382 243 QRTLKIADFGVARV 256 (390)
Q Consensus 243 ~~~~kL~DfG~a~~ 256 (390)
++.++|+|||+++.
T Consensus 463 ~~~~~liDFGla~~ 476 (535)
T PRK09605 463 DDRLYLIDFGLGKY 476 (535)
T ss_pred CCcEEEEeCccccc
Confidence 78999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-20 Score=176.86 Aligned_cols=177 Identities=21% Similarity=0.437 Sum_probs=137.1
Q ss_pred CCCCCCCCceEEEEecCCCCCHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEe
Q 036382 171 GNAAVPARACCVVVEYLPGGNLKQYLIR-NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249 (390)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~ 249 (390)
.+........||.|+++...+|.++|.+ ......+......++.|++.|+.| +|.+|||+||.||+...+..+||+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 3344445668999999999999999963 334567888899999999999999 999999999999999999999999
Q ss_pred ecccceeccCCC------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHc
Q 036382 250 DFGVARVEAQNP------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQ 322 (390)
Q Consensus 250 DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~ 322 (390)
|||+........ ...+...||..||+||.+.+..|+.++||||||++|+|++. -..+|....... .+...
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~---d~r~g 475 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT---DIRDG 475 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh---hhhcC
Confidence 999987654432 24556789999999999999999999999999999999997 454443221111 12222
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 323 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
.+.+.+.... +.-..|+.+++.+.|.+||++
T Consensus 476 ~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 476 IIPPEFLQDY-PEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred CCChHHhhcC-cHHHHHHHHhcCCCcccCchH
Confidence 2222333333 345689999999999999943
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=154.57 Aligned_cols=143 Identities=22% Similarity=0.242 Sum_probs=107.5
Q ss_pred ccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHH-------------HHHHHHHHHHHHHHHHhcCCCc--
Q 036382 83 LDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAE-------------TAALRSSFQQEVAVWQKLDHPN-- 146 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~hpn-- 146 (390)
|.+.+.||+|+||.||++.. +|+.||||+++........... .......+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 77788999999999999987 6899999998643321111100 1112234678899999997774
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
+...++. ...++||||+.|++|.+.... .....++.+++.++.++|+.
T Consensus 97 v~~~~~~------------------------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 97 VPKPIDW------------------------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred CCceeec------------------------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC
Confidence 3333321 123789999999999775421 23567889999999999999
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
||+||||+|.||+++.++.++|+|||++...
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-17 Score=146.42 Aligned_cols=147 Identities=16% Similarity=0.182 Sum_probs=107.5
Q ss_pred cccc-ccCceEEEEEEECCceEEEEEeccCCCCccch----HHHHHHHHHHHHHHHHHHhcCCCcc--ceEEEEEecccc
Q 036382 87 NLIA-QGTYGSVYRGTYDNQEVAVKLLDWGEDGMATT----AETAALRSSFQQEVAVWQKLDHPNV--TKFVGASVGTSN 159 (390)
Q Consensus 87 ~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~~ 159 (390)
..|| .|+.|+||.+...+..++||.+..+..-.... .........+.+|++++.+|.|++| .+.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 88899999988889999999886432100000 0011234567889999999998875 667766443211
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCC-CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPG-GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
. ....++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.||
T Consensus 117 ~----------------~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NI 173 (239)
T PRK01723 117 L----------------FYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNI 173 (239)
T ss_pred c----------------ceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhE
Confidence 1 1123699999997 689998843 2455543 56889999999999999999999999
Q ss_pred EECCCCcEEEeeccccee
Q 036382 239 LLDSQRTLKIADFGVARV 256 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~ 256 (390)
|++.++.++|+|||.+..
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999999999999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.7e-17 Score=140.65 Aligned_cols=143 Identities=22% Similarity=0.212 Sum_probs=96.1
Q ss_pred cccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHH---------------HHHHHHHHHHHHHHHhcCCCc--c
Q 036382 86 RNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAET---------------AALRSSFQQEVAVWQKLDHPN--V 147 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~hpn--I 147 (390)
.+.||+|+||.||+|... ++.||||+++............ .........|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999875 8999999987433211111000 000011134555666654332 3
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHH-HHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ-YLIRNRRKKLALKIVIQLALDLSRGLSYLHS- 225 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~- 225 (390)
.+.++. ...++||||+.++++.. .+.... .. .....++.+++.++.++|+
T Consensus 82 ~~~~~~------------------------~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~ 133 (187)
T cd05119 82 PKPIDL------------------------NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE 133 (187)
T ss_pred CceEec------------------------CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc
Confidence 333332 12389999999954322 111110 11 5678899999999999999
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
.||+|+||||+||+++ ++.++|+|||.+...
T Consensus 134 ~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 134 AGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999999999 999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-18 Score=173.87 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=190.3
Q ss_pred ccCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEe
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASV 155 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 155 (390)
...|.+.+.||+|+|+.|-.... ....+|+|.+.... ...........|..+-+.+. |+|++.+++...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~ 91 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS 91 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-------CccchhhhcCccccccccccccccccccCCccC
Confidence 34688888899999999987755 33466777665332 11112244556777777775 999999998766
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH-SKKIVHRDVK 234 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~iiHrDlk 234 (390)
.. +..+++++|..++++.+-+........+......++.|+..++.|+| ..++.|||||
T Consensus 92 ~~--------------------~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ik 151 (601)
T KOG0590|consen 92 SP--------------------RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIK 151 (601)
T ss_pred CC--------------------cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCC
Confidence 44 34477999999999998873112225677778899999999999999 9999999999
Q ss_pred CCCEEECCCC-cEEEeecccceeccC-C--CCCCCCCCC-CCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 235 TENMLLDSQR-TLKIADFGVARVEAQ-N--PRDMTGETG-TLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 235 p~NILl~~~~-~~kL~DfG~a~~~~~-~--~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
|+|.+++..+ .++++|||+|..... . .......+| ++.|+|||...+. -..+..|+||.|+++..+++|..||.
T Consensus 152 P~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~ 231 (601)
T KOG0590|consen 152 PSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD 231 (601)
T ss_pred CccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence 9999999999 999999999986544 2 223344678 9999999999885 44678999999999999999999997
Q ss_pred CCChhhHH-HHHHHc--CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 309 DLSFADVS-SAVVRQ--NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 309 ~~~~~~~~-~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.....+.. ...... ..........+....+++.+++..+|..|.+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 232 FPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 65444322 111111 1123345567788999999999999999999888753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=127.60 Aligned_cols=131 Identities=23% Similarity=0.297 Sum_probs=107.1
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC--CccceEEEEEecccccccC
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH--PNVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~~~ 163 (390)
.+.||.|.++.||++...+..+++|....... ...+.+|+.+++.++| .++.+++++....
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~------ 65 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----------GADREREVAILQLLARKGLPVPKVLASGESD------ 65 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC------
Confidence 46799999999999999889999999863211 2467789999999976 5888888776432
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCCEEE
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK---KIVHRDVKTENMLL 240 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---~iiHrDlkp~NILl 240 (390)
+..+++|||+.++++..+ +......++.+++.+|.+||.. +++|+|++|.||++
T Consensus 66 --------------~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~ 122 (155)
T cd05120 66 --------------GWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV 122 (155)
T ss_pred --------------CccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE
Confidence 345899999998877643 4456677889999999999985 79999999999999
Q ss_pred CCCCcEEEeeccccee
Q 036382 241 DSQRTLKIADFGVARV 256 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~ 256 (390)
+..+.++++|||.+..
T Consensus 123 ~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 123 DDGKILGIIDWEYAGY 138 (155)
T ss_pred ECCcEEEEEecccccC
Confidence 9989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-14 Score=142.52 Aligned_cols=161 Identities=16% Similarity=0.182 Sum_probs=104.8
Q ss_pred ccCccccccccccCceEEEEEEE-C-CceEEEEEeccCCCCc-------------------------cchHHHHHHHHHH
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY-D-NQEVAVKLLDWGEDGM-------------------------ATTAETAALRSSF 132 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~vavK~~~~~~~~~-------------------------~~~~~~~~~~~~~ 132 (390)
..+|+. +.||.|++|+||+|+. + |+.||||+++.+-... ..........+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455666 7899999999999987 3 8999999998542110 0011112334445
Q ss_pred HHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccC----CCCHHH
Q 036382 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK----KLALKI 208 (390)
Q Consensus 133 ~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~ 208 (390)
.+|+...+.. +|+.++...|.+...+++|.-.... ....++||||+.|++|.++-.-...+ .+.+..
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~-------st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDY-------CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG 268 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeeccc-------CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence 5666666555 4666666666555555554332221 23347999999999998753211111 233333
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC----cEEEeecccceec
Q 036382 209 VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR----TLKIADFGVARVE 257 (390)
Q Consensus 209 ~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~----~~kL~DfG~a~~~ 257 (390)
+..++. .+...|++|+|+||.||+++.+| .++++|||++...
T Consensus 269 v~~~~~-------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 269 VEVFFT-------QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHH-------HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 333333 44569999999999999999988 9999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=146.73 Aligned_cols=149 Identities=19% Similarity=0.223 Sum_probs=97.2
Q ss_pred ccccccCceEEEEEEE-CCceEEEEEeccCCCCccch-------------------------HHHHHHHH------HHHH
Q 036382 87 NLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATT-------------------------AETAALRS------SFQQ 134 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~-------------------------~~~~~~~~------~~~~ 134 (390)
+.||.|++|+||+|+. +|+.||||+.+.+-...... ........ .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999988 78999999997542111000 00001111 2444
Q ss_pred HHHHHHhc----CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHH
Q 036382 135 EVAVWQKL----DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVI 210 (390)
Q Consensus 135 E~~~l~~l----~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~ 210 (390)
|++.+.++ +|.+-+.+-.++.+ .....++||||++|++|.++...... ..+ ..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~-------------------~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~ 259 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWD-------------------RTSERVLTMEWIDGIPLSDIAALDEA-GLD---RK 259 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehh-------------------hcCCceEEEEeECCcccccHHHHHhc-CCC---HH
Confidence 55555444 22222222222211 11234899999999999987643221 222 23
Q ss_pred HHHHHHHH-HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceecc
Q 036382 211 QLALDLSR-GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258 (390)
Q Consensus 211 ~i~~~i~~-~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~ 258 (390)
.++..++. .+..+|..|++|+|++|.||+++.++.++|+|||++....
T Consensus 260 ~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 260 ALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 45556555 4788999999999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.5e-14 Score=127.14 Aligned_cols=200 Identities=22% Similarity=0.345 Sum_probs=143.2
Q ss_pred HHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHH
Q 036382 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALD 215 (390)
Q Consensus 138 ~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ 215 (390)
-+-++-|.|||+++.++.+..+- ......++.|||..|+|..+|++. ....+......+|+.|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~---------------e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tq 184 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYE---------------EKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQ 184 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccc---------------cccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 34556799999999998765542 234567899999999999999753 3566888999999999
Q ss_pred HHHHHHHHHhCC--CcccCCCCCCEEECCCCcEEEeecccceeccC----CCCCCCCCCCCCccccccccCCCCCCCchh
Q 036382 216 LSRGLSYLHSKK--IVHRDVKTENMLLDSQRTLKIADFGVARVEAQ----NPRDMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 216 i~~~L~yLH~~~--iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
|+.||.|||+.. |+|+++..+.|++..+|-+|++--........ .........+-++|.+||.-.....+-++|
T Consensus 185 Ilsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~d 264 (458)
T KOG1266|consen 185 ILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASD 264 (458)
T ss_pred HHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchh
Confidence 999999999874 99999999999999999999853222111000 001112234678899999877777788999
Q ss_pred HHHHHHHHHHHHhCCCC-CCCCC---hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 290 VYSFGICLWEIYCCDMP-YPDLS---FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 290 iwSlG~il~ell~g~~P-f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
||+||....+|.-+..- =...+ .++.+.... .++. .+--+.++.+|++..|..||++.+++-+
T Consensus 265 Iy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 265 IYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-IGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred hhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-eecc-------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 99999999999876543 22211 122221111 1110 1224568999999999999999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.8e-13 Score=117.75 Aligned_cols=144 Identities=15% Similarity=0.155 Sum_probs=99.8
Q ss_pred cccccccCceEEEEEEEC--------CceEEEEEeccCCCCccch-----------------HHHHHHHHHHHHHHHHHH
Q 036382 86 RNLIAQGTYGSVYRGTYD--------NQEVAVKLLDWGEDGMATT-----------------AETAALRSSFQQEVAVWQ 140 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~~l~ 140 (390)
...||.|-=+.||.|... +..+|||+.+.+...+... ...........+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999653 3799999996432211111 111122223348999999
Q ss_pred hcCC--CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHH-HHHhhccCCCCHHHHHHHHHHHH
Q 036382 141 KLDH--PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ-YLIRNRRKKLALKIVIQLALDLS 217 (390)
Q Consensus 141 ~l~h--pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~ 217 (390)
++.. -++.+.+++. .-++||||+.++.+.. .++ ...++......+..+++
T Consensus 82 rl~~~Gv~vP~pi~~~------------------------~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~ 134 (197)
T cd05146 82 RMQKAGIPCPEVVVLK------------------------KHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVL 134 (197)
T ss_pred HHHHcCCCCCeEEEec------------------------CCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHH
Confidence 8843 3455555431 1278999997654422 221 12355666778889999
Q ss_pred HHHHHH-HhCCCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 218 RGLSYL-HSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 218 ~~L~yL-H~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
.+|..| |+.||+|+||++.|||+. ++.+.|+|||.+-..
T Consensus 135 ~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 135 SMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999 899999999999999996 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-12 Score=128.16 Aligned_cols=224 Identities=14% Similarity=0.170 Sum_probs=151.5
Q ss_pred EECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCce
Q 036382 101 TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARAC 180 (390)
Q Consensus 101 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (390)
+.++.+|.|...++... .......+-+..|+.++||||++++..+..+. ..
T Consensus 34 k~~~~~vsVF~~~~~~~---------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--------------------~~ 84 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--------------------TL 84 (690)
T ss_pred eccCCceEEEEEeCCCc---------hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--------------------ce
Confidence 34678888888875432 12234556778899999999999998877544 44
Q ss_pred EEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCCEEECCCCcEEEeecccceeccC
Q 036382 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH-SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259 (390)
Q Consensus 181 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~ 259 (390)
|+|+|-+ -.|..++++ ++...+...+.||+.||.+|| ..+++|++|.-..|+|+..|.+||++|-+++....
T Consensus 85 ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 85 YLVTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred EEEeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 7899998 478888854 446778888999999999998 66899999999999999999999999998864433
Q ss_pred CCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC------CCCChhhHHHHHHHcCCCCCCCCCCc
Q 036382 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY------PDLSFADVSSAVVRQNLRPEIPRCCP 333 (390)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf------~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (390)
.........--..|..|+.+.... ...|.|.|||+++|++.|..+= .+..+.-.+....+.-.. .+..-|
T Consensus 158 ~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~--~~~~r~ 233 (690)
T KOG1243|consen 158 FNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGA--TELKRP 233 (690)
T ss_pred CCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhcc--cccccc
Confidence 221111122233456666543222 5679999999999999982221 111110111111000001 111112
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 334 SSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 334 ~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
. ...++..|...-+--|=.+-+++..|+.+.
T Consensus 234 n-~~~~~~~~~~~~gff~n~fvd~~~fLeel~ 264 (690)
T KOG1243|consen 234 N-KLRFILECRLLGGFFRNDFVDTLLFLEELR 264 (690)
T ss_pred c-hhhHHHHHHhccccccchHHHHHHHHHhcc
Confidence 3 567788888888888888888888888775
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.6e-13 Score=115.89 Aligned_cols=126 Identities=20% Similarity=0.236 Sum_probs=94.1
Q ss_pred ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc-eEEEEEecccccccCCc
Q 036382 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT-KFVGASVGTSNLKIPSK 165 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~~~ 165 (390)
+.++.|.++.||+++..+..|++|+...... ....+.+|+.+++.+.+.+++ +++....
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~---------- 63 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE----------LLINRENEAENSKLAAEAGIGPKLYYFDP---------- 63 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc----------cccCHHHHHHHHHHHHHhCCCCceEEEeC----------
Confidence 4688999999999999999999999753221 012356788999988655544 4443321
Q ss_pred ccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-----cccCCCCCCEEE
Q 036382 166 TASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI-----VHRDVKTENMLL 240 (390)
Q Consensus 166 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i-----iHrDlkp~NILl 240 (390)
...++||||++|.++...- . ....++.+++.+|..||+.++ +|+|++|.||++
T Consensus 64 ------------~~~~lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~ 121 (170)
T cd05151 64 ------------ETGVLITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL 121 (170)
T ss_pred ------------CCCeEEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE
Confidence 1236899999998876430 1 112456789999999999985 999999999999
Q ss_pred CCCCcEEEeecccce
Q 036382 241 DSQRTLKIADFGVAR 255 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~ 255 (390)
+ ++.++++||+.+.
T Consensus 122 ~-~~~~~liDf~~a~ 135 (170)
T cd05151 122 D-DGRLWLIDWEYAG 135 (170)
T ss_pred E-CCeEEEEeccccc
Confidence 8 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.3e-14 Score=137.31 Aligned_cols=246 Identities=22% Similarity=0.207 Sum_probs=174.5
Q ss_pred Cccccccccc--cCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEE
Q 036382 82 KLDMRNLIAQ--GTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGAS 154 (390)
Q Consensus 82 ~~~~~~~lg~--G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 154 (390)
.+.+.+.+|. |.+|.||.+.- ++..+|+|.-+.-..... ....=.+|+..-+++ .|+|.++.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-------~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-------DSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-------ccccccchhhcccccCccccccccCccc
Confidence 4666778999 99999997654 678899987431111000 011123566666667 689999977777
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHH----HHHHHHhCCCcc
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR----GLSYLHSKKIVH 230 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~iiH 230 (390)
.....+ ++-+|++ +.+|..+.... ...++...++.+..+... ||.++|+.+++|
T Consensus 188 e~~~~l--------------------fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~ 245 (524)
T KOG0601|consen 188 EGSGIL--------------------FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVH 245 (524)
T ss_pred ccCCcc--------------------eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccc
Confidence 655544 5567777 57888888542 234788889999999999 999999999999
Q ss_pred cCCCCCCEEECCC-CcEEEeecccceeccCCCCCCCC-----CCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 036382 231 RDVKTENMLLDSQ-RTLKIADFGVARVEAQNPRDMTG-----ETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 231 rDlkp~NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
.|+||.||+...+ ...+++|||+............. ..+...|++||..++. ++...|+|++|.++.+..++.
T Consensus 246 ~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 246 DDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred cccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhc
Confidence 9999999999999 89999999998765544322222 2577889999998754 788999999999999999876
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
.+....-+ .....+...-+..++-..-+.++...+.+++..+|..|++++.+.
T Consensus 325 ~~~~~g~~-~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 325 HLPSVGKN-SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccccCCCC-CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 55432200 000011111123334444567888899999999999999977554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5e-14 Score=144.93 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=181.9
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+....+.+.+.+.+-.|.++.++.++- .|...+.|+......-... ..+....+-.+.-.-.+|-++...-.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~------~~~s~r~~s~~~i~p~~P~v~~~~~s 872 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN------DYESIRSKSNILITPRSPAVVRSFPS 872 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc------cccccCCccCccccCCCCceecccCC
Confidence 667788999999999999999997754 3445555554321110000 00111112222212233444433322
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+....+.+++++|+.+++|...|.+ ....+++....+...+..+++|||+..+.|||+
T Consensus 873 --------------------~~~rsP~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~ 930 (1205)
T KOG0606|consen 873 --------------------FPCRSPLPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDL 930 (1205)
T ss_pred --------------------CCCCCCcchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccc
Confidence 2245566889999999999998843 345777778888889999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccC---------------------C----------CCCCCCCCCCCccccccccCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQ---------------------N----------PRDMTGETGTLGYMAPEVLQGK 282 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~---------------------~----------~~~~~~~~gt~~y~aPE~~~~~ 282 (390)
+|.|+|+..+++.+++|||......- . ........+|+.|.+||...+.
T Consensus 931 ~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~ 1010 (1205)
T KOG0606|consen 931 KPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR 1010 (1205)
T ss_pred cccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc
Confidence 99999999999999999984321000 0 0011223589999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 036382 283 PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR-PEIPRCCPSSLANIMRKCWDANAEKRPEMG 355 (390)
Q Consensus 283 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 355 (390)
.....+|+|++|++++|.++|..||...++..+...+...... +..+...+++..+++...+..+|.+|..+.
T Consensus 1011 ~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1011 RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999999999999999988888776554432 234566789999999999999999997765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.7e-11 Score=104.14 Aligned_cols=139 Identities=24% Similarity=0.288 Sum_probs=99.6
Q ss_pred ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcc
Q 036382 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
..+++|+-+.+|.+.+-|.++++|.=... .--....+..-....-.+|++++.++.--.|.-.+=++.+..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K-~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPK-RYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-------- 72 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCc-ccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--------
Confidence 36789999999999888878777753221 111122333344566678999999885444443333333332
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcE
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~ 246 (390)
...|+|||++|..|.+++... ...++..+-.-+.-||..||+|+||.++||++..++ +
T Consensus 73 ------------~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i 130 (204)
T COG3642 73 ------------NGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-I 130 (204)
T ss_pred ------------CCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-E
Confidence 235799999999999998543 145666777788899999999999999999996554 9
Q ss_pred EEeeccccee
Q 036382 247 KIADFGVARV 256 (390)
Q Consensus 247 kL~DfG~a~~ 256 (390)
.++|||++..
T Consensus 131 ~~IDfGLg~~ 140 (204)
T COG3642 131 YFIDFGLGEF 140 (204)
T ss_pred EEEECCcccc
Confidence 9999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-11 Score=102.79 Aligned_cols=151 Identities=22% Similarity=0.286 Sum_probs=109.5
Q ss_pred ccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCC
Q 036382 85 MRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 85 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
...++-+|+-+.|+++.+.|+...||.=....-. ....+..-.+..-.+|++.+.++.--.|.-..-++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YR-HP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~------ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYR-HPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY------ 83 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeeccccccc-chHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC------
Confidence 4567889999999999999999888853211111 122334444566788999999885444443333333322
Q ss_pred cccccCCCCCCCCCceEEEEecCCC-CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPG-GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~ 243 (390)
.-+++|||++| .++.+++...............++..|-+.+.-||..+|||+||..+||++..+
T Consensus 84 --------------~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~ 149 (229)
T KOG3087|consen 84 --------------GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSD 149 (229)
T ss_pred --------------CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecC
Confidence 12689999977 478888876655555555558889999999999999999999999999999766
Q ss_pred C---cEEEeeccccee
Q 036382 244 R---TLKIADFGVARV 256 (390)
Q Consensus 244 ~---~~kL~DfG~a~~ 256 (390)
+ .+-++|||++..
T Consensus 150 ~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 150 GNQITPILIDFGLSSV 165 (229)
T ss_pred CCcCceEEEeecchhc
Confidence 5 347999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.9e-12 Score=122.35 Aligned_cols=250 Identities=20% Similarity=0.194 Sum_probs=172.3
Q ss_pred cccCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGAS 154 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 154 (390)
...+|..+..||.|.|+.|+.... .+..+++|.+..+-... .. ...-..|+.+...+ .|.++++.+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~---~~----di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF---AS----DIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch---Hh----hhcchhhhhHhhHhhcccccCCCCCCc
Confidence 456888999999999999997643 46788998775332111 11 11123566666666 677777766554
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
... ...|+=.||+.++++...+ .-...+++...+.+..|++.++.++|+..++|+|++
T Consensus 336 ~~~--------------------r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ 393 (524)
T KOG0601|consen 336 SQL--------------------RQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK 393 (524)
T ss_pred ccc--------------------ccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhccccc
Confidence 432 3335678899998877655 223458888899999999999999999999999999
Q ss_pred CCCEEECCC-CcEEEeecccceeccCCCCCCCCCC-CCCcc-ccccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCC
Q 036382 235 TENMLLDSQ-RTLKIADFGVARVEAQNPRDMTGET-GTLGY-MAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-PYPDL 310 (390)
Q Consensus 235 p~NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~-gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~-Pf~~~ 310 (390)
|+||++..+ +..+++|||.+...... ..... .+..| .++.......+..+.|++|||..+.+.+++.. ++...
T Consensus 394 psni~i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 394 PSNILISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred ccceeeccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 999999886 78899999988632111 11122 23333 35556667788899999999999999988763 33222
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
... .+..+..+ .....+..+..+...+...++..||.+.++....+-...
T Consensus 471 ~~~-----~i~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 471 QSL-----TIRSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cce-----eeeccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 111 11222222 223334788889999999999999999988766655443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.2e-10 Score=99.87 Aligned_cols=133 Identities=26% Similarity=0.315 Sum_probs=84.1
Q ss_pred EEEEEEE-CCceEEEEEeccCCCCcc-----------------chHHHHHHHHHHHHHHHHHHhcCCC--ccceEEEEEe
Q 036382 96 SVYRGTY-DNQEVAVKLLDWGEDGMA-----------------TTAETAALRSSFQQEVAVWQKLDHP--NVTKFVGASV 155 (390)
Q Consensus 96 ~Vy~~~~-~~~~vavK~~~~~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~ 155 (390)
.||.|.. +|..+|||+.+.+...+. .............+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899987 688999999964422211 1122333456678899999999655 455555442
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCC--CCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLP--GGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSY-LHSKKIVHRD 232 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~iiHrD 232 (390)
.-++||||+. |..+..+.... ++......++.+++..+.. +|+.||+|+|
T Consensus 80 -----------------------~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGD 132 (188)
T PF01163_consen 80 -----------------------RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGD 132 (188)
T ss_dssp -----------------------TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS
T ss_pred -----------------------CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecC
Confidence 1268999998 65565543211 2234456677788875555 5799999999
Q ss_pred CCCCCEEECCCCcEEEeecccceec
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
|.+.|||++.+ .+.|+|||.+...
T Consensus 133 Ls~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 133 LSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp -STTSEEEETT-CEEE--GTTEEET
T ss_pred CChhhEEeecc-eEEEEecCcceec
Confidence 99999999877 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-09 Score=106.14 Aligned_cols=216 Identities=19% Similarity=0.284 Sum_probs=152.8
Q ss_pred eEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCC
Q 036382 95 GSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGN 172 (390)
Q Consensus 95 g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~ 172 (390)
.+-|++.. +|..|++|.++....... ...-.-+++|+++.|+|+|+|..+|....
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---------nk~t~lve~wkkl~h~NvV~frevf~t~t-------------- 346 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST---------NKDTSLVEAWKKLCHTNVVPFREVFLTYT-------------- 346 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc---------ccchHHHHHHHHhccCceeehhhhhhhhc--------------
Confidence 56688855 899999999953222111 11124578999999999999999987332
Q ss_pred CCCCCCceEEEEecCCC-CCHHHHHHhh-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 173 AAVPARACCVVVEYLPG-GNLKQYLIRN-------------RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 173 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
......++|++|.++ ++|.++.... .+.+.++..+|.++.|++.||.++|+.|+.-+-|.|.+|
T Consensus 347 --F~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI 424 (655)
T KOG3741|consen 347 --FGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI 424 (655)
T ss_pred --cCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence 234556999999886 4777765321 134578999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP-YPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P-f~~~~~~~~~~ 317 (390)
|++.+.+++|+..|........+ .+| +. --.+-|.=.||.+++.|.||..- +......+...
T Consensus 425 lv~G~~RIriS~C~i~Dvl~~d~------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~ 487 (655)
T KOG3741|consen 425 LVTGKMRIRISGCGIMDVLQEDP------------TEP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL 487 (655)
T ss_pred EeeCcceEEEecccceeeecCCC------------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHH
Confidence 99999999999888776554332 011 11 12356888999999999998632 21111111111
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
. .+....+.++++++......++++ -++.+++..+
T Consensus 488 ~--------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 T--------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred H--------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 1 123345788999999999999887 6777777543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-09 Score=101.26 Aligned_cols=146 Identities=17% Similarity=0.114 Sum_probs=97.4
Q ss_pred eEEEEEEECCceEEEEEeccCCCC--ccchHHHHHHHHHHHHHHHHHHhcCCCcc--ceEEEEEecccccccCCcccccC
Q 036382 95 GSVYRGTYDNQEVAVKLLDWGEDG--MATTAETAALRSSFQQEVAVWQKLDHPNV--TKFVGASVGTSNLKIPSKTASVD 170 (390)
Q Consensus 95 g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~~~~~~~~~~~~~ 170 (390)
..|++....|+.|.||........ .........-...+.+|.+.+..|..-+| ...+++......
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~----------- 104 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN----------- 104 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC-----------
Confidence 346678888999999976421100 00000000001136788888887743333 334444322110
Q ss_pred CCCCCCCCceEEEEecCCCC-CHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC-------
Q 036382 171 GNAAVPARACCVVVEYLPGG-NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS------- 242 (390)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~------- 242 (390)
+.....++|||++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.
T Consensus 105 ----~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 105 ----PATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ----CccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCC
Confidence 0123458999999886 8999985432344667778899999999999999999999999999999975
Q ss_pred CCcEEEeecccce
Q 036382 243 QRTLKIADFGVAR 255 (390)
Q Consensus 243 ~~~~kL~DfG~a~ 255 (390)
+..+.|+||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4689999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-09 Score=103.30 Aligned_cols=189 Identities=17% Similarity=0.301 Sum_probs=137.2
Q ss_pred eEEEEecCCCC-CHHHHHH----hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccc
Q 036382 180 CCVVVEYLPGG-NLKQYLI----RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254 (390)
Q Consensus 180 ~~lv~e~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a 254 (390)
..++|+.+.+- ...+++. +..-...+|+.+.+.++.++.+..-||..|.+-+|+.++|+|+++++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 56788877654 2444442 122345789999999999999999999999999999999999999999999875432
Q ss_pred eeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-------hhh-HH----
Q 036382 255 RVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCC-DMPYPDLS-------FAD-VS---- 316 (390)
Q Consensus 255 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~-------~~~-~~---- 316 (390)
... ..+......+|...|.+||... +..-+...|.|.||+++++++.| ++||.+.. +-| .+
T Consensus 165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 222 3445566778999999999875 33456789999999999999986 99997642 111 11
Q ss_pred ---HHHHHcCCCCC---CC-CCCcHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHhHhcCC
Q 036382 317 ---SAVVRQNLRPE---IP-RCCPSSLANIMRKCWDA--NAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 317 ---~~~~~~~~~~~---~~-~~~~~~l~~li~~cl~~--dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
......++++. .| ..+|+++..+..+|+.. ++.-|||++..+..|..+..+..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00011222221 11 24678999999999964 36689999999999988876443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=3e-10 Score=101.81 Aligned_cols=142 Identities=23% Similarity=0.248 Sum_probs=102.2
Q ss_pred ccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCC--ccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP--NVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~ 163 (390)
+.|+.|.++.||++...+ ..++||+....... .....+..|.++++.+.+. ++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~----- 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS----- 70 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-----
Confidence 468999999999998765 89999987533210 1124567899999999653 4566666643211
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS------------------ 225 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~------------------ 225 (390)
..+..++||||++|.+|.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 71 ------------~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 71 ------------VLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred ------------ccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 11345899999999888765421 246667777777777777777773
Q ss_pred --------------------------------------CCCcccCCCCCCEEECC--CCcEEEeeccccee
Q 036382 226 --------------------------------------KKIVHRDVKTENMLLDS--QRTLKIADFGVARV 256 (390)
Q Consensus 226 --------------------------------------~~iiHrDlkp~NILl~~--~~~~kL~DfG~a~~ 256 (390)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23599999999999998 67789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.2e-10 Score=99.42 Aligned_cols=141 Identities=21% Similarity=0.254 Sum_probs=102.3
Q ss_pred cccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHH-------------HHHHHHHHHHHHHHHHhcCCC--cc
Q 036382 84 DMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAE-------------TAALRSSFQQEVAVWQKLDHP--NV 147 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~hp--nI 147 (390)
.++..||-|-=|.||.|.. .|.++|||.-+.+...+..... ....+....+|.++|..|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999988 5899999988755433322211 122344567899999998544 44
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
.+.+ .++.-++||||++|-.|...- ++....-.++..|++-+.-+-..|
T Consensus 174 P~P~------------------------~~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 174 PKPI------------------------AWNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred CCcc------------------------ccccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC
Confidence 4444 445568999999997765431 234445556666666666666899
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccce
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
|||+|+++-||+++++|.+.++||-.+.
T Consensus 223 iVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 223 IVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred ccccCCchheEEEecCCCEEEEeCcccc
Confidence 9999999999999999999999997664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-08 Score=99.67 Aligned_cols=153 Identities=18% Similarity=0.217 Sum_probs=94.3
Q ss_pred ccccccCceEEEEEEEC-CceEEEEEeccCCCC-------------------------ccchHHHHHHHHHH------HH
Q 036382 87 NLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDG-------------------------MATTAETAALRSSF------QQ 134 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-------------------------~~~~~~~~~~~~~~------~~ 134 (390)
..|+.++-|+||+|+.. |+.||||+.+++-.. ...........+.+ .+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999995 999999999755211 11111111222222 23
Q ss_pred HHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHH
Q 036382 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLAL 214 (390)
Q Consensus 135 E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 214 (390)
|+..+.++ -..+.++..+++|.-.-.. .+.-.++|||+.|-.+.+...-+. ..++.+.+.....
T Consensus 211 EA~n~~~~--------~~nf~~~~~v~VP~V~we~-------t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~ 274 (517)
T COG0661 211 EAANAERF--------RENFKDDPDVYVPKVYWEY-------TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLV 274 (517)
T ss_pred HHHHHHHH--------HHHcCCCCCeEeceeehhc-------cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHH
Confidence 33333333 1122233333333221111 133479999999999988853332 3466444333333
Q ss_pred HHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 215 DLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 215 ~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
+ .-+..+=..|++|.|.+|-||+++.+|.+.+.|||+....
T Consensus 275 ~--~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 275 R--AFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred H--HHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 2 2245555689999999999999999999999999998644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.3e-08 Score=87.96 Aligned_cols=148 Identities=14% Similarity=0.107 Sum_probs=105.1
Q ss_pred ccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCC--ccceEEEEEecccccccCCcc
Q 036382 89 IAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP--NVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~~~~ 166 (390)
-|+||-+.|++....|+.+-||.....-... -..+.-...|.+|+..+.+|..- .+.+.+..-...
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s---~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k--------- 93 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHS---VRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVK--------- 93 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCccccc---ccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeec---------
Confidence 4679999999999888888898763110000 00012346788999999988432 233443221111
Q ss_pred cccCCCCCCCCCceEEEEecCCC-CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCc
Q 036382 167 ASVDGNAAVPARACCVVVEYLPG-GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~ 245 (390)
.+..-..+||+|-+.+ -+|.+++....-.+.+......++.+|+..+.-||+.|+.|+|+.+.|||++.++.
T Consensus 94 -------~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~ 166 (216)
T PRK09902 94 -------IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGK 166 (216)
T ss_pred -------cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCC
Confidence 1123345789997764 48999886544445688888899999999999999999999999999999987777
Q ss_pred --EEEeecccce
Q 036382 246 --LKIADFGVAR 255 (390)
Q Consensus 246 --~kL~DfG~a~ 255 (390)
++++||--++
T Consensus 167 ~~v~lIDlEk~r 178 (216)
T PRK09902 167 AEAGFLDLEKSR 178 (216)
T ss_pred eeEEEEEhhccc
Confidence 9999997665
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.2e-10 Score=111.14 Aligned_cols=144 Identities=22% Similarity=0.336 Sum_probs=103.9
Q ss_pred HHHHHHHHHHh-CCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC------C---CCCCCCCCccccccccCCCCC
Q 036382 215 DLSRGLSYLHS-KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR------D---MTGETGTLGYMAPEVLQGKPY 284 (390)
Q Consensus 215 ~i~~~L~yLH~-~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~------~---~~~~~gt~~y~aPE~~~~~~~ 284 (390)
+++.||.|+|. .++||++|.|++|.++.++.+||+.|+++-....... + .........|.|||.+.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 34489999996 4899999999999999999999999998753322111 0 011124578999999999888
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHH-cC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 285 NRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVR-QN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 285 ~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
+.++|+||+|+++|.+.. |+.-+.............. .+ -.......+|+++++=+.+++..++..||++..+.
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 999999999999999995 4444544322222211111 11 11124577899999999999999999999766554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.9e-08 Score=88.41 Aligned_cols=109 Identities=23% Similarity=0.300 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhcCCCc--cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCC-CHHHHHHhhccCCCCH
Q 036382 130 SSFQQEVAVWQKLDHPN--VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG-NLKQYLIRNRRKKLAL 206 (390)
Q Consensus 130 ~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~ 206 (390)
....+|...+..|..-+ ..+.+++...... .....++|+|++++. +|.+++.... ..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~----------------~~~~s~lite~l~~~~~L~~~~~~~~--~~~~ 117 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKG----------------GGYRSYLITEALPGAQDLRDLLQQWE--QLDP 117 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC----------------CceeEEEEEEeCCCcccHHHHHHhhc--ccch
Confidence 45667888877774333 3455555443211 113458999999884 7999986532 2667
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC---cEEEeeccccee
Q 036382 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARV 256 (390)
Q Consensus 207 ~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~---~~kL~DfG~a~~ 256 (390)
.....++.+++..+.-||..||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 118 ~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 77889999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=9.1e-08 Score=84.56 Aligned_cols=144 Identities=15% Similarity=0.149 Sum_probs=93.8
Q ss_pred cCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHH-----HHHHHHHHHHHhc---CCCccceEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALR-----SSFQQEVAVWQKL---DHPNVTKFVG 152 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-----~~~~~E~~~l~~l---~hpnIv~~~~ 152 (390)
.+|...+++-......|.+-..+|+.+++|..+.... ....... ....+.+..+..+ ....+..++.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~-----r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR-----RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh-----hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4677888888888888999899999999998863221 1111111 1123334433333 2333344444
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
+.......+ ....+++|||++|..|.++.. +++ .++..+.+++..||+.|+.|+|
T Consensus 106 ~~ekk~~~~---------------~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD 160 (229)
T PF06176_consen 106 AAEKKIFRY---------------TSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGD 160 (229)
T ss_pred eeeeeeccc---------------eeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCC
Confidence 433222111 233468999999988877541 333 2445677889999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccce
Q 036382 233 VKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.+|.|++++.+ .++++||+..+
T Consensus 161 ~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 161 PHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CCcCcEEEECC-cEEEEECcccc
Confidence 99999999754 59999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.6e-07 Score=77.87 Aligned_cols=150 Identities=23% Similarity=0.377 Sum_probs=101.6
Q ss_pred cCccccccccccCc-eEEEEEEECCceEEEEEe---ccCCCCcc---------chHHHHHHHHHHHHHHHHHHhc---CC
Q 036382 81 SKLDMRNLIAQGTY-GSVYRGTYDNQEVAVKLL---DWGEDGMA---------TTAETAALRSSFQQEVAVWQKL---DH 144 (390)
Q Consensus 81 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~vavK~~---~~~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l---~h 144 (390)
.++++++.||.|+- |.||+++..|+.+|+|++ ........ ...........|..|-+...+| .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 999999999999999993 22222111 0111123445678888876665 45
Q ss_pred Ccc--ceEEEEEeccc--ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Q 036382 145 PNV--TKFVGASVGTS--NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGL 220 (390)
Q Consensus 145 pnI--v~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L 220 (390)
.++ |+++|+..-.. ....... +.........+.||.||.+... .++... +.+|.+-|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~----~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl 177 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQ----RGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDL 177 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhc----ccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHH
Confidence 666 99999986442 1110000 1222334456789999987654 133333 45666788
Q ss_pred HHHHhCCCcccCCCCCCEEECCCCcEEEeecccc
Q 036382 221 SYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254 (390)
Q Consensus 221 ~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a 254 (390)
..+|+.||+-+|+++.|.. .-+|+|||.+
T Consensus 178 ~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 8999999999999999987 3378999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.3e-07 Score=79.12 Aligned_cols=142 Identities=20% Similarity=0.191 Sum_probs=91.1
Q ss_pred cccccCceEEEEEEE-CCceEEEEEeccCCCCccch---------------HHHHHHHHHHHHHHHHHHhcC--CCccce
Q 036382 88 LIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATT---------------AETAALRSSFQQEVAVWQKLD--HPNVTK 149 (390)
Q Consensus 88 ~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l~--hpnIv~ 149 (390)
.|+.|.-+.||+|.. ++..+|||+++.....+... ........-..+|+.-|+++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 677888899999875 68899999997432221110 001111122345666666662 223334
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCH-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL-KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KK 227 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~ 227 (390)
.+++. .-.+||||+....+ .=.| +..++.......+..++++.+.-|-. .+
T Consensus 135 Pi~~~------------------------~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 135 PIAFR------------------------NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred ceeec------------------------CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 44332 23689999965310 0001 11223344677788888888888876 89
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
+||+||+.-|||+. ++.+.|+|||.|...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999998 899999999988643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-06 Score=73.34 Aligned_cols=130 Identities=25% Similarity=0.299 Sum_probs=94.9
Q ss_pred CccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce-EEEEEeccccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK-FVGASVGTSNL 160 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~ 160 (390)
..+..+.|++|++|.||+|.+.|..+|+|+-+.... +..+..|+++|..+.-.++.+ ++.+-.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-----------r~~l~kEakiLeil~g~~~~p~vy~yg~----- 86 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-----------RRNLEKEAKILEILAGEGVTPEVYFYGE----- 86 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-----------hhhHHHHHHHHHHhhhcCCCceEEEech-----
Confidence 346677899999999999999999999999863322 466788999999997766653 343321
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC-C-CE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT-E-NM 238 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp-~-NI 238 (390)
-++.|||+.|-+|.+.-.. .+.++ ...+++.---|-..||-|..|.- . ||
T Consensus 87 -------------------~~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~v 138 (201)
T COG2112 87 -------------------DFIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNV 138 (201)
T ss_pred -------------------hhhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeE
Confidence 1467999999898876521 12333 34555666667788999999874 4 55
Q ss_pred EECCCCcEEEeeccccee
Q 036382 239 LLDSQRTLKIADFGVARV 256 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~ 256 (390)
++ .++.+.|+||..|+.
T Consensus 139 lv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 139 LV-NDRDVYIIDFDSATF 155 (201)
T ss_pred Ee-cCCcEEEEEccchhh
Confidence 55 556999999998873
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.1e-07 Score=89.57 Aligned_cols=77 Identities=14% Similarity=0.282 Sum_probs=52.9
Q ss_pred ceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC----CCcEEEeecccc
Q 036382 179 ACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS----QRTLKIADFGVA 254 (390)
Q Consensus 179 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~----~~~~kL~DfG~a 254 (390)
...++|||++|..+.|.-.-. ...++...+..-+.++. ++.+=..|++|.|-+|-||+++. ++.+.+.|||+.
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~ 352 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY 352 (538)
T ss_pred ceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence 447999999998776653212 22355554444333322 34444678999999999999984 678999999998
Q ss_pred eecc
Q 036382 255 RVEA 258 (390)
Q Consensus 255 ~~~~ 258 (390)
....
T Consensus 353 ~~is 356 (538)
T KOG1235|consen 353 AVIS 356 (538)
T ss_pred cccc
Confidence 6543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.8e-06 Score=75.84 Aligned_cols=135 Identities=12% Similarity=0.187 Sum_probs=77.2
Q ss_pred ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc--ceEEEEEecccccccCC
Q 036382 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV--TKFVGASVGTSNLKIPS 164 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~~~~~~~ 164 (390)
..||.|..+.||+. .+..+++|+..... . .....+|.++++.+..-++ .+.+++..+.
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~-------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~------- 66 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----D-------KETIKREFDASRKVFSLGIPTPHPFDLVEDG------- 66 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----C-------HHHHHHHHHHHHHHHHcCCCCCceEEEEecC-------
Confidence 47899999999984 35678889876321 0 1234678999888753333 4555554322
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCC-HHHHH--------------Hh-----hc--cCCCCHHHH-HHHHH-------
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGN-LKQYL--------------IR-----NR--RKKLALKIV-IQLAL------- 214 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l--------------~~-----~~--~~~l~~~~~-~~i~~------- 214 (390)
+...+|||+++|.+ +...+ .+ +. ....+.... ..+..
T Consensus 67 -------------~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~ 133 (226)
T TIGR02172 67 -------------GRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDF 133 (226)
T ss_pred -------------CeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccC
Confidence 23467999999863 21111 00 00 001111110 01100
Q ss_pred ---HHHH-HHHHHH----hCCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 215 ---DLSR-GLSYLH----SKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 215 ---~i~~-~L~yLH----~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.+.. ...+|. ...++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 134 ~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 134 VPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 0011 122222 12478999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.5e-06 Score=74.47 Aligned_cols=143 Identities=22% Similarity=0.262 Sum_probs=81.9
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCC--ccceEEEEEecccccccC
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP--NVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~~~ 163 (390)
++.++.|..+.||+....+..+++|+... . .....+.+|..+++.+... .+.+++........
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~-------~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~---- 66 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRP-------P----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF---- 66 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESS-------H----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE----
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCC-------C----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc----
Confidence 35789999999999999888999999751 1 2235566888888888433 34566654432221
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHH----------------HHHh---h--ccCCCCHHH---------HHHH-
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQ----------------YLIR---N--RRKKLALKI---------VIQL- 212 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~----------------~l~~---~--~~~~l~~~~---------~~~i- 212 (390)
....+++|++++|.++.. .+.. . ....+.... ....
T Consensus 67 -------------~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (239)
T PF01636_consen 67 -------------NGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWT 133 (239)
T ss_dssp -------------TSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHH
T ss_pred -------------cccceEEEEEeccccccccccccccccccccchhhhhhccccccccccccccccccccccccccccc
Confidence 223589999999988877 1111 0 000011000 0000
Q ss_pred -----------HHHHHH-HHHHHH-------hCCCcccCCCCCCEEEC-CCCcEEEeeccccee
Q 036382 213 -----------ALDLSR-GLSYLH-------SKKIVHRDVKTENMLLD-SQRTLKIADFGVARV 256 (390)
Q Consensus 213 -----------~~~i~~-~L~yLH-------~~~iiHrDlkp~NILl~-~~~~~kL~DfG~a~~ 256 (390)
...+.. .+..++ ...++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 134 ARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 011111 233333 23599999999999999 667778999998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.2e-05 Score=71.65 Aligned_cols=135 Identities=16% Similarity=0.176 Sum_probs=79.4
Q ss_pred ccccCc-eEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecccccccCCcc
Q 036382 89 IAQGTY-GSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPSKT 166 (390)
Q Consensus 89 lg~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~ 166 (390)
|..|.+ +.||+....+..+.||+..... ...+.+|+++++.+. +--+.+++++....
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--------- 64 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP------------TYELEREAERLRWLAGKLPVPEVIDYGSDD--------- 64 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc------------ccchHHHHHHHHHHHhcCCCCeEEEEEecC---------
Confidence 444555 8899998777889999875221 123567888888873 33344666654321
Q ss_pred cccCCCCCCCCCceEEEEecCCCCCHHHHHH----------------h-hc----cCCCCHH--HHHHHHH---------
Q 036382 167 ASVDGNAAVPARACCVVVEYLPGGNLKQYLI----------------R-NR----RKKLALK--IVIQLAL--------- 214 (390)
Q Consensus 167 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~----------------~-~~----~~~l~~~--~~~~i~~--------- 214 (390)
+..++|||+++|.+|..... + +. ...+... .......
T Consensus 65 -----------~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (244)
T cd05150 65 -----------GRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVD 133 (244)
T ss_pred -----------CccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcC
Confidence 23478999999987764320 0 00 0011100 0000000
Q ss_pred -----------HHHHHHHHHH-------hCCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 215 -----------DLSRGLSYLH-------SKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 215 -----------~i~~~L~yLH-------~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.+...+..|- ...++|+|+.|.|||++.++...|+||+.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 134 EDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 0111122221 1248999999999999998888899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=8.4e-07 Score=88.35 Aligned_cols=187 Identities=18% Similarity=0.155 Sum_probs=129.4
Q ss_pred CccccccccccCceEEEEEEECCc-eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc-cceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN-VTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~ 159 (390)
.+.+.+-+++|+++.+++.+.+.+ ....+.+.. . ....-++++|.+++||| .+..++-+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~-------~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~---- 304 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-------T-------LSRRLAIELLDKVNNPNPVVRYLEDYD---- 304 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeecc-------c-------hhhHHHHHHHHHccCCCCcccccccCC----
Confidence 356667889999999999987543 223554421 1 22345889999999999 443333332
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCC-CHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGG-NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.+...+++++++.++ +-..... -..-.+.+-+...+.+.-+++++|||+.-=+|+| ||
T Consensus 305 ----------------~E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~ 363 (829)
T KOG0576|consen 305 ----------------GEDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NI 363 (829)
T ss_pred ----------------cccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cc
Confidence 233447799999877 2211110 0111244455666777778899999998778998 77
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
+..+ +..+.+||+.+....... ......+|+.++|||+.....+....|.|++|.-..+|--|.+|-..
T Consensus 364 l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 364 LGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 7744 788999999876443322 34456799999999999999999999999999888888777777533
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.2e-05 Score=65.46 Aligned_cols=100 Identities=23% Similarity=0.224 Sum_probs=78.4
Q ss_pred HHHHHHHHhcCC-CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh-hccCCCCHHHHH
Q 036382 133 QQEVAVWQKLDH-PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR-NRRKKLALKIVI 210 (390)
Q Consensus 133 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~ 210 (390)
.+|.-+++.+++ +++.+++|+|-. +++.||...+++...-.. ..-...+|..+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------------------------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~ 62 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------------------------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRA 62 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------------------------EEEEEeecCccccccccccccccccCHHHHH
Confidence 368888999966 699999999842 579999987765421000 011236899999
Q ss_pred HHHHHHHHHHHHHHh---CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 211 QLALDLSRGLSYLHS---KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~---~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.|+.++++.+.+|+. ..+.-.|++|+|+-+++++.+|++|...+..
T Consensus 63 ~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 63 KIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred HHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 999999999999997 3466689999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.3e-05 Score=82.88 Aligned_cols=81 Identities=17% Similarity=0.188 Sum_probs=54.1
Q ss_pred cccccccCceEEEEEEECC----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCcc--ceEEEEEeccc
Q 036382 86 RNLIAQGTYGSVYRGTYDN----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNV--TKFVGASVGTS 158 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~~ 158 (390)
...++.|.++.+|+....+ ..+++|+...+... . ....+.+|+++|+.+. |+++ .+++.++.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--Q------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--c------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 3567999999999987654 46778876432110 0 1235678999999995 6665 67777765432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gs 191 (390)
..+..|+||||++|..
T Consensus 115 -----------------v~G~~flVME~v~G~~ 130 (822)
T PLN02876 115 -----------------VIGTAFYIMEYLEGRI 130 (822)
T ss_pred -----------------cCCCceEEEEecCCcc
Confidence 1234589999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.6e-05 Score=82.78 Aligned_cols=202 Identities=19% Similarity=0.225 Sum_probs=141.0
Q ss_pred HHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHH
Q 036382 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIV 209 (390)
Q Consensus 130 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~ 209 (390)
.....|...+.++.|+|++..+.+-....... -...+..+++...++...+.. -...+...+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g----------------~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~ 288 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRG----------------IVLDVLQEICSKVELRSLLQS--VGSIPLETL 288 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcch----------------HHHHHHHhhcCccchHHHHhh--ccccCHHHH
Confidence 33446777888999999999998876443221 122356678888888888743 346888999
Q ss_pred HHHHHHHHHHHHHHHhCCCcccCCCCC---CEEECCCCcEEEe--ecccceeccCCCCCCCCCCCCCccccccccCCCCC
Q 036382 210 IQLALDLSRGLSYLHSKKIVHRDVKTE---NMLLDSQRTLKIA--DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY 284 (390)
Q Consensus 210 ~~i~~~i~~~L~yLH~~~iiHrDlkp~---NILl~~~~~~kL~--DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 284 (390)
+.+..++.+||.|+|+....|.-|... +..++..+...++ ||+.+........ ......+..+.+||......+
T Consensus 289 r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~ 367 (1351)
T KOG1035|consen 289 RILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTA 367 (1351)
T ss_pred HHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccc
Confidence 999999999999999997777766666 5555666777776 8887764433222 222345567788888877666
Q ss_pred CCc--hhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 285 NRR--CDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 285 ~~~--~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
+.+ .|+|.+|..+..+..|..+-.. ......+ .+..+...+.+...+|+..++++|+.+.+++...
T Consensus 368 ~~~r~~dL~~lgll~~~~~~~~~i~~~---~~~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 368 KKSRLTDLWCLGLLLLQLSQGEDISEK---SAVPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhHHHHHHHHHhhhhhcCccccc---ccchhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 554 7999999999999887644211 0111111 1222233788999999999999999999988654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=9.7e-06 Score=75.21 Aligned_cols=141 Identities=21% Similarity=0.233 Sum_probs=98.1
Q ss_pred ccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHH-------------HHHHHHHHHHHHHHhcC-CCc-
Q 036382 83 LDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETA-------------ALRSSFQQEVAVWQKLD-HPN- 146 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~-hpn- 146 (390)
+.+++.||-|.-+-||.+-+ .|++.++|+-+.+...+....... ..+-...+|+..|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56778899999999999877 589999998765543333222211 12233457888888883 322
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
+.+.+ ....-|+|||++.+-+|...- ...+. ..+...+..-+.-|-.+
T Consensus 174 VPkpi------------------------D~~RH~Vvmelv~g~Pl~~v~-----~v~d~---~~ly~~lm~~Iv~la~~ 221 (465)
T KOG2268|consen 174 VPKPI------------------------DHNRHCVVMELVDGYPLRQVR-----HVEDP---PTLYDDLMGLIVRLANH 221 (465)
T ss_pred CCCcc------------------------cccceeeHHHhhcccceeeee-----ecCCh---HHHHHHHHHHHHHHHHc
Confidence 22223 344558999999998886542 11222 23445555667778899
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
|+||+|..--||++++++.++++||-...
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhh
Confidence 99999999999999999999999998653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=7.2e-05 Score=68.85 Aligned_cols=134 Identities=20% Similarity=0.191 Sum_probs=77.0
Q ss_pred ccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc-eEEEEEecccccccCCccc
Q 036382 89 IAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT-KFVGASVGTSNLKIPSKTA 167 (390)
Q Consensus 89 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~~~~~~~ 167 (390)
+..|-.+.+|+...++..+++|+......... -...+|.++++.+...++. +++....
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~i~~~~------------ 62 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG---------VDRQREYQILQALSALGLAPKPILVNE------------ 62 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc---------CcHHHHHHHHHHHHhcCCCCceEEEeC------------
Confidence 55688889999988888999997642211110 1235788888888543332 3333221
Q ss_pred ccCCCCCCCCCceEEEEecCCCCCHHH--------------HHHhhc-----cCCCCHH-HHHHHHHHH---------HH
Q 036382 168 SVDGNAAVPARACCVVVEYLPGGNLKQ--------------YLIRNR-----RKKLALK-IVIQLALDL---------SR 218 (390)
Q Consensus 168 ~~~~~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-----~~~l~~~-~~~~i~~~i---------~~ 218 (390)
-++||||++|..+.. .+.+-. ..+++.. .+..+..++ ..
T Consensus 63 ------------~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (256)
T TIGR02721 63 ------------HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLR 130 (256)
T ss_pred ------------CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHH
Confidence 157999998866532 111101 1112211 112221111 11
Q ss_pred HHHHHHh--------CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 219 GLSYLHS--------KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 219 ~L~yLH~--------~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.+..+-. ..++|+|+.|.||+++.++ +.|+||..|..
T Consensus 131 ~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 131 LYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred HHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 1222221 2489999999999998877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00044 Score=65.17 Aligned_cols=82 Identities=13% Similarity=0.076 Sum_probs=56.8
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC---CccceEEEEEecccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH---PNVTKFVGASVGTSN 159 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~~~~ 159 (390)
..-...||.|..+.||+....+..+.+|..+.... ...+..|.+.|+.+.- -.+.++++++.+..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~-----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~- 83 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFST-----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ- 83 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEeccccc-----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC-
Confidence 33455799999999999887666788888642100 1457789999988843 35677787764321
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCH
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 192 (390)
..+..++|||+++++++
T Consensus 84 ----------------~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 84 ----------------SPGPDVLLLERLRGVSV 100 (297)
T ss_pred ----------------cCCCeEEEEeccCCEec
Confidence 23446899999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00046 Score=60.79 Aligned_cols=137 Identities=22% Similarity=0.309 Sum_probs=87.5
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccc-------hHHHHHHHHHHHHHHHHHHhcC------CCccceEEE
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMAT-------TAETAALRSSFQQEVAVWQKLD------HPNVTKFVG 152 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~ 152 (390)
...||+|+.-.||.--.+ ....||+.+........ ............+|+.....+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 457999999999965433 45678988744300000 0000011344556666665555 788999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCC------CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG------GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
+..++.-+ .+|+|.+.+ -+|.+++.. ..++. .....+ -+-..||-..
T Consensus 85 ~veT~~G~--------------------Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L---~~f~~~l~~~ 137 (199)
T PF10707_consen 85 FVETNLGL--------------------GLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQAL---DEFKRYLLDH 137 (199)
T ss_pred EEecCCce--------------------EEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHH---HHHHHHHHHc
Confidence 98865444 557776543 378888843 33655 333333 3456788899
Q ss_pred CCcccCCCCCCEEECCC--C--cEEEee
Q 036382 227 KIVHRDVKTENMLLDSQ--R--TLKIAD 250 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~--~--~~kL~D 250 (390)
+|+.+||+|.||++... + .+.|+|
T Consensus 138 ~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 138 HIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCeecCCCcccEEEEecCCCceEEEEEe
Confidence 99999999999999543 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=65.17 Aligned_cols=29 Identities=28% Similarity=0.450 Sum_probs=25.3
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
+++|+|+.|.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999876666799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3e-06 Score=91.62 Aligned_cols=162 Identities=12% Similarity=0.034 Sum_probs=118.3
Q ss_pred HHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCC
Q 036382 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLA 205 (390)
Q Consensus 128 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~ 205 (390)
..+....|..-+++..|+++...+.-.... ...+-+.+++|+.+|.+++.|.+.. .+.++
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps------------------~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPS------------------ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCC------------------CChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 344555666667778899887654322211 2344578999999999999997632 33344
Q ss_pred HHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC
Q 036382 206 LKIVIQLALDLSRGLSYLHSKK-----IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ 280 (390)
Q Consensus 206 ~~~~~~i~~~i~~~L~yLH~~~-----iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 280 (390)
+..+.....+.+.+..-.|+.. .+|++||+.|.+|..+-++|++++|+.+.............+++-|++|++.+
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH
Confidence 4444444444466666666542 79999999999999999999999999984443333344466788899999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 281 GKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 281 ~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
.-.++.++|+|+.|+.+|+...|..+|
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 888999999999999999998888776
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00099 Score=63.06 Aligned_cols=148 Identities=24% Similarity=0.278 Sum_probs=82.7
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc--cceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN--VTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~ 160 (390)
......++.|....+|+...++..+++|+.+... . ...+..|.+++..|...+ +.+++..... .
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~-------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g---~ 89 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----K-------AEELPFFLALTTHLAARGLPVPKPVKSRDG---R 89 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC----C-------HHHHHHHHHHHHHHHHCCCCCCccccCCCC---C
Confidence 4445678888889999987766688899875211 0 122345667777764322 3343332110 0
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHH-----------HHHHh-hc-cCCC-----------CHHHHH------
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLK-----------QYLIR-NR-RKKL-----------ALKIVI------ 210 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~-----------~~l~~-~~-~~~l-----------~~~~~~------ 210 (390)
.+ ....+..+++++|++|.++. ..+.+ +. ...+ .+....
T Consensus 90 ~~-----------~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (307)
T TIGR00938 90 QL-----------STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEA 158 (307)
T ss_pred ee-----------hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhc
Confidence 00 11235568999999885431 11110 00 0000 000000
Q ss_pred ------HHHHHHHHHHHHHHh-------CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 211 ------QLALDLSRGLSYLHS-------KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 211 ------~i~~~i~~~L~yLH~-------~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.....+...++++.. .+++|+|+++.||+++.++...|+||+.+.
T Consensus 159 ~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 159 APQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001122334555542 589999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00092 Score=60.48 Aligned_cols=29 Identities=21% Similarity=0.461 Sum_probs=26.3
Q ss_pred CCcccCCCCCCEEECC-CCcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDS-QRTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~-~~~~kL~DfG~a~ 255 (390)
+++|+|+.+.|||++. ++.+.|+||-.|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.002 Score=61.17 Aligned_cols=30 Identities=27% Similarity=0.475 Sum_probs=26.3
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999876666899999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00093 Score=63.39 Aligned_cols=144 Identities=19% Similarity=0.219 Sum_probs=91.8
Q ss_pred cccccccCceEEEEEEE-CCceEEEEEeccCCCC-----------------ccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 86 RNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDG-----------------MATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-----------------~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
-..|..|--+.||.+.. +|..+|||+++-+-.- ...........--...|++-|+++..-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34577888899999976 7889999998622110 01111122223334567777877754333
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCH-HHHHHhhccCCCCHHHHHHHHHHHHHHHHHH-Hh
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL-KQYLIRNRRKKLALKIVIQLALDLSRGLSYL-HS 225 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~ 225 (390)
.-.--+. -..-.+||+|+....- .-.| +...++...+..+-.+++.-|.-| |.
T Consensus 229 P~PePIl----------------------Lk~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~ 283 (520)
T KOG2270|consen 229 PCPEPIL----------------------LKNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQK 283 (520)
T ss_pred CCCCcee----------------------eecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHH
Confidence 2110000 1122689999953211 1111 234577778888888888888777 45
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.++||.||+--|+|+ .+|.+.|+|-+.+-
T Consensus 284 c~LVHADLSEfN~Ly-hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 284 CRLVHADLSEFNLLY-HDGKLYIIDVSQSV 312 (520)
T ss_pred hceeccchhhhhheE-ECCEEEEEEccccc
Confidence 689999999999999 67899999988764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0011 Score=62.38 Aligned_cols=144 Identities=21% Similarity=0.222 Sum_probs=83.2
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc--cceEEEEEecccccccC
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN--VTKFVGASVGTSNLKIP 163 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~~~ 163 (390)
.+.+..|....+|+...++..+++|+.... . ...+..|++++..+.+.+ +.+++.... ...+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~-------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~-g~~~--- 82 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S-------AEELPFFLALLDHLAERGLPVPRPIADRD-GEYL--- 82 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-----C-------hHhccHHHHHHHHHHHCCCCCCccccCCC-CcEe---
Confidence 456777888999998877778999987521 0 134556788888774332 334433211 0000
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHH-----------HHHh---h-cc--CC------CCHHHH----------H
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQ-----------YLIR---N-RR--KK------LALKIV----------I 210 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-----------~l~~---~-~~--~~------l~~~~~----------~ 210 (390)
....+..++|++|++|.++.. .+.+ . .. .. ..+... .
T Consensus 83 ----------~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 152 (296)
T cd05153 83 ----------SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSA 152 (296)
T ss_pred ----------eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCH
Confidence 012345688999998866421 1100 0 00 00 011000 0
Q ss_pred HHHHHHHHHHHHHHh-------CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 211 QLALDLSRGLSYLHS-------KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~-------~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.....+..++.++.+ .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 153 EDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 011112334455543 479999999999999988778999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0016 Score=61.34 Aligned_cols=29 Identities=31% Similarity=0.493 Sum_probs=26.3
Q ss_pred CCcccCCCCCCEEECCC----CcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDSQ----RTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~----~~~kL~DfG~a~ 255 (390)
.++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999875 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.012 Score=57.39 Aligned_cols=81 Identities=16% Similarity=0.021 Sum_probs=49.2
Q ss_pred ccccccCceEEEEEEECC--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-C--CCccceEEEEEecccccc
Q 036382 87 NLIAQGTYGSVYRGTYDN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D--HPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~--hpnIv~~~~~~~~~~~~~ 161 (390)
+.||.|.+..||++...+ +.|+||.-....... ........+....|.+.|+.+ . -.++.+++.+..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~--g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------ 103 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVV--GESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------ 103 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccc--cccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC------
Confidence 468999999999998854 389999753110000 000011234556678888776 2 235666666622
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCC
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGN 191 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gs 191 (390)
...++||||+++..
T Consensus 104 ----------------~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ----------------ELAVTVMEDLSDHK 117 (401)
T ss_pred ----------------CCCEEEEecCCCcc
Confidence 23478999998743
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0026 Score=62.86 Aligned_cols=155 Identities=20% Similarity=0.259 Sum_probs=94.1
Q ss_pred HHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHH
Q 036382 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVI 210 (390)
Q Consensus 131 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~ 210 (390)
++.-.+.+++.+.|+|....+.+.... .....+|||++ +.+|.+++..+. +-..
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-------------------~~r~IVV~e~~-~~Sled~~~~~~---l~~~--- 81 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-------------------HERVIVVMEHY-TMSLEDILKTGN---LKDE--- 81 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-------------------cceEEEEehhh-ccchHHHHHhcc---cchh---
Confidence 344567899999999999988775432 33357899999 459999885432 1100
Q ss_pred HHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhH
Q 036382 211 QLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDV 290 (390)
Q Consensus 211 ~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 290 (390)
+++ .+|+.| -| .++.+| -++... | .+.++++||
T Consensus 82 -------s~~----~~~~~~-----~~-------~~~~td-~~~t~~------------------~-----~~~~pKsdV 114 (725)
T KOG1093|consen 82 -------SLL----AHGVLH-----LN-------IIYITD-HFLTKY------------------P-----SPIGPKSDV 114 (725)
T ss_pred -------hhc----ccccce-----eh-------hhhccc-cccccC------------------C-----CCCCcchhh
Confidence 011 122222 12 222333 111000 0 112249999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCC----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 291 YSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPE----------IPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 291 wSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
||+|.++.++.-|..-|+..+..+....+.+-...+. +.-.++....++..+|+...|..||.+.++.
T Consensus 115 wsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 115 WSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 9999999999999888877766666555443221110 1123456677889999999999888665543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=55.94 Aligned_cols=29 Identities=28% Similarity=0.573 Sum_probs=25.8
Q ss_pred CCcccCCCCCCEEECC-CCcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDS-QRTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~-~~~~kL~DfG~a~ 255 (390)
.++|+|+++.|||++. ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4789999998875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.017 Score=53.74 Aligned_cols=30 Identities=27% Similarity=0.499 Sum_probs=25.3
Q ss_pred CCcccCCCCCCEEECCCCc-EEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRT-LKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~-~kL~DfG~a~~ 256 (390)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.025 Score=53.33 Aligned_cols=29 Identities=24% Similarity=0.464 Sum_probs=25.5
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.062 Score=52.58 Aligned_cols=80 Identities=10% Similarity=0.002 Sum_probs=48.8
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC---CCccceEEEEEeccccccc
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD---HPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~ 162 (390)
.+.||.|....||+....+..++||.-......... ........-..|.+.|+.+. -.++.+++.++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga--~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------ 108 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGE--SWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------ 108 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCc--cccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------
Confidence 457899999999999887778999976522110000 00001122234566666553 2367778877642
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPG 189 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~ 189 (390)
..+++||++++
T Consensus 109 ----------------~~vlvME~L~~ 119 (418)
T PLN02756 109 ----------------MALIGMRYLEP 119 (418)
T ss_pred ----------------CCEEEEeecCC
Confidence 23679999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.026 Score=54.02 Aligned_cols=29 Identities=24% Similarity=0.463 Sum_probs=25.6
Q ss_pred CcccCCCCCCEEECC-CCcEEEeeccccee
Q 036382 228 IVHRDVKTENMLLDS-QRTLKIADFGVARV 256 (390)
Q Consensus 228 iiHrDlkp~NILl~~-~~~~kL~DfG~a~~ 256 (390)
++|+|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 47899999998863
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.03 Score=52.97 Aligned_cols=30 Identities=27% Similarity=0.545 Sum_probs=27.4
Q ss_pred CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+|+++.||+++.++-+-|.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 369999999999999998899999999864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.032 Score=53.54 Aligned_cols=30 Identities=17% Similarity=0.337 Sum_probs=24.9
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
..++|+|+.+.||+++.+ .++++||.++..
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 358999999999999765 477999987753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.062 Score=50.83 Aligned_cols=29 Identities=24% Similarity=0.331 Sum_probs=27.2
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
+++|+|+.+.|+|++.++.+.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998876
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.022 Score=55.40 Aligned_cols=29 Identities=21% Similarity=0.368 Sum_probs=24.9
Q ss_pred CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+||+|.|||++++ ..|++|.-+|..
T Consensus 228 aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy 256 (409)
T PRK12396 228 ALIHGDLHTGSVFVKND-STKVIDPEFAFY 256 (409)
T ss_pred hhccCcCCCCCEEecCC-ceEEEccccccc
Confidence 47999999999999865 589999888864
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.017 Score=55.73 Aligned_cols=63 Identities=19% Similarity=0.193 Sum_probs=45.6
Q ss_pred CceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccCCCCCCEEECCC
Q 036382 178 RACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSY-LHSKKIVHRDVKTENMLLDSQ 243 (390)
Q Consensus 178 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~iiHrDlkp~NILl~~~ 243 (390)
....++-+|..|-++..++... ..++..+..++.-.+.|+-. |--.+++|.|++|.||++...
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ccceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4446777899999999998543 35566667777666666443 345689999999999999543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.041 Score=51.46 Aligned_cols=76 Identities=21% Similarity=0.273 Sum_probs=44.7
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC--CC-ccceEEEEEecccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD--HP-NVTKFVGASVGTSN 159 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~ 159 (390)
.+-.+.++.|....+|+...+++.+.||+-.... ...|..|.+-|+.|. .+ .+.+.+++....
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~------------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-- 84 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG------------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-- 84 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG------------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhh------------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--
Confidence 3445578899999999999888999999875211 135667888888873 33 456777765432
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCC
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGG 190 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~g 190 (390)
...++||||++.+
T Consensus 85 ------------------~~~fLlle~l~~~ 97 (288)
T PF03881_consen 85 ------------------DDAFLLLEFLEMG 97 (288)
T ss_dssp ------------------SCCEEEEE-----
T ss_pred ------------------CCceEEEEeecCC
Confidence 2238899999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.04 Score=52.54 Aligned_cols=100 Identities=16% Similarity=0.262 Sum_probs=66.3
Q ss_pred eEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCCEEECCCCcEEEeecccceecc
Q 036382 180 CCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258 (390)
Q Consensus 180 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~ 258 (390)
.|++|++- |++|.- + .--.++++..++.+.+..+.-+..+ .+-|||+.-.||||+ +|++.|+||-+++...
T Consensus 301 ~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 301 LYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred EEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 36677766 555542 2 1234677888888888888777765 589999999999999 9999999999998544
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCCCchhHHHH
Q 036382 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSF 293 (390)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 293 (390)
.+...... ..--|-.+.|.. +.+-+||-+
T Consensus 373 ~q~~isy~-----rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 373 SQGIISYN-----RLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred CCceeecc-----ccCchhhhcCcc-ceeeeHHHH
Confidence 33222221 122333444332 566677763
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.15 Score=49.75 Aligned_cols=29 Identities=24% Similarity=0.249 Sum_probs=24.2
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
..++|.|+-+.||+.+ ++.+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence 4679999999999975 4569999998774
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.39 Score=45.80 Aligned_cols=28 Identities=25% Similarity=0.291 Sum_probs=24.1
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.++||+|+.+.|||++ + .+.|+||+.++
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.36 Score=48.07 Aligned_cols=28 Identities=21% Similarity=0.489 Sum_probs=23.8
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.++|.|+.+.|||.+.+ .++|+||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccc
Confidence 48999999999998654 49999998775
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.062 Score=50.50 Aligned_cols=72 Identities=14% Similarity=0.143 Sum_probs=53.2
Q ss_pred EEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCCEEECCCCcEEEeecccce
Q 036382 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYL-HSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255 (390)
Q Consensus 181 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~ 255 (390)
.+||.|+...-+.. -+-+...++...+...-.|+..+|..| |..-+||-||+--|+|...+ .+.++|-.-+-
T Consensus 359 vLVMsFiGd~~~aA--PkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 359 VLVMSFIGDQGLAA--PKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred eEEEEeecCCCCCC--ccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhcc
Confidence 57999984422211 112334588888888888999988877 56679999999999999765 88888877653
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.039 Score=44.40 Aligned_cols=28 Identities=32% Similarity=0.357 Sum_probs=25.2
Q ss_pred ccccccCceEEEEEEE-CCceEEEEEecc
Q 036382 87 NLIAQGTYGSVYRGTY-DNQEVAVKLLDW 114 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~ 114 (390)
..||.|+.|.||+|+. +|+.||||+.++
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP 45 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRP 45 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcch
Confidence 5799999999999998 589999999873
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.23 Score=45.55 Aligned_cols=75 Identities=19% Similarity=0.195 Sum_probs=50.9
Q ss_pred cccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHH---HHHHhcCCCccceEEEEEecccccc
Q 036382 86 RNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV---AVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
...+..|..+.|+.++. +|+++++|+...... ...|. ..|+..+-...|++++.-.+
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~--------------~~~E~~g~~~L~~w~G~GaVrll~~d~~----- 67 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE--------------AEHEARGEAALRWWNGRGAVRLLAADPE----- 67 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc--------------chhhhhHHhHhheeCCCCceeeeccccc-----
Confidence 35567899999999965 789999999863221 11233 55777777888999977422
Q ss_pred cCCcccccCCCCCCCCCceEEEEecC-CCCCHHHHH
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYL-PGGNLKQYL 196 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l 196 (390)
.-.+++|.+ .+.+|.++.
T Consensus 68 -----------------~~AlLLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 68 -----------------RGALLLERLDPGRSLASLP 86 (253)
T ss_pred -----------------cchhhhhhccCCCchhhcc
Confidence 225688888 444666544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.37 Score=47.58 Aligned_cols=28 Identities=29% Similarity=0.458 Sum_probs=22.6
Q ss_pred CcccCCCCCCEEECCCC-----cEEEeecccce
Q 036382 228 IVHRDVKTENMLLDSQR-----TLKIADFGVAR 255 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~-----~~kL~DfG~a~ 255 (390)
++|+||...|||.+.++ -..|+||-.+.
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh 302 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVH 302 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhh
Confidence 79999999999998743 35688887664
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 390 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-39 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-33 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-33 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-33 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-33 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-33 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-33 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-33 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-33 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-33 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-33 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-33 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-33 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-33 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-33 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-33 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-33 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-33 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-33 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-33 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-33 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-33 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-33 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-33 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-32 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-32 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-32 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-32 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-32 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-32 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-32 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-32 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-32 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-32 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-32 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-31 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-31 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-31 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-31 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-31 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-31 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-31 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-31 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-31 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-31 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-31 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-31 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-31 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-31 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-31 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-31 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-30 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-30 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-30 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-30 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-30 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-30 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-30 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-30 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-29 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-28 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-27 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-27 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-27 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-27 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-27 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-27 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-27 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-27 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-27 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-27 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-27 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-27 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-27 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-27 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-27 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-27 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-27 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-27 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-26 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-26 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-26 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-26 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-26 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-26 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-26 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-26 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-26 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-26 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-26 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-26 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-26 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-26 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-26 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-26 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-25 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-25 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-25 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-25 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-25 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-25 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-25 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-25 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-24 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-24 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-24 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-24 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-24 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-24 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-24 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-24 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-24 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-24 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-24 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-24 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-24 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-24 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-24 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-24 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-24 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-24 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-23 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-23 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-23 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-23 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-23 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-23 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-23 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-23 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-23 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-22 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-22 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-22 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-22 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-22 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-22 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-22 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-22 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-22 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-22 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-22 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-22 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-22 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-22 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-22 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-22 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-22 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-22 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-22 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-22 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-22 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-22 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-22 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-22 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-22 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-22 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-22 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-22 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-22 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-22 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-22 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-22 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-22 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-22 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-22 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-22 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-22 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-22 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-22 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-22 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-22 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-22 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-22 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-21 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-21 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-21 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-21 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-21 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-21 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-21 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-21 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-21 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-21 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-20 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-20 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-20 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-20 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-19 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-19 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-19 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-19 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-19 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-19 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-19 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-18 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-18 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-18 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-17 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-132
Identities = 95/306 (31%), Positives = 163/306 (53%), Gaps = 30/306 (9%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAE 124
+ ++ +I L+++ I G++G+V+R + +VAVK+L +
Sbjct: 21 LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQD-------F 73
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
A + F +EVA+ ++L HPN+ F+GA NL +V
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL--------------------SIVT 113
Query: 185 EYLPGGNLKQYLIRN-RRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLD 241
EYL G+L + L ++ R++L + + +A D+++G++YLH++ IVHR++K+ N+L+D
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173
Query: 242 SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+ T+K+ DFG++R++A GT +MAPEVL+ +P N + DVYSFG+ LWE+
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 302 CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
P+ +L+ A V +AV + R EIPR +A I+ CW KRP ++ +L
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
Query: 362 EAIDTS 367
+ S
Sbjct: 294 RPLIKS 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-124
Identities = 67/296 (22%), Positives = 130/296 (43%), Gaps = 35/296 (11%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQ 133
+ ID +L+ + + G +++G + ++ VK+L + + F
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-------STRKSRDFN 55
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+E + HPNV +GA PA ++ ++P G+L
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSP------------------PAPHPTLITHWMPYGSLY 97
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDSQRTLKIADF 251
L + ++ ALD++RG+++LH+ + I + + ++++D T +I+
Sbjct: 98 NVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157
Query: 252 GVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN---RRCDVYSFGICLWEIYCCDMPYP 308
V G ++APE LQ KP + R D++SF + LWE+ ++P+
Sbjct: 158 DVKFS-----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
DLS ++ V + LRP IP ++ +M+ C + + KRP+ +V +LE +
Sbjct: 213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-122
Identities = 85/300 (28%), Positives = 141/300 (47%), Gaps = 41/300 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
EID ++L + +I G +G VYR + EVAVK D + + + +QE
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD-----EDISQTIENVRQE 56
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
++ L HPN+ G + NL C+V+E+ GG L +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNL--------------------CLVMEFARGGPLNRV 96
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKK---IVHRDVKTENMLLD--------SQR 244
L K++ I++ A+ ++RG++YLH + I+HRD+K+ N+L+ S +
Sbjct: 97 L---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
LKI DFG+AR + G +MAPEV++ +++ DV+S+G+ LWE+ +
Sbjct: 154 ILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+P+ + V+ V L IP CP A +M CW+ + RP ++ L I
Sbjct: 212 VPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-120
Identities = 81/311 (26%), Positives = 144/311 (46%), Gaps = 42/311 (13%)
Query: 68 ESQRPK-EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAE 124
S+ PK + ++++ I +G +G V++G D VA+K L G+ E
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS--EGETE 62
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
FQ+EV + L+HPN+ K G +V+
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMH----------------------NPPRMVM 100
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDS 242
E++P G+L L ++ + + ++L LD++ G+ Y+ ++ IVHRD+++ N+ L S
Sbjct: 101 EFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS 159
Query: 243 Q-----RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGI 295
K+ADFG+++ ++G G +MAPE + + Y + D YSF +
Sbjct: 160 LDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 296 CLWEIYCCDMPYPDLSFADVS--SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE 353
L+ I + P+ + S+ + + + + LRP IP CP L N++ CW + +KRP
Sbjct: 217 ILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 354 MGEVVKMLEAI 364
+VK L +
Sbjct: 277 FSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-120
Identities = 73/329 (22%), Positives = 154/329 (46%), Gaps = 52/329 (15%)
Query: 57 EKHLSWVWSRNESQRPK------EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVK 110
E +LS + +R+ ++ +EW+I +L++ LI +G +G VY G + + EVA++
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGEVAIR 61
Query: 111 LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVD 170
L+D D +F++EV +++ H NV F+GA + +L
Sbjct: 62 LIDIERD-------NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL---------- 104
Query: 171 GNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230
++ G L + R+ + L + Q+A ++ +G+ YLH+K I+H
Sbjct: 105 ----------AIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 231 RDVKTENMLLDSQRTLKIADFGVARVEA-----QNPRDMTGETGTLGYMAPEVLQG---- 281
+D+K++N+ D + I DFG+ + + + + G L ++APE+++
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 282 -----KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRC-CPSS 335
P+++ DV++ G +E++ + P+ + + ++P + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKPNLSQIGMGKE 271
Query: 336 LANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+++I+ CW E+RP +++ MLE +
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-119
Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 42/309 (13%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
ID ++++ ++ +G +G V + + ++VA+K ++ + R +F
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-----------RKAFIV 50
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E+ +++HPN+ K GA + C+V+EY GG+L
Sbjct: 51 ELRQLSRVNHPNIVKLYGACL----------------------NPVCLVMEYAEGGSLYN 88
Query: 195 YLIRNRRK-KLALKIVIQLALDLSRGLSYLHS---KKIVHRDVKTENMLLDSQ-RTLKIA 249
L + L S+G++YLHS K ++HRD+K N+LL + LKI
Sbjct: 89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309
DFG A + MT G+ +MAPEV +G Y+ +CDV+S+GI LWE+ P+ +
Sbjct: 149 DFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 310 LSFADVS-SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368
+ V RP + + P + ++M +CW + +RP M E+VK++ +
Sbjct: 206 IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 369 GGGMIPEDQ 377
G P
Sbjct: 266 PGADEPLQY 274
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-116
Identities = 85/313 (27%), Positives = 156/313 (49%), Gaps = 39/313 (12%)
Query: 61 SWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMA 120
+ S+ ++WEI ++ + I G++G+VY+G + + +VAVK+L+
Sbjct: 4 GHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAP--- 59
Query: 121 TTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARAC 180
T +F+ EV V +K H N+ F+G S P
Sbjct: 60 ----TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ---------------L 94
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
+V ++ G +L +L K +K +I +A +RG+ YLH+K I+HRD+K+ N+ L
Sbjct: 95 AIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL 153
Query: 241 DSQRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLQGK---PYNRRCDVYSFGI 295
T+KI DFG+A +++ +G++ +MAPEV++ + PY+ + DVY+FGI
Sbjct: 154 HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213
Query: 296 CLWEIYCCDMPYPDLSFAD-VSSAVVRQNLRPEIPRC---CPSSLANIMRKCWDANAEKR 351
L+E+ +PY +++ D + V R +L P++ + CP + +M +C ++R
Sbjct: 214 VLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
Query: 352 PEMGEVVKMLEAI 364
P ++ +E +
Sbjct: 274 PSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-107
Identities = 80/322 (24%), Positives = 132/322 (40%), Gaps = 47/322 (14%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRS 130
S L ++ +G +G + T+ + + +K L +
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI---------RFDEETQR 52
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+F +EV V + L+HPNV KF+G L + EY+ GG
Sbjct: 53 TFLKEVKVMRCLEHPNVLKFIGVLYKDKRL--------------------NFITEYIKGG 92
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L+ + ++ + + A D++ G++YLHS I+HRD+ + N L+ + + +AD
Sbjct: 93 TLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVAD 151
Query: 251 FGVARVEAQNP--------------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
FG+AR+ + G +MAPE++ G+ Y+ + DV+SFGI
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 297 LWEIYCCDMPYPDLSFADVSSAV-VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355
L EI PD + + VR L P CP S I +C D + EKRP
Sbjct: 212 LCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFV 271
Query: 356 EVVKMLEAIDTSKGGGMIPEDQ 377
++ LE + G + Q
Sbjct: 272 KLEHWLETLRMHLAGHLPLGPQ 293
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = e-106
Identities = 97/376 (25%), Positives = 148/376 (39%), Gaps = 77/376 (20%)
Query: 37 SKDMLFRADKIDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGS 96
S D F ++ LK L + S + S P + ++ I +G +G
Sbjct: 4 SLDRPFISEGTTLKDLIYDMTT------SGSGSGLPLLVQRTIARTIVLQESIGKGRFGE 57
Query: 97 VYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ--KLDHPNVTKFVGAS 154
V+RG + +EVAVK+ E S+ +E ++Q L H N+ F+ A
Sbjct: 58 VWRGKWRGEEVAVKIFSSRE------------ERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLAL 214
+ +V +Y G+L YL R + ++ +I+LAL
Sbjct: 106 NKDNGTWTQ----------------LWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLAL 146
Query: 215 DLSRGLSYLHSK--------KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD--- 263
+ GL++LH + I HRD+K++N+L+ T IAD G+A
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 264 -MTGETGTLGYMAPEVLQG------KPYNRRCDVYSFGICLWEIYCC------------- 303
GT YMAPEVL +R D+Y+ G+ WEI
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 304 --DMPYPDLSFADVSSAVVRQNLRPEIP---RCCP--SSLANIMRKCWDANAEKRPEMGE 356
D+ D S ++ V Q LRP IP + C +A IMR+CW AN R
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 357 VVKMLEAIDTSKGGGM 372
+ K L + +G M
Sbjct: 327 IKKTLSQLSQQEGIKM 342
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-105
Identities = 85/344 (24%), Positives = 135/344 (39%), Gaps = 71/344 (20%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAE 124
S + S P ++ M I +G YG V+ G + ++VAVK+ E
Sbjct: 21 SGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-------- 72
Query: 125 TAALRSSFQQEVAVWQ--KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
+S+ +E ++Q + H N+ F+ A + + +
Sbjct: 73 ----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ----------------LYL 112
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK--------KIVHRDVK 234
+ +Y G+L YL + L K +++LA GL +LH++ I HRD+K
Sbjct: 113 ITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 235 TENMLLDSQRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQG------KPY 284
++N+L+ T IAD G+A + + GT YM PEVL
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 285 NRRCDVYSFGICLWEIYCC----------DMPYPDL-----SFADVSSAVVRQNLRPEIP 329
D+YSFG+ LWE+ +PY DL S+ D+ V + LRP P
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 330 RC-----CPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368
C + +M +CW N R V K L + S+
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-103
Identities = 78/323 (24%), Positives = 133/323 (41%), Gaps = 71/323 (21%)
Query: 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ-- 140
+ + + +G YG V+RG++ + VAVK+ ++ S+ +E ++
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE------------KSWFRETELYNTV 57
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
L H N+ F+ + + + + ++ Y G+L YL +
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQ----------------LWLITHYHEMGSLYDYL---Q 98
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSK--------KIVHRDVKTENMLLDSQRTLKIADFG 252
L +++ L ++ GL++LH + I HRD+K++N+L+ IAD G
Sbjct: 99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 253 VARVEAQNPRD----MTGETGTLGYMAPEVLQGKP------YNRRCDVYSFGICLWEIYC 302
+A + +Q+ GT YMAPEVL +R D+++FG+ LWE+
Sbjct: 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
Query: 303 C---------------DMPYPDLSFADVSSAVVRQNLRPEIPR-----CCPSSLANIMRK 342
D+ D SF D+ V RP IP +SLA +M++
Sbjct: 219 RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE 278
Query: 343 CWDANAEKRPEMGEVVKMLEAID 365
CW N R + K L ID
Sbjct: 279 CWYQNPSARLTALRIKKTLTKID 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 86/348 (24%), Positives = 142/348 (40%), Gaps = 80/348 (22%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALR 129
+ E +DL L + LI +G YG+VY+G+ D + VAVK+ + R
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------R 49
Query: 130 SSFQQEVAVWQ--KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+F E +++ ++H N+ +F+ + +V+EY
Sbjct: 50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME---------------YLLVMEYY 94
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS---------KKIVHRDVKTENM 238
P G+L +YL +LA ++RGL+YLH+ I HRD+ + N+
Sbjct: 95 PNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151
Query: 239 LLDSQRTLKIADFGVARVEAQNPR--------DMTGETGTLGYMAPEVLQG-------KP 283
L+ + T I+DFG++ N E GT+ YMAPEVL+G +
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 284 YNRRCDVYSFGICLWEIY--CCD-----------MPYPDL-----SFADVSSAVVRQNLR 325
++ D+Y+ G+ WEI+ C D M + +F D+ V R+ R
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271
Query: 326 PEIPRCC------PSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
P+ P SL + CWD +AE R + + +
Sbjct: 272 PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = e-100
Identities = 79/338 (23%), Positives = 137/338 (40%), Gaps = 71/338 (21%)
Query: 67 NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETA 126
+ E L + + A+G +G V++ N+ VAVK+ +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---------- 59
Query: 127 ALRSSFQQEVAVWQ--KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
+ S+Q E V+ + H N+ +F+GA +++ + ++
Sbjct: 60 --KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD----------------LWLIT 101
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK----------KIVHRDVK 234
+ G+L +L + ++ + +A ++RGL+YLH I HRD+K
Sbjct: 102 AFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 235 TENMLLDSQRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLQG-----KPYNRR 287
++N+LL + T IADFG+A ++ D G+ GT YMAPEVL+G + R
Sbjct: 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 288 CDVYSFGICLWEIYCCDMPY----------------PDLSFADVSSAVVRQNLRPEIPRC 331
D+Y+ G+ LWE+ S D+ VV + RP +
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY 278
Query: 332 CPS-----SLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
L + +CWD +AE R G V + + +
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-72
Identities = 87/298 (29%), Positives = 138/298 (46%), Gaps = 35/298 (11%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
PK++W ++ L + I +G +G V+ G DN VAVK E +
Sbjct: 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ETLPPDL------K 156
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+ F QE + ++ HPN+ + +G V T I +V+E + G
Sbjct: 157 AKFLQEARILKQYSHPNIVRLIG--VCTQKQPI------------------YIVMELVQG 196
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G+ +L R +L +K ++Q+ D + G+ YL SK +HRD+ N L+ + LKI+
Sbjct: 197 GDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKIS 255
Query: 250 DFGVARVEAQNPRDMTGETGTLGY--MAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMP 306
DFG++R EA +G + APE L Y+ DV+SFGI LWE + P
Sbjct: 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
YP+LS V + R P CP ++ +M +CW +RP + + L++I
Sbjct: 316 YPNLSNQQTREF-VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-67
Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 41/300 (13%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSS 131
+ W +++ +L + I +G +G V G Y +VAVK + D A
Sbjct: 184 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQA--------- 232
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F E +V +L H N+ + +G + + +V EY+ G+
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGV-IVEEKGGL------------------YIVTEYMAKGS 273
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L YL R L +++ +LD+ + YL VHRD+ N+L+ K++DF
Sbjct: 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 333
Query: 252 GVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPY 307
G+ + + + + + + APE L+ K ++ + DV+SFGI LWEIY +PY
Sbjct: 334 GLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
P + DV V + + + P CP ++ ++M+ CW +A RP ++ + LE I T
Sbjct: 388 PRIPLKDVVPR-VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-66
Identities = 77/299 (25%), Positives = 136/299 (45%), Gaps = 35/299 (11%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE--VAVKLLDWGEDGMATTAETAALRS 130
++WE++ + + M++ + G YG VY G + VAVK T E
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK----------TLKEDTMEVE 261
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
F +E AV +++ HPN+ + +G V T ++ E++ G
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLG--VCTREPPF------------------YIITEFMTYG 301
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
NL YL R++++ +++ +A +S + YL K +HR++ N L+ +K+AD
Sbjct: 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 251 FGVARVEAQNPRDMTGETG-TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPYP 308
FG++R+ + + + APE L ++ + DV++FG+ LWEI PYP
Sbjct: 362 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
+ + V + ++ R E P CP + +MR CW N RP E+ + E +
Sbjct: 422 GIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-66
Identities = 84/310 (27%), Positives = 132/310 (42%), Gaps = 39/310 (12%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSS 131
K+ WEI L + + QG +G V+ GT++ VA+K T +
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK----------TLKPGTMSPEA 225
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F QE V +KL H + + V +V EY+ G+
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAV---------------------VSEEPIYIVTEYMSKGS 264
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L +L K L L ++ +A ++ G++Y+ VHRD++ N+L+ K+ADF
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 324
Query: 252 GVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPY 307
G+AR+ N + T G + + APE + + DV+SFGI L E+ +PY
Sbjct: 325 GLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
P + +V V + R P CP SL ++M +CW E+RP + LE TS
Sbjct: 383 PGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
Query: 368 KGGGMIPEDQ 377
P +
Sbjct: 442 TEPQYQPGEN 451
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-66
Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 39/300 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSS 131
K+ WEI L + + G +G V+ TY+ +VAVK T + +
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVK----------TMKPGSMSVEA 229
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F E V + L H + K V ++ E++ G+
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAV---------------------VTKEPIYIITEFMAKGS 268
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L +L + K L +I + ++ G++++ + +HRD++ N+L+ + KIADF
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 328
Query: 252 GVARVEAQNPRDMTGETGTLG---YMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPY 307
G+ARV N + T G + APE + + + DV+SFGI L EI +PY
Sbjct: 329 GLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
P +S +V A + + R P CP L NIM +CW E+RP + +L+ T+
Sbjct: 387 PGMSNPEVIRA-LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-65
Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSF 132
+ W +++ +L + I +G +G V G Y +VAVK + D +F
Sbjct: 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDAT---------AQAF 61
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
E +V +L H N+ + +G + + +V EY+ G+L
Sbjct: 62 LAEASVMTQLRHSNLVQLLGV-IVEEKGGL------------------YIVTEYMAKGSL 102
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
YL R L +++ +LD+ + YL VHRD+ N+L+ K++DFG
Sbjct: 103 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162
Query: 253 VARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYP 308
+ + + + + + + APE L+ K ++ + DV+SFGI LWEIY +PYP
Sbjct: 163 LTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
+ DV V + + + P CP ++ +M+ CW +A RP ++ + LE I T
Sbjct: 217 RIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-65
Identities = 76/323 (23%), Positives = 142/323 (43%), Gaps = 34/323 (10%)
Query: 67 NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMAT 121
+E + E+ I + + ++ +G +GSV +VAVK+L + +
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIA 65
Query: 122 TAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+++ F +E A ++ DHP+V K VG S+ A
Sbjct: 66 SSD----IEEFLREAACMKEFDHPHVAKLVGVSL--------------RSRAKGRLPIPM 107
Query: 182 VVVEYLPGGNLKQYLIRNR----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
V++ ++ G+L +L+ +R L L+ +++ +D++ G+ YL S+ +HRD+ N
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGI 295
+L T+ +ADFG++R G L ++A E L Y DV++FG+
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
Query: 296 CLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354
+WEI PY + A++ + + R + P C + ++M +CW A+ ++RP
Sbjct: 228 TMWEIMTRGQTPYAGIENAEIYNYL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSF 286
Query: 355 GEVVKMLEAIDTSKGGGMIPEDQ 377
+ LE I +D
Sbjct: 287 TCLRMELENILGHLSVLSTSQDP 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-65
Identities = 76/301 (25%), Positives = 134/301 (44%), Gaps = 39/301 (12%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRS 130
++EWE+ L + + G +G V+ G Y+ +VAVK + + +
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK----------SLKQGSMSPD 53
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+F E + ++L H + + V T P ++ EY+ G
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYA--VVTQE----------------PI---YIITEYMENG 92
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
+L +L KL + ++ +A ++ G++++ + +HRD++ N+L+ + KIAD
Sbjct: 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD 152
Query: 251 FGVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMP 306
FG+AR+ N + T G + APE + + + DV+SFGI L EI +P
Sbjct: 153 FGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366
YP ++ +V + + R P CP L +MR CW E RP + +LE T
Sbjct: 211 YPGMTNPEVIQN-LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
Query: 367 S 367
+
Sbjct: 270 A 270
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-65
Identities = 84/310 (27%), Positives = 131/310 (42%), Gaps = 39/310 (12%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSS 131
K+ WEI L + + QG +G V+ GT++ VA+K T +
Sbjct: 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK----------TLKPGTMSPEA 308
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F QE V +KL H + + V +V EY+ G+
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAV---------------------VSEEPIYIVTEYMSKGS 347
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L +L K L L ++ +A ++ G++Y+ VHRD++ N+L+ K+ADF
Sbjct: 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 407
Query: 252 GVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPY 307
G+AR+ N + T G + APE + + DV+SFGI L E+ +PY
Sbjct: 408 GLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
P + +V V + R P CP SL ++M +CW E+RP + LE TS
Sbjct: 466 PGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
Query: 368 KGGGMIPEDQ 377
P +
Sbjct: 525 TEPQYQPGEN 534
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-65
Identities = 73/331 (22%), Positives = 141/331 (42%), Gaps = 54/331 (16%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDG 118
+ + ++ + + L + +G +GSV YD + VAVK L
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HST 82
Query: 119 MATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPAR 178
+ F++E+ + + L H N+ K+ G V S +
Sbjct: 83 EEHLRD-------FEREIEILKSLQHDNIVKYKG--VCYSAGRRN--------------- 118
Query: 179 ACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+++EYLP G+L+ YL + ++++ ++Q + +G+ YL +K+ +HRD+ T N+
Sbjct: 119 -LKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI 176
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGI 295
L++++ +KI DFG+ +V Q+ + + + APE L ++ DV+SFG+
Sbjct: 177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 296 CLWEI--YCCD--------------MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANI 339
L+E+ Y + + ++ N R P CP + I
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMI 295
Query: 340 MRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370
M +CW+ N +RP ++ ++ I G
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-65
Identities = 95/328 (28%), Positives = 148/328 (45%), Gaps = 50/328 (15%)
Query: 47 IDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---- 102
IDL +L+ +L + + V + +I +G +G VY GT
Sbjct: 2 IDLSALNPELVQAVQHVV-----------IGPSSLIVHFNEVIGRGHFGCVYHGTLLDND 50
Query: 103 -DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161
AVK L+ E S F E + + HPNV +G + +
Sbjct: 51 GKKIHCAVKSLNRI----TDIGE----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-- 100
Query: 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLS 221
+ VV+ Y+ G+L+ ++ RN +K +I L +++G+
Sbjct: 101 -----------------SPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMK 142
Query: 222 YLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR-VEAQNPRDMTGETGTL---GYMAPE 277
YL SKK VHRD+ N +LD + T+K+ADFG+AR + + + +TG +MA E
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 278 VLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSL 336
LQ + + + DV+SFG+ LWE+ PYPD++ D++ + Q R P CP L
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPL 261
Query: 337 ANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+M KCW AE RP E+V + AI
Sbjct: 262 YEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-64
Identities = 74/327 (22%), Positives = 135/327 (41%), Gaps = 54/327 (16%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMAT 121
Q P + L + +G +G V YD + VAVK L
Sbjct: 18 LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH- 76
Query: 122 TAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
RS ++QE+ + + L H ++ K+ G
Sbjct: 77 -------RSGWKQEIDILRTLYHEHIIKYKG--CCEDAGAAS----------------LQ 111
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V+EY+P G+L+ YL R + L ++ A + G++YLH++ +HRD+ N+LLD
Sbjct: 112 LVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 242 SQRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLW 298
+ R +KI DFG+A+ + + + APE L+ + DV+SFG+ L+
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 299 EI--YC-------------CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKC 343
E+ +C + ++ ++ + + R P CP+ + ++M+ C
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LERGERLPRPDKCPAEVYHLMKNC 287
Query: 344 WDANAEKRPEMGEVVKMLEAIDTSKGG 370
W+ A RP ++ +L+ + G
Sbjct: 288 WETEASFRPTFENLIPILKTVHEKYQG 314
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-64
Identities = 76/310 (24%), Positives = 136/310 (43%), Gaps = 35/310 (11%)
Query: 67 NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMAT 121
E Q E+ ID + L + ++ +G +GSV G +VAVK + + ++
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM---KLDNSS 76
Query: 122 TAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
E F E A + HPNV + +G + S+ IP
Sbjct: 77 QRE----IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP---------------M 117
Query: 182 VVVEYLPGGNLKQYLIRNR----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
V++ ++ G+L YL+ +R K + L+ +++ +D++ G+ YL ++ +HRD+ N
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGI 295
+L T+ +ADFG+++ G + ++A E L + Y + DV++FG+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 296 CLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354
+WEI PYP + ++ + R + P C L IM CW + RP
Sbjct: 238 TMWEIATRGMTPYPGVQNHEMYDYL-LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF 296
Query: 355 GEVVKMLEAI 364
+ LE +
Sbjct: 297 SVLRLQLEKL 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-64
Identities = 73/323 (22%), Positives = 139/323 (43%), Gaps = 54/323 (16%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETA 126
+ + + L + +G +GSV YD + VAVK L +
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRD-- 57
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
F++E+ + + L H N+ K+ G V S + +++EY
Sbjct: 58 -----FEREIEILKSLQHDNIVKYKG--VCYSAGRRN----------------LKLIMEY 94
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
LP G+L+ YL + ++++ ++Q + +G+ YL +K+ +HRD+ T N+L++++ +
Sbjct: 95 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 247 KIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEI--Y 301
KI DFG+ +V Q+ + + + APE L ++ DV+SFG+ L+E+ Y
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213
Query: 302 CCD--------------MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
+ + ++ N R P CP + IM +CW+ N
Sbjct: 214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNN 272
Query: 348 AEKRPEMGEVVKMLEAIDTSKGG 370
+RP ++ ++ I + G
Sbjct: 273 VNQRPSFRDLALRVDQIRDNMAG 295
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-64
Identities = 82/299 (27%), Positives = 139/299 (46%), Gaps = 39/299 (13%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE--VAVKLLDWGEDGMATTAETAALR 129
++WE++ + + M++ + G YG VY G + VAVK L ED M
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTME--------V 53
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
F +E AV +++ HPN+ + +G V T ++ E++
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLG--VCTREPPF------------------YIITEFMTY 93
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
GNL YL R++++ +++ +A +S + YL K +HRD+ N L+ +K+A
Sbjct: 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 250 DFGVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DM 305
DFG++R+ + T G + APE L ++ + DV++FG+ LWEI
Sbjct: 154 DFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PYP + + V + ++ R E P CP + +MR CW N RP E+ + E +
Sbjct: 212 PYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-63
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 39/298 (13%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQ 133
+W ID S+L I G +G V+ G + N+ +VA+K + E M+ F
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMS--------EEDFI 51
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+E V KL HP + + G V I C+V E++ G L
Sbjct: 52 EEAEVMMKLSHPKLVQLYG--VCLEQAPI------------------CLVTEFMEHGCLS 91
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
YL R +R A + ++ + LD+ G++YL ++HRD+ N L+ + +K++DFG+
Sbjct: 92 DYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 150
Query: 254 ARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPD 309
R + T TGT + +PEV Y+ + DV+SFG+ +WE++ +PY +
Sbjct: 151 TRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
Query: 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
S ++V + R PR + + IM CW E RP +++ L I S
Sbjct: 209 RSNSEVVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 2e-63
Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSS 131
WEID L + G +G V G + Q +VA+K++ E M+
Sbjct: 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMS--------EDE 65
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
F +E V L H + + G V T I ++ EY+ G
Sbjct: 66 FIEEAKVMMNLSHEKLVQLYG--VCTKQRPI------------------FIITEYMANGC 105
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L YL R R + + ++++ D+ + YL SK+ +HRD+ N L++ Q +K++DF
Sbjct: 106 LLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 252 GVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPY 307
G++R + + T G+ + PEVL ++ + D+++FG+ +WEIY MPY
Sbjct: 165 GLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ ++ + + Q LR P + IM CW A++RP ++ + +
Sbjct: 223 ERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 85/310 (27%), Positives = 138/310 (44%), Gaps = 47/310 (15%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAET 125
+EWE+ K+ M + QG++G VY G VA+K ++ A+ E
Sbjct: 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRE- 71
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
R F E +V ++ + +V + +G S+ V++E
Sbjct: 72 ---RIEFLNEASVMKEFNCHHVVRLLGVV---------SQGQPT-----------LVIME 108
Query: 186 YLPGGNLKQYLIRNR--------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+ G+LK YL R +L +IQ+A +++ G++YL++ K VHRD+ N
Sbjct: 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGI 295
++ T+KI DFG+ R + G G L +M+PE L+ + DV+SFG+
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228
Query: 296 CLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354
LWEI + PY LS V V+ + P CP L +MR CW N + RP
Sbjct: 229 VLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSF 287
Query: 355 GEVVKMLEAI 364
E++ ++
Sbjct: 288 LEIISSIKEE 297
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-63
Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 39/294 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ-EVAVKLLDWGEDGMATTAETAALRSSFQQ 134
E+ ++ + + G +G V G + Q +VAVK++ E M+ F Q
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK--EGSMS--------EDEFFQ 52
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E KL HP + KF G V + I +V EY+ G L
Sbjct: 53 EAQTMMKLSHPKLVKFYG--VCSKEYPI------------------YIVTEYISNGCLLN 92
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
YL R+ K L ++++ D+ G+++L S + +HRD+ N L+D +K++DFG+
Sbjct: 93 YL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
Query: 255 RVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDL 310
R + GT + APEV Y+ + DV++FGI +WE++ MPY
Sbjct: 152 RYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ ++V V Q R P ++ IM CW EKRP +++ +E +
Sbjct: 210 TNSEVVLK-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-62
Identities = 73/316 (23%), Positives = 137/316 (43%), Gaps = 52/316 (16%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDGMATTAETA 126
+ + L + +G +G V YD ++VAVK L G
Sbjct: 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH------ 66
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
+ ++E+ + + L H N+ K+ G + T + +++E+
Sbjct: 67 --IADLKKEIEILRNLYHENIVKYKG--ICTEDGGNG----------------IKLIMEF 106
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
LP G+LK+YL + K+ LK ++ A+ + +G+ YL S++ VHRD+ N+L++S+ +
Sbjct: 107 LPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165
Query: 247 KIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEI--Y 301
KI DFG+ + + T + + + APE L + DV+SFG+ L E+ Y
Sbjct: 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
Query: 302 C-------------CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANA 348
C + ++ + + +++ R P CP + +MRKCW+
Sbjct: 226 CDSDSSPMALFLKMIGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 349 EKRPEMGEVVKMLEAI 364
R +++ EA+
Sbjct: 285 SNRTSFQNLIEGFEAL 300
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 78/317 (24%), Positives = 126/317 (39%), Gaps = 53/317 (16%)
Query: 69 SQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMAT 121
+ + E+ + + + G +G VY G +VAVK L +
Sbjct: 18 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CS 73
Query: 122 TAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+ F E + K +H N+ + +G S+ +P
Sbjct: 74 EQD----ELDFLMEALIISKFNHQNIVRCIGVSL----QSLP----------------RF 109
Query: 182 VVVEYLPGGNLKQYLIRNRRK-----KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236
+++E + GG+LK +L R + LA+ ++ +A D++ G YL +HRD+
Sbjct: 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 169
Query: 237 NMLLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGY-----MAPEVLQGKPYNRRC 288
N LL R KI DFG+AR + G M PE + +
Sbjct: 170 NCLLTCPGPGRVAKIGDFGMARDIYRA--SYY-RKGGCAMLPVKWMPPEAFMEGIFTSKT 226
Query: 289 DVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
D +SFG+ LWEI+ MPYP S +V V R + P+ CP + IM +CW
Sbjct: 227 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQ 285
Query: 348 AEKRPEMGEVVKMLEAI 364
E RP +++ +E
Sbjct: 286 PEDRPNFAIILERIEYC 302
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-62
Identities = 88/300 (29%), Positives = 137/300 (45%), Gaps = 39/300 (13%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALR 129
+ +I +G +G VY GT AVK L+ D
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--------V 134
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
S F E + + HPNV +G + + + VV+ Y+
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEG-------------------SPLVVLPYMKH 175
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G+L+ ++ RN +K +I L +++G+ +L SKK VHRD+ N +LD + T+K+A
Sbjct: 176 GDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVA 234
Query: 250 DFGVAR-VEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CD 304
DFG+AR + + + +TG +MA E LQ + + + DV+SFG+ LWE+
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PYPD++ D++ + Q R P CP L +M KCW AE RP E+V + AI
Sbjct: 295 PPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 73/324 (22%), Positives = 137/324 (42%), Gaps = 53/324 (16%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD------NQEVAVKLLDWGEDG 118
+ ++ + L + + +G +GSV YD VAVK L G
Sbjct: 7 HHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSG 64
Query: 119 MATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPAR 178
+ FQ+E+ + + L + K+ G S G +
Sbjct: 65 PDQQRD-------FQREIQILKALHSDFIVKYRGVSYGPGRQSL---------------- 101
Query: 179 ACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+V+EYLP G L+ +L + R +L ++ + + +G+ YL S++ VHRD+ N+
Sbjct: 102 --RLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGI 295
L++S+ +KIADFG+A++ + + + APE L ++R+ DV+SFG+
Sbjct: 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218
Query: 296 CLWEIY-CCDMPY--------------PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIM 340
L+E++ CD + + + + + R P CP+ + +M
Sbjct: 219 VLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL-LEEGQRLPAPPACPAEVHELM 277
Query: 341 RKCWDANAEKRPEMGEVVKMLEAI 364
+ CW + + RP + L+ +
Sbjct: 278 KLCWAPSPQDRPSFSALGPQLDML 301
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-62
Identities = 78/317 (24%), Positives = 125/317 (39%), Gaps = 53/317 (16%)
Query: 69 SQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMAT 121
+ + E+ + + + G +G VY G +VAVK L +
Sbjct: 59 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CS 114
Query: 122 TAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+ F E + K +H N+ + +G S+ +P
Sbjct: 115 EQD----ELDFLMEALIISKFNHQNIVRCIGVSL----QSLP----------------RF 150
Query: 182 VVVEYLPGGNLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236
+++E + GG+LK +L R LA+ ++ +A D++ G YL +HRD+
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 210
Query: 237 NMLLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGY-----MAPEVLQGKPYNRRC 288
N LL R KI DFG+AR + G M PE + +
Sbjct: 211 NCLLTCPGPGRVAKIGDFGMARDIYRA--GYY-RKGGCAMLPVKWMPPEAFMEGIFTSKT 267
Query: 289 DVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
D +SFG+ LWEI+ MPYP S +V V R + P+ CP + IM +CW
Sbjct: 268 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQ 326
Query: 348 AEKRPEMGEVVKMLEAI 364
E RP +++ +E
Sbjct: 327 PEDRPNFAIILERIEYC 343
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 8e-62
Identities = 80/323 (24%), Positives = 132/323 (40%), Gaps = 54/323 (16%)
Query: 69 SQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMAT 121
I + ++ + +G +G V+ N VAVK L
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------ 56
Query: 122 TAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
T A R FQ+E + L H ++ KF G L
Sbjct: 57 ---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL--------------------I 93
Query: 182 VVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKK 227
+V EY+ G+L ++L + + +L L ++ +A ++ G+ YL S+
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYN 285
VHRD+ T N L+ + +KI DFG++R G L +M PE + + +
Sbjct: 154 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 213
Query: 286 RRCDVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCW 344
DV+SFG+ LWEI+ P+ LS +V + Q E PR CP + ++M CW
Sbjct: 214 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-ITQGRVLERPRVCPKEVYDVMLGCW 272
Query: 345 DANAEKRPEMGEVVKMLEAIDTS 367
++R + E+ K+L A+ +
Sbjct: 273 QREPQQRLNIKEIYKILHALGKA 295
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-61
Identities = 80/303 (26%), Positives = 137/303 (45%), Gaps = 41/303 (13%)
Query: 74 EEWEI--DLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETA 126
++ I + +I +G +G VY G Y + + A+K L +
Sbjct: 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ------ 65
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
+F +E + + L+HPNV +G + L V++ Y
Sbjct: 66 --VEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-------------------PHVLLPY 104
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+ G+L Q++ R+ ++ +K +I L ++RG+ YL +K VHRD+ N +LD T+
Sbjct: 105 MCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTV 163
Query: 247 KIADFGVAR-VEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIY- 301
K+ADFG+AR + + + + A E LQ + + DV+SFG+ LWE+
Sbjct: 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
Query: 302 CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
PY + D++ + Q R P CP SL +M++CW+A+ RP +V +
Sbjct: 224 RGAPPYRHIDPFDLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
Query: 362 EAI 364
E I
Sbjct: 283 EQI 285
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-61
Identities = 79/304 (25%), Positives = 135/304 (44%), Gaps = 39/304 (12%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAA 127
EI+ S++ + +I G G V G + VA+K L
Sbjct: 41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK--AGYTERQ----- 93
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
R F E ++ + DHPN+ + G V T +V EY+
Sbjct: 94 -RRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLA------------------MIVTEYM 132
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G+L +L R + + ++ + + G+ YL VHRD+ N+L+DS K
Sbjct: 133 ENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCK 191
Query: 248 IADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC- 303
++DFG++RV +P TG + + APE + + ++ DV+SFG+ +WE+
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
+ PY +++ DV S+ V + R P CP +L +M CW + +RP ++V +L+A
Sbjct: 252 ERPYWNMTNRDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
Query: 364 IDTS 367
+ S
Sbjct: 311 LIRS 314
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-61
Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 59/319 (18%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAE 124
I + ++ + +G +G V+ N VAVK L
Sbjct: 32 DACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------- 82
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
+ + R FQ+E + L H ++ +F G L +V
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL--------------------LMVF 122
Query: 185 EYLPGGNLKQYLIRNR-------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231
EY+ G+L ++L + L L ++ +A ++ G+ YL VHR
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLG-----YMAPEVLQGKPYNR 286
D+ T N L+ +KI DFG++R D G +M PE + + +
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYST--DYY-RVGGRTMLPIRWMPPESILYRKFTT 239
Query: 287 RCDVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWD 345
DV+SFG+ LWEI+ P+ LS + + Q E PR CP + IMR CW
Sbjct: 240 ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-ITQGRELERPRACPPEVYAIMRGCWQ 298
Query: 346 ANAEKRPEMGEVVKMLEAI 364
++R + +V L+A+
Sbjct: 299 REPQQRHSIKDVHARLQAL 317
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 9e-61
Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 42/301 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE-----VAVKLLDWGEDGMATTAETAA 127
++ I + + ++ +G +G VY G Y N + VAVK +D
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK--KDCTLDN----- 56
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+ F E + + LDHP++ K +G + P +++E
Sbjct: 57 -KEKFMSEAVIMKNLDHPHIVKLIG--IIEEE----------------PT---WIIMELY 94
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
P G L YL + L + ++ +L + + ++YL S VHRD+ N+L+ S +K
Sbjct: 95 PYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVK 153
Query: 248 IADFGVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CC 303
+ DFG++R D + T +M+PE + + + DV+ F +C+WEI
Sbjct: 154 LGDFGLSRYIEDE--DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
P+ L DV + + R P CP L +M +CWD + RP E+V L
Sbjct: 212 KQPFFWLENKDVIGV-LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
Query: 364 I 364
+
Sbjct: 271 V 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 42/301 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE-----VAVKLLDWGEDGMATTAETAA 127
++EI ++++ I +G +G V++G Y + E VA+K + +
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--------SDS 58
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+R F QE ++ DHP++ K +G V T N P +++E
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIG--VITEN----------------PV---WIIMELC 97
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G L+ +L + R+ L L +I A LS L+YL SK+ VHRD+ N+L+ S +K
Sbjct: 98 TLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 156
Query: 248 IADFGVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC- 303
+ DFG++R + + +MAPE + + + DV+ FG+C+WEI
Sbjct: 157 LGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
P+ + DV + R +P CP +L ++M KCW + +RP E+ L
Sbjct: 215 VKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273
Query: 364 I 364
I
Sbjct: 274 I 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-60
Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 40/302 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETA 126
K EI S + + +I G +G VY+G VA+K L
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--AGYTEKQ---- 89
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
R F E + + H N+ + G V + + ++ EY
Sbjct: 90 --RVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPM------------------MIITEY 127
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+ G L ++L R + + ++ ++ + ++ G+ YL + VHRD+ N+L++S
Sbjct: 128 MENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186
Query: 247 KIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
K++DFG++RV +P +G + + APE + + + DV+SFGI +WE+
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246
Query: 304 -DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
+ PY +LS +V A + R P CPS++ +M +CW +RP+ ++V +L+
Sbjct: 247 GERPYWELSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
Query: 363 AI 364
+
Sbjct: 306 KL 307
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 75/309 (24%), Positives = 124/309 (40%), Gaps = 37/309 (11%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATT 122
E I L + + G++G V RG + VAVK L D ++
Sbjct: 5 EGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQP 62
Query: 123 AETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
F +EV LDH N+ + G V +
Sbjct: 63 EAMDD----FIREVNAMHSLDHRNLIRLYGV---------------------VLTPPMKM 97
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242
V E P G+L L R + L + + A+ ++ G+ YL SK+ +HRD+ N+LL +
Sbjct: 98 VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 156
Query: 243 QRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
+ +KI DFG+ R QN + + APE L+ + ++ D + FG+ LWE
Sbjct: 157 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 216
Query: 300 IY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
++ P+ L+ + + + ++ R P CP + N+M +CW E RP +
Sbjct: 217 MFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 276
Query: 359 KMLEAIDTS 367
L +
Sbjct: 277 DFLLEAQPT 285
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-60
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 34/281 (12%)
Query: 87 NLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
LI G +G V++ D + +K + + ++EV KLDH
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------------NEKAEREVKALAKLDH 63
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ + G G S S + + + +E+ G L+Q++ + R +KL
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNS----SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 205 ----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
AL++ Q+ G+ Y+HSKK+++RD+K N+ L + +KI DFG+ +N
Sbjct: 120 DKVLALELFEQITK----GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKN 174
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
T GTL YM+PE + + Y + D+Y+ G+ L E+ + S
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFF 228
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361
I +++K E RP E+++ L
Sbjct: 229 TDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-60
Identities = 75/323 (23%), Positives = 130/323 (40%), Gaps = 61/323 (18%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETA 126
E + ++ I +G +G V++ VAVK+L E+ A+
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EE--ASADM-- 93
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
++ FQ+E A+ + D+PN+ K +G + C++ EY
Sbjct: 94 --QADFQREAALMAEFDNPNIVKLLGVCAVGKPM--------------------CLLFEY 131
Query: 187 LPGGNLKQYLIRNR----------------------RKKLALKIVIQLALDLSRGLSYLH 224
+ G+L ++L L+ + +A ++ G++YL
Sbjct: 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191
Query: 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGK 282
+K VHRD+ T N L+ +KIADFG++R + +M PE +
Sbjct: 192 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251
Query: 283 PYNRRCDVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMR 341
Y DV+++G+ LWEI+ PY ++ +V V N P CP L N+MR
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMR 310
Query: 342 KCWDANAEKRPEMGEVVKMLEAI 364
CW RP + ++L+ +
Sbjct: 311 LCWSKLPADRPSFCSIHRILQRM 333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-59
Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 42/301 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE-----VAVKLLDWGEDGMATTAETAA 127
++EI ++++ I +G +G V++G Y + E VA+K + +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--------SDS 433
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+R F QE ++ DHP++ K +G V T N P +++E
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIG--VITEN----------------PV---WIIMELC 472
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G L+ +L + R+ L L +I A LS L+YL SK+ VHRD+ N+L+ S +K
Sbjct: 473 TLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531
Query: 248 IADFGVARVEAQNPRDMTGETGTL---GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC- 303
+ DFG++R + + +MAPE + + + DV+ FG+C+WEI
Sbjct: 532 LGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
P+ + DV + R +P CP +L ++M KCW + +RP E+ L
Sbjct: 590 VKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
Query: 364 I 364
I
Sbjct: 649 I 649
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-59
Identities = 78/318 (24%), Positives = 135/318 (42%), Gaps = 60/318 (18%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE----VAVKLLDWGEDGMATTAETAA 127
P +D + + +++I +G +G V + A+K + A+ +
Sbjct: 16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDD--- 68
Query: 128 LRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
F E+ V KL HPN+ +GA L + +EY
Sbjct: 69 -HRDFAGELEVLCKLGHHPNIINLLGACEHRGYL--------------------YLAIEY 107
Query: 187 LPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232
P GNL +L ++R L+ + ++ A D++RG+ YL K+ +HRD
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLG-----YMAPEVLQGKPYNRR 287
+ N+L+ KIADFG++R + ++ T+G +MA E L Y
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQ-----EVY-VKKTMGRLPVRWMAIESLNYSVYTTN 221
Query: 288 CDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA 346
DV+S+G+ LWEI PY ++ A++ + Q R E P C + ++MR+CW
Sbjct: 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE 280
Query: 347 NAEKRPEMGEVVKMLEAI 364
+RP +++ L +
Sbjct: 281 KPYERPSFAQILVSLNRM 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-59
Identities = 74/316 (23%), Positives = 126/316 (39%), Gaps = 61/316 (19%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAAL 128
EI LS + + + +G VY+G Q VA+K L A
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK----AEGPL---- 55
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
R F+ E + +L HPNV +G + D P ++ Y
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVV-------------TKDQ----PL---SMIFSYCS 95
Query: 189 GGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234
G+L ++L+ + L + L ++ G+ YL S +VH+D+
Sbjct: 96 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA 155
Query: 235 TENMLLDSQRTLKIADFGVAR-VEAQNPRDMTGETGTLG-----YMAPEVLQGKPYNRRC 288
T N+L+ + +KI+D G+ R V A + + +MAPE + ++
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKFSIDS 211
Query: 289 DVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
D++S+G+ LWE++ PY S DV + R P CP+ + +M +CW+
Sbjct: 212 DIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEF 270
Query: 348 AEKRPEMGEVVKMLEA 363
+RP ++ L A
Sbjct: 271 PSRRPRFKDIHSRLRA 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-59
Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 39/301 (12%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAA 127
+ E+D + + + ++ G +G V G VA+K L
Sbjct: 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK--VGYTEKQ----- 89
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
R F E ++ + DHPN+ + G V T + + +V EY+
Sbjct: 90 -RRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPV------------------MIVTEYM 128
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G+L +L R + + ++ + ++ G+ YL VHRD+ N+L++S K
Sbjct: 129 ENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 248 IADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC- 303
++DFG+ RV +P G + + +PE + + + DV+S+GI LWE+
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
+ PY ++S DV A V + R P CP++L +M CW + RP+ ++V +L+
Sbjct: 248 ERPYWEMSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 364 I 364
+
Sbjct: 307 L 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 40/303 (13%)
Query: 74 EEWEIDLSKLDM-RNLIAQGTYGSVYRGTYDNQ----EVAVKLLDWGEDGMATTAETAAL 128
++ + L + + G +GSV +G Y + +VA+K+L G +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------- 53
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+E + +LD+P + + +G A A +V+E
Sbjct: 54 TEEMMREAQIMHQLDNPYIVRLIGV---------------------CQAEALMLVMEMAG 92
Query: 189 GGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI 248
GG L ++L +R+++ + V +L +S G+ YL K VHRD+ N+LL ++ KI
Sbjct: 93 GGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 151
Query: 249 ADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-D 304
+DFG+++ + T + L + APE + + ++ R DV+S+G+ +WE
Sbjct: 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PY + +V + + Q R E P CP L +M CW E RP+ V + + A
Sbjct: 212 KPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
Query: 365 DTS 367
S
Sbjct: 271 YYS 273
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-58
Identities = 85/325 (26%), Positives = 138/325 (42%), Gaps = 61/325 (18%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAE 124
+WE L + + +G +G V + T VAVK+L A+ +E
Sbjct: 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----ASPSE 69
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
E V ++++HP+V K GA S DG P ++V
Sbjct: 70 ----LRDLLSEFNVLKQVNHPHVIKLYGAC-------------SQDG----PL---LLIV 105
Query: 185 EYLPGGNLKQYLIRNR----------------------RKKLALKIVIQLALDLSRGLSY 222
EY G+L+ +L +R + L + +I A +S+G+ Y
Sbjct: 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165
Query: 223 LHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQ 280
L K+VHRD+ N+L+ R +KI+DFG++R + + G + +MA E L
Sbjct: 166 LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225
Query: 281 GKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANI 339
Y + DV+SFG+ LWEI PYP + + + ++ R E P C + +
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-LKTGHRMERPDNCSEEMYRL 284
Query: 340 MRKCWDANAEKRPEMGEVVKMLEAI 364
M +CW +KRP ++ K LE +
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-58
Identities = 62/298 (20%), Positives = 126/298 (42%), Gaps = 40/298 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQ------EVAVKLLDWGEDGMATTAETAALR 129
++L ++ G +G+V++G + + V +K+++ +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--------F 59
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+ + LDH ++ + +G P + +V +YLP
Sbjct: 60 QAVTDHMLAIGSLDHAHIVRLLGL---------------------CPGSSLQLVTQYLPL 98
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G+L ++ R R L ++++ + +++G+ YL +VHR++ N+LL S +++A
Sbjct: 99 GSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA 157
Query: 250 DFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMP 306
DFGVA + + + + +MA E + Y + DV+S+G+ +WE+ P
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
Y L A+V + + R P+ C + +M KCW + RP E+ +
Sbjct: 218 YAGLRLAEVPDL-LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-58
Identities = 65/296 (21%), Positives = 137/296 (46%), Gaps = 40/296 (13%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQ------EVAVKLLDWGEDGMATTAETAALRSS 131
+ ++ ++ G +G+VY+G + + VA+K L E
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKA------NKE 63
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
E V +D+P+V + +G + ++ ++ + +P G
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ---------------------LITQLMPFGC 102
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L Y+ R + + + ++ + +++G++YL +++VHRD+ N+L+ + + +KI DF
Sbjct: 103 LLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 252 GVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPYP 308
G+A++ ++ E G + +MA E + + Y + DV+S+G+ +WE+ PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ +++SS + + R P C + IMRKCW +A+ RP+ E++ +
Sbjct: 222 GIPASEISSI-LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-58
Identities = 78/302 (25%), Positives = 134/302 (44%), Gaps = 40/302 (13%)
Query: 72 PKEEWEIDLSKLDMRN-LIAQGTYGSVYRGTYDNQ----EVAVKLLDWGEDGMATTAETA 126
+E +D L + + + G +G+V +G Y + VAVK+L A
Sbjct: 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-------ANDP 59
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
AL+ E V Q+LD+P + + +G A + +V+E
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGI---------------------CEAESWMLVMEM 98
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
G L +YL +NR + K +I+L +S G+ YL VHRD+ N+LL +Q
Sbjct: 99 AELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156
Query: 247 KIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
KI+DFG+++ + +T + + APE + ++ + DV+SFG+ +WE +
Sbjct: 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216
Query: 304 -DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
PY + ++V++ + + R P CP + ++M CW + E RP V L
Sbjct: 217 GQKPYRGMKGSEVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
Query: 363 AI 364
Sbjct: 276 NY 277
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-57
Identities = 60/314 (19%), Positives = 116/314 (36%), Gaps = 62/314 (19%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATTAETA 126
+I L + QGT+ +++G EV +K+LD
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---------HR 53
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
SF + ++ KL H ++ G V + +V E+
Sbjct: 54 NYSESFFEAASMMSKLSHKHLVLNYG--VCVCGDEN------------------ILVQEF 93
Query: 187 LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+ G+L YL + + + + +++A L+ + +L ++H +V +N+LL +
Sbjct: 94 VKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152
Query: 247 --------KIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQ-GKPYNRRCDVYSFG 294
K++D G++ + + + ++ PE ++ K N D +SFG
Sbjct: 153 KTGNPPFIKLSDPGIS-------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 295 ICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE 353
LWEI D P L + P+ LAN++ C D + RP
Sbjct: 206 TTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLPAPKAAE--LANLINNCMDYEPDHRPS 262
Query: 354 MGEVVKMLEAIDTS 367
+++ L ++ T
Sbjct: 263 FRAIIRDLNSLFTP 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-57
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 52/316 (16%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETA 126
+WE +L + + +G +G V + VAVK+L G AT +E
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSE-- 73
Query: 127 ALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
+ E+ + + H NV +GA + P V+VE
Sbjct: 74 --HRALMSELKILIHIGHHLNVVNLLGAC---TKPGGP----------------LMVIVE 112
Query: 186 YLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231
+ GNL YL R + L L+ +I + +++G+ +L S+K +HR
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172
Query: 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCD 289
D+ N+LL + +KI DFG+AR ++P + L +MAPE + + Y + D
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 290 VYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANA 348
V+SFG+ LWEI+ PYP + + +++ R P + M CW
Sbjct: 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292
Query: 349 EKRPEMGEVVKMLEAI 364
+RP E+V+ L +
Sbjct: 293 SQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 85/326 (26%), Positives = 141/326 (43%), Gaps = 56/326 (17%)
Query: 67 NESQRPKE-EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDG 118
+ +Q P + +WE ++L + G +G V T VAVK+L
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--- 64
Query: 119 MATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPA 177
A E R + E+ V L +H N+ +GA ++ G P
Sbjct: 65 -AHLTE----REALMSELKVLSYLGNHMNIVNLLGAC-------------TIGG----PT 102
Query: 178 RACCVVVEYLPGGNLKQYLIRNR----------------RKKLALKIVIQLALDLSRGLS 221
V+ EY G+L +L R R L L+ ++ + +++G++
Sbjct: 103 ---LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 222 YLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVL 279
+L SK +HRD+ N+LL R KI DFG+AR + + L +MAPE +
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219
Query: 280 QGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLAN 338
Y DV+S+GI LWE++ PYP + ++++ R P P+ + +
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279
Query: 339 IMRKCWDANAEKRPEMGEVVKMLEAI 364
IM+ CWDA+ KRP ++V+++E
Sbjct: 280 IMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-57
Identities = 85/320 (26%), Positives = 139/320 (43%), Gaps = 56/320 (17%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATT 122
+WE KL + + +G +G V + VAVK+L AT
Sbjct: 72 EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATE 127
Query: 123 AETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+ S E+ + + + H N+ +GA T + +
Sbjct: 128 KD----LSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPL------------------Y 163
Query: 182 VVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKK 227
V+VEY GNL++YL R +++ K ++ L+RG+ YL S+K
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYN 285
+HRD+ N+L+ +KIADFG+AR G L +MAPE L + Y
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283
Query: 286 RRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCW 344
+ DV+SFG+ +WEI+ PYP + ++ + ++ R + P C + L +MR CW
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCW 342
Query: 345 DANAEKRPEMGEVVKMLEAI 364
A +RP ++V+ L+ I
Sbjct: 343 HAVPSQRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 85/320 (26%), Positives = 139/320 (43%), Gaps = 56/320 (17%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATT 122
+WE KL + + +G +G V + VAVK+L AT
Sbjct: 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATE 81
Query: 123 AETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+ S E+ + + + H N+ +GA T + +
Sbjct: 82 KD----LSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPL------------------Y 117
Query: 182 VVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKK 227
V+VEY GNL++YL R +++ K ++ L+RG+ YL S+K
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYN 285
+HRD+ N+L+ +KIADFG+AR G L +MAPE L + Y
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 286 RRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCW 344
+ DV+SFG+ +WEI+ PYP + ++ +++ R + P C + L +MR CW
Sbjct: 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LKEGHRMDKPANCTNELYMMMRDCW 296
Query: 345 DANAEKRPEMGEVVKMLEAI 364
A +RP ++V+ L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-57
Identities = 87/320 (27%), Positives = 141/320 (44%), Gaps = 56/320 (17%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN---------QEVAVKLLDWGEDGMATT 122
WE+ +L + + +G +G V +VAVK+L AT
Sbjct: 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATE 115
Query: 123 AETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+ S E+ + + + H N+ +GA T + +
Sbjct: 116 KD----LSDLISEMEMMKMIGKHKNIINLLGAC--TQDGPL------------------Y 151
Query: 182 VVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKK 227
V+VEY GNL++YL R ++L+ K ++ A ++RG+ YL SKK
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211
Query: 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYN 285
+HRD+ N+L+ +KIADFG+AR G L +MAPE L + Y
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271
Query: 286 RRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCW 344
+ DV+SFG+ LWEI+ PYP + ++ +++ R + P C + L +MR CW
Sbjct: 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCW 330
Query: 345 DANAEKRPEMGEVVKMLEAI 364
A +RP ++V+ L+ I
Sbjct: 331 HAVPSQRPTFKQLVEDLDRI 350
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-56
Identities = 77/327 (23%), Positives = 143/327 (43%), Gaps = 40/327 (12%)
Query: 50 KSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNL-IAQGTYGSVYRGTYDNQ--- 105
K M ++ + + + ++ + L + ++ + G +GSV +G Y +
Sbjct: 304 KPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ 363
Query: 106 -EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPS 164
+VA+K+L G + +E + +LD+P + + +G
Sbjct: 364 IDVAIKVLKQGTEKAD--------TEEMMREAQIMHQLDNPYIVRLIGV----------- 404
Query: 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH 224
A A +V+E GG L ++L +R+++ + V +L +S G+ YL
Sbjct: 405 ----------CQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGT---LGYMAPEVLQG 281
K VHR++ N+LL ++ KI+DFG+++ + T + L + APE +
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 282 KPYNRRCDVYSFGICLWEIY-CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIM 340
+ ++ R DV+S+G+ +WE PY + +V + + Q R E P CP L +M
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALM 572
Query: 341 RKCWDANAEKRPEMGEVVKMLEAIDTS 367
CW E RP+ V + + A S
Sbjct: 573 SDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 79/323 (24%), Positives = 130/323 (40%), Gaps = 54/323 (16%)
Query: 67 NESQRPK-EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDG 118
+ +Q P E+WE + L + G +G V T +VAVK+L
Sbjct: 31 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--- 87
Query: 119 MATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPA 177
A E + + E+ + L H N+ +GA T +
Sbjct: 88 -AHADE----KEALMSELKIMSHLGQHENIVNLLGAC--THGGPV--------------- 125
Query: 178 RACCVVVEYLPGGNLKQYLIRNRR------------KKLALKIVIQLALDLSRGLSYLHS 225
V+ EY G+L +L R R + + ++ + +++G+++L S
Sbjct: 126 ---LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182
Query: 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGKP 283
K +HRDV N+LL + KI DFG+AR + + L +MAPE +
Sbjct: 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 242
Query: 284 YNRRCDVYSFGICLWEIYCC-DMPYP-DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMR 341
Y + DV+S+GI LWEI+ PYP L + V+ + P P ++ +IM+
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL-VKDGYQMAQPAFAPKNIYSIMQ 301
Query: 342 KCWDANAEKRPEMGEVVKMLEAI 364
CW RP ++ L+
Sbjct: 302 ACWALEPTHRPTFQQICSFLQEQ 324
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-55
Identities = 76/323 (23%), Positives = 128/323 (39%), Gaps = 60/323 (18%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETA 126
+WE L+ ++ G +G V T + +VAVK+L A ++E
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSE-- 91
Query: 127 ALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
R + E+ + +L H N+ +GA T + I ++ E
Sbjct: 92 --REALMSELKMMTQLGSHENIVNLLGAC--TLSGPI------------------YLIFE 129
Query: 186 YLPGGNLKQYLIRNR---------------------RKKLALKIVIQLALDLSRGLSYLH 224
Y G+L YL R L + ++ A +++G+ +L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189
Query: 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTL--GYMAPEVLQGK 282
K VHRD+ N+L+ + +KI DFG+AR + + L +MAPE L
Sbjct: 190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249
Query: 283 PYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMR 341
Y + DV+S+GI LWEI+ PYP + +++ + + P + IM+
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ 309
Query: 342 KCWDANAEKRPEMGEVVKMLEAI 364
CW ++ KRP + L
Sbjct: 310 SCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-54
Identities = 63/296 (21%), Positives = 135/296 (45%), Gaps = 40/296 (13%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSS 131
+ ++ ++ G +G+VY+G + VA+K L +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKE 63
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
E V +D+P+V + +G + ++ ++ + +P G
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ---------------------LITQLMPFGC 102
Query: 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADF 251
L Y+ R + + + ++ + +++G++YL +++VHRD+ N+L+ + + +KI DF
Sbjct: 103 LLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 252 GVARVEAQNPRDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIY-CCDMPYP 308
G+A++ ++ E G + +MA E + + Y + DV+S+G+ +WE+ PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ +++SS + + R P C + IM KCW +A+ RP+ E++ +
Sbjct: 222 GIPASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 62/302 (20%), Positives = 130/302 (43%), Gaps = 38/302 (12%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATT 122
S + + + K I +G++G T D ++ +K ++ M
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS--RM--- 62
Query: 123 AETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
++ R ++EVAV + HPN+ ++ + +L +
Sbjct: 63 --SSKEREESRREVAVLANMKHPNIVQYRESFEENGSL--------------------YI 100
Query: 183 VVEYLPGGNLKQYLIRNRRKKL----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
V++Y GG+L + + + L +Q+ L L ++H +KI+HRD+K++N+
Sbjct: 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL----ALKHVHDRKILHRDIKSQNI 156
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
L T+++ DFG+ARV GT Y++PE+ + KPYN + D+++ G L+
Sbjct: 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
E+ + S ++ ++ + P + L +++ + + N RP + ++
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 359 KM 360
+
Sbjct: 276 EK 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 45/302 (14%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
S + ++ QG +G V + D++ A+K + E+ S+ EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE----------KLSTILSEVM 54
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ L+H V ++ A + N P + +EY G L +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST-------LFIQMEYCENGTLYDLIH 107
Query: 198 RNRR---KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+ ++ Q+ LSY+HS+ I+HRD+K N+ +D R +KI DFG+A
Sbjct: 108 SENLNQQRDEYWRLFRQILE----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 255 RV--------------EAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWE 299
+ + ++T GT Y+A EVL G YN + D+YS GI +E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 300 IYCCDMPYPDLSFADVSSAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+ + ++ + ++ P+ I+R D + KRP +
Sbjct: 224 MIY--PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
Query: 358 VK 359
+
Sbjct: 282 LN 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 56/295 (18%), Positives = 112/295 (37%), Gaps = 50/295 (16%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G +G V+ + D+ A+K + R +EV KL+HP
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIR--------LPNRELAREKVMREVKALAKLEHP 63
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK--- 202
+ ++ A + + K + + ++ NLK ++
Sbjct: 64 GIVRYFNAWLEKNT---TEKLQPSSPKVYL-----YIQMQLCRKENLKDWMNGRCTIEER 115
Query: 203 --KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV---- 256
+ L I +Q+A + +LHSK ++HRD+K N+ +K+ DFG+
Sbjct: 116 ERSVCLHIFLQIAE----AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 257 --------EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308
TG+ GT YM+PE + G Y+ + D++S G+ L+E+ P+
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF- 227
Query: 309 DLSFADVSSAVVRQNLR----PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ ++R P + +++ + +RPE +++
Sbjct: 228 ---STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 43/286 (15%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G+YG R D + + K LD+G M T A + EV + ++L HP
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYG--SM-----TEAEKQMLVSEVNLLRELKHP 65
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK-- 203
N+ ++ + +N + +V+EY GG+L + + +++
Sbjct: 66 NIVRYYDRIIDRTNTTL------------------YIVMEYCEGGDLASVITKGTKERQY 107
Query: 204 ----LALKIVIQLALDLSRGLSYLHSKK-----IVHRDVKTENMLLDSQRTLKIADFGVA 254
L+++ QL L L H + ++HRD+K N+ LD ++ +K+ DFG+A
Sbjct: 108 LDEEFVLRVMTQLTL----ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
Query: 255 RVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
R+ + GT YM+PE + YN + D++S G L+E+ P+ S +
Sbjct: 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360
++ + R IP L I+ + + RP + E+++
Sbjct: 224 LAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 9e-52
Identities = 62/309 (20%), Positives = 127/309 (41%), Gaps = 43/309 (13%)
Query: 65 SRNESQRPKEEWEIDLSKLD---MRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGM 119
+ ++ + L + I +G + VYR D VA+K + +
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD--- 69
Query: 120 ATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARA 179
A R+ +E+ + ++L+HPNV K+ + + + L
Sbjct: 70 ---LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL------------------- 107
Query: 180 CCVVVEYLPGGNLKQYLIRNRRKK------LALKIVIQLALDLSRGLSYLHSKKIVHRDV 233
+V+E G+L + + +++K K +QL L ++HS++++HRD+
Sbjct: 108 -NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHSRRVMHRDI 162
Query: 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSF 293
K N+ + + +K+ D G+ R + GT YM+PE + YN + D++S
Sbjct: 163 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 294 GICLWEIYCCDMPY--PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
G L+E+ P+ ++ + + + + P L ++ C + + EKR
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
Query: 352 PEMGEVVKM 360
P++ V +
Sbjct: 283 PDVTYVYDV 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 41/301 (13%)
Query: 65 SRNESQRPKEEWEIDLSKLD-------MRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWG 115
RN+ Q EE E + I +G++ +VY+G T EVA L
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ-- 60
Query: 116 EDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAV 175
T + R F++E + + L HPN+ +F + T K
Sbjct: 61 -----DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-------------- 101
Query: 176 PARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDV 233
+ +V E + G LK YL R K + +K++ + +GL +LH++ I+HRD+
Sbjct: 102 --KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157
Query: 234 KTENMLLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYS 292
K +N+ + ++KI D G+A ++ + GT +MAPE+ + K Y+ DVY+
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMYEEK-YDESVDVYA 214
Query: 293 FGICLWEIYCCDMPYPDLS-FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
FG+C+ E+ + PY + A + V + + I+ C N ++R
Sbjct: 215 FGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274
Query: 352 P 352
Sbjct: 275 Y 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-51
Identities = 64/317 (20%), Positives = 115/317 (36%), Gaps = 42/317 (13%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATT 122
R ID + +G + V G +D A+K + E
Sbjct: 13 GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--- 69
Query: 123 AETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
R Q+E + + +HPN+ + V + K +
Sbjct: 70 ------REEAQREADMHRLFNHPNILRLVAYCLRERGAK----------------HEAWL 107
Query: 183 VVEYLPGGNLKQYLIRNRRKKLAL--KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
++ + G L + R + K L ++ L L + RGL +H+K HRD+K N+LL
Sbjct: 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL 167
Query: 241 DSQRTLKIADFGVARV---------EAQNPRDMTGETGTLGYMAPEVLQGKPY---NRRC 288
+ + D G +A +D + T+ Y APE+ + + + R
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 289 DVYSFGICLWEIYCCDMPY-PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
DV+S G L+ + + PY D + V+ L S+L ++ +
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVD 287
Query: 348 AEKRPEMGEVVKMLEAI 364
+RP + ++ LEA+
Sbjct: 288 PHQRPHIPLLLSQLEAL 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-48
Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 52/338 (15%)
Query: 31 GTGSLSSK---DMLFRADKIDLKSLDMQLEKHLSW----VWSRNESQRPKEEWEIDLSKL 83
G+GS+SS + A S +Q + V + + E+ ++ +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 84 DMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ + +G++G V+R + AVK + L +E+
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------------LEVFRVEELVACAG 106
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L P + GA + I +E L GG+L Q + +
Sbjct: 107 LSSPRIVPLYGAVREGPWVNI--------------------FMELLEGGSLGQLI--KQM 144
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ-RTLKIADFGVARVEAQN 260
L + GL YLH+++I+H DVK +N+LL S + DFG A +
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 261 PRDMTGET-----GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
+ T GT +MAPEV+ GKP + + D++S + + P+ +
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264
Query: 316 SSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ + EIP C A +++ R
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 60/311 (19%), Positives = 101/311 (32%), Gaps = 67/311 (21%)
Query: 67 NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAE 124
R E+ I G +GSV++ D A+K G
Sbjct: 4 GMKSRYTTEFHEL-------EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD--- 53
Query: 125 TAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVV 183
+ +EV L H +V ++ A ++ +
Sbjct: 54 ----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM--------------------LIQ 89
Query: 184 VEYLPGGNLKQYLIRNRRKKLALK--IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
EY GG+L + N R K + L L + RGL Y+HS +VH D+K N+ +
Sbjct: 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 242 -------------------SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG- 281
++ KI D G + E G ++A EVLQ
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQV-EEGDSRFLANEVLQEN 205
Query: 282 KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMR 341
+ + D+++ + + P P +RQ P IP+ +++
Sbjct: 206 YTHLPKADIFALALTVVCA-AGAEPLP---RNGDQWHEIRQGRLPRIPQVLSQEFTELLK 261
Query: 342 KCWDANAEKRP 352
+ E+RP
Sbjct: 262 VMIHPDPERRP 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 77/299 (25%), Positives = 136/299 (45%), Gaps = 50/299 (16%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAET 125
+ + E++ + + R ++ +GTYG VY G + +A+K + + +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS----- 63
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
+E+A+ + L H N+ +++G+ +KI +E
Sbjct: 64 ----QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI--------------------FME 99
Query: 186 YLPGGNLKQYLIRNRRKKLALK--IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
+PGG+L L+R++ L + + GL YLH +IVHRD+K +N+L+++
Sbjct: 100 QVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY 158
Query: 244 R-TLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLWE 299
LKI+DFG + R+ NP T TGTL YMAPE++ P Y + D++S G + E
Sbjct: 159 SGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
Query: 300 IYCCDMPYPDLS------FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ P+ +L F V + PEIP + + KC++ + +KR
Sbjct: 218 MATGKPPFYELGEPQAAMF-----KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 51/302 (16%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATT 122
SR ES ++ ++ + + G+YG V++ D + AVK
Sbjct: 49 SRPES-FFQQSFQRL-------SRLGHGSYGEVFKVRSKEDGRLYAVKRSM--SPFRGPK 98
Query: 123 AETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
L EV +K+ HP + A L
Sbjct: 99 DRARKL-----AEVGSHEKVGQHPCCVRLEQAWEEGGIL--------------------Y 133
Query: 182 VVVEYLPGGNLKQYLIRNRRK---KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+ E G +L+Q+ + L L++LHS+ +VH DVK N+
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL----ALAHLHSQGLVHLDVKPANI 188
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
L + K+ DFG+ E G YMAPE+LQG Y DV+S G+ +
Sbjct: 189 FLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQG-SYGTAADVFSLGLTIL 246
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358
E+ C+M P + + + L PE S L +++ + + + R ++
Sbjct: 247 EV-ACNMELP--HGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL 303
Query: 359 KM 360
+
Sbjct: 304 AL 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 79/320 (24%), Positives = 126/320 (39%), Gaps = 88/320 (27%)
Query: 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSS------FQQEVAVWQ 140
N + +G +G VY+G +N VAVK L D ++ F QE+ V
Sbjct: 37 NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVD-----------ITTEELKQQFDQEIKVMA 85
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV-------VVEYLPGGNLK 193
K H N+ + +G V Y+P G+L
Sbjct: 86 KCQHENLVELLG---------------------------FSSDGDDLCLVYVYMPNGSLL 118
Query: 194 QYL-IRNRRKKLA----LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI 248
L + L+ KI A + G+++LH +HRD+K+ N+LLD T KI
Sbjct: 119 DRLSCLDGTPPLSWHMRCKI----AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKI 174
Query: 249 ADFGVARVEAQNPRDMTGET----GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-- 302
+DFG+AR + T T GT YMAPE L+G+ + D+YSFG+ L EI
Sbjct: 175 SDFGLARASEKF--AQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGL 231
Query: 303 --CDMPYPDLSFADVSSAVVRQNLR----------PEIPRCCPSSL---ANIMRKCWDAN 347
D D + + ++ +S+ ++ +C
Sbjct: 232 PAVDEHREPQLLLD----IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEK 287
Query: 348 AEKRPEMGEVVKMLEAIDTS 367
KRP++ +V ++L+ + S
Sbjct: 288 KNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 9e-46
Identities = 80/312 (25%), Positives = 135/312 (43%), Gaps = 75/312 (24%)
Query: 84 DMRNLIAQGTYGSVYRGT-YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
D + LI G +G VY+G D +VA+K + E F+ E+
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE-------FETEIETLSFC 92
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV-------VVEYLPGGNLKQY 195
HP++ +G C + +Y+ GNLK++
Sbjct: 93 RHPHLVSLIG---------------------------FCDERNEMILIYKYMENGNLKRH 125
Query: 196 LIRNRRKKLAL--KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
L + +++ + +++ + +RGL YLH++ I+HRDVK+ N+LLD KI DFG+
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 254 ARVEAQNPRDMTGET-------GTLGYMAPE-VLQGKPYNRRCDVYSFGICLWEIYC--- 302
++ + +T GTLGY+ PE ++G+ + DVYSFG+ L+E+ C
Sbjct: 186 SKKGTE-----LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARS 239
Query: 303 ---CDMPYPDLSFAD---------VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEK 350
+P ++ A+ +V NL +I + KC ++E
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 351 RPEMGEVVKMLE 362
RP MG+V+ LE
Sbjct: 300 RPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 84/319 (26%)
Query: 84 DMRNLIAQGTYGSVYRGT-YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+N++ +G +G VY+G D VAVK L E + FQ EV +
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLK-EERTQGGELQ-------FQTEVEMISMA 84
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV-------VVEYLPGGNLKQY 195
H N+ + G C+ V Y+ G++
Sbjct: 85 VHRNLLRLRG---------------------------FCMTPTERLLVYPYMANGSVASC 117
Query: 196 LIRNRRKKLAL------KIVIQLALDLSRGLSYLHSK---KIVHRDVKTENMLLDSQRTL 246
L + L +I AL +RGL+YLH KI+HRDVK N+LLD +
Sbjct: 118 LRERPESQPPLDWPKRQRI----ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 247 KIADFGVARVEAQNPRDMTGET----GTLGYMAPE-VLQGKPYNRRCDVYSFGICLWEIY 301
+ DFG+A++ T T GT+G++APE + GK + + DV+ +G+ L E+
Sbjct: 174 VVGDFGLAKL---MDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELI 229
Query: 302 CCDMPYPDLSFADVSSA------------------VVRQNLRPEIPRCCPSSLANIMRKC 343
+ DL+ +V +L+ L + C
Sbjct: 230 TGQRAF-DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLC 288
Query: 344 WDANAEKRPEMGEVVKMLE 362
++ +RP+M EVV+MLE
Sbjct: 289 TQSSPMERPKMSEVVRMLE 307
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-44
Identities = 60/333 (18%), Positives = 120/333 (36%), Gaps = 79/333 (23%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G +G V+ + D+ A+K + +A R +EV KL+HP
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--------REKVMREVKALAKLEHP 64
Query: 146 NVTKFVGASVGT------------------------------------SNLKIPSKTASV 169
+ ++ A + T + S +V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 170 DGNAAVPARAC-CVVVEYLPGGNLKQYL-----IRNRRKKLALKIVIQLALDLSRGLSYL 223
+ + ++ NLK ++ + +R + L I IQ+A + +L
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFL 180
Query: 224 HSKKIVHRDVKTENMLLDSQRTLKIADFGVARV------------EAQNPRDMTGETGTL 271
HSK ++HRD+K N+ +K+ DFG+ TG+ GT
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 272 GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR----PE 327
YM+PE + G Y+ + D++S G+ L+E+ + + ++R P
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQM----ERVRIITDVRNLKFPL 293
Query: 328 IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360
+ +++ + +RPE ++++
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 50/288 (17%), Positives = 105/288 (36%), Gaps = 48/288 (16%)
Query: 87 NLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G V++ + Q A+K ++ S++ E+A KL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVN-------LEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 146 N--VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
+ + + + + +V+E +L +L + +K
Sbjct: 68 SDKIIRLYDYEITDQYI--------------------YMVMEC-GNIDLNSWLKK--KKS 104
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ ++ + +H IVH D+K N L+ LK+ DFG+A +
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTS 163
Query: 264 MTGET--GTLGYMAPEVLQGKP-----------YNRRCDVYSFGICLWEIYCCDMPYPDL 310
+ ++ GT+ YM PE ++ + + DV+S G L+ + P+ +
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 311 -SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+ A++ N E P L ++++ C + ++R + E+
Sbjct: 224 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 50/288 (17%), Positives = 105/288 (36%), Gaps = 48/288 (16%)
Query: 87 NLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G V++ + Q A+K ++ S++ E+A KL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVN-------LEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 146 N--VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
+ + + + + +V+E +L +L + +K
Sbjct: 87 SDKIIRLYDYEITDQYI--------------------YMVMEC-GNIDLNSWLKK--KKS 123
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ ++ + +H IVH D+K N L+ LK+ DFG+A +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTS 182
Query: 264 MTGET--GTLGYMAPEVLQGKP-----------YNRRCDVYSFGICLWEIYCCDMPYPDL 310
+ ++ GT+ YM PE ++ + + DV+S G L+ + P+ +
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 311 -SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
+ A++ N E P L ++++ C + ++R + E+
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-42
Identities = 76/322 (23%), Positives = 135/322 (41%), Gaps = 47/322 (14%)
Query: 64 WSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMAT 121
R++S + E+ +L +R ++A+G + VY + +E A+K L
Sbjct: 11 SGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL-------- 62
Query: 122 TAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARAC 180
+ E R+ QEV +KL HPN+ +F A+ K S G A
Sbjct: 63 SNEEEKNRAI-IQEVCFMKKLSGHPNIVQFCSAA-------SIGKEESDTGQAEF----- 109
Query: 181 CVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTEN 237
+++ L G L ++L + R L+ V+++ R + ++H +K I+HRD+K EN
Sbjct: 110 -LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVEN 168
Query: 238 MLLDSQRTLKIADFGVARVEAQNPR------------DMTGETGTLGYMAPEVL---QGK 282
+LL +Q T+K+ DFG A + P + T Y PE++
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 283 PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRK 342
P + D+++ G L+ + P+ D + +V + +++R
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRA 284
Query: 343 CWDANAEKRPEMGEVVKMLEAI 364
N E+R + EVV L+ I
Sbjct: 285 MLQVNPEERLSIAEVVHQLQEI 306
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-42
Identities = 76/346 (21%), Positives = 130/346 (37%), Gaps = 64/346 (18%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAA 127
+WE +L + + +G +G V + VAVK+L G AT +E A
Sbjct: 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRA 71
Query: 128 LRSSFQQEVAVWQKLD-HPNVTKFVGA--------------------------------- 153
E+ + + H NV +GA
Sbjct: 72 ----LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
Query: 154 ----------SVGTSNLKIPSKTASVDGNAAVPARACCVVVE--YLPGGNLKQYLIRNRR 201
+D + + A VE L ++ +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
L L+ +I + +++G+ +L S+K +HRD+ N+LL + +KI DFG+AR ++P
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
Query: 262 RDMTGETGTL--GYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSA 318
+ L +MAPE + + Y + DV+SFG+ LWEI+ PYP + +
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+++ R P + M CW +RP E+V+ L +
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 51/310 (16%), Positives = 108/310 (34%), Gaps = 48/310 (15%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTA 123
S E + + I G V++ + Q A+K ++
Sbjct: 40 DDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN-------LEE 92
Query: 124 ETAALRSSFQQEVAVWQKLDHPN--VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
S++ E+A KL + + + + +
Sbjct: 93 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI--------------------Y 132
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
+V+E +L +L + +K + ++ + +H IVH D+K N L+
Sbjct: 133 MVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189
Query: 242 SQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKP-----------YNRRC 288
LK+ DFG+A + + ++ G + YM PE ++ + +
Sbjct: 190 DGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 289 DVYSFGICLWEIYCCDMPYPDL-SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
DV+S G L+ + P+ + + A++ N E P L ++++ C +
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRD 308
Query: 348 AEKRPEMGEV 357
++R + E+
Sbjct: 309 PKQRISIPEL 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 70/292 (23%), Positives = 133/292 (45%), Gaps = 40/292 (13%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALR 129
K +W ++ ++ + +G +G+VY R +A+K+L E A +
Sbjct: 2 KKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF------KAQLEKAGVE 53
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
++EV + L HPN+ + G ++ +++EY P
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYG--YFHDATRV------------------YLILEYAPL 93
Query: 190 GNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G + + L + + ++ + +LA LSY HSK+++HRD+K EN+LL S LK
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELAN----ALSYCHSKRVIHRDIKPENLLLGSAGELK 149
Query: 248 IADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307
IADFG + V A + R GTL Y+ PE+++G+ ++ + D++S G+ +E P+
Sbjct: 150 IADFGWS-VHAPSSRRTD-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++ + + R P +++ + N +RP + EV++
Sbjct: 208 EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 42/313 (13%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+M+ + G +G V R ++VA+K + R + E+ + +K
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR--------QELSPKNRERWCLEIQIMKK 68
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L+HPNV ++P P + +EY GG+L++YL +
Sbjct: 69 LNHPNVVSA---------REVPD-----GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 202 K-----KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS---QRTLKIADFGV 253
++ ++ L YLH +I+HRD+K EN++L + KI D G
Sbjct: 115 CCGLKEGPIRTLLSDISS----ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170
Query: 254 ARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
A+ Q T GTL Y+APE+L+ K Y D +SFG +E P+
Sbjct: 171 AKELDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
Query: 314 DVSSAVVRQNLRPEIPRC-CPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI---DTSKG 369
VR+ I + N G++ + L+ + +
Sbjct: 230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289
Query: 370 GGMIPEDQATGCF 382
G P++ GCF
Sbjct: 290 GT-DPQNPNVGCF 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 69/295 (23%), Positives = 136/295 (46%), Gaps = 40/295 (13%)
Query: 69 SQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETA 126
++ PK ++ ID D+ + +G +G+VY R + +A+K+L + E
Sbjct: 4 AEMPKRKFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF------KSQLEKE 55
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
+ ++E+ + L HPN+ + +I +++E+
Sbjct: 56 GVEHQLRREIEIQSHLRHPNILRMYN--YFHDRKRI------------------YLMLEF 95
Query: 187 LPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
P G L + L ++ R ++ + + +LA L Y H +K++HRD+K EN+L+ +
Sbjct: 96 APRGELYKELQKHGRFDEQRSATFMEELAD----ALHYCHERKVIHRDIKPENLLMGYKG 151
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
LKIADFG + V A + R T GTL Y+ PE+++GK ++ + D++ G+ +E
Sbjct: 152 ELKIADFGWS-VHAPSLRRRT-MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P+ S + +V +L+ P +++ K + +R + V++
Sbjct: 210 PPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P++ W+ L I +G YGSV + + Q +AVK + +T E +
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR------STVDE--KEQ 64
Query: 130 SSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
++ V + D P + +F GA + I +E +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI--------------------CMELMS 104
Query: 189 GGNLKQY--LIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRT 245
K Y + + +I+ ++ L + L++L KI+HRD+K N+LLD
Sbjct: 105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN 164
Query: 246 LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG----KPYNRRCDVYSFGICLWEIY 301
+K+ DFG++ + + T + G YMAPE + + Y+ R DV+S GI L+E+
Sbjct: 165 IKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 302 CCDMPYPDL-SFADVSSAVVRQN---LRPEIPRCCPSSLANIMRKCWDANAEKRP 352
PYP S D + VV+ + L R S N + C + KRP
Sbjct: 224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 52/285 (18%), Positives = 100/285 (35%), Gaps = 55/285 (19%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ +++ QG +V+RG A+K+ + +E V +K
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFN--------NISFLRPVDVQMREFEVLKK 63
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L+H N+ K T+ +++E+ P G+L L
Sbjct: 64 LNHKNIVKLFAIEEETTTRHK------------------VLIMEFCPCGSLYTVLEEPSN 105
Query: 202 K-----KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL----DSQRTLKIADFG 252
L ++ + G+++L IVHR++K N++ D Q K+ DFG
Sbjct: 106 AYGLPESEFLIVLRDVV----GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQG--------KPYNRRCDVYSFGICLWEIYCCD 304
AR + GT Y+ P++ + K Y D++S G+ +
Sbjct: 162 AARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAE 349
+P F + + +I PS + ++K + +
Sbjct: 221 LP-----FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 68/312 (21%), Positives = 122/312 (39%), Gaps = 51/312 (16%)
Query: 65 SRNESQRPKEEWEIDLSKL--DMRNLIAQGTYGS-VYRGTYDNQEVAVKLLDWGEDGMAT 121
S + +E + + K+ ++++ G G+ VYRG +DN++VAVK +
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------- 57
Query: 122 TAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARAC 180
S +EV + ++ D HPNV ++ I
Sbjct: 58 ----PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI------------------ 95
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
+E L++Y + + I L + GL++LHS IVHRD+K N+L+
Sbjct: 96 --AIELC-AATLQEY-VEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151
Query: 241 -----DSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQG---KPYNRRCD 289
+ I+DFG+ + A +G GT G++APE+L + D
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 290 VYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLA-NIMRKCWDAN 347
++S G + + P+ + + +L P +A ++ K +
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 348 AEKRPEMGEVVK 359
+KRP V+K
Sbjct: 272 PQKRPSAKHVLK 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 72/321 (22%), Positives = 136/321 (42%), Gaps = 43/321 (13%)
Query: 48 DLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQ 105
L+ L++ ++ + ++ E+ + + + G G V++ ++
Sbjct: 3 KLEELELDEQQRKR---LEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGL 59
Query: 106 EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSK 165
+A KL+ A+R+ +E+ V + + P + F GA + I
Sbjct: 60 VMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI--- 108
Query: 166 TASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS 225
+E++ GG+L Q L + ++ +I+ ++++ + +GL+YL
Sbjct: 109 -----------------CMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 226 K-KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGE-TGTLGYMAPEVLQGKP 283
K KI+HRDVK N+L++S+ +K+ DFGV+ Q M GT YM+PE LQG
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH 206
Query: 284 YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKC 343
Y+ + D++S G+ L E+ P P ++ Q P R
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV--EGDAAETPPRPRTPGRPL 264
Query: 344 WDANAEKRPEMGEVVKMLEAI 364
+ RP M + ++L+ I
Sbjct: 265 NKFGMDSRPPMA-IFELLDYI 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 56/274 (20%)
Query: 45 DKIDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-- 102
+ + L++ + K L + P+E +++ + +G+YGSVY+ +
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQ---PEEVFDV-------LEKLGEGSYGSVYKAIHKE 52
Query: 103 DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162
Q VA+K + D +E+++ Q+ D P+V K+ G+ ++L I
Sbjct: 53 TGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101
Query: 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA---LKIVIQLALDLSRG 219
V+EY G++ +IR R K L + ++Q L +G
Sbjct: 102 --------------------VMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTL---KG 137
Query: 220 LSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET---GTLGYMAP 276
L YLH + +HRD+K N+LL+++ K+ADFGVA Q M GT +MAP
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAP 194
Query: 277 EVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310
EV+Q YN D++S GI E+ PY D+
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 53/295 (17%), Positives = 100/295 (33%), Gaps = 62/295 (21%)
Query: 67 NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAE 124
W + +++ QG +V+RG A+K+ +
Sbjct: 2 GSQSTSNHLWLLS-------DILGQGATANVFRGRHKKTGDLFAIKVFN--------NIS 46
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
+E V +KL+H N+ K T+ +++
Sbjct: 47 FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK------------------VLIM 88
Query: 185 EYLPGGNLKQYLIRNRRK-----KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
E+ P G+L L L ++ + G+++L IVHR++K N++
Sbjct: 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG----GMNHLRENGIVHRNIKPGNIM 144
Query: 240 L----DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--------KPYNRR 287
D Q K+ DFG AR + + GT Y+ P++ + K Y
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 288 CDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRK 342
D++S G+ + +P F + + +I PS + ++K
Sbjct: 204 VDLWSIGVTFYHAATGSLP-----FRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-39
Identities = 69/254 (27%), Positives = 114/254 (44%), Gaps = 44/254 (17%)
Query: 65 SRNESQRPKEEWEIDLSKL-DMRNLIAQGTYGSVYRGTY--DNQEVAVKL--LDWGEDGM 119
+ + D +L I +G++G V++G + VA+K+ L+ ED +
Sbjct: 5 PVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI 64
Query: 120 ATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARA 179
QQE+ V + D P VTK+ G+ + + L I
Sbjct: 65 ----------EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI----------------- 97
Query: 180 CCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239
++EYL GG+ L + + +++ L +GL YLHS+K +HRD+K N+L
Sbjct: 98 ---IMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVL 151
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGET---GTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
L +K+ADFGVA Q GT +MAPEV++ Y+ + D++S GI
Sbjct: 152 LSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 208
Query: 297 LWEIYCCDMPYPDL 310
E+ + P+ +L
Sbjct: 209 AIELARGEPPHSEL 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 53/344 (15%), Positives = 110/344 (31%), Gaps = 70/344 (20%)
Query: 49 LKSLDMQLEKHLSW-VWSRN-ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---- 102
L L + + + W + +PK E+++ + + +L+ +G + VY T
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 103 ---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159
+ Q+ +K+ A E Q + + KF A + +
Sbjct: 91 DAKNKQKFVLKVQK-----PANPWEFYIGT----QLMERLKPSMQHMFMKFYSAHLFQNG 141
Query: 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR---KKLALKIVIQLALDL 216
+V E G L + + K + +VI A+ +
Sbjct: 142 --------------------SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 217 SRGLSYLHSKKIVHRDVKTENMLL-----------DSQRTLKIADFGVARVEAQNPRD-- 263
+ +H +I+H D+K +N +L D L + D G + P+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP--------------YPD 309
T + T G+ E+L KP+N + D + ++ + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 310 LSFADVSSAVVRQ--NLRPEIPRCCPSSLANIMRKCWDANAEKR 351
L D+ + N+ L ++K + + +
Sbjct: 302 LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 54/307 (17%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLL--DWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+ G +VY D N +VA+K + E E R F++EV +L
Sbjct: 18 KLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREK------EETLKR--FEREVHNSSQL 68
Query: 143 DHPNVTKF--VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
H N+ V L V+EY+ G L +Y+
Sbjct: 69 SHQNIVSMIDVDEEDDCYYL----------------------VMEYIEGPTLSEYI--ES 104
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
L++ I + G+ + H +IVHRD+K +N+L+DS +TLKI DFG+A+ ++
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164
Query: 261 PRDMTGET-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319
T GT+ Y +PE +G+ + D+YS GI L+E+ + P+ + + ++
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN----GETAVSI 220
Query: 320 VRQNLRPEIPRC-------CPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGM 372
++++ +P P SL+N++ + + + R + + +M + + +
Sbjct: 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ--EMKDDLSSVLHENR 278
Query: 373 IPEDQAT 379
ED
Sbjct: 279 ANEDVYE 285
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV 138
K I QG G+VY QEVA++ ++ + + E+ V
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---------LQQQPKKELIINEILV 70
Query: 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR 198
++ +PN+ ++ + + L + V+EYL GG+L +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWV--------------------VMEYLAGGSLTDVVTE 110
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
+ + V + L + L +LHS +++HRD+K++N+LL ++K+ DFG A
Sbjct: 111 TCMDEGQIAAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---A 164
Query: 259 QNPRDMTGET---GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311
Q + + + GT +MAPEV+ K Y + D++S GI E+ + PY + +
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 50/264 (18%)
Query: 53 DMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVK 110
Q + L V + + P+ + I +G+ G V ++VAVK
Sbjct: 27 HEQFKAALRMVVDQGD---PRLLLDS-------YVKIGEGSTGIVCLAREKHSGRQVAVK 76
Query: 111 LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVD 170
++D R EV + + H NV + + + L +
Sbjct: 77 MMD---------LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV-------- 119
Query: 171 GNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230
++E+L GG L + + R + + V + L + L+YLH++ ++H
Sbjct: 120 ------------LMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQGVIH 164
Query: 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET---GTLGYMAPEVLQGKPYNRR 287
RD+K++++LL +K++DFG AQ +D+ GT +MAPEV+ Y
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221
Query: 288 CDVYSFGICLWEIYCCDMPYPDLS 311
D++S GI + E+ + PY S
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 38/277 (13%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G + + + + A K++ + R E+++ + L H
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPK------SLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
+V F G N + VV+E +L + R + +
Sbjct: 76 HVVGFHG--FFEDNDFV------------------FVVLELCRRRSLLELHKRRKALTEP 115
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVEAQNPR 262
A + Q+ G YLH +++HRD+K N+ L+ +KI DFG+A +VE R
Sbjct: 116 EARYYLRQIV----LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
GT Y+APEVL K ++ DV+S G ++ + P+ + + +
Sbjct: 172 KKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
IP+ A++++K + RP + E++
Sbjct: 231 EYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 40/326 (12%), Positives = 98/326 (30%), Gaps = 30/326 (9%)
Query: 55 QLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLL 112
+E + VW +N KL + + G V+ ++ A+K+
Sbjct: 36 MVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVF 95
Query: 113 DWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN---VTKFVGASVGTSNLKIPSKTASV 169
G + + E + +L + + + + + S+
Sbjct: 96 TMGAENSRSELE------RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149
Query: 170 DGNAAVPARACC--VVVEYLPGGNLKQYL-----IRNRRKKLALKIVIQLALDLSRGLSY 222
+ A +++ +L+ + R + + L L R +
Sbjct: 150 QLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 223 LHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK 282
L SK +VH +N+ + L + D + + Y E L
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS---SVPVTYAPREFLNAS 266
Query: 283 --PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIP----RCC---P 333
+ + + G+ ++ ++C +P+ ++ S P C P
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP 326
Query: 334 SSLANIMRKCWDANAEKRPEMGEVVK 359
+ ++ + + + +R E ++
Sbjct: 327 DFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 75/308 (24%), Positives = 128/308 (41%), Gaps = 59/308 (19%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLL--DWGEDGMATTAETAALRSSFQQE---VAVW 139
++ G V+ D +++VAVK+L D D + LR F++E A
Sbjct: 19 ILGFGGMSEVHLA-RDLRDHRDVAVKVLRADLARD------PSFYLR--FRREAQNAA-- 67
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASV-D-GNAAVPARACC-VVVEYLPGGNLKQYL 196
L+HP + +V D G A PA +V+EY+ G L+ +
Sbjct: 68 -ALNHPAI-------------------VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 107
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
+ + K I++ D + L++ H I+HRDVK N+++ + +K+ DFG+AR
Sbjct: 108 --HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 257 EAQNPRDMTGET---GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
A + +T GT Y++PE +G + R DVYS G L+E+ + P+
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----G 221
Query: 314 DVSSAVVRQNLRPEIPR------CCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
D +V Q++R + + L ++ K N E R + +M +
Sbjct: 222 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA--EMRADLVRV 279
Query: 368 KGGGMIPE 375
G
Sbjct: 280 HNGEPPEA 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 38/277 (13%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G + + + + A K++ + R E+++ + L H
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPK------SLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
+V F G N + VV+E +L + R + +
Sbjct: 102 HVVGFHG--FFEDNDFV------------------FVVLELCRRRSLLELHKRRKALTEP 141
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA-RVEAQNPR 262
A + Q+ G YLH +++HRD+K N+ L+ +KI DFG+A +VE R
Sbjct: 142 EARYYLRQIV----LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
GT Y+APEVL K ++ DV+S G ++ + P+ + + +
Sbjct: 198 KKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
IP+ A++++K + RP + E++
Sbjct: 257 EYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 62/253 (24%), Positives = 114/253 (45%), Gaps = 56/253 (22%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P E WEI + G +G VY+ A K+++ ++
Sbjct: 17 PNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAKVIE---------TKSEEEL 60
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+ E+ + DHP + K +GA L +++E+ PG
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKL--------------------WIMIEFCPG 100
Query: 190 GNLKQYLIRNRRKKLA---LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
G + ++ + L +++V + L L++LHSK+I+HRD+K N+L+ + +
Sbjct: 101 GAVDA-IMLELDRGLTEPQIQVVCRQML---EALNFLHSKRIIHRDLKAGNVLMTLEGDI 156
Query: 247 KIADFGVARVEAQNPRDMTGET---GTLGYMAPEV-----LQGKPYNRRCDVYSFGICLW 298
++ADFGV+ A+N + + GT +MAPEV ++ PY+ + D++S GI L
Sbjct: 157 RLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213
Query: 299 EIYCCDMPYPDLS 311
E+ + P+ +L+
Sbjct: 214 EMAQIEPPHHELN 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 46/259 (17%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKL--LDWGEDGMATTA 123
W I+ +++ +I G V ++VA+K L+ + M
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---- 57
Query: 124 ETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVV 183
+E+ + HPN+ + + V L +V
Sbjct: 58 ------DELLKEIQAMSQCHHPNIVSYYTSFVVKDEL--------------------WLV 91
Query: 184 VEYLPGGNL----KQYLIRNRRKKLALK-IVIQLAL-DLSRGLSYLHSKKIVHRDVKTEN 237
++ L GG++ K + + K L I L ++ GL YLH +HRDVK N
Sbjct: 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGET-----GTLGYMAPEVL-QGKPYNRRCDVY 291
+LL +++IADFGV+ A + GT +MAPEV+ Q + Y+ + D++
Sbjct: 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 292 SFGICLWEIYCCDMPYPDL 310
SFGI E+ PY
Sbjct: 212 SFGITAIELATGAAPYHKY 230
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 39/286 (13%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
+ + NL+ +G++ VYR + EVA+K++D A + Q EV
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDK------KAMYKAGMVQRVQNEVK 63
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ +L HP++ + + + +V+E G + +YL
Sbjct: 64 IHCQLKHPSILELYN--YFEDSNYV------------------YLVLEMCHNGEMNRYLK 103
Query: 198 RNRRK---KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVA 254
+ A + Q+ G+ YLHS I+HRD+ N+LL +KIADFG+A
Sbjct: 104 NRVKPFSENEARHFMHQII----TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
Query: 255 -RVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
+++ + + T GT Y++PE+ + DV+S G + + P+ +
Sbjct: 160 TQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218
Query: 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + VV + +P +++ + N R + V+
Sbjct: 219 NTLNKVVLADYE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-37
Identities = 75/298 (25%), Positives = 116/298 (38%), Gaps = 51/298 (17%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLD-----------------WGEDGMATTAETAAL 128
I +G+YG V DN A+K+L +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
QE+A+ +KLDHPNV K V V L P++ +V E +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV--EV----LDDPNEDH------------LYMVFELVN 121
Query: 189 GGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G + + + A L G+ YLH +KI+HRD+K N+L+ +K
Sbjct: 122 QGPVMEVPTLKPLSEDQARFYFQDLIK----GIEYLHYQKIIHRDIKPSNLLVGEDGHIK 177
Query: 248 IADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQG--KPYN-RRCDVYSFGICLWEIYC 302
IADFGV+ D GT +MAPE L K ++ + DV++ G+ L+
Sbjct: 178 IADFGVSNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
Query: 303 CDMPYPDLSFADVSSAVVRQNLR-PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P+ D + S + Q L P+ P L +++ + D N E R + E+
Sbjct: 236 GQCPFMDERIMCLHSKIKSQALEFPDQPDIAE-DLKDLITRMLDKNPESRIVVPEIKL 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 74/308 (24%), Positives = 113/308 (36%), Gaps = 60/308 (19%)
Query: 88 LIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
L+ +G G VY D + VA+KL+ T + R+ Q+E +L
Sbjct: 41 LVGRGGMGDVYEA-EDTVRERIVALKLMS------ETLSSDPVFRTRMQREARTAGRLQE 93
Query: 145 PNVTKFVGASV---GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
P+V + G +DG V + + G +L L R
Sbjct: 94 PHV-----VPIHDFGE-----------IDGQLYV-------DMRLINGVDLAAMLRRQGP 130
Query: 202 --KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
A+ IV Q+ L H+ HRDVK EN+L+ + + DFG+A
Sbjct: 131 LAPPRAVAIVRQIG----SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186
Query: 260 NPRDMTGET-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
G T GTL YMAPE R D+Y+ L+E PY D +
Sbjct: 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ----GD-QLS 241
Query: 319 VVRQNLRPEIPR------CCPSSLANIMRKCWDANAEKRPE-MGEVVKMLEAIDTSKGGG 371
V+ ++ IPR P + ++ + N E R G+ + A +
Sbjct: 242 VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGD---LSAAAHAALATA 298
Query: 372 MIPEDQAT 379
+D+AT
Sbjct: 299 --DQDRAT 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 42/296 (14%), Positives = 90/296 (30%), Gaps = 31/296 (10%)
Query: 83 LDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
L ++ Q + T + V + + E + ++EV +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER------PPSNAIKQMKEEVLRLR 133
Query: 141 KLDH----PNVTKFVGASVGTSNLKIPSKTASVD--GNAAVPARACCVVVEYLPGGNLKQ 194
L + +K P K + + + NL+
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 195 YL-----IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+ + K L +QL L + R L+ LH +VH ++ +++LD + + +
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 250 DFGVARVEAQNPRDMTGET-GTLGYMAPEVLQGKP-----YNRRCDVYSFGICLWEIYCC 303
F + + G A +L D ++ G+ ++ I+C
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
D+P D + S + R P + ++ E R + ++
Sbjct: 314 DLPNTDDAALGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRLLPLQAME 363
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 62/289 (21%), Positives = 121/289 (41%), Gaps = 45/289 (15%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
E+ L+ + +G YG V + + Q +AVK + + + +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--------SQEQKRLLM 54
Query: 135 EVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
++ + + D P F GA ++ I +E + K
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWI--------------------CMELMDTSLDK 94
Query: 194 QY-LIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADF 251
Y + ++ + + I+ ++A+ + + L +LHSK ++HRDVK N+L+++ +K+ DF
Sbjct: 95 FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
Query: 252 GVARVEAQNPRDMTGET--GTLGYMAPEV----LQGKPYNRRCDVYSFGICLWEIYCCDM 305
G++ D+ + G YMAPE L K Y+ + D++S GI + E+
Sbjct: 155 GIS---GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
Query: 306 PYPDL-SFADVSSAVVRQNLRPEIPR-CCPSSLANIMRKCWDANAEKRP 352
PY + VV + P++P + + +C N+++RP
Sbjct: 212 PYDSWGTPFQQLKQVVEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERP 259
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 42/261 (16%), Positives = 91/261 (34%), Gaps = 53/261 (20%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLD--------WGE 116
+++ I+ + + QG + + DN+ A+K +
Sbjct: 17 IYLNKYVKEKDKYIN--DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFT 74
Query: 117 DGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVP 176
+ F+ E+ + + + G + T+ ++
Sbjct: 75 KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG--IITNYDEV-------------- 118
Query: 177 ARACCVVVEYLPGGNLKQYLIRNRRKK----------LALKIVIQLALDLSRGLSYLHSK 226
++ EY+ ++ ++ + I+ + SY+H++
Sbjct: 119 ----YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN----SFSYIHNE 170
Query: 227 K-IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKP 283
K I HRDVK N+L+D +K++DFG + + GT +M PE +
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI----KGSRGTYEFMPPEFFSNES 226
Query: 284 --YNRRCDVYSFGICLWEIYC 302
+ D++S GICL+ ++
Sbjct: 227 SYNGAKVDIWSLGICLYVMFY 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 57/290 (19%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSS 131
+ ++ +++ L+ + GT G V++ + +AVK + +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--------KEENKR 69
Query: 132 FQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
++ V K D P + + G + +++ I +E +
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--------------------AMELMGTC 109
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIA 249
K + +I+ ++ + + + L YL K ++HRDVK N+LLD + +K+
Sbjct: 110 AEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLC 167
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCD 304
DFG++ + + G YMAPE + Y+ R DV+S GI L E+
Sbjct: 168 DFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 305 MPYPDL-SFADVSSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRP 352
PY + + +V + V+++ + ++ C + KRP
Sbjct: 227 FPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 65/280 (23%), Positives = 117/280 (41%), Gaps = 46/280 (16%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLD---WGEDGMATTAETAALRSSFQQEVAVWQKLD 143
+ G +G V+ N+EV VK + ED + + E+A+ +++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT----LEIAILSRVE 87
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE-YLPGGNLKQYLIRNRR- 201
H N+ K + + + +V+E + G +L ++ R+ R
Sbjct: 88 HANIIKVL--DIFENQGFF------------------QLVMEKHGSGLDLFAFIDRHPRL 127
Query: 202 -KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+ LA I QL + YL K I+HRD+K EN+++ T+K+ DFG A +
Sbjct: 128 DEPLASYIFRQLV----SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319
T GT+ Y APEVL G PY +++S G+ L+ + + P+ +L + A
Sbjct: 184 KLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEAA 240
Query: 320 VRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ P L +++ E+R + ++V
Sbjct: 241 IH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 43/289 (14%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLD----WGEDGMATTAETAALRSSFQQEVA 137
+ G YG V + E A+K++ E++
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ + LDHPN+ K + V E+ GG L + +I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYL--------------------VTEFYEGGELFEQII 138
Query: 198 RNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFG 252
+ + A I+ Q+ G+ YLH IVHRD+K EN+LL+++ +KI DFG
Sbjct: 139 NRHKFDECDAANIMKQIL----SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312
++ +++ + + GT Y+APEVL+ K YN +CDV+S G+ ++ + C P+ +
Sbjct: 195 LSSFFSKDYK-LRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQND 252
Query: 313 ADVSSAVVRQNL---RPEIPRCCPSSLA-NIMRKCWDANAEKRPEMGEV 357
D+ V + + S A +++ + KR E
Sbjct: 253 QDIIKKVEKGKYYFDFNDWKNI--SDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 45/266 (16%), Positives = 97/266 (36%), Gaps = 40/266 (15%)
Query: 58 KHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQG--TYGSVYRGTY--DNQEVAVKLLD 113
H N + + + ++ +I +G +V Y + V V+ ++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 114 WGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNA 173
A + + + Q E+ V + +HPN+ + + + L
Sbjct: 62 -------LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL------------- 101
Query: 174 AVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233
VV ++ G+ K + + + + + + + L Y+H VHR V
Sbjct: 102 -------WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSV 154
Query: 234 KTENMLLDSQRTLKIADFGV-ARVEAQNPRDMTGET------GTLGYMAPEVLQ--GKPY 284
K ++L+ + ++ + + R L +++PEVLQ + Y
Sbjct: 155 KASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 214
Query: 285 NRRCDVYSFGICLWEIYCCDMPYPDL 310
+ + D+YS GI E+ +P+ D+
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDM 240
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ G YG V + E A+K++ T+ + + S +EVAV +
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-------KTSVSTSSNSKLLEEVAVLKL 92
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
LDHPN+ K N + V+E GG L +I +
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYL--------------------VMECYKGGELFDEIIHRMK 132
Query: 202 --KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARV 256
+ A I+ Q+ G++YLH IVHRD+K EN+LL+S+ +KI DFG++ V
Sbjct: 133 FNEVDAAVIIKQVL----SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316
+ M GT Y+APEVL+ K Y+ +CDV+S G+ L+ + P+ + ++
Sbjct: 189 FENQKK-MKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246
Query: 317 SAVVRQNL---RPEIPRCCPSSLA-NIMRKCWDANAEKRPEMGEV 357
V + PE S A +++++ ++++R +
Sbjct: 247 RKVEKGKYTFDSPEWKNV--SEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 41/283 (14%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ ++ +G++G V QE AVK++ + + + +L +EV + ++
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL----REVQLLKQ 82
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
LDHPN+ K + V E GG L +I +R
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYL--------------------VGEVYTGGELFDEIISRKR 122
Query: 202 --KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARV 256
+ A +I+ Q+ G++Y+H KIVHRD+K EN+LL+S+ ++I DFG++
Sbjct: 123 FSEVDAARIIRQVL----SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316
+ + M + GT Y+APEVL G Y+ +CDV+S G+ L+ + P+ + D+
Sbjct: 179 FEASKK-MKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 317 SAVVRQNLR-PEIPRCCPSSLA-NIMRKCWDANAEKRPEMGEV 357
V + S A +++RK R +
Sbjct: 237 KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 41/317 (12%), Positives = 98/317 (30%), Gaps = 32/317 (10%)
Query: 63 VWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMA 120
+W+ + R + E L ++ Q + T + V + + E
Sbjct: 55 LWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--RP 112
Query: 121 TTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVD--GNAAVPAR 178
+ ++ + + + + +K P K + +
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 179 ACCVVVEYLPGGNLKQYL-----IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233
+ NL+ + + K L +QL L + R L+ LH +VH +
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232
Query: 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----------GK 282
+ +++LD + + + F + + + G+ PE+
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 283 PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRK 342
D ++ G+ ++ I+C D+P + S + R + P + ++
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEG 342
Query: 343 CWDANAEKRPEMGEVVK 359
E R + ++
Sbjct: 343 FLRYPKEDRLLPLQAME 359
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 47/251 (18%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P +E+ L+ GTYG VY+G + Q A+K++D D
Sbjct: 22 PAGIFELV-------ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----------EE 64
Query: 130 SSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+QE+ + +K H N+ + GA + + + + +V+E+
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ--------------LWLVMEFCG 110
Query: 189 GGNLKQYLIRNRRKKLALKIVIQLAL-DLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G++ LI+N + + I ++ RGLS+LH K++HRD+K +N+LL +K
Sbjct: 111 AGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169
Query: 248 IADFGVARVEAQNPRDMTGET---GTLGYMAPEVLQGK-----PYNRRCDVYSFGICLWE 299
+ DFGV+ AQ R + GT +MAPEV+ Y+ + D++S GI E
Sbjct: 170 LVDFGVS---AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 300 IYCCDMPYPDL 310
+ P D+
Sbjct: 227 MAEGAPPLCDM 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 42/247 (17%)
Query: 66 RNESQRPKEEWEIDLSKL-DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATT 122
+ + + + L M + G G V ++VA++++ +
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGS 177
Query: 123 AETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
A A + + E+ + +KL+HP + K A +
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNF---------------------FDAEDYYI 216
Query: 183 VVEYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+E + GG L ++ N+R + Q+ L + YLH I+HRD+K EN+LL
Sbjct: 217 VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLHENGIIHRDLKPENVLL 272
Query: 241 DSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFG 294
SQ +KI DFG +++ + M GT Y+APEVL YNR D +S G
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 295 ----ICL 297
ICL
Sbjct: 332 VILFICL 338
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 77/285 (27%), Positives = 131/285 (45%), Gaps = 46/285 (16%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ ++ +G++G V + QE AVK+++ + S+ +EV + +K
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-------KASAKNKDTSTILREVELLKK 77
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
LDHPN+ K +S+ I V E GG L +I+ +R
Sbjct: 78 LDHPNIMKLFEILEDSSSFYI--------------------VGELYTGGELFDEIIKRKR 117
Query: 202 --KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARV 256
+ A +I+ Q+ G++Y+H IVHRD+K EN+LL+S+ +KI DFG++
Sbjct: 118 FSEHDAARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316
QN + M GT Y+APEVL+G Y+ +CDV+S G+ L+ + P+ + D+
Sbjct: 174 FQQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 317 SAVVRQNL---RPEIPRCCPSSLA-NIMRKCWDANAEKRPEMGEV 357
V P+ S A +++RK + R +
Sbjct: 232 KRVETGKYAFDLPQWRTI--SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 39/276 (14%)
Query: 89 IAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G + V + +EVA+K++D T +EV + + L+HPN
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIID-------KTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KKL 204
+ K V + + +++EY GG + YL+ + R +K
Sbjct: 76 IVKLF--EVIETEKTL------------------YLIMEYASGGEVFDYLVAHGRMKEKE 115
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
A Q+ + Y H K+IVHRD+K EN+LLD+ +KIADFG + +
Sbjct: 116 ARSKFRQIV----SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKL 170
Query: 265 TGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323
G Y APE+ QGK Y+ DV+S G+ L+ + +P+ + ++ V+R
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 324 LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
R IP + N++++ N KR + +++K
Sbjct: 231 YR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 50/247 (20%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P++ + I G++G+VY +++ VA+K + + ++
Sbjct: 52 PEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMS------YSGKQSNEKW 98
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+EV QKL HPN ++ G + + V+EY G
Sbjct: 99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL--------------------VMEYCLG 138
Query: 190 GNLKQYLIRNRRKKLA---LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
L+ +K L + V AL +GL+YLHS ++HRDVK N+LL +
Sbjct: 139 SASD--LLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNMIHRDVKAGNILLSEPGLV 193
Query: 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEV---LQGKPYNRRCDVYSFGICLWEIYCC 303
K+ DFG A + + GT +MAPEV + Y+ + DV+S GI E+
Sbjct: 194 KLGDFGSA---SIMAPANS-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
Query: 304 DMPYPDL 310
P ++
Sbjct: 250 KPPLFNM 256
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G YG V + VAVK++D + ++E+ + + L+H
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKMLNHE 65
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
NV KF G + +EY GG L + + +
Sbjct: 66 NVVKFYG--HRREGNIQ------------------YLFLEYCSGGELFDRIEPDIGMPEP 105
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
A + QL ++ G+ YLH I HRD+K EN+LLD + LKI+DFG+A V N R+
Sbjct: 106 DAQRFFHQL---MA-GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 264 MTGET--GTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLS 311
GTL Y+APE+L+ + ++ DV+S GI L + ++P+ S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-34
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 44/231 (19%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ + ++ +G V R + +E AVK++D G + E LR + +EV + +K
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 142 LD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
+ HPN+ + + + V + + G L YL
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFL--------------------VFDLMKKGELFDYLTE-- 117
Query: 201 RKKL----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
+ L KI+ L + LH IVHRD+K EN+LLD +K+ DFG +
Sbjct: 118 KVTLSEKETRKIMRALL----EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQG------KPYNRRCDVYSFG----ICL 297
+ + GT Y+APE+++ Y + D++S G L
Sbjct: 174 LDPGEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 64/281 (22%), Positives = 115/281 (40%), Gaps = 38/281 (13%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
L+ +G+YG V AVK+L ++ ++E+ + ++L H
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILK-----KKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN--LKQYLIRNRRK- 202
NV + V K+ +V+EY G + + R
Sbjct: 67 NVIQLVDVLYNEEKQKM------------------YMVMEYCVCGMQEMLDSVPEKRFPV 108
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
A QL + GL YLHS+ IVH+D+K N+LL + TLKI+ GVA
Sbjct: 109 CQAHGYFCQL---ID-GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 263 DMTGET--GTLGYMAPEVLQG-KPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
D T T G+ + PE+ G ++ + D++S G+ L+ I P+ + +
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + + IP C L+++++ + KR + ++ +
Sbjct: 225 IGKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-34
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAAL--RSSFQQEVAVW 139
++ G + V+ + A+K + + SS + E+AV
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----------KSPAFRDSSLENEIAVL 60
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
+K+ H N+ T++ + V++ + GG L ++
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYL--------------------VMQLVSGGELFDRILER 100
Query: 200 RR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVA 254
+K A ++ Q+ + YLH IVHRD+K EN+L + + I DFG++
Sbjct: 101 GVYTEKDASLVIQQVL----SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
Query: 255 RVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
++E M+ GT GY+APEVL KPY++ D +S G+
Sbjct: 157 KMEQNGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 64/314 (20%), Positives = 118/314 (37%), Gaps = 64/314 (20%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLD------WGE 116
++ E ++ + L+ +G +G+V+ G D +VA+K++ W
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP 74
Query: 117 DGMATTAETAALRSSFQQEVAVWQKLD----HPNVTKFVGASVGTSNLKIPSKTASVDGN 172
+ T EVA+ K+ HP V + + +
Sbjct: 75 LSDSVTCP---------LEVALLWKVGAGGGHPGVIRLLD--WFETQEGF---------- 113
Query: 173 AAVPARACCVVVEY-LPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIV 229
+V+E LP +L Y+ + + Q+ + + HS+ +V
Sbjct: 114 --------MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQHCHSRGVV 161
Query: 230 HRDVKTENMLLDSQR-TLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYN- 285
HRD+K EN+L+D +R K+ DFG + D GT Y PE + Y+
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 286 RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWD 345
V+S GI L+++ C D+P+ ++ A + P ++R+C
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERDQ--EILEAELH------FPAHVSPDCCALIRRCLA 269
Query: 346 ANAEKRPEMGEVVK 359
RP + E++
Sbjct: 270 PKPSSRPSLEEILL 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 47/227 (20%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D++ + +G + V R E A K+++ T +A ++E + +K
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-------TKKLSARDFQKLEREARICRK 61
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN+ + + S + V + + GG L + ++ R
Sbjct: 62 LQHPNIVRLHDSIQEESFHYL--------------------VFDLVTGGELFEDIVA--R 99
Query: 202 KKL----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVA 254
+ A + Q+ ++Y HS IVHR++K EN+LL S+ +K+ADFG+A
Sbjct: 100 EFYSEADASHCIQQIL----ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
Query: 255 RVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG----ICL 297
+ G GT GY++PEVL+ PY++ D+++ G I L
Sbjct: 156 IEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G YG V + VAVK++D + ++E+ + + L+H
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKMLNHE 65
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
NV KF G + +EY GG L + + +
Sbjct: 66 NVVKFYG--HRREGNIQ------------------YLFLEYCSGGELFDRIEPDIGMPEP 105
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
A + QL ++ G+ YLH I HRD+K EN+LLD + LKI+DFG+A V N R+
Sbjct: 106 DAQRFFHQL---MA-GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 264 MTGET--GTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPD 309
GTL Y+APE+L+ + ++ DV+S GI L + ++P+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 40/221 (18%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ ++ +G++G V + QE AVK+++ + S+ +EV + +K
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-------KASAKNKDTSTILREVELLKK 77
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
LDHPN+ K +S+ I V E GG L +I+ +R
Sbjct: 78 LDHPNIMKLFEILEDSSSFYI--------------------VGELYTGGELFDEIIKRKR 117
Query: 202 --KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARV 256
+ A +I+ Q+ G++Y+H IVHRD+K EN+LL+S+ +KI DFG++
Sbjct: 118 FSEHDAARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
QN + M GT Y+APEVL+ Y+ +CDV+S G+ L
Sbjct: 174 FQQNTK-MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 40/217 (18%)
Query: 89 IAQGTYGSVYRGTY-DNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +GTYG VY+ + VA+K LD ++G+ +TA +R E+++ ++L HP
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----IR-----EISLLKELHHP 79
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ + L +V E++ +LK+ + + L
Sbjct: 80 NIVSLIDVIHSERCL--------------------TLVFEFMEK-DLKKV-LDENKTGLQ 117
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT 265
+ L RG+++ H +I+HRD+K +N+L++S LK+ADFG+AR R T
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
E TL Y AP+VL G YS + +W I C
Sbjct: 178 HEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGC 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 41/218 (18%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG+V++ ++ VA+K LD ++G+ ++A LR E+ + ++L H
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LR-----EICLLKELKH 60
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ + L + V E+ +LK+Y + L
Sbjct: 61 KNIVRLHDVLHSDKKLTL--------------------VFEFCDQ-DLKKYF-DSCNGDL 98
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+IV L +GL + HS+ ++HRD+K +N+L++ LK+A+FG+AR R
Sbjct: 99 DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ E TL Y P+VL G +YS I +W C
Sbjct: 159 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGC 190
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 62/289 (21%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLD------WGEDGMATTAETAALRSSFQQEVAVW 139
L+ G +GSVY G DN VA+K ++ WGE T EV +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---------MEVVLL 100
Query: 140 QKLDH--PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY-LPGGNLKQYL 196
+K+ V + + +++E P +L ++
Sbjct: 101 KKVSSGFSGVIRLLD--WFERPDSF------------------VLILERPEPVQDLFDFI 140
Query: 197 IRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIADFGV 253
++LA Q+ + + H+ ++HRD+K EN+L+D R LK+ DFG
Sbjct: 141 TERGALQEELARSFFWQVL----EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196
Query: 254 ARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDL 310
+ +D GT Y PE ++ Y+ R V+S GI L+++ C D+P+
Sbjct: 197 GAL----LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
Query: 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++ V + S +++R C RP E+
Sbjct: 253 E--EIIRGQVF------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 87 NLIAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
I G YG+VY+ + VA+K + G G + +R EVA+ ++L
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST-VR-----EVALLRRL 68
Query: 143 ---DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
+HPNV + + + + T +V E++ +L+ YL +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVT---------------LVFEHVDQ-DLRTYLDKA 112
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQ 259
L + + L RGL +LH+ IVHRD+K EN+L+ S T+K+ADFG+AR
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYS 171
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294
+T TL Y APEVL Y D++S G
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 89 IAQGTYGSVYRGTYD-NQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I +GTYG VY+ + + A+K L+ ++G+ +T +R E+++ ++L H
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----IR-----EISILKELKHS 60
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ K L +V E+L +LK+ + L
Sbjct: 61 NIVKLYDVIHTKKRL--------------------VLVFEHLDQ-DLKKL-LDVCEGGLE 98
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT 265
L L G++Y H ++++HRD+K +N+L++ + LKIADFG+AR R T
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158
Query: 266 GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
E TL Y AP+VL G YS I +W + C
Sbjct: 159 HEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGC 189
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 38/277 (13%)
Query: 88 LIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ GT+G V G + +VAVK+L+ + + ++E+ + HP
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILN------RQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
++ K V ++ +V+EY+ GG L Y+ ++ R +
Sbjct: 72 HIIKLY--QVISTPTDF------------------FMVMEYVSGGELFDYICKHGRVEEM 111
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
A ++ Q+ LS + Y H +VHRD+K EN+LLD+ KIADFG++ + +
Sbjct: 112 EARRLFQQI---LS-AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
Query: 264 MTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
T G+ Y APEV+ G+ Y D++S G+ L+ + C +P+ D + +
Sbjct: 168 RT-SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG 226
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
IP S+A ++ + KR + ++ +
Sbjct: 227 VFY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 62/320 (19%), Positives = 120/320 (37%), Gaps = 69/320 (21%)
Query: 74 EEWEIDLSKL-DMRNLIAQGTYGSV-YRGTYDNQEVAVKLLDWGEDGMATTAETAALRSS 131
+E L L ++ G+ G+V ++G++ + VAVK +
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML------------IDFCDI 54
Query: 132 FQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
E+ + + D HPNV ++ + L I +E
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYI--------------------ALELC-NL 93
Query: 191 NLKQYLIRN-----RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR- 244
NL+ + K I L ++ G+++LHS KI+HRD+K +N+L+ +
Sbjct: 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSR 153
Query: 245 ------------TLKIADFGVARV----EAQNPRDMTGETGTLGYMAPEVLQG------- 281
+ I+DFG+ + ++ ++ +GT G+ APE+L+
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 282 KPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCP--SSLA- 337
+ R D++S G + I P+ D + + +L + A
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT 273
Query: 338 NIMRKCWDANAEKRPEMGEV 357
+++ + D + KRP +V
Sbjct: 274 DLISQMIDHDPLKRPTAMKV 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 47/252 (18%)
Query: 59 HLSWVWSRNESQRPKEEWEIDLSKL----DMRNLIAQGTYGSVYRGTY--DNQEVAVKLL 112
H++ + + R E +K D++ + +G + V R + E A K++
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 113 DWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGN 172
+ T +A ++E + +KL HPN+ + + S +
Sbjct: 63 N-------TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL---------- 105
Query: 173 AAVPARACCVVVEYLPGGNLKQYLIRNRRKKL----ALKIVIQLALDLSRGLSYLHSKKI 228
V + + GG L + ++ R+ A + Q+ ++Y HS I
Sbjct: 106 ----------VFDLVTGGELFEDIVA--REFYSEADASHCIQQIL----ESIAYCHSNGI 149
Query: 229 VHRDVKTENMLLDSQR---TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN 285
VHR++K EN+LL S+ +K+ADFG+A +E + G GT GY++PEVL+ PY+
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 286 RRCDVYSFGICL 297
+ D+++ G+ L
Sbjct: 209 KPVDIWACGVIL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 91 QGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148
G G V ++VA+K++ +A A + + E+ + +KL+HP +
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KKLAL 206
K + I V+E + GG L ++ N+R +
Sbjct: 79 KIKNF-FDAEDYYI--------------------VLELMEGGELFDKVVGNKRLKEATCK 117
Query: 207 KIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNPRD 263
Q+ L + YLH I+HRD+K EN+LL SQ +KI DFG +++ +
Sbjct: 118 LYFYQMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172
Query: 264 MTGETGTLGYMAPEVLQG---KPYNRRCDVYSFG----ICL 297
M GT Y+APEVL YNR D +S G ICL
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 45/218 (20%)
Query: 91 QGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148
G +G V+ E +K ++ + + E+ V + LDHPN+
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTIN--------KDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK------ 202
K N+ I V+E GG L + ++ + +
Sbjct: 84 KIFEVFEDYHNMYI--------------------VMETCEGGELLERIVSAQARGKALSE 123
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQ 259
+++ Q+ L+Y HS+ +VH+D+K EN+L +KI DFG+A +
Sbjct: 124 GYVAELMKQMM----NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
+ T GT YMAPEV + +CD++S G+ +
Sbjct: 180 DEH-STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVM 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 64/314 (20%), Positives = 113/314 (35%), Gaps = 59/314 (18%)
Query: 88 LIAQGTYGSVYRGT---YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
IA G G +Y + + V +K L D A ++ E ++ H
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--------AEAQAMAMAERQFLAEVVH 138
Query: 145 PNVTKF--VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
P++ + + +V+EY+ G +LK+ +
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGY-----------------IVMEYVGGQSLKRSK----GQ 177
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
KL + I L++ LSYLHS +V+ D+K EN++L ++ LK+ D G
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-----RI 231
Query: 263 DMTGET-GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
+ G GT G+ APE+++ P D+Y+ G L + +
Sbjct: 232 NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN----GRYVDGLPE 286
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRP----EM-GEVVKMLEAIDTSKGGGMIPED 376
+ + S ++R+ D + +R EM ++ +L + G P
Sbjct: 287 DDPVLKTYD----SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGL 342
Query: 377 QATGCFCFSPVRGP 390
FSP R
Sbjct: 343 STI----FSPSRST 352
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 44/221 (19%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK-----LLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ +G + +VY+ NQ VA+K +DG+ TA LR E+ + Q+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA----LR-----EIKLLQE 68
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN+ + A SN+ +V +++ +L+ I++
Sbjct: 69 LSHPNIIGLLDAFGHKSNI--------------------SLVFDFMET-DLEVI-IKDNS 106
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP 261
L + L +GL YLH I+HRD+K N+LLD LK+ADFG+A+
Sbjct: 107 LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
R T + T Y APE+L G +Y G+ +W + C
Sbjct: 167 RAYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGC 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 87 NLIAQGTYGSVYRGT---YDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
I +G YG V++ + VA+K + GE+GM + +R EVAV +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IR-----EVAVLRH 67
Query: 142 L---DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR 198
L +HPNV + + + T +V E++ +L YL +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLT---------------LVFEHVDQ-DLTTYLDK 111
Query: 199 NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEA 258
+ + + + L RGL +LHS ++VHRD+K +N+L+ S +K+ADFG+AR+
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-Y 170
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294
+T TL Y APEVL Y D++S G
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 41/218 (18%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +G+YG V++ Q VA+K L + + A LR E+ + ++L H
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LR-----EIRMLKQLKH 61
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ + L + V EY + + ++ +
Sbjct: 62 PNLVNLLEVFRRKRRLHL--------------------VFEYCDH-TVLHE-LDRYQRGV 99
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+V + + +++ H +HRDVK EN+L+ +K+ DFG AR+
Sbjct: 100 PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
E T Y +PE+L G Y + +W I C
Sbjct: 160 DDEVATRWYRSPELLVG------DTQYGPPVDVWAIGC 191
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 42/216 (19%)
Query: 91 QGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148
+G + V R QE A +++ T +A ++E + + L HPN+
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIIN-------TKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL---- 204
+ + + + + + + GG L + ++ R+
Sbjct: 74 RLHDSISEEGHHYL--------------------IFDLVTGGELFEDIVA--REYYSEAD 111
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNP 261
A + Q+ + + H +VHR++K EN+LL S+ +K+ADFG+A
Sbjct: 112 ASHCIQQIL----EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
+ G GT GY++PEVL+ PY + D+++ G+ L
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 39/225 (17%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ +I +G + V R Q+ AVK++D T+ ++E ++
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVD----VAKFTSSPGLSTEDLKREASICHM 82
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HP++ + + L + V E++ G +L +++
Sbjct: 83 LKHPHIVELLETYSSDGMLYM--------------------VFEFMDGADLCFEIVKRAD 122
Query: 202 K------KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFG 252
+A + Q+ L Y H I+HRDVK +LL S+ +K+ FG
Sbjct: 123 AGFVYSEAVASHYMRQIL----EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
VA ++ G GT +MAPEV++ +PY + DV+ G+ L
Sbjct: 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 71/335 (21%), Positives = 128/335 (38%), Gaps = 52/335 (15%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNL------IAQGTYGSVYRGT--YDNQEVAVKLLDWGE 116
+ S + + S L+++ I QG+YG V A+K+++ +
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 117 DGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL--------------KI 162
+ ++ EV + +KL HPN+ + + K+
Sbjct: 64 IRQINPKDVERIK----TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119
Query: 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK--------KLALKIVIQLAL 214
G A+ + I R+ KL I+ Q+
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 215 DLSRGLSYLHSKKIVHRDVKTENMLLDSQR--TLKIADFGVARV----EAQNPRDMTGET 268
L YLH++ I HRD+K EN L + + +K+ DFG+++ MT +
Sbjct: 180 ----ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 269 GTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR- 325
GT ++APEVL + Y +CD +S G+ L + +P+P ++ AD S V+ + L
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295
Query: 326 --PEIPRCCPSSLA-NIMRKCWDANAEKRPEMGEV 357
P S LA +++ + N ++R +
Sbjct: 296 ENPNYNVL--SPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 42/218 (19%)
Query: 89 IAQGTYGSVYRGTYD--NQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GTY +VY+G + VA+K L+ E+G TA +R EV++ + L H
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLE-HEEGAPCTA----IR-----EVSLLKDLKH 59
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ +L + V EYL +LKQYL + +
Sbjct: 60 ANIVTLHDIIHTEKSLTL--------------------VFEYLDK-DLKQYL-DDCGNII 97
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+ V L RGL+Y H +K++HRD+K +N+L++ + LK+ADFG+AR ++ +
Sbjct: 98 NMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157
Query: 265 TGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
E TL Y P++L G YS I +W + C
Sbjct: 158 DNEVVTLWYRPPDILLG------STDYSTQIDMWGVGC 189
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 56/288 (19%)
Query: 88 LIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G +G R + VAVK ++ AA+ + Q+E+ + L HP
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIE----------RGAAIDENVQREIINHRSLRHP 76
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
N+ +F V + + +++EY GG L + + R +
Sbjct: 77 NIVRFK--EVILTPTHL------------------AIIMEYASGGELYERICNAGRFSED 116
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT--LKIADFGVARVEAQNP 261
A QL LS G+SY HS +I HRD+K EN LLD LKI DFG ++ +
Sbjct: 117 EARFFFQQL---LS-GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
Query: 262 RDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
+ + GT Y+APEVL + Y+ + DV+S G+ L+ + P F D
Sbjct: 173 QPKS-TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP-----FEDPEEPRD 226
Query: 321 RQNLRPEIPRC---CPSSL------ANIMRKCWDANAEKRPEMGEVVK 359
+ I P + +++ + + A+ R + E+
Sbjct: 227 YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 45/222 (20%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ GTY +VY+G VA+K LD E+G +TA +R E+++ ++L H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGTPSTA----IR-----EISLMKELKH 62
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL----IRNR 200
N+ + + L + V E++ +LK+Y+ + N
Sbjct: 63 ENIVRLYDVIHTENKLTL--------------------VFEFMDN-DLKKYMDSRTVGNT 101
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+ L L +V L +GL++ H KI+HRD+K +N+L++ + LK+ DFG+AR
Sbjct: 102 PRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ E TL Y AP+VL G YS I +W C
Sbjct: 162 VNTFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGC 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 46/216 (21%)
Query: 91 QGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRS--SFQQEVAVWQKLDHPN 146
+G++G V A K + + F+QE+ + + LDHPN
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIP-----------KYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KKL 204
+ + +++ + V+E GG L + ++ R +
Sbjct: 68 IIRLYETFEDNTDIYL--------------------VMELCTGGELFERVVHKRVFRESD 107
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNP 261
A +I+ + ++Y H + HRD+K EN L + LK+ DFG+A
Sbjct: 108 AARIMKDVL----SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
M + GT Y++P+VL+G Y CD +S G+ +
Sbjct: 164 M-MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMM 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 41/220 (18%)
Query: 87 NLIAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
L+ +G+YG V + + VA+K L + + A +R E+ + ++L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MR-----EIKLLKQL 81
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
H N+ + + V E++ + L
Sbjct: 82 RHENLVNLLEVCKKKKRWYL--------------------VFEFVDH-TILDDL-ELFPN 119
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
L ++V + + G+ + HS I+HRD+K EN+L+ +K+ DFG AR A
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
E T Y APE+L G Y + +W I C
Sbjct: 180 VYDDEVATRWYRAPELLVG------DVKYGKAVDVWAIGC 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 56/220 (25%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 86 RNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV-WQKL 142
+ ++ G G V Q+ A+KLL +QEV WQ
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLY--------------DSPKARQEVDHHWQAS 79
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
P++ + V N R +++E + GG L + +
Sbjct: 80 GGPHIVCILD----------------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ 123
Query: 203 KL----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVAR 255
A +I+ + + +LHS I HRDVK EN+L S+ LK+ DFG A+
Sbjct: 124 AFTEREAAEIMRDIG----TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
QN + T Y+APEVL + Y++ CD++S G+
Sbjct: 180 ETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G++G V T Q+VA+K + + + + ++E++ + L HP
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFIS------RQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KK 203
++ K V T+ I +V+EY GG L Y++ +R +
Sbjct: 70 HIIKLY--DVITTPTDI------------------VMVIEYA-GGELFDYIVEKKRMTED 108
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ Q+ + + Y H KIVHRD+K EN+LLD +KIADFG++ +
Sbjct: 109 EGRRFFQQI---IC-AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164
Query: 264 MTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
T G+ Y APEV+ GK Y DV+S GI L+ + +P+ D ++ V
Sbjct: 165 KT-SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC 223
Query: 323 NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+P +++R+ A+ +R + E+ +
Sbjct: 224 VYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 46/214 (21%)
Query: 91 QGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNV 147
+G++ + NQ AVK++ + ++ Q+E+ + + HPN+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIIS------------KRMEANTQKEITALKLCEGHPNI 68
Query: 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK---KL 204
K + + V+E L GG L + I+ ++
Sbjct: 69 VKLHEVFHDQLHTFL--------------------VMELLNGGELFER-IKKKKHFSETE 107
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNP 261
A I+ +L +S++H +VHRD+K EN+L + +KI DFG AR++ +
Sbjct: 108 ASYIMRKLV----SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ + TL Y APE+L Y+ CD++S G+
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 47/216 (21%)
Query: 91 QGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148
+G VYR + A+K+L + + E+ V +L HPN+
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLK-----------KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL---- 204
K + + + V+E + GG L ++ +
Sbjct: 112 KLKEIFETPTEISL--------------------VLELVTGGELFDRIVE--KGYYSERD 149
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNP 261
A V Q+ ++YLH IVHRD+K EN+L + LKIADFG++++ ++
Sbjct: 150 AADAVKQIL----EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQ 204
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
M GT GY APE+L+G Y D++S GI
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 69/298 (23%), Positives = 136/298 (45%), Gaps = 42/298 (14%)
Query: 69 SQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETA 126
+++ K + + + + + + GT+G V G ++ +VAVK+L+ +
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN------RQKIRSL 57
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
+ ++E+ + HP++ K V ++ I +V+EY
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKLY--QVISTPSDI------------------FMVMEY 97
Query: 187 LPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
+ GG L Y+ +N R +K + ++ Q+ LS G+ Y H +VHRD+K EN+LLD+
Sbjct: 98 VSGGELFDYICKNGRLDEKESRRLFQQI---LS-GVDYCHRHMVVHRDLKPENVLLDAHM 153
Query: 245 TLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIY 301
KIADFG++ + + T G+ Y APEV+ G+ Y D++S G+ L+ +
Sbjct: 154 NAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210
Query: 302 CCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
C +P+ D + + P+ S+ ++++ + KR + ++ +
Sbjct: 211 CGTLPFDDDHVPTLFKKICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 51/231 (22%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D +++I +G V R + E AVK+++ + + + +R + ++E + ++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAE-RLSPEQLEEVREATRRETHILRQ 155
Query: 142 L-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
+ HP++ + + +S + + V + + G L YL
Sbjct: 156 VAGHPHIITLIDSYESSSFMFL--------------------VFDLMRKGELFDYLTE-- 193
Query: 201 RKKL----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
+ L I+ L +S+LH+ IVHRD+K EN+LLD ++++DFG +
Sbjct: 194 KVALSEKETRSIMRSLL----EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQG------KPYNRRCDVYSFG----ICL 297
+ + GT GY+APE+L+ Y + D+++ G L
Sbjct: 250 LEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 47/223 (21%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ +GTYG VY+ T N+ VA+K L+ E+G+ TA +R EV++ ++L H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA----IR-----EVSLLKELQH 92
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ + L + + EY +LK+Y+ ++ +
Sbjct: 93 RNIIELKSVIHHNHRLHL--------------------IFEYAEN-DLKKYM--DKNPDV 129
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT-----LKIADFGVARVEAQ 259
+++++ L G+++ HS++ +HRD+K +N+LL LKI DFG+AR
Sbjct: 130 SMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
R T E TL Y PE+L G YS + +W I C
Sbjct: 190 PIRQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIAC 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I QGT+G V++ Q+VA+K L++ ++G TA LR E+ + Q L H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----LR-----EIKILQLLKH 75
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
NV + ++ K + +V ++ +L L N K
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIY------------LVFDFCEH-DLAGLL-SNVLVKF 121
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV----EAQN 260
L + ++ L GL Y+H KI+HRD+K N+L+ LK+ADFG+AR +
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 261 PRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
P T TL Y PE+L G + Y D++ G
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 34/213 (15%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-P 145
+ +G + V + QE A K L R+ E+AV + P
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLK-------KRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
V TS + +++EY GG + + + ++
Sbjct: 90 RVINLHEVYENTSEI--------------------ILILEYAAGGEIFSLCLPELAEMVS 129
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNPR 262
VI+L + G+ YLH IVH D+K +N+LL S +KI DFG++R
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ GT Y+APE+L P D+++ GI
Sbjct: 190 -LREIMGTPEYLAPEILNYDPITTATDMWNIGI 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 46/218 (21%), Positives = 91/218 (41%), Gaps = 32/218 (14%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+M + G + V + +E A K + +++ R ++EV + ++
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIK---KRRLSSSRRGVSREEIEREVNILRE 64
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+ HPN+ +++ +++E + GG L +L +
Sbjct: 65 IRHPNIITLHDIFENKTDV--------------------VLILELVSGGELFDFLAE--K 102
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR----TLKIADFGVARVE 257
+ L Q + G+ YLHSK+I H D+K EN++L + +K+ DFG+A
Sbjct: 103 ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ GT ++APE++ +P D++S G+
Sbjct: 163 EAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 48/223 (21%), Positives = 90/223 (40%), Gaps = 50/223 (22%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV-WQ 140
+++ I G+Y R N E AVK++D + +E+ + +
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------------KSKRDPTEEIEILLR 71
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
HPN+ + + V E + GG L ++R
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYV--------------------VTELMKGGELLDKILR-- 109
Query: 201 RKKL----ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR----TLKIADFG 252
+K A ++ + + + YLH++ +VHRD+K N+L + +++I DFG
Sbjct: 110 QKFFSEREASAVLFTIT----KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
A+ + T ++APEVL+ + Y+ CD++S G+
Sbjct: 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGV 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 45/218 (20%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+ + G + V + E A K + + + + R ++EV++ ++
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQ---SRASRRGVSREEIEREVSILRQ 71
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+ H NV +++ +++E + GG L +L + +
Sbjct: 72 VLHHNVITLHDVYENRTDV--------------------VLILELVSGGELFDFLAQ--K 109
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR----TLKIADFGVARVE 257
+ L+ + + G++YLH+KKI H D+K EN++L + +K+ DFG+A
Sbjct: 110 ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ GT ++APE++ +P D++S G+
Sbjct: 170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 45/218 (20%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+ + G + V + E A K + + + R ++EV++ ++
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVCREEIEREVSILRQ 71
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+ HPN+ +++ +++E + GG L +L + +
Sbjct: 72 VLHPNIITLHDVYENRTDV--------------------VLILELVSGGELFDFLAQ--K 109
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR----TLKIADFGVARVE 257
+ L+ + + G++YLH+KKI H D+K EN++L + +K+ DFG+A
Sbjct: 110 ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ GT ++APE++ +P D++S G+
Sbjct: 170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D + G + V + + A K + ++ R ++EV++ ++
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKE 70
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+ HPNV +++ +++E + GG L +L +
Sbjct: 71 IQHPNVITLHEVYENKTDV--------------------ILILELVAGGELFDFLAE--K 108
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR----TLKIADFGVARVE 257
+ L + + + G+ YLHS +I H D+K EN++L + +KI DFG+A
Sbjct: 109 ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ GT ++APE++ +P D++S G+
Sbjct: 169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 47/216 (21%)
Query: 91 QGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV-WQKLDHPNV 147
G G V + ++ A+K+L ++EV + W+ P++
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQDCPK--------------ARREVELHWRASQCPHI 117
Query: 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL--- 204
+ V V N + +V+E L GG L + +
Sbjct: 118 VRIVD----------------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 205 -ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVAR-VEAQ 259
A +I+ + + YLHS I HRDVK EN+L S+R LK+ DFG A+ +
Sbjct: 162 EASEIMKSIG----EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
N +T T Y+APEVL + Y++ CD++S G+
Sbjct: 218 NS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 46/218 (21%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 82 KLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW 139
+ ++ G +G V++ ++A K++ + + E++V
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK---------TRGMKDKEEVKNEISVM 140
Query: 140 QKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN 199
+LDH N+ + A +++ +V+EY+ GG L +I
Sbjct: 141 NQLDHANLIQLYDAFESKNDI--------------------VLVMEYVDGGELFDRIID- 179
Query: 200 RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT--LKIADFGVARVE 257
L I + G+ ++H I+H D+K EN+L ++ +KI DFG+AR
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ GT ++APEV+ + D++S G+
Sbjct: 240 KPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 43/216 (19%), Positives = 88/216 (40%), Gaps = 35/216 (16%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+ + G +G V+R + K ++ + + + E+++ +
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFIN---------TPYPLDKYTVKNEISIMNQ 104
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HP + A + +++E+L GG L +
Sbjct: 105 LHHPKLINLHDAFEDKYEM--------------------VLILEFLSGGELFDRIAA-ED 143
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR--TLKIADFGVARVEAQ 259
K++ VI GL ++H IVH D+K EN++ ++++ ++KI DFG+A +
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLN 202
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ T T + APE++ +P D+++ G+
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 52/247 (21%), Positives = 96/247 (38%), Gaps = 48/247 (19%)
Query: 65 SRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATT 122
S +Q P + + ++ +G++ +V R ++E A+K+L+ + +
Sbjct: 14 SLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKE 71
Query: 123 AETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
+ + E V +LDHP K L
Sbjct: 72 NKVPYVTR----ERDVMSRLDHPFFVKLYFTFQDDEKL--------------------YF 107
Query: 183 VVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIVHRDVK 234
+ Y G L +Y+ + +R L YLH K I+HRD+K
Sbjct: 108 GLSYAKNGELLKYIRKIGS----------FDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYS 292
EN+LL+ ++I DFG A+V + + + GT Y++PE+L K + D+++
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 293 FGICLWE 299
G +++
Sbjct: 218 LGCIIYQ 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 35/216 (16%)
Query: 84 DMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D+ + G +G V+R T A K + + + + ++E+
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVM---------TPHESDKETVRKEIQTMSV 210
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HP + A + + ++ E++ GG L + + +
Sbjct: 211 LRHPTLVNLHDAFEDDNEM--------------------VMIYEFMSGGELFEKVA-DEH 249
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR--TLKIADFGVARVEAQ 259
K++ ++ + +GL ++H VH D+K EN++ ++R LK+ DFG+
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
+ TGT + APEV +GKP D++S G+
Sbjct: 310 KQS-VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 38/216 (17%), Positives = 78/216 (36%), Gaps = 36/216 (16%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ + +G +G V+R + K + + ++E+++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKF-------VKVKGTD---QVLVKKEISILNI 57
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
H N+ + L ++ E++ G ++ + +
Sbjct: 58 ARHRNILHLHESFESMEEL--------------------VMIFEFISGLDIFERINT-SA 96
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR--TLKIADFGVARVEAQ 259
+L + ++ + L +LHS I H D++ EN++ ++R T+KI +FG AR
Sbjct: 97 FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 260 NPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295
Y APEV Q + D++S G
Sbjct: 157 GDN-FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C V+EY GG L +L +R + + ++ L YLHS+ +V+RD+K EN++L
Sbjct: 81 CFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
D +KI DFG+ + E + T GT Y+APEVL+ Y R D + G+ ++
Sbjct: 139 DKDGHIKITDFGLCK-EGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ C +P+ + + ++ + +R PR +++ + ++R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 57/232 (24%)
Query: 86 RNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAAL--RSSFQQEVAVWQK 141
+++ +G + V +QE AVK+++ RS +EV + +
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIE-----------KQPGHIRSRVFREVEMLYQ 66
Query: 142 L-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
H NV + + + V E + GG++ ++ + R
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYL--------------------VFEKMRGGSILSHIHKRR 106
Query: 201 R--KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVAR 255
+ A +V +A L +LH+K I HRD+K EN+L + +KI DF +
Sbjct: 107 HFNELEASVVVQDVA----SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
Query: 256 VEAQNPRDMTGET-------GTLGYMAPEVLQG-----KPYNRRCDVYSFGI 295
N T G+ YMAPEV++ Y++RCD++S G+
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 180 CCVVVEYLPGGNLKQYLIRNRR-KKLALKIVI-QLALDLSRGLSYLHSKKIVHRDVKTEN 237
+VV+ L GG+L+ +L +N K+ +K+ I +L + L YL +++I+HRD+K +N
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM----ALDYLQNQRIIHRDMKPDN 145
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP---YNRRCDVYSFG 294
+LLD + I DF +A +T GT YMAPE+ + Y+ D +S G
Sbjct: 146 ILLDEHGHVHITDFNIAA-MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 295 ICLWEIYCCDMPYPDLSFADVSSAVVR-QNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
+ +E+ PY S V + P + ++++K + N ++R
Sbjct: 205 VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 58/173 (33%), Positives = 88/173 (50%), Gaps = 8/173 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EYL GG+L ++ K L A ++ GL +LHSK IV+RD+K +N+LL
Sbjct: 94 FFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
D +KIADFG+ + E T T GT Y+APE+L G+ YN D +SFG+ L+
Sbjct: 152 DKDGHIKIADFGMCK-ENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ ++ ++ N PR +++ K + EKR
Sbjct: 210 EMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 52/292 (17%)
Query: 25 VNSKVKGTGSLSSKDML---FRADKIDLKSLDMQLEKHLSWVWSRNESQRPK-EEWEIDL 80
+++ ++ S + D L A DL ++ K++ SR + K + +
Sbjct: 9 MDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKA 68
Query: 81 SKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV 138
++ +I +G +G V R + A+KLL + M +++A F +E +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSA----FFWEERDI 122
Query: 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR 198
+ P V + A L +V+EY+PGG+L +
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYL--------------------YMVMEYMPGGDLVNLM-- 160
Query: 199 NRRKKLALKIV------IQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
+ K + LALD +HS +HRDVK +NMLLD LK+ADFG
Sbjct: 161 -SNYDVPEKWARFYTAEVVLALD------AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 253 VARVEAQNPRDMTGET-GTLGYMAPEVLQGKP----YNRRCDVYSFGICLWE 299
+ GT Y++PEVL+ + Y R CD +S G+ L+E
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 51/180 (28%), Positives = 97/180 (53%), Gaps = 13/180 (7%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EY+ GG+L ++ R++KL + + ++S L+YLH + I++RD+K +N+LL
Sbjct: 86 FFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
DS+ +K+ D+G+ + E P D T T GT Y+APE+L+G+ Y D ++ G+ ++
Sbjct: 144 DSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNL-------RPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ + +D L + IPR A++++ + + ++R
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 51/180 (28%), Positives = 97/180 (53%), Gaps = 13/180 (7%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EY+ GG+L ++ R++KL + + ++S L+YLH + I++RD+K +N+LL
Sbjct: 129 FFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
DS+ +K+ D+G+ + E P D T T GT Y+APE+L+G+ Y D ++ G+ ++
Sbjct: 187 DSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNL-------RPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ + +D L + IPR A++++ + + ++R
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 68/317 (21%), Positives = 134/317 (42%), Gaps = 59/317 (18%)
Query: 13 DSLRKSDNEEGSVNSKVKGTGSLSSKDMLFRADKI---DLKSLDMQLEKHLS--WVWSRN 67
+R E+ ++ + G S + L + + ++ EK++ W++
Sbjct: 2 GEVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKP 61
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAET 125
+ + K+ + ++ +I +G +G V + ++ A+K+L+ + M AET
Sbjct: 62 FTSKVKQM-RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAET 118
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
A F++E V D +T A +NL +V++
Sbjct: 119 A----CFREERDVLVNGDSKWITTLHYAFQDDNNL--------------------YLVMD 154
Query: 186 YLPGGNLKQYLIRNRRKKLALKIV------IQLALDLSRGLSYLHSKKIVHRDVKTENML 239
Y GG+L L+ +L ++ + +A+D +H VHRD+K +N+L
Sbjct: 155 YYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIAID------SVHQLHYVHRDIKPDNIL 207
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGET----GTLGYMAPEVLQGKP-----YNRRCDV 290
+D +++ADFG + D T ++ GT Y++PE+LQ Y CD
Sbjct: 208 MDMNGHIRLADFGSC---LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 291 YSFGICLWEIYCCDMPY 307
+S G+C++E+ + P+
Sbjct: 265 WSLGVCMYEMLYGETPF 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 57/270 (21%), Positives = 111/270 (41%), Gaps = 52/270 (19%)
Query: 48 DLKSLDMQLEKHLS--WVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYD 103
+L + ++ +K+++ W+ R KE + ++ +I +G + V +
Sbjct: 27 ELGASELAQDKYVADFLQWAEPIVVRLKEV-RLQRDDFEILKVIGRGAFSEVAVVKMKQT 85
Query: 104 NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIP 163
Q A+K+++ + M E + F++E V D +T+ A + L
Sbjct: 86 GQVYAMKIMN--KWDMLKRGEVS----CFREERDVLVNGDRRWITQLHFAFQDENYL--- 136
Query: 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIV------IQLALDLS 217
+V+EY GG+L L+ +++ ++ I +A+D
Sbjct: 137 -----------------YLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAID-- 176
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET-GTLGYMAP 276
+H VHRD+K +N+LLD +++ADFG + + GT Y++P
Sbjct: 177 ----SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 277 EVLQGK-------PYNRRCDVYSFGICLWE 299
E+LQ Y CD ++ G+ +E
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+E++ GG+L ++ + ++ A ++ L +LH K I++RD+K +N+LL
Sbjct: 100 FFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
D + K+ADFG+ + E T T GT Y+APE+LQ Y D ++ G+ L+
Sbjct: 158 DHEGHCKLADFGMCK-EGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ C P+ + D+ A++ + P I++ N R
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 58/254 (22%), Positives = 107/254 (42%), Gaps = 60/254 (23%)
Query: 67 NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRG----TYDNQEVAVKLLDWGEDGMATT 122
+E +R ++ +E + K + +GTYG VY+ D+++ A+K + G++ +
Sbjct: 13 SERERVEDLFEYEGCK------VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMS 64
Query: 123 AETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCV 182
A R E+A+ ++L HPNV + ++ K+ +
Sbjct: 65 A----CR-----EIALLRELKHPNVISLQKVFLSHADRKV------------------WL 97
Query: 183 VVEYLPGGNLKQYL-------IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235
+ +Y +L + + +L +V L + G+ YLH+ ++HRD+K
Sbjct: 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156
Query: 236 ENMLLDSQR----TLKIADFGVARVEAQNPRDMTGETG---TLGYMAPEVLQGKPYNRRC 288
N+L+ + +KIAD G AR+ + + T Y APE+L G
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------A 210
Query: 289 DVYSFGICLWEIYC 302
Y+ I +W I C
Sbjct: 211 RHYTKAIDIWAIGC 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 48/173 (27%), Positives = 90/173 (52%), Gaps = 8/173 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EY+ GG+L ++ + + + A +++ GL +L SK I++RD+K +N++L
Sbjct: 97 YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
DS+ +KIADFG+ + E T T GT Y+APE++ +PY + D ++FG+ L+
Sbjct: 155 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ ++ +++ N+ P+ I + + KR
Sbjct: 213 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C+V+ + GG+LK ++ + + A ++ GL LH ++IV+RD+K EN+LL
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
D ++I+D G+A V + + G GT+GYMAPEV++ + Y D ++ G L+E+
Sbjct: 320 DDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 301 YCCDMPYPD----LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
P+ + +V V ++ + + +R
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 8/173 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
V+EY+ GG+L ++ + R + A +++ GL +L SK I++RD+K +N++L
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 241 DSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
DS+ +KIADFG+ + E T T GT Y+APE++ +PY + D ++FG+ L+
Sbjct: 476 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ ++ +++ N+ P+ I + + KR
Sbjct: 534 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 584
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 5/172 (2%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK-IVHRDVKTENML 239
C V+EY GG L +L R R + ++ L YLHS+K +V+RD+K EN++
Sbjct: 224 CFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
LD +KI DFG+ + ++ M GT Y+APEVL+ Y R D + G+ ++E
Sbjct: 282 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 300 IYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
+ C +P+ + + ++ + +R PR +++ + ++R
Sbjct: 342 MMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 24/181 (13%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIVHRD 232
V++Y+ GG L +L R R +R L YLHS IV+RD
Sbjct: 115 YFVLDYINGGELFYHLQRERC----------FLEPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDV 290
+K EN+LLDSQ + + DFG+ + E T T GT Y+APEVL +PY+R D
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 291 YSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEK 350
+ G L+E+ P+ + A++ ++ + L+ + +S +++ + K
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTK 280
Query: 351 R 351
R
Sbjct: 281 R 281
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 89 IAQGTYGSVYRGT-YDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G++G V++ ++ EVA+K L D + R E+ + + + HP
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD----------KRFKNR-----ELQIMRIVKHP 92
Query: 146 NVTKFVGASVGTSNLK--IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
NV LK S D +V+EY+P + + + K
Sbjct: 93 NVVD----------LKAFFYSNGDKKDEVFLN------LVLEYVPE-TVYRASRHYAKLK 135
Query: 204 LAL-KIVIQLAL-DLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIADFGVARVEAQN 260
+ ++I+L + L R L+Y+HS I HRD+K +N+LLD LK+ DFG A++
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 261 PRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
+ Y APE++ G Y D++S G
Sbjct: 196 -EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 181 CVVVEYLPGGNLKQYL--IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
C+V+ + GG+++ ++ + I + GL +LH + I++RD+K EN+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
LLD ++I+D G+A G GT G+MAPE+L G+ Y+ D ++ G+ L+
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 299 EIYCCDMPYPD----LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKR 351
E+ P+ + ++ V+ Q + P + + + EKR
Sbjct: 381 EMIAARGPFRARGEKVENKELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIVHRD 232
+++EYL GG L L R D + L +LH K I++RD
Sbjct: 97 YLILEYLSGGELFMQLEREGI----------FMEDTACFYLAEISMALGHLHQKGIIYRD 146
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDV 290
+K EN++L+ Q +K+ DFG+ + E+ + +T T GT+ YMAPE+L +NR D
Sbjct: 147 LKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTH-TFCGTIEYMAPEILMRSGHNRAVDW 204
Query: 291 YSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEK 350
+S G ++++ P+ + +++ L +P ++++K NA
Sbjct: 205 WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAAS 262
Query: 351 R 351
R
Sbjct: 263 R 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 42/181 (23%), Positives = 88/181 (48%), Gaps = 24/181 (13%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIVHRD 232
+++++L GG+L L + + + L +LHS I++RD
Sbjct: 102 YLILDFLRGGDLFTRLSKEVM----------FTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDV 290
+K EN+LLD + +K+ DFG+++ E+ + + GT+ YMAPEV+ + + + D
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADW 209
Query: 291 YSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEK 350
+SFG+ ++E+ +P+ + + +++ L +P+ +++R + N
Sbjct: 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPAN 267
Query: 351 R 351
R
Sbjct: 268 R 268
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/316 (21%), Positives = 126/316 (39%), Gaps = 53/316 (16%)
Query: 44 ADKIDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVY--RGT 101
+++ +K + ++ W L + D + G++G V +
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNT------AQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 102 YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161
A+K+LD + + + + E + Q ++ P + K + SNL
Sbjct: 64 ESGNHYAMKILD--KQKVVKLKQIEHTLN----EKRILQAVNFPFLVKLEFSFKDNSNL- 116
Query: 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--KKLALKIVIQLALDLSRG 219
+V+EY+ GG + +L R R + A Q+ L
Sbjct: 117 -------------------YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----T 153
Query: 220 LSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET----GTLGYMA 275
YLHS +++RD+K EN+L+D Q +++ DFG A+ + G T GT +A
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-------VKGRTWTLCGTPEALA 206
Query: 276 PEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSS 335
PE++ K YN+ D ++ G+ ++E+ P+ + +V +R P S
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFSSD 264
Query: 336 LANIMRKCWDANAEKR 351
L +++R + KR
Sbjct: 265 LKDLLRNLLQVDLTKR 280
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I G++G VY+ + VA+K L D + R E+ + +KLDH
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQD----------KRFKNR-----ELQIMRKLDH 106
Query: 145 PNVTKFVGASVGTSNLK--IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
N+ + L+ S D +V++Y+P + + R
Sbjct: 107 CNIVR----------LRYFFYSSGEKKDEVY------LNLVLDYVPE-TVYRVARHYSRA 149
Query: 203 KLAL-KIVIQLAL-DLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIADFGVARVEAQ 259
K L I ++L + L R L+Y+HS I HRD+K +N+LLD LK+ DFG A+ +
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 260 NPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
+ Y APE++ G Y DV+S G
Sbjct: 210 GE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 53/238 (22%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALR 129
PK L + + G++G V+ R ++ + A+K+L ++ + +
Sbjct: 1 PK----YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTN 54
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
E + + HP + + G + ++++Y+ G
Sbjct: 55 D----ERLMLSIVTHPFIIRMWGTFQDAQQI--------------------FMIMDYIEG 90
Query: 190 GNLKQYLIRNRR------KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
G L L +++R K A ++ LAL+ YLHSK I++RD+K EN+LLD
Sbjct: 91 GELFSLLRKSQRFPNPVAKFYAAEVC--LALE------YLHSKDIIYRDLKPENILLDKN 142
Query: 244 RTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299
+KI DFG A+ D+T T GT Y+APEV+ KPYN+ D +SFGI ++E
Sbjct: 143 GHIKITDFGFAKYV----PDVTY-TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 53/232 (22%), Positives = 89/232 (38%), Gaps = 43/232 (18%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ G++G V + A+K L D R E+ + + LDH
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQD---------PRYK-NR-----ELDIMKVLDH 59
Query: 145 PNVTK----FVGASVGTSNLKIPSKTASVDGNAAVPARACC--------------VVVEY 186
N+ K F P + G V++EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 187 LPGGNLKQYLIRNRRKKLALKIV-IQLAL-DLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
+P L + L R ++ + I + + L R + ++HS I HRD+K +N+L++S+
Sbjct: 120 VPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 245 -TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
TLK+ DFG A+ + + Y APE++ G Y D++S G
Sbjct: 179 NTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 37/121 (30%), Positives = 66/121 (54%), Gaps = 7/121 (5%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
+++ + GG+L +L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 268 SFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 241 DSQRTLKIADFGVARVEAQNPRDMT-GETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLW 298
D ++I+D G+A + GT GYMAPEVLQ G Y+ D +S G L+
Sbjct: 326 DEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 299 E 299
+
Sbjct: 383 K 383
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 40/187 (21%), Positives = 88/187 (47%), Gaps = 29/187 (15%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR--------GLSYLHSKKIVHRD 232
++++Y+ GG L +L + R + L +LH I++RD
Sbjct: 135 HLILDYINGGELFTHLSQRER----------FTEHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQG--KPYNRRC 288
+K EN+LLDS + + DFG+++ + + GT+ YMAP++++G +++
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 289 DVYSFGICLWEIYCCDMPY----PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCW 344
D +S G+ ++E+ P+ S A++S +++ P+ + +++++
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLL 301
Query: 345 DANAEKR 351
+ +KR
Sbjct: 302 MKDPKKR 308
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 48/239 (20%), Positives = 95/239 (39%), Gaps = 49/239 (20%)
Query: 69 SQRPKEEWEIDLSKLD--------MRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDG 118
+ RP+E W+ + ++ + + +G Y V+ +N++V VK+L
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----- 70
Query: 119 MATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPA 177
+ R E+ + + L PN+ V + P+
Sbjct: 71 --PVKKKKIKR-----EIKILENLRGGPNIITLADI-VKDPVSRTPA------------- 109
Query: 178 RACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+V E++ + KQ + L + ++ + L Y HS I+HRDVK N
Sbjct: 110 ----LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160
Query: 238 MLLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
+++D R L++ D+G+A ++ + + PE+L + Y+ D++S G
Sbjct: 161 VMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-22
Identities = 51/239 (21%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTA----ETAA 127
E + S ++ I+ G+YG+V G + VA+K + T
Sbjct: 15 AELHAMQ-SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
R +E+ + HPN+ +G ++ + + ++ +V L
Sbjct: 74 KRV--LREIRLLNHFHHPNI-------LGLRDIFVHFEEPAMHK---------LYLVTEL 115
Query: 188 PGGNLKQYLIRNRRKKLALK----IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ 243
+L Q +I ++R ++ + + + GL LH +VHRD+ N+LL
Sbjct: 116 MRTDLAQ-VIHDQRIVISPQHIQYFMYHIL----LGLHVLHEAGVVHRDLHPGNILLADN 170
Query: 244 RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEIY 301
+ I DF +AR + + + T Y APE+ +Q K + + D++S G + E++
Sbjct: 171 NDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 49/217 (22%), Positives = 80/217 (36%), Gaps = 66/217 (30%)
Query: 91 QGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV-WQKLDHPNV 147
G G V + ++ A+K+L ++EV + W+ P++
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPK--------------ARREVELHWRASQCPHI 73
Query: 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL--- 204
+ V V N + +V+E L GG L + +
Sbjct: 74 VRIVD----------------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 205 -ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQN 260
A +I+ + + YLHS I HRDVK EN+L S+R LK+ DFG
Sbjct: 118 EASEIMKSIG----EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
A E G+ Y++ CD++S G+ +
Sbjct: 166 -------------FAKETT-GEKYDKSCDMWSLGVIM 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 11/131 (8%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENML 239
+V E L G NL + + + + L V Q++ L GL Y+H + I+H D+K EN+L
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 240 LD------SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSF 293
++ + +KIAD G A ++ T T Y +PEVL G P+ D++S
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWST 221
Query: 294 GICLWEIYCCD 304
++E+ D
Sbjct: 222 ACLIFELITGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 30/290 (10%), Positives = 73/290 (25%), Gaps = 79/290 (27%)
Query: 88 LIAQGTYGSVYRGTYDNQ---EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
++ D +VA+ +D + ++D
Sbjct: 38 FHGGVPPLQFWQA-LDTALDRQVALTFVD------PQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 145 PNVTKF--VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
P V + V + VV E++ GG+L++ +
Sbjct: 91 PGVARVLDVVHTRAG----------------------GLVVAEWIRGGSLQEVADTSPSP 128
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
A++ + LA H + + + + +A
Sbjct: 129 VGAIRAMQSLA----AAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP----------- 173
Query: 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
M N + D+ G L+ + P P+ + R
Sbjct: 174 ---------ATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217
Query: 323 ---------NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
++ +IP ++ + + + R ++ +++
Sbjct: 218 TAGQPIEPADIDRDIPF----QISAVAARSVQGDGGIRSA-STLLNLMQQ 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 30/230 (13%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRS 130
+ + + I G G V ++ VA+K L +T A R+
Sbjct: 55 DSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-----SRPFQNQTHAKRA 108
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+E+ + + ++H N+ + N+ P KT + +V+E +
Sbjct: 109 --YRELVLMKCVNHKNI-------ISLLNVFTPQKTLEEF-------QDVYLVMELM-DA 151
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
NL Q + + +L + + L + G+ +LHS I+HRD+K N+++ S TLKI D
Sbjct: 152 NLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
Query: 251 FGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEI 300
FG+AR + MT T Y APEV+ G Y D++S G + E+
Sbjct: 208 FGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 34/83 (40%), Positives = 48/83 (57%), Gaps = 1/83 (1%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 277
G+ +LHS I+HRD+K N+++ S TLKI DFG+AR + MT T Y APE
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 196
Query: 278 VLQGKPYNRRCDVYSFGICLWEI 300
V+ G Y D++S G + E+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEM 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 52/240 (21%), Positives = 99/240 (41%), Gaps = 37/240 (15%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRS 130
+++ S+ + G G V+ ++ VA+K + + A LR
Sbjct: 4 IHGFDLG-SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA----LR- 57
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
E+ + ++LDH N+ K L + D + + +V EY+
Sbjct: 58 ----EIKIIRRLDHDNIVKVFEI------LGPSGSQLTDDVGSLTELNSVYIVQEYM-ET 106
Query: 191 NLKQYLIRNR-----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR- 244
+L ++ +L + QL RGL Y+HS ++HRD+K N+ ++++
Sbjct: 107 DLAN-VLEQGPLLEEHARL---FMYQLL----RGLKYIHSANVLHRDLKPANLFINTEDL 158
Query: 245 TLKIADFGVARV---EAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEI 300
LKI DFG+AR+ + ++ T Y +P + L Y + D+++ G E+
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 89 IAQGTYGSVYRG--TYDNQEVAVK--LLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
QGT+G+V G VA+K + D R Q + L H
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQD----------PRFRNRE--LQIMQDLAVLHH 78
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ + L+ T + VV+EY+P L + R+++
Sbjct: 79 PNIVQ----------LQSYFYTLGERDRRDI---YLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 205 ALKIV-IQLAL-DLSRGLSYLH--SKKIVHRDVKTENMLLDSQR-TLKIADFGVARVEAQ 259
A + I++ L L R + LH S + HRD+K N+L++ TLK+ DFG A+ +
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 260 NPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294
+ + Y APE++ G + Y D++S G
Sbjct: 185 S-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 6/123 (4%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C+ E L NL + + +N+ + +L +V + A + + L LH +I+H D+K EN+LL
Sbjct: 175 CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233
Query: 241 DSQR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLW 298
Q +K+ DFG + E Q + + Y APEV+ G Y D++S G L
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILA 290
Query: 299 EIY 301
E+
Sbjct: 291 ELL 293
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRS 130
K WE+ + G YGSV ++VA+K L +E A R+
Sbjct: 17 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRA 70
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+E+ + + + H NV +G ++ P+ + +V+ ++
Sbjct: 71 --YRELLLLKHMQHENV-------IGLLDVFTPASSLRNF-------YDFYLVMPFM-QT 113
Query: 191 NLKQYLIRNRRKKLALK-IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
+L++ ++ + + ++ +V Q+ +GL Y+HS +VHRD+K N+ ++ LKI
Sbjct: 114 DLQK-IMGLKFSEEKIQYLVYQML----KGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301
DFG+AR +MTG T Y APEV+ YN+ D++S G + E+
Sbjct: 169 DFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 40/235 (17%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVY--RGTYDNQEVAVKLLDWGEDGMATTAETAALRS 130
K WE+ + + + G YGSV T VAVK L + A R+
Sbjct: 22 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----SRPFQSIIHAKRT 75
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+E+ + + + H NV +G ++ P+++ + + V + G
Sbjct: 76 --YRELRLLKHMKHENV-------IGLLDVFTPARSLEEFNDVYL-------VTHLM-GA 118
Query: 191 NLKQYLIRNRRKKLALK----IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+L + + +KL ++ Q+ RGL Y+HS I+HRD+K N+ ++ L
Sbjct: 119 DLNNIV---KCQKLTDDHVQFLIYQIL----RGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEI 300
KI DFG+AR A +MTG T Y APE++ YN+ D++S G + E+
Sbjct: 172 KILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 65/269 (24%), Positives = 107/269 (39%), Gaps = 75/269 (27%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVK-LLDWGEDGMATTAETA 126
RP +W+I + ++R+LI G+YG V + + VA+K +L ED +
Sbjct: 43 PRPHSDWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRI 99
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
LR E+A+ +L+H +V K + ++ IP D VV+E
Sbjct: 100 -LR-----EIAILNRLNHDHVVKVL-------DIVIPKDVEKFDE--------LYVVLEI 138
Query: 187 LPGGNLKQYLIRNRRKKLALK------IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
+ K+ R + L ++ L G+ Y+HS I+HRD+K N L+
Sbjct: 139 A-DSDFKKLF----RTPVYLTELHIKTLLYNLL----VGVKYVHSAGILHRDLKPANCLV 189
Query: 241 DSQRTLKIADFGVARV---------------------------EAQNPRDMTGETGTLGY 273
+ ++K+ DFG+AR R +TG T Y
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249
Query: 274 MAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
APE++ + Y+ I +W I C
Sbjct: 250 RAPELILL------QENYTEAIDVWSIGC 272
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.5 bits (200), Expect = 3e-17
Identities = 39/263 (14%), Positives = 81/263 (30%), Gaps = 44/263 (16%)
Query: 69 SQRPKEEWEIDLSKLDMRNL--IAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETA 126
SQ+ + L ++ I +G +G V++ D+ VA+K++ + +
Sbjct: 6 SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 127 ALRSSFQQEVAVWQKL---------DHPNVTKFVGASVGTSNLK----------IPSKTA 167
E+ + ++L + +K +
Sbjct: 66 TFE-EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 168 SVDGNAAVPARACCVVVEYLPGGN-LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK 226
+ D +V+E+ GG L+Q + A I+ QL L+ +
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLT----ASLAVAEAS 180
Query: 227 -KIVHRDVKTENMLLDSQRTLKIADFG-------------VARVEAQNPRDMTGET--GT 270
+ HRD+ N+LL K+ V+ ++ R
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC 240
Query: 271 LGYMAPEVLQGKPYNRRCDVYSF 293
M ++ G + + D+Y
Sbjct: 241 DVSMDEDLFTGD-GDYQFDIYRL 262
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 45/233 (19%), Positives = 87/233 (37%), Gaps = 48/233 (20%)
Query: 89 IAQGTYGSVYRGT----------YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV 138
+ G +Y Q+ ++KL +DG + R++ +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAKPLQVNK 107
Query: 139 WQKL---DHPNVTKFV--GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
W+KL + + G +V+ L G +L+
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYR---------------------FLVLPSL-GRSLQ 145
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI--ADF 251
L + + L+ + V+Q+A L L +LH + VH +V EN+ +D + ++ A +
Sbjct: 146 SALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 252 GVARV-------EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
G A A + G L +++ ++ +G +RR D+ S G C+
Sbjct: 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRS 130
+ +++ + + I +G YG V + VA+K + E T LR
Sbjct: 20 GQVFDVG-PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYC-QRTLR- 74
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
E+ + + H N+ +G +++ +++ V +V + +
Sbjct: 75 ----EIKILLRFRHENI-------IGINDIIRAP---TIEQMKDV-----YIVQDLM-ET 114
Query: 191 NLKQYLIRNRRKKLALK----IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+L + L + + L+ + Q+ RGL Y+HS ++HRD+K N+LL++ L
Sbjct: 115 DLYKLL---KTQHLSNDHICYFLYQIL----RGLKYIHSANVLHRDLKPSNLLLNTTCDL 167
Query: 247 KIADFGVARV---EAQNPRDMTGETGTLGYMAPEV-LQGKPYNRRCDVYSFGICLWEIY 301
KI DFG+ARV + + +T T Y APE+ L K Y + D++S G L E+
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 8/125 (6%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENM 238
C+V E L NL L + ++L + + A + L +L + + I+H D+K EN+
Sbjct: 132 CLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 239 LLDSQR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
LL + + +KI DFG + Q + + Y +PEVL G PY+ D++S G
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI 247
Query: 297 LWEIY 301
L E++
Sbjct: 248 LVEMH 252
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRS 130
K WE+ + + G YG+V +VA+K L +E A R+
Sbjct: 18 KTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRA 71
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+E+ + + + H NV +G ++ P +T +V+ ++ G
Sbjct: 72 --YRELRLLKHMRHENV-------IGLLDVFTPDETLD-------DFTDFYLVMPFM-GT 114
Query: 191 NLKQYLIRNRRKKLALK----IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+L + + + +KL +V Q+ +GL Y+H+ I+HRD+K N+ ++ L
Sbjct: 115 DLGKLM---KHEKLGEDRIQFLVYQML----KGLRYIHAAGIIHRDLKPGNLAVNEDCEL 167
Query: 247 KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIY 301
KI DFG+AR +MTG T Y APEV+ Y + D++S G + E+
Sbjct: 168 KILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 53/239 (22%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSF 132
+ I S +++L+ +G YG V T+ + VA+K ++ + A LR
Sbjct: 6 VYNIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFA-LRTLR--- 58
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
E+ + + H N+ + N++ P + + ++ E + +L
Sbjct: 59 --EIKILKHFKHENI-------ITIFNIQRPDSFENFNE--------VYIIQELM-QTDL 100
Query: 193 KQYLIRNRRKKLALK------IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTL 246
+ +I + L + Q L R + LH ++HRD+K N+L++S L
Sbjct: 101 HR-VISTQM----LSDDHIQYFIYQT---L-RAVKVLHGSNVIHRDLKPSNLLINSNCDL 151
Query: 247 KIADFGVARVEAQNPRDMTGETGTLGYM----------APEV-LQGKPYNRRCDVYSFG 294
K+ DFG+AR+ ++ D + TG M APEV L Y+R DV+S G
Sbjct: 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 53/276 (19%), Positives = 97/276 (35%), Gaps = 34/276 (12%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G +G +Y ++ A E E+ +Q++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARH---------VVKVEYQE-NGPLFSELKFYQRVAKK 93
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
+ K L IP S G R+ +V G +L++ +N
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGS--GLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFK 149
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI--ADFGVARV------- 256
V+QL + + L Y+H + VH D+K N+LL + ++ AD+G++
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316
+ G GT+ + + + +G +RR DV G C+ C +P+ V+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269
Query: 317 SAVVRQNLRPEIPR-------C--CPSSLANIMRKC 343
+ NL E+P+ +A +
Sbjct: 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 46/230 (20%), Positives = 90/230 (39%), Gaps = 34/230 (14%)
Query: 88 LIAQGTYGSVYRG-------TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
I QG +G +Y + VK+ ++ L + E+ +Q
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKV---------EPSDNGPLFT----ELKFYQ 88
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
+ P + + L +P S G ++ ++ G +L++ N
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGS--GLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI--ADFGVARV-- 256
++ + K V+QL+L + L Y+H + VH D+K N+LL+ + ++ D+G+A
Sbjct: 147 KR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 257 -----EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
+A GT+ + + + G +RR D+ G C+ I
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM--IQ 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 67/301 (22%), Positives = 114/301 (37%), Gaps = 54/301 (17%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-P 145
I G++G +Y GT +EVA+KL E E +++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTK-------HPQLHIESKIYKMMQGGV 65
Query: 146 NVTKFVGA-SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ + G N +V+E L G +L+ L +K
Sbjct: 66 GIPTIRWCGAEGDYN---------------------VMVMELL-GPSLED-LFNFCSRKF 102
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL---DSQRTLKIADFGVAR--VEAQ 259
+LK V+ LA + + Y+HSK +HRDVK +N L+ + I DFG+A+ +A+
Sbjct: 103 SLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162
Query: 260 N-----PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
R+ TGT Y + G +RR D+ S G L +P+ L A
Sbjct: 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222
Query: 315 VSSAVVR-----QNLRPE-IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368
R + E + + PS A + C + +P+ + ++ + +
Sbjct: 223 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282
Query: 369 G 369
G
Sbjct: 283 G 283
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 54/171 (31%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENML 239
C+V E L G +L +++I++ + L L V ++ + +GL YLH+K +I+H D+K EN+L
Sbjct: 121 CMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 240 L-------------------------------------------------DSQRTLKIAD 250
L + +KIAD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 251 FGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
G A ++ T + T Y + EVL G YN D++S +E+
Sbjct: 240 LGNACWVHKHF---TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 55/259 (21%), Positives = 93/259 (35%), Gaps = 70/259 (27%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVK-LLDWGEDGMATTAETAALRSS 131
+ +++LI +G+YG VY + VA+K + ED LR
Sbjct: 21 NVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDC-KRILR-- 74
Query: 132 FQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
E+ + +L + + +L IP D +V+E +
Sbjct: 75 ---EITILNRLKSDYIIRLY-------DLIIPDDLLKFDE--------LYIVLEIA-DSD 115
Query: 192 LKQYLIRNRRKKLALK------IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245
LK+ L + L I+ L L G +++H I+HRD+K N LL+ +
Sbjct: 116 LKK-LFKTPIF---LTEEHIKTILYNL---L-LGENFIHESGIIHRDLKPANCLLNQDCS 167
Query: 246 LKIADFGVARVEAQNP----------------------RDMTGETGTLGYMAPEVLQGKP 283
+K+ DFG+AR + +T T Y APE++
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-- 225
Query: 284 YNRRCDVYSFGICLWEIYC 302
+ Y+ I +W C
Sbjct: 226 ----QENYTKSIDIWSTGC 240
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 89 IAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-P 145
I G +G + G Y N+ VA+KL + E +++L
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEP-----------MKSRAPQLHLEYRFYKQLGSGD 65
Query: 146 NVTKFVGA-SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ + G N +V+E L G +L+ R
Sbjct: 66 GIPQVYYFGPCGKYN---------------------AMVLELL-GPSLEDLFDLCDRT-F 102
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL-----DSQRTLKIADFGVAR--VE 257
+LK V+ +A+ L + Y+HSK +++RDVK EN L+ +Q+ + I DF +A+ ++
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
Query: 258 AQN-----PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
+ R+ TGT YM+ GK +RR D+ + G +Y
Sbjct: 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMF--MYFL 211
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 27/106 (25%)
Query: 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV--------------------- 256
+ + YLHS ++HRD+K N+LL+++ +K+ADFG++R
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 257 EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302
+ +T T Y APE+L G Y+ GI +W + C
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGC 219
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 39/140 (27%), Positives = 62/140 (44%), Gaps = 23/140 (16%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C+ E L G N ++L N + L V +A L L +LH ++ H D+K EN+L
Sbjct: 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 241 DSQR-------------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG 281
+ ++++ADFG A + ++ T T Y PEV+
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE 213
Query: 282 KPYNRRCDVYSFGICLWEIY 301
+ + CDV+S G L+E Y
Sbjct: 214 LGWAQPCDVWSIGCILFEYY 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 35/146 (23%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C+V E L G + ++ N L + ++A + + +++LHS K+ H D+K EN+L
Sbjct: 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 241 DSQR-------------------TLKIADFGVARVEAQNP------RDMTGETGTLGYMA 275
+K+ DFG A + ++ R Y A
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH---------YRA 202
Query: 276 PEVLQGKPYNRRCDVYSFGICLWEIY 301
PEV+ +++ CDV+S G L E Y
Sbjct: 203 PEVILALGWSQPCDVWSIGCILIEYY 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 29/146 (19%)
Query: 181 CVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240
C++ E L G +L + + RN ++ + +++ + L+YL + H D+K EN+LL
Sbjct: 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 241 DSQR-------------------------TLKIADFGVARVEAQNPRDMTGETGTLGYMA 275
D +K+ DFG A ++ T Y A
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRA 227
Query: 276 PEVLQGKPYNRRCDVYSFGICLWEIY 301
PEV+ ++ D++SFG L E+Y
Sbjct: 228 PEVILNLGWDVSSDMWSFGCVLAELY 253
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 58/303 (19%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHP 145
I G++G +Y GT N+EVA+KL E+ E +++ L
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTK-------HPQLLYESKIYRILQGGT 63
Query: 146 NVTKFVGA-SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ G N +V++ L G +L+ L +KL
Sbjct: 64 GIPNVRWFGVEGDYN---------------------VLVMDLL-GPSLED-LFNFCSRKL 100
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL---DSQRTLKIADFGVA---RVEA 258
+LK V+ LA + + ++HSK +HRD+K +N L+ + I DFG+A R +
Sbjct: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
Query: 259 QN----PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC--DMPYPDLSF 312
+ R+ TGT Y + G +RR D+ S G L +Y +P+ L
Sbjct: 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL--MYFLRGSLPWQGLKA 218
Query: 313 ADVSSAVVR-----QNLRPE-IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366
+ E + R P+ A+ C + +P+ + ++ +
Sbjct: 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278
Query: 367 SKG 369
+G
Sbjct: 279 REG 281
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 47/229 (20%), Positives = 89/229 (38%), Gaps = 52/229 (22%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-P 145
I +G++G ++ GT +NQ+VA+K E + + E ++ L
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSD-------APQLRDEYRTYKLLAGCT 66
Query: 146 NVTKFVGA-SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ G N +V++ L G +L+ L RK
Sbjct: 67 GIPNVYYFGQEGLHN---------------------VLVIDLL-GPSLEDLLDLCGRK-F 103
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL-----DSQRTLKIADFGVAR--VE 257
++K V A + + +H K +V+RD+K +N L+ + + + DFG+ + +
Sbjct: 104 SVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
Query: 258 AQN-----PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301
R+ +GT YM+ G+ +RR D+ + G +Y
Sbjct: 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF--MY 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 1e-07
Identities = 60/426 (14%), Positives = 128/426 (30%), Gaps = 110/426 (25%)
Query: 2 DLTTKDDLGVVDSLRK--SDNEEGSVNSKVKGTGSLSSKDMLF-----RADKIDLKSLDM 54
+ KD V D + S E ++ + ++S LF + +++ K ++
Sbjct: 32 NFDCKD---VQDMPKSILSKEE---IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEE 85
Query: 55 QLEKHLSWVWS--RNESQRPKEEWEIDLSKLD-MRNLIAQGTYGSVYRG-TYDNQEVAVK 110
L + ++ S + E ++P + + + D + N +V R Y A+
Sbjct: 86 VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145
Query: 111 LLDWGE----DGMA----TTAETAALRSS-----FQQEVAVWQKLDHPNVTKFVGASVGT 157
L + DG+ T S ++ W L + N + V +
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQK 204
Query: 158 SNLKI-PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDL 216
+I P+ T+ D ++ + R + + + L++++ + L L L
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLR-----IHSIQ--AELRRLLKSKPYENCL-----LVLL- 251
Query: 217 SRGLSYLHSKKIVHRDVKTENML--LDSQ-RTL------KIADFGVA----RVEAQNPRD 263
+V+ + + L ++ DF A + +
Sbjct: 252 ---------------NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 264 MTGETGTLGYMA-----------PEVLQGKPYNRRCDV----YSFGICLWEIYCCDMPYP 308
+ EVL P RR + G+ W+ +
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNP--RRLSIIAESIRDGLATWD------NWK 348
Query: 309 DLSFADVSSAVVR--QNLRPEIPRCCPSSLA------NIMRKC----WDANAEKRPEMGE 356
++ +++ + L P R L+ +I W +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM--V 406
Query: 357 VVKMLE 362
VV L
Sbjct: 407 VVNKLH 412
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 1e-06
Identities = 53/368 (14%), Positives = 101/368 (27%), Gaps = 143/368 (38%)
Query: 3 LTTKDDLGVVDSLRKSDNEEGSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEK---- 58
LTT+ V D L + S++ K +L + + L ++
Sbjct: 270 LTTRFK-QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 59 HLSWVWS--RNESQRPKEEWE-IDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWG 115
LS + R+ + W+ ++ KL +I E ++ +L+
Sbjct: 329 RLSIIAESIRDGLATW-DNWKHVNCDKLT--TII----------------ESSLNVLEPA 369
Query: 116 EDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASV---DGN 172
E R F ++V+ + IP+ S+ D
Sbjct: 370 E-----------YRKMF-DRLSVFPP-----------------SAHIPTILLSLIWFDVI 400
Query: 173 AAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232
+ VVV L + L K + S ++ +
Sbjct: 401 KSDVM----VVVNKL------------HKYSLVEK-------QPKESTISIPS---IYLE 434
Query: 233 VKTENMLLDSQRTL--KIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ----GKPYNR 286
+K + L+++ L I V+ Y P+ PY
Sbjct: 435 LKVK---LENEYALHRSI-------VDH--------------YNIPKTFDSDDLIPPYL- 469
Query: 287 RCDVYSFGICLWEI-Y---CCDMP---------YPDLSFADVSSAVVRQNLRPE-IPRCC 332
D Y + I + + P + D F + Q +R +
Sbjct: 470 --DQYFY----SHIGHHLKNIEHPERMTLFRMVFLDFRF-------LEQKIRHDSTAWNA 516
Query: 333 PSSLANIM 340
S+ N +
Sbjct: 517 SGSILNTL 524
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 390 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.09 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.76 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.39 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-62 Score=457.41 Aligned_cols=264 Identities=30% Similarity=0.582 Sum_probs=221.9
Q ss_pred CCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...|+|+.+++++.+.||+|+||+||+|++.+ .||||+++.... .....+.|.+|+.+|++++|||||+++|
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~-------~~~~~~~f~~E~~il~~l~HpNIV~l~g 99 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP-------TPEQFQAFRNEVAVLRKTRHVNILLFMG 99 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 35799999999999999999999999999865 699999974322 1223467899999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+ +.+|+||||+++|+|.++|... ...+++..+..|+.||+.||+|||+++|||||
T Consensus 100 ~~~~---------------------~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRD 157 (307)
T 3omv_A 100 YMTK---------------------DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRD 157 (307)
T ss_dssp EECS---------------------SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred EEEC---------------------CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence 8753 2348899999999999999653 35699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||+|||++.++.+||+|||+|+..... .......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||
T Consensus 158 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp CCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999864432 223445689999999999854 46899999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 308 PDLSFADVSSAVVRQNLRP----EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.+.+....+...+..+... ..+..+|+++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 238 SHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9887776666666555433 3567799999999999999999999999999999998864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-62 Score=457.83 Aligned_cols=264 Identities=26% Similarity=0.493 Sum_probs=227.2
Q ss_pred ccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
+.|+.++|.+.+.||+|+||.||+|++ ++..||||+++... ....+.|.+|+++|++++|||||
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnIV 78 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIV 78 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---------hHHHHHHHHHHHHHHhCCCCCCc
Confidence 467788999999999999999999986 35789999996321 12346789999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-----------cCCCCHHHHHHHHHHHH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-----------RKKLALKIVIQLALDLS 217 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~ 217 (390)
+++|+|.+.. ..|+||||+++|+|.++|.+.. ...+++..+..|+.||+
T Consensus 79 ~l~g~~~~~~--------------------~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 138 (299)
T 4asz_A 79 KFYGVCVEGD--------------------PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138 (299)
T ss_dssp CEEEEECSSS--------------------SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHH
T ss_pred cEEEEEeeCC--------------------EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHH
Confidence 9999998544 4488999999999999997532 34699999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHH
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGI 295 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 295 (390)
.||.|||+++||||||||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||
T Consensus 139 ~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218 (299)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHH
Confidence 999999999999999999999999999999999999985433221 122345899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 296 CLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 296 il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
++|||+| |+.||.+.+..++...+.. +.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+..+.-
T Consensus 219 vl~Ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 219 VLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 9999998 8999999999888877654 55677899999999999999999999999999999999999976653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=454.85 Aligned_cols=262 Identities=27% Similarity=0.513 Sum_probs=226.6
Q ss_pred CcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 146 (390)
..++++.+++++.++||+|+||.||+|++ +++.||||+++..... ...+.|.+|+.+|++++|||
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------~~~~~f~~E~~il~~l~HpN 90 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------PLREEFRHEAMLRARLQHPN 90 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------CHHHHHHHHHHHHHCCCTT
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--------HHHHHHHHHHHHHHhCCCCC
Confidence 34578889999999999999999999986 3578999999743211 12357889999999999999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHH
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQL 212 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i 212 (390)
||+++|+|.+... .|+||||+++|+|.++|..+. ...+++..+..|
T Consensus 91 IV~l~g~~~~~~~--------------------~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 150 (308)
T 4gt4_A 91 VVCLLGVVTKDQP--------------------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150 (308)
T ss_dssp BCCEEEEECSSSS--------------------CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred CCCcceEEEECCE--------------------EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence 9999999975443 478999999999999996432 246899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhH
Q 036382 213 ALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDV 290 (390)
Q Consensus 213 ~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 290 (390)
+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+..... .......+||+.|||||++.+..|+.++||
T Consensus 151 ~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDV 230 (308)
T 4gt4_A 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 230 (308)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchh
Confidence 999999999999999999999999999999999999999999854322 223345679999999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 291 YSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 291 wSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
|||||++|||+| |..||.+.+..++...+. .+.+++.|..||+++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 231 wSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 231 WSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred hhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999998 899999999888887664 5567778999999999999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-61 Score=456.92 Aligned_cols=264 Identities=28% Similarity=0.511 Sum_probs=223.5
Q ss_pred cccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
.+.|+.++|.+.++||+|+||.||+|++ +++.||||+++... ....+.|.+|+++|++++||||
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnI 105 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTMLQHQHI 105 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---------HHHHHHHHHHHHHHTTCCCTTB
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---------HHHHHHHHHHHHHHHhCCCCCC
Confidence 4567888999999999999999999986 35789999996321 2234678999999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-------------cCCCCHHHHHHHHH
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------------RKKLALKIVIQLAL 214 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~ 214 (390)
|+++|+|.+.. ..|+||||+++|+|.+++.+.. ..++++..+..|+.
T Consensus 106 V~l~g~~~~~~--------------------~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 165 (329)
T 4aoj_A 106 VRFFGVCTEGR--------------------PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165 (329)
T ss_dssp CCEEEEECSSS--------------------SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHH
T ss_pred CcEEEEEEECC--------------------EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHH
Confidence 99999997543 4488999999999999996532 24699999999999
Q ss_pred HHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHH
Q 036382 215 DLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYS 292 (390)
Q Consensus 215 ~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 292 (390)
||+.||.|||+++||||||||+|||++.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++||||
T Consensus 166 qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS 245 (329)
T 4aoj_A 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245 (329)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccc
Confidence 99999999999999999999999999999999999999998543322 2223467999999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 293 FGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 293 lG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
|||++|||+| |+.||.+.+..++...+. .+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus 246 ~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 246 FGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHHHHTTSCCTTCSSCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 9999999999 899999999888887765 45678889999999999999999999999999999999999997653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-62 Score=463.22 Aligned_cols=254 Identities=22% Similarity=0.437 Sum_probs=217.9
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
.+++|++++.||+|+||.||+|++ +|+.||||+++..... ....+.+.+|+++|++|+|||||++++++.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-------SKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-------HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 467999999999999999999987 5899999999743221 1234678899999999999999999999986
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... +|+||||++||+|.++|..+.+..+++..++.|+.||+.||.|||++|||||||||+
T Consensus 95 ~~~--------------------~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 154 (350)
T 4b9d_A 95 NGS--------------------LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154 (350)
T ss_dssp TTE--------------------EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGG
T ss_pred CCE--------------------EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence 544 478999999999999998766667899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|||++.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.
T Consensus 155 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp GEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 99999999999999999986543322234467999999999999999999999999999999999999999999999988
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+....+ ++.+..+|+++.+||.+||++||++|||+.+++++
T Consensus 235 ~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 235 LKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 88876654 45677899999999999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-61 Score=460.70 Aligned_cols=269 Identities=28% Similarity=0.548 Sum_probs=232.0
Q ss_pred CcccccccCccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC-C
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-P 145 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p 145 (390)
..|+|+.++|++.+.||+|+||.||+|++.+ +.||||+++.... ....+.|.+|+++|++++| |
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--------~~~~~~~~~E~~il~~l~hhp 128 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHHL 128 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCCT
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--------hHHHHHHHHHHHHHHHcCCCC
Confidence 4699999999999999999999999998733 5799999963221 1224678899999999965 8
Q ss_pred ccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHH
Q 036382 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQ 211 (390)
Q Consensus 146 nIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ 211 (390)
|||+++|+|... ...+|+||||+++|+|.++|.+.. ...+++..+..
T Consensus 129 nIV~l~g~~~~~-------------------~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 189 (353)
T 4ase_A 129 NVVNLLGACTKP-------------------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189 (353)
T ss_dssp TBCCEEEEECCT-------------------TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHH
T ss_pred cEEEEEEEEEec-------------------CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHH
Confidence 999999998643 234588999999999999997543 23489999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchh
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+....... .....+||+.|||||++.+..|+.++|
T Consensus 190 ~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksD 269 (353)
T 4ase_A 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 269 (353)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCccc
Confidence 999999999999999999999999999999999999999999986543322 223456899999999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 290 VYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 290 iwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
||||||++|||+| |..||.+.+..+.+...+..+.+++.|..+|+++.+||.+||+.||++|||+.+|+++|+.+-.+.
T Consensus 270 VwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 270 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred EeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999998 899999987767676777788899999999999999999999999999999999999999986554
Q ss_pred C
Q 036382 369 G 369 (390)
Q Consensus 369 ~ 369 (390)
.
T Consensus 350 ~ 350 (353)
T 4ase_A 350 A 350 (353)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=448.52 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=221.0
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
...++|++.+.||+|+||+||+|++ +|+.||||+++.. ........+.+.+|+++|++++|||||++++++.
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~------~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR------HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHH------HCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3457899999999999999999987 6889999999621 1112223467889999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+...+ |+||||++||+|.+++.+. ..+++..+..|+.||+.||+|||++||+||||||
T Consensus 103 ~~~~~--------------------yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKP 160 (311)
T 4aw0_A 103 DDEKL--------------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 160 (311)
T ss_dssp CSSEE--------------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eCCEE--------------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 65544 7899999999999999654 4699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
+|||++.++++||+|||+|+..... .....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 161 eNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 240 (311)
T 4aw0_A 161 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999865432 22345678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
++...+.... ..+|..+++++++||.+||.+||++|||+.|++.
T Consensus 241 ~~~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 241 LIFAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 9888887765 4578889999999999999999999999998743
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-60 Score=449.34 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=217.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.++||+|+||.||+|++ +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.+..
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---------GGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999988 58899999997433211 245779999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
. +|+||||++||+|.+++.+ ..+++..+..|+.||+.||+|||++|||||||||+||
T Consensus 145 ~--------------------~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 201 (346)
T 4fih_A 145 E--------------------LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 201 (346)
T ss_dssp E--------------------EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred E--------------------EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 4 4789999999999999954 3599999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....
T Consensus 202 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~ 281 (346)
T 4fih_A 202 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 281 (346)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 99999999999999998766555556678999999999999999999999999999999999999999999988888777
Q ss_pred HHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..... ....+..+++++.+||.+||++||++|||+.|++++
T Consensus 282 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 282 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 654321 223445789999999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-60 Score=447.18 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=222.7
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+....+.|++.++||+|+||.||+|++ +|+.||||+++... ...+|+.+|+.++|||||+++++
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--------------~~~~E~~il~~l~HpnIV~l~~~ 118 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------------FRVEELVACAGLSSPRIVPLYGA 118 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------------CCTHHHHTTTTCCCTTBCCEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--------------hHHHHHHHHHhCCCCCCCcEEEE
Confidence 444567799999999999999999987 58899999997422 12369999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+... +|+||||++||+|.++|.+. ..+++..+..|+.||+.||+|||++|||||||
T Consensus 119 ~~~~~~--------------------~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 176 (336)
T 4g3f_A 119 VREGPW--------------------VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176 (336)
T ss_dssp EEETTE--------------------EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred EEECCE--------------------EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 986544 47899999999999999654 46999999999999999999999999999999
Q ss_pred CCCCEEECCCC-cEEEeecccceeccCCCC-----CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 234 KTENMLLDSQR-TLKIADFGVARVEAQNPR-----DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 234 kp~NILl~~~~-~~kL~DfG~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
||+|||++.+| ++||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||
T Consensus 177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp CGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 99999999987 699999999986543221 123357999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 308 PDLSFADVSSAVVRQNLRP-EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
.+.+..++...+....... .+|..+|+++.+||.+||++||.+|||+.||++.|.......+..
T Consensus 257 ~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l 321 (336)
T 4g3f_A 257 TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321 (336)
T ss_dssp TTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred CCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence 9988888887777654332 467889999999999999999999999999999999887665543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-59 Score=430.58 Aligned_cols=249 Identities=25% Similarity=0.484 Sum_probs=202.6
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||+||+|++ +|+.||||+++... .........+.+|+++|+.++|||||++++++.+.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV------LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK 85 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH------cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 46899999999999999999987 68999999996332 11222346788999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. +|+||||+ +|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 86 ~~--------------------~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~N 142 (275)
T 3hyh_A 86 DE--------------------IIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 142 (275)
T ss_dssp SE--------------------EEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTT
T ss_pred CE--------------------EEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHH
Confidence 43 47899999 6899999965 3579999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++++||+|||+|+..... ....+.+||+.|||||++.+..| +.++||||+||++|+|++|+.||.+.+..+..
T Consensus 143 ILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 143 LLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp EEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999865432 23445789999999999999886 57999999999999999999999998888888
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+.... ..+|..+|+++.+||.+||+.||++|||+.|++++
T Consensus 222 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 222 KNISNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 7776553 45788899999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-60 Score=443.32 Aligned_cols=252 Identities=23% Similarity=0.408 Sum_probs=212.5
Q ss_pred cccccCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
.++.++|++.+.||+|+||+||+|+. +++.||||+++........ ...+.+|+++|++++|||||+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~ 92 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMERDILVEVNHPFIVKLH 92 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-------CC------CCCCCCCCTTEECEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-------HHHHHHHHHHHHHCCCCCCCeEE
Confidence 45678999999999999999999976 4678999999643211111 12467899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+... +|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||
T Consensus 93 ~~~~~~~~--------------------~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 150 (304)
T 3ubd_A 93 YAFQTEGK--------------------LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYR 150 (304)
T ss_dssp EEEEETTE--------------------EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEECCE--------------------EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 99986544 47899999999999999654 469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||||+|||++.+|.+||+|||+|+..........+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus 151 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp SCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999999865544445566789999999999999999999999999999999999999999999
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM-----GEVVK 359 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~ 359 (390)
..+....+.... ..+|..+|+++.+||.+||++||++|||+ +|+++
T Consensus 231 ~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 231 RKETMTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999888887654 45788899999999999999999999984 67764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=451.19 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=219.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.+.|++.++||+|+||.||+|++ +|+.||||+++...... .+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---------GGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 35699999999999999999988 58999999997543221 24578999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. +||||||++||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 221 ~~--------------------~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~N 277 (423)
T 4fie_A 221 DE--------------------LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277 (423)
T ss_dssp TE--------------------EEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTT
T ss_pred CE--------------------EEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 44 4889999999999999954 359999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+.+.
T Consensus 278 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 357 (423)
T 4fie_A 278 ILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 357 (423)
T ss_dssp EEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 99999999999999999876655555667899999999999999999999999999999999999999999998888887
Q ss_pred HHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+..... ....+..+++++++||.+||.+||++|||+.|++++
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 7654321 234456789999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=430.97 Aligned_cols=250 Identities=27% Similarity=0.499 Sum_probs=207.7
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.++||+|+||.||+|.+ ++..||||++..... .....+.|.+|+++|++++|||||++++++.+...
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~- 99 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK- 99 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-
Confidence 47788999999999999988 577999999863221 12234678999999999999999999999864211
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENM 238 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrDlkp~NI 238 (390)
....+|+||||+++|+|.+++.+. ..+++..+..|+.||+.||+|||++| ||||||||+||
T Consensus 100 ---------------~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NI 162 (290)
T 3fpq_A 100 ---------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162 (290)
T ss_dssp ---------------TEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGE
T ss_pred ---------------CCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhe
Confidence 123458999999999999999653 56999999999999999999999998 99999999999
Q ss_pred EECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++. +|.+||+|||+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+....+.
T Consensus 163 Ll~~~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~ 239 (290)
T 3fpq_A 163 FITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239 (290)
T ss_dssp EESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred eEECCCCCEEEEeCcCCEeCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH
Confidence 9975 79999999999975432 23345689999999999875 59999999999999999999999998765555444
Q ss_pred HHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+..+. .+..+..+++++.+||.+||+.||++|||+.+++++
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4444443 334667788999999999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=425.23 Aligned_cols=260 Identities=32% Similarity=0.500 Sum_probs=206.4
Q ss_pred cCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
.+|.+.++||+|+||.||+|+++|+.||||+++.. ... ...+..|+..+.+++|||||+++|++.+....
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-------~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EER---SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-------GHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 46889999999999999999999999999998621 111 11223466666788999999999999764321
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccC
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK--------KIVHRD 232 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~iiHrD 232 (390)
...+|+||||+++|+|.++|.+ .++++..+..++.|++.||+|||++ +|||||
T Consensus 73 ----------------~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 73 ----------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp ----------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred ----------------ceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 2245899999999999999964 3599999999999999999999987 999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC----CCCCCCCCCccccccccCCC------CCCCchhHHHHHHHHHHHHh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLQGK------PYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~ 302 (390)
|||+|||++.++.+||+|||+|+....... .....+||+.|||||++.+. .++.++|||||||++|||+|
T Consensus 134 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t 213 (303)
T 3hmm_A 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH
Confidence 999999999999999999999986544322 12345799999999999764 36779999999999999999
Q ss_pred CCCCCC----------CC-----ChhhHHHHHHHcCCCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 303 CDMPYP----------DL-----SFADVSSAVVRQNLRPEIPRC-----CPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 303 g~~Pf~----------~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
|..||. +. ...+....+...++++.+|.. ++..+.+||.+||+.||++|||+.+|++.|+
T Consensus 214 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 976552 21 233444455566777777654 3467899999999999999999999999999
Q ss_pred HhHhcCC
Q 036382 363 AIDTSKG 369 (390)
Q Consensus 363 ~~~~~~~ 369 (390)
.+...++
T Consensus 294 ~l~~~~~ 300 (303)
T 3hmm_A 294 QLSQQEG 300 (303)
T ss_dssp HHHHC--
T ss_pred HHHHHcC
Confidence 9976543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=418.00 Aligned_cols=259 Identities=21% Similarity=0.408 Sum_probs=192.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||+||+|++ +|+.||||+++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--------ELAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 4699999999999999999987 588999999974321 123456889999999999999999999997654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.... ..........|+||||+.+|+|.+++..+.. ...++..++.|+.||+.||+|||++||+||||||+|
T Consensus 77 ~~~~--------~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~N 148 (299)
T 4g31_A 77 TTEK--------LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSN 148 (299)
T ss_dssp ------------------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cccc--------ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHH
Confidence 3211 0111234457999999999999999965432 235677789999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCC------------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNP------------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
||++.++.+||+|||+|+...... ...++.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 149 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp EEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred eEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence 999999999999999998643321 12234679999999999999999999999999999999996
Q ss_pred CCCCCChh-hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 306 PYPDLSFA-DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 306 Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
||...... ..+..+ .....++.+...++.+.+||.+||+.||++|||+.++++
T Consensus 226 Pf~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 PFSTQMERVRTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp CCSSHHHHHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccHHHHHHHHH-hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 87653221 222222 222222222334567889999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=422.78 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=212.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||+||+|++ +|+.||||+++.... .......+.+|+++|+.++|||||++++++....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-------chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 6799999999999999999988 689999999963321 1122356789999999999999999999986432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.. ...+.+|+||||+. |+|.+++.+ ...+++..+..|+.||+.||.|||++|||||||||+||
T Consensus 127 ~~--------------~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI 189 (398)
T 4b99_A 127 PY--------------GEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189 (398)
T ss_dssp CT--------------TTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred cc--------------ccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccc
Confidence 11 23466799999996 689999954 45799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCC----CCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 239 LLDSQRTLKIADFGVARVEAQN----PRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|++.+|.+||+|||+|+..... .....+.+||+.|+|||++.+. .++.++||||+||++|||++|.+||.+.+..
T Consensus 190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999999854322 2234567899999999998875 4699999999999999999999999999888
Q ss_pred hHHHHHHHcCCCCC----------------------C-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPE----------------------I-------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~----------------------~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.+..+......+. . ...+++++.+||.+||..||.+|||+.|++++
T Consensus 270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 88777654322211 1 12467899999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-53 Score=427.68 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=207.9
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+.+++|++.++||+|+||.||+|++ +|+.||||+++.... ..............++.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i---~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHc---chhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 45678999999999999999999988 688999999962110 0000011112223446667778999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+...+ |+||||++||+|.++|.+. ..+++..+..|+.||+.||+|||++||||||||
T Consensus 262 ~~~~~l--------------------ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 262 HTPDKL--------------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp ECSSEE--------------------EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred EECCEE--------------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 876554 7899999999999999654 569999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC--
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS-- 311 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-- 311 (390)
|+|||++.+|++||+|||+|+..... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+
T Consensus 320 PeNILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 320 PANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred hHHeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999999865432 3345799999999999964 679999999999999999999999997643
Q ss_pred -hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 036382 312 -FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVK 359 (390)
Q Consensus 312 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~ 359 (390)
..++...+.. ....+|..+++++++||.+||.+||.+|++ +.+|++
T Consensus 398 ~~~~i~~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 398 DKHEIDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHHhhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 3334444433 345678889999999999999999999998 677775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=426.86 Aligned_cols=250 Identities=21% Similarity=0.346 Sum_probs=217.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||.||+|.+ +|+.||||+++... ....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 57899999999999999999988 68899999986321 11235678999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. +|+||||+.||+|.++|.+. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 227 ~~--------------------~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N 285 (573)
T 3uto_A 227 NE--------------------MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285 (573)
T ss_dssp SE--------------------EEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CE--------------------EEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 44 47899999999999999543 3569999999999999999999999999999999999
Q ss_pred EEECCC--CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLDSQ--RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~~--~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||++.+ +.+||+|||+|+..... ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+.
T Consensus 286 ill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~ 364 (573)
T 3uto_A 286 IMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364 (573)
T ss_dssp EEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 999864 89999999999865433 333456899999999999999999999999999999999999999999999998
Q ss_pred HHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..+....+.. ..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 88887665443 3346789999999999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=399.51 Aligned_cols=243 Identities=22% Similarity=0.308 Sum_probs=195.2
Q ss_pred cCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGAS 154 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 154 (390)
++|++.+.||+|+||+||+|++ +++.||||.+..... ...+.+|+++|+.+ +||||+++++++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----------PIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----------HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----------HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 5799999999999999999976 357899998863211 13467899999998 799999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+..+ .|+||||+++|+|.+++. .+++..+..++.||+.||+|||++||+|||||
T Consensus 90 ~~~~~--------------------~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiK 144 (361)
T 4f9c_A 90 RKNDH--------------------VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVK 144 (361)
T ss_dssp EETTE--------------------EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EECCE--------------------EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCC
Confidence 86544 478999999999999982 49999999999999999999999999999999
Q ss_pred CCCEEECCC-CcEEEeecccceeccCCC----------------------------CCCCCCCCCCccccccccCCC-CC
Q 036382 235 TENMLLDSQ-RTLKIADFGVARVEAQNP----------------------------RDMTGETGTLGYMAPEVLQGK-PY 284 (390)
Q Consensus 235 p~NILl~~~-~~~kL~DfG~a~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~ 284 (390)
|+|||++.+ +.+||+|||+|+...... ......+||+.|+|||++.+. .|
T Consensus 145 PeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y 224 (361)
T 4f9c_A 145 PSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQ 224 (361)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCC
T ss_pred HHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 999999877 899999999997533211 112345799999999999875 48
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHc------------------------------------C----
Q 036382 285 NRRCDVYSFGICLWEIYCCDMPYPDL-SFADVSSAVVRQ------------------------------------N---- 323 (390)
Q Consensus 285 ~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~~~~~~~~~------------------------------------~---- 323 (390)
+.++||||+||++|||++|+.||... +..+.+..+... .
T Consensus 225 ~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 304 (361)
T 4f9c_A 225 TTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSS 304 (361)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----
T ss_pred CCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccc
Confidence 99999999999999999999999543 333333322210 0
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 324 ------------LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 324 ------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+....+++++.+||.+||+.||++|||++|+++
T Consensus 305 ~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 305 TPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 001123457889999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=390.00 Aligned_cols=269 Identities=35% Similarity=0.631 Sum_probs=224.0
Q ss_pred CCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...+++..++|++.+.||+|+||.||+|+++++.||||++..... .......+.+|++++++++||||+++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-------HAERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-------SHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 457888899999999999999999999999999999999864321 1122456889999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKK--IV 229 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~--ii 229 (390)
++.+... .++||||+.+|+|.+++.+.. ...+++..++.++.||+.||.|||++| |+
T Consensus 102 ~~~~~~~--------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~iv 161 (309)
T 3p86_A 102 AVTQPPN--------------------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161 (309)
T ss_dssp EECSTTC--------------------CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCC
T ss_pred EEEECCc--------------------eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEE
Confidence 9875443 478999999999999996532 234999999999999999999999999 99
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
||||||+|||++.++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 162 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp CTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999997654443334456799999999999999999999999999999999999999999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
.+..+....+.....+...+..+++++.+||.+||..||.+|||+.+|++.|+.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 99888888777777788889999999999999999999999999999999999997653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=399.11 Aligned_cols=262 Identities=30% Similarity=0.627 Sum_probs=230.4
Q ss_pred CCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...|+++.++|++.+.||+|+||.||+|.+.++.||||+++... ..+.+.+|+.+|++++||||+++++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 253 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLG 253 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----------TSHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----------HHHHHHHHHHHHHhccCCCEEEEEE
Confidence 35689999999999999999999999999999999999997322 1256789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.... ...|+||||+.+|+|.+++.+.....+++..++.++.||+.||.|||++||+|||
T Consensus 254 ~~~~~~-------------------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrD 314 (450)
T 1k9a_A 254 VIVEEK-------------------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314 (450)
T ss_dssp EEECTT-------------------SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEEcCC-------------------CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 986432 2458999999999999999876555589999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
|||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+
T Consensus 315 lkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 315 LAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred CCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999999854322 222367889999999999999999999999999999998 999999988
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
..++...+ ..+.++..|..+|+++.+||.+||..||.+|||+.+|++.|+.+.+..
T Consensus 392 ~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 392 LKDVVPRV-EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp TTTHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 88877655 566788889999999999999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=387.88 Aligned_cols=267 Identities=31% Similarity=0.577 Sum_probs=228.5
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL- 142 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 142 (390)
...|++..++|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+.+++.+
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~ 144 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIG 144 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--------BHHHHHHHHHHHHHHHHSC
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--------CHHHHHHHHHHHHHHHHhc
Confidence 3457888999999999999999999999862 3469999996321 122346788999999999
Q ss_pred CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHH
Q 036382 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKI 208 (390)
Q Consensus 143 ~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~ 208 (390)
+||||+++++++.+.. ..|+||||+.+|+|.+++.... ...+++..
T Consensus 145 ~hpnIv~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (370)
T 2psq_A 145 KHKNIINLLGACTQDG--------------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204 (370)
T ss_dssp CCTTBCCEEEEECSSS--------------------SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHH
T ss_pred CCCCEeeEEEEEccCC--------------------CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHH
Confidence 8999999999987544 3488999999999999997643 13589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCC
Q 036382 209 VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNR 286 (390)
Q Consensus 209 ~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 286 (390)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.
T Consensus 205 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 284 (370)
T 2psq_A 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284 (370)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence 99999999999999999999999999999999999999999999998554322 2233456788999999999999999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 287 RCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 287 ~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
++|||||||++|||++ |..||.+.+..+....+ ..+.++..|..++.++.++|.+||+.||.+|||+.++++.|+++.
T Consensus 285 ~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 285 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999 99999998887776554 556677888899999999999999999999999999999999987
Q ss_pred hcC
Q 036382 366 TSK 368 (390)
Q Consensus 366 ~~~ 368 (390)
+..
T Consensus 364 ~~~ 366 (370)
T 2psq_A 364 TLT 366 (370)
T ss_dssp HHH
T ss_pred HHh
Confidence 644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=398.98 Aligned_cols=302 Identities=26% Similarity=0.491 Sum_probs=248.9
Q ss_pred CCceEEecCCCcCChHHHHHhhhhhccc-------c-----cCCCCCCCcccccccCccccccccccCceEEEEEEEC-C
Q 036382 38 KDMLFRADKIDLKSLDMQLEKHLSWVWS-------R-----NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-N 104 (390)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~-----~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~ 104 (390)
.+.++......+.++...+..+...... . .........|++..++|++.+.||+|+||.||+|.+. +
T Consensus 133 ~g~~~i~~~~~F~sl~eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~ 212 (454)
T 1qcf_A 133 NGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212 (454)
T ss_dssp TSCEESSSSSCBSSHHHHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTT
T ss_pred CCcEEEeCccccCCHHHHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCc
Confidence 3456666777888887554433221110 0 0111235779999999999999999999999999985 6
Q ss_pred ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEE
Q 036382 105 QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184 (390)
Q Consensus 105 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 184 (390)
..||||+++.... ..+.+.+|+.+|++++||||+++++++.. ...|+||
T Consensus 213 ~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---------------------~~~~lv~ 261 (454)
T 1qcf_A 213 TKVAVKTMKPGSM----------SVEAFLAEANVMKTLQHDKLVKLHAVVTK---------------------EPIYIIT 261 (454)
T ss_dssp EEEEEEEECTTSB----------CHHHHHHHHHHHTTCCCTTBCCEEEEECS---------------------SSCEEEE
T ss_pred cEEEEEEecCCCc----------cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---------------------CccEEEE
Confidence 7899999974321 13568899999999999999999999752 2348899
Q ss_pred ecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC-CC
Q 036382 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RD 263 (390)
Q Consensus 185 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~ 263 (390)
||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 99999999999976555578999999999999999999999999999999999999999999999999998543221 11
Q ss_pred CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHH
Q 036382 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRK 342 (390)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 342 (390)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. .+.+.+.|..+|+++.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 233456789999999998899999999999999999999 999999999888876654 566777889999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 343 CWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 343 cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
||..||++|||+.+|++.|+++.++...+
T Consensus 421 cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred HccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 99999999999999999999998776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=392.07 Aligned_cols=296 Identities=29% Similarity=0.549 Sum_probs=240.3
Q ss_pred eEEecCCCcCChHHHHHhhhhhcccc-------cCCCCCCCcccccccCccccccccccCceEEEEEEE--CCceEEEEE
Q 036382 41 LFRADKIDLKSLDMQLEKHLSWVWSR-------NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKL 111 (390)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~ 111 (390)
.+..+...+.++...+..+....... .....+...|+++.++|++.+.||+|+||.||+|++ +++.||||+
T Consensus 67 ~~~~~~~~F~sl~~LI~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~ 146 (377)
T 3cbl_A 67 LYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146 (377)
T ss_dssp CCCC----CCSHHHHHHHHHHHTCCC-----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEE
T ss_pred eEEecceeccchHHHHHHHhhccCCcccccCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEE
Confidence 44455567788876555444322111 012235678999999999999999999999999998 578999999
Q ss_pred eccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCC
Q 036382 112 LDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191 (390)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gs 191 (390)
++... .......+.+|+++|++++||||+++++++.+.. ..|+||||+++|+
T Consensus 147 ~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------------------~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 147 CRETL--------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--------------------PIYIVMELVQGGD 198 (377)
T ss_dssp CCTTS--------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--------------------SCEEEEECCTTCB
T ss_pred ccccC--------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--------------------CcEEEEEcCCCCC
Confidence 86321 1223456889999999999999999999987543 3488999999999
Q ss_pred HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCC--CCCCC
Q 036382 192 LKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM--TGETG 269 (390)
Q Consensus 192 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~--~~~~g 269 (390)
|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ....+
T Consensus 199 L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~ 277 (377)
T 3cbl_A 199 FLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277 (377)
T ss_dssp HHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEE
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCC
Confidence 99999654 3469999999999999999999999999999999999999999999999999998543321111 12235
Q ss_pred CCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCC
Q 036382 270 TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANA 348 (390)
Q Consensus 270 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 348 (390)
++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+ ..+.+.+.|..+|+++.+||.+||+.||
T Consensus 278 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP 356 (377)
T 3cbl_A 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQCWAYEP 356 (377)
T ss_dssp EGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 778999999998889999999999999999998 99999998887766544 5666778889999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhHh
Q 036382 349 EKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 349 ~~Rpt~~~ll~~L~~~~~ 366 (390)
++|||+.+|++.|+++..
T Consensus 357 ~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 357 GQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=382.41 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=219.9
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+..++|++.+.||+|+||.||+|+. +|+.||||+++.. ..........+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE------VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHH------HhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 4568999999999999999999988 5889999999621 1111223456789999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 76 ~~~--------------------~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 133 (337)
T 1o6l_A 76 THD--------------------RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp CSS--------------------EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred eCC--------------------EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCH
Confidence 544 448899999999999999653 4699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.+|.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+.
T Consensus 134 ~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999999998644444445567899999999999999999999999999999999999999999888888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
...+.... ..+|..+++++.+||.+||+.||.+|| ++.+++++
T Consensus 214 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 214 FELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 87776654 447788999999999999999999999 89999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.72 Aligned_cols=302 Identities=28% Similarity=0.476 Sum_probs=245.3
Q ss_pred CceEEecCCCcCChHHHHHhhhhhcccc-------------cCCCCCCCcccccccCccccccccccCceEEEEEEECC-
Q 036382 39 DMLFRADKIDLKSLDMQLEKHLSWVWSR-------------NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN- 104 (390)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~- 104 (390)
+.++..+...+.++...+..+....... .........|++..++|++.+.||+|+||.||+|.+.+
T Consensus 129 g~~~~~~~~~F~Sl~~Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~ 208 (452)
T 1fmk_A 129 GGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208 (452)
T ss_dssp SCEESSTTSEESSHHHHHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT
T ss_pred CCEEEecCcccCCHHHHHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCC
Confidence 4566667778888876554432211110 01112356899999999999999999999999999965
Q ss_pred ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEE
Q 036382 105 QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184 (390)
Q Consensus 105 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 184 (390)
..||||+++.... . .+.+.+|+.+|++++||||+++++++.+ ...|+||
T Consensus 209 ~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~---------------------~~~~iv~ 257 (452)
T 1fmk_A 209 TRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE---------------------EPIYIVT 257 (452)
T ss_dssp EEEEEEECCTTSS---C-------HHHHHHHHHHHHHCCCTTBCCEEEEECS---------------------SSCEEEE
T ss_pred ceEEEEEeccCCC---C-------HHHHHHHHHHHHhCCCCCEeeEEEEEcC---------------------CceEEEe
Confidence 5799999974321 1 2467899999999999999999999853 2348899
Q ss_pred ecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC-CC
Q 036382 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RD 263 (390)
Q Consensus 185 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~ 263 (390)
||+.+|+|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999999976555679999999999999999999999999999999999999999999999999998644322 12
Q ss_pred CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHH
Q 036382 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRK 342 (390)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 342 (390)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+ ..+.+.+.|..+|+.+.+||.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHH
Confidence 233456789999999998899999999999999999999 99999999888877665 4667778889999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHhHhcCCCCC
Q 036382 343 CWDANAEKRPEMGEVVKMLEAIDTSKGGGM 372 (390)
Q Consensus 343 cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~ 372 (390)
||+.||++|||+.+|++.|+.+.++....+
T Consensus 417 cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred HccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 999999999999999999999998777443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=369.51 Aligned_cols=261 Identities=25% Similarity=0.489 Sum_probs=229.7
Q ss_pred cccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.++++.++|++.+.||+|+||.||+|+++++.||||+++.... .......+.+|+.++++++||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-------STRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-------CHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 4678889999999999999999999999999999999974321 112235688999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRD 232 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrD 232 (390)
.+.. ....++||||+++|+|.+++.+.....+++..++.++.|++.||.|||++| |+|||
T Consensus 77 ~~~~------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~d 138 (271)
T 3kmu_A 77 QSPP------------------APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138 (271)
T ss_dssp CTTT------------------SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCC
T ss_pred ccCC------------------CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCC
Confidence 7542 234589999999999999997655556999999999999999999999999 99999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCC---chhHHHHHHHHHHHHhCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNR---RCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
|||+|||++.++.++|+|||++.... .....+|+.|+|||++.+..++. ++|||||||++|+|++|..||.+
T Consensus 139 ikp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 139 LNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp CSGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred CccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999999999999999875422 23457899999999998765554 79999999999999999999999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
.+..+....+.....++..+..+|+++.++|.+||+.||++|||+.++++.|+.+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 214 LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 99988888888888888999999999999999999999999999999999999885
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=378.31 Aligned_cols=250 Identities=26% Similarity=0.477 Sum_probs=218.1
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+++++.++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-------NPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 457899999999999999999987 688999999963221 12234567899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 86 ~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 143 (328)
T 3fe3_A 86 EK--------------------TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAE 143 (328)
T ss_dssp SS--------------------EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CC--------------------EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHH
Confidence 43 458899999999999999654 46999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|||++.++.+||+|||++...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.
T Consensus 144 NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 222 (328)
T 3fe3_A 144 NLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222 (328)
T ss_dssp GEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999754432 334567899999999999888775 799999999999999999999999998888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+....+ ..|..+++++.+||.+||..||.+|||+.+++++
T Consensus 223 ~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 223 RERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 888776644 4677889999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=383.91 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=212.4
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 153 (390)
.+..++|++.+.||+|+||.||+|++ +++.||||+++.. ..........+.+|..+++.+ +||||++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~------~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD------VILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH------HhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 45678999999999999999999987 5789999999621 122233346678899999998 79999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 93 ~~~~~--------------------~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 150 (353)
T 3txo_A 93 FQTPD--------------------RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDL 150 (353)
T ss_dssp EECSS--------------------EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred EEeCC--------------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Confidence 98654 348899999999999999654 46999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||+|||++.++++||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 151 kp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 151 KLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999985444444455678999999999999889999999999999999999999999999999
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM------GEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~~ll~ 359 (390)
+....+.... ..+|..+++++.+||.+||..||.+||++ .++++
T Consensus 231 ~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 231 DLFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 9888887654 34677899999999999999999999998 67765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=372.39 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=216.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---------HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 46799999999999999999986 6789999998643221 124577899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+|+|.+++.+. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 90 ~--------------------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~N 146 (297)
T 3fxz_A 90 D--------------------ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146 (297)
T ss_dssp T--------------------EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred C--------------------EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHH
Confidence 3 348899999999999999643 59999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999876555555556789999999999999999999999999999999999999999888777666
Q ss_pred HHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+.... .....+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 554433 3344567789999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=365.53 Aligned_cols=271 Identities=28% Similarity=0.550 Sum_probs=230.2
Q ss_pred CCCCcccccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 71 RPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 71 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
...++|++..++|++.+.||+|+||.||+|.+. +..||||+++..... .+.+.+|+++++.++||||++
T Consensus 3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~ 72 (279)
T 1qpc_A 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVR 72 (279)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cchhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----------HHHHHHHHHHHHhCCCcCcce
Confidence 345789999999999999999999999999985 458999998743211 246789999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.+ +..++||||+.+++|.+++.......+++..++.++.|++.||.|||++||+
T Consensus 73 ~~~~~~~---------------------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 131 (279)
T 1qpc_A 73 LYAVVTQ---------------------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131 (279)
T ss_dssp EEEEECS---------------------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcC---------------------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9998752 2348999999999999999654444799999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPY 307 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf 307 (390)
||||||+|||++.++.+||+|||++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 132 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 211 (279)
T 1qpc_A 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (279)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654332 12233457889999999988889999999999999999999 99999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCCCC
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMI 373 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~ 373 (390)
.+.+..+....+ ..+.....+..+|.++.+++.+||..||++|||+.++++.|+.+.+...+...
T Consensus 212 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 212 PGMTNPEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp TTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred cccCHHHHHHHH-hcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 998887776655 45566777888999999999999999999999999999999999987765443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=365.42 Aligned_cols=258 Identities=32% Similarity=0.664 Sum_probs=215.5
Q ss_pred cccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
+++.++|++.+.||+|+||.||+|.+.++.||||+++.... .......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD-----EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCc-----ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 56778999999999999999999999999999999864321 1112234668899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK---IVHRDV 233 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---iiHrDl 233 (390)
.. ..++||||+.+++|.+++. ...+++..++.++.|++.||.|||++| |+||||
T Consensus 78 ~~--------------------~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 78 EP--------------------NLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp C----------------------CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred CC--------------------ceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 43 3488999999999999984 346999999999999999999999999 899999
Q ss_pred CCCCEEECC--------CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 234 KTENMLLDS--------QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 234 kp~NILl~~--------~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
||+|||++. ++.+||+|||++....... .....+|+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred chHHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999986 7789999999997543322 224578999999999998899999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
||.+.+.................+..+|+.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 213 PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999888888888777778888899999999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=381.10 Aligned_cols=272 Identities=31% Similarity=0.561 Sum_probs=232.4
Q ss_pred CCCcccccccCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 142 (390)
....|++..++|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+++++.+
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l 131 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--------TEKDLSDLISEMEMMKMI 131 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHH
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--------CHHHHHHHHHHHHHHHHh
Confidence 34578999999999999999999999999862 2579999996321 122346788999999999
Q ss_pred -CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHH
Q 036382 143 -DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALK 207 (390)
Q Consensus 143 -~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~ 207 (390)
+||||+++++++.+.. ..|+||||+.+|+|.+++.... ...+++.
T Consensus 132 ~~hpnIv~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~ 191 (382)
T 3tt0_A 132 GKHKNIINLLGACTQDG--------------------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191 (382)
T ss_dssp CCCTTBCCEEEEECSSS--------------------SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHH
T ss_pred cCCchhhhheeeeccCC--------------------ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHH
Confidence 9999999999987543 3488999999999999997643 2359999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCC
Q 036382 208 IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYN 285 (390)
Q Consensus 208 ~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 285 (390)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++
T Consensus 192 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 999999999999999999999999999999999999999999999998544322 223345678899999999999999
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 286 RRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 286 ~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.++|||||||++|+|++ |..||.+.+..+....+ ..+.+...+..+++++.+||.+||+.||++|||+.+|++.|+++
T Consensus 272 ~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999 99999998887776554 55667778889999999999999999999999999999999999
Q ss_pred HhcCCCCC
Q 036382 365 DTSKGGGM 372 (390)
Q Consensus 365 ~~~~~~~~ 372 (390)
.......-
T Consensus 351 ~~~~~~~~ 358 (382)
T 3tt0_A 351 VALTSNQE 358 (382)
T ss_dssp HHHSCSCC
T ss_pred HHHHhcCC
Confidence 87665443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=375.67 Aligned_cols=266 Identities=29% Similarity=0.577 Sum_probs=224.9
Q ss_pred cccccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
.+++..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++||||++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~ 114 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--------TERQRRDFLSEASIMGQFDHPNIIR 114 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--------CHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 35677889999999999999999999872 3459999996321 1223467889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.+... .|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+.||+
T Consensus 115 ~~~~~~~~~~--------------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 173 (325)
T 3kul_A 115 LEGVVTRGRL--------------------AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173 (325)
T ss_dssp EEEEECGGGC--------------------CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEEeCCc--------------------cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999875443 47899999999999999643 35699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDM 305 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 305 (390)
||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986543221 2233456788999999998899999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
||.+.+..+....+. .+.+.+.+..+|+++.+||.+||..||.+|||+.+|++.|+.+..+..+
T Consensus 254 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 254 PYWNMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CcccCCHHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 999998888776664 5567778889999999999999999999999999999999999866543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=382.83 Aligned_cols=268 Identities=29% Similarity=0.550 Sum_probs=228.9
Q ss_pred CCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CC
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 144 (390)
...|++..++|++.+.||+|+||.||+|.+ +++.||||+++... .......+.+|+++++++ +|
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h 85 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHH 85 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--------CHHHHHHHHHHHHHHHhhcCC
Confidence 457899999999999999999999999984 34789999996321 112245688999999999 89
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-----------------------
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR----------------------- 201 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------- 201 (390)
|||+++++++.+.. ...++||||+.+|+|.+++.....
T Consensus 86 pniv~~~~~~~~~~-------------------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (359)
T 3vhe_A 86 LNVVNLLGACTKPG-------------------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146 (359)
T ss_dssp TTBCCEEEEECSTT-------------------SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred cceeeeeeeeecCC-------------------CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence 99999999986532 335889999999999999975432
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE
Q 036382 202 -----------------------------------------KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL 240 (390)
Q Consensus 202 -----------------------------------------~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl 240 (390)
..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll 226 (359)
T 3vhe_A 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226 (359)
T ss_dssp -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 128999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHH
Q 036382 241 DSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSS 317 (390)
Q Consensus 241 ~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (390)
+.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+...
T Consensus 227 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 306 (359)
T 3vhe_A 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306 (359)
T ss_dssp CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH
Confidence 999999999999997543322 12334567899999999999999999999999999999998 999999887777776
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.....+.....+..+++++.++|.+||+.||.+|||+.+|+++|+.+..+
T Consensus 307 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 77777777888899999999999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=399.68 Aligned_cols=305 Identities=28% Similarity=0.478 Sum_probs=251.6
Q ss_pred CCceEEecCCCcCChHHHHHhhhhhcccc-------------cCCCCCCCcccccccCccccccccccCceEEEEEEECC
Q 036382 38 KDMLFRADKIDLKSLDMQLEKHLSWVWSR-------------NESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN 104 (390)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~ 104 (390)
.+.++......+.++...+..+....... .........|++..++|++.+.||+|+||.||+|.+.+
T Consensus 211 ~g~~~i~~~~~F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 290 (535)
T 2h8h_A 211 SGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290 (535)
T ss_dssp CSCEEEETTEEESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT
T ss_pred CCcEEeeccccccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECC
Confidence 34577777788888876554433211110 01112356899999999999999999999999999965
Q ss_pred -ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEE
Q 036382 105 -QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVV 183 (390)
Q Consensus 105 -~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv 183 (390)
..||||+++.... . .+.|.+|+++|++++||||+++++++.+ ...|+|
T Consensus 291 ~~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~---------------------~~~~lv 339 (535)
T 2h8h_A 291 TTRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE---------------------EPIYIV 339 (535)
T ss_dssp TEEEEEEEECTTSS---C-------HHHHHHHHHHHHHCCCTTBCCEEEEECS---------------------SSCEEE
T ss_pred CceEEEEEeCCCCC---C-------HHHHHHHHHHHHhCCCCCEeeEEEEEee---------------------ccceEe
Confidence 6799999974321 1 2467899999999999999999999853 234889
Q ss_pred EecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC-C
Q 036382 184 VEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-R 262 (390)
Q Consensus 184 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~ 262 (390)
|||+.+|+|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999999976555679999999999999999999999999999999999999999999999999997543211 1
Q ss_pred CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHH
Q 036382 263 DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMR 341 (390)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 341 (390)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+ ..+.+...+..+|.++.+||.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMC 498 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHH
Confidence 1233457789999999998899999999999999999999 99999999888877665 566777888899999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHhHhcCCCCCCC
Q 036382 342 KCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIP 374 (390)
Q Consensus 342 ~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~~ 374 (390)
+||..||++|||+.+|++.|+.+.++....+.|
T Consensus 499 ~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~ 531 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531 (535)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred HHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence 999999999999999999999999877755443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=363.32 Aligned_cols=261 Identities=29% Similarity=0.600 Sum_probs=225.6
Q ss_pred CcccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
..|.++.++|++.+.||+|+||.||+|.+ +++.||||+++..... .+.+.+|++++++++||||+++++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~ 72 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYG 72 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46889999999999999999999999998 6778999999743211 145789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+|||
T Consensus 73 ~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 131 (269)
T 4hcu_A 73 VCLEQA--------------------PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131 (269)
T ss_dssp EECSSS--------------------SEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecCC--------------------ceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 987543 358899999999999999653 35699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
|||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 132 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999997543221 22334557888999999998899999999999999999999 99999998
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+..+....+. .......+..+++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 212 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 212 SNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHh-cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 8888776664 456667788899999999999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=370.55 Aligned_cols=271 Identities=29% Similarity=0.535 Sum_probs=232.4
Q ss_pred CCCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-C
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-D 143 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 143 (390)
....|++..++|++.+.||+|+||.||+|++ +++.||||+++.... ....+.+.+|+.+++++ +
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~ 85 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGN 85 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCC
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--------HHHHHHHHHHHHHHhhccc
Confidence 4567999999999999999999999999985 457899999973321 12246788999999999 9
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc----------------CCCCHH
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR----------------KKLALK 207 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~ 207 (390)
||||+++++++.+.. ..++||||+++|+|.+++..... ..+++.
T Consensus 86 h~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (313)
T 1t46_A 86 HMNIVNLLGACTIGG--------------------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145 (313)
T ss_dssp CTTBCCEEEEECSSS--------------------SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred CCCeeeEEEEEecCC--------------------CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHH
Confidence 999999999987543 34789999999999999976432 248999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCC
Q 036382 208 IVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYN 285 (390)
Q Consensus 208 ~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 285 (390)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++
T Consensus 146 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 225 (313)
T 1t46_A 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC
Confidence 9999999999999999999999999999999999999999999999976543322 12234567899999999888999
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 286 RRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 286 ~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
.++|||||||++|+|++ |..||.+...............+...+..+|.++.++|.+||..||.+|||+.++++.|+++
T Consensus 226 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 99999999999999999 99999988777766677777777778888999999999999999999999999999999999
Q ss_pred HhcCCC
Q 036382 365 DTSKGG 370 (390)
Q Consensus 365 ~~~~~~ 370 (390)
.....+
T Consensus 306 ~~~~~~ 311 (313)
T 1t46_A 306 ISESTN 311 (313)
T ss_dssp HHHTCC
T ss_pred HHHhhc
Confidence 876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=378.96 Aligned_cols=271 Identities=27% Similarity=0.494 Sum_probs=226.3
Q ss_pred CcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCC
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHP 145 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 145 (390)
..|+++.++|++.+.||+|+||.||+|.+ ++..||||+++... .......+.+|+.+++++ +||
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp 109 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--------DSSEREALMSELKMMTQLGSHE 109 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCT
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--------CHHHHHHHHHHHHHHHhhcCCC
Confidence 46899999999999999999999999986 34589999996321 112246788999999999 999
Q ss_pred ccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc---------------------CCC
Q 036382 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR---------------------KKL 204 (390)
Q Consensus 146 nIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l 204 (390)
||+++++++.... ..++||||+++|+|.+++..... ..+
T Consensus 110 ~iv~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 169 (344)
T 1rjb_A 110 NIVNLLGACTLSG--------------------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169 (344)
T ss_dssp TBCCEEEEECSSS--------------------SCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred CeeeEEEEEeeCC--------------------ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence 9999999987543 34889999999999999975432 237
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCC
Q 036382 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGK 282 (390)
Q Consensus 205 ~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 282 (390)
++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+.
T Consensus 170 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 249 (344)
T 1rjb_A 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence 9999999999999999999999999999999999999999999999999975543221 12234567899999999888
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 283 PYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 283 ~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
.++.++|||||||++|+|++ |..||.+.............+..+..+..+++++.+||.+||..||.+|||+.+|++.|
T Consensus 250 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999999999999998 99999988877777777778888888899999999999999999999999999999999
Q ss_pred HHhHhcCCCCC
Q 036382 362 EAIDTSKGGGM 372 (390)
Q Consensus 362 ~~~~~~~~~~~ 372 (390)
+.+.....+.+
T Consensus 330 ~~~~~~~~~~~ 340 (344)
T 1rjb_A 330 GCQLADAEEAM 340 (344)
T ss_dssp HHHC-------
T ss_pred HHHHHHHHHHH
Confidence 99977655443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=379.84 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=215.6
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFV 151 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 151 (390)
...+..++|++.+.||+|+||.||+|++ +++.||||+++.. ..........+..|..+++.+ +||||++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhH------HhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 3456778999999999999999999998 5789999999621 111112235567899999887 999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+.. ..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++||+||
T Consensus 85 ~~~~~~~--------------------~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 142 (345)
T 1xjd_A 85 CTFQTKE--------------------NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYR 142 (345)
T ss_dssp EEEECSS--------------------EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred EEEEeCC--------------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 9998654 348899999999999999653 469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||||+|||++.+|++||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+
T Consensus 143 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999999854433344556789999999999999999999999999999999999999999998
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG-EVV 358 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll 358 (390)
..+....+.... +.+|..+++++.+||.+||..||.+||++. +|+
T Consensus 223 ~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 223 EEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 888887776553 457788999999999999999999999997 665
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=395.90 Aligned_cols=263 Identities=29% Similarity=0.606 Sum_probs=230.3
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
...|++..++|++.+.||+|+||.||+|.+. +..||||+++.... ..+.|.+|+.+|++++||||+++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l 281 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQL 281 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----------chHHHHHHHHHHHhcCCCCEeeE
Confidence 3579999999999999999999999999985 78999999974321 13568899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.+.. ..|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+|
T Consensus 282 ~~~~~~~~--------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 341 (495)
T 1opk_A 282 LGVCTREP--------------------PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341 (495)
T ss_dssp EEEECSSS--------------------SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEecCC--------------------cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99987543 3478999999999999997765667999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
|||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 342 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~ 421 (495)
T 1opk_A 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421 (495)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998654322 12233456789999999998899999999999999999999 999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+.+..++... +..+.+...|..+|+++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 422 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 422 GIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 9888777654 45677888899999999999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=375.46 Aligned_cols=266 Identities=27% Similarity=0.519 Sum_probs=224.6
Q ss_pred cccccccCccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
.+++..++|++.+.||+|+||.||+|++.+ +.||||+++... .......+.+|+.++++++||||
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~i 112 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDNPNI 112 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHHTCCCTTB
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCE
Confidence 467788999999999999999999998753 789999997321 12234678899999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----------------------cCCCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----------------------RKKLA 205 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~ 205 (390)
+++++++.+.. ..|+||||+.+|+|.+++.... ...++
T Consensus 113 v~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 172 (343)
T 1luf_A 113 VKLLGVCAVGK--------------------PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172 (343)
T ss_dssp CCEEEEECSSS--------------------SCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred EEEEEEEccCC--------------------ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCC
Confidence 99999987543 3488999999999999997632 15699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCC
Q 036382 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKP 283 (390)
Q Consensus 206 ~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 283 (390)
+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..
T Consensus 173 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC
Confidence 99999999999999999999999999999999999999999999999997543221 2223456889999999999888
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 284 YNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 284 ~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
++.++|||||||++|+|++ |..||.+.+..+....+. .+.....+..+|+++.++|.+||+.||.+|||+.++++.|+
T Consensus 253 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 253 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 9999999999999999999 999999988888776654 44455678889999999999999999999999999999999
Q ss_pred HhHhcCC
Q 036382 363 AIDTSKG 369 (390)
Q Consensus 363 ~~~~~~~ 369 (390)
++....+
T Consensus 332 ~~~~~~~ 338 (343)
T 1luf_A 332 RMCERAE 338 (343)
T ss_dssp HTTC---
T ss_pred HHHhhhh
Confidence 9875443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=363.73 Aligned_cols=262 Identities=30% Similarity=0.624 Sum_probs=221.4
Q ss_pred CCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
...|.++.++|++.+.||+|+||.||+++++++.||||+++... ..+.+.+|+.++++++||||+++++
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLG 81 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEE
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 45688999999999999999999999999999999999986321 1356789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+. ....++||||+.+++|.+++.+.....+++..++.++.|++.||.|||++||+|||
T Consensus 82 ~~~~~-------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 142 (278)
T 1byg_A 82 VIVEE-------------------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142 (278)
T ss_dssp EECCC---------------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEcC-------------------CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 87543 23458999999999999999765544589999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
|||+|||++.++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred CCcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998754332 223467889999999998899999999999999999998 999999888
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
..+....+ ..+.....+..+|+.+.++|.+||..||.+|||+.++++.|+.+.+..
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 220 LKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp GGGHHHHH-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHH-hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 77766554 455667788889999999999999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=362.05 Aligned_cols=263 Identities=26% Similarity=0.552 Sum_probs=224.2
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
...|+++.++|++.+.||+|+||.||++.+. +..||||+++..... ...+.+|+++++.++||||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----------HHHHHHHHHHHhcCCCCCEeeEE
Confidence 4679999999999999999999999999885 458999999743211 14577999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+. ...++||||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||
T Consensus 86 ~~~~~~--------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 144 (283)
T 3gen_A 86 GVCTKQ--------------------RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144 (283)
T ss_dssp EEECSS--------------------SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEecC--------------------CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 998644 3458899999999999999653 3569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 145 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp SCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999997543221 22334457888999999998889999999999999999998 9999999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.+..+....+ ....+...+..+++.+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 225 FTNSETAEHI-AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp SCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChhHHHHHH-hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 8888777665 45566677888999999999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=367.53 Aligned_cols=265 Identities=26% Similarity=0.514 Sum_probs=216.1
Q ss_pred ccccccCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
.++..++|++.+.||+|+||.||+|++ +++.||||+++... ......+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~ 75 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------EEHLRDFEREIEILKSLQHDNIVK 75 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 345678899999999999999999985 57899999986321 223456889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++..... ...++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+
T Consensus 76 ~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 136 (295)
T 3ugc_A 76 YKGVCYSAGR------------------RNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYI 136 (295)
T ss_dssp EEEEECHHHH------------------TSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecCCC------------------CceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 9999865432 2348999999999999999654 34599999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
||||||+|||++.++.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 137 H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred cCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999998654322 112234577789999999999999999999999999999999999
Q ss_pred CCCCChh---------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 307 YPDLSFA---------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 307 f~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
|...... ...........+.+.+..+|+++.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 8653211 0122334456677788899999999999999999999999999999999997554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=375.78 Aligned_cols=269 Identities=28% Similarity=0.462 Sum_probs=218.0
Q ss_pred CCCCCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 70 ~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
..+..+|.++.++|++.++||+|+||.||+|++.++.||||+++... .....+..|+.++++++||||++
T Consensus 13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~ 82 (322)
T 3soc_A 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD----------KQSWQNEYEVYSLPGMKHENILQ 82 (322)
T ss_dssp -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG----------HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred ccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc----------hHHHHHHHHHHHHhcCCCCCchh
Confidence 34567888999999999999999999999999999999999996321 11233456889999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK--- 226 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--- 226 (390)
+++++.+.... ...+|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 83 ~~~~~~~~~~~----------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~ 143 (322)
T 3soc_A 83 FIGAEKRGTSV----------------DVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPG 143 (322)
T ss_dssp EEEEEEEECSS----------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEE
T ss_pred hcceeccCCCC----------------CceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccc
Confidence 99998764321 2346899999999999999954 3499999999999999999999999
Q ss_pred -------CCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCC-----CCCCchhHHH
Q 036382 227 -------KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGK-----PYNRRCDVYS 292 (390)
Q Consensus 227 -------~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwS 292 (390)
||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+. .++.++||||
T Consensus 144 l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 223 (322)
T 3soc_A 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223 (322)
T ss_dssp ETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHH
T ss_pred cccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHH
Confidence 999999999999999999999999999976543222 23346799999999999873 4566889999
Q ss_pred HHHHHHHHHhCCCCCCCCC----------------hhhHHHHHHHcCCCCCCCC-----CCcHHHHHHHHHhhhhCCCCC
Q 036382 293 FGICLWEIYCCDMPYPDLS----------------FADVSSAVVRQNLRPEIPR-----CCPSSLANIMRKCWDANAEKR 351 (390)
Q Consensus 293 lG~il~ell~g~~Pf~~~~----------------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~R 351 (390)
|||++|||++|..||.+.. ..+....+.....++..+. .+++++.+||.+||+.||++|
T Consensus 224 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (322)
T 3soc_A 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303 (322)
T ss_dssp HHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhC
Confidence 9999999999999996532 2233333333444444333 235669999999999999999
Q ss_pred CCHHHHHHHHHHhHhc
Q 036382 352 PEMGEVVKMLEAIDTS 367 (390)
Q Consensus 352 pt~~~ll~~L~~~~~~ 367 (390)
||+.+|++.|+.+...
T Consensus 304 ps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 304 LSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHH
Confidence 9999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=367.84 Aligned_cols=267 Identities=29% Similarity=0.543 Sum_probs=227.8
Q ss_pred CCCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 144 (390)
....|++..++|++.+.||+|+||.||+|.+ +++.||||+++... .......+.+|+.+++.++|
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h 85 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--------SPSELRDLLSEFNVLKQVNH 85 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHTTCCC
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--------CHHHHHHHHHHHHHHhhCCC
Confidence 3467889999999999999999999999976 23789999996321 12234668899999999999
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc----------------------C
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR----------------------K 202 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~ 202 (390)
|||+++++++.+.. ..++||||+.+|+|.+++..... .
T Consensus 86 p~iv~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (314)
T 2ivs_A 86 PHVIKLYGACSQDG--------------------PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145 (314)
T ss_dssp TTBCCEEEEECSSS--------------------SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred CceeeEEEEEecCC--------------------ceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence 99999999987543 34889999999999999975432 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccC
Q 036382 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQ 280 (390)
Q Consensus 203 ~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~ 280 (390)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 489999999999999999999999999999999999999999999999999986543221 223456788999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 281 GKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 281 ~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+..++.++|||||||++|+|++ |..||.+.+..+....+ ........+..+++++.++|.+||+.||.+|||+.+|++
T Consensus 226 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 226 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8889999999999999999999 99999998877766554 455667788899999999999999999999999999999
Q ss_pred HHHHhHhc
Q 036382 360 MLEAIDTS 367 (390)
Q Consensus 360 ~L~~~~~~ 367 (390)
.|+++...
T Consensus 305 ~l~~~~~~ 312 (314)
T 2ivs_A 305 DLEKMMVK 312 (314)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhh
Confidence 99998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=369.61 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=217.2
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+.+++|++.+.||+|+||.||+++. +|+.||+|+++.. ..........+.+|..+++.++||||+++++++.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE------IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH------HhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 4567899999999999999999988 5889999998621 1111123456778999999999999999999997
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||
T Consensus 77 ~~~--------------------~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 134 (318)
T 1fot_A 77 DAQ--------------------QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134 (318)
T ss_dssp CSS--------------------EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCG
T ss_pred eCC--------------------EEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 544 44889999999999999965 34699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.+|.+||+|||++...... ....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+.
T Consensus 135 ~NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 135 ENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred heEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999999865432 3356899999999999999999999999999999999999999999888888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
...+.... ..+|..+++++.++|.+||..||.+|| ++++++++
T Consensus 212 ~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 212 YEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 88877654 446788999999999999999999999 88888853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=379.92 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=208.0
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
..+..++|++.++||+|+||.||+|++ +++.||||+++.... ........+.+|..+++++ +||||+++++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~------~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 120 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV------NDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT------C----CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc------cCHHHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence 456778999999999999999999988 577999999973221 1112234567899999887 8999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+|||
T Consensus 121 ~~~~~~--------------------~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 178 (396)
T 4dc2_A 121 CFQTES--------------------RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRD 178 (396)
T ss_dssp EEECSS--------------------EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred EEEECC--------------------EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecc
Confidence 998654 348899999999999999653 4699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-- 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-- 310 (390)
|||+|||++.++++||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~ 258 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC
T ss_pred CCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 999999999999999999999986444444556678999999999999999999999999999999999999999643
Q ss_pred -------ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 036382 311 -------SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354 (390)
Q Consensus 311 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 354 (390)
........+... ...+|..+++++.+||.+||+.||.+||++
T Consensus 259 ~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccccchhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 122233444333 456788899999999999999999999995
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=362.65 Aligned_cols=263 Identities=29% Similarity=0.570 Sum_probs=214.4
Q ss_pred CcccccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
.+|++..++|++.+.||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.++++++||||+
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv 79 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--------SDSVREKFLQEALTMRQFDHPHIV 79 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--------SHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--------CHHHHHHHHHHHHHHHhCCCCccc
Confidence 468889999999999999999999999873 3469999986321 123346788999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.+ +..|+||||+.+++|.+++... ...+++..++.++.|++.||.|||++||
T Consensus 80 ~~~~~~~~---------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 137 (281)
T 1mp8_A 80 KLIGVITE---------------------NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRF 137 (281)
T ss_dssp CEEEEECS---------------------SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEEEcc---------------------CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 99999742 2348899999999999999653 3469999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMP 306 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~P 306 (390)
+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 138 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 217 (281)
T 1mp8_A 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217 (281)
T ss_dssp CCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999976543221 1223456789999999998899999999999999999996 9999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|.+.+..+....+. ...+...+..+|+++.++|.+||..||++|||+.+|++.|+.+...
T Consensus 218 f~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 218 FQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99988887776664 4445667888999999999999999999999999999999998643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=376.08 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=216.8
Q ss_pred cccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 153 (390)
.+..++|++.+.||+|+||.||+|++. ++.||||+++.. ..........+..|..+++.+ +||||++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~------~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD------VVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHH------HHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH------HhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 356789999999999999999999984 578999999621 111122345677899999988 89999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 90 ~~~~~--------------------~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 147 (353)
T 2i0e_A 90 FQTMD--------------------RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147 (353)
T ss_dssp EECSS--------------------EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred EEcCC--------------------EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 98544 448899999999999999653 46999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||+|||++.+|++||+|||++.............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 148 kp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999986444444455678999999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
+....+.... ..+|..+++++.+||.+||..||.+||+ +.+++++
T Consensus 228 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 228 ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 8888887654 4577889999999999999999999995 5777653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=383.36 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=216.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-------SARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 5799999999999999999987 688999999974321 1223456889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 84 --------------------~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI 141 (444)
T 3soa_A 84 --------------------HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141 (444)
T ss_dssp --------------------EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred --------------------EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 448899999999999999653 5699999999999999999999999999999999999
Q ss_pred EEC---CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLD---SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|++ .++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 142 ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221 (444)
T ss_dssp EESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 998 46889999999998665555555667899999999999999999999999999999999999999999998888
Q ss_pred HHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+....+..+.+ ..+++++.+||.+||+.||.+|||+.+++++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 88887766544333 4789999999999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=358.42 Aligned_cols=260 Identities=28% Similarity=0.544 Sum_probs=224.1
Q ss_pred cccccccCccccccccccCceEEEEEEECC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.|++..++|++.+.||+|+||.||+|.+.+ ..||||+++..... ...+.+|+.++++++||||++++++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----------EDEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 467888999999999999999999998854 58999999743211 1457899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+. ...++||||+++++|.+++... +..+++..++.++.|++.||.|||++||+||||
T Consensus 72 ~~~~--------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 130 (268)
T 3sxs_A 72 CSKE--------------------YPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130 (268)
T ss_dssp ECSS--------------------SSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSC
T ss_pred EccC--------------------CceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCc
Confidence 8644 3458899999999999999654 346999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+
T Consensus 131 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp SGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 9999999999999999999998554332 22334556788999999998889999999999999999999 999999988
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
..+....+. .......+..+++++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 211 NSEVVLKVS-QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred hHHHHHHHH-cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 887776654 455666778889999999999999999999999999999998863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=372.22 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=211.7
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGAS 154 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 154 (390)
+..++|++.+.||+|+||.||+|++ +++.||||+++.... ........+.+|..+++++ +||||+++++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV------NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS------CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh------cchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 4567899999999999999999988 478999999973321 1122345678899999988 899999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 80 ~~~~--------------------~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 137 (345)
T 3a8x_A 80 QTES--------------------RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLK 137 (345)
T ss_dssp ECSS--------------------EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred EeCC--------------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 7544 448899999999999999653 469999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL---- 310 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~---- 310 (390)
|+|||++.++++||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 138 p~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 217 (345)
T 3a8x_A 138 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217 (345)
T ss_dssp GGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--
T ss_pred HHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccc
Confidence 9999999999999999999985444444455678999999999999999999999999999999999999999652
Q ss_pred -----ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 036382 311 -----SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM------GEVVK 359 (390)
Q Consensus 311 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~~ll~ 359 (390)
........+... ...+|..++.++.+||.+||..||.+||++ .++++
T Consensus 218 ~~~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 218 NPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -----CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ccccccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 223333444443 445788899999999999999999999995 56654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=377.67 Aligned_cols=264 Identities=29% Similarity=0.516 Sum_probs=222.2
Q ss_pred cccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
.+++..++|++.+.||+|+||.||+|++ +++.||||+++... . ......+.+|+.++++++||||
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----S----EQDELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----C----HHHHHHHHHHHHHHHHCCCTTB
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----C----hhhHHHHHHHHHHHHhCCCCCC
Confidence 4567788999999999999999999985 34689999986221 1 1123467789999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHH
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-----KKLALKIVIQLALDLSRGLSY 222 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~y 222 (390)
+++++++.+.. ..++||||+.+|+|.+++..... ..+++..++.++.||+.||.|
T Consensus 137 v~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 196 (367)
T 3l9p_A 137 VRCIGVSLQSL--------------------PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196 (367)
T ss_dssp CCEEEEECSSS--------------------SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEecCC--------------------CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHH
Confidence 99999987543 33789999999999999976432 458999999999999999999
Q ss_pred HHhCCCcccCCCCCCEEECCCC---cEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 036382 223 LHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297 (390)
Q Consensus 223 LH~~~iiHrDlkp~NILl~~~~---~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 297 (390)
||++||+||||||+|||++.++ .+||+|||+++..... ........+|+.|+|||++.+..++.++|||||||++
T Consensus 197 LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999555 5999999999743221 1222234578999999999988999999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 298 WEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 298 ~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|||++ |..||...+..+....+. .+.+...+..+|..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 99998 999999998888776654 4556677888999999999999999999999999999999998654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=368.98 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=208.6
Q ss_pred ccccccCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
..+..++|++.+.||+|+||.||+++. +++.||||+++.... .........+.+|+.+++.++||||+++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 86 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-----VRNAKDTAHTKAERNILEEVKHPFIVDL 86 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHHhCCCCCccce
Confidence 456678999999999999999999986 578999999973321 1112233557789999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.+.. ..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++||+|
T Consensus 87 ~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH 144 (327)
T 3a62_A 87 IYAFQTGG--------------------KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIY 144 (327)
T ss_dssp EEEEECSS--------------------CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eEEEEcCC--------------------EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 99997543 448899999999999999653 46899999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 145 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999975443333344568999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
+..+....+.... ...|..+++++.+||.+||..||.+|| ++.+++++
T Consensus 225 ~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 225 NRKKTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp SHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 8888887776653 456778899999999999999999999 77788763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=370.56 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=216.1
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+.+..++|++.+.||+|+||.||+|.+ +++.||+|++... .......+.+|+++++.++||||++++++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---------DEETQRTFLKEVKVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---------CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---------CHHHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence 456678999999999999999999998 4789999988521 12234678899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..++||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||
T Consensus 76 ~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dl 134 (310)
T 3s95_A 76 LYKDK--------------------RLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134 (310)
T ss_dssp EEETT--------------------EEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EecCC--------------------eeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 97543 347899999999999999653 456999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCC--------------CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHH
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRD--------------MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 299 (390)
||+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 135 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e 214 (310)
T 3s95_A 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214 (310)
T ss_dssp STTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999754332211 124579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhh-----HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 300 IYCCDMPYPDLSFAD-----VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 300 ll~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|++|..||....... ...... ....+..+|+++.++|.+||+.||++|||+.+|++.|+.+.....
T Consensus 215 l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 215 IIGRVNADPDYLPRTMDFGLNVRGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHTCCSSTTTSCBCTTSSBCHHHHH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcchhhhHHHHhhhhhccc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999987643221 111111 123467788999999999999999999999999999999976543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=364.23 Aligned_cols=262 Identities=27% Similarity=0.375 Sum_probs=213.1
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccc-----------------hHHHHHHHHHHHHHHHH
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMAT-----------------TAETAALRSSFQQEVAV 138 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~~~~~E~~~ 138 (390)
+..++|++.+.||+|+||.||+|.+ +++.||||+++........ ........+.+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4567899999999999999999987 5789999999743211000 00011223568899999
Q ss_pred HHhcCCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHH
Q 036382 139 WQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 139 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~ 218 (390)
++.++||||+++++++.+.. ....|+||||+++++|.+++ ....+++..++.++.||+.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~------------------~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~ 148 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPN------------------EDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIK 148 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSS------------------SSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCC------------------CCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHH
Confidence 99999999999999987532 34558999999999998865 2346999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC---CCCchhHHHHHH
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP---YNRRCDVYSFGI 295 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~ 295 (390)
||.|||++||+||||||+|||++.++.+||+|||++..............||+.|+|||++.+.. ++.++|||||||
T Consensus 149 ~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~ 228 (298)
T 2zv2_A 149 GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228 (298)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHH
T ss_pred HHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHH
Confidence 99999999999999999999999999999999999986654433445568999999999998765 377899999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 296 CLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 296 il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
++|+|++|..||.+.........+.......+.+..+++++.+||.+||+.||++|||+.+++++
T Consensus 229 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 229 TLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999999999999887777777766655555556789999999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=377.67 Aligned_cols=264 Identities=28% Similarity=0.587 Sum_probs=214.0
Q ss_pred cccccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
..+++.++|++.+.||+|+||.||+|++. +..||||+++... .......+.+|+.++++++||||++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~ 110 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--------TEKQRRDFLGEASIMGQFDHPNIIR 110 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--------CHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34677789999999999999999999763 5689999997431 1223467889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.+.. ..++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++||+
T Consensus 111 ~~~~~~~~~--------------------~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (373)
T 2qol_A 111 LEGVVTKSK--------------------PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYV 169 (373)
T ss_dssp EEEEECSSS--------------------SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEeeCC--------------------ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 999987543 348899999999999999653 35699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCCC---CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDM 305 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 305 (390)
||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865432211 122345778999999998999999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
||...+..+....+ ..+.+.+.+..+|.++.++|.+||+.||.+|||+.+|++.|+.+....
T Consensus 250 P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 250 PYWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TTTTCCHHHHHHHH-HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 99998888777655 455566677889999999999999999999999999999999997543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=361.49 Aligned_cols=263 Identities=29% Similarity=0.611 Sum_probs=229.0
Q ss_pred CcccccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|++..++|++.+.||+|+||.||+|.+. +..||||+++.... ..+.+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 578999999999999999999999999984 78999999863221 135678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+. ...++||||+.+++|.+++.......+++..++.++.|++.||.|||++||+||
T Consensus 76 ~~~~~~--------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~ 135 (288)
T 3kfa_A 76 GVCTRE--------------------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135 (288)
T ss_dssp EEECSS--------------------SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCS
T ss_pred EEEccC--------------------CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCC
Confidence 998754 345889999999999999977666779999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 136 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997544322 12233456788999999998899999999999999999999 9999999
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.+.......+ ........+..+|+.+.+|+.+||..||.+|||+.++++.|+.+...
T Consensus 216 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 216 IDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHH-hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 8877766554 55667778889999999999999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=372.35 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=217.9
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
...++|++.+.||+|+||.||++++ +|+.||||+++.. ..........+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ------KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhH------HhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4568999999999999999999988 5889999998621 1111223456788999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 112 ~~~--------------------~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 169 (350)
T 1rdq_E 112 DNS--------------------NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169 (350)
T ss_dssp CSS--------------------EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCC--------------------EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCcc
Confidence 544 348899999999999999654 4699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 170 ~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 170 ENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence 9999999999999999999865432 3346799999999999999999999999999999999999999999988888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
...+.... ..+|..+++++.+||.+||+.||.+||+ +.+|+++
T Consensus 247 ~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 247 YEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 88877654 4577889999999999999999999998 8888753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=369.43 Aligned_cols=266 Identities=27% Similarity=0.507 Sum_probs=228.2
Q ss_pred CCcccccccCccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CC
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 144 (390)
...|++..++|++.+.||+|+||.||+|.+.+ ..||+|+++... .......+.+|+.+++.+ +|
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~h 109 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--------HADEKEALMSELKIMSHLGQH 109 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--------CHHHHHHHHHHHHHHHHHCCC
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--------ChHHHHHHHHHHHHHHhhcCC
Confidence 35689999999999999999999999998732 379999996321 112346788999999999 89
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc------------cCCCCHHHHHHH
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR------------RKKLALKIVIQL 212 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i 212 (390)
|||+++++++.+.. ..++||||+++|+|.+++.... ...+++..++.+
T Consensus 110 ~~iv~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (333)
T 2i1m_A 110 ENIVNLLGACTHGG--------------------PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169 (333)
T ss_dssp TTBCCEEEEECSSS--------------------SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHH
T ss_pred CCeeeEEEEEecCC--------------------ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHH
Confidence 99999999987543 3488999999999999997543 346899999999
Q ss_pred HHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhH
Q 036382 213 ALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDV 290 (390)
Q Consensus 213 ~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di 290 (390)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++||
T Consensus 170 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 249 (333)
T 2i1m_A 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249 (333)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHH
Confidence 99999999999999999999999999999999999999999985433221 1223456789999999988899999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 291 YSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 291 wSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
|||||++|+|++ |..||.+...................+..+|+.+.++|.+||+.||.+|||+.+|++.|+.+..
T Consensus 250 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 999999999998 9999998877777777777777888888899999999999999999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=372.01 Aligned_cols=253 Identities=20% Similarity=0.365 Sum_probs=215.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +|+.||||+++......... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc---hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 5799999999999999999988 58899999997543221110 011356789999999999999999999997543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 89 --------------------~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI 146 (361)
T 2yab_A 89 --------------------DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146 (361)
T ss_dssp --------------------EEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred --------------------EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 45889999999999999954 45799999999999999999999999999999999999
Q ss_pred EECCCC----cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~----~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|++.++ .+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 147 ll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~ 225 (361)
T 2yab_A 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (361)
T ss_dssp EESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred EEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 998877 7999999999865432 33455789999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
....+....+... .+..+++++.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8877765544322 23578899999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=354.57 Aligned_cols=260 Identities=29% Similarity=0.601 Sum_probs=224.5
Q ss_pred cccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.|.++.++|++.+.||+|+||.||+|.+ +++.||+|+++..... .+.+.+|+++++.++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 5889999999999999999999999998 5678999999743211 1457899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||
T Consensus 72 ~~~~~--------------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 130 (267)
T 3t9t_A 72 CLEQA--------------------PICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130 (267)
T ss_dssp ECSSS--------------------SCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred EccCC--------------------CeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 87543 348899999999999999654 356899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCC-CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
||+|||++.++.+||+|||++...... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+
T Consensus 131 ~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred chheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 999999999999999999999754321 112234567889999999998889999999999999999999 899999988
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
..+....+ ..+.+...+..++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus 211 ~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 211 NSEVVEDI-STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHH-hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 88777665 4455666788899999999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=362.39 Aligned_cols=260 Identities=24% Similarity=0.426 Sum_probs=215.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
-.++|++.+.||+|+||.||+|.+ +++.||+|++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE------KEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC------CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc------cHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 356899999999999999999987 5789999998643221 12334678899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ...|+||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 83 ~--------------------~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 140 (294)
T 4eqm_A 83 D--------------------DCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140 (294)
T ss_dssp S--------------------SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred C--------------------CeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 4 3458899999999999999654 46999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 141 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 141 NILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp GEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred HEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9999999999999999997543322 222335689999999999999999999999999999999999999999887776
Q ss_pred HHHHHHcCCCC---CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHh
Q 036382 316 SSAVVRQNLRP---EIPRCCPSSLANIMRKCWDANAEKRP-EMGEVVKMLEAIDT 366 (390)
Q Consensus 316 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~~ 366 (390)
........... ..+..+|+.+.++|.+||+.||.+|| ++.++.+.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 65555443222 24567899999999999999999998 99999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=367.11 Aligned_cols=268 Identities=31% Similarity=0.575 Sum_probs=227.3
Q ss_pred CCcccccccCccccccccccCceEEEEEEE---------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL- 142 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 142 (390)
...|++..++|++.+.||+|+||.||+|++ ++..||||+++... .......+.+|+.+++.+
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~ 98 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--------TEKDLSDLVSEMEMMKMIG 98 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--------CHHHHHHHHHHHHHHHHHC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--------cHHHHHHHHHHHHHHHHhh
Confidence 356899999999999999999999999986 34689999996321 112346688999999999
Q ss_pred CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc--------------CCCCHHH
Q 036382 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--------------KKLALKI 208 (390)
Q Consensus 143 ~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~ 208 (390)
+||||+++++++.+.. ..++||||+.+|+|.+++..... ..+++..
T Consensus 99 ~hp~iv~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (334)
T 2pvf_A 99 KHKNIINLLGACTQDG--------------------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158 (334)
T ss_dssp CCTTBCCEEEEECSSS--------------------CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHH
T ss_pred cCCCEeeEEEEEccCC--------------------ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHH
Confidence 9999999999987543 34889999999999999975431 3489999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCC
Q 036382 209 VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNR 286 (390)
Q Consensus 209 ~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 286 (390)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.
T Consensus 159 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 238 (334)
T 2pvf_A 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238 (334)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence 99999999999999999999999999999999999999999999998654322 1223345788999999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 287 RCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 287 ~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
++|||||||++|+|++ |..||.+.+..+....+. .+.+...+..++.++.++|.+||..||.+|||+.++++.|+++.
T Consensus 239 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999 999999988877766554 45566778889999999999999999999999999999999997
Q ss_pred hcCC
Q 036382 366 TSKG 369 (390)
Q Consensus 366 ~~~~ 369 (390)
+...
T Consensus 318 ~~~~ 321 (334)
T 2pvf_A 318 TLTT 321 (334)
T ss_dssp HHHC
T ss_pred hccc
Confidence 6543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=358.81 Aligned_cols=270 Identities=28% Similarity=0.515 Sum_probs=229.2
Q ss_pred CcccccccCccccc-cccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 74 EEWEIDLSKLDMRN-LIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 74 ~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
..|.+..++|.+.+ .||+|+||.||+|.+ ++..||||+++... .......+.+|+++++.++||||+
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~ 73 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--------EKADTEEMMREAQIMHQLDNPYIV 73 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--------CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--------chhHHHHHHHHHHHHHhCCCCCEe
Confidence 45778888999988 999999999999976 46789999997431 122346788999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.. ...++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++||
T Consensus 74 ~~~~~~~~---------------------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 131 (287)
T 1u59_A 74 RLIGVCQA---------------------EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNF 131 (287)
T ss_dssp CEEEEEES---------------------SSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEEecC---------------------CCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 99999842 235899999999999999954 34569999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CD 304 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~ 304 (390)
+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 132 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 211 (287)
T 1u59_A 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211 (287)
T ss_dssp ECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999986543221 1223456889999999988889999999999999999998 99
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCCCCC
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIP 374 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~~ 374 (390)
.||...+..+....+ ..+.++..+..+|+++.++|.+||..||++|||+.++++.|+.+..+.+....+
T Consensus 212 ~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 212 KPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp CTTTTCCTHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCcccCCHHHHHHHH-hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 999988877766555 455567788899999999999999999999999999999999998776655443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=375.88 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=207.6
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHH-HHhcCCCccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV-WQKLDHPNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~ 153 (390)
.+..++|++.+.||+|+||.||+|++ +++.||||+++..... .......+.+|..+ ++.++||||++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL------KKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 45678999999999999999999988 5678999999633211 11123445567766 567899999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 108 ~~~~~--------------------~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 165 (373)
T 2r5t_A 108 FQTAD--------------------KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165 (373)
T ss_dssp EECSS--------------------EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEeCC--------------------EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 98654 448899999999999999653 46999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||+|||++.+|++||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 166 kp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 245 (373)
T 2r5t_A 166 KPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245 (373)
T ss_dssp CGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH
T ss_pred CHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999986444444455678999999999999999999999999999999999999999999888
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
+....+.... ..++..++.++.+||.+||+.||.+||++.+
T Consensus 246 ~~~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 246 EMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 8888887654 3467789999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=360.97 Aligned_cols=264 Identities=31% Similarity=0.646 Sum_probs=209.0
Q ss_pred CCCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
....++|..++|++.+.||+|+||.||+|++.+ .||||+++.... .......+.+|+.++++++||||++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-------TPQQLQAFKNEVGVLRKTRHVNILLFM 86 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC-------CHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 346789999999999999999999999998765 599999974432 122346788999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++. ....++||||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||
T Consensus 87 ~~~~---------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 144 (289)
T 3og7_A 87 GYST---------------------APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144 (289)
T ss_dssp EEEC---------------------SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eecc---------------------CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 9753 22348899999999999999543 4569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccC--CCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQ--NPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
||||+|||++.++.+||+|||++..... .........||+.|+|||++. +..++.++|||||||++|+|++|..|
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp CCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999975432 122233456899999999986 56788999999999999999999999
Q ss_pred CCCCChhhHHHHHHHcC-CCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 307 YPDLSFADVSSAVVRQN-LRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
|.+....+........+ ..+. .+..+|+++.+||.+||+.||.+|||+.++++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 98876655554444333 3322 34578999999999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=371.18 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=214.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-------ARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 35799999999999999999988 5789999999743221 12235688999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 101 ~--------------------~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~N 158 (362)
T 2bdw_A 101 S--------------------FHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 158 (362)
T ss_dssp S--------------------EEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred C--------------------EEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence 3 44889999999999999954 3569999999999999999999999999999999999
Q ss_pred EEECCC---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++.+ +.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 159 Ill~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 159 LLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp EEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999865 45999999999765432 33445689999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+....+..+.+ ..+++++.+||.+||..||++|||+.+++++
T Consensus 238 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 238 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 887777665543332 4679999999999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=364.98 Aligned_cols=272 Identities=26% Similarity=0.494 Sum_probs=213.8
Q ss_pred CcccccccCccccccccccCceEEEEEEECC-----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
+.+.+..++|++.+.||+|+||.||+|.+.. ..||||+++.... .....+.+.+|++++++++||||+
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv 88 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-------ASSDIEEFLREAACMKEFDHPHVA 88 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------CHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-------CHHHHHHHHHHHHHHHHCCCCcee
Confidence 4567788899999999999999999998733 2799999863211 112246788999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR----KKLALKIVIQLALDLSRGLSYLH 224 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~i~~~L~yLH 224 (390)
++++++....... .....++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||
T Consensus 89 ~~~~~~~~~~~~~--------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 154 (323)
T 3qup_A 89 KLVGVSLRSRAKG--------------RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS 154 (323)
T ss_dssp CCCEEEECC---------------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhceeecccccc--------------CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9999987543221 12234899999999999999965431 25899999999999999999999
Q ss_pred hCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 036382 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 225 ~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 302 (390)
++||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 234 (323)
T 3qup_A 155 SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234 (323)
T ss_dssp HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence 9999999999999999999999999999997543322 12223456789999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 303 -CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 303 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|..||.+.+..+....+. .......+..+++++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 235 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 235 RGQTPYAGIENAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCccccChHHHHHHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999999988888776664 4445667788999999999999999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=356.93 Aligned_cols=260 Identities=30% Similarity=0.626 Sum_probs=218.4
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+..++|++.+.||+|+||.||+|++ +++.||||++....... ..........+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG--ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC--CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc--chhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 35567899999999999999999988 67899999997543221 111111225688999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRD 232 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrD 232 (390)
.+.. ++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++| |+|||
T Consensus 93 ~~~~----------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~d 149 (287)
T 4f0f_A 93 HNPP----------------------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRD 149 (287)
T ss_dssp TTTT----------------------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSC
T ss_pred cCCC----------------------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCC
Confidence 5321 6899999999999988653 456999999999999999999999999 99999
Q ss_pred CCCCCEEECCCCc-----EEEeecccceeccCCCCCCCCCCCCCccccccccC--CCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 233 VKTENMLLDSQRT-----LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ--GKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 233 lkp~NILl~~~~~-----~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
|||+|||++.++. +||+|||++..... ......+|+.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 150 ikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 226 (287)
T 4f0f_A 150 LRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226 (287)
T ss_dssp CSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred CCcceEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCC
Confidence 9999999988776 99999999974332 234567999999999994 4567899999999999999999999
Q ss_pred CCCCCChhhH--HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 306 PYPDLSFADV--SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 306 Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
||...+.... ...+.....++..+..+|+++.++|.+||+.||.+|||+.++++.|+++
T Consensus 227 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9987654443 5555667778888999999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.24 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=213.1
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..+.+..++|++.+.||+|+||.||++.+ +++.||+|+++.. ..........+.+|+.+++.++||||++++
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~------~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 81 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ------KCVERNEVRNVFKELQIMQGLEHPFLVNLW 81 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehh------hcccHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35677889999999999999999999988 5688999998621 111222345678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+.. ..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||
T Consensus 82 ~~~~~~~--------------------~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHr 139 (384)
T 4fr4_A 82 YSFQDEE--------------------DMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHR 139 (384)
T ss_dssp EEEECSS--------------------EEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EEEEeCC--------------------EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 9998654 34889999999999999954 4569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
||||+|||++.+|.+||+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 140 Dlkp~NIll~~~g~vkL~DFG~a~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 140 DMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCT-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcHHHeEECCCCCEEEeccceeeeccC-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986543 233456789999999999964 458999999999999999999999997
Q ss_pred CC---ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 036382 309 DL---SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-MGEVVK 359 (390)
Q Consensus 309 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~ 359 (390)
.. ...+....+.. .....|..+++++.+||.+||..||.+||+ +.+|++
T Consensus 219 ~~~~~~~~~~~~~~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 219 IRSSTSSKEIVHTFET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCTTSCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCccHHHHHHHHhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 54 33333333332 345578889999999999999999999998 666654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.36 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=216.8
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.+.+..++|++.+.||+|+||.||+|++ +++.||+|+++.. ..........+.+|+.+++.++||||+++++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~------~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF------EMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehh------hhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4556778999999999999999999988 5789999998621 1111111234778999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+|||
T Consensus 137 ~~~~~~--------------------~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrD 193 (410)
T 3v8s_A 137 AFQDDR--------------------YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193 (410)
T ss_dssp EEECSS--------------------EEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEEECC--------------------EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 998654 34789999999999999854 3599999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccCCCC----CCCchhHHHHHHHHHHHHhCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQGKP----YNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||+|||++.++++||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 194 LKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 999999999999999999999986543321 234578999999999997665 789999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
.+.+..+....+........+ ...+++++.+||.+||..+|.+ ||++.+|+++
T Consensus 274 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 274 YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 999988888888754423333 3468999999999999999988 9999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=361.15 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=207.2
Q ss_pred ccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.++|++.+.||+|+||.||+|++ +++.||||+++... ........+.+|++++++++||||+++++++.+..
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-------EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc-------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 57899999999999999999998 67899999996322 12223466789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||++||+||||||+||
T Consensus 93 --------------------~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 150 (311)
T 3niz_A 93 --------------------CLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150 (311)
T ss_dssp --------------------CEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred --------------------EEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence 45889999975 888888653 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++.++.+||+|||++..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 151 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 230 (311)
T 3niz_A 151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP 230 (311)
T ss_dssp EECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH
T ss_pred EECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999876554455556789999999999876 568999999999999999999999999887777666
Q ss_pred HHHHcCCCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQNLRPE----------------------------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+......+. ....+++++.+||.+||+.||++|||+.++++
T Consensus 231 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 5543111110 11246788999999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=385.14 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=210.2
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.+.+..++|++.+.||+|+||.||+|.+ +++.||||+++.. ..........+.+|+.+++.++||||+++++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 215 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE------VIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHC-------------CCCCCSCTTSCCEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhh------hhhhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence 4556778999999999999999999987 5789999998621 1112223356678999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCccc
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHR 231 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHr 231 (390)
++.+.. ..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+ .||+||
T Consensus 216 ~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr 273 (446)
T 4ejn_A 216 SFQTHD--------------------RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273 (446)
T ss_dssp EEEETT--------------------EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred EEeeCC--------------------EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence 997544 348899999999999999653 469999999999999999999998 999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999999864444445566789999999999999999999999999999999999999999998
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVK 359 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~ 359 (390)
..+....+..... .+|..+++++.+||.+||+.||.+|| |+.++++
T Consensus 354 ~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 354 HEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 8888877766543 46788999999999999999999999 9999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=358.69 Aligned_cols=265 Identities=28% Similarity=0.515 Sum_probs=221.8
Q ss_pred CCcccccccCccccc-cccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 73 KEEWEIDLSKLDMRN-LIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
..++.++.++|++.+ .||+|+||.||+|.+ .++.||||+++... ........+.+|+.+++.++||||
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i 80 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-------NDPALKDELLAEANVMQQLDNPYI 80 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTB
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-------cCHHHHHHHHHHHHHHHhCCCCCE
Confidence 356788889999998 999999999999965 35789999996321 122335678899999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
+++++++.. ...++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++|
T Consensus 81 ~~~~~~~~~---------------------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ 137 (291)
T 1xbb_A 81 VRMIGICEA---------------------ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN 137 (291)
T ss_dssp CCEEEEEES---------------------SSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEECC---------------------CCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999832 234789999999999999965 346999999999999999999999999
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-C
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-C 303 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g 303 (390)
|+||||||+|||++.++.+||+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 138 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 217 (291)
T 1xbb_A 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 217 (291)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999986543221 1223446788999999988889999999999999999999 9
Q ss_pred CCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 304 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
..||.+.+..+....+ ..+.++..+..+|+++.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 218 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 218 QKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 9999998887766555 455567788889999999999999999999999999999999997654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=367.63 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=209.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++....... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS----PGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS----SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc----ccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5799999999999999999987 578999999862110000 0001356789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..|+||||+.+|+|.+++.+.. +..+++..+..++.||+.||.|||++||+||||||+
T Consensus 100 --------------------~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~ 159 (351)
T 3c0i_A 100 --------------------MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 159 (351)
T ss_dssp --------------------EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred --------------------EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChH
Confidence 4488999999999998886532 345899999999999999999999999999999999
Q ss_pred CEEECCCCc---EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLLDSQRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~~~~---~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||++.++. +||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..
T Consensus 160 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~ 238 (351)
T 3c0i_A 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KE 238 (351)
T ss_dssp GEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HH
T ss_pred HeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HH
Confidence 999987654 99999999987655444455678999999999999999999999999999999999999999875 34
Q ss_pred hHHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+....+....+... ....+++++.+||.+||..||++|||+.++++
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 45555555443322 22567899999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=355.72 Aligned_cols=263 Identities=28% Similarity=0.553 Sum_probs=220.8
Q ss_pred CcccccccCccccccccccCceEEEEEEECC-----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
..|.+..++|++.+.||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--------TLDNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--------CHHHHHHHHHHHHHHHHHCCTTBC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--------CchHHHHHHHHHHHHHhCCCCCcc
Confidence 4578888999999999999999999998632 359999986321 112346788999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.+ ...++||||+.+++|.+++.+. ...+++..++.++.|++.||.|||++||
T Consensus 77 ~~~~~~~~---------------------~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i 134 (281)
T 3cc6_A 77 KLIGIIEE---------------------EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINC 134 (281)
T ss_dssp CEEEEECS---------------------SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEEEcC---------------------CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999753 2337899999999999999654 3469999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMP 306 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~P 306 (390)
+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p 214 (281)
T 3cc6_A 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214 (281)
T ss_dssp CCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999997543322 12233457889999999988899999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|......+....+. .......+..+|+.+.++|.+||..||.+|||+.++++.|+.+...
T Consensus 215 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 215 FFWLENKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TTTSCGGGHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCChHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 98887777665554 4455667788999999999999999999999999999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=363.97 Aligned_cols=264 Identities=30% Similarity=0.545 Sum_probs=224.0
Q ss_pred CCCcccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 144 (390)
...+|++..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++.++|
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h 87 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNC 87 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--------CHHHHHHHHHHHHHGGGCCC
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--------CHHHHHHHHHHHHHHHhcCC
Confidence 34689999999999999999999999999763 5789999986321 11223567899999999999
Q ss_pred CccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc--------CCCCHHHHHHHHHHH
Q 036382 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--------KKLALKIVIQLALDL 216 (390)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~i 216 (390)
|||+++++++.+.. ..++||||+.+|+|.+++..... ..+++..++.++.||
T Consensus 88 ~~i~~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi 147 (322)
T 1p4o_A 88 HHVVRLLGVVSQGQ--------------------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147 (322)
T ss_dssp TTBCCEEEEECSSS--------------------SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred CCEeeeEEEEccCC--------------------ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHH
Confidence 99999999987543 34789999999999999965321 457999999999999
Q ss_pred HHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHH
Q 036382 217 SRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFG 294 (390)
Q Consensus 217 ~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 294 (390)
+.||.|||++||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||
T Consensus 148 ~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 227 (322)
T 1p4o_A 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227 (322)
T ss_dssp HHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHH
Confidence 999999999999999999999999999999999999997543221 112234568899999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 295 ICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 295 ~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
|++|+|++ |..||.+.+..+....+... .....+..+|+++.++|.+||..||.+|||+.++++.|+.+
T Consensus 228 ~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHHHHTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHhcCCCccccCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 99999999 89999998888877666543 44566788999999999999999999999999999999886
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=365.01 Aligned_cols=269 Identities=28% Similarity=0.549 Sum_probs=227.0
Q ss_pred CcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCC
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHP 145 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 145 (390)
..|++..++|++.+.||+|+||.||+|.+ +++.||||+++.... ......+.+|+.+++++ +||
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp 91 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHHL 91 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCCT
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--------cHHHHHHHHHHHHHHhcccCC
Confidence 46788889999999999999999999975 347899999963211 12235678999999999 799
Q ss_pred ccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc--------------CCCCHHHHHH
Q 036382 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR--------------KKLALKIVIQ 211 (390)
Q Consensus 146 nIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ 211 (390)
||+++++++... ....++||||+.+|+|.+++..... ..+++..++.
T Consensus 92 ~iv~~~~~~~~~-------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (316)
T 2xir_A 92 NVVNLLGACTKP-------------------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152 (316)
T ss_dssp TBCCEEEEECCT-------------------TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHH
T ss_pred CeeeEEEEEecC-------------------CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHH
Confidence 999999998643 2335899999999999999965432 1289999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchh
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|
T Consensus 153 ~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 232 (316)
T 2xir_A 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232 (316)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhH
Confidence 999999999999999999999999999999999999999999975433221 122345788999999999889999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 290 VYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 290 iwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
||||||++|+|++ |..||.+....+........+.....+..+++++.++|.+||+.||.+|||+.++++.|+.+..+.
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 9999999999998 999998877666665666666677788889999999999999999999999999999999987654
Q ss_pred C
Q 036382 369 G 369 (390)
Q Consensus 369 ~ 369 (390)
.
T Consensus 313 ~ 313 (316)
T 2xir_A 313 A 313 (316)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=371.45 Aligned_cols=265 Identities=17% Similarity=0.320 Sum_probs=213.4
Q ss_pred CcccccccCcccccccccc--CceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 74 EEWEIDLSKLDMRNLIAQG--TYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
..+....++|++.+.||+| +||.||+|++ +++.||||+++.... .......+.+|+.+++.++||||++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~ 90 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-------SNEMVTFLQGELHVSKLFNHPNIVP 90 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-------ChHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3455667899999999999 9999999998 588999999974321 1234567889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.+.. ..|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+
T Consensus 91 ~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 150 (389)
T 3gni_B 91 YRATFIADN--------------------ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV 150 (389)
T ss_dssp EEEEEEETT--------------------EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EeEEEEECC--------------------EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999998544 448899999999999999776556799999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC-------CCCCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHH
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEI 300 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el 300 (390)
||||||+|||++.++.+||+|||.+....... .......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 151 HrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 230 (389)
T 3gni_B 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230 (389)
T ss_dssp CCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHH
Confidence 99999999999999999999999886432211 11223478999999999987 6799999999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHcCC--------------------------------------------CCCCCCCCcHHH
Q 036382 301 YCCDMPYPDLSFADVSSAVVRQNL--------------------------------------------RPEIPRCCPSSL 336 (390)
Q Consensus 301 l~g~~Pf~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l 336 (390)
++|..||.+.+..+....+..... ..+.+..+++++
T Consensus 231 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 310 (389)
T 3gni_B 231 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310 (389)
T ss_dssp HHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHH
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHH
Confidence 999999988765555443322111 012345678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 036382 337 ANIMRKCWDANAEKRPEMGEVVKM--LEAID 365 (390)
Q Consensus 337 ~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~ 365 (390)
.+||.+||+.||++|||+.+++++ ++.+.
T Consensus 311 ~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred HHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999999999865 44443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=360.32 Aligned_cols=256 Identities=30% Similarity=0.560 Sum_probs=206.1
Q ss_pred cccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHh--cCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK--LDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~ 156 (390)
-.++|++.+.||+|+||.||+|+++++.||||++... . ...+..|.+++.. ++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------D-----EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------G-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------c-----chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 3578999999999999999999999999999998621 1 1344567777776 799999999999764
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH--------SKKI 228 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~i 228 (390)
... .....|+||||+.+|+|.+++.. ..+++..++.++.||+.||.||| +.||
T Consensus 74 ~~~----------------~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 74 SRH----------------SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp EET----------------TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred ccC----------------CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 321 13446899999999999999943 46999999999999999999999 9999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCC----CCCCCCCCccccccccCCC------CCCCchhHHHHHHHHH
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQGK------PYNRRCDVYSFGICLW 298 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ 298 (390)
+||||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 99999999999999999999999999764433221 2334799999999999876 4557999999999999
Q ss_pred HHHhC----------CCCCCCCC-----hhhHHHHHHHcCCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 299 EIYCC----------DMPYPDLS-----FADVSSAVVRQNLRPEIPR-----CCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 299 ell~g----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
||++| ..||.... .............++..+. .+++++.+||.+||+.||.+|||+.+|+
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 99999 88886532 2222222223333444443 2567899999999999999999999999
Q ss_pred HHHHHhH
Q 036382 359 KMLEAID 365 (390)
Q Consensus 359 ~~L~~~~ 365 (390)
+.|+++.
T Consensus 295 ~~L~~i~ 301 (301)
T 3q4u_A 295 KTLTKID 301 (301)
T ss_dssp HHHHHHC
T ss_pred HHHhccC
Confidence 9999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.47 Aligned_cols=258 Identities=24% Similarity=0.558 Sum_probs=213.8
Q ss_pred ccccCccccccccccCceEEEEEEE--CCce----EEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQE----VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+..++|++.+.||+|+||.||+|++ +++. ||+|.++.. ........+.+|+.++++++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--------TSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--------cCHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 4457899999999999999999987 3443 588877521 1122346788999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+. ..++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~---------------------~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~ 141 (327)
T 3poz_A 84 GICLTS---------------------TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 141 (327)
T ss_dssp EEEESS---------------------SEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEecC---------------------CeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence 998743 247899999999999999654 3569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 142 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 9999999999999999999999986543222 2233456889999999999999999999999999999999 999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+.+..+.... +..+.+...+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 222 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 222 GIPASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCGGGHHHH-HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCHHHHHHH-HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 8887776544 45566677788899999999999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=357.43 Aligned_cols=259 Identities=32% Similarity=0.633 Sum_probs=213.1
Q ss_pred cccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
.++.++|++.+.||+|+||.||+|++.++.||||++... ...+.+.+|++++++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----------SERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 466789999999999999999999999999999998521 123567899999999999999999998752
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCCcccC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHS---KKIVHRD 232 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~---~~iiHrD 232 (390)
..|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ +||+|||
T Consensus 73 ----------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~d 130 (307)
T 2eva_A 73 ----------------------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130 (307)
T ss_dssp ----------------------TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred ----------------------CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCC
Confidence 24889999999999999965332 247899999999999999999999 8999999
Q ss_pred CCCCCEEECCCCc-EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 233 VKTENMLLDSQRT-LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~-~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||+|||++.++. +||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 131 LKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp CSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred CChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 9999999998886 799999999754322 234568999999999999999999999999999999999999997653
Q ss_pred hhh-HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 312 FAD-VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 312 ~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
... ........+.++..+..+|..+.++|.+||+.||.+|||+.++++.|+.+.....+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 208 GPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp SSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred ccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 322 222233455666777889999999999999999999999999999999998665543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=378.67 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=214.8
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
++.+..++|++.+.||+|+||.||+++. +++.||||+++.. ..........+.+|..++..++||||+++++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~------~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW------DMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH------HhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 4556778999999999999999999988 5889999998621 1112222355789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+... .|+||||+.+|+|.+++.+. +..+++..++.++.||+.||.|||++||+|||
T Consensus 129 ~~~~~~~--------------------~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrD 187 (412)
T 2vd5_A 129 AFQDENY--------------------LYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187 (412)
T ss_dssp EEECSSE--------------------EEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeeCCE--------------------EEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9986543 47899999999999999654 34699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccC-------CCCCCCchhHHHHHHHHHHHHhCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQ-------GKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
|||+|||++.++++||+|||+++....... .....+||+.|+|||++. +..++.++|||||||++|||++|.
T Consensus 188 LKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 999999999999999999999986543322 233468999999999997 457899999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHcCCC---CCCCCCCcHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 036382 305 MPYPDLSFADVSSAVVRQNLR---PEIPRCCPSSLANIMRKCWDANAEKR---PEMGEVVKM 360 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~~ll~~ 360 (390)
.||.+.+..+....+...... +..+..+|+++++||.+||. +|.+| |++++++++
T Consensus 268 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 268 TPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 999999888888777653322 22346789999999999999 99998 589998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=361.72 Aligned_cols=265 Identities=28% Similarity=0.570 Sum_probs=219.1
Q ss_pred cccccccCccccccccccCceEEEEEEECC------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
.+++...+|++.+.||+|+||.||+|.+.. ..||||+++... .......+.+|+.+++.++||||+
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv 109 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--------TEKQRVDFLGEAGIMGQFSHHNII 109 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--------CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--------CHHHHHHHHHHHHHHHhCCCCCCC
Confidence 357888899999999999999999997632 359999996321 112345688999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.+. ...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||
T Consensus 110 ~~~~~~~~~--------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (333)
T 1mqb_A 110 RLEGVISKY--------------------KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNY 168 (333)
T ss_dssp CEEEEECSS--------------------SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cEEEEEecC--------------------CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 999998643 3458899999999999999653 3569999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CD 304 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~ 304 (390)
+||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999986443221 1222346788999999999999999999999999999999 99
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
.||...+..+....+ ..+.+...+..+|.++.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 249 ~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 249 RPYWELSNHEVMKAI-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CTTTTCCHHHHHHHH-HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCcccCCHHHHHHHH-HCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 999998887777655 4455666788899999999999999999999999999999999875433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=355.27 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=207.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 73 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-------THHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-------CcchHHHHHHHHHhcCCCCCEeeEEeEEEeC
Confidence 36899999999999999999988 57899999997543211 1235677899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+ +|.+++... +..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 74 ~--------------------~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~N 131 (292)
T 3o0g_A 74 K--------------------KLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp T--------------------EEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred C--------------------EEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3 44889999975 676666543 4569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCChhhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMP-YPDLSFADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~P-f~~~~~~~~ 315 (390)
||++.++.+||+|||++..............+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.
T Consensus 132 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp EEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred EEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 9999999999999999987655555556678999999999998765 89999999999999999988877 566666666
Q ss_pred HHHHHHcCCCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNLRP---------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+......+ .....+++++.+||.+||+.||++|||+.++++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 65554321110 112347889999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=359.22 Aligned_cols=273 Identities=26% Similarity=0.494 Sum_probs=219.1
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
...+.++.++|++.+.||+|+||.||+|.+. +..||||+++.... .......+.+|+.++++++||||
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i 98 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-------SQREIEEFLSEAACMKDFSHPNV 98 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-------CHHHHHHHHHHHHHHHTCCCTTB
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-------chhHHHHHHHHHHHHhcCCCCCe
Confidence 4567888899999999999999999999762 34799999874321 11224568899999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHH
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN----RRKKLALKIVIQLALDLSRGLSYL 223 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~yL 223 (390)
+++++++.+.... .....++||||+.+|+|.+++... ....+++..++.++.||+.||.||
T Consensus 99 v~~~~~~~~~~~~---------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 163 (313)
T 3brb_A 99 IRLLGVCIEMSSQ---------------GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163 (313)
T ss_dssp CCCCEEEEC----------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred eeeeEEEeecccc---------------CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH
Confidence 9999998764322 123458999999999999998542 235699999999999999999999
Q ss_pred HhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHH
Q 036382 224 HSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 224 H~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 301 (390)
|++||+||||||+|||++.++.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 164 H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp HTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999999997543321 1223345788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 302 C-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 302 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
+ |..||......+....+. .+.++..+..+++++.++|.+||..||.+|||+.+|++.|+++....
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hcCCCCCccCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9 899999988877776654 44566778889999999999999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=361.11 Aligned_cols=254 Identities=20% Similarity=0.350 Sum_probs=214.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.+.||+|+||.||+|.+ +++.||||+++......... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5699999999999999999988 57899999997543221110 001356789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 88 --------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 145 (326)
T 2y0a_A 88 --------------------DVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145 (326)
T ss_dssp --------------------EEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred --------------------EEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHE
Confidence 45889999999999999954 45699999999999999999999999999999999999
Q ss_pred EECCCC----cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~----~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|++.++ .+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 146 ll~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 146 MLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp EESCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred EEecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 999887 8999999999865432 23445679999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+........ .+..++..+.+||.+||..||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7777665443322 235678999999999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=382.27 Aligned_cols=258 Identities=21% Similarity=0.388 Sum_probs=216.3
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+.+..++|++.++||+|+||.||+|++ +++.||||+++.. ..........+.+|..+++.++||||++++++
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~------~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW------EMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH------HHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHH------HhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 456678999999999999999999988 4689999998621 11111122347889999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+... .|+||||+.+|+|.+++.+. ...+++..++.++.||+.||.|||++||+||||
T Consensus 143 ~~~~~~--------------------~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDL 201 (437)
T 4aw2_A 143 FQDDNN--------------------LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201 (437)
T ss_dssp EECSSE--------------------EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EeeCCE--------------------EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccc
Confidence 986543 48899999999999999653 356999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCC-CCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPR-DMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
||+|||++.++.+||+|||+++....... .....+||+.|+|||++. ...++.++|||||||++|||++|..||
T Consensus 202 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999976543322 234468999999999996 567999999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIP---RCCPSSLANIMRKCWDANAEK--RPEMGEVVKM 360 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~ 360 (390)
.+.+..+....+........+| ..+++++.+||++||..+|++ ||++++++++
T Consensus 282 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 9999888888876543333333 458999999999999988888 9999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=370.07 Aligned_cols=250 Identities=26% Similarity=0.466 Sum_probs=209.5
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|.+ +++.||||+++.. ..........+.+|+.+++.++||||+++++++.+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ------LLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehH------HccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 357899999999999999999998 6789999998621 11111223467899999999999999999999975
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..++||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 81 ~~--------------------~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 137 (336)
T 3h4j_B 81 PT--------------------DIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137 (336)
T ss_dssp SS--------------------EEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTT
T ss_pred CC--------------------EEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchh
Confidence 43 348899999 78999998654 46999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|||++.++.+||+|||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+.
T Consensus 138 NIll~~~~~~kl~DFG~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 138 NLLLDDNLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp TEEECTTCCEEECCSSCTBTTTT-SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred hEEEcCCCCEEEEEeccceeccC-CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 99999999999999999975443 233455789999999999998876 7899999999999999999999987655443
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+ .......|..+++++.+||.+||..||.+|||+.++++.
T Consensus 217 ~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 FKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp BCCC--CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHH--HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 3222 122345677889999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=355.30 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=204.0
Q ss_pred cCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
++|++.+.||+|+||.||+|++ +++.||||+++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-------GIPSTTIREISILKELKHSNIVKLYDVIHTKK- 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-------ccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-
Confidence 6899999999999999999988 47899999996433211 11245678999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++||||+.+ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 74 -------------------~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 132 (288)
T 1ob3_A 74 -------------------RLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL 132 (288)
T ss_dssp -------------------CEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred -------------------eEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 45889999975 999998643 356999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
++.++.+||+|||++..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (288)
T 1ob3_A 133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (288)
T ss_dssp ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999765443344455678999999999976 4589999999999999999999999999887776665
Q ss_pred HHHcCCC----------------C-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQNLR----------------P-----------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~~~----------------~-----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+...... + .....+++++.+||.+||+.||++|||+.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 5431100 0 1124578999999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=356.19 Aligned_cols=264 Identities=26% Similarity=0.475 Sum_probs=217.5
Q ss_pred cccccccCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
...+....|++.+.||+|+||.||+|++ +++.||||+++.... ......+.+|+.+++.++||||+
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--------chhHHHHHHHHHHHHhCCCCCee
Confidence 3445567799999999999999999984 578999999973321 11235678999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.+.. ....++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++||
T Consensus 87 ~~~~~~~~~~------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i 147 (302)
T 4e5w_A 87 KYKGICTEDG------------------GNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQY 147 (302)
T ss_dssp CEEEEEEC---------------------CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eeeeEEecCC------------------CceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCc
Confidence 9999987542 23458999999999999999654 3569999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
+||||||+|||++.++.+||+|||++....... .......+|..|+|||++.+..++.++|||||||++|+|++|..
T Consensus 148 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 999999999999999999999999998654432 12334568888999999998889999999999999999999998
Q ss_pred CCCCC--------------ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 306 PYPDL--------------SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 306 Pf~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
|+... ............+.+...+..+|+++.+||.+||+.||.+|||+.++++.|+++.
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 228 SDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 76322 2222333444566677788899999999999999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=355.89 Aligned_cols=266 Identities=22% Similarity=0.429 Sum_probs=208.7
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|.+ +++.||||+++..... .......+.+|+.+++.++||||+++++++..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM------DAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 457899999999999999999987 6889999999743211 12234667899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.. ..++||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+|||||
T Consensus 104 ~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~ 163 (310)
T 2wqm_A 104 DN--------------------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK 163 (310)
T ss_dssp TT--------------------EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CC--------------------cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCc
Confidence 43 447899999999999999642 34568999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--h
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS--F 312 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~ 312 (390)
|+|||++.++.+||+|||++..............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .
T Consensus 164 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 243 (310)
T 2wqm_A 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243 (310)
T ss_dssp GGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH
T ss_pred HHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH
Confidence 99999999999999999999765443333444578999999999999999999999999999999999999997643 3
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
......+....+.+..+..+++++.++|.+||..||.+|||+.+|++.|+.+.....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 3444444444444444567899999999999999999999999999999999877664
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=363.59 Aligned_cols=249 Identities=16% Similarity=0.254 Sum_probs=214.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||+|+++... . ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------T----DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------H----HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------c----cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 36899999999999999999988 57899999986321 1 134578999999999999999999999754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 74 ~--------------------~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~N 132 (321)
T 1tki_A 74 E--------------------ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132 (321)
T ss_dssp T--------------------EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred C--------------------EEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 3 348899999999999999542 3469999999999999999999999999999999999
Q ss_pred EEECC--CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLDS--QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~--~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||++. ++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 133 Il~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 211 (321)
T 1tki_A 133 IIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 99987 789999999999865432 223345689999999999998899999999999999999999999999988888
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+........ ....+|+++.+||.+||..||.+|||+.+++++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 888776654432 224689999999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.75 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=211.5
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||+|+||.||+|++ +|+.||||+++..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---------RRELLFNEVVIMRDYQHFNVVEMYKSYLVGE- 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------SHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---------HHHHHHHHHHHHHhCCCCCcceEEEEEEECC-
Confidence 367778999999999999987 5889999999744321 1245779999999999999999999987543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
..++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 116 -------------------~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 116 -------------------ELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173 (321)
T ss_dssp -------------------EEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred -------------------EEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 34889999999999999843 45999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
++.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999986654444445668999999999999999999999999999999999999999988887777666
Q ss_pred HHcCCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 320 VRQNLR-PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 320 ~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...... ...+..+++++.++|.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 543321 12334578999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=357.76 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=196.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--------PSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS--------CHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 46799999999999999999987 578999999975432111 24567899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+..|+||||+. |+|.+++.... ...+++..+..++.||+.||.|||++||+||||
T Consensus 76 --------------------~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl 134 (317)
T 2pmi_A 76 --------------------NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134 (317)
T ss_dssp --------------------TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred --------------------CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 34588999998 59999996543 235899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||+|||++.++.+||+|||++..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999999876544444556689999999999976 4689999999999999999999999999887
Q ss_pred hhHHHHHHHcCCC--------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLR--------------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+...... +..+..++.++.+||.+||+.||++|||+.++++.
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 215 EEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 7776655431100 01123578899999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=362.62 Aligned_cols=266 Identities=27% Similarity=0.510 Sum_probs=219.2
Q ss_pred ccccCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
++.++|++.+.||+|+||.||+|++ +++.||||+++... ....+.+.+|++++++++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---------PDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 4567899999999999999999984 56899999986321 12245688999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.... ....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||
T Consensus 91 ~~~~~~~------------------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 151 (327)
T 3lxl_A 91 GVSYGPG------------------RQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHR 151 (327)
T ss_dssp EEEECSS------------------SCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EEEecCC------------------CceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 9987432 334589999999999999997543 469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999986543221 2233568888999999998889999999999999999999999985
Q ss_pred CCChh--------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 309 DLSFA--------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 309 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
..... .........+.+...+..+++++.+||.+||+.||.+|||+.+|++.|+.+.....+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp SHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 53321 2333445566777788899999999999999999999999999999999997655543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=364.36 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=200.1
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
....++|++.+.||+|+||.||++++ +++.||||++...... ...+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~ 85 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----------DENVQREIINHRSLRHPNIVRFKEVI 85 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----------CHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----------cHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 44567899999999999999999988 6789999999743211 13467899999999999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+.. ..|+||||+.+|+|.+++... ..+++..++.++.|++.||.|||++||+|||||
T Consensus 86 ~~~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlk 143 (361)
T 3uc3_A 86 LTPT--------------------HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143 (361)
T ss_dssp ECSS--------------------EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCC
T ss_pred eeCC--------------------EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 8543 348899999999999999653 469999999999999999999999999999999
Q ss_pred CCCEEECCCCc--EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 235 TENMLLDSQRT--LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRR-CDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 235 p~NILl~~~~~--~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..
T Consensus 144 p~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 144 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp GGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred HHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 99999987765 999999999743322 22344679999999999988887665 899999999999999999998754
Q ss_pred h----hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 F----ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
. ......+.......+....+++++.+||.+||..||.+|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 223 EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 3 334444444444444455689999999999999999999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.23 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=209.4
Q ss_pred cccccCccccccccccCceEEEEEEEC--C-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD--N-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
++..++|++.+.||+|+||.||+|.+. + ..||+|+++... ....+.+.+|+.++++++||||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---------RNYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---------GGGHHHHHHHHHHHHTSCCTTB
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---------HHHHHHHHHHHHHHHhCCCCCE
Confidence 566789999999999999999999763 3 469999986321 1123568899999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
+++++++.+.. ..++||||+.+|+|.+++.+. ...+++..++.++.||+.||.|||++|
T Consensus 75 v~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ 133 (289)
T 4fvq_A 75 VLNYGVCVCGD--------------------ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT 133 (289)
T ss_dssp CCEEEEECCTT--------------------CCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEEEeCC--------------------CCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 99999987543 347899999999999999654 345999999999999999999999999
Q ss_pred CcccCCCCCCEEECCCCc--------EEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHH
Q 036382 228 IVHRDVKTENMLLDSQRT--------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLW 298 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~--------~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ 298 (390)
|+||||||+|||++.++. +||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 134 ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 209 (289)
T 4fvq_A 134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209 (289)
T ss_dssp CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence 999999999999998887 999999998643221 12347889999999987 77999999999999999
Q ss_pred HHHhC-CCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCCCCCC
Q 036382 299 EIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGGMIPE 375 (390)
Q Consensus 299 ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~~~ 375 (390)
+|++| ..||...+........ .. ....+..+++++.+||.+||+.||.+|||+.++++.|+++.+..+..-...
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~ 284 (289)
T 4fvq_A 210 EICSGGDKPLSALDSQRKLQFY-ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284 (289)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHH-HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----------
T ss_pred HHHcCCCCCccccchHHHHHHh-hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCcc
Confidence 99995 5566665555444332 22 445666778899999999999999999999999999999998776544333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=348.39 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=215.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-------SARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 36899999999999999999987 578999999963321 122235678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~--------------------~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 135 (284)
T 3kk8_A 78 S--------------------FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 135 (284)
T ss_dssp S--------------------EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred C--------------------EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHH
Confidence 3 447899999999999998654 469999999999999999999999999999999999
Q ss_pred EEECCCCc---EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~---~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++.++. +||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+
T Consensus 136 il~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 136 LLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp EEESSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 99987655 999999999765432 33345679999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+.........+ ..+++++.+||.+||+.||++|||+.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 887776665544333 4689999999999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=350.30 Aligned_cols=252 Identities=26% Similarity=0.472 Sum_probs=213.8
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
...++|++.+.||+|+||.||+|.+ +++.||||++.. ...........+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK------AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEH------HHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEec------cccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 3457899999999999999999988 456899999852 11222233467889999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..++||||+.+|+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||
T Consensus 80 ~~~--------------------~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp 137 (279)
T 3fdn_A 80 DAT--------------------RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137 (279)
T ss_dssp CSS--------------------EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCG
T ss_pred cCC--------------------EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCCh
Confidence 543 448899999999999999654 4699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.++.++|+|||++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus 138 ~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 215 (279)
T 3fdn_A 138 ENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215 (279)
T ss_dssp GGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred HhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH
Confidence 9999999999999999998643322 23345789999999999999999999999999999999999999999888887
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
...+... ....|..+++++.+||.+||+.||.+|||+.+++++-
T Consensus 216 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 216 YKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHHHT--CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHHhC--CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 7766543 4457788999999999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=387.78 Aligned_cols=266 Identities=28% Similarity=0.525 Sum_probs=222.4
Q ss_pred CcccccccCccccc-cccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 74 EEWEIDLSKLDMRN-LIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 74 ~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
..|.+..+++.+.+ .||+|+||.||+|.+ ++..||||+++..... ...+.+.+|+++|++++||||+
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~~E~~il~~l~hpniv 399 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--------ADTEEMMREAQIMHQLDNPYIV 399 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--------TTHHHHHHHHHHHTTCCCTTBC
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--------HHHHHHHHHHHHHHhCCCCCEe
Confidence 35667777787777 899999999999977 3457999999743211 1135688999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.. ...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||
T Consensus 400 ~l~~~~~~---------------------~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~i 457 (613)
T 2ozo_A 400 RLIGVCQA---------------------EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNF 457 (613)
T ss_dssp CEEEEEES---------------------SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEEecc---------------------CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 99999863 2248899999999999999643 4569999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CD 304 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~ 304 (390)
+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 458 iHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 537 (613)
T 2ozo_A 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 537 (613)
T ss_dssp CCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999975432221 1122345689999999998899999999999999999998 99
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
.||.+.+..++...+ ..+.++..|..+|+++.+||.+||..||++|||+.+|++.|+.+..+.+.
T Consensus 538 ~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 538 KPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CTTTTCCSHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 999998888877655 45667888899999999999999999999999999999999999776554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=391.23 Aligned_cols=263 Identities=28% Similarity=0.526 Sum_probs=219.5
Q ss_pred CcccccccCccccc-cccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 74 EEWEIDLSKLDMRN-LIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 74 ~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
..|.++...+.+.. .||+|+||.||+|.+ .++.||||+++.... .....+.+.+|+++|++++||||+
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv 433 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIV 433 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-------CGGGHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCEe
Confidence 45667766666654 799999999999966 357899999974321 112246688999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++... ..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||
T Consensus 434 ~l~~~~~~~---------------------~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~i 490 (635)
T 4fl3_A 434 RMIGICEAE---------------------SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNF 490 (635)
T ss_dssp CEEEEEESS---------------------SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEEEecC---------------------CEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 999998532 34789999999999999954 4569999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CD 304 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~ 304 (390)
+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 491 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp CCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999997543322 12233456789999999999999999999999999999998 99
Q ss_pred CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 305 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
.||.+.+..++...+ ..+.++..|..+|+++.+||.+||..||++|||+.+|++.|+++...
T Consensus 571 ~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 571 KPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999888877655 45667788899999999999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=360.96 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=211.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----------APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----------SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----------hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 46899999999999999999986 688999999864321 13467899999999 99999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 77 ~~--------------------~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 134 (330)
T 2izr_A 77 GK--------------------YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE 134 (330)
T ss_dssp TT--------------------EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CC--------------------ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 43 348899999 99999999654 457999999999999999999999999999999999
Q ss_pred CEEECCCCc-----EEEeecccceeccCCCC-------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 036382 237 NMLLDSQRT-----LKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 237 NILl~~~~~-----~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
|||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 135 Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 135 NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp GEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 999998887 99999999986443221 124567999999999999999999999999999999999999
Q ss_pred CCCCCCChh---hHHHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 305 MPYPDLSFA---DVSSAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 305 ~Pf~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
.||.+.+.. +....+........ ....+| ++.++|.+||..||.+||++.+|++.|+++....+
T Consensus 215 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 215 LPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp CTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 999885433 33333322221111 123466 99999999999999999999999999999986554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=362.10 Aligned_cols=258 Identities=24% Similarity=0.514 Sum_probs=214.6
Q ss_pred ccccCccccccccccCceEEEEEEE--CCce----EEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQE----VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+..++|++.+.||+|+||.||+|.+ +++. ||+|++........ ...+.+|+.+++.++||||++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--------FQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC--------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH--------HHHHHHHHHHHhcCCCCCcCeEE
Confidence 4457899999999999999999987 3443 78887753221111 13456899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+ ...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 82 ~~~~~---------------------~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 139 (325)
T 3kex_A 82 GLCPG---------------------SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139 (325)
T ss_dssp EEECB---------------------SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEcC---------------------CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 98742 2357899999999999999653 3569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 140 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999986543221 2234567889999999998899999999999999999999 999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+....+....+ ....+...+..++.++.++|.+||..||.+|||+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 220 GLRLAEVPDLL-EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TSCTTHHHHHH-HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ccCHHHHHHHH-HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 88777766554 4555667788899999999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=377.66 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=217.5
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+..++|.+.+.||+|+||.||+|++ +|+.||||+++.. ..........+.+|+.+++.++||||+++++++
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~------~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQ------KIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHH------HHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhh------hccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45567899999999999999999988 5889999999621 111122345788999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+.. ..|+||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++||+|||||
T Consensus 86 ~~~~--------------------~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLk 143 (476)
T 2y94_A 86 STPS--------------------DIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143 (476)
T ss_dssp ECSS--------------------EEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred EECC--------------------EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCccccc
Confidence 7543 34889999999999999953 4569999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|+|||++.++.+||+|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..
T Consensus 144 p~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 222 (476)
T 2y94_A 144 PENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222 (476)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH
T ss_pred HHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH
Confidence 99999999999999999999865432 33455789999999999998775 68999999999999999999999998887
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.....+.... ...|..+++++.+||.+||..||.+|||+.+++++
T Consensus 223 ~~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 223 TLFKKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 7777765543 34677889999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=363.92 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=206.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--------cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 46899999999999999999987 578999999863321 11235678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 78 ~--------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N 135 (323)
T 3tki_A 78 N--------------------IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 135 (323)
T ss_dssp S--------------------EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred C--------------------eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHH
Confidence 3 44789999999999999843 4569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++.++.+||+|||++....... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...
T Consensus 136 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 215 (323)
T 3tki_A 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (323)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS
T ss_pred EEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999999997543221 22345679999999999987765 778999999999999999999998765543
Q ss_pred HH-HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VS-SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.. ...............+++++.+||.+||..||++|||+.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 32 23333333333345689999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=368.49 Aligned_cols=274 Identities=20% Similarity=0.287 Sum_probs=210.2
Q ss_pred ccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHH--HHHHHHHHHHHHHHHhcCCCccc
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAET--AALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
+..++|++.+.||+|+||.||+|.+. ++.||||++............. ......+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45568999999999999999999873 4789999986432110000000 00112344566777888999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++..... .....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||
T Consensus 112 ~~~~~~~~~~~----------------~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~i 173 (364)
T 3op5_A 112 KYWGSGLHDKN----------------GKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEY 173 (364)
T ss_dssp CEEEEEEEEET----------------TEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEeeeeeccC----------------CcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 99999875421 123458999999 99999999653 3579999999999999999999999999
Q ss_pred cccCCCCCCEEEC--CCCcEEEeecccceeccCCCC-------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHH
Q 036382 229 VHRDVKTENMLLD--SQRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 229 iHrDlkp~NILl~--~~~~~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 299 (390)
+||||||+|||++ .++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 174 iHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e 253 (364)
T 3op5_A 174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253 (364)
T ss_dssp ECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred EEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHH
Confidence 9999999999999 889999999999975432211 1233459999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHcCCCCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 300 IYCCDMPYPDLSFADVSSAVVRQNLRPE---------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|++|..||.+.................. .+..+|.++.++|..||..||.+|||+.+|++.|+.+....+
T Consensus 254 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 254 WLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 9999999986432222211111111111 125679999999999999999999999999999999987554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=380.69 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=214.6
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+..++|++.+.||+|+||.||+|++ +|+.||||+++.. ..........+.+|+.++++++||||+++++++
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~------~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK------RLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhH------HhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 35668899999999999999999988 5889999998621 111112235678999999999999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
.+.. ..|+||||+.||+|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 255 ~~~~--------------------~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrD 314 (543)
T 3c4z_A 255 ETKT--------------------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314 (543)
T ss_dssp ECSS--------------------EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred eeCC--------------------EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 7544 3488999999999999996543 45699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-- 310 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-- 310 (390)
|||+|||++.+|++||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 315 LKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred CChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 999999999999999999999986654443344568999999999999999999999999999999999999999775
Q ss_pred --ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 036382 311 --SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM-----GEVVK 359 (390)
Q Consensus 311 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~ 359 (390)
...++...+... ...+|..+++++.+||.+||+.||.+||++ .+|++
T Consensus 395 ~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 395 KVENKELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred chhHHHHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 334555555443 345778899999999999999999999975 56654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.03 Aligned_cols=266 Identities=28% Similarity=0.472 Sum_probs=214.0
Q ss_pred cccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+.+...++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---------QGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---------SHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4445567899999999999999999987 478999998864321 123567899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+.+.. ..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++||+||
T Consensus 104 ~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~ 163 (321)
T 2qkw_B 104 CDERN--------------------EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR 163 (321)
T ss_dssp CCCTT--------------------CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EcCCC--------------------eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecC
Confidence 86543 3488999999999999985432 2358999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
||||+|||++.++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 164 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp CCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred CCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 99999999999999999999999754322 1222334589999999999888999999999999999999999999976
Q ss_pred CChhhHHH------HHHH---------cCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 310 LSFADVSS------AVVR---------QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 310 ~~~~~~~~------~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
....+... .... .......+..++..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 54322111 0111 111112233456789999999999999999999999999999876554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=367.88 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=201.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+++.+. ||||+++++++..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-------QNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-------cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 46899999999999999999987 58899999985221 11222356678999999996 9999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ....|+||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+
T Consensus 81 ~~------------------~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~ 138 (388)
T 3oz6_A 81 DN------------------DRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPS 138 (388)
T ss_dssp TT------------------SSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CC------------------CCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH
Confidence 42 234589999997 589999854 36999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCC---------------------CCCCCCCCCCCccccccccCC-CCCCCchhHHHHH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQN---------------------PRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFG 294 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 294 (390)
|||++.++.+||+|||+|+..... ....+..+||+.|+|||++.+ ..++.++||||||
T Consensus 139 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 218 (388)
T 3oz6_A 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218 (388)
T ss_dssp GEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH
Confidence 999999999999999999754321 122344679999999999986 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHHHcCCCC---------------------------------------------CCC
Q 036382 295 ICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP---------------------------------------------EIP 329 (390)
Q Consensus 295 ~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~ 329 (390)
|++|||++|..||.+.+..+.+..+......+ ..+
T Consensus 219 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (388)
T 3oz6_A 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298 (388)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccc
Confidence 99999999999999988777766654221111 012
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 036382 330 RCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAID 365 (390)
Q Consensus 330 ~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~ 365 (390)
..+++++.+||.+||..||++|||+.+++++ +..+.
T Consensus 299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred ccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 2678899999999999999999999999976 54443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=358.42 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=209.6
Q ss_pred cccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|.+. ++.||||+++.... ....+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 3467999999999999999999984 78999999863221 1113456789999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.. ....|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 79 ~~------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 140 (319)
T 4euu_A 79 TT------------------TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (319)
T ss_dssp TT------------------TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CC------------------CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 43 2345899999999999999975432 3399999999999999999999999999999999
Q ss_pred CCEEE----CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC--------CCCCCCchhHHHHHHHHHHHHhC
Q 036382 236 ENMLL----DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ--------GKPYNRRCDVYSFGICLWEIYCC 303 (390)
Q Consensus 236 ~NILl----~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ell~g 303 (390)
+|||+ +.++.+||+|||+++..... .......+|+.|+|||++. +..++.++|||||||++|||++|
T Consensus 141 ~NIll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 141 GNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp GGEEEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred HHEEEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999 77888999999999865433 3334567999999999985 57789999999999999999999
Q ss_pred CCCCCCCCh----hhHHHHHHHcCCCC-----------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 304 DMPYPDLSF----ADVSSAVVRQNLRP-----------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 304 ~~Pf~~~~~----~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
..||..... .+....+....... ..+..++..+.++|++||+.||++|||+.|
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 999975432 33344444322110 112234567999999999999999999999
Q ss_pred HHHHHHHhH
Q 036382 357 VVKMLEAID 365 (390)
Q Consensus 357 ll~~L~~~~ 365 (390)
+++...+-.
T Consensus 300 ll~h~~d~~ 308 (319)
T 4euu_A 300 FFAETSDIL 308 (319)
T ss_dssp HHHHHHHHT
T ss_pred hhhccHHHh
Confidence 999988653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=351.24 Aligned_cols=260 Identities=18% Similarity=0.304 Sum_probs=215.5
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGA 153 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 153 (390)
.+..++|++.+.||+|+||.||+|.+ +++.||||+++.... ...+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~i~~~~~~ 74 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLLAGCTGIPNVYYF 74 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----------SCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----------cHHHHHHHHHHHHHhcCCCCCeEEee
Confidence 34567899999999999999999986 688999999863321 13467899999999 89999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+. ...++||||+ +++|.+++... +..+++..++.++.||+.||.|||++||+||||
T Consensus 75 ~~~~--------------------~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dl 132 (298)
T 1csn_A 75 GQEG--------------------LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 132 (298)
T ss_dssp EEET--------------------TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred cCCC--------------------ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 8644 3448899999 99999999654 346999999999999999999999999999999
Q ss_pred CCCCEEECCCCc-----EEEeecccceeccCCCC-------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHH
Q 036382 234 KTENMLLDSQRT-----LKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 234 kp~NILl~~~~~-----~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 301 (390)
||+|||++.++. +||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 133 kp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 133 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp CGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 999999987776 99999999986543321 234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCC---hhhHHHHHHHcCCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 302 CCDMPYPDLS---FADVSSAVVRQNLRP---EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 302 ~g~~Pf~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+|..||...+ ..+....+....... .....+|+++.++|.+||+.||++|||+.+|++.|+.+....+
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 213 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 9999998743 333333333222222 2345789999999999999999999999999999999987655
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=359.12 Aligned_cols=264 Identities=27% Similarity=0.487 Sum_probs=218.8
Q ss_pred cccccCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
.++...|++.+.||+|+||.||++.+ +++.||||+++... .......+.+|+++++.++||||+++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~ 98 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--------GPQHRSGWKQEIDILRTLYHEHIIKY 98 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--------CHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--------ChHHHHHHHHHHHHHHhCCCcchhhE
Confidence 34444569999999999999998865 57899999997321 12234668899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.+.. ....++||||+++|+|.+++.+ ..+++..++.++.|++.||.|||+.||+|
T Consensus 99 ~~~~~~~~------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH 157 (318)
T 3lxp_A 99 KGCCEDAG------------------AASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIH 157 (318)
T ss_dssp EEEEEETT------------------TTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEecCC------------------CceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 99987542 2345899999999999999954 34999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 158 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 99999999999999999999999986543321 123456788899999999888999999999999999999999999
Q ss_pred CCCChh--------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 308 PDLSFA--------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 308 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
...... ...............+..+|+++.+||.+||+.||.+|||+.++++.|+.+.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 238 QSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp GSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 653221 12234445666777888999999999999999999999999999999999976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=360.75 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=211.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +++.||||+++.... ........+.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT------TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc------CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 46899999999999999999997 678999999974321 1223346788999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... ....|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~----------------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 146 (311)
T 3ork_A 85 TPA----------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 146 (311)
T ss_dssp ETT----------------EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCC----------------CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence 322 12348999999999999999653 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 147 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 226 (311)
T 3ork_A 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226 (311)
T ss_dssp EEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999975443221 2223568999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHHHHHHhHhc
Q 036382 315 VSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMG-EVVKMLEAIDTS 367 (390)
Q Consensus 315 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll~~L~~~~~~ 367 (390)
...........+. .+..+|+++.+||.+||+.||.+||+.. .+.+.|.++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 227 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 7766665544332 2356899999999999999999999554 555667666543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=359.87 Aligned_cols=265 Identities=28% Similarity=0.529 Sum_probs=220.5
Q ss_pred cccccCccccccccccCceEEEEEEE--CCce--EEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQE--VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFV 151 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 151 (390)
.++.++|++.+.||+|+||.||+|++ ++.. ||||.++... .......+.+|+++++++ +||||++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--------chHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 35678999999999999999999976 5554 4999886321 112235678999999999 999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHHHHHHHH
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLS 217 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~ 217 (390)
+++.+.. ..|+||||+++|+|.+++.... ...+++..++.++.||+
T Consensus 93 ~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 152 (327)
T 1fvr_A 93 GACEHRG--------------------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152 (327)
T ss_dssp EEEEETT--------------------EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHH
T ss_pred eeeeeCC--------------------ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHH
Confidence 9987543 4488999999999999996532 24699999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 297 (390)
.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++
T Consensus 153 ~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 153 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 9999999999999999999999999999999999998743221 122334578899999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCCC
Q 036382 298 WEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGGG 371 (390)
Q Consensus 298 ~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~ 371 (390)
|+|++ |..||.+.+..+....+ ..+.....+..+++++.+||.+||..||.+|||+.++++.|+.+...+...
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHG-GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred HHHHcCCCCCCCCCcHHHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 99998 99999998887766554 455666778889999999999999999999999999999999998766544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=392.23 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=217.5
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
..+..++|++.++||+|+||.||+|++ +++.||||+++.. ..........+..|..++..+ +||||+++++
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~------~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD------VVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHH------HHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecc------ccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 456778999999999999999999988 5678999998621 111122235677899999988 7999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+.+|+|.+++.+. ..+++..++.|+.||+.||.|||++||+|||
T Consensus 410 ~~~~~~--------------------~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrD 467 (674)
T 3pfq_A 410 CFQTMD--------------------RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467 (674)
T ss_dssp ECBCSS--------------------EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCC
T ss_pred EEEeCC--------------------EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 987544 347899999999999999654 4699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|||+|||++.++++||+|||+++............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.
T Consensus 468 LKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp CCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999999998654444455667899999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM-----GEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~ 359 (390)
.++...+.... ..+|..+++++.+||.+||+.||.+||++ .+|++
T Consensus 548 ~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 548 DELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 99888887654 45778899999999999999999999997 66664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=354.22 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=215.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ +++.||+|+++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-------CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 46899999999999999999988 578999999974321 112346788999999999999999999988643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccc
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKK-----IVH 230 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~-----iiH 230 (390)
. ....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.| |+|
T Consensus 78 ~------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 78 T------------------NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp G------------------GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred C------------------CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 2 234589999999999999997543 345999999999999999999999999 999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||||+|||++.++.+||+|||++..............+|+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 99999999999999999999999975443222222346899999999999989999999999999999999999999998
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
+..+....+... ..+..+..++.++.++|.+||+.||.+|||+.+|++.+.
T Consensus 220 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 220 SQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CHHHHHHHHhhc-ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 877776666543 445677889999999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=353.62 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=212.3
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
+....++|++.+.||+|+||.||+|++ +++.||||+++..... ...+.+|+.+++++ +||||+++++
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----------THHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----------HHHHHHHHHHHHhccCCCCeeeeee
Confidence 334567899999999999999999998 6889999999743221 24577899999999 8999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++...... ......++||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+|+|
T Consensus 89 ~~~~~~~~--------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 154 (326)
T 2x7f_A 89 AFIKKNPP--------------GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154 (326)
T ss_dssp EEEECC----------------CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEeeccCc--------------cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 98754211 1245679999999999999999876556799999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
|||+|||++.++.+||+|||++..............+|+.|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 155 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 155 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234 (326)
T ss_dssp CSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred CcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999876543333334467899999999997 567899999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+.........+.........+..++..+.+||.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 235 CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp TTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 9888777776666555554556778999999999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=359.38 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=213.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.+.||+|+||.||+|++ +++.||||+++.... ........+.+|++++++++||||+++++++.+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc------cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 4588999999999999999986 688999999974321 12233467889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+. |+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||
T Consensus 128 --------------------~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 185 (348)
T 1u5q_A 128 --------------------TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185 (348)
T ss_dssp --------------------EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred --------------------eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 4488999997 6898888643 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|++.++.+||+|||++..... .....||+.|+|||++. +..++.++|||||||++|||++|..||.+.+..+.
T Consensus 186 ll~~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 186 LLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp EEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EECCCCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999975432 23467999999999984 56789999999999999999999999999888777
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
...+.........+..+++.+.+||.+||+.||++|||+.++++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 7777666655556678899999999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.55 Aligned_cols=264 Identities=27% Similarity=0.506 Sum_probs=215.7
Q ss_pred ccccccCccccccccccCceEEEEEEEC---Cc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD---NQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
..+..++|++.+.||+|+||.||+|++. ++ .||||+++.... ......+.+.+|+++++.++||||+++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL------SQPEAMDDFIREVNAMHSLDHRNLIRL 86 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc------CCHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 3456678999999999999999999862 23 689999863211 122345678899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.+. ..++||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+|
T Consensus 87 ~~~~~~~---------------------~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 144 (291)
T 1u46_A 87 YGVVLTP---------------------PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144 (291)
T ss_dssp EEEECSS---------------------SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEccC---------------------CceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9998643 247899999999999999754 356999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMP 306 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~P 306 (390)
|||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 145 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 224 (291)
T 1u46_A 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224 (291)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543321 1223457788999999988889999999999999999999 9999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|...+..+....+.........+..+|.++.++|.+||..||.+|||+.++++.|+++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 225 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 9999988888888777777778888999999999999999999999999999999988643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=350.96 Aligned_cols=261 Identities=33% Similarity=0.575 Sum_probs=215.7
Q ss_pred ccCccccccccccCceEEEEEEECC-----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
..+|++.+.||+|+||.||+|.+.+ ..||+|.++... .......+.+|+.++++++||||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--------DIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 3468999999999999999998632 258999886321 122346688999999999999999999987
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
... .+..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++||+|||||
T Consensus 96 ~~~-------------------~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dik 155 (298)
T 3f66_A 96 LRS-------------------EGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLA 155 (298)
T ss_dssp CCS-------------------SSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EcC-------------------CCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence 543 23458999999999999999643 4568999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPD 309 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~ 309 (390)
|+|||++.++.+||+|||++....... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||..
T Consensus 156 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 156 ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999997543221 22334567889999999998899999999999999999999 6677877
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
....+....+. .+.....+..+|+.+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 236 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp SCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 77666665553 455666788899999999999999999999999999999999987554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=348.34 Aligned_cols=260 Identities=30% Similarity=0.532 Sum_probs=215.6
Q ss_pred CccccccccccCceEEEEEEE--CCc---eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQ---EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
.|++.++||+|+||.||+|.+ +++ .||+|+++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 356679999999999999986 222 79999986321 12234678899999999999999999999865
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ...++||||+.+|+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+
T Consensus 94 ~~-------------------~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~ 153 (298)
T 3pls_A 94 PE-------------------GLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAAR 153 (298)
T ss_dssp SS-------------------SCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CC-------------------CCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc
Confidence 43 223789999999999999965 3456899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCC----CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQN----PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLS 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~ 311 (390)
|||++.++.+||+|||+++..... ........+|+.|+|||.+.+..++.++|||||||++|+|++| .+||...+
T Consensus 154 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp GEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 999999999999999999743321 2223345678999999999999999999999999999999995 45566666
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
..+.... .........+..+++.+.++|.+||+.||.+|||+.++++.|+.+..+..+
T Consensus 234 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 234 PFDLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp GGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHH-hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 6665544 455556677888999999999999999999999999999999999876653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=368.00 Aligned_cols=260 Identities=33% Similarity=0.586 Sum_probs=209.1
Q ss_pred CccccccccccCceEEEEEEEC---C--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 82 KLDMRNLIAQGTYGSVYRGTYD---N--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
.|++.+.||+|+||.||+|++. + ..||||.++.... ......+.+|+.++++++||||+++++++..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--------SHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 4778899999999999999862 2 3689998863211 1224678899999999999999999998754
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. .+..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 162 ~-------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 221 (373)
T 3c1x_A 162 S-------------------EGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221 (373)
T ss_dssp C-------------------SSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred C-------------------CCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchh
Confidence 2 23458899999999999999643 356899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLS 311 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~ 311 (390)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+
T Consensus 222 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp GEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred eEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 9999999999999999997543221 11233457889999999999999999999999999999999 788898877
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCCC
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~ 370 (390)
..+....+ ..+.+...|..+|+.+.++|.+||..||++|||+.++++.|+.+..+..+
T Consensus 302 ~~~~~~~~-~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 302 TFDITVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp SSCHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 77766555 44556677888999999999999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.48 Aligned_cols=259 Identities=24% Similarity=0.555 Sum_probs=212.9
Q ss_pred ccccCccccccccccCceEEEEEEE--CCce----EEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQE----VAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.++..... .....+.+|+.+++.++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--------KANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--------CCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--------HHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 4457899999999999999999987 4554 477766532211 1135678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++... ..++|++|+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~---------------------~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 141 (327)
T 3lzb_A 84 GICLTS---------------------TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR 141 (327)
T ss_dssp EEEESS---------------------SEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEecC---------------------CceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCC
Confidence 998743 247899999999999999654 3569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 142 Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998643322 22233456889999999999999999999999999999999 999999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
+.+..+....+ ........+..++.++.+||.+||..||.+|||+.++++.|+.+...
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 222 GIPASEISSIL-EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCGGGHHHHH-HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 98877766544 55666777888999999999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=354.15 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=202.7
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK 74 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-------cchHHHHHHHHHHHHHHhCCCCCccchhheeecC
Confidence 36899999999999999999988 47899999986332 1223346678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 75 ~--------------------~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~N 132 (311)
T 4agu_A 75 R--------------------RLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPEN 132 (311)
T ss_dssp T--------------------EEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred C--------------------eEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhh
Confidence 3 44889999999999998743 3569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.+||+|||++..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 133 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 133 ILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp EEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999866544444455679999999999976 67899999999999999999999999998877665
Q ss_pred HHHHHc-------------------CCCCCCC----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQ-------------------NLRPEIP----------RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~-------------------~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+... ......+ ..++.++.+||.+||+.||.+|||+.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 544321 0011111 3578889999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=361.33 Aligned_cols=246 Identities=22% Similarity=0.400 Sum_probs=207.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||++.+ +++.||||+++.... ...+|++++.++ +||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------------DPTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------------CCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------------ChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 36799999999999999999988 578999999974321 124688888888 89999999999975
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 88 ~~--------------------~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~ 145 (342)
T 2qr7_A 88 GK--------------------YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145 (342)
T ss_dssp SS--------------------EEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CC--------------------EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHH
Confidence 43 44889999999999999954 356999999999999999999999999999999999
Q ss_pred CEEECCC----CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---
Q 036382 237 NMLLDSQ----RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPD--- 309 (390)
Q Consensus 237 NILl~~~----~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~--- 309 (390)
|||+..+ +.+||+|||++.............++|+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 9998543 359999999998665544445567899999999999888899999999999999999999999975
Q ss_pred CChhhHHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 310 LSFADVSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+..++...+....+... .+..+++++.+||.+||..||++|||+.+++++
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 355666666665554432 346789999999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=380.83 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=214.6
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+..++|++.+.||+|+||.||+|++ +|+.||||+++.. ..........+.+|+.+|+.++||||+++++++.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~------~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK------RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhH------hhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 5678899999999999999999988 6889999998621 1111222356789999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..|+||||+.||+|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 255 ~~~--------------------~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP 314 (576)
T 2acx_A 255 TKD--------------------ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314 (576)
T ss_dssp CSS--------------------EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred eCC--------------------EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch
Confidence 544 348899999999999999765555699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLS---- 311 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---- 311 (390)
+|||++.+|++||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 315 eNILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~ 393 (576)
T 2acx_A 315 ENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393 (576)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC
T ss_pred heEEEeCCCCeEEEecccceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh
Confidence 9999999999999999999865432 23345689999999999999999999999999999999999999998753
Q ss_pred hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
..++...+.. ....++..+++++.+||.+||+.||.+|| ++.+|+++
T Consensus 394 ~~~i~~~i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 394 REEVERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHhhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 2333333332 34557788999999999999999999999 78888854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=350.94 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=188.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +++.||||+++.. ..........+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK------AMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehh------hhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 46799999999999999999987 6889999998621 111122246688999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++||||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 84 --------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 142 (278)
T 3cok_A 84 --------------------NYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN 142 (278)
T ss_dssp --------------------SEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGG
T ss_pred --------------------CeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3458899999999999999643 3569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||++..............+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 143 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (278)
T 3cok_A 143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222 (278)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred EEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH
Confidence 99999999999999999865433333344678999999999999899999999999999999999999998776555444
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+... ....|..++.++.++|.+||..||++|||+.++++
T Consensus 223 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 223 KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 33222 23467778999999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.78 Aligned_cols=264 Identities=32% Similarity=0.575 Sum_probs=204.0
Q ss_pred CcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHH--HHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAV--WQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~ 151 (390)
.++.++.++|++.+.||+|+||.||+|+++++.||||+++... ...+..|.++ ++.++||||++++
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~ 73 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFI 73 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhhe
Confidence 3466788999999999999999999999999999999986321 1223334444 4458999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK----- 226 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----- 226 (390)
+.+..... .....+++||||+++|+|.+++... ..++..++.++.||+.||.|||+.
T Consensus 74 ~~~~~~~~---------------~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~ 135 (336)
T 3g2f_A 74 VGDERVTA---------------DGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGD 135 (336)
T ss_dssp EEEEEECT---------------TSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred eccccccc---------------CCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence 87643211 1234568999999999999999543 368999999999999999999999
Q ss_pred ----CCcccCCCCCCEEECCCCcEEEeecccceeccCC--------CCCCCCCCCCCccccccccCC-------CCCCCc
Q 036382 227 ----KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN--------PRDMTGETGTLGYMAPEVLQG-------KPYNRR 287 (390)
Q Consensus 227 ----~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~ 287 (390)
||+||||||+|||++.++.+||+|||++...... ........||+.|+|||++.+ ..++.+
T Consensus 136 ~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 136 HYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp GCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred ccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 9999999999999999999999999999754322 122234579999999999987 456678
Q ss_pred hhHHHHHHHHHHHHhCCCCCCC-CC-----------------hhhHHHHHHHcCCCCCCCCC------CcHHHHHHHHHh
Q 036382 288 CDVYSFGICLWEIYCCDMPYPD-LS-----------------FADVSSAVVRQNLRPEIPRC------CPSSLANIMRKC 343 (390)
Q Consensus 288 ~DiwSlG~il~ell~g~~Pf~~-~~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~c 343 (390)
+|||||||++|||++|..||.. .. ..+....+.....++.+|.. +++++.+||.+|
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHH
Confidence 9999999999999999776532 11 11222222234445555554 345899999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 344 WDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 344 l~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|+.||++|||+.++++.|+.+...
T Consensus 296 l~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 296 WDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp SCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCChhhCcchHHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=356.33 Aligned_cols=263 Identities=29% Similarity=0.527 Sum_probs=217.0
Q ss_pred cccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
..++..++|++.+.||+|+||.||+|++ +++.||||+++... . ......+.+|+.++++++||||
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~~i 95 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----S----EQDELDFLMEALIISKFNHQNI 95 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----C----HHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----c----hhhHHHHHHHHHHHhhCCCCCC
Confidence 3467778999999999999999999984 45689999986221 1 1123467889999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHH
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-----KKLALKIVIQLALDLSRGLSY 222 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~y 222 (390)
+++++++.+.. ..|+||||+++++|.+++..... ..+++..++.++.||+.||.|
T Consensus 96 v~~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 155 (327)
T 2yfx_A 96 VRCIGVSLQSL--------------------PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155 (327)
T ss_dssp CCEEEEECSSS--------------------SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEcCCC--------------------CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999987543 34789999999999999976432 458999999999999999999
Q ss_pred HHhCCCcccCCCCCCEEECC---CCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 036382 223 LHSKKIVHRDVKTENMLLDS---QRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297 (390)
Q Consensus 223 LH~~~iiHrDlkp~NILl~~---~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 297 (390)
||++||+||||||+|||++. +..+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 156 LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235 (327)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHH
Confidence 99999999999999999984 4569999999987433221 112234578899999999888999999999999999
Q ss_pred HHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 298 WEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 298 ~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
|+|++ |..||......+....+. .+.....+..++..+.++|.+||..||.+|||+.+|++.|+.+..
T Consensus 236 ~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 236 WEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 99998 999999888777666554 445666788899999999999999999999999999999998865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=365.41 Aligned_cols=250 Identities=19% Similarity=0.328 Sum_probs=213.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 46899999999999999999988 57899999986321 11234678999999999999999999999754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 121 ~--------------------~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N 179 (387)
T 1kob_A 121 Y--------------------EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179 (387)
T ss_dssp S--------------------EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred C--------------------EEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHH
Confidence 3 458899999999999998543 3469999999999999999999999999999999999
Q ss_pred EEECC--CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLDS--QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~--~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||++. ++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 180 Ill~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 258 (387)
T 1kob_A 180 IMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258 (387)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred eEEecCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence 99974 478999999999865432 222335799999999999999999999999999999999999999999888887
Q ss_pred HHHHHHcCCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+...... ......+++++.+||.+||..||.+|||+.+++++
T Consensus 259 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 7777665433 23445789999999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=358.98 Aligned_cols=255 Identities=20% Similarity=0.334 Sum_probs=207.6
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC--CccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH--PNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~ 152 (390)
..+..++|++.+.||+|+||.||++.+ +++.||||+++.... .......+.+|+.+++.++| |||+++++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 76 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-------chHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence 456677899999999999999999987 567899999974321 12234678899999999976 99999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+|||+ .+++|.+++.+ ...+++..+..++.||+.||.|||++||+|||
T Consensus 77 ~~~~~~--------------------~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrD 133 (343)
T 3dbq_A 77 YEITDQ--------------------YIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133 (343)
T ss_dssp EEECSS--------------------EEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred eEeeCC--------------------EEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 987543 45889994 57899999965 35699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCC-----------CCCCCchhHHHHHHHHHH
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQG-----------KPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~e 299 (390)
|||+|||++ ++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 134 ikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~e 212 (343)
T 3dbq_A 134 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212 (343)
T ss_dssp CCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHH
T ss_pred CCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHH
Confidence 999999996 68899999999986543221 2234679999999999854 678899999999999999
Q ss_pred HHhCCCCCCCCC-hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 300 IYCCDMPYPDLS-FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 300 ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
|++|..||.... .......+.........|..++.++.+||.+||..||.+|||+.+++++-
T Consensus 213 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 999999998753 33444555556667778888899999999999999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=365.94 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=198.8
Q ss_pred ccCcccc-ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHH-hcCCCccceEEEEEe
Q 036382 80 LSKLDMR-NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ-KLDHPNVTKFVGASV 155 (390)
Q Consensus 80 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~ 155 (390)
.++|.+. +.||+|+||.||++.+ +++.||||+++.. ..+.+|+.++. ..+||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 4677776 6899999999999988 5789999998621 23567888875 458999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... ......|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||
T Consensus 126 ~~~----------------~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 189 (400)
T 1nxk_A 126 NLY----------------AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189 (400)
T ss_dssp EEE----------------TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ecc----------------cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCc
Confidence 411 0123458999999999999999765555799999999999999999999999999999999
Q ss_pred CCEEECC---CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 236 ENMLLDS---QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 236 ~NILl~~---~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
+|||++. ++.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 190 ~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 190 ENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999988 789999999999854432 234457899999999999999999999999999999999999999976543
Q ss_pred hh----HHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 313 AD----VSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 313 ~~----~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
.. ....+....+.... ...++.++.+||.+||..||++|||+.+++++-.
T Consensus 269 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 22 33444444443332 2568999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=348.99 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=216.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc------cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 46799999999999999999998 478999999863221 1123346788999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 88 ~--------------------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 145 (294)
T 2rku_A 88 D--------------------FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 145 (294)
T ss_dssp S--------------------EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred C--------------------EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 3 458899999999999998653 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||++..............+|+.|+|||++.+..++.++||||||+++|+|++|..||......+...
T Consensus 146 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 225 (294)
T 2rku_A 146 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 225 (294)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999866544444455679999999999999999999999999999999999999999988777766
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+... ....|..+++.+.++|.+||+.||++|||+.++++.
T Consensus 226 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 226 RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 65443 345677889999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=352.83 Aligned_cols=261 Identities=28% Similarity=0.362 Sum_probs=207.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGA 153 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~ 153 (390)
..++|++.+.||+|+||.||+|++ +++.||||+++.......... ....+.+|+.+++.+ +||||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG----LPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC----CCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc----cchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 356899999999999999999986 688999999864321111000 012344667666665 59999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.....- .....++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||
T Consensus 83 ~~~~~~~---------------~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 146 (308)
T 3g33_A 83 CATSRTD---------------REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 146 (308)
T ss_dssp EEECCSS---------------SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eeccCCC---------------CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 8754311 1224689999997 59999997765556999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||+|||++.++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 147 kp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 147 KPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp CTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999754332 2334467899999999999999999999999999999999999999998888
Q ss_pred hHHHHHHHcCCCCC-------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPE-------------------------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+......+. ....+++++.+||.+||+.||++|||+.+++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 87766654211110 113567899999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=352.40 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=206.7
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|.+ +++.||||+++... .........+.+|+.+++.++||||+++++++.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL------SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG------GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc------ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 357899999999999999999987 57899999986321 1223345678899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 106 ~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 163 (309)
T 2h34_A 106 DG--------------------QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163 (309)
T ss_dssp TT--------------------EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CC--------------------eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChH
Confidence 43 448899999999999999653 46999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 164 NILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp GEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred HEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 9999999999999999987543322 223345789999999999999999999999999999999999999988766544
Q ss_pred HHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHhcC
Q 036382 316 SSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRP-EMGEVVKMLEAIDTSK 368 (390)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~~~~ 368 (390)
... ....... ..+..+|+++.++|.+||..||++|| |++++++.|+.+....
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 244 GAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHH-HHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHH-hccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 333 3333221 34567899999999999999999999 9999999999876443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=357.44 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=195.0
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
-.++|++.+.||+|+||.||+|++ +++.||||+++... ..+.+.+|+.++++++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----------DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----------hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 346799999999999999999998 46789999997321 12457789999999999999999999975
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 120 ~~--------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 177 (349)
T 2w4o_A 120 PT--------------------EISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177 (349)
T ss_dssp SS--------------------EEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CC--------------------eEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcc
Confidence 43 45889999999999999954 356999999999999999999999999999999999
Q ss_pred CEEECC---CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLLDS---QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~---~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 178 NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 178 NLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp GEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred cEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 999975 899999999999754332 2234467999999999999999999999999999999999999999876555
Q ss_pred h-HHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 D-VSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~-~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+ ....+....... +....++.++.+||.+||..||++|||+.++++.
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4 444454443322 2335689999999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=346.50 Aligned_cols=252 Identities=22% Similarity=0.420 Sum_probs=216.1
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+..++|++.+.||+|+||.||+|++ +++.||||++... ..........+.+|+++++.++||||+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS------QLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccc------ccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 34567899999999999999999988 4678999998521 111122245688999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+. ...++||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+|||||
T Consensus 84 ~~~--------------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 141 (284)
T 2vgo_A 84 HDR--------------------KRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIK 141 (284)
T ss_dssp ECS--------------------SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred EcC--------------------CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 754 3458899999999999999654 469999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.++.+||+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 142 PENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp GGGEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred HHHEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 99999999999999999998754332 2334678999999999999999999999999999999999999999888877
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+... ....|..++.++.++|.+||..||.+|||+.+++++
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 220 THRRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 77666543 345778889999999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=365.57 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=209.8
Q ss_pred CcccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.++.+..++|++.+.||+|+||.||+|.+ +++.||||+++..... .....+.+|+.+++.++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--------GGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--------hHHHHHHHHHHHHHhccCCCccceEE
Confidence 45667778999999999999999999987 5789999998643211 11125789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSK---K 227 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~---~ 227 (390)
++.+.. ..++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++ |
T Consensus 95 ~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 154 (326)
T 3uim_A 95 FCMTPT--------------------ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154 (326)
T ss_dssp EECCSS--------------------CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred EEecCC--------------------ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 987543 3478999999999999996543 33499999999999999999999999 9
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 155 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 234 (326)
T 3uim_A 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234 (326)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCS
T ss_pred eEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCc
Confidence 9999999999999999999999999998654322 223345699999999999888899999999999999999999999
Q ss_pred CCCC----ChhhHHHHHHHcC-------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 307 YPDL----SFADVSSAVVRQN-------------LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 307 f~~~----~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
|... ............. .....+...+..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 235 FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp BCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 9521 1111111111111 11122223457899999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=356.39 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=217.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL------LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 46799999999999999999988 467999999863221 1123346788999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 114 ~--------------------~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 171 (335)
T 2owb_A 114 D--------------------FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGN 171 (335)
T ss_dssp S--------------------EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred C--------------------eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchh
Confidence 3 458899999999999998653 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||++..............+|+.|+|||++.+..++.++|||||||++|+|++|..||......+...
T Consensus 172 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 251 (335)
T 2owb_A 172 LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251 (335)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 99999999999999999866544444455679999999999999899999999999999999999999999888777776
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+.... ...+..+++++.+||.+||+.||++|||+.++++.
T Consensus 252 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 252 RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 665543 34677889999999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=359.82 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=209.3
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|++ .++|++.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++||||++++
T Consensus 19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~ 90 (367)
T 1cm8_A 19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMRHENVIGLL 90 (367)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-------SHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-------CHHHHHHHHHHHHHHHhCCCcCCCCce
Confidence 34555 36899999999999999999987 588999999853211 122346678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++....... .....|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||
T Consensus 91 ~~~~~~~~~~--------------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~ 152 (367)
T 1cm8_A 91 DVFTPDETLD--------------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR 152 (367)
T ss_dssp EEECSCSSTT--------------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred eeEecCCccc--------------cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9987543221 224568999999 7899999854 459999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 153 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 153 DLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcCHHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999986543 2345678999999999877 67999999999999999999999999988
Q ss_pred ChhhHHHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH-
Q 036382 311 SFADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM- 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~- 360 (390)
+..+.+..+......+ .....+++++.+||.+||..||.+|||+.+++++
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 8777665554321111 1234568999999999999999999999999873
Q ss_pred -HHHhH
Q 036382 361 -LEAID 365 (390)
Q Consensus 361 -L~~~~ 365 (390)
++.+.
T Consensus 310 ~f~~~~ 315 (367)
T 1cm8_A 310 YFESLH 315 (367)
T ss_dssp GGTTTC
T ss_pred HHHhhc
Confidence 44443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=358.35 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=198.5
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
...++|++.+.||+|+||.||+|.+ +++.||||+++.... .......+.+|+.++++++||||+++++++.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-------EEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-------ccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3457899999999999999999987 678999999964321 1223456678999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..|+||||+.+ +|.+++.+. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 104 ~~~--------------------~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp 160 (329)
T 3gbz_A 104 HNH--------------------RLHLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKP 160 (329)
T ss_dssp ETT--------------------EEEEEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCC--------------------EEEEEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCH
Confidence 543 44889999974 999999653 4699999999999999999999999999999999
Q ss_pred CCEEEC-----CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 036382 236 ENMLLD-----SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPD 309 (390)
Q Consensus 236 ~NILl~-----~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~ 309 (390)
+|||++ ..+.+||+|||+++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 999994 45569999999998655444445556789999999999874 589999999999999999999999999
Q ss_pred CChhhHHHHHHHcCCCCC----------------C------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 310 LSFADVSSAVVRQNLRPE----------------I------------PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+..+....+......+. . +..+++++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 888777766654211111 0 0116789999999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=361.63 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=204.9
Q ss_pred cccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccc
Q 036382 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 161 (390)
...+.||+|+||.||+|.+ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 159 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---------MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN--- 159 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence 3367899999999999987 57899999997321 112356889999999999999999999997543
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEE-
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL- 240 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl- 240 (390)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 160 -----------------~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 221 (373)
T 2x4f_A 160 -----------------DIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCV 221 (373)
T ss_dssp -----------------EEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred -----------------EEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEe
Confidence 458899999999999998653 3469999999999999999999999999999999999999
Q ss_pred -CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 241 -DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 241 -~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
+.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 222 ~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 300 (373)
T 2x4f_A 222 NRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300 (373)
T ss_dssp ETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56789999999999865433 2334467999999999999999999999999999999999999999999888888877
Q ss_pred HHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 320 VRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 320 ~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
........ ....+++++.+||.+||..||.+|||+.++++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 76554332 23568999999999999999999999999997
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=351.31 Aligned_cols=258 Identities=29% Similarity=0.473 Sum_probs=207.2
Q ss_pred ccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
|...+.||+|+||.||+|.++++.||||++....... .......+.+|+.+++.++||||+++++++.+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 103 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT-----TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD---- 103 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSC-----TTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcc-----hHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC----
Confidence 4556899999999999999999999999986432111 1123466889999999999999999999987543
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEEC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~ 241 (390)
..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 104 ----------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 104 ----------------DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167 (307)
T ss_dssp ----------------SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ----------------ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc
Confidence 3478999999999999996432 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 036382 242 SQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAV 319 (390)
Q Consensus 242 ~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (390)
.++.+||+|||++........ ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999976543221 1233578999999999876 4889999999999999999999999775433322111
Q ss_pred H---Hc----------CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 320 V---RQ----------NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 320 ~---~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
. .. ......+..++..+.+++.+||..||.+|||+.+|++.|+.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1 11 11112233456789999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=370.45 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=203.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-------ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 57899999999999999999987 5789999999632 11223346678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... ......|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 134 ~~~--------------~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~N 194 (464)
T 3ttj_A 134 KTL--------------EEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194 (464)
T ss_dssp CST--------------TTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred Ccc--------------ccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHh
Confidence 322 123567999999976 5777663 249999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||+++.... ....+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 195 Ill~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 195 IVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp EEECTTSCEEECCCCCC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeCCCCEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999999986543 233455789999999999999999999999999999999999999999988777766
Q ss_pred HHHHcCCCC--------------------CC---------CCC-----------CcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNLRP--------------------EI---------PRC-----------CPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~~~--------------------~~---------~~~-----------~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+......+ .. +.. .++++.+||.+||..||++|||+.++
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 654321110 00 000 15679999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+++
T Consensus 354 L~H 356 (464)
T 3ttj_A 354 LQH 356 (464)
T ss_dssp HTS
T ss_pred hcC
Confidence 864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=344.76 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=219.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++................+.+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999988 57899999997554333333444556678899999999995 9999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ...++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 96 ~--------------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 153 (298)
T 1phk_A 96 N--------------------TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 153 (298)
T ss_dssp S--------------------SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred C--------------------CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 3 3458899999999999999653 46999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||++.++.+||+|||++...... .......+|+.|+|||++. ...++.++||||||+++|+|++|..||...
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999999999999999999865432 2334567899999999984 456889999999999999999999999998
Q ss_pred ChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+..+....+.........+ ..++.++.++|.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 8888777776665544333 468899999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=351.47 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=214.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +|+.||||+++......... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc---chhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35799999999999999999988 57899999997543321110 00135678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 88 --------------------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~N 145 (321)
T 2a2a_A 88 --------------------TDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (321)
T ss_dssp --------------------SEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred --------------------CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHH
Confidence 345889999999999999954 3568999999999999999999999999999999999
Q ss_pred EEECCCC----cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 238 MLLDSQR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 238 ILl~~~~----~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||++.++ .+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 146 Il~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 224 (321)
T 2a2a_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (321)
T ss_dssp EEESCTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred EEEecCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999888 7999999999865432 2334567999999999999999999999999999999999999999998888
Q ss_pred hHHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+....+....... ..+..++..+.+||.+||..||++|||+.++++
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8777765443322 123568899999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=345.87 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=201.8
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+++..++|++.+.||+|+||.||+|.+ +++.||||+++... ........+.++...++.++||||++++++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-------NSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-------CcHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 567788999999999999999999998 78899999996321 112223445556666888899999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcc
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSK-KIVH 230 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiH 230 (390)
+.+.. ..++||||+. |+|.+++.. ..+..+++..++.++.|++.||.|||++ ||+|
T Consensus 75 ~~~~~--------------------~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 133 (290)
T 3fme_A 75 LFREG--------------------DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133 (290)
T ss_dssp EECSS--------------------SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCC
T ss_pred eeccC--------------------CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence 87543 4588999997 589888754 2346799999999999999999999998 9999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCcccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL----QGKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|||||+|||++.++.+||+|||++...... .......+|+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 134 RDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCCCHHHEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999754432 223335799999999996 566789999999999999999999999
Q ss_pred CCCC-ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHh
Q 036382 307 YPDL-SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK--MLEAI 364 (390)
Q Consensus 307 f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~ 364 (390)
|... ..................+..+++++.++|.+||+.||++|||+.++++ .+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9863 4445555555555444455678999999999999999999999999997 44443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=356.45 Aligned_cols=269 Identities=25% Similarity=0.496 Sum_probs=218.1
Q ss_pred CCCCcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 71 RPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 71 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
....+|+++.++|++.+.||+|+||.||+|.+.+ .||+|+++........ ...+.+|+.++++++||||+++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ-------LKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC-------CCCCCTTGGGGTTCCCTTBCCC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH-------HHHHHHHHHHHhcCCCCCEeEE
Confidence 3457899999999999999999999999999876 5999999754322111 1346689999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.+.. ..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 95 ~~~~~~~~--------------------~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 153 (319)
T 2y4i_B 95 MGACMSPP--------------------HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153 (319)
T ss_dssp CEEEECSS--------------------CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEecCC--------------------ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99987543 348899999999999999543 346999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccC-----CCCCCCCCCCCCccccccccCC---------CCCCCchhHHHHHHH
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQ-----NPRDMTGETGTLGYMAPEVLQG---------KPYNRRCDVYSFGIC 296 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~i 296 (390)
|||||+|||++ ++.+||+|||++..... .........||+.|+|||++.+ ..++.++|||||||+
T Consensus 154 ~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp CCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred cCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 99999999997 78999999999864321 1122334568999999999874 457889999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 297 LWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 297 l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+|+|++|..||...+.......+.........+..+|.++.++|.+||..||.+|||+.++++.|+.+.....
T Consensus 233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 233 WYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 9999999999999888887766655444333445688999999999999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=345.00 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=210.1
Q ss_pred cCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|++++++++||||+++++++.+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 78 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---------DVDRFKQEIEIMKSLDHPNIIRLYETFEDN- 78 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---------CHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 56999999999999999999884 568999998632211 135678999999999999999999998754
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 79 -------------------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 137 (277)
T 3f3z_A 79 -------------------TDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137 (277)
T ss_dssp -------------------SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred -------------------CeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence 3458899999999999998653 4699999999999999999999999999999999999
Q ss_pred EE---CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LL---DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|+ +.++.+||+|||++...... .......+|+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+.
T Consensus 138 l~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 215 (277)
T 3f3z_A 138 LFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215 (277)
T ss_dssp EESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99 78899999999999765432 334456799999999998765 89999999999999999999999999988888
Q ss_pred HHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+.......... ..+++.+.+||.+||+.||.+|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 87776654433221 267899999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.80 Aligned_cols=241 Identities=23% Similarity=0.410 Sum_probs=180.6
Q ss_pred cccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEeccccccc
Q 036382 86 RNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~ 162 (390)
.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+..
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~---- 79 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL---- 79 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----
Confidence 37899999999999988 4789999998621 1245668999999996 999999999997543
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
..|+||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ----------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~ 141 (325)
T 3kn6_A 80 ----------------HTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD 141 (325)
T ss_dssp ----------------EEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC
T ss_pred ----------------EEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEec
Confidence 44889999999999999965 356999999999999999999999999999999999999977
Q ss_pred CC---cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------
Q 036382 243 QR---TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF------- 312 (390)
Q Consensus 243 ~~---~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~------- 312 (390)
++ .+||+|||+++............++|+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 142 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 221 (325)
T 3kn6_A 142 ENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221 (325)
T ss_dssp ----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH
T ss_pred CCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH
Confidence 65 89999999998665544445567789999999999999999999999999999999999999976432
Q ss_pred hhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+......... ...+++++.+||.+||..||.+|||+.+++++
T Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 3444444333322111 13578999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=362.01 Aligned_cols=254 Identities=20% Similarity=0.330 Sum_probs=208.5
Q ss_pred ccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC--CCccceEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD--HPNVTKFVG 152 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~ 152 (390)
..+...+|++.+.||+|+||.||++.+ +++.||||+++.... .......+.+|+.+++.++ ||||+++++
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~ 123 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-------cHHHHHHHHHHHHHHHHcccCCCeEEEEEE
Confidence 445566799999999999999999987 478899999974322 1223467889999999996 599999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.... ..|+||| +.+++|.+++.+. ..+++..+..++.||+.||.|||++||+|||
T Consensus 124 ~~~~~~--------------------~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrD 180 (390)
T 2zmd_A 124 YEITDQ--------------------YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180 (390)
T ss_dssp EEECSS--------------------EEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred EEecCC--------------------EEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 987543 3488999 5688999999653 4689999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCC-----------CCCCCchhHHHHHHHHHH
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQG-----------KPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~e 299 (390)
|||+|||++ ++.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 181 lkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 181 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp CCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 999999995 68999999999986543221 2344679999999999865 368899999999999999
Q ss_pred HHhCCCCCCCCC-hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 300 IYCCDMPYPDLS-FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 300 ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
|++|..||.... .......+.........|...+.++.+||.+||..||.+|||+.++++.
T Consensus 260 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 260 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 999999998753 3445556666666777788889999999999999999999999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=362.22 Aligned_cols=270 Identities=20% Similarity=0.326 Sum_probs=204.5
Q ss_pred ccccCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHH--HHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAE--TAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
+..++|++.+.||+|+||.||+|.+ ++..||||++............ .......+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 4457899999999999999999998 4578999998744321111100 01112346788999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.... ......|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 114 ~~~~~~~~----------------~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 174 (345)
T 2v62_A 114 YGSGLTEF----------------KGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVH 174 (345)
T ss_dssp EEEEEEES----------------SSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred eccccccc----------------CCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 99987531 1234568999999 99999999543 37999999999999999999999999999
Q ss_pred cCCCCCCEEECCCC--cEEEeecccceeccCCC-------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHH
Q 036382 231 RDVKTENMLLDSQR--TLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 231 rDlkp~NILl~~~~--~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 301 (390)
|||||+|||++.++ .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999998887 99999999997543221 1123457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHcCCCCCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 302 CCDMPYPDLSFADVSSAVVRQNLRPEIP---------RCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 302 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+|..||.....................+ ..+|+++.++|.+||..||++|||+.+|++.|+.+..
T Consensus 255 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 255 CGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred hCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 9999996532211111111111112222 2688999999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.99 Aligned_cols=260 Identities=31% Similarity=0.553 Sum_probs=207.4
Q ss_pred cccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc--CCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL--DHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~ 156 (390)
-.++|++.+.||+|+||.||+|+++++.||||++... . ...+..|.+++..+ +||||+++++++..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT-------E-----EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG-------G-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc-------c-----cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3468999999999999999999999999999998521 1 12334556665554 99999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK--------KI 228 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~i 228 (390)
... .....++||||+.+|+|.+++.. ..+++..++.++.|++.||.|||++ ||
T Consensus 103 ~~~----------------~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 103 GTG----------------SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp SCG----------------GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred CCC----------------CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 421 11456899999999999999954 3599999999999999999999999 99
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCCCC----CCCCCCCCccccccccCCCCCCCc------hhHHHHHHHHH
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD----MTGETGTLGYMAPEVLQGKPYNRR------CDVYSFGICLW 298 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~ 298 (390)
+||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+..++.. +|||||||++|
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 99999999999999999999999999754332221 124579999999999988776665 99999999999
Q ss_pred HHHhC----------CCCCCCCC-----hhhHHHHHHHcCCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 299 EIYCC----------DMPYPDLS-----FADVSSAVVRQNLRPEIPR-----CCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 299 ell~g----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
||++| ..||.... .......+.....++..+. .+++++.+||.+||+.||.+|||+.+|+
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 99999 77775532 2233333333445555553 5678899999999999999999999999
Q ss_pred HHHHHhHhcCC
Q 036382 359 KMLEAIDTSKG 369 (390)
Q Consensus 359 ~~L~~~~~~~~ 369 (390)
+.|+.+..+..
T Consensus 324 ~~L~~l~~~~~ 334 (337)
T 3mdy_A 324 KTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHTTT
T ss_pred HHHHHHHhhcc
Confidence 99999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=372.61 Aligned_cols=250 Identities=28% Similarity=0.491 Sum_probs=212.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++..... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-------NKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-------chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 36799999999999999999988 5889999998522110 11135678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 94 ~--------------------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 151 (486)
T 3mwu_A 94 S--------------------SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151 (486)
T ss_dssp S--------------------EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred C--------------------EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHH
Confidence 3 458899999999999998654 469999999999999999999999999999999999
Q ss_pred EEEC---CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLD---SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~---~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++ .++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+
T Consensus 152 il~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 229 (486)
T 3mwu_A 152 ILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (486)
T ss_dssp EEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9995 4567999999999754432 33445679999999999976 49999999999999999999999999999988
Q ss_pred HHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+....+....+ ..+++++.+||.+||..||.+|||+.+++++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 888887766554443 4688999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=356.45 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=209.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.... ..........+.+|+.+++.++||||+++++++.+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI----RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH----HC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhh----cccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 35799999999999999999988 567999999862110 000122346788999999999999999999999754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-------------------------------------
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR------------------------------------- 200 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------- 200 (390)
. ..|+||||+++|+|.+++....
T Consensus 101 ~--------------------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (345)
T 3hko_A 101 Q--------------------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160 (345)
T ss_dssp S--------------------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEE
T ss_pred C--------------------eEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 3 4588999999999999984210
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC--cEEEeecccceeccCCC----CCCCCCCCCCcc
Q 036382 201 -RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR--TLKIADFGVARVEAQNP----RDMTGETGTLGY 273 (390)
Q Consensus 201 -~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~--~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y 273 (390)
...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... .......+|+.|
T Consensus 161 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 161 LDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence 12246788999999999999999999999999999999998776 89999999998543211 123456799999
Q ss_pred ccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhhCCC
Q 036382 274 MAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPR--CCPSSLANIMRKCWDANAE 349 (390)
Q Consensus 274 ~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~ 349 (390)
+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.........+. .+++++.+||.+||+.||.
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999975 6789999999999999999999999999999888888877665544433 4789999999999999999
Q ss_pred CCCCHHHHHHH
Q 036382 350 KRPEMGEVVKM 360 (390)
Q Consensus 350 ~Rpt~~~ll~~ 360 (390)
+|||+.++++.
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=345.74 Aligned_cols=250 Identities=29% Similarity=0.466 Sum_probs=217.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.+.||+|+||.||+|.+ +++.||||+++..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--------TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--------HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 5699999999999999999987 5789999999744321 11356789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 94 --------------------~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 150 (303)
T 3a7i_A 94 --------------------KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150 (303)
T ss_dssp --------------------EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred --------------------eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence 34889999999999999843 4699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++..............+|+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 151 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 230 (303)
T 3a7i_A 151 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230 (303)
T ss_dssp EECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH
Confidence 99999999999999998665444444556799999999999999999999999999999999999999998887776655
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
+. ....+..+..++..+.+||.+||..||.+|||+.++++...
T Consensus 231 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 231 IP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HH-HSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred hh-cCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 54 34456677889999999999999999999999999998644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=355.42 Aligned_cols=271 Identities=22% Similarity=0.319 Sum_probs=215.1
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+.+.++.++|++.+.||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++||||++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~ 92 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---------QQDREEAQREADMHRLFNHPNILRLV 92 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---------HHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 45667788999999999999999999986 68899999986321 12346678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++..... .....++||||+.+|+|.+++... .+..+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~----------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 156 (317)
T 2buj_A 93 AYCLRERG----------------AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156 (317)
T ss_dssp EEEEEEET----------------TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEeccC----------------CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99863211 133568999999999999999653 345699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCC---------CCCCCCCCCccccccccCCCC---CCCchhHHHHHHHH
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---------DMTGETGTLGYMAPEVLQGKP---YNRRCDVYSFGICL 297 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il 297 (390)
||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+.. ++.++|||||||++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875321110 011234689999999997654 68999999999999
Q ss_pred HHHHhCCCCCCCCCh-hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 298 WEIYCCDMPYPDLSF-ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 298 ~ell~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|+|++|..||..... .+............+.+..++.++.++|.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 237 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred HHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 999999999954211 111222233444555566789999999999999999999999999999999875443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=357.27 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=200.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +++.||||+++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--------cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 6899999999999999999988 578999999863321 111123457999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+. |+|.+++... +..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 74 --------------------~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI 131 (324)
T 3mtl_A 74 --------------------SLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131 (324)
T ss_dssp --------------------CEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred --------------------EEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence 4588999997 5999998654 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++.++.+||+|||++..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 132 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 211 (324)
T 3mtl_A 132 LINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211 (324)
T ss_dssp EECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999999865544444555678999999999876 568999999999999999999999999988887776
Q ss_pred HHHHcCCCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 318 AVVRQNLRPE----------------------------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+......+. .+..+++++.+||.+||+.||.+|||+.++++.
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 212 FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 6544211110 112467899999999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=341.65 Aligned_cols=253 Identities=24% Similarity=0.458 Sum_probs=207.2
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
.+..++|++.+.||+|+||.||+|.+ +++.||||+++.. ..........+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ------KIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccc------cccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 45567899999999999999999988 5889999998621 111222345788999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.+. ...++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++||+|+|||
T Consensus 81 ~~~--------------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 138 (276)
T 2h6d_A 81 STP--------------------TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138 (276)
T ss_dssp ECS--------------------SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCC
T ss_pred ecC--------------------CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 754 3458899999999999999654 469999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|+|||++.++.+||+|||++...... .......+|+.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..
T Consensus 139 p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 217 (276)
T 2h6d_A 139 PENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP 217 (276)
T ss_dssp GGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhEEECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 99999999999999999999754432 22334578999999999988765 68999999999999999999999988877
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.....+... ....|..++.++.++|.+||+.||.+|||+.+++++
T Consensus 218 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 218 TLFKKIRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 777666543 334677889999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=342.63 Aligned_cols=249 Identities=24% Similarity=0.448 Sum_probs=204.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++.+ ++..||+|++....... ..+.+.+|+++++.++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--------PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--------CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--------hHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 6799999999999999999987 57899999987432211 1356789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
..++||||+.+|+|.+++... .+..+++..++.++.|++.||.|||++||+||||||+
T Consensus 94 --------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~ 153 (285)
T 3is5_A 94 --------------------NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153 (285)
T ss_dssp --------------------EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred --------------------eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH
Confidence 458899999999999998643 2467999999999999999999999999999999999
Q ss_pred CEEE---CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLL---DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl---~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||+ +.++.+||+|||++...... .......+|+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..
T Consensus 154 NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~ 231 (285)
T 3is5_A 154 NILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231 (285)
T ss_dssp GEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 45688999999999754432 2334567999999999986 46899999999999999999999999998888
Q ss_pred hHHHHHHHcCCCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQNLRPEI-PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+.............. ...+++++.+||.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 232 EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 877666544333222 2347899999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.52 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=190.7
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|.+. ++|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+|+.++||||++++
T Consensus 47 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~ 118 (458)
T 3rp9_A 47 SDWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-------DLIDCKRILREIAILNRLNHDHVVKVL 118 (458)
T ss_dssp SSCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-------CHHHHHHHHHHHHHHHhCCCCCCCceE
Confidence 445553 6899999999999999999977 578999999863211 122346688999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++..... ......|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~---------------~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHr 180 (458)
T 3rp9_A 119 DIVIPKDV---------------EKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180 (458)
T ss_dssp EECCCSCT---------------TTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred EEEecCCc---------------ccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCC
Confidence 99864321 1234579999998 5699999854 4569999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCC---------------------------CCCCCCCCCCcccccccc-CCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNP---------------------------RDMTGETGTLGYMAPEVL-QGKP 283 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~ 283 (390)
||||+|||++.++.+||+|||+++...... ...+..+||+.|+|||++ .+..
T Consensus 181 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 260 (458)
T 3rp9_A 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260 (458)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCC
T ss_pred CCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCC
Confidence 999999999999999999999998643211 123456789999999986 5667
Q ss_pred CCCchhHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------hhHHHHHHH-----------
Q 036382 284 YNRRCDVYSFGICLWEIYC-----------CDMPYPDLSF--------------------ADVSSAVVR----------- 321 (390)
Q Consensus 284 ~~~~~DiwSlG~il~ell~-----------g~~Pf~~~~~--------------------~~~~~~~~~----------- 321 (390)
++.++|||||||++|||++ |.++|++.+. .+.+..+..
T Consensus 261 ~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~ 340 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIE 340 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHh
Confidence 9999999999999999998 6777766442 111111110
Q ss_pred -----------cCCCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 322 -----------QNLRP-------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 322 -----------~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+.. .....+++++.+||.+||..||++|||+.+++++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 341 ALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 0123458899999999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.47 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=207.9
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-----CCcc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-----HPNV 147 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnI 147 (390)
...+-.++|++.+.||+|+||.||+|++ +++.||||+++.. ......+..|+.+++.+. ||||
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----------KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----------HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----------hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3445567899999999999999999998 6789999998621 112345678999999996 9999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
+++++++.... ..|+||||+ +++|.+++.+.....+++..+..++.||+.||.|||++|
T Consensus 99 v~~~~~~~~~~--------------------~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 157 (360)
T 3llt_A 99 VKYHGKFMYYD--------------------HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS 157 (360)
T ss_dssp CCEEEEEEETT--------------------EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecccceeeECC--------------------eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999987543 448899999 899999998766567999999999999999999999999
Q ss_pred CcccCCCCCCEEECC-------------------------CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC
Q 036382 228 IVHRDVKTENMLLDS-------------------------QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK 282 (390)
Q Consensus 228 iiHrDlkp~NILl~~-------------------------~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 282 (390)
|+||||||+|||++. ++.+||+|||++...... .....||+.|+|||++.+.
T Consensus 158 ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 234 (360)
T 3llt_A 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNL 234 (360)
T ss_dssp EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTC
T ss_pred eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCC
Confidence 999999999999975 789999999999864432 2346789999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCC------------------------CCC--------
Q 036382 283 PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPE------------------------IPR-------- 330 (390)
Q Consensus 283 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------------~~~-------- 330 (390)
.++.++|||||||++|+|++|..||...+..+....+.......+ .|.
T Consensus 235 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 314 (360)
T 3llt_A 235 GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314 (360)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHH
T ss_pred CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhh
Confidence 999999999999999999999999998877766655433211100 111
Q ss_pred ------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 331 ------------CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 331 ------------~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..++.+.+||.+||+.||.+|||+.++++
T Consensus 315 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 12367889999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=371.52 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=211.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ ++..||||+++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-------SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-------hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 4699999999999999999998 57899999997432111 11356789999999999999999999997543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 110 --------------------~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 167 (494)
T 3lij_A 110 --------------------NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167 (494)
T ss_dssp --------------------EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred --------------------EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhE
Confidence 458899999999999998654 4699999999999999999999999999999999999
Q ss_pred EECCC---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|++.. +.+||+|||++...... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 168 l~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 168 LLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp EESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99764 55999999999865433 3345578999999999986 4699999999999999999999999999999998
Q ss_pred HHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 036382 316 SSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAI 364 (390)
Q Consensus 316 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~ 364 (390)
...+....+....+ ..+++++.+||.+||+.||.+|||+.+++++ +...
T Consensus 246 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 88887766554433 5689999999999999999999999999964 4444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=354.46 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=204.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +|+.||||+++..... .........+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS----EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc----hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 46899999999999999999987 5789999999643211 11112234677999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 85 ~--------------------~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 142 (346)
T 1ua2_A 85 S--------------------NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 142 (346)
T ss_dssp T--------------------CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred C--------------------ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHH
Confidence 3 34789999986 899888543 3568999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.+||+|||+++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+..
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 143 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp EEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999999999998665444455567899999999999764 5899999999999999999999999998887777
Q ss_pred HHHHHcCCCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLRPE--------------------------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+......+. ....+++++.+||.+||..||.+|||+.+++++
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 66654211110 014567899999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=353.50 Aligned_cols=264 Identities=26% Similarity=0.513 Sum_probs=217.1
Q ss_pred ccccccCccccccccccCceEEEEEEE------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
..+..++|++.+.||+|+||.||++++ +++.||||+++... ......+.+|+.+++.++||||++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~ 106 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------EEHLRDFEREIEILKSLQHDNIVK 106 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---------SHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCCeee
Confidence 345667899999999999999999985 57899999987421 122456889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.... ....++||||+++++|.+++.+. ...+++..++.++.|++.||.|||++||+
T Consensus 107 ~~~~~~~~~------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 167 (326)
T 2w1i_A 107 YKGVCYSAG------------------RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYI 167 (326)
T ss_dssp EEEEECC----------------------CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEEecC------------------CCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 999986432 22458999999999999999654 34699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
||||||+|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 168 H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999986543321 12234577889999999888899999999999999999999999
Q ss_pred CCCCChh---------------hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 307 YPDLSFA---------------DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 307 f~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|...... ..+...+..+.+.+.+..+|+++.++|.+||..||++|||+.+|++.|+.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp GGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 8643110 112233445556677888999999999999999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=353.72 Aligned_cols=255 Identities=22% Similarity=0.419 Sum_probs=216.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 157 (390)
++|++.+.||+|+||.||+|.+ +|+.||||+++...... ...........+.+|+.+++++ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL-SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 5699999999999999999988 58899999997554322 2233445567788999999999 899999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 173 ~--------------------~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~N 230 (365)
T 2y7j_A 173 S--------------------FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230 (365)
T ss_dssp S--------------------EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred C--------------------EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3 458899999999999999643 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||++.++.+||+|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||...+
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999865432 2344578999999999985 3368899999999999999999999999888
Q ss_pred hhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.......+.........+ ..++.++.+||.+||..||++|||+.++++
T Consensus 310 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 887777776655443322 467899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=344.47 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=211.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.+++.++|++++..+..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----------hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 36899999999999999999986 688999999864321 12467899999999998887777666432
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 -------------------~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 135 (296)
T 3uzp_A 77 -------------------GDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp -------------------TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -------------------CCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 34458999999 89999999643 3569999999999999999999999999999999999
Q ss_pred EEEC---CCCcEEEeecccceeccCCCC-------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q 036382 238 MLLD---SQRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 238 ILl~---~~~~~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
||++ .++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 136 Il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred eEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 9994 789999999999986543322 124467999999999999999999999999999999999999999
Q ss_pred CCCC---hhhHHHHHHHcCCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 308 PDLS---FADVSSAVVRQNLRP---EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 308 ~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
.... ..+....+....... ..+..+|+++.++|.+||+.||.+|||+.+|++.|+.+....+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 216 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 8743 223333333222221 1336789999999999999999999999999999999987665
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=343.59 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=209.0
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
.+...|++.+.||+|+||.||+|.+ ++..||+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 3455689999999999999999988 567899999863221 1223567889999999999999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDV 233 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrDl 233 (390)
.... .....++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.| |+||||
T Consensus 96 ~~~~----------------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~di 157 (290)
T 1t4h_A 96 STVK----------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp EESS----------------SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred cccC----------------CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCC
Confidence 4311 234568999999999999999653 56999999999999999999999999 999999
Q ss_pred CCCCEEEC-CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 234 KTENMLLD-SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 234 kp~NILl~-~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 158 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 158 KCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred CHHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 99999997 7899999999999744322 2234568999999998875 589999999999999999999999988655
Q ss_pred hhHHHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..........+ .....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 44444444333 3334566778999999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=347.25 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=210.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||++++ +|+.||||+++.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 78 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---------FRDSSLENEIAVLKKIKHENIVTLEDIYEST- 78 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---------cchHHHHHHHHHHHhCCCCCeeehhhhcccC-
Confidence 5799999999999999999988 588999999973321 1124577999999999999999999998754
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 -------------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI 137 (304)
T 2jam_A 79 -------------------THYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137 (304)
T ss_dssp -------------------SEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred -------------------CEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3458899999999999999653 4699999999999999999999999999999999999
Q ss_pred EE---CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LL---DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|+ +.++.+||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 138 l~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 215 (304)
T 2jam_A 138 LYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215 (304)
T ss_dssp EESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99 77899999999998753321 22234589999999999999999999999999999999999999999888887
Q ss_pred HHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+....... ..+..+|+++.+||.+||..||++|||+.++++.
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 77776654433 3446789999999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=350.12 Aligned_cols=271 Identities=25% Similarity=0.398 Sum_probs=203.1
Q ss_pred CCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccce
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTK 149 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~ 149 (390)
...+++...+|++.++||+|+||.||+|++ +++.||||++.... ......+.+|+.+++++. ||||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---------EEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---------hHHHHHHHHHHHHHHHhccCCChhh
Confidence 356777778999999999999999999998 78899999885221 123456789999999995 999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN-RRKKLALKIVIQLALDLSRGLSYLHSKK- 227 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~- 227 (390)
+++++....... ......+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++|
T Consensus 91 ~~~~~~~~~~~~------------~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 157 (337)
T 3ll6_A 91 FCSAASIGKEES------------DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP 157 (337)
T ss_dssp EEEEEEECTTTS------------TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred cccccccccccc------------ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 999986432211 123455789999996 6999998652 3456999999999999999999999999
Q ss_pred -CcccCCCCCCEEECCCCcEEEeecccceeccCCCCC------------CCCCCCCCcccccccc---CCCCCCCchhHH
Q 036382 228 -IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD------------MTGETGTLGYMAPEVL---QGKPYNRRCDVY 291 (390)
Q Consensus 228 -iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Diw 291 (390)
|+||||||+|||++.++.+||+|||++......... .....+|+.|+|||++ .+..++.++|||
T Consensus 158 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~ 237 (337)
T 3ll6_A 158 PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237 (337)
T ss_dssp CCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHH
T ss_pred CEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHH
Confidence 999999999999999999999999999764432211 1134589999999998 566789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 292 SFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 292 SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
||||++|+|++|..||........ .........+..++..+.+||.+||+.||.+|||+.++++.|+.+.....
T Consensus 238 slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp HHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 999999999999999977554432 33444555566778899999999999999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=372.71 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=215.4
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
-.++|++.+.||+|+||.||+|.+ +++.||||++......... ....+.+|+.++++++||||+++++++.+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT------DKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS------CHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch------HHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 346799999999999999999988 5789999998643221111 13567899999999999999999999975
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 98 ~~--------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 155 (484)
T 3nyv_A 98 KG--------------------YFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPE 155 (484)
T ss_dssp SS--------------------EEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CC--------------------EEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence 43 45889999999999999954 356999999999999999999999999999999999
Q ss_pred CEEE---CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLL---DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl---~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..
T Consensus 156 Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 156 NLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp GEEESSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 9999 56789999999999754432 22334579999999999976 6999999999999999999999999999999
Q ss_pred hHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+....+....+ ..+++++.+||.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 9888887776655443 4689999999999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=355.01 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=205.5
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
+....++|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+++.++||||++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-------DKMVKKIAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-------chHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 344567899999999999999999988 478999999864321 12234567799999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||
T Consensus 93 ~~~~~--------------------~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 150 (331)
T 4aaa_A 93 CKKKK--------------------RWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150 (331)
T ss_dssp EEETT--------------------EEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred eecCC--------------------EEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCc
Confidence 87543 44889999999989887643 346999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||+|||++.++.+||+|||++..............+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+.
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp CGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999997655444444556799999999999875 789999999999999999999999998877
Q ss_pred hhHHHHHHHcCC-------------------C-CC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNL-------------------R-PE---------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~-------------------~-~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+..... . +. ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 766655432110 0 00 012568999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=355.37 Aligned_cols=269 Identities=21% Similarity=0.391 Sum_probs=201.7
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +++.||||+++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--------ELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 5799999999999999999988 588999999974321 112366889999999999999999999987653
Q ss_pred ccc---------cCC----------------------------cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-
Q 036382 159 NLK---------IPS----------------------------KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR- 200 (390)
Q Consensus 159 ~~~---------~~~----------------------------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~- 200 (390)
... +.. ................++||||+.+|+|.+++.+..
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 210 000 000000011123345799999999999999997543
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC------------CCCCCCC
Q 036382 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP------------RDMTGET 268 (390)
Q Consensus 201 ~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~------------~~~~~~~ 268 (390)
....++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .......
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 2345677899999999999999999999999999999999999999999999998654432 2234457
Q ss_pred CCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCC
Q 036382 269 GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANA 348 (390)
Q Consensus 269 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 348 (390)
||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ........ .....+..+...++++.+||.+||+.||
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDV-RNLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHh-hccCCCcccccCChhHHHHHHHHccCCC
Confidence 99999999999999999999999999999999998776422 11222222 2222222223456788999999999999
Q ss_pred CCCCCHHHHHHH
Q 036382 349 EKRPEMGEVVKM 360 (390)
Q Consensus 349 ~~Rpt~~~ll~~ 360 (390)
.+|||+.+++++
T Consensus 315 ~~Rps~~~~l~~ 326 (332)
T 3qd2_B 315 TERPEATDIIEN 326 (332)
T ss_dssp GGSCCHHHHHHS
T ss_pred CcCCCHHHHhhc
Confidence 999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.40 Aligned_cols=265 Identities=24% Similarity=0.429 Sum_probs=213.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+|.+ +++.||||+++... ..+.+|+++++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 5799999999999999999998 48899999997432 24568999999999999999999886422
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...... ............++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 153 (284)
T 2a19_B 78 YDPETS----SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI 153 (284)
T ss_dssp EC-------------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCcccc----cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHE
Confidence 110000 0000011234578999999999999999876667899999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||... ......
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~ 230 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTD 230 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHH
T ss_pred EEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHH
Confidence 99999999999999998654332 334467999999999999999999999999999999999999887432 222222
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+. ....+..++..+.++|.+||..||.+|||+.++++.|+.+..+..
T Consensus 231 ~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LR----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hh----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 22 233566789999999999999999999999999999999976544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.33 Aligned_cols=258 Identities=27% Similarity=0.478 Sum_probs=210.9
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..+....++|.....||+|+||.||+|.+ +++.||||+++.... .....+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~ 85 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---------RYSQPLHEEIALHKHLKHKNIVQYL 85 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---------HHHHHHHHHHHHHHhCCCCCEeeEe
Confidence 45566667788888999999999999998 578999999874321 1235678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
+++.+.. ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++||+|
T Consensus 86 ~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 145 (295)
T 2clq_A 86 GSFSENG--------------------FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145 (295)
T ss_dssp EEEEETT--------------------EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred eEEEeCC--------------------cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 9987543 4478999999999999997643 235679999999999999999999999999
Q ss_pred cCCCCCCEEECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCC
Q 036382 231 RDVKTENMLLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 231 rDlkp~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
+||||+|||++. ++.+||+|||++..............+|+.|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus 146 ~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (295)
T 2clq_A 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225 (295)
T ss_dssp CCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT
T ss_pred cCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999999999987 89999999999986544333344567899999999997643 889999999999999999999999
Q ss_pred CCCChh-hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 308 PDLSFA-DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 308 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...... ............+..+..+++++.+||.+||+.||++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 226 YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp GGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 764332 22233333455667888899999999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=369.46 Aligned_cols=257 Identities=24% Similarity=0.417 Sum_probs=212.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCcc----chHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMA----TTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.++|++.++||+|+||.||+|.+ +++.||||+++....... .........+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999988 568999999974321100 000111234678899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..|+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 115 ~~~~~--------------------~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dl 172 (504)
T 3q5i_A 115 FEDKK--------------------YFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDI 172 (504)
T ss_dssp EECSS--------------------EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEcCC--------------------EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 97543 448899999999999999654 46999999999999999999999999999999
Q ss_pred CCCCEEECCCC---cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 234 KTENMLLDSQR---TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 234 kp~NILl~~~~---~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||+|||++.++ .+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 173 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 173 KPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp SGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998776 6999999999865433 33455689999999999874 5899999999999999999999999999
Q ss_pred ChhhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..+....+....+.... ...+++++.+||.+||..||.+|||+.+++++
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 251 NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999888888776554432 25789999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.92 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=208.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.+++.++|++++..++.+...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----------chHHHHHHHHHHHhcCCCCCCeeeeecCC-
Confidence 6799999999999999999986 678999998753221 13467899999999998888877776432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 77 ------------------~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 136 (296)
T 4hgt_A 77 ------------------GDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp ------------------TTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ------------------CCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 34458999999 99999999643 35699999999999999999999999999999999999
Q ss_pred EE---CCCCcEEEeecccceeccCCCC-------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 239 LL---DSQRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 239 Ll---~~~~~~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
|+ +.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 137 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 99 7889999999999986543221 2234679999999999999999999999999999999999999997
Q ss_pred CCChh---hHHHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 309 DLSFA---DVSSAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 309 ~~~~~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
+.+.. .....+........ ....+|+++.+||.+||+.||++|||+.+|++.|+.+....+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 75332 22323222222221 235678999999999999999999999999999999987655
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=343.46 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=212.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||++.+ +++.||||+++... ..........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKK-----LRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHH-----HHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccc-----ccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 36899999999999999999988 57899999986211 011112346788999999999999999999998543
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ....|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 79 ~------------------~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N 139 (305)
T 2wtk_C 79 E------------------KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139 (305)
T ss_dssp ---------------------CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred C------------------CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence 2 33458999999876 8888876666779999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||++.++.+||+|||++...... ........+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..
T Consensus 140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (305)
T 2wtk_C 140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219 (305)
T ss_dssp EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence 99999999999999999865322 12233456899999999998654 377999999999999999999999998887
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+... ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 220 ~~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 220 KLFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 777766554 345677899999999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.86 Aligned_cols=259 Identities=33% Similarity=0.565 Sum_probs=213.2
Q ss_pred ccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHh--cCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK--LDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|+++++.||||+++.. . ...+.+|.++++. ++||||+++++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------E-----ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------G-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------h-----HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 468999999999999999999999999999998621 1 2456688999888 7999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCc
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH--------SKKIV 229 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~ii 229 (390)
.. .....++||||+.+|+|.+++.+ ..+++..++.++.|++.||.||| +.||+
T Consensus 109 ~~----------------~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 169 (342)
T 1b6c_B 109 NG----------------TWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169 (342)
T ss_dssp CS----------------SCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred CC----------------ccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee
Confidence 31 12356899999999999999954 35999999999999999999999 89999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCC----CCCCCCCCCccccccccCCCC------CCCchhHHHHHHHHHH
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLQGKP------YNRRCDVYSFGICLWE 299 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~e 299 (390)
||||||+|||++.++.+||+|||++........ ......+|+.|+|||++.+.. ++.++|||||||++|+
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 999999999999999999999999976543321 234457999999999997752 3368999999999999
Q ss_pred HHhC----------CCCCCCCC-----hhhHHHHHHHcCCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 300 IYCC----------DMPYPDLS-----FADVSSAVVRQNLRPEIPR-----CCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 300 ll~g----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
|++| ..||.... .......+.....++..+. .++..+.+||.+||+.||++|||+.+|++
T Consensus 250 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999 78986642 3344444444555665554 34568999999999999999999999999
Q ss_pred HHHHhHhcCC
Q 036382 360 MLEAIDTSKG 369 (390)
Q Consensus 360 ~L~~~~~~~~ 369 (390)
.|+.+....+
T Consensus 330 ~L~~i~~~~~ 339 (342)
T 1b6c_B 330 TLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHHHHhc
Confidence 9999986654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.41 Aligned_cols=275 Identities=20% Similarity=0.303 Sum_probs=208.8
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
++...++|++.+.||+|+||.||+|.+ +|+.||||++..... ...+|+.+++.++||||++++++
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------------~~~~E~~il~~l~hpnIv~l~~~ 68 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------------YKNRELDIMKVLDHVNIIKLVDY 68 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHTTCCCTTBCCEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------------hHHHHHHHHHHcCCCCccchhhe
Confidence 345567899999999999999999987 688999999864321 12369999999999999999999
Q ss_pred EecccccccCCccccc------------------CCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHH
Q 036382 154 SVGTSNLKIPSKTASV------------------DGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLA 213 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~ 213 (390)
+............... ...........++||||+. |+|.+++.. ..+..+++..+..++
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI 147 (383)
T ss_dssp EEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred eeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHH
Confidence 8654321000000000 0000023445789999998 588888754 335679999999999
Q ss_pred HHHHHHHHHHHhCCCcccCCCCCCEEEC-CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHH
Q 036382 214 LDLSRGLSYLHSKKIVHRDVKTENMLLD-SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVY 291 (390)
Q Consensus 214 ~~i~~~L~yLH~~~iiHrDlkp~NILl~-~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 291 (390)
.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||
T Consensus 148 ~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999999999999999999999999997 6899999999999865433 233456789999999998875 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCC---------------------------CCCCCCcHHHHHHHHHhh
Q 036382 292 SFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP---------------------------EIPRCCPSSLANIMRKCW 344 (390)
Q Consensus 292 SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl 344 (390)
||||++|+|++|..||.+.+..+.+..++.....+ .++..+|+++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999999988877776665321110 135568899999999999
Q ss_pred hhCCCCCCCHHHHHH--HHHHhH
Q 036382 345 DANAEKRPEMGEVVK--MLEAID 365 (390)
Q Consensus 345 ~~dP~~Rpt~~~ll~--~L~~~~ 365 (390)
..||.+|||+.++++ .++.+.
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999984 344443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=339.82 Aligned_cols=261 Identities=20% Similarity=0.369 Sum_probs=213.8
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++......... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR---GVSREEIEREVNILREIRHPNIITLHDIFENK- 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc---chHHHHHHHHHHHHHhCCCCCeeehhheecCC-
Confidence 5699999999999999999988 47899999997543221110 01135678999999999999999999998754
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
...++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 81 -------------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 139 (283)
T 3bhy_A 81 -------------------TDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139 (283)
T ss_dssp -------------------SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred -------------------CeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence 3458899999999999999653 4699999999999999999999999999999999999
Q ss_pred EECCCC----cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~----~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|++.++ .+||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 140 l~~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 218 (283)
T 3bhy_A 140 MLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218 (283)
T ss_dssp EESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred EEecCCCCCCceEEEecccceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence 998877 8999999999865432 22344578999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHhc
Q 036382 315 VSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK--MLEAIDTS 367 (390)
Q Consensus 315 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~~ 367 (390)
....+....... ..+..++..+.++|.+||..||.+|||+.++++ .++.+...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 219 TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 776665443322 123567899999999999999999999999997 56666543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.11 Aligned_cols=272 Identities=19% Similarity=0.260 Sum_probs=210.5
Q ss_pred cccCccccccccccCceEEEEEEEC----------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD----------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
..++|++.+.||+|+||.||+|++. ++.||||+++.. ..+.+|++++++++||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchh
Confidence 3578999999999999999999873 679999998632 3567899999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++.+.......++...... .......|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~----~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 180 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFG----VHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEE----EETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhccCCccCccchhhcc----ccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 854433222211111100000 00245679999999 9999999976545679999999999999999999999999
Q ss_pred cccCCCCCCEEECCCC--cEEEeecccceeccCCC-------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHH
Q 036382 229 VHRDVKTENMLLDSQR--TLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 229 iHrDlkp~NILl~~~~--~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 299 (390)
+||||||+|||++.++ .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 9999999999999998 99999999997543221 11234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC--hhhHHHHHHH-cCCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 300 IYCCDMPYPDLS--FADVSSAVVR-QNLRPEIP------RCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 300 ll~g~~Pf~~~~--~~~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|++|..||.... .......... .......+ ..+|+++.+||.+||..||.+|||+.+|++.|+.+....+
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 999999998753 2222222110 11111122 2468999999999999999999999999999999987655
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.97 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=208.8
Q ss_pred ccccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.++..++|++.+.||+|+||.||+|.+. ++.||+|+++... .......+.+|+.+++.++||||++++++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--------KPAIRNQIIRELQVLHECNSPYIVGFYGA 99 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--------CHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--------CHHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence 3556678999999999999999999984 7899999997431 12234678899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRD 232 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiHrD 232 (390)
+.+.. ..|+||||+++++|.+++.+. ..+++..+..++.|++.||.|||++ ||+|||
T Consensus 100 ~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 157 (360)
T 3eqc_A 100 FYSDG--------------------EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157 (360)
T ss_dssp EEETT--------------------EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred EEECC--------------------EEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 87543 448899999999999999654 4699999999999999999999996 999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|||+|||++.++.+||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 158 VKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999998644322 22345789999999999999999999999999999999999999987665
Q ss_pred hhHH------------------------------------------HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 036382 313 ADVS------------------------------------------SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEK 350 (390)
Q Consensus 313 ~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 350 (390)
.+.. ..+.........+..++.++.+||.+||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 315 (360)
T 3eqc_A 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315 (360)
T ss_dssp HHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred HHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhh
Confidence 4432 1222222222233457899999999999999999
Q ss_pred CCCHHHHHHH
Q 036382 351 RPEMGEVVKM 360 (390)
Q Consensus 351 Rpt~~~ll~~ 360 (390)
|||+.+++++
T Consensus 316 Rpt~~ell~h 325 (360)
T 3eqc_A 316 RADLKQLMVH 325 (360)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhhC
Confidence 9999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=346.37 Aligned_cols=250 Identities=24% Similarity=0.455 Sum_probs=207.3
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---------EELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---------HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 467999999999999999999984 78999999863321 1235678899999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~--------------------~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (302)
T 2j7t_A 89 G--------------------KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147 (302)
T ss_dssp ---------------------CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred C--------------------eEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHH
Confidence 3 458899999999999998653 3569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCcccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL-----QGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||++.++.+||+|||++..............+|+.|+|||++ .+..++.++|||||||++|+|++|..||...+.
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp EEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 999999999999999976432222223345789999999998 467789999999999999999999999999888
Q ss_pred hhHHHHHHHcCCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVSSAVVRQNLRP-EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
......+....... ..+..++.++.++|.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 77776665544322 245678899999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=346.67 Aligned_cols=247 Identities=24% Similarity=0.280 Sum_probs=196.7
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
-.++|++.++||+|+||.||+|.+ +++.||||++...... .. ....+..|+..+..+ +||||+++++++.
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG------PK-DRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS------HH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC------hH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 346799999999999999999988 5889999988632211 11 123344555555554 9999999999997
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+.. ..|+||||+ +++|.+++... +..+++..++.++.||+.||.|||++||+||||||
T Consensus 128 ~~~--------------------~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 185 (311)
T 3p1a_A 128 EGG--------------------ILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185 (311)
T ss_dssp ETT--------------------EEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred eCC--------------------EEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 543 448899999 67999998654 35699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|||++|..||.... .
T Consensus 186 ~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~ 260 (311)
T 3p1a_A 186 ANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G 260 (311)
T ss_dssp GGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H
T ss_pred HHEEECCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H
Confidence 9999999999999999999765432 23344679999999999886 69999999999999999999977664432 2
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+......+..+..+++++.+||.+||+.||++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22333333334456678999999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=379.25 Aligned_cols=263 Identities=29% Similarity=0.569 Sum_probs=221.7
Q ss_pred CCcccccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
...+++..++|++.+.||+|+||.||+|.+. +..||||.++... .....+.+.+|+.++++++||||
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~HpnI 453 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--------SDSVREKFLQEALTMRQFDHPHI 453 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--------CHHHHHHHHHHHHHHHhCCCCCC
Confidence 3567888899999999999999999999873 3469999886321 12234678899999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
+++++++.+ +..|+||||+.+|+|.+++... ...+++..++.++.|++.||.|||++|
T Consensus 454 v~l~~~~~~---------------------~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g 511 (656)
T 2j0j_A 454 VKLIGVITE---------------------NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR 511 (656)
T ss_dssp CCEEEEECS---------------------SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CeEEEEEec---------------------CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999742 2348899999999999999653 346999999999999999999999999
Q ss_pred CcccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDM 305 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 305 (390)
|+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 512 ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~ 591 (656)
T 2j0j_A 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591 (656)
T ss_dssp CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999998553322 12223456789999999998899999999999999999997 999
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
||.+....+....+.. +.+...|..+|+.+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus 592 Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 592 PFQGVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp TTTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999988887776654 45566788999999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=343.14 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=207.5
Q ss_pred ccccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
...++|++.+.||+|+||.||+|.+. |+.||||+++.... ...+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 34568999999999999999999884 78999999974321 245778999999999999999999987
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... ..|+||||+.+++|.+++... ...+++..++.++.|++.||.|||+.||+|+||||
T Consensus 95 ~~~--------------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p 153 (314)
T 3com_A 95 KNT--------------------DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKA 153 (314)
T ss_dssp ETT--------------------EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred eCC--------------------EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCH
Confidence 543 448899999999999999643 45799999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.++.+||+|||++..............+|+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp GGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999999999999998665444444556799999999999999999999999999999999999999998877665
Q ss_pred HHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+..... ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 554433321 22335567899999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=345.15 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=198.0
Q ss_pred cCcccc-ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 81 SKLDMR-NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 81 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
+.|++. +.||+|+||.||+|.+ +++.||||+++..... ....+.+|+++++++ +||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---------CHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 468874 7899999999999987 6889999999743221 124677899999995 79999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 83 ~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 140 (316)
T 2ac3_A 83 ED--------------------RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140 (316)
T ss_dssp TT--------------------EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CC--------------------EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence 43 458899999999999999654 46999999999999999999999999999999999
Q ss_pred CEEECCCCc---EEEeecccceeccCCC-------CCCCCCCCCCccccccccCC-----CCCCCchhHHHHHHHHHHHH
Q 036382 237 NMLLDSQRT---LKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 237 NILl~~~~~---~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell 301 (390)
|||++.++. +||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999988776 9999999987543211 12234569999999999865 45889999999999999999
Q ss_pred hCCCCCCCCCh---------------hhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 302 CCDMPYPDLSF---------------ADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 302 ~g~~Pf~~~~~---------------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+|..||..... ......+.......+. ...+++++.+||.+||..||.+|||+.+++++
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99999977542 2233444443332211 14578999999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=358.53 Aligned_cols=265 Identities=21% Similarity=0.315 Sum_probs=201.4
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.+.+ .++|++.+.||+|+||.||+|.+ +++.||||+++... ........+.+|+.+|+.++||||+++++
T Consensus 21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 92 (432)
T 3n9x_A 21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-------EDLIDCKRILREITILNRLKSDYIIRLYD 92 (432)
T ss_dssp GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-------TSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-------cChHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence 3444 46899999999999999999987 57899999996321 11223467889999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++...... .....|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 93 ~~~~~~~~---------------~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrD 154 (432)
T 3n9x_A 93 LIIPDDLL---------------KFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRD 154 (432)
T ss_dssp ECCCSCTT---------------TCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEecCCCC---------------cCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Confidence 98654211 2245799999986 599999954 45699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC----------------------CCCCCCCCCCcccccccc-CCCCCCCchh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP----------------------RDMTGETGTLGYMAPEVL-QGKPYNRRCD 289 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~----------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~D 289 (390)
|||+|||++.++.+||+|||+++...... ...+..+||+.|+|||++ .+..++.++|
T Consensus 155 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D 234 (432)
T 3n9x_A 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234 (432)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred CCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccc
Confidence 99999999999999999999998654321 123567899999999986 5667999999
Q ss_pred HHHHHHHHHHHHhCC-----------CCCCCCCh-----------------hhHHHHHHH--------------------
Q 036382 290 VYSFGICLWEIYCCD-----------MPYPDLSF-----------------ADVSSAVVR-------------------- 321 (390)
Q Consensus 290 iwSlG~il~ell~g~-----------~Pf~~~~~-----------------~~~~~~~~~-------------------- 321 (390)
||||||++|||++|. ++|++.+. .+.+..+..
T Consensus 235 iwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~ 314 (432)
T 3n9x_A 235 IWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314 (432)
T ss_dssp HHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence 999999999999843 44444321 111111110
Q ss_pred --cCCCCCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 036382 322 --QNLRPEI-------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAID 365 (390)
Q Consensus 322 --~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~ 365 (390)
....... ...+++++.+||.+||..||++|||+.+++++ ++.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 0011111 13578999999999999999999999999974 44443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=347.23 Aligned_cols=259 Identities=24% Similarity=0.432 Sum_probs=194.6
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||+++... .......+.+|+.+++.++||||++++
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 79 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--------CQTSMDELLKEIQAMSQCHHPNIVSYY 79 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--------cchhHHHHHHHHHHHhhcCCCCEeeEE
Confidence 35788889999999999999999999976 68899999986321 112245678899999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHh
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN------RRKKLALKIVIQLALDLSRGLSYLHS 225 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~ 225 (390)
+++.... ..++||||+.+++|.+++... ....+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 139 (303)
T 2vwi_A 80 TSFVVKD--------------------ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139 (303)
T ss_dssp EEEESSS--------------------CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecC--------------------CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9987543 348899999999999999642 23569999999999999999999999
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeecccceeccCCC-----CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHH
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-----RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~e 299 (390)
+||+||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++|||||||++|+
T Consensus 140 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 219 (303)
T 2vwi_A 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219 (303)
T ss_dssp TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHH
T ss_pred CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999999987543221 11233568999999999865 568999999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHcCCC--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 300 IYCCDMPYPDLSFADVSSAVVRQNLR--------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
|++|..||.................. ......++.++.++|.+||+.||.+|||+.++++.
T Consensus 220 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 99999999988777665544433211 12335678999999999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.75 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=209.0
Q ss_pred cCcccc-ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 81 SKLDMR-NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 81 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
++|.+. +.||+|+||.||+|.+ +++.||||+++....... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-------CRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-------CHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-------HHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 356666 8899999999999988 488999999974322111 135677899999999 56999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..++||||+.+|+|.+++.......+++..++.++.|++.||.|||++||+||||||+
T Consensus 101 ~~--------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~ 160 (327)
T 3lm5_A 101 TS--------------------EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ 160 (327)
T ss_dssp SS--------------------EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CC--------------------eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChH
Confidence 43 4488999999999999986555567999999999999999999999999999999999
Q ss_pred CEEECC---CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLLDS---QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~---~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||++. ++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 239 (327)
T 3lm5_A 161 NILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239 (327)
T ss_dssp GEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 999988 789999999999865432 2234467999999999999999999999999999999999999999998888
Q ss_pred hHHHHHHHcCC--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNL--RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+..... ....+..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 240 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 87776655443 333446789999999999999999999999999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.58 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=197.6
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||++........ ..........+.+|+.++++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG-SAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccc-ccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 46899999999999999999987 568999999974321111 11112223457899999999999999999999753
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...|+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 212 --------------------~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 269 (419)
T 3i6u_A 212 --------------------EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269 (419)
T ss_dssp --------------------SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred --------------------CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 234889999999999998843 4579999999999999999999999999999999999
Q ss_pred EEECCCC---cEEEeecccceeccCCCCCCCCCCCCCccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 238 MLLDSQR---TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 238 ILl~~~~---~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||++.++ .+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 270 Ill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 270 VLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp EEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred EEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 9997544 5999999999865432 23345679999999999864 568889999999999999999999998765
Q ss_pred hhhHHHHHHHcCCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQNLRPE---IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...........+.... .+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 349 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 349 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 4443433333332222 235678999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.53 Aligned_cols=250 Identities=28% Similarity=0.399 Sum_probs=206.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--------TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--------hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 5799999999999999999988 578999999864321 112356789999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus 79 --------------------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 136 (276)
T 2yex_A 79 --------------------IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136 (276)
T ss_dssp --------------------EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred --------------------EEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHE
Confidence 44789999999999998843 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+++.++.+||+|||++....... .......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||........
T Consensus 137 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 216 (276)
T 2yex_A 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (276)
T ss_dssp EECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred EEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 99999999999999997543221 22344678999999999987765 7789999999999999999999987654432
Q ss_pred -HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 -SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
................+++.+.+||.+||..||.+|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 217 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 233333222223345688999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=340.15 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=203.5
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 157 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.++..+ +||||+++++++.+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-------VDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-------HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 5799999999999999999998 58899999997432211 1235677899999999 999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
. ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 84 ~--------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp 143 (289)
T 1x8b_A 84 D--------------------HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP 143 (289)
T ss_dssp T--------------------EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred C--------------------eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCH
Confidence 3 4488999999999999997543 25699999999999999999999999999999999
Q ss_pred CCEEECCC-------------------CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHH
Q 036382 236 ENMLLDSQ-------------------RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGI 295 (390)
Q Consensus 236 ~NILl~~~-------------------~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 295 (390)
+|||++.+ ..+||+|||++...... ....+|+.|+|||++.+. .++.++|||||||
T Consensus 144 ~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp GGEEEC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 99999844 47999999999865432 234689999999999776 5678999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 296 CLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 296 il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
++|+|++|..|+..... ... ...+..+..+..+++++.++|.+||+.||++|||+.+++++
T Consensus 220 il~~l~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNGDQ---WHE-IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHTTCCCCCSSSHH---HHH-HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHhcCCCCCcchhH---HHH-HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 99999999887754432 222 34455667888899999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=364.79 Aligned_cols=262 Identities=21% Similarity=0.335 Sum_probs=210.6
Q ss_pred cccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|.+. ++.||||+++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--------cchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 3467999999999999999999984 78999999963211 1113456789999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
.. ....|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 79 ~~------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 140 (396)
T 4eut_A 79 TT------------------TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (396)
T ss_dssp TT------------------TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CC------------------CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence 43 2345899999999999999965432 2399999999999999999999999999999999
Q ss_pred CCEEE----CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC--------CCCCCchhHHHHHHHHHHHHhC
Q 036382 236 ENMLL----DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--------KPYNRRCDVYSFGICLWEIYCC 303 (390)
Q Consensus 236 ~NILl----~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g 303 (390)
+|||+ +.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 141 ~NIll~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 141 GNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp GGEEEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHEEEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 99999 77788999999999865432 33445679999999999864 4678899999999999999999
Q ss_pred CCCCCCC----ChhhHHHHHHHcCCCC-----------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 304 DMPYPDL----SFADVSSAVVRQNLRP-----------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 304 ~~Pf~~~----~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
..||... ...+....+....... ..+..++..+.++|++||+.||++|||+.+
T Consensus 220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 9999643 2334444444432110 111234567899999999999999999999
Q ss_pred HHHHHHHhHhc
Q 036382 357 VVKMLEAIDTS 367 (390)
Q Consensus 357 ll~~L~~~~~~ 367 (390)
+++.++++...
T Consensus 300 ~l~~l~~il~~ 310 (396)
T 4eut_A 300 FFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhhc
Confidence 99999988643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.79 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=194.1
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|++. ++|++.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++||||++++
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~ 94 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELRLLKHMKHENVIGLL 94 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 356664 6899999999999999999987 678999999863221 122345677999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++....... .....|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~~~--------------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~ 156 (367)
T 2fst_X 95 DVFTPARSLE--------------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHR 156 (367)
T ss_dssp EEECSCSSGG--------------GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred EEEecCCccc--------------cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 9986542221 124468999999 6899998854 469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 157 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 157 DLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp CCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCHhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999975432 2345679999999999987 67999999999999999999999999998
Q ss_pred ChhhHHHHHHHcCCCC---------------------C--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRP---------------------E--------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..+.+..+......+ . ....+++++.+||.+||..||.+|||+.+++++
T Consensus 234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 8777665554311100 0 112467889999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=346.38 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=207.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +|+.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-------hHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 57899999999999999999988 5789999998644322211 23466899999999999999999998765
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...+. ...+..|+||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~~~------------~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 154 (351)
T 3mi9_A 89 ASPYN------------RCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 154 (351)
T ss_dssp --------------------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ccccc------------cCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence 32211 124567999999975 888877543 3569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccC----CCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQ----NPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||++.++.+||+|||++..... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 155 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 155 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999986432 1223345678999999999976 5689999999999999999999999999887
Q ss_pred hhHHHHHHHcC--CCCCCCCC----------------------------CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQN--LRPEIPRC----------------------------CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~--~~~~~~~~----------------------------~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+.... ..+..... .++++.+||.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 77666554321 11111111 26779999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=350.74 Aligned_cols=257 Identities=17% Similarity=0.243 Sum_probs=211.1
Q ss_pred CCCcccccccCccccccccccCceEEEEEE-------ECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGT-------YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD- 143 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 143 (390)
+..++++..++|++.+.||+|+||.||+|. .+++.||||+++... ...+..|+++++.++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~l~~ 123 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------PWEFYIGTQLMERLKP 123 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------HHHHHHHHHHHHHSCG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------hhHHHHHHHHHHHhhh
Confidence 456678888999999999999999999993 367899999996321 235677888888886
Q ss_pred --CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh---ccCCCCHHHHHHHHHHHHH
Q 036382 144 --HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN---RRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 144 --hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~i~~ 218 (390)
|+||+++++++.... ..|+||||+.+|+|.+++... ....+++..++.++.||+.
T Consensus 124 ~~~~~iv~~~~~~~~~~--------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~ 183 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQN--------------------GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183 (365)
T ss_dssp GGGGGBCCEEEEEECSS--------------------CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhhheeeecCC--------------------CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHH
Confidence 999999999987543 448899999999999999653 2456999999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECC-----------CCcEEEeecccceecc--CCCCCCCCCCCCCccccccccCCCCCC
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDS-----------QRTLKIADFGVARVEA--QNPRDMTGETGTLGYMAPEVLQGKPYN 285 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~-----------~~~~kL~DfG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~ 285 (390)
||+|||++||+||||||+|||++. ++.+||+|||+|+... .........+||+.|+|||++.+..++
T Consensus 184 ~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 263 (365)
T 3e7e_A 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263 (365)
T ss_dssp HHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS
T ss_pred HHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC
Confidence 999999999999999999999998 8999999999997543 223344567899999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCC-CCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHH
Q 036382 286 RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEI-PRCCPSSLANIMRKCWDANAEKR-PEMGEVVKMLEA 363 (390)
Q Consensus 286 ~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~R-pt~~~ll~~L~~ 363 (390)
.++|||||||++|||++|+.||......... ....+ ....++.+.+++..||+.+|.+| |++.++.+.|++
T Consensus 264 ~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 264 YQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp THHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHHHhCCCccccCCCCcee-------echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 9999999999999999999999543321110 01111 11246789999999999999999 688999999998
Q ss_pred hHhc
Q 036382 364 IDTS 367 (390)
Q Consensus 364 ~~~~ 367 (390)
+...
T Consensus 337 ~l~~ 340 (365)
T 3e7e_A 337 VFQQ 340 (365)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=356.96 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=207.5
Q ss_pred ccccccCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccce
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTK 149 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~ 149 (390)
..+..++|++.+.||+|+||.||+++. +++.||||+++....... ......+.+|+.+++.+ +||||++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~ 123 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-----AKTTEHTRTERQVLEHIRQSPFLVT 123 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-----ESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh-----hhHHHHHHHHHHHHHHccCCCceeE
Confidence 355678999999999999999999987 678999999863211000 00123456799999999 7999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.... ..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+
T Consensus 124 ~~~~~~~~~--------------------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iv 181 (355)
T 1vzo_A 124 LHYAFQTET--------------------KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGII 181 (355)
T ss_dssp EEEEEEETT--------------------EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEeeCc--------------------eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999987543 447899999999999999654 4699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCC-CCCCCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
||||||+|||++.++.+||+|||+++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 182 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp CCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999754322 222334579999999999986 3578999999999999999999999
Q ss_pred CCCCC----hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHH
Q 036382 307 YPDLS----FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKML 361 (390)
Q Consensus 307 f~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~L 361 (390)
|.... ...+...+.. ..+..+..++..+.+||.+||..||.+|| |+.+++++.
T Consensus 262 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 262 FTVDGEKNSQAEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TSCTTSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CccCCccchHHHHHHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 97542 2333333332 34567788999999999999999999999 999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=358.13 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=205.9
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc------CCCccceE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL------DHPNVTKF 150 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~ 150 (390)
...+|++.+.||+|+||.||+|.+ +++.||||+++.. ......+.+|+++++.+ .|+||+++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----------cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 346799999999999999999988 4689999999621 11234566788888877 57799999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++.... ..|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+|
T Consensus 165 ~~~~~~~~--------------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 223 (429)
T 3kvw_A 165 LENFTFRN--------------------HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIH 223 (429)
T ss_dssp EEEEEETT--------------------EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEEC
T ss_pred EeecccCC--------------------eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99987543 4588999996 69999998766667999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCc--EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 231 RDVKTENMLLDSQRT--LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 231 rDlkp~NILl~~~~~--~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
|||||+|||++.++. +||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 224 rDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp SCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHeEEccCCCcceEEeecccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 999999999999987 999999999754332 334678999999999999999999999999999999999999999
Q ss_pred CCChhhHHHHHHHcCCCC---------------------------------------------------------CCCCC
Q 036382 309 DLSFADVSSAVVRQNLRP---------------------------------------------------------EIPRC 331 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~---------------------------------------------------------~~~~~ 331 (390)
+.+..+.+..+......+ ..+..
T Consensus 301 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 380 (429)
T 3kvw_A 301 GEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380 (429)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTC
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcccc
Confidence 988777665554311000 01223
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 332 CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 332 ~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.++++.+||.+||+.||++|||+.+++++
T Consensus 381 ~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 47889999999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=350.70 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=207.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|++++++++||||+++++++....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 5899999999999999999987 57899999986321 1223466789999999999999999999986432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.. .....|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 99 ~~---------------~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 159 (364)
T 3qyz_A 99 IE---------------QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159 (364)
T ss_dssp TT---------------TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cc---------------ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhE
Confidence 11 2345689999997 599999854 3599999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|++.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+
T Consensus 160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp EECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred EECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 999999999999999986543221 134457999999999865 4568999999999999999999999999988777
Q ss_pred HHHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+......+ .....+++++.+||.+||..||++|||+.+++++
T Consensus 240 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 240 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 766654211111 0124568899999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=349.90 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=203.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++......... ........+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW-IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSE-EEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 5799999999999999999986 67899999997443211000 00001234668999999999999999999997543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCC-CHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGG-NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..++||||+.+| +|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 103 --------------------~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 160 (335)
T 3dls_A 103 --------------------FFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160 (335)
T ss_dssp --------------------EEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred --------------------EEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence 447899999777 99999954 3469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 161 Ill~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--- 236 (335)
T 3dls_A 161 IVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--- 236 (335)
T ss_dssp EEECTTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---
T ss_pred EEEcCCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---
Confidence 99999999999999999865433 22334579999999999988876 78999999999999999999999763211
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.......|..+++++.+||.+||..||++|||+.++++.
T Consensus 237 -----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112334566789999999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.14 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=199.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++.... .......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-------ChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 46899999999999999999987 578999999963221 122345678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... ......|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 97 ~~~--------------~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 157 (371)
T 2xrw_A 97 KSL--------------EEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157 (371)
T ss_dssp CST--------------TTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ccc--------------ccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 322 123467999999975 7888884 348999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 158 Il~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 158 IVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp EEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999754432 22344679999999999999999999999999999999999999999988777666
Q ss_pred HHHHcCCCC--------------------CC--------------CC------CCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNLRP--------------------EI--------------PR------CCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~~~--------------------~~--------------~~------~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+......+ .. |. ..++++.+||.+||..||.+|||+.++
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 554321110 00 00 115679999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+++
T Consensus 317 l~h 319 (371)
T 2xrw_A 317 LQH 319 (371)
T ss_dssp HHS
T ss_pred hCC
Confidence 874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=355.67 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=202.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+|++.+.||+|+||.||+|++ +++.||||++..... .+.+|+++++.++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 4699999999999999999998 588999999863321 2236999999999999999999986432
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ......++||||+.+ +|.+++.. .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 121 ~~--------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 185 (420)
T 1j1b_A 121 EK--------------KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185 (420)
T ss_dssp TT--------------TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGG
T ss_pred CC--------------CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChh
Confidence 11 012335789999976 67776643 23467999999999999999999999999999999999
Q ss_pred CEEECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 237 NMLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|||++.+ +.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+
T Consensus 186 NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~ 264 (420)
T 1j1b_A 186 NLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264 (420)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999965 67899999999865432 223446789999999999765 79999999999999999999999999988776
Q ss_pred HHHHHHHcCC---------------CCC------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNL---------------RPE------------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~---------------~~~------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+..++.... ... ++..+++++.+||.+||..||.+|||+.+++++
T Consensus 265 ~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 6655543100 001 234568999999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=340.86 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=208.2
Q ss_pred ccCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGA 153 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~ 153 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++........ ...+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-------CchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 46899999999999999999987 4678999998743321111 12345677777665 89999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+..... ......++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||
T Consensus 83 ~~~~~~---------------~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dl 146 (326)
T 1blx_A 83 CTVSRT---------------DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146 (326)
T ss_dssp EEEEEC---------------SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred eeeccc---------------CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 863210 02345689999997 69999997765566999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||+|||++.++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 147 KPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CHHHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999999999999999999999754322 2334567899999999999999999999999999999999999999998877
Q ss_pred hHHHHHHHcCCC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 314 DVSSAVVRQNLR-------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 314 ~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+....+...... ...+..++..+.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 777666532100 0123567899999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.61 Aligned_cols=259 Identities=20% Similarity=0.387 Sum_probs=211.6
Q ss_pred cccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccch--------HHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATT--------AETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
.+..++|++.+.||+|+||.||+|.++++.||||+++......... .........+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 4456799999999999999999999999999999986321100000 00000115678999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHH------HHhhccCCCCHHHHHHHHHHHHHHHHH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY------LIRNRRKKLALKIVIQLALDLSRGLSY 222 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~i~~~L~y 222 (390)
++++++.+. ...++||||+++|+|.++ +.+.....+++..++.++.|++.||.|
T Consensus 107 ~~~~~~~~~--------------------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 107 TCEGIITNY--------------------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp CCSEEEESS--------------------SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeeC--------------------CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 999998754 345889999999999998 644335679999999999999999999
Q ss_pred HHh-CCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCC-chhHHHHHHHHHH
Q 036382 223 LHS-KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNR-RCDVYSFGICLWE 299 (390)
Q Consensus 223 LH~-~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~e 299 (390)
||+ +||+||||||+|||++.++.+||+|||++...... ......+|+.|+|||++.+. .++. ++|||||||++|+
T Consensus 167 lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp HHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHH
T ss_pred HhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHH
Confidence 999 99999999999999999999999999999865433 33456799999999999887 6666 9999999999999
Q ss_pred HHhCCCCCCCCCh-hhHHHHHHHcCCCCCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 300 IYCCDMPYPDLSF-ADVSSAVVRQNLRPEIP-------------------RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 300 ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
|++|..||...+. .+....+..... ..| ..+++++.+||.+||+.||.+|||+.++++
T Consensus 245 l~~g~~pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 245 MFYNVVPFSLKISLVELFNNIRTKNI--EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHSSCSSCCSSCSHHHHHHHTSCCC--CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCCCCcHHHHHHHHhccCc--CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999988766 555555433322 233 568999999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=335.24 Aligned_cols=250 Identities=28% Similarity=0.489 Sum_probs=211.2
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +++.||||+++....... ....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-------DTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-------CHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-------HHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 46799999999999999999988 578999999864322111 135678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 --------------------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 151 (287)
T 2wei_A 94 --------------------SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151 (287)
T ss_dssp --------------------SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred --------------------CeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhh
Confidence 3458899999999999998654 469999999999999999999999999999999999
Q ss_pred EEECCC---CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQ---RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~---~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++.+ +.+||+|||++...... .......+|+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+
T Consensus 152 Ilv~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (287)
T 2wei_A 152 ILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (287)
T ss_dssp EEESCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999764 47999999998754332 222334588999999998764 8999999999999999999999999988888
Q ss_pred HHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+.........+ ..+++++.++|.+||..||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 877776665544433 5689999999999999999999999999973
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.98 Aligned_cols=270 Identities=15% Similarity=0.188 Sum_probs=197.4
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHH---HHHHhcCCCccce
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV---AVWQKLDHPNVTK 149 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~ 149 (390)
.|....++|++.+.||+|+||.||+|++ +|+.||||+++....... ...+.+.+|+ +++++++||||++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~l~hpniv~ 140 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS------NAIKQMKEEVLRLRLLRGIKNQKQAK 140 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT------THHHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch------HHHHHHHHHHHHHHhccccCCHHHHH
Confidence 3444567899999999999999999986 589999999974322111 1235678899 4555668999999
Q ss_pred EE-------EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc-----CCCCHHHHHHHHHHHH
Q 036382 150 FV-------GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR-----KKLALKIVIQLALDLS 217 (390)
Q Consensus 150 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~ 217 (390)
++ +++.+........ .+.+ .....-...|+||||+ +|+|.+++.+... ..+++..++.++.||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~ 216 (377)
T 3byv_A 141 VHLRFIFPFDLVKDPQKKKMIR--VRLD-ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216 (377)
T ss_dssp HHHCBCCCSEEEECTTSCSEEE--C-------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHH
T ss_pred HHhhhhhhhhhhhccCCccccc--cccC-CCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHH
Confidence 98 4443321100000 0000 0000001368999999 6899999975421 1233488889999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-----------CCCC
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-----------PYNR 286 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ 286 (390)
.||+|||++||+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.
T Consensus 217 ~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 217 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 999999999999999999999999999999999999985332 2344567 999999999877 8999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHh
Q 036382 287 RCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK--MLEAI 364 (390)
Q Consensus 287 ~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~ 364 (390)
++|||||||++|||++|..||.+.+..+....+. ..+..+|+++.+||.+||..||++|||+.++++ .++.+
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999999999999999997765444332221 233578999999999999999999999999986 44443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.75 Aligned_cols=265 Identities=20% Similarity=0.300 Sum_probs=205.7
Q ss_pred ccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCcc--chHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMA--TTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
...++|++.+.||+|+||.||+|.+ +++.||||++........ ...........+.+|++++++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 3457899999999999999999977 578999999864322211 1122333457788999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
...... .....|+||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+|||||
T Consensus 99 ~~~~~~---------------~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 161 (362)
T 3pg1_A 99 VHFEEP---------------AMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161 (362)
T ss_dssp EECCTT---------------TCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred EeccCC---------------CcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCC
Confidence 643211 2345699999997 5898888643 4569999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999743322 23344678999999999977 67999999999999999999999999998877
Q ss_pred hHHHHHHHcCCCC------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRP------------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+......+ ..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 7666554321111 0123467889999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.06 Aligned_cols=257 Identities=23% Similarity=0.400 Sum_probs=207.9
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|++. ++|.+.+.||+|+||.||+|.+ +|+.||||+++.... .......+.+|+.+++.++||||++++
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~ 107 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-------SEIFAKRAYRELLLLKHMQHENVIGLL 107 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-------chhHHHHHHHHHHHHHhcCCCCchhhh
Confidence 456664 6899999999999999999987 578999999963221 123346778999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++....... .....|+||||+. ++|.+++ ...+++..+..++.||+.||.|||++||+||
T Consensus 108 ~~~~~~~~~~--------------~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 168 (371)
T 4exu_A 108 DVFTPASSLR--------------NFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHR 168 (371)
T ss_dssp EEECSCSSST--------------TCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hheeccCCcc--------------cceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 9987654331 1223489999997 5888877 2349999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 169 Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 169 DLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp CCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcCHHHeEECCCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999975433 2344678999999999987 68999999999999999999999999998
Q ss_pred ChhhHHHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+..+....+......+ ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 8777666554311111 0123568999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=340.00 Aligned_cols=245 Identities=20% Similarity=0.335 Sum_probs=200.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|.+ +++.||||+++... ...+.+|+.+++.++ ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 46899999999999999999987 67899999986321 245789999999996 9999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ....++||||+.+++|.+++. .+++..+..++.||+.||.|||++||+||||||+
T Consensus 103 ~~------------------~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 159 (330)
T 3nsz_A 103 PV------------------SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 159 (330)
T ss_dssp TT------------------TCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CC------------------CCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 32 334589999999999999873 3899999999999999999999999999999999
Q ss_pred CEEECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-Chh
Q 036382 237 NMLLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL-SFA 313 (390)
Q Consensus 237 NILl~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~ 313 (390)
|||++.++ .+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..
T Consensus 160 Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 238 (330)
T 3nsz_A 160 NVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238 (330)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred HEEEcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH
Confidence 99999776 8999999999865432 23445678999999999977 67999999999999999999999999443 332
Q ss_pred hHHHHHHH-------------cC----------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 314 DVSSAVVR-------------QN----------------------LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 314 ~~~~~~~~-------------~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
+....+.. .. .....+..+++++.+||.+||+.||.+|||+.+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 22222111 00 01112223789999999999999999999999998
Q ss_pred HH
Q 036382 359 KM 360 (390)
Q Consensus 359 ~~ 360 (390)
++
T Consensus 319 ~h 320 (330)
T 3nsz_A 319 EH 320 (330)
T ss_dssp TS
T ss_pred cC
Confidence 73
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.54 Aligned_cols=271 Identities=12% Similarity=0.155 Sum_probs=190.2
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc--CCCccceE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL--DHPNVTKF 150 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~ 150 (390)
.|.....+|++.+.||+|+||.||+|++ +++.||||+++.... ........+.+|+.+++.+ +||||+++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~~~~l~~~hp~iv~~ 129 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE------NSRSELERLHEATFAAARLLGESPEEARD 129 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST------THHHHHHHHHHHHHHHHHHHC--------
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc------ccccHHHHHHHHHHHHHHhcccChhhhhh
Confidence 3444556799999999999999999987 578999999974321 1223345677886555555 69998886
Q ss_pred EEE-------EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHH------HHHHHHHH
Q 036382 151 VGA-------SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIV------IQLALDLS 217 (390)
Q Consensus 151 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~i~ 217 (390)
+.. +.....-.. ....+..........|+||||+. |+|.+++.... ..+++..+ ..++.||+
T Consensus 130 ~~~~~~p~d~~~~~~~~~~---~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~ 204 (371)
T 3q60_A 130 RRRLLLPSDAVAVQSQPPF---AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLI 204 (371)
T ss_dssp --CBCCCCEEEEETTSCSS---SBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEEeeehheecCCCCCe---eeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHH
Confidence 633 322211000 00000001111245799999998 89999997643 23555556 67889999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC--CCCCCchhHHHHHH
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGI 295 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~ 295 (390)
.||.|||++||+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||
T Consensus 205 ~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 99999999999999999999999999999999999998654321 13456799999999987 67999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHH--H-----HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 296 CLWEIYCCDMPYPDLSFADVS--S-----AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 296 il~ell~g~~Pf~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
++|+|++|..||......... . .........+.+..+|+.+.+||.+||+.||++|||+.++++
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999876432210 0 000112222333578999999999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.57 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=199.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +++.||||+++....... ..........+.+|++++++++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG-SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhc-ccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 5799999999999999999988 568999999964321110 011122335678999999999999999999998532
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
..|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 88 --------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NI 145 (322)
T 2ycf_A 88 --------------------DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 145 (322)
T ss_dssp --------------------SEEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred --------------------ceEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 25899999999999999853 45799999999999999999999999999999999999
Q ss_pred EECCCCc---EEEeecccceeccCCCCCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 239 LLDSQRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 239 Ll~~~~~---~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|++.++. +||+|||++...... .......+|+.|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 146 l~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 146 LLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp EESSSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred EEecCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9987664 999999999865332 1122345899999999973 56789999999999999999999999977654
Q ss_pred hhHH-HHHHHcCCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVS-SAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~-~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.... ..+...... +..+..++.++.+||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 225 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 4333 333322221 1223567899999999999999999999999984
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=342.56 Aligned_cols=259 Identities=21% Similarity=0.331 Sum_probs=206.7
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +|+.||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--------KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--------cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 46899999999999999999998 48899999986321 122335677899999999999999999987643
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. ......|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 82 ~~---------------~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (353)
T 2b9h_A 82 SF---------------ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142 (353)
T ss_dssp CS---------------TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred cc---------------CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 21 12356799999997 599999854 359999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCC----------CCCCCCCCCccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPR----------DMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
||++.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..|
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999986432211 122357899999999875 47789999999999999999999999
Q ss_pred CCCCChhhHHHHHHHcCCCC------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 307 YPDLSFADVSSAVVRQNLRP------------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
|.+.+..+....+......+ ..+..+++++.+||.+||..||++|||+.+
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 223 FPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 99887666554433211000 012357899999999999999999999999
Q ss_pred HHH--HHHHhH
Q 036382 357 VVK--MLEAID 365 (390)
Q Consensus 357 ll~--~L~~~~ 365 (390)
+++ .++.+.
T Consensus 303 ll~hp~~~~~~ 313 (353)
T 2b9h_A 303 ALEHPYLQTYH 313 (353)
T ss_dssp HHTSGGGTTTC
T ss_pred HhcCccccccC
Confidence 987 344443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=348.59 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=204.1
Q ss_pred ccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
..+|++.+.||+|+||.||+|++ .+..||+|.+..... ...+|+++++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------------~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------------FKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------------hHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 45799999999999999999998 455689888753221 1236999999999999999999986543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ......++||||+.++ |.+.+.. .....+++..++.++.||+.||.|||++||+||||||+
T Consensus 106 ~~--------------~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 106 DK--------------KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp SS--------------SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CC--------------CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 21 1233468999999874 4444432 23467999999999999999999999999999999999
Q ss_pred CEEEC-CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 237 NMLLD-SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~-~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|||++ .++.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+
T Consensus 171 Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 249 (394)
T 4e7w_A 171 NLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249 (394)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99998 7899999999999865432 223446789999999999765 59999999999999999999999999988777
Q ss_pred HHHHHHHcCCCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 036382 315 VSSAVVRQNLRP---------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAID 365 (390)
Q Consensus 315 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~ 365 (390)
.+..+......+ .++..+++++.+||.+||..||.+|||+.+++++ ++.+.
T Consensus 250 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 666554321000 1234578999999999999999999999999874 44443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=338.16 Aligned_cols=257 Identities=20% Similarity=0.328 Sum_probs=208.3
Q ss_pred CCcccccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC--CCccce
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD--HPNVTK 149 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~ 149 (390)
.+...+..++|++.+.||+|+||.||++.+ +++.||||+++..... ......+.+|+.++++++ ||||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-------HHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-------ccchHHHHHHHHHHHhccccCCceEE
Confidence 345677778899999999999999999987 5788999999743221 223467889999999996 599999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
+++++.+.. ..++||| +.+++|.+++.+. ..+++..++.++.|++.||.|||++||+
T Consensus 93 ~~~~~~~~~--------------------~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iv 149 (313)
T 3cek_A 93 LYDYEITDQ--------------------YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIV 149 (313)
T ss_dssp EEEEEECSS--------------------EEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEeecCC--------------------EEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 999987543 3488999 5678999999653 4689999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCC-----------CCCCCchhHHHHHHH
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQG-----------KPYNRRCDVYSFGIC 296 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~i 296 (390)
||||||+|||++ ++.+||+|||++........ ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 150 H~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i 228 (313)
T 3cek_A 150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228 (313)
T ss_dssp CCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred ecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence 999999999996 58999999999975433221 1234568999999999875 468889999999999
Q ss_pred HHHHHhCCCCCCCCC-hhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 297 LWEIYCCDMPYPDLS-FADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 297 l~ell~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+|+|++|..||.... .......+.........+..++.++.++|.+||..||.+|||+.++++.
T Consensus 229 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 229 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 999999999998753 3344455555566667788889999999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=343.48 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=206.0
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|++. ++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++||||+++++
T Consensus 19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 90 (353)
T 3coi_A 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-------SEIFAKRAYRELLLLKHMQHENVIGLLD 90 (353)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCCcccHhh
Confidence 45553 6899999999999999999987 588999999863221 1223466789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++........ ....|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+|||
T Consensus 91 ~~~~~~~~~~--------------~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~d 151 (353)
T 3coi_A 91 VFTPASSLRN--------------FYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 151 (353)
T ss_dssp EECSCSSGGG--------------CCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred eEeccccccc--------------ceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 9876543311 234589999997 58887762 3599999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
|||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 152 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 152 LKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999754322 334578999999999987 678999999999999999999999999887
Q ss_pred hhhHHHHHHHcC--------------------------CC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQN--------------------------LR---PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+....+.... .+ ...+..+++++.+||.+||..||++|||+.+++++
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 766655543210 01 12234678999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=355.90 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=208.1
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc-eEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT-KFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~ 156 (390)
.++|++.++||+|+||.||+|.+ +++.||||+++..... ..+.+|+++++.++|++++ .+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 46899999999999999999987 5889999998643321 2467899999999875544 44444332
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
....++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+
T Consensus 75 --------------------~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~ 132 (483)
T 3sv0_A 75 --------------------GDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (483)
T ss_dssp --------------------TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred --------------------CCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcc
Confidence 33458999999 89999999643 356999999999999999999999999999999999
Q ss_pred CEEE---CCCCcEEEeecccceeccCCCC-------CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 036382 237 NMLL---DSQRTLKIADFGVARVEAQNPR-------DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 237 NILl---~~~~~~kL~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 306 (390)
|||| +.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp GEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999 5789999999999986543321 12256799999999999999999999999999999999999999
Q ss_pred CCCCCh---hhHHHHHHHcCCC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 307 YPDLSF---ADVSSAVVRQNLR---PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 307 f~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|.+... .+.+..+...... ...+..+|.++.+||.+||..||++||++.+|++.|+.+...++
T Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 987543 2233333222211 12335789999999999999999999999999999999977654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=340.50 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=204.5
Q ss_pred ccccCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc------cc
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN------VT 148 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv 148 (390)
+-.++|++.+.||+|+||.||+|.+ +++.||||+++.. ......+.+|+.+++.++|+| |+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----------DRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----------HHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----------CchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 4457899999999999999999987 5789999998621 122456778999999887654 99
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
++++++.+.. ..|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||
T Consensus 81 ~~~~~~~~~~--------------------~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 139 (339)
T 1z57_A 81 QMLEWFEHHG--------------------HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139 (339)
T ss_dssp CEEEEEEETT--------------------EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eeecccccCC--------------------cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCC
Confidence 9999987543 458899999 8899999977655679999999999999999999999999
Q ss_pred cccCCCCCCEEECC-------------------CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchh
Q 036382 229 VHRDVKTENMLLDS-------------------QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 229 iHrDlkp~NILl~~-------------------~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
+||||||+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|
T Consensus 140 vH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~D 216 (339)
T 1z57_A 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCD 216 (339)
T ss_dssp ECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHH
T ss_pred cCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchh
Confidence 99999999999987 668999999999864332 23457899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCC------------------------------------------CC
Q 036382 290 VYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLR------------------------------------------PE 327 (390)
Q Consensus 290 iwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------~~ 327 (390)
||||||++|||++|..||...+..+....+...... ..
T Consensus 217 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (339)
T 1z57_A 217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296 (339)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcc
Confidence 999999999999999999988776655433221100 00
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 328 IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 328 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 297 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 122346789999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=336.72 Aligned_cols=262 Identities=19% Similarity=0.285 Sum_probs=201.8
Q ss_pred ccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---------PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---------hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 468999999999999999999884 7899999986321 12346678999999999999999999998654
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
..... .+..........|+||||+. |+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 81 ~~~~~------~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 150 (320)
T 2i6l_A 81 GSQLT------DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN 150 (320)
T ss_dssp SCBCC------C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred ccccc------cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 32111 00111224567899999997 699999843 469999999999999999999999999999999999
Q ss_pred EEEC-CCCcEEEeecccceeccCC---CCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLD-SQRTLKIADFGVARVEAQN---PRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~-~~~~~kL~DfG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||++ .++.+||+|||++...... ........+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus 151 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp EEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9997 5679999999999754321 112233457899999998865 6789999999999999999999999998887
Q ss_pred hhHHHHHHHcCCC-----------------------C-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLR-----------------------P-----EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~-----------------------~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+...... + ..+..++.++.+||.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 7666555432110 0 1124578999999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=336.13 Aligned_cols=255 Identities=22% Similarity=0.455 Sum_probs=191.3
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||+++.... .......+..+..+++.++||||++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~i~~~~ 90 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-------KEENKRILMDLDVVLKSHDCPYIVQCF 90 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-------HHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCceeeEE
Confidence 46777889999999999999999999998 588999999974321 112234455566678888999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCcc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVH 230 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~iiH 230 (390)
+++.+.. ..++||||+ ++.+..+.. .....+++..++.++.|++.||.|||++ ||+|
T Consensus 91 ~~~~~~~--------------------~~~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H 148 (318)
T 2dyl_A 91 GTFITNT--------------------DVFIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148 (318)
T ss_dssp EEEECSS--------------------EEEEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred EEEecCC--------------------cEEEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEe
Confidence 9987543 458899999 555655554 3356799999999999999999999995 9999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
|||||+|||++.++.+||+|||++...... .......+|+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 149 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 149 RDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 999999999999999999999999754332 2233457899999999994 4568899999999999999999999
Q ss_pred CCCCC-ChhhHHHHHHHcCCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 306 PYPDL-SFADVSSAVVRQNLRPEIP--RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 306 Pf~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
||... ...+....+... ..+..+ ..+++++.+||.+||..||.+|||+.++++
T Consensus 228 pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 228 PYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp TTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 99874 444445444433 333333 458999999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=350.06 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=201.3
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC--------CCcc
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD--------HPNV 147 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnI 147 (390)
+-.++|++.+.||+|+||.||+|++ +++.||||+++.. ......+.+|+.+++.++ ||||
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----------EHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----------CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 3357899999999999999999987 5789999999621 123456788999999985 7889
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK- 226 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~- 226 (390)
+++++++..... .....|+||||+ +++|.+++.+.....+++..++.++.||+.||.|||++
T Consensus 104 v~~~~~~~~~~~----------------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ 166 (397)
T 1wak_A 104 VQLLDDFKISGV----------------NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC 166 (397)
T ss_dssp CCEEEEEEEEET----------------TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeeecceeecCC----------------CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 999999863210 133568999999 66788877665556799999999999999999999998
Q ss_pred CCcccCCCCCCEEECCCC-------------------------------------------------cEEEeecccceec
Q 036382 227 KIVHRDVKTENMLLDSQR-------------------------------------------------TLKIADFGVARVE 257 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~-------------------------------------------------~~kL~DfG~a~~~ 257 (390)
||+||||||+|||++.++ .+||+|||+++..
T Consensus 167 givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~ 246 (397)
T 1wak_A 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246 (397)
T ss_dssp CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEET
T ss_pred CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccc
Confidence 999999999999998775 7999999999865
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh------hHHHHHHH--cC------
Q 036382 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA------DVSSAVVR--QN------ 323 (390)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~------~~~~~~~~--~~------ 323 (390)
... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.. +....+.. ..
T Consensus 247 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 323 (397)
T 1wak_A 247 HKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323 (397)
T ss_dssp TBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred ccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence 432 34567999999999999999999999999999999999999999765422 22222111 00
Q ss_pred ----C----------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 324 ----L----------------------------RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 324 ----~----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+ ....+..+++++.+||.+||+.||++|||+.+++++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 001123345678999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=332.83 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=199.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +++.||||+++.. ......+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 5799999999999999999987 6889999998521 122466889999999999999999999987654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
....+. .........|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus 76 ~~~~~~-------~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Ni 147 (303)
T 1zy4_A 76 NFVKPM-------TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNI 147 (303)
T ss_dssp CCCC-------------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred chhhhh-------cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhE
Confidence 322100 1112346679999999999999999653 35688999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCC--------------CCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhC
Q 036382 239 LLDSQRTLKIADFGVARVEAQN--------------PRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCC 303 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g 303 (390)
|++.++.+||+|||++...... ........+|+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 9999999999999998754321 1223345689999999999865 68999999999999999998
Q ss_pred CCCCCCC-ChhhHHHHHHHc--CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 304 DMPYPDL-SFADVSSAVVRQ--NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 304 ~~Pf~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
||... +..+....+... .+.+..+..++..+.++|.+||+.||.+|||+.++++.
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 66432 223333333222 23344556678889999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=341.62 Aligned_cols=258 Identities=28% Similarity=0.485 Sum_probs=185.6
Q ss_pred CCCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHH-HHHhcCCCccc
Q 036382 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA-VWQKLDHPNVT 148 (390)
Q Consensus 72 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv 148 (390)
+...|.+..++|++.+.||+|+||.||+|.+ +++.||||+++.... .. ....+..|+. +++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~-~~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-------EK-EQKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-------HH-HHHHHHHHHHHHHSSCCCTTBC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-------ch-HHHHHHHHHHHHHHcCCCCcEe
Confidence 4567889999999999999999999999998 488999999974321 11 1233445555 67778999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHh
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR---NRRKKLALKIVIQLALDLSRGLSYLHS 225 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~yLH~ 225 (390)
++++++.+.. ..++||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+
T Consensus 85 ~~~~~~~~~~--------------------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 143 (327)
T 3aln_A 85 QFYGALFREG--------------------DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143 (327)
T ss_dssp CEEEEEECSS--------------------EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeeEEEeCC--------------------ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc
Confidence 9999987543 45889999985 88888753 224679999999999999999999999
Q ss_pred C-CCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCcccccccc----CCCCCCCchhHHHHHHHHHHH
Q 036382 226 K-KIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL----QGKPYNRRCDVYSFGICLWEI 300 (390)
Q Consensus 226 ~-~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el 300 (390)
. ||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++ .+..++.++|||||||++|+|
T Consensus 144 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 222 (327)
T 3aln_A 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222 (327)
T ss_dssp HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHH
T ss_pred cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHH
Confidence 9 9999999999999999999999999999754432 222334789999999998 456789999999999999999
Q ss_pred HhCCCCCCCCChh-hHHHHHHHcCCCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 301 YCCDMPYPDLSFA-DVSSAVVRQNLRPEI----PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 301 l~g~~Pf~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
++|..||...... +....+ ..+..+.. +..+++++.+||.+||..||.+|||+.++++.
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 223 ATGRFPYPKWNSVFDQLTQV-VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HHSCCCSSCC-------CCC-CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHCCCCCCCcchHHHHHHHH-hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 9999999875422 211111 11112222 24689999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=341.80 Aligned_cols=265 Identities=21% Similarity=0.258 Sum_probs=199.3
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.....++|++.+.||+|+||.||+|++ +++.||||++....... ..+.++++.++.++||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~l~~l~h~niv~~~~~ 87 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----------NRELQIMQDLAVLHHPNIVQLQSY 87 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----------CHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----------HHHHHHHHHHHhcCCCCcccHHHh
Confidence 345568999999999999999999998 47899999886432211 234567888889999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHH--hCCCc
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR--NRRKKLALKIVIQLALDLSRGLSYLH--SKKIV 229 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~ii 229 (390)
+...... .......++||||+.+ +|.+.+.. .....+++..+..++.|++.||.||| +.||+
T Consensus 88 ~~~~~~~-------------~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~iv 153 (360)
T 3e3p_A 88 FYTLGER-------------DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153 (360)
T ss_dssp EEEECSS-------------CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCB
T ss_pred hhccccc-------------cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCee
Confidence 8653321 0122346899999986 66655542 23456899999999999999999999 99999
Q ss_pred ccCCCCCCEEECC-CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCC
Q 036382 230 HRDVKTENMLLDS-QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 230 HrDlkp~NILl~~-~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
||||||+|||++. ++.+||+|||++...... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCCHHHEEEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence 9999999999997 899999999999865433 2334467899999999997654 899999999999999999999999
Q ss_pred CCCChhhHHHHHHHcCC------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 308 PDLSFADVSSAVVRQNL------------------------------RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+.+..+....+..... ....+..+++++.+||.+||+.||.+|||+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 312 (360)
T 3e3p_A 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312 (360)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence 99887777766653211 112233367899999999999999999999999
Q ss_pred HHH--HHHhH
Q 036382 358 VKM--LEAID 365 (390)
Q Consensus 358 l~~--L~~~~ 365 (390)
+++ ++.+.
T Consensus 313 l~hp~f~~~~ 322 (360)
T 3e3p_A 313 LCHPYFDELH 322 (360)
T ss_dssp TTSGGGGGGG
T ss_pred hcCccccccC
Confidence 974 44444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=347.89 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=183.0
Q ss_pred cCccc-cccccccCceEEEEEEE----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 81 SKLDM-RNLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 81 ~~~~~-~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
+.|++ .++||+|+||.||+|++ +++.||||+++.... ...+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----------CHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----------CHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 34666 45899999999999986 367999999963221 134678999999999999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-------RKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
... ....|+||||+. |+|.+++.... ...+++..++.++.||+.||.|||++||
T Consensus 89 ~~~------------------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 149 (405)
T 3rgf_A 89 SHA------------------DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV 149 (405)
T ss_dssp ETT------------------TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cCC------------------CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 432 334589999996 58988885332 2249999999999999999999999999
Q ss_pred cccCCCCCCEEE----CCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHH
Q 036382 229 VHRDVKTENMLL----DSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEI 300 (390)
Q Consensus 229 iHrDlkp~NILl----~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el 300 (390)
+||||||+|||+ +.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred eCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 999999999999 677899999999998654321 22344678999999999987 4589999999999999999
Q ss_pred HhCCCCCCCCChh---------hHHHHHHHcCCCCC------------------------------------CCCCCcHH
Q 036382 301 YCCDMPYPDLSFA---------DVSSAVVRQNLRPE------------------------------------IPRCCPSS 335 (390)
Q Consensus 301 l~g~~Pf~~~~~~---------~~~~~~~~~~~~~~------------------------------------~~~~~~~~ 335 (390)
++|..||.+.... +.+..+......+. .....++.
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 9999999765431 22222221100000 01122678
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 336 LANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 336 l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.+||.+||..||.+|||+.+++++
T Consensus 310 ~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCCcccCCCHHHHhcC
Confidence 8999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.21 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=177.1
Q ss_pred ccCccccc-cccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 80 LSKLDMRN-LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
.++|.+.+ +||+|+||.||+|.+ +++.||||++... . .........++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------P-------KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------H-------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------H-------HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 46899855 699999999999988 4889999998621 1 111223334567799999999999864
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... .....++||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus 94 ~~~----------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~ 157 (336)
T 3fhr_A 94 MHH----------------GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157 (336)
T ss_dssp EET----------------TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ccC----------------CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 221 1234589999999999999997665567999999999999999999999999999999999
Q ss_pred CEEECC---CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLLDS---QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~---~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||++. ++.+||+|||++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred HEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 999976 455999999999754432 233467899999999999889999999999999999999999999776544
Q ss_pred hHHH----HHHHc--CCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSS----AVVRQ--NLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~----~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.... .+... .........+++++.+||.+||..||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4321 11111 12222335789999999999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=335.61 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=200.5
Q ss_pred ccCccccccccccCceEEEEEEE--CC-ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc------cceE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DN-QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN------VTKF 150 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~ 150 (390)
.++|++.+.||+|+||.||+|.+ ++ +.||||+++.. ......+.+|+.+++.++|++ ++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----------GKYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----------ccchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 47899999999999999999987 33 68999999621 122356778999999987765 8888
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
++++... +..|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|
T Consensus 88 ~~~~~~~--------------------~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH 146 (355)
T 2eu9_A 88 SDWFNFH--------------------GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTH 146 (355)
T ss_dssp EEEEEET--------------------TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred eeeeeeC--------------------CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 8888644 3458899999 678888887665567999999999999999999999999999
Q ss_pred cCCCCCCEEE-------------------CCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHH
Q 036382 231 RDVKTENMLL-------------------DSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVY 291 (390)
Q Consensus 231 rDlkp~NILl-------------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 291 (390)
|||||+|||+ +.++.+||+|||++...... .....||+.|+|||++.+..++.++|||
T Consensus 147 ~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 223 (355)
T 2eu9_A 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVW 223 (355)
T ss_dssp CCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred CCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchH
Confidence 9999999999 56789999999999864332 3446799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCC------------------------------------------CCC
Q 036382 292 SFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP------------------------------------------EIP 329 (390)
Q Consensus 292 SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------------------------~~~ 329 (390)
||||++|||++|..||...+..+....+....... ...
T Consensus 224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (355)
T 2eu9_A 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303 (355)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence 99999999999999999887766554432211000 001
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 330 RCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 330 ~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+.++.+||.+||..||++|||+.++++
T Consensus 304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 122467999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.21 Aligned_cols=254 Identities=21% Similarity=0.345 Sum_probs=201.3
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-----------
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD----------- 143 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------- 143 (390)
.+..++|++.+.||+|+||.||+|++ +++.||||+++.. . .....+.+|+.+++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------K----VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------c----cchhhhhHHHHHHHHhhcccccchhccc
Confidence 34567899999999999999999987 6789999998621 1 12355778999988876
Q ss_pred CCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Q 036382 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYL 223 (390)
Q Consensus 144 hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yL 223 (390)
||||+++++++..... .....++||||+ +++|.+++.......+++..++.++.||+.||.||
T Consensus 85 ~~~i~~~~~~~~~~~~----------------~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l 147 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGP----------------NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 147 (373)
T ss_dssp HTTBCCCCEEEEEEET----------------TEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHhhccCC----------------CCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH
Confidence 8999999999875421 122458999999 88999999876666799999999999999999999
Q ss_pred HhC-CCcccCCCCCCEEEC------CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHH
Q 036382 224 HSK-KIVHRDVKTENMLLD------SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296 (390)
Q Consensus 224 H~~-~iiHrDlkp~NILl~------~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 296 (390)
|++ ||+||||||+|||++ ..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||+
T Consensus 148 H~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 224 (373)
T 1q8y_A 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 224 (373)
T ss_dssp HHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred HhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHH
Confidence 998 999999999999994 4458999999999865432 344578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh------hhHHHHHHHcC----------------------------------------CCCCCCC
Q 036382 297 LWEIYCCDMPYPDLSF------ADVSSAVVRQN----------------------------------------LRPEIPR 330 (390)
Q Consensus 297 l~ell~g~~Pf~~~~~------~~~~~~~~~~~----------------------------------------~~~~~~~ 330 (390)
+|+|++|..||...+. .+....+.... ....++.
T Consensus 225 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (373)
T 1q8y_A 225 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304 (373)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCc
Confidence 9999999999976531 22222221100 0112334
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 331 CCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 331 ~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.++.++.+||.+||+.||.+|||+.+++++
T Consensus 305 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred chHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 456789999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=338.26 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=202.0
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CC-----ccce
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HP-----NVTK 149 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~ 149 (390)
.-.++|++.+.||+|+||.||+|.+ +++.||||+++.. ......+..|+.+++.++ |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----------KAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----------HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 3467899999999999999999987 5789999999621 112355677888888884 55 4999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCC
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLH--SKK 227 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~ 227 (390)
+++++.... ..|+||||+. |+|.+++.......+++..+..++.|++.||.||| +.|
T Consensus 121 ~~~~~~~~~--------------------~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ 179 (382)
T 2vx3_A 121 LKRHFMFRN--------------------HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS 179 (382)
T ss_dssp EEEEEEETT--------------------EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred eeeeeccCC--------------------ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC
Confidence 999987543 4588999996 59999997765567999999999999999999999 479
Q ss_pred CcccCCCCCCEEEC--CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 036382 228 IVHRDVKTENMLLD--SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 228 iiHrDlkp~NILl~--~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 305 (390)
|+||||||+|||++ .++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 180 ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEcCCCCcccEEEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999995 4688999999999865432 344678999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHHHcCCCCC----------------CCC---------------------C-----------------
Q 036382 306 PYPDLSFADVSSAVVRQNLRPE----------------IPR---------------------C----------------- 331 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~----------------~~~---------------------~----------------- 331 (390)
||.+.+..+....+......++ .+. .
T Consensus 257 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 336 (382)
T 2vx3_A 257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336 (382)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTT
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcccc
Confidence 9999887777666553211000 000 0
Q ss_pred --------CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 332 --------CPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 332 --------~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+++.+||.+||+.||++|||+.+++++
T Consensus 337 ~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp TCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcC
Confidence 01478999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=333.33 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=202.6
Q ss_pred CCcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC--CCccc
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD--HPNVT 148 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv 148 (390)
....+.-.++|++.+.||+|+||.||+|.+ +++.||||+++.......... .....+.+|+.++++++ ||||+
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh---hhhhHHHHHHHHHHhhccCCCCce
Confidence 345556678899999999999999999987 678999999974322110000 01134567999999995 59999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCC-CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG-GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK 227 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 227 (390)
++++++.... ..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 112 ~~~~~~~~~~--------------------~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ 169 (320)
T 3a99_A 112 RLLDWFERPD--------------------SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG 169 (320)
T ss_dssp CEEEEEECSS--------------------EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEecCC--------------------cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999997543 44789999986 8999999653 46999999999999999999999999
Q ss_pred CcccCCCCCCEEEC-CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCC
Q 036382 228 IVHRDVKTENMLLD-SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDM 305 (390)
Q Consensus 228 iiHrDlkp~NILl~-~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~ 305 (390)
|+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 170 ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 247 (320)
T 3a99_A 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247 (320)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence 99999999999999 6799999999999865432 2344679999999999976665 688999999999999999999
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
||.... .+... ....+..+++++.+||.+||..||.+|||+.+|++
T Consensus 248 pf~~~~------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 248 PFEHDE------EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SCCSHH------HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCChh------hhhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 996532 12222 23456778999999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=329.31 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=197.2
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc----CCCccce
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL----DHPNVTK 149 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~hpnIv~ 149 (390)
.+.-.++|++.+.||+|+||.||+|.+ +++.||||+++...... .........+.+|+.+++++ +||||++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG---WSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccc---cccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 344457899999999999999999987 67899999996432211 11111234566799999998 8999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEec-CCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY-LPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
+++++.+.. ..++|||| +.+++|.+++.+. ..+++..++.++.||+.||.|||++||
T Consensus 103 ~~~~~~~~~--------------------~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i 160 (312)
T 2iwi_A 103 LLDWFETQE--------------------GFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGV 160 (312)
T ss_dssp EEEEC-------------------------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTE
T ss_pred EEEEEecCC--------------------eEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 999987543 34789999 7899999999653 469999999999999999999999999
Q ss_pred cccCCCCCCEEEC-CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCC
Q 036382 229 VHRDVKTENMLLD-SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMP 306 (390)
Q Consensus 229 iHrDlkp~NILl~-~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~P 306 (390)
+||||||+|||++ .++.+||+|||++...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 161 ~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 238 (312)
T 2iwi_A 161 VHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238 (312)
T ss_dssp ECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred eecCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCC
Confidence 9999999999999 7899999999999865432 2345679999999999876665 4589999999999999999999
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
|.... .+... ...++..++.++.+||.+||+.||++|||+.++++.
T Consensus 239 f~~~~------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 239 FERDQ------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCSHH------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCChH------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 96532 12222 345677889999999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.81 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=190.1
Q ss_pred cccccccCccccccccccCceE-EEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGS-VYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~ 152 (390)
.+.+...+|++.+.||+|+||. ||++..+++.||||++..... ..+.+|+.+++++ +||||+++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------------~~~~~E~~~l~~l~~HpnIv~l~~ 85 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------------SFADREVQLLRESDEHPNVIRYFC 85 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------------EECHHHHHHHHHSCCCTTBCCEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------------HHHHHHHHHHHhccCCCCcCeEEE
Confidence 4556667799999999999998 556777999999999863211 2245799999999 8999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+.. ..|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 86 ~~~~~~--------------------~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 143 (432)
T 3p23_A 86 TEKDRQ--------------------FQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143 (432)
T ss_dssp EEEETT--------------------EEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEecCC--------------------EEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCC
Confidence 987543 3478999996 59999996543 3455556789999999999999999999999
Q ss_pred CCCCCEEECCC-----CcEEEeecccceeccCCC---CCCCCCCCCCccccccccC---CCCCCCchhHHHHHHHHHHHH
Q 036382 233 VKTENMLLDSQ-----RTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQ---GKPYNRRCDVYSFGICLWEIY 301 (390)
Q Consensus 233 lkp~NILl~~~-----~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell 301 (390)
|||+|||++.+ ..+||+|||+++...... ......+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 99999999532 368899999998654321 2234467999999999997 456788999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHHHcCCCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 302 C-CDMPYPDLSFADVSSAVVRQNLRPE-IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 302 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+ |..||.................... .+...+..+.+||.+||+.||.+|||+.++++
T Consensus 224 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 224 SEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9 9999976544443222111111111 12234566899999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.11 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=186.3
Q ss_pred cccccccCc-cccccccccCceEEE-EEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEE
Q 036382 75 EWEIDLSKL-DMRNLIAQGTYGSVY-RGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFV 151 (390)
Q Consensus 75 ~~~i~~~~~-~~~~~lg~G~~g~Vy-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 151 (390)
+++..+.++ ...+.||+|+||+|| .+..+|+.||||++... . .+.+.+|+.+++++ +||||++++
T Consensus 8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~------~~~~~~E~~~l~~l~~HpnIv~~~ 75 (434)
T 2rio_A 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------F------CDIALMEIKLLTESDDHPNVIRYY 75 (434)
T ss_dssp CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------G------HHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred chhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------H------HHHHHHHHHHHHhccCCCCcCeEE
Confidence 344444444 556889999999996 45668999999998621 1 23467899999887 899999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhC
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK-----LALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
+++.+.. ..|+||||+. |+|.+++....... .++..++.++.||+.||.|||++
T Consensus 76 ~~~~~~~--------------------~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 134 (434)
T 2rio_A 76 CSETTDR--------------------FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134 (434)
T ss_dssp EEEECSS--------------------EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT
T ss_pred EEEecCC--------------------eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC
Confidence 9987543 4488999995 69999996543211 12334578999999999999999
Q ss_pred CCcccCCCCCCEEECCC-------------CcEEEeecccceeccCCCC----CCCCCCCCCccccccccCC-------C
Q 036382 227 KIVHRDVKTENMLLDSQ-------------RTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLQG-------K 282 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~-------------~~~kL~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~ 282 (390)
||+||||||+|||++.+ +.+||+|||++........ ......||+.|+|||++.+ .
T Consensus 135 ~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 214 (434)
T 2rio_A 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKR 214 (434)
T ss_dssp TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCC
T ss_pred CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccccc
Confidence 99999999999999754 4899999999986543321 1234579999999999976 6
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 036382 283 PYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIP-----RCCPSSLANIMRKCWDANAEKRPEMGE 356 (390)
Q Consensus 283 ~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~ 356 (390)
.++.++|||||||++|||++ |..||.+....+ ..+.......... ..+++++.+||.+||+.||.+|||+.+
T Consensus 215 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (434)
T 2rio_A 215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292 (434)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence 78999999999999999999 999997654433 2333333322211 234688999999999999999999999
Q ss_pred HHH
Q 036382 357 VVK 359 (390)
Q Consensus 357 ll~ 359 (390)
|++
T Consensus 293 il~ 295 (434)
T 2rio_A 293 VLR 295 (434)
T ss_dssp HHT
T ss_pred HHh
Confidence 985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=318.61 Aligned_cols=233 Identities=12% Similarity=0.134 Sum_probs=187.2
Q ss_pred cccCccccccccccCceEEEEEEEC--CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD--NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
-.++|++.+.||+|+||.||+|.+. ++.||||+++..... .......+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL------PDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc------CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 3467999999999999999999984 789999999743221 12234678899999999999999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..|+||||+.+++|.+++.+ ......+..++.|++.||.|||++||+||||||+
T Consensus 103 ~~--------------------~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~ 158 (286)
T 3uqc_A 103 RA--------------------GGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPS 158 (286)
T ss_dssp TT--------------------EEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CC--------------------cEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcc
Confidence 43 45889999999999999843 2466678999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|||++.+|.+||+++| |++ +++.++|||||||++|+|++|..||.+.+..+..
T Consensus 159 NIll~~~g~~kl~~~~--------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 159 RVRVSIDGDVVLAYPA--------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp GEEEETTSCEEECSCC--------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred cEEEcCCCCEEEEecc--------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 9999999999998543 233 3788999999999999999999999876543321
Q ss_pred H---HHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 317 S---AVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 317 ~---~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
. ......... ..+..+|+++.+||.+||+.||++| |+.++++.|+.+.....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0 001111111 1235689999999999999999999 99999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=316.96 Aligned_cols=229 Identities=22% Similarity=0.400 Sum_probs=182.0
Q ss_pred ccCcccc-ccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHH-HhcCCCccceEEEEEe
Q 036382 80 LSKLDMR-NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVW-QKLDHPNVTKFVGASV 155 (390)
Q Consensus 80 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~ 155 (390)
.++|.+. +.||+|+||.||++.+ +++.||||+++.. ..+.+|+.++ +.++||||+++++++.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 4678777 7899999999999988 6789999998621 3456788887 5569999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... ......++||||+.+|+|.+++.......+++..++.++.|++.||.|||++||+||||||
T Consensus 82 ~~~----------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 82 NLY----------------AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp EEE----------------TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred hhc----------------CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 411 0133458999999999999999876556799999999999999999999999999999999
Q ss_pred CCEEECC---CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 236 ENMLLDS---QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 236 ~NILl~~---~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
+|||++. ++.+||+|||++.... +..++.++|||||||++|+|++|..||.....
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred HHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9999998 7899999999986432 23478899999999999999999999977654
Q ss_pred hhHHHHHHHcCC--CCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNL--RPEIP----RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~--~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
............ ....+ ..+++++.+||.+||+.||.+|||+.+++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 332211111100 11122 4678999999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.23 Aligned_cols=263 Identities=16% Similarity=0.174 Sum_probs=189.6
Q ss_pred ccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC-CccceE--
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-PNVTKF-- 150 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~-- 150 (390)
+......|+..+.||+|+||.||+|.+ +|+.||||+++...... ....+.+.+|+.+++.++| +|+...
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~------~~~~~~~~~E~~~~~~l~~~~~~~~~~~ 146 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP------SNAIKQMKEEVLRLRLLRGIKNQKQAKV 146 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc------HHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence 334456688999999999999999998 48999999987332211 1223568899999999977 332211
Q ss_pred -------EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHh-----hccCCCCHHHHHHHHHHHHH
Q 036382 151 -------VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIR-----NRRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 151 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~i~~ 218 (390)
+........... ...............+++|+++ +++|.+++.. ..+..+++..++.++.||+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~ 222 (413)
T 3dzo_A 147 HLRFIFPFDLVKDPQKKKM---IRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222 (413)
T ss_dssp HTCBCCCCEEEECCC------------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHH
T ss_pred hcccccchhhcccCCCCcc---ccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHH
Confidence 111111000000 0000000011123456777766 6799999852 22445788899999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCcccccccc----------CCCCCCCch
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVL----------QGKPYNRRC 288 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~ 288 (390)
||.|||++||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++
T Consensus 223 aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 223 LLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 999999999999999999999999999999999998764432 344567 999999999 666788999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 289 DVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 289 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
|||||||++|||++|+.||...+..+....+. .....+|+++.+||.+||+.||++|||+.+++
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999999999998766554333221 12246789999999999999999999976664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.63 Aligned_cols=266 Identities=27% Similarity=0.357 Sum_probs=202.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +|+.||||+++... .......+.+|++++++++||||+++++++...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--------SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--------CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 47899999999999999999987 67899999986321 122346688999999999999999999987542
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR-RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... ......|+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+.||+||||||+
T Consensus 85 ~~~--------------~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~ 150 (676)
T 3qa8_A 85 QKL--------------APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPE 150 (676)
T ss_dssp CCC--------------CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCST
T ss_pred ccc--------------cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 211 12456689999999999999996532 235899999999999999999999999999999999
Q ss_pred CEEECCCCc---EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 237 NMLLDSQRT---LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 237 NILl~~~~~---~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|||++.++. +||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 151 NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 151 NIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp TEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred HeEeecCCCceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 999997765 999999999865433 2334568999999999999999999999999999999999999999764222
Q ss_pred hHHH---------HHH-----HcC--C------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHhHh
Q 036382 314 DVSS---------AVV-----RQN--L------RPEIPRCCPSSLANIMRKCWDANAEKRPEMGE-----VVKMLEAIDT 366 (390)
Q Consensus 314 ~~~~---------~~~-----~~~--~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~-----ll~~L~~~~~ 366 (390)
.... ... ... + ....+..+++.+.++|.+||..||++|||+.+ ..+.++++..
T Consensus 230 ~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 1100 000 000 0 00122336789999999999999999999988 4566666654
Q ss_pred cC
Q 036382 367 SK 368 (390)
Q Consensus 367 ~~ 368 (390)
.+
T Consensus 310 ~k 311 (676)
T 3qa8_A 310 LK 311 (676)
T ss_dssp CC
T ss_pred cc
Confidence 33
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=347.43 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=194.5
Q ss_pred ccccCccccccccccCceEEEEEEE---CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
+-.++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++||||+++++++
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--------DAEAQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 4457899999999999999999987 47899999986321 112345678999999999999999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
...... .....|+||||+.+++|.+++.. .+++..++.++.||+.||.|||++||+|||||
T Consensus 149 ~~~~~~---------------~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk 209 (681)
T 2pzi_A 149 EHTDRH---------------GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209 (681)
T ss_dssp EEECTT---------------SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred eecCCC---------------CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence 764321 11225899999999999987732 69999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.+ .+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....
T Consensus 210 p~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~ 283 (681)
T 2pzi_A 210 PENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283 (681)
T ss_dssp GGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS
T ss_pred hHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc
Confidence 999999875 9999999999865432 446799999999998765 4889999999999999999999886532111
Q ss_pred HHHHHHHcCCCCC-CCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhH
Q 036382 315 VSSAVVRQNLRPE-IPRCCPSSLANIMRKCWDANAEKRP-EMGEVVKMLEAID 365 (390)
Q Consensus 315 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~ 365 (390)
.... ....+++.+.+||.+||+.||.+|| +++++.+.|..+.
T Consensus 284 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 ---------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 0011357899999999999999999 5667777776653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=325.49 Aligned_cols=266 Identities=15% Similarity=0.207 Sum_probs=191.8
Q ss_pred ccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC---------CCccc
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD---------HPNVT 148 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------hpnIv 148 (390)
+..++|++.+.||+|+||.||+|+++|+.||||+++........ .......+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVN-GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBT-TBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccc-cccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 45678999999999999999999999999999999754321100 000111245778999988885 88888
Q ss_pred eEEEEEeccc--ccccCCc-cc-------ccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHH
Q 036382 149 KFVGASVGTS--NLKIPSK-TA-------SVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSR 218 (390)
Q Consensus 149 ~~~~~~~~~~--~~~~~~~-~~-------~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~ 218 (390)
++.+++.... +-.+... .. .............|+||||+.+|++.+.+.+ ..+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 8877654211 0000000 00 0000011135678999999999977666632 45899999999999999
Q ss_pred HHHHHH-hCCCcccCCCCCCEEECCCC--------------------cEEEeecccceeccCCCCCCCCCCCCCcccccc
Q 036382 219 GLSYLH-SKKIVHRDVKTENMLLDSQR--------------------TLKIADFGVARVEAQNPRDMTGETGTLGYMAPE 277 (390)
Q Consensus 219 ~L~yLH-~~~iiHrDlkp~NILl~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE 277 (390)
||.||| ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 999999 99999999999999999887 8999999999865432 247999999999
Q ss_pred ccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-hhHHHHHHHcC-CCCCC----CCCCcHHHHHHHHHhhhhCCCC
Q 036382 278 VLQGKPYNRRCDVYSFGIC-LWEIYCCDMPYPDLSF-ADVSSAVVRQN-LRPEI----PRCCPSSLANIMRKCWDANAEK 350 (390)
Q Consensus 278 ~~~~~~~~~~~DiwSlG~i-l~ell~g~~Pf~~~~~-~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~cl~~dP~~ 350 (390)
++.+.. +.++|||||+++ .+++++|..||.+... ......+.... ..... +..+++++.+||.+||++|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 998776 899999998777 7788889999854321 11222332221 11111 2246788999999999977
Q ss_pred CCCHHHHH
Q 036382 351 RPEMGEVV 358 (390)
Q Consensus 351 Rpt~~~ll 358 (390)
|+.+++
T Consensus 324 --sa~e~l 329 (336)
T 2vuw_A 324 --SATDLL 329 (336)
T ss_dssp --SHHHHH
T ss_pred --CHHHHH
Confidence 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=289.13 Aligned_cols=190 Identities=16% Similarity=0.164 Sum_probs=132.4
Q ss_pred ccccCceEEEEE--EECCceEEEEEeccCCC-CccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccccccCC
Q 036382 89 IAQGTYGSVYRG--TYDNQEVAVKLLDWGED-GMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 89 lg~G~~g~Vy~~--~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 164 (390)
.+.|++|.+..+ .+.|+.||||++..... ........+...+.|.+|+++|+++ .|+||+++++++.++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~----- 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS----- 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE-----
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE-----
Confidence 445666655543 34789999999974432 2223444555667899999999999 79999999999986544
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCC
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~ 244 (390)
.||||||++|++|.++|.+ +..+++. .|+.||+.||+|+|++|||||||||+|||++.+|
T Consensus 317 ---------------~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg 376 (569)
T 4azs_A 317 ---------------GWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ 376 (569)
T ss_dssp ---------------EEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS
T ss_pred ---------------EEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC
Confidence 4789999999999999964 3457765 4789999999999999999999999999999999
Q ss_pred cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 036382 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 245 ~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
.+||+|||+|+..........+.+||+.|||||++.+. +..++|+||+|++++++.++.
T Consensus 377 ~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 377 HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 99999999998765555555567899999999999764 677899999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=259.15 Aligned_cols=190 Identities=17% Similarity=0.210 Sum_probs=146.0
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccccccCCc
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSK 165 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 165 (390)
.++||+|+||.||+|...++.+++|........ ..........+.+.+|++++++++||||+++..++...
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-------- 411 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYR-DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-------- 411 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTS-CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--------
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEeccccc-chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--------
Confidence 568999999999999989999999987542211 12223333457789999999999999999544444332
Q ss_pred ccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCc
Q 036382 166 TASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRT 245 (390)
Q Consensus 166 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~ 245 (390)
...|+||||+++++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .
T Consensus 412 ------------~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 412 ------------DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp ------------TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S
T ss_pred ------------CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e
Confidence 223889999999999999843 5689999999999999999999999999999988 9
Q ss_pred EEEeecccceeccCCCCC-------CCCCCCCCccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 246 LKIADFGVARVEAQNPRD-------MTGETGTLGYMAPEVLQG--KPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 246 ~kL~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
+||+|||+++........ ....+||+.|+|||++.+ ..|+..+|+||..+-..+.+.++.+|.
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999999999865432111 124579999999999977 568888999999999888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-26 Score=211.65 Aligned_cols=150 Identities=17% Similarity=0.156 Sum_probs=113.1
Q ss_pred cccccccccCceEEEEEEE-CCceEEEEEeccCCCCccch---------HHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 84 DMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATT---------AETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.+.+.||+|+||.||+|.+ +|+.||||+++.+....... .........+.+|+.++++++| +++.++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 3459999999999999998 57899999997433211100 0011235678899999999984 555554
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.. +..|+||||+++++|.+ +. . .....++.|++.||.|||++||+||||
T Consensus 170 ~~~---------------------~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDl 219 (282)
T 1zar_A 170 YAW---------------------EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDL 219 (282)
T ss_dssp EEE---------------------ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred Eec---------------------cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCC
Confidence 421 23388999999999987 41 1 224579999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ 280 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 280 (390)
||+|||++ ++.+||+|||+|+. +..++|||.+.
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 99999999 99999999999863 33468899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=177.60 Aligned_cols=144 Identities=16% Similarity=0.165 Sum_probs=106.7
Q ss_pred ccccccccccCceEEEEEEE--CCce--EEEEEeccCCCCccch---------------HHHHHHHHHHHHHHHHHHhcC
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQE--VAVKLLDWGEDGMATT---------------AETAALRSSFQQEVAVWQKLD 143 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l~ 143 (390)
|++.+.||+|+||.||+|.+ +|+. ||||+++......... .........+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67888999999999999987 7888 9999986432111100 001222346789999999998
Q ss_pred CCcc--ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCC-C----CHHHHHHhhccCCCCHHHHHHHHHHH
Q 036382 144 HPNV--TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG-G----NLKQYLIRNRRKKLALKIVIQLALDL 216 (390)
Q Consensus 144 hpnI--v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~i 216 (390)
|+|+ ..+++. ...++||||+.+ | +|.++... .++..+..++.|+
T Consensus 129 ~~~i~~p~~~~~------------------------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi 179 (258)
T 1zth_A 129 EAGVSVPQPYTY------------------------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDV 179 (258)
T ss_dssp HTTCCCCCEEEE------------------------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHH
T ss_pred hCCCCCCeEEEc------------------------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHH
Confidence 8764 333332 123789999942 3 77776422 2345678899999
Q ss_pred HHHHHHHH-hCCCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 217 SRGLSYLH-SKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 217 ~~~L~yLH-~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
+.||.||| +.||+||||||.|||++. .++|+|||+|...
T Consensus 180 ~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 180 VENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999 999999999999999988 9999999999743
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=167.58 Aligned_cols=142 Identities=15% Similarity=0.126 Sum_probs=99.5
Q ss_pred ccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccc-------------hHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMAT-------------TAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
|++.+.||+|+||.||+|.. +|+.||||+++.+...... ........-...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 78899999999999999987 6889999998643221110 011111112234566667666444432
Q ss_pred --eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036382 149 --KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK 226 (390)
Q Consensus 149 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 226 (390)
..++. ...++||||+.|++|.++.. . .....++.|++.+|.|||+.
T Consensus 177 vp~p~~~------------------------~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~ 224 (397)
T 4gyi_A 177 VPEPIAQ------------------------SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH 224 (397)
T ss_dssp CCCEEEE------------------------ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT
T ss_pred CCeeeec------------------------cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC
Confidence 22221 12278999999988865431 1 23456789999999999999
Q ss_pred CCcccCCCCCCEEECCCC----------cEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQR----------TLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~----------~~kL~DfG~a~~ 256 (390)
|||||||||.|||++.++ .+.|+||+.+-.
T Consensus 225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999999999998876 389999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=7.6e-13 Score=120.76 Aligned_cols=140 Identities=14% Similarity=0.085 Sum_probs=107.6
Q ss_pred cCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEecccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSN 159 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 159 (390)
+.|++...++.|+.+.||++...++.+++|+........ ...+.+|+++++.+ .+.++.++++++.+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-- 82 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---------TYDVEREKDMMLWLEGKLPVPKVLHFERHD-- 82 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---------HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--
Confidence 468888889999999999998888999999986321100 13477899999998 466777888887532
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--------------
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-------------- 225 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-------------- 225 (390)
+..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 83 ------------------~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~ 137 (263)
T 3tm0_A 83 ------------------GWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp ------------------TEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHH
T ss_pred ------------------CceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHH
Confidence 34588999999999987531 112234678899999999998
Q ss_pred ---------------------------------------------CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 226 ---------------------------------------------KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 226 ---------------------------------------------~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=6.7e-11 Score=107.15 Aligned_cols=134 Identities=18% Similarity=0.173 Sum_probs=94.4
Q ss_pred cCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc--cceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN--VTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~ 157 (390)
..+.+..+.+.|..+.||++... |..++||+..... ...+.+|+.+++.+.+.+ +.+++++....
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 34555555556777999999764 6789999975321 134668999999885444 44577765432
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC----------
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK---------- 227 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------- 227 (390)
+..++||||++|.+|. . . ..+. ..++.+++..|..||+..
T Consensus 88 --------------------~~~~~v~e~i~G~~l~--~--~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~ 137 (264)
T 1nd4_A 88 --------------------GRDWLLLGEVPGQDLL--S--S---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQA 137 (264)
T ss_dssp --------------------SCEEEEEECCSSEETT--T--S---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCH
T ss_pred --------------------CCCEEEEEecCCcccC--c--C---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 3458999999998884 2 1 1121 255667777777777643
Q ss_pred ------------------------------------------------CcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 228 ------------------------------------------------IVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 228 ------------------------------------------------iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 138 KHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=9.2e-11 Score=112.03 Aligned_cols=142 Identities=14% Similarity=0.199 Sum_probs=105.3
Q ss_pred cccccccCceEEEEEEECCceEEEEEec--cCCCCccchHHHHHHHHHHHHHHHHHHhcC--CCccceEEEEEecccccc
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLD--WGEDGMATTAETAALRSSFQQEVAVWQKLD--HPNVTKFVGASVGTSNLK 161 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~ 161 (390)
.+.++.|.++.||+....+..+++|+.. .+.. ......+.+|..+++.+. +..+.+++.++.+...
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-- 112 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--------LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-- 112 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC--------CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--
Confidence 4568899999999998888899999875 3211 011246778999999996 3457788887754321
Q ss_pred cCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh----------------
Q 036382 162 IPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS---------------- 225 (390)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~---------------- 225 (390)
.+..|+||||++|.++.+.. -..++......++.+++..|..||+
T Consensus 113 ---------------~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~ 173 (359)
T 3dxp_A 113 ---------------IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN 173 (359)
T ss_dssp ---------------TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred ---------------cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence 23458999999998775421 2347788888999999999999997
Q ss_pred ------------------------------------------CCCcccCCCCCCEEECCCCc--EEEeeccccee
Q 036382 226 ------------------------------------------KKIVHRDVKTENMLLDSQRT--LKIADFGVARV 256 (390)
Q Consensus 226 ------------------------------------------~~iiHrDlkp~NILl~~~~~--~kL~DfG~a~~ 256 (390)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=4.1e-10 Score=104.99 Aligned_cols=185 Identities=19% Similarity=0.255 Sum_probs=119.6
Q ss_pred ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCc--cceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPN--VTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~~~~~~ 163 (390)
+.++.|.+..||+.. ..++||+... . .....+.+|.++++.+ .+.. +.+++........
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~-------~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~---- 87 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH-------S----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET---- 87 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS-------H----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS----
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC-------c----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC----
Confidence 358999999999864 6789998641 1 1235678899999888 4333 2344433221111
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS------------------ 225 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~------------------ 225 (390)
....|+||++++|.+|.+... ..++......++.+++..|..||+
T Consensus 88 -------------~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~ 150 (304)
T 3sg8_A 88 -------------YQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKI 150 (304)
T ss_dssp -------------CSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHH
T ss_pred -------------CCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHH
Confidence 122378999999988875432 237777788888888888888886
Q ss_pred ----------------------------------------CCCcccCCCCCCEEECC--CCcEEEeecccceeccCCCCC
Q 036382 226 ----------------------------------------KKIVHRDVKTENMLLDS--QRTLKIADFGVARVEAQNPRD 263 (390)
Q Consensus 226 ----------------------------------------~~iiHrDlkp~NILl~~--~~~~kL~DfG~a~~~~~~~~~ 263 (390)
..++|+|++|.||+++. ++.+.|+||+.+..... ..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~D 229 (304)
T 3sg8_A 151 NEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DND 229 (304)
T ss_dssp HHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THH
T ss_pred HHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHH
Confidence 13699999999999988 55688999999875422 111
Q ss_pred CCCCCCCCccccccccCC-----CC---------CCCchhHHHHHHHHHHHHhCCCCC
Q 036382 264 MTGETGTLGYMAPEVLQG-----KP---------YNRRCDVYSFGICLWEIYCCDMPY 307 (390)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~-----~~---------~~~~~DiwSlG~il~ell~g~~Pf 307 (390)
.........-..|+.... .. .....+.|+++.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 110000000022222110 00 112368999999999999999776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=8.2e-07 Score=82.69 Aligned_cols=133 Identities=18% Similarity=0.189 Sum_probs=89.1
Q ss_pred ccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCC---ccceEEEEEecccccccC
Q 036382 87 NLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP---NVTKFVGASVGTSNLKIP 163 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~~~~~~~ 163 (390)
..++.|....||+. +..++||+.. .. .....+.+|.++|+.+.+. .+.+.+.+...
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~-------~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~------- 83 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK-------SQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR------- 83 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES-------SH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-------
T ss_pred eecCCCcceeEEEE---CCEEEEEecC-------Cc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-------
Confidence 45788999999988 6789999853 11 1235678999999999642 24455554421
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------------
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK----------------- 226 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------------- 226 (390)
..+..++|||+++|.+|.+... ..++......++.++...|..||+.
T Consensus 84 ------------~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~ 147 (306)
T 3tdw_A 84 ------------SDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKN 147 (306)
T ss_dssp ------------TTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHH
T ss_pred ------------CCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHH
Confidence 1234579999999988876321 1234444444555555555555432
Q ss_pred -------------------------------------------CCcccCCCCCCEEECC---CCc-EEEeeccccee
Q 036382 227 -------------------------------------------KIVHRDVKTENMLLDS---QRT-LKIADFGVARV 256 (390)
Q Consensus 227 -------------------------------------------~iiHrDlkp~NILl~~---~~~-~kL~DfG~a~~ 256 (390)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 148 KILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 48999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.3e-06 Score=76.66 Aligned_cols=130 Identities=18% Similarity=0.167 Sum_probs=88.8
Q ss_pred ccccCce-EEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecccccccCC
Q 036382 89 IAQGTYG-SVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSNLKIPS 164 (390)
Q Consensus 89 lg~G~~g-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~ 164 (390)
+..|..| .||+... .+..++||+...+ ....+.+|..+|+.+. +--+-++++++.+.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~------- 92 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP------- 92 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-------
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-------
Confidence 3445554 6898765 4568999987521 1245678999998883 22355667766532
Q ss_pred cccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC------------------
Q 036382 165 KTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK------------------ 226 (390)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------ 226 (390)
+..++|||+++|.++.+..... ......++.+++..|..||+.
T Consensus 93 -------------~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 93 -------------DDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp -------------TEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred -------------CeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 3458899999999888765321 112334556666667777642
Q ss_pred ----------------------------------------CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 ----------------------------------------KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ----------------------------------------~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=3e-06 Score=80.39 Aligned_cols=84 Identities=11% Similarity=0.077 Sum_probs=52.4
Q ss_pred ccccc-cccCceEEEEEEEC--------CceEEEEEeccCCC-CccchHHHHHHHHHHHHHHHHHHhcC-C--CccceEE
Q 036382 85 MRNLI-AQGTYGSVYRGTYD--------NQEVAVKLLDWGED-GMATTAETAALRSSFQQEVAVWQKLD-H--PNVTKFV 151 (390)
Q Consensus 85 ~~~~l-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~~~ 151 (390)
..+.| +.|....+|+.... +..+++|+...... .... ...+.+|+.+++.+. + -.+.+++
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-------~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-------TYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-------CCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-------hhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 34567 88999999988764 67899998753220 0000 023567888888773 3 2456677
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCH
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 192 (390)
.++.+.. ..+..++||||++|.++
T Consensus 97 ~~~~~~~-----------------~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 97 WIETTGD-----------------VLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEECSST-----------------TTSSCEEEEECCCCBCC
T ss_pred EEccCCC-----------------ccCCceEEEEecCCCCh
Confidence 7654321 11345789999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=2.3e-05 Score=73.37 Aligned_cols=31 Identities=23% Similarity=0.385 Sum_probs=28.0
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=2.7e-05 Score=74.91 Aligned_cols=31 Identities=19% Similarity=0.330 Sum_probs=26.3
Q ss_pred hCCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 225 ~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
...++|+|+.|.|||++.+ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3579999999999999765 489999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.94 E-value=0.00014 Score=63.30 Aligned_cols=139 Identities=12% Similarity=0.112 Sum_probs=94.7
Q ss_pred CHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCC
Q 036382 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETG 269 (390)
Q Consensus 191 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~g 269 (390)
+|.+.|... +.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ +.+. ..
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 799999754 5789999999999999999877622 1212344567899999999998763 1110 11
Q ss_pred CCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhh---
Q 036382 270 TLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDA--- 346 (390)
Q Consensus 270 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--- 346 (390)
...+.+||... ...+.+.-|||||+++|..+--.. ....+..+++.|.+||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHHHhcccc
Confidence 23456787763 345678899999999999875332 3345556788999999998755
Q ss_pred ----------------------CCCCCCCHHHHHHHHHH
Q 036382 347 ----------------------NAEKRPEMGEVVKMLEA 363 (390)
Q Consensus 347 ----------------------dP~~Rpt~~~ll~~L~~ 363 (390)
.+..|+++++|++.=..
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 34688999999876543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00034 Score=64.47 Aligned_cols=29 Identities=28% Similarity=0.378 Sum_probs=25.1
Q ss_pred CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667889999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00022 Score=66.35 Aligned_cols=75 Identities=20% Similarity=0.206 Sum_probs=55.5
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC---CCccceEEEEEeccccccc
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD---HPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~~ 162 (390)
.+.|+.|.+..+|+...++..++||+.... ....+..|.+.|+.|. ...+.+++++...
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~------ 102 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS------ 102 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC------
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec------
Confidence 456899999999999888889999987521 1355778989888873 2456677776542
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCH
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNL 192 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 192 (390)
.+..++||||+++.++
T Consensus 103 --------------~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 103 --------------QGHSFLLLEALNKSKN 118 (312)
T ss_dssp --------------SSEEEEEEECCCCCCC
T ss_pred --------------CCceEEEEEeccCCCC
Confidence 2346899999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00032 Score=67.95 Aligned_cols=78 Identities=10% Similarity=0.148 Sum_probs=47.0
Q ss_pred HhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCC--CCCccccccccCCCC---CCCchhHHHHHHHHH
Q 036382 224 HSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKP---YNRRCDVYSFGICLW 298 (390)
Q Consensus 224 H~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ 298 (390)
+...++|+|++|.|||++.++ ++|+||+.+...... .+..... -...|++|+...... -....++.+....+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 456799999999999998776 999999998753211 1110000 113455655443111 112344557777777
Q ss_pred HHHhC
Q 036382 299 EIYCC 303 (390)
Q Consensus 299 ell~g 303 (390)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00094 Score=61.04 Aligned_cols=78 Identities=15% Similarity=0.135 Sum_probs=52.7
Q ss_pred cCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC--C-ccceEEEEEec
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH--P-NVTKFVGASVG 156 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p-nIv~~~~~~~~ 156 (390)
..+.-...+|.|..+.||+.+. +|+.|+||+........ ...|..|.+.|+.|.- + -+.+++++.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---------DGLFRAEALGLDWLGRSFGSPVPQVAGWD-- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---------hhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence 3455567899999999999987 68899999875332211 1346789999988842 1 234455432
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gs 191 (390)
..++||||+.++.
T Consensus 84 ----------------------~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 ----------------------DRTLAMEWVDERP 96 (288)
T ss_dssp ----------------------TTEEEEECCCCCC
T ss_pred ----------------------CceEEEEeecccC
Confidence 1267999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00029 Score=65.39 Aligned_cols=146 Identities=16% Similarity=0.183 Sum_probs=77.3
Q ss_pred cccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc--ceEEEEEecccccccC
Q 036382 86 RNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV--TKFVGASVGTSNLKIP 163 (390)
Q Consensus 86 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~~~~~~~ 163 (390)
.+.|+.|....+|+...++..+++|+..... ....+..|..+++.+...++ .+++... +...+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-----------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~--- 91 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV-----------EKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELL--- 91 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC--------------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSC---
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCC-----------CHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEE---
Confidence 4567788889999998776689999986310 01234567777777632222 2222110 00000
Q ss_pred CcccccCCCCCCCCCceEEEEecCCCCCHH-----------HHH---Hhh-cc--CC----CC---HHHHHH--------
Q 036382 164 SKTASVDGNAAVPARACCVVVEYLPGGNLK-----------QYL---IRN-RR--KK----LA---LKIVIQ-------- 211 (390)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~-~~--~~----l~---~~~~~~-------- 211 (390)
....+..+++|+|++|..+. ..+ ... .. .. .. +.....
T Consensus 92 ----------~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 92 ----------GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp ----------EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ----------EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 00124468899999886431 111 100 00 00 01 111000
Q ss_pred ----HHHHHHHHHHHHHh-------CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 212 ----LALDLSRGLSYLHS-------KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 212 ----i~~~i~~~L~yLH~-------~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
+...+...+..++. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113344555552 3699999999999998776668999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0014 Score=61.09 Aligned_cols=32 Identities=28% Similarity=0.457 Sum_probs=27.8
Q ss_pred CCCcccCCCCCCEEECCC----CcEEEeecccceec
Q 036382 226 KKIVHRDVKTENMLLDSQ----RTLKIADFGVARVE 257 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~----~~~kL~DfG~a~~~ 257 (390)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999875 68999999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00085 Score=63.68 Aligned_cols=29 Identities=21% Similarity=0.454 Sum_probs=24.5
Q ss_pred CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+|+.+.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999997654 89999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0015 Score=63.55 Aligned_cols=57 Identities=16% Similarity=0.200 Sum_probs=36.9
Q ss_pred ccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc-ceEEEEE
Q 036382 87 NLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV-TKFVGAS 154 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~ 154 (390)
+.|+.|....||+.... +..+++|+.... .. ...+.+|..+++.+...++ .++++.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~------~~~li~E~~~l~~L~~~g~~P~l~~~~ 145 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ET------ESHLVAESVIFTLLSERHLGPKLYGIF 145 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CC------HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----Cc------HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence 45778888999999864 478999988421 01 0233468888888743333 5666654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0046 Score=57.29 Aligned_cols=29 Identities=24% Similarity=0.243 Sum_probs=25.4
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.015 Score=56.89 Aligned_cols=58 Identities=14% Similarity=0.082 Sum_probs=37.2
Q ss_pred ccccccCceEEEEEEECC--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc-ceEEEEE
Q 036382 87 NLIAQGTYGSVYRGTYDN--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV-TKFVGAS 154 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~ 154 (390)
+.|+.|-...+|+....+ ..+++|+......... ...+|..+++.|...++ .++++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i----------dR~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII----------NREREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS----------CHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc----------CHHHHHHHHHHHHhcCCCCCEEEEe
Confidence 457778889999998876 7899998743221111 11478899998865544 4666665
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0024 Score=60.90 Aligned_cols=141 Identities=18% Similarity=0.247 Sum_probs=79.8
Q ss_pred cCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKF 150 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~ 150 (390)
+.+++ +.|..|-...+|+.... ++.+++|+.-.. .. ....+.+|.++++.|. +.-..++
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~-------~~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQ-------GVDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------C-------CHHHHHHHHHHHHHHHHTTSSCCE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cc-------hHHHHHHHHHHHHHHHhcCCCCeE
Confidence 34443 35666888899998763 368999985211 00 1233457888888773 3223456
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHH--------------HHHHhhc------cCCCC--HHH
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK--------------QYLIRNR------RKKLA--LKI 208 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~------~~~l~--~~~ 208 (390)
++.+.+ .+||||++|.+|. +.|.+-. ..... +.+
T Consensus 120 l~~~~~------------------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~ 175 (379)
T 3feg_A 120 YGVFPE------------------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGT 175 (379)
T ss_dssp EEEETT------------------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHH
T ss_pred EEEcCC------------------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHH
Confidence 665531 2699999875442 1111100 11122 345
Q ss_pred HHHHHHHHHH-------------------HHHHHH----h----CCCcccCCCCCCEEECCC----CcEEEeeccccee
Q 036382 209 VIQLALDLSR-------------------GLSYLH----S----KKIVHRDVKTENMLLDSQ----RTLKIADFGVARV 256 (390)
Q Consensus 209 ~~~i~~~i~~-------------------~L~yLH----~----~~iiHrDlkp~NILl~~~----~~~kL~DfG~a~~ 256 (390)
+..+..++-. .+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 176 i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 176 MERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 5555544322 233332 2 248999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.014 Score=54.52 Aligned_cols=31 Identities=19% Similarity=0.427 Sum_probs=27.8
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999998888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.12 Score=49.87 Aligned_cols=29 Identities=21% Similarity=0.572 Sum_probs=26.0
Q ss_pred CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.81 E-value=0.32 Score=46.42 Aligned_cols=29 Identities=28% Similarity=0.517 Sum_probs=25.2
Q ss_pred CcccCCCCCCEEE------CCCCcEEEeeccccee
Q 036382 228 IVHRDVKTENMLL------DSQRTLKIADFGVARV 256 (390)
Q Consensus 228 iiHrDlkp~NILl------~~~~~~kL~DfG~a~~ 256 (390)
++|+|+.+.|||+ ++++.++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.39 E-value=0.043 Score=53.70 Aligned_cols=63 Identities=11% Similarity=0.064 Sum_probs=19.4
Q ss_pred cccccccccCceEEEEEEECC--ceEEE------EEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 84 DMRNLIAQGTYGSVYRGTYDN--QEVAV------KLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
.+.+.+| ||.||+|.+.+ .+||| |..+.+. ........+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-------~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-------VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccc-------ccccccccccccccccccccccccCCCcceEE
Confidence 5566776 99999998864 57888 6554211 11122346778999999999999999988765
Q ss_pred c
Q 036382 156 G 156 (390)
Q Consensus 156 ~ 156 (390)
.
T Consensus 215 ~ 215 (463)
T 3cxl_A 215 H 215 (463)
T ss_dssp E
T ss_pred e
Confidence 3
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 390 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-78 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-78 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-74 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-62 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-62 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-47 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 3e-78
Identities = 82/303 (27%), Positives = 150/303 (49%), Gaps = 39/303 (12%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQ 133
++WEI ++ + I G++G+VY+G + + +VAVK+L+ TA T +F+
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLN-------VTAPTPQQLQAFK 52
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
EV V +K H N+ F+G S +V ++ G +L
Sbjct: 53 NEVGVLRKTRHVNILLFMGYSTAPQ---------------------LAIVTQWCEGSSLY 91
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
+L K + +I +A ++G+ YLH+K I+HRD+K+ N+ L T+KI DFG+
Sbjct: 92 HHL-HIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150
Query: 254 ARV--EAQNPRDMTGETGTLGYMAPEVLQGK---PYNRRCDVYSFGICLWEIYCCDMPYP 308
A V +G++ +MAPEV++ + PY+ + DVY+FGI L+E+ +PY
Sbjct: 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
Query: 309 DLSFADVSSAVVRQNLR----PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+++ D +V + ++ CP ++ +M +C ++RP +++ +E +
Sbjct: 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
Query: 365 DTS 367
S
Sbjct: 271 ARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 4e-78
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 35/294 (11%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
W +++ +L + I +G +G V G Y +VAVK + A +F E
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----------NDATAQAFLAE 50
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+V +L H N+ + +G V +V EY+ G+L Y
Sbjct: 51 ASVMTQLRHSNLVQLLGVIVEEKG-------------------GLYIVTEYMAKGSLVDY 91
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
L R L +++ +LD+ + YL VHRD+ N+L+ K++DFG+ +
Sbjct: 92 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFAD 314
+ + + APE L+ K ++ + DV+SFGI LWEIY +PYP + D
Sbjct: 152 ---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368
V V + + + P CP ++ +M+ CW +A RP ++ + LE I T +
Sbjct: 209 VVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 9e-74
Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 37/302 (12%)
Query: 71 RP--KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAA 127
+P ++EWE+ L + + G +G V+ G Y + +VAVK L + +
Sbjct: 1 KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK----------QGSM 50
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+F E + ++L H + + ++ EY+
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---------------------IYIITEYM 89
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G+L +L KL + ++ +A ++ G++++ + +HRD++ N+L+ + K
Sbjct: 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149
Query: 248 IADFGVAR-VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-M 305
IADFG+AR +E G + + APE + + + DV+SFGI L EI +
Sbjct: 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365
PYP ++ +V + R R P CP L +MR CW E RP + +LE
Sbjct: 210 PYPGMTNPEVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
Query: 366 TS 367
T+
Sbjct: 269 TA 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 35/299 (11%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRS 130
K+ WEI L + + QG +G V+ GT+ VA+K L G
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PE 57
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+F QE V +KL H + + V +V EY+ G
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAV---------------------VSEEPIYIVTEYMSKG 96
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
+L +L K L L ++ +A ++ G++Y+ VHRD++ N+L+ K+AD
Sbjct: 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 156
Query: 251 FGVAR-VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYP 308
FG+AR +E G + + APE + + DV+SFGI L E+ +PYP
Sbjct: 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367
+ +V V R R P CP SL ++M +CW E+RP + LE TS
Sbjct: 217 GMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 3e-68
Identities = 75/301 (24%), Positives = 134/301 (44%), Gaps = 34/301 (11%)
Query: 68 ESQRP-KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAE 124
+ P ++WE++ + + M++ + G YG VY G + + VAVK L E
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----------E 52
Query: 125 TAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
F +E AV +++ HPN+ + +G ++
Sbjct: 53 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF--------------------YIIT 92
Query: 185 EYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR 244
E++ GNL YL R++++ +++ +A +S + YL K +HRD+ N L+
Sbjct: 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 152
Query: 245 TLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC 303
+K+ADFG++R+ + G + + APE L ++ + DV++FG+ LWEI
Sbjct: 153 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 304 DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEA 363
M ++ ++ R E P CP + +MR CW N RP E+ + E
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
Query: 364 I 364
+
Sbjct: 273 M 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 9e-68
Identities = 74/300 (24%), Positives = 134/300 (44%), Gaps = 40/300 (13%)
Query: 74 EEWEIDLSKLDMRNL-IAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAAL 128
++ + L + ++ + G +GSV +G Y +VA+K+L G + A
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KAD 52
Query: 129 RSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLP 188
+E + +LD+P + + +G + +V+E
Sbjct: 53 TEEMMREAQIMHQLDNPYIVRLIGVCQAEA---------------------LMLVMEMAG 91
Query: 189 GGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKI 248
GG L ++L +R+++ + V +L +S G+ YL K VHRD+ N+LL ++ KI
Sbjct: 92 GGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 150
Query: 249 ADFGVARVEAQNPRDMTGET---GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-D 304
+DFG+++ + T + L + APE + + ++ R DV+S+G+ +WE
Sbjct: 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PY + +V + + Q R E P CP L +M CW E RP+ V + + A
Sbjct: 211 KPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 8e-67
Identities = 73/322 (22%), Positives = 127/322 (39%), Gaps = 60/322 (18%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRG-------TYDNQEVAVKLLDWGEDGMATTAETA 126
+WE L+ ++ G +G V T + +VAVK+L D +
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------S 81
Query: 127 ALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
+ R + E+ + +L H N+ +GA + + ++ E
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPI--------------------YLIFE 121
Query: 186 YLPGGNLKQYLIRNRRK---------------------KLALKIVIQLALDLSRGLSYLH 224
Y G+L YL R K L + ++ A +++G+ +L
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 225 SKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGK 282
K VHRD+ N+L+ + +KI DFG+AR + + + +MAPE L
Sbjct: 182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 283 PYNRRCDVYSFGICLWEIYCCD-MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMR 341
Y + DV+S+GI LWEI+ PYP + +++ + + P + IM+
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ 301
Query: 342 KCWDANAEKRPEMGEVVKMLEA 363
CW ++ KRP + L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLGC 323
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-66
Identities = 64/285 (22%), Positives = 125/285 (43%), Gaps = 35/285 (12%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
++ I G+YG + D + + K LD+G T A + EV + ++
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-------MTEAEKQMLVSEVNLLRE 59
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
L HPN+ ++ + +N + +V+EY GG+L + + +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTL------------------YIVMEYCEGGDLASVITKGTK 101
Query: 202 KK--LALKIVIQLALDLSRGLSYLHSK-----KIVHRDVKTENMLLDSQRTLKIADFGVA 254
++ L + V+++ L+ L H + ++HRD+K N+ LD ++ +K+ DFG+A
Sbjct: 102 ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
Query: 255 RVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
R+ + GT YM+PE + YN + D++S G L+E+ P+ S +
Sbjct: 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++ + IP L I+ + + RP + E+++
Sbjct: 222 LAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-64
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 35/290 (12%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
ID L + G +G V G + +VA+K++ E + F +E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK----------EGSMSEDEFIEEA 50
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V L H + + G + ++ EY+ G L YL
Sbjct: 51 KVMMNLSHEKLVQLYGVCTKQRPI--------------------FIITEYMANGCLLNYL 90
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR- 255
R R + + ++++ D+ + YL SK+ +HRD+ N L++ Q +K++DFG++R
Sbjct: 91 -REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD-MPYPDLSFAD 314
V G + + PEVL ++ + D+++FG+ +WEIY MPY + ++
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ + Q LR P + IM CW A++RP ++ + +
Sbjct: 210 TAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-64
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 33/289 (11%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
ID S+L I G +G V+ G + + +VA+K + E A F +E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR----------EGAMSEEDFIEEA 51
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
V KL HP + + G + + + C+V E++ G L Y
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPI--------------------CLVFEFMEHGCLSDY- 90
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
+R +R A + ++ + LD+ G++YL ++HRD+ N L+ + +K++DFG+ R
Sbjct: 91 LRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150
Query: 257 EAQNPRDMT-GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
+ + G + + +PEV Y+ + DV+SFG+ +WE++ +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ R PR + + IM CW E RP +++ L I
Sbjct: 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-64
Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 87 NLIAQGTYGSVYRGTY----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142
+ G +G+V +G Y + VAVK+L A AL+ E V Q+L
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILK-------NEANDPALKDELLAEANVMQQL 65
Query: 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK 202
D+P + + +G S +V+E G L +YL +NR
Sbjct: 66 DNPYIVRMIGICEAES---------------------WMLVMEMAELGPLNKYLQQNRH- 103
Query: 203 KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR 262
+ K +I+L +S G+ YL VHRD+ N+LL +Q KI+DFG+++ +
Sbjct: 104 -VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 263 DMTGET---GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYPDLSFADVSSA 318
+T + + APE + ++ + DV+SFG+ +WE + PY + ++V +A
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 221
Query: 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
++ + R P CP + ++M CW + E RP V L
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 8e-64
Identities = 66/287 (22%), Positives = 129/287 (44%), Gaps = 36/287 (12%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSF 132
+W ++ ++ + +G +G+VY +A+K+L + E A +
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQL 53
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
++EV + L HPN+ + G + + +++EY P G +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRV--------------------YLILEYAPLGTV 93
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
+ L + K + +L+ LSY HSK+++HRD+K EN+LL S LKIADFG
Sbjct: 94 YREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312
+ + R GTL Y+ PE+++G+ ++ + D++S G+ +E P+ ++
Sbjct: 152 WSVHAPSSRRTTL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209
Query: 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + R + P +++ + N +RP + EV++
Sbjct: 210 QETYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-63
Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 36/296 (12%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQE-----VAVKLLDWGEDGMATTAETAALR 129
++EI ++++ I +G +G V++G Y + E VA+K + ++R
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--------NCTSDSVR 52
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
F QE ++ DHP++ K +G + +++E
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGV---------------------ITENPVWIIMELCTL 91
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G L+ + ++ R+ L L +I A LS L+YL SK+ VHRD+ N+L+ S +K+
Sbjct: 92 GELRSF-LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 150
Query: 250 DFGVAR-VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308
DFG++R +E + + +MAPE + + + DV+ FG+C+WEI +
Sbjct: 151 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ + R +P CP +L ++M KCW + +RP E+ L I
Sbjct: 211 QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 7e-63
Identities = 98/330 (29%), Positives = 153/330 (46%), Gaps = 54/330 (16%)
Query: 47 IDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSKLDMR--NLIAQGTYGSVYRGTYDN 104
IDL +L+ +L + + + I S L + +I +G +G VY GT +
Sbjct: 4 IDLSALNPELVQAV-------------QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD 50
Query: 105 -----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159
AVK L+ D S F E + + HPNV +G + +
Sbjct: 51 NDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102
Query: 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRG 219
+ VV+ Y+ G+L+ + IRN +K +I L +++G
Sbjct: 103 -------------------SPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKG 142
Query: 220 LSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV----EAQNPRDMTGETGTLGYMA 275
+ +L SKK VHRD+ N +LD + T+K+ADFG+AR E + + TG + +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 276 PEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPS 334
E LQ + + + DV+SFG+ LWE+ PYPD++ D++ ++ Q R P CP
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 261
Query: 335 SLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
L +M KCW AE RP E+V + AI
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 1e-62
Identities = 77/300 (25%), Positives = 137/300 (45%), Gaps = 41/300 (13%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRS 130
EID+S + + +I G +G V G VA+K L + T R
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK--------SGYTEKQRR 72
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
F E ++ + DHPNV G ++ + ++ E++ G
Sbjct: 73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPV--------------------MIITEFMENG 112
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
+L + +R + + ++ + ++ G+ YL VHRD+ N+L++S K++D
Sbjct: 113 SLDSF-LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSD 171
Query: 251 FGVARVEAQNPRDMT-----GETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-D 304
FG++R + D T G + + APE +Q + + DV+S+GI +WE+ +
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 305 MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
PY D++ DV +A + Q+ R P CPS+L +M CW + RP+ G++V L+ +
Sbjct: 232 RPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 79/326 (24%), Positives = 133/326 (40%), Gaps = 56/326 (17%)
Query: 67 NESQRPK-EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDG 118
+ +Q P +WE ++L + G +G V T VAVK+L
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH- 66
Query: 119 MATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPA 177
R + E+ V L +H N+ +GA
Sbjct: 67 -------LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT----------------- 102
Query: 178 RACCVVVEYLPGGNLKQYLIRNR----------------RKKLALKIVIQLALDLSRGLS 221
V+ EY G+L +L R R L L+ ++ + +++G++
Sbjct: 103 ---LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 222 YLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM--TGETGTLGYMAPEVL 279
+L SK +HRD+ N+LL R KI DFG+AR + + + +MAPE +
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219
Query: 280 QGKPYNRRCDVYSFGICLWEIYCCDMP-YPDLSFADVSSAVVRQNLRPEIPRCCPSSLAN 338
Y DV+S+GI LWE++ YP + ++++ R P P+ + +
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279
Query: 339 IMRKCWDANAEKRPEMGEVVKMLEAI 364
IM+ CWDA+ KRP ++V+++E
Sbjct: 280 IMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 2e-62
Identities = 77/326 (23%), Positives = 135/326 (41%), Gaps = 62/326 (19%)
Query: 72 PK-EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTA 123
PK E + ++ I +G +G V++ VAVK+L
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--------EE 54
Query: 124 ETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVV 183
+A +++ FQ+E A+ + D+PN+ K +G + C++
Sbjct: 55 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM--------------------CLL 94
Query: 184 VEYLPGGNLKQYLIRNRR----------------------KKLALKIVIQLALDLSRGLS 221
EY+ G+L ++L L+ + +A ++ G++
Sbjct: 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154
Query: 222 YLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVL 279
YL +K VHRD+ T N L+ +KIADFG++R A + + + +M PE +
Sbjct: 155 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214
Query: 280 QGKPYNRRCDVYSFGICLWEIYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLAN 338
Y DV+++G+ LWEI+ + PY ++ +V V N P CP L N
Sbjct: 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYN 273
Query: 339 IMRKCWDANAEKRPEMGEVVKMLEAI 364
+MR CW RP + ++L+ +
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-62
Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 45/296 (15%)
Query: 72 PKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALR 129
P++ WEI + G +G VY+ + A K++D ++
Sbjct: 10 PEDFWEI-------IGELGDGAFGKVYKAQNKETSVLAAAKVID---------TKSEEEL 53
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
+ E+ + DHPN+ K + A +NL +++E+ G
Sbjct: 54 EDYMVEIDILASCDHPNIVKLLDAFYYENNL--------------------WILIEFCAG 93
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G + ++ + L + + L+YLH KI+HRD+K N+L +K+A
Sbjct: 94 GAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLA 152
Query: 250 DFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-----KPYNRRCDVYSFGICLWEIYCCD 304
DFGV+ + + GT +MAPEV+ +PY+ + DV+S GI L E+ +
Sbjct: 153 DFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
Query: 305 MPYPDLSFADVSSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
P+ +L+ V + + P S+ + ++KC + N + R ++++
Sbjct: 213 PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-62
Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 37/296 (12%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSF 132
I L + + G++G V RG +D VAVK L F
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK------PDVLSQPEAMDDF 58
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
+EV LDH N+ + G + +V E P G+L
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPPM---------------------KMVTELAPLGSL 97
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
+R + L + + A+ ++ G+ YL SK+ +HRD+ N+LL ++ +KI DFG
Sbjct: 98 LDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 253 VARVEAQNPRDMTGET---GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPYP 308
+ R QN + + APE L+ + ++ D + FG+ LWE++ P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
L+ + + + ++ R P CP + N+M +CW E RP + L
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 7e-61
Identities = 82/307 (26%), Positives = 134/307 (43%), Gaps = 47/307 (15%)
Query: 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETA 126
+EWE+ K+ M + QG++G VY G VA+K ++ A +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASM 64
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
R F E +V ++ + +V + +G V++E
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT--------------------LVIMEL 104
Query: 187 LPGGNLKQYLIRNRRK--------KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238
+ G+LK YL R +L +IQ+A +++ G++YL++ K VHRD+ N
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164
Query: 239 LLDSQRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296
++ T+KI DFG+ R E R + +M+PE L+ + DV+SFG+
Sbjct: 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224
Query: 297 LWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG 355
LWEI + PY LS V V+ + P CP L +MR CW N + RP
Sbjct: 225 LWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 356 EVVKMLE 362
E++ ++
Sbjct: 284 EIISSIK 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 8e-61
Identities = 74/308 (24%), Positives = 130/308 (42%), Gaps = 50/308 (16%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDN----QEVAVKLLDWGEDGMATTAETAALRSSF 132
+D + + +++I +G +G V + + A+K + + F
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--------EYASKDDHRDF 57
Query: 133 QQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGN 191
E+ V KL HPN+ +GA L + +EY P GN
Sbjct: 58 AGELEVLCKLGHHPNIINLLGACEHRGYL--------------------YLAIEYAPHGN 97
Query: 192 LKQYLIRN--------------RRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
L +L ++ L+ + ++ A D++RG+ YL K+ +HRD+ N
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157
Query: 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297
+L+ KIADFG++R + + G + +MA E L Y DV+S+G+ L
Sbjct: 158 ILVGENYVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216
Query: 298 WEIYCCDM-PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
WEI PY ++ A++ + Q R E P C + ++MR+CW +RP +
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 357 VVKMLEAI 364
++ L +
Sbjct: 276 ILVSLNRM 283
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 2e-60
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 37/278 (13%)
Query: 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I G++G+VY +++ VA+K + + ++ +EV QKL H
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMS------YSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN ++ G + +V+EY G + +K L
Sbjct: 75 PNTIQYRGCYLREHTA--------------------WLVMEYCLGSASDLLEVH--KKPL 112
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+ + +GL+YLHS ++HRDVK N+LL +K+ DFG A + A
Sbjct: 113 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168
Query: 265 TGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
GT +MAPEV+ Y+ + DV+S GI E+ P +++ + +
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
N + C + RP ++K
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-59
Identities = 85/317 (26%), Positives = 140/317 (44%), Gaps = 56/317 (17%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY---------DNQEVAVKLLDWGEDGMATTAET 125
WE+ +L + + +G +G V +VAVK+L + T
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--------SDAT 58
Query: 126 AALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVV 184
S E+ + + + H N+ +GA L V+V
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL--------------------YVIV 98
Query: 185 EYLPGGNLKQYL--------------IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230
EY GNL++YL N ++L+ K ++ A ++RG+ YL SKK +H
Sbjct: 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158
Query: 231 RDVKTENMLLDSQRTLKIADFGVARV--EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRC 288
RD+ N+L+ +KIADFG+AR + T + +MAPE L + Y +
Sbjct: 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
Query: 289 DVYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDAN 347
DV+SFG+ LWEI+ PYP + ++ ++++ R + P C + L +MR CW A
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 277
Query: 348 AEKRPEMGEVVKMLEAI 364
+RP ++V+ L+ I
Sbjct: 278 PSQRPTFKQLVEDLDRI 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-59
Identities = 65/298 (21%), Positives = 121/298 (40%), Gaps = 38/298 (12%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAALR 129
EI S + + +I G +G VY+G VA+K L T R
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--------AGYTEKQR 53
Query: 130 SSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPG 189
F E + + H N+ + G + ++ EY+
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPM--------------------MIITEYMEN 93
Query: 190 GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIA 249
G +R + + ++ ++ + ++ G+ YL + VHRD+ N+L++S K++
Sbjct: 94 G-ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 152
Query: 250 DFGVARVEAQNPRD---MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP 306
DFG++RV +P +G + + APE + + + DV+SFGI +WE+
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
Query: 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ R P CPS++ +M +CW +RP+ ++V +L+ +
Sbjct: 213 PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 69/277 (24%), Positives = 125/277 (45%), Gaps = 34/277 (12%)
Query: 89 IAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146
I +G++ +VY+G EVA L T + R F++E + + L HPN
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQ-------DRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLAL 206
+ +F + T K + +V E + G LK YL R K + +
Sbjct: 70 IVRFYDSWESTVKGK----------------KCIVLVTELMTSGTLKTYL--KRFKVMKI 111
Query: 207 KIVIQLALDLSRGLSYLHSKK--IVHRDVKTENMLLDSQR-TLKIADFGVARVEAQNPRD 263
K++ + +GL +LH++ I+HRD+K +N+ + ++KI D G+A + +
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASF 169
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323
GT +MAPE+ + K Y+ DVY+FG+C+ E+ + PY + A V
Sbjct: 170 AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228
Query: 324 LRP-EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++P + + I+ C N ++R + +++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 4e-59
Identities = 76/316 (24%), Positives = 127/316 (40%), Gaps = 50/316 (15%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAET 125
+WE +L + + +G +G V + VAVK+L G
Sbjct: 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------H 57
Query: 126 AALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVE 185
+ R+ + + H NV +GA V+VE
Sbjct: 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP-------------------LMVIVE 98
Query: 186 YLPGGNLKQYLIRNR--------------RKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231
+ GNL YL R + L L+ +I + +++G+ +L S+K +HR
Sbjct: 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158
Query: 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGET--GTLGYMAPEVLQGKPYNRRCD 289
D+ N+LL + +KI DFG+AR ++P + L +MAPE + + Y + D
Sbjct: 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218
Query: 290 VYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANA 348
V+SFG+ LWEI+ PYP + + +++ R P + M CW
Sbjct: 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 278
Query: 349 EKRPEMGEVVKMLEAI 364
+RP E+V+ L +
Sbjct: 279 SQRPTFSELVEHLGNL 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-59
Identities = 61/277 (22%), Positives = 114/277 (41%), Gaps = 37/277 (13%)
Query: 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I QG G+VY QEVA++ ++ + + E+ V ++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKN 76
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRK-K 203
PN+ ++ + + L VV+EYL GG+L +
Sbjct: 77 PNIVNYLDSYLVGDEL--------------------WVVMEYLAGGSLTDVVTETCMDEG 116
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRD 263
+ + + L +LHS +++HRD+K++N+LL ++K+ DFG
Sbjct: 117 QIAAVCRECL----QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323
+ GT +MAPEV+ K Y + D++S GI E+ + PY + + +
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 324 -LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ P + + + +C D + EKR E+++
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 189 bits (482), Expect = 1e-57
Identities = 52/309 (16%), Positives = 114/309 (36%), Gaps = 37/309 (11%)
Query: 57 EKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDW 114
+K +W + Q + + D+ + G +G V+R + K ++
Sbjct: 5 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN- 63
Query: 115 GEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAA 174
+ + + E+++ +L HP + A +
Sbjct: 64 --------TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM-------------- 101
Query: 175 VPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234
+++E+L GG L I K++ VI GL ++H IVH D+K
Sbjct: 102 ------VLILEFLSGGELFDR-IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 154
Query: 235 TENMLLDSQR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYS 292
EN++ ++++ ++KI DFG+A + + T T + APE++ +P D+++
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFYTDMWA 213
Query: 293 FGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEK 350
G+ + + P+ + V R + + + ++ K
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273
Query: 351 RPEMGEVVK 359
R + + ++
Sbjct: 274 RLTVHDALE 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-57
Identities = 84/323 (26%), Positives = 128/323 (39%), Gaps = 67/323 (20%)
Query: 85 MRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
++ I +G +G V+RG + +EVAVK+ E+ + E+ L H
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER----------SWFREAEIYQTVMLRH 56
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ F+ A + +V +Y G+L YL R +
Sbjct: 57 ENILGFIAADNKDNGTWTQ----------------LWLVSDYHEHGSLFDYL---NRYTV 97
Query: 205 ALKIVIQLALDLSRGLSYLHS--------KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
++ +I+LAL + GL++LH I HRD+K++N+L+ T IAD G+A
Sbjct: 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 257 EAQNPRDM----TGETGTLGYMAPEVLQGK------PYNRRCDVYSFGICLWEIYC---- 302
+ GT YMAPEVL +R D+Y+ G+ WEI
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
Query: 303 -----------CDMPYPDLSFADVSSAVVRQNLRPEIPRC-----CPSSLANIMRKCWDA 346
D+ D S ++ V Q LRP IP +A IMR+CW A
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277
Query: 347 NAEKRPEMGEVVKMLEAIDTSKG 369
N R + K L + +G
Sbjct: 278 NGAARLTALRIKKTLSQLSQQEG 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 188 bits (478), Expect = 4e-57
Identities = 55/309 (17%), Positives = 118/309 (38%), Gaps = 37/309 (11%)
Query: 57 EKHLSWVWSRNESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDW 114
+ ++ +W + Q + + + L D+ + G +G V+R T A K +
Sbjct: 2 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM- 60
Query: 115 GEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAA 174
+ + + ++E+ L HP + A + +
Sbjct: 61 --------TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM-------------- 98
Query: 175 VPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234
++ E++ GG L + + K++ ++ + +GL ++H VH D+K
Sbjct: 99 ------VMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 151
Query: 235 TENMLLDSQR--TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYS 292
EN++ ++R LK+ DFG+ + + TGT + APEV +GKP D++S
Sbjct: 152 PENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 210
Query: 293 FGICLWEIYCCDMPYPDLSFADVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEK 350
G+ + + P+ + + V + + +RK A+
Sbjct: 211 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 270
Query: 351 RPEMGEVVK 359
R + + ++
Sbjct: 271 RMTIHQALE 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-57
Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 36/286 (12%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
+ D+ + +G YG V + VAVK++D + ++E+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEIC 55
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ + L+H NV KF G + + +EY GG L +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQ--------------------YLFLEYCSGGELFDRI- 94
Query: 198 RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
+ + L G+ YLH I HRD+K EN+LLD + LKI+DFG+A V
Sbjct: 95 -EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153
Query: 258 AQNPRD--MTGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
N R+ + GTL Y+APE+L+ + ++ DV+S GI L + ++P+ S +
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
Query: 315 VSSAVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ ++ + S+ ++ K N R + ++ K
Sbjct: 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-55
Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQ 134
E+ + + + G G V++ ++ +A KL+ A+R+ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIR 53
Query: 135 EVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQ 194
E+ V + + P + F GA + + +E++ GG+L Q
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEI--------------------SICMEHMDGGSLDQ 93
Query: 195 YLIRNRRKKLALKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRTLKIADFGV 253
L + ++ +I+ ++++ + +GL+YL K KI+HRDVK N+L++S+ +K+ DFGV
Sbjct: 94 VL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151
Query: 254 ARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
+ + GT YM+PE LQG Y+ + D++S G+ L E+ P P
Sbjct: 152 SGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEM 354
++ Q P R + RP M
Sbjct: 210 ELELMFGCQVE--GDAAETPPRPRTPGRPLSSYGMDSRPPM 248
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-55
Identities = 65/297 (21%), Positives = 135/297 (45%), Gaps = 43/297 (14%)
Query: 77 EIDLSKLDMRNLIAQGTYGSVYRGTY------DNQEVAVKLLDWGEDGMATTAETAALRS 130
E + K+ ++ G +G+VY+G + VA+K L A
Sbjct: 8 ETEFKKI---KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NK 56
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
E V +D+P+V + +G + ++ ++ + +P G
Sbjct: 57 EILDEAYVMASVDNPHVCRLLGICLTST---------------------VQLITQLMPFG 95
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L Y +R + + + ++ + +++G++YL +++VHRD+ N+L+ + + +KI D
Sbjct: 96 CLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD 154
Query: 251 FGVARV--EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMPY 307
FG+A++ + G + +MA E + + Y + DV+S+G+ +WE+ PY
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214
Query: 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
+ +++SS ++ + R P C + IM KCW +A+ RP+ E++ +
Sbjct: 215 DGIPASEISS-ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 179 bits (454), Expect = 2e-54
Identities = 59/287 (20%), Positives = 116/287 (40%), Gaps = 34/287 (11%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
+ + ++ +G V R + +E AVK++D G + E LR + +EV + +K
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 142 L-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
+ HPN+ + + +V + + G L YL
Sbjct: 66 VSGHPNIIQLKDTYETNTFF--------------------FLVFDLMKKGELFDYL--TE 103
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+ L+ K ++ L + LH IVHRD+K EN+LLD +K+ DFG +
Sbjct: 104 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163
Query: 261 PRDMTGETGTLGYMAPEVLQG------KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
+ + GT Y+APE+++ Y + D++S G+ ++ + P+
Sbjct: 164 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
Query: 315 VSSAVVRQNLRPEIPRC--CPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ ++ N + P ++ +++ + +KR E +
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (452), Expect = 4e-54
Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 32/285 (11%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
++ G V+ +++VAVK+L A A + F++E L+HP
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLR------ADLARDPSFYLRFRREAQNAAALNHP 67
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
+ + +V+EY+ G L+ + + +
Sbjct: 68 AIVAVYDTGEAETPAGPL----------------PYIVMEYVDGVTLRDIV--HTEGPMT 109
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT 265
K I++ D + L++ H I+HRDVK N+++ + +K+ DFG+AR A + +T
Sbjct: 110 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 266 GET---GTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQ 322
GT Y++PE +G + R DVYS G L+E+ + P+ S V+ VR+
Sbjct: 170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
Query: 323 NLRP--EIPRCCPSSLANIMRKCWDANAEKRPE-MGEVVKMLEAI 364
+ P + L ++ K N E R + E+ L +
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-54
Identities = 69/282 (24%), Positives = 119/282 (42%), Gaps = 31/282 (10%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
+ + ++ +G++G V+ + NQ A+K L + + ++
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----KDVVLMDDDVECTMVEKRV 55
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ +HP +T NL V+EYL GG+L ++
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENL--------------------FFVMEYLNGGDLMYHI- 94
Query: 198 RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVE 257
K L A ++ GL +LHSK IV+RD+K +N+LLD +KIADFG+ +
Sbjct: 95 -QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153
Query: 258 AQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317
GT Y+APE+L G+ YN D +SFG+ L+E+ P+ ++
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
++ N P PR +++ K + EKR + ++
Sbjct: 214 SIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 9e-54
Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 42/297 (14%)
Query: 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAA 127
+RP E+++ ++ +G++ +V ++E A+K+L+
Sbjct: 5 KRP-EDFKFG-------KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKEN 50
Query: 128 LRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYL 187
+E V +LDHP K L + Y
Sbjct: 51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL--------------------YFGLSYA 90
Query: 188 PGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLK 247
G L +Y+ + ++ L YLH K I+HRD+K EN+LL+ ++
Sbjct: 91 KNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ 148
Query: 248 IADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM 305
I DFG A+V + + GT Y++PE+L K + D+++ G ++++
Sbjct: 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
Query: 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362
P+ + + ++ L + P +++ K +A KR E+
Sbjct: 209 PFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 3e-52
Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 38/283 (13%)
Query: 84 DMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQK 141
D R+++ G + V + VA+K + S + E+AV K
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--------KKALEGKEGSMENEIAVLHK 63
Query: 142 LDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR 201
+ HPN+ +L ++++ + GG L ++ +
Sbjct: 64 IKHPNIVALDDIYESGGHL--------------------YLIMQLVSGGELFDRIVE--K 101
Query: 202 KKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLL---DSQRTLKIADFGVARVEA 258
+ +L + + YLH IVHRD+K EN+L D + I+DFG++++E
Sbjct: 102 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
++ GT GY+APEVL KPY++ D +S G+ + + C P+ D + A +
Sbjct: 162 PGSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 319 VVRQNLRPEIPRC--CPSSLANIMRKCWDANAEKRPEMGEVVK 359
+++ + P S + +R + + EKR + ++
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-51
Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 43/284 (15%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DH 144
++ G G V + ++ A+K+L ++EV + +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ--------------DCPKARREVELHWRASQC 64
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
P++ + V V N + +V+E L GG L + +
Sbjct: 65 PHIVRIVD----------------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARVEAQNP 261
+ ++ + + YLHS I HRDVK EN+L S+R LK+ DFG A+ +
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
T T Y+APEVL + Y++ CD++S G+ ++ + C P+ +S +
Sbjct: 169 SLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
Query: 322 QNLRPEI------PRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + + ++R +R + E +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-51
Identities = 44/278 (15%), Positives = 100/278 (35%), Gaps = 38/278 (13%)
Query: 88 LIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ +G +G V+R T + K + + ++E+++ H
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----------QVLVKKEISILNIARHR 61
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ + L ++ E++ G ++ + I +L
Sbjct: 62 NILHLHESFESMEEL--------------------VMIFEFISGLDIFER-INTSAFELN 100
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR--TLKIADFGVARVEAQNPRD 263
+ ++ + L +LHS I H D++ EN++ ++R T+KI +FG AR + + +
Sbjct: 101 EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDN 159
Query: 264 MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323
Y APEV Q + D++S G ++ + P+ + + ++
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219
Query: 324 LRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
E + + + + + R E ++
Sbjct: 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-50
Identities = 52/291 (17%), Positives = 116/291 (39%), Gaps = 36/291 (12%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ G + V + + A K + ++ R ++EV++ +++ HP
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
NV +++ +++E + GG L + ++ L
Sbjct: 74 NVITLHEVYENKTDV--------------------ILILELVAGGELFDF--LAEKESLT 111
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ----RTLKIADFGVARVEAQNP 261
+ + + G+ YLHS +I H D+K EN++L + +KI DFG+A +
Sbjct: 112 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFG 170
Query: 262 RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
+ GT ++APE++ +P D++S G+ + + P+ + + + V
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 322 QN--LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAIDTSK 368
N E + + +R+ + +KR + + ++ ++ DT +
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 5e-49
Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 39/277 (14%)
Query: 80 LSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVA 137
L + + G++G V+ ++ + A+K+L E
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK------KEIVVRLKQVEHTNDERL 56
Query: 138 VWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI 197
+ + HP + + G + ++++Y+ GG L L
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQI--------------------FMIMDYIEGGELFSLLR 96
Query: 198 RNRRK--KLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
+++R +A ++ L L YLHSK I++RD+K EN+LLD +KI DFG A+
Sbjct: 97 KSQRFPNPVAKFYAAEVCLALE----YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 152
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
P GT Y+APEV+ KPYN+ D +SFGI ++E+ P+ D +
Sbjct: 153 ---YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
++ P + +++ + + +R
Sbjct: 210 YEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 2e-48
Identities = 58/279 (20%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
+ ++ + +I +G +G VY + A+K LD + L + +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIM 57
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
+++ D P + A L +++ + GG+L +
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKL--------------------SFILDLMNGGDLHYH 97
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
L ++ A + A ++ GL ++H++ +V+RD+K N+LLD ++I+D G+A
Sbjct: 98 LSQHGVFSEAD--MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 155
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQ-GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314
++ + GT GYMAPEVLQ G Y+ D +S G L+++ P+ D
Sbjct: 156 DFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
Query: 315 VSSAVVR-QNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ E+P L +++ + +R
Sbjct: 214 KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 7e-48
Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 50/300 (16%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I G++G +Y GT +EVA+KL E +++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC-----------VKTKHPQLHIESKIYKMMQGG 62
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
+ + +V+E L + +R+ +
Sbjct: 63 VGIPTIRWCGAEGDY-------------------NVMVMELLGPSLEDLFNFCSRK--FS 101
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR---TLKIADFGVARV------ 256
LK V+ LA + + Y+HSK +HRDVK +N L+ + + I DFG+A+
Sbjct: 102 LKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 257 -EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
+ R+ TGT Y + G +RR D+ S G L +P+ L A
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 316 SSAVVRQNLR------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369
R + + + + PS A + C + +P+ + ++ + +G
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 32/281 (11%)
Query: 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQE 135
+ ++ D L+ +GT+G V + A+K+L + E
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTE 55
Query: 136 VAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQY 195
V Q HP +T A L C V+EY GG L +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRL--------------------CFVMEYANGGELFFH 95
Query: 196 LIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVAR 255
L +R + + ++ L YLHS+ +V+RD+K EN++LD +KI DFG+ +
Sbjct: 96 L--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 256 VEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315
+ M GT Y+APEVL+ Y R D + G+ ++E+ C +P+ + +
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
++ + PR +++ + ++R G
Sbjct: 214 FELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (406), Expect = 3e-47
Identities = 51/297 (17%), Positives = 99/297 (33%), Gaps = 52/297 (17%)
Query: 88 LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I +G++G ++ GT +NQ+VA+K D + E ++ L
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLLAGC 60
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
V +V++ L G + L+ +K +
Sbjct: 61 TGIPNVYYFGQEGLH-------------------NVLVIDLL--GPSLEDLLDLCGRKFS 99
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ-----RTLKIADFGVARV---- 256
+K V A + + +H K +V+RD+K +N L+ + + DFG+ +
Sbjct: 100 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159
Query: 257 ---EAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313
+ R+ +GT YM+ G+ +RR D+ + G +P+ L A
Sbjct: 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219
Query: 314 DVSSAVVR------QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364
R E+ P M + + P+ + + +
Sbjct: 220 TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-47
Identities = 58/278 (20%), Positives = 103/278 (37%), Gaps = 40/278 (14%)
Query: 88 LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-- 143
L+ G +GSVY G DN VA+K ++ + + EV + +K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 144 HPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKK 203
V + + + +++E I R
Sbjct: 68 FSGVIRLLDWFERPDSF--------------------VLILERPEPVQDLFDFIT-ERGA 106
Query: 204 LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQR-TLKIADFGVARVEAQNPR 262
L ++ + + + H+ ++HRD+K EN+L+D R LK+ DFG +
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDT 164
Query: 263 DMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321
T GT Y PE ++ Y R V+S GI L+++ C D+P+ ++R
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIR 218
Query: 322 QNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
+ + S +++R C RP E+
Sbjct: 219 GQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-44
Identities = 67/303 (22%), Positives = 116/303 (38%), Gaps = 55/303 (18%)
Query: 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
+ + +G + +VY+ NQ VA+K + G + + + +E+ + Q+L H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR----SEAKDGINRTALREIKLLQELSH 59
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ + A SN+ +V +++ +I++ L
Sbjct: 60 PNIIGLLDAFGHKSNI--------------------SLVFDFMETDLE--VIIKDNSLVL 97
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+ L +GL YLH I+HRD+K N+LLD LK+ADFG+A+ R
Sbjct: 98 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157
Query: 265 TGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323
T + T Y APE+L G + Y D+++ G L E+ P S D + +
Sbjct: 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
Query: 324 LRP--------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
P I L ++++ + N R +
Sbjct: 218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
Query: 358 VKM 360
+KM
Sbjct: 278 LKM 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 65/304 (21%), Positives = 111/304 (36%), Gaps = 55/304 (18%)
Query: 87 NLIAQGTYGSVYRGTY---DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL- 142
I +G YG V++ + VA+K + + S +EVAV + L
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVAVLRHLE 65
Query: 143 --DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
+HPNV + + + +V E++ YL +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETK---------------LTLVFEHVDQDLT-TYLDKVP 109
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+ + + + L RGL +LHS ++VHRD+K +N+L+ S +K+ADFG+AR+ +
Sbjct: 110 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
+ TL Y APEVL Y D++S G E++ + S D ++
Sbjct: 170 MALTS-VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 321 RQNLRP-------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMG 355
P + +++ KC N KR
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 356 EVVK 359
+
Sbjct: 289 SALS 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 2e-41
Identities = 68/332 (20%), Positives = 124/332 (37%), Gaps = 53/332 (15%)
Query: 23 GSVNSKVKGTGSLSSKDMLFRADKIDLKSLDMQLEKHLSWVWSRNESQRPKEEWEIDLSK 82
G+ + KG+ S K+ L +A + LK W + L +
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKK------------WETPSQNTAQ------LDQ 42
Query: 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ 140
D + G++G V + A+K+LD E + Q
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD------KQKVVKLKQIEHTLNEKRILQ 96
Query: 141 KLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR 200
++ P + K + SNL +V+EY+ GG + +L R
Sbjct: 97 AVNFPFLVKLEFSFKDNSNL--------------------YMVMEYVAGGEMFSHL--RR 134
Query: 201 RKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN 260
+ + A + YLHS +++RD+K EN+L+D Q +++ DFG A+
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 261 PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVV 320
+ G +APE++ K YN+ D ++ G+ ++E+ P+ + +V
Sbjct: 195 TWTLCGTP---EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 321 RQNLRPEIPRCCPSSLANIMRKCWDANAEKRP 352
+ P S L +++R + KR
Sbjct: 252 SG--KVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-41
Identities = 65/303 (21%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG VY+ + VA+K + ET + S+ +E+++ ++L+H
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIR-------LDTETEGVPSTAIREISLLKELNH 60
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
PN+ K + + L + V +LK+++ + +
Sbjct: 61 PNIVKLLDVIHTENKLYL---------------------VFEFLHQDLKKFMDASALTGI 99
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
L ++ L +GL++ HS +++HRD+K +N+L++++ +K+ADFG+AR R
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 265 TGETGTLGYMAPEVLQGKPYN-RRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQN 323
T E TL Y APE+L G Y D++S G E+ +P S D + R
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
Query: 324 LRP---------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
P ++ +++ + + KR
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279
Query: 357 VVK 359
+
Sbjct: 280 ALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 62/319 (19%), Positives = 115/319 (36%), Gaps = 63/319 (19%)
Query: 76 WEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQ 133
+++ + + I +G YG V + VA+K + E
Sbjct: 4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------QTYCQRTL 54
Query: 134 QEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLK 193
+E+ + + H N+ + ++ +V +L G +L
Sbjct: 55 REIKILLRFRHENIIGINDIIRAPTIEQMKD----------------VYLVTHLMGADLY 98
Query: 194 QYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGV 253
+ L + + L+ + + RGL Y+HS ++HRD+K N+LL++ LKI DFG+
Sbjct: 99 KLL---KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155
Query: 254 ARVEAQNPRDMTGET---GTLGYMAPEVL-QGKPYNRRCDVYSFGICLWEIYCCDMPYPD 309
ARV + T T Y APE++ K Y + D++S G L E+ +P
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215
Query: 310 LSFADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIM 340
+ D + ++ P + S +++
Sbjct: 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 275
Query: 341 RKCWDANAEKRPEMGEVVK 359
K N KR E+ + +
Sbjct: 276 DKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (356), Expect = 6e-40
Identities = 68/302 (22%), Positives = 115/302 (38%), Gaps = 58/302 (19%)
Query: 87 NLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
I +GTYG VY+ + A+K + E + S+ +E+++ ++L H
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR-------LEKEDEGIPSTTIREISILKELKHS 60
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
N+ K L +V E+L L+ L
Sbjct: 61 NIVKLYDVIHTKKRL--------------------VLVFEHLDQDLK--KLLDVCEGGLE 98
Query: 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMT 265
L L G++Y H ++++HRD+K +N+L++ + LKIADFG+AR R T
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158
Query: 266 GETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVRQNL 324
E TL Y AP+VL G K Y+ D++S G E+ +P +S AD + R
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 325 RP---------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEV 357
P + S +++ K + +R +
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 358 VK 359
++
Sbjct: 279 LE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 59/322 (18%), Positives = 105/322 (32%), Gaps = 61/322 (18%)
Query: 69 SQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETA 126
Q P E+ + +I G++G VY+ + VA+K + +
Sbjct: 11 GQGPDRPQEVSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------- 58
Query: 127 ALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEY 186
+E+ + +KLDH N+ + + K +V++Y
Sbjct: 59 ----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--------------LNLVLDY 100
Query: 187 LPGGNLKQYLIRNRRKK-LALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQ-R 244
+P + +R K+ L + V L R L+Y+HS I HRD+K +N+LLD
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 160
Query: 245 TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304
LK+ DFG A+ + +++ + Y DV+S G L E+
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
Query: 305 MPYPDLSFADVSSAVVR---------------------------QNLRPEIPRCCPSSLA 337
+P S D +++ P
Sbjct: 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 338 NIMRKCWDANAEKRPEMGEVVK 359
+ + + R E
Sbjct: 281 ALCSRLLEYTPTARLTPLEACA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 58/300 (19%), Positives = 125/300 (41%), Gaps = 38/300 (12%)
Query: 68 ESQRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGT-----YDNQEVAVKLLDWGEDGMATT 122
+ ++ + ++ ++ G YG V+ + A+K+L AT
Sbjct: 11 TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-----KATI 65
Query: 123 AETAALRSSFQQEVAVWQKLDH-PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACC 181
+ A + E V + + P + A + L
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL--------------------H 105
Query: 182 VVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLD 241
++++Y+ GG L +L ++R++ V ++ L +LH I++RD+K EN+LLD
Sbjct: 106 LILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 163
Query: 242 SQRTLKIADFGVA-RVEAQNPRDMTGETGTLGYMAPEVLQGKP--YNRRCDVYSFGICLW 298
S + + DFG++ A GT+ YMAP++++G +++ D +S G+ ++
Sbjct: 164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 223
Query: 299 EIYCCDMPYPDLSFADVSSAVVRQNLR--PEIPRCCPSSLANIMRKCWDANAEKRPEMGE 356
E+ P+ + + + R+ L+ P P+ + +++++ + +KR G
Sbjct: 224 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-37
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 31/297 (10%)
Query: 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEV 136
++SK + I QGT+G V++ + Q+VA+K + E + +E+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-------MENEKEGFPITALREI 60
Query: 137 AVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYL 196
+ Q L H NV + ++ K + +V ++
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCK------------GSIYLVFDFCEHDLAGLLS 108
Query: 197 IRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARV 256
N K L + ++ L GL Y+H KI+HRD+K N+L+ LK+ADFG+AR
Sbjct: 109 --NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166
Query: 257 ----EAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311
+ P T TL Y PE+L G + Y D++ G + E++ +
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226
Query: 312 FADVSSAVVRQNLRP---EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365
+ + + P L + + + + V+ A+D
Sbjct: 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-37
Identities = 65/319 (20%), Positives = 114/319 (35%), Gaps = 61/319 (19%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDGMATTAETAALRS 130
K WE+ + + G YG+V +VA+K L ++
Sbjct: 11 KTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAK 62
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+E+ + + + H NV + L + +V+ ++ G
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD--------------FYLVMPFM--G 106
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
L++ +KL + L + +GL Y+H+ I+HRD+K N+ ++ LKI D
Sbjct: 107 TDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 164
Query: 251 FGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPD 309
FG+AR Q +MTG T Y APEV+ Y + D++S G + E+ +
Sbjct: 165 FGLAR---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 310 LSFADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIM 340
D +++ P I N++
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281
Query: 341 RKCWDANAEKRPEMGEVVK 359
K +AE+R GE +
Sbjct: 282 EKMLVLDAEQRVTAGEALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-35
Identities = 62/304 (20%), Positives = 114/304 (37%), Gaps = 60/304 (19%)
Query: 87 NLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH 144
I +GTYG+V++ ++ VA+K + + + SS +E+ + ++L H
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKH 60
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
N+ + +V E+ K + N
Sbjct: 61 KNIVRLHDVLHSDKK--------------------LTLVFEFCDQDLKKYFDSCNGDLDP 100
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
+IV L +GL + HS+ ++HRD+K +N+L++ LK+A+FG+AR R
Sbjct: 101 --EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158
Query: 265 TGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMP-YPDLSFADVSSAVVRQ 322
+ E TL Y P+VL G K Y+ D++S G E+ P +P D + R
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 323 NLRP---------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMG 355
P + ++ ++++ N +R
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
Query: 356 EVVK 359
E ++
Sbjct: 279 EALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (318), Expect = 4e-34
Identities = 56/340 (16%), Positives = 114/340 (33%), Gaps = 85/340 (25%)
Query: 69 SQRPKEEWEIDLSKLDMRN--------LIAQGTYGSVYRGT--YDNQEVAVKLLDWGEDG 118
+ RP+E W+ + ++ N + +G Y V+ +N++V VK+L
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----- 69
Query: 119 MATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPA 177
+ ++E+ + + L PN+ +
Sbjct: 70 -------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP--------------- 107
Query: 178 RACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237
+V E++ + KQ + L + ++ + L Y HS I+HRDVK N
Sbjct: 108 ---ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 159
Query: 238 MLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGI 295
+++D + R L++ D+G+A ++ + + PE+L + Y+ D++S G
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 218
Query: 296 CLWEIYCCDMPYP--------------------------------DLSFADVSSAVVRQN 323
L + P+ D F D+ R+
Sbjct: 219 MLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278
Query: 324 LR----PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359
E + + K + + R E ++
Sbjct: 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 4e-33
Identities = 67/319 (21%), Positives = 114/319 (35%), Gaps = 61/319 (19%)
Query: 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRS 130
K WE+ + + + G YGSV T VAVK L ++
Sbjct: 11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAK 62
Query: 131 SFQQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG 190
+E+ + + + H NV + ++ +V +L G
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDV---------------FTPARSLEEFNDVYLVTHLMGA 107
Query: 191 NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIAD 250
+L + +KL V L + RGL Y+HS I+HRD+K N+ ++ LKI D
Sbjct: 108 DLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164
Query: 251 FGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPD 309
FG+AR +MTG T Y APE++ YN+ D++S G + E+ +P
Sbjct: 165 FGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 310 LSFADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIM 340
D ++R P + +++
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 341 RKCWDANAEKRPEMGEVVK 359
K +++KR + +
Sbjct: 282 EKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-30
Identities = 62/316 (19%), Positives = 114/316 (36%), Gaps = 32/316 (10%)
Query: 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSF 132
+ + L + I G G V ++ VA+K L +
Sbjct: 12 TFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRA 63
Query: 133 QQEVAVWQKLDHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192
+E+ + + ++H N+ + L+ +V+E +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD--------------VYLVMELMDANLC 109
Query: 193 KQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFG 252
Q + + ++ Q+ G+ +LHS I+HRD+K N+++ S TLKI DFG
Sbjct: 110 -QVIQMELDHERMSYLLYQML----CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164
Query: 253 VARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312
+AR + MT T Y APEV+ G Y D++S G + E+ + +P +
Sbjct: 165 LARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 313 ADVSSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKGG 370
D + V+ Q P E + ++ N + P++ + +K
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283
Query: 371 GMIPEDQATGCFCFSP 386
D + P
Sbjct: 284 ASQARDLLSKMLVIDP 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 2e-25
Identities = 54/258 (20%), Positives = 101/258 (39%), Gaps = 28/258 (10%)
Query: 88 LIAQGTYGSVYRG--TYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHP 145
+ G + +V+ +N VA+K++ + + E+ + Q+++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR----------GDKVYTEAAEDEIKLLQRVNDA 69
Query: 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLA 205
+ TK + N P V+V + G NL + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDH------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 123
Query: 206 LKIVIQLALDLSRGLSYLHSK-KIVHRDVKTENMLLDSQRT------LKIADFGVARVEA 258
L V Q++ L GL Y+H + I+H D+K EN+L++ + +KIAD G A
Sbjct: 124 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 259 QNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318
++ + T Y +PEVL G P+ D++S ++E+ D + +
Sbjct: 184 EHYTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 319 VVRQNLRPEIPRCCPSSL 336
E+ PS L
Sbjct: 241 DDHIAQIIELLGELPSYL 258
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 5e-17
Identities = 29/213 (13%), Positives = 61/213 (28%), Gaps = 41/213 (19%)
Query: 87 NLIAQGTYGSVYRGT-YDNQEVAVKLLDWGEDGMATTAETAALRS-SFQQEVAVWQKLDH 144
L+ +G +V+ E VK G E F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 145 PNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKL 204
+ K G +V V + L + + ++
Sbjct: 66 RALQKLQGLAV-------------------------PKVYAWEGNAVLMELIDAKELYRV 100
Query: 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDM 264
++ ++ + ++ + + IVH D+ N+L+ + + I DF + VE
Sbjct: 101 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS-VEVGEEGWR 158
Query: 265 TGETGTLGYMAPEVLQ-----GKPYNRRCDVYS 292
+ +V + Y D+ S
Sbjct: 159 E-------ILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 390 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.44 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-60 Score=439.35 Aligned_cols=267 Identities=28% Similarity=0.556 Sum_probs=231.8
Q ss_pred CCCCCcccccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 70 ~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
+..+++|+|+.++|++.+.||+|+||.||+|.+. ++.||||+++..... .+.|.+|+.++++++|||||
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~HpnIv 71 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLV 71 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----------HHHHHHHHHHHHhCCCCCEe
Confidence 3456899999999999999999999999999985 568999999743211 24688999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
+++|++.+ +..++||||+++|+|.+++......++++..+..|+.||+.||.|||+++|
T Consensus 72 ~~~g~~~~---------------------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i 130 (272)
T d1qpca_ 72 RLYAVVTQ---------------------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130 (272)
T ss_dssp CEEEEECS---------------------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEeeecc---------------------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 99998753 234789999999999998866555679999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCC
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCC-DMP 306 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~P 306 (390)
+||||||+|||++.++.+||+|||+|+...... .......+|+.|+|||++.+..++.++|||||||++|||+|| .+|
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999998654332 233456789999999999988999999999999999999995 555
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
|...+..+....+ ..+.++..|..+|+++.+||.+||+.||++|||+.+|++.|++++++.
T Consensus 211 ~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 211 YPGMTNPEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp STTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHH-HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 6666766666555 566788889999999999999999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-60 Score=437.92 Aligned_cols=264 Identities=30% Similarity=0.592 Sum_probs=221.3
Q ss_pred CcccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
++|+|+.++|++.+.||+|+||.||+|++.+ .||||+++...... ...+.|.+|+.+|++++|||||+++++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-------QQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT-------THHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH-------HHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 4799999999999999999999999998765 69999997543221 124678899999999999999999998
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+ ...++||||+++|+|.+++... ...+++..+..++.||+.||+|||++|||||||
T Consensus 73 ~~~---------------------~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDl 130 (276)
T d1uwha_ 73 STA---------------------PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130 (276)
T ss_dssp ECS---------------------SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred Eec---------------------cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEecccc
Confidence 743 2348899999999999999653 356999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
||+|||++.++.+||+|||+|+..... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.
T Consensus 131 Kp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp CGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence 999999999999999999999765432 223345679999999999964 358999999999999999999999999
Q ss_pred CCChhhHHHHHHHcCCCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 309 DLSFADVSSAVVRQNLRP----EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
+.+........+..+... ..+..+|+++.+||.+||+.||++|||+.+|++.|+.+..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 987776666665555433 35677999999999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-59 Score=438.10 Aligned_cols=262 Identities=28% Similarity=0.599 Sum_probs=227.8
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+.|+|+.++|++.+.||+|+||.||+|++ +++.||||+++..... .+.|.+|+.+|++++|||||+++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----------HHHHHHHHHHHHhCCCCCEecCC
Confidence 57999999999999999999999999998 5789999998743211 24578999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+... .++||||+++|+|.+++.+.....+++..+..++.||+.||+|||++||+||
T Consensus 80 ~~~~~~~~--------------------~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 139 (287)
T d1opja_ 80 GVCTREPP--------------------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 139 (287)
T ss_dssp EEECSSSS--------------------CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ccEeeCCe--------------------eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 99976544 4789999999999999987666789999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPY-PD 309 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf-~~ 309 (390)
||||+|||++.++.+||+|||+|+...... .......+|+.|+|||++.+..|+.++|||||||++|||++|..|| .+
T Consensus 140 DlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999998654332 2233345889999999999999999999999999999999976665 55
Q ss_pred CChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 310 LSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.+..+ ....+..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 220 ~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 220 IDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred chHHH-HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 55554 445567788889999999999999999999999999999999999988753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=425.20 Aligned_cols=251 Identities=27% Similarity=0.501 Sum_probs=219.0
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|. +++|++.+.||+|+||.||+|++ +++.||||+++.. ..........+.+|+.+++.++|||||++++
T Consensus 2 ~~~--l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 73 (263)
T d2j4za1 2 QWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA------QLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73 (263)
T ss_dssp CCC--GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred Ccc--hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchH------HccChHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 354 46899999999999999999988 5789999998621 1222233567889999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+... .|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+|||
T Consensus 74 ~~~~~~~--------------------~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrD 131 (263)
T d2j4za1 74 YFHDATR--------------------VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRD 131 (263)
T ss_dssp EEECSSE--------------------EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEEECCE--------------------EEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeee
Confidence 9986544 47899999999999999653 4699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
|||+|||++.++.+||+|||+|...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eccccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999999754432 23446799999999999999999999999999999999999999999998
Q ss_pred hhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 313 ADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+....+... .+.+|..+|+++.+||.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 210 QETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 8888777554 34578889999999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-59 Score=428.24 Aligned_cols=254 Identities=25% Similarity=0.482 Sum_probs=208.6
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +|+.||||+++.... . ....+.+.+|++++++++|||||++++++.+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---T----EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---C----HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---C----HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 36899999999999999999987 588999999974321 1 12246688999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccc
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--RRKKLALKIVIQLALDLSRGLSYLHSKK-----IVH 230 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----iiH 230 (390)
. .+.+|+||||+++|+|.+++.+. .+..+++..++.++.||+.||.|||++| |+|
T Consensus 76 ~------------------~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH 137 (269)
T d2java1 76 T------------------NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137 (269)
T ss_dssp ---------------------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-------
T ss_pred C------------------CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe
Confidence 2 23458999999999999999653 3467999999999999999999999976 999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
|||||+|||++.++.+||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999986654444455678999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+..++...+..... +..|..+|+++.+||.+||+.||.+|||+.||++
T Consensus 218 ~~~~~~~~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 218 SQKELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SHHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 98888877765543 4678889999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-58 Score=421.19 Aligned_cols=257 Identities=29% Similarity=0.595 Sum_probs=213.8
Q ss_pred ccccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
|+.++|++.+.||+|+||.||+|.+ +++.||||+++.... . .+.|.+|++++++++|||||+++|++.+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~-------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---S-------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---C-------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---c-------HHHHHHHHHHHHhcCCCCcccccceecc
Confidence 5678999999999999999999998 467899999974321 1 2457899999999999999999999975
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... .++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+
T Consensus 72 ~~~--------------------~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~ 130 (263)
T d1sm2a_ 72 QAP--------------------ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 130 (263)
T ss_dssp SSS--------------------CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGG
T ss_pred CCc--------------------eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchh
Confidence 443 47899999999999998653 356899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+
T Consensus 131 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 131 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp GEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred heeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999998654332 22334568999999999999999999999999999999999 567777777777
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+...+ ..+.++..|..+|+++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 211 ~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 211 VVEDI-STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH-HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 76655 4567788899999999999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=438.33 Aligned_cols=261 Identities=27% Similarity=0.518 Sum_probs=225.2
Q ss_pred CcccccccCccccccccccCceEEEEEEECC-------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCC
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN-------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHP 145 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 145 (390)
..|+++.++|++.++||+|+||+||+|++.+ ..||||.+.... .......+.+|+.+++++ +||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~~Hp 101 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--------DSSEREALMSELKMMTQLGSHE 101 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCT
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--------CHHHHHHHHHHHHHHHHhcCCC
Confidence 4699999999999999999999999998732 269999886321 122345688999999998 899
Q ss_pred ccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhcc---------------------CCC
Q 036382 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRR---------------------KKL 204 (390)
Q Consensus 146 nIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l 204 (390)
|||++++++.+...+ |+||||+++|+|.++|..+.. ..+
T Consensus 102 nIv~l~~~~~~~~~~--------------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 161 (325)
T d1rjba_ 102 NIVNLLGACTLSGPI--------------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161 (325)
T ss_dssp TBCCEEEEECSSSSC--------------------EEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred cEeEEEEEEeeCCeE--------------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCC
Confidence 999999999865444 789999999999999965421 358
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCC
Q 036382 205 ALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGK 282 (390)
Q Consensus 205 ~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 282 (390)
++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....... ...+..||+.|||||++.+.
T Consensus 162 ~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 241 (325)
T d1rjba_ 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC
Confidence 9999999999999999999999999999999999999999999999999986544322 12345679999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 036382 283 PYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKML 361 (390)
Q Consensus 283 ~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L 361 (390)
.|+.++|||||||++|||++ |..||.+.+..+.+..++..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|
T Consensus 242 ~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999997 89999998887878888889999999999999999999999999999999999999998
Q ss_pred H
Q 036382 362 E 362 (390)
Q Consensus 362 ~ 362 (390)
.
T Consensus 322 ~ 322 (325)
T d1rjba_ 322 G 322 (325)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-58 Score=424.84 Aligned_cols=268 Identities=31% Similarity=0.532 Sum_probs=226.1
Q ss_pred CCCCCcccccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccc
Q 036382 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVT 148 (390)
Q Consensus 70 ~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 148 (390)
...+++|+|+.++|++.+.||+|+||.||+|++. ++.||||+++..... .+.|.+|+.+|++++|||||
T Consensus 6 ~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----------~~~~~~E~~~l~~l~h~nIv 75 (285)
T d1fmka3 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLV 75 (285)
T ss_dssp SSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----------HHHHHHHHHHHHhcccCCEe
Confidence 3457899999999999999999999999999985 458999999743211 25688999999999999999
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKI 228 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~i 228 (390)
+++|++.+ +..++||||+++|+|..++.......+++..++.++.||+.||+|||++||
T Consensus 76 ~~~g~~~~---------------------~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i 134 (285)
T d1fmka3 76 QLYAVVSE---------------------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134 (285)
T ss_dssp CEEEEECS---------------------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEEec---------------------CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe
Confidence 99999853 234789999999999999976666679999999999999999999999999
Q ss_pred cccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCC-C
Q 036382 229 VHRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDM-P 306 (390)
Q Consensus 229 iHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~-P 306 (390)
+||||||+||||+.++.+||+|||+|+...... .......+|+.|+|||.+.+..++.++|||||||++|||++|.. |
T Consensus 135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 999999999999999999999999998653322 23344678999999999999999999999999999999999654 5
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|......+.+..+ ..+.+++.+..+|.++.+||.+||+.||++|||+.+|++.|+.+.++..
T Consensus 215 ~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 215 YPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp STTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCHHHHHHHH-HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 5666666666554 5567778899999999999999999999999999999999999998776
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=427.47 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=217.4
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|.+ +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+..
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---------HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 4699999999999999999987 5899999999743321 1256789999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
. +|+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 ~--------------------~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 147 (293)
T d1yhwa1 91 E--------------------LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (293)
T ss_dssp E--------------------EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred E--------------------EEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence 3 4789999999999998754 3599999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSA 318 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (390)
|++.++.+||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....
T Consensus 148 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 227 (293)
T d1yhwa1 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (293)
T ss_dssp EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 99999999999999998765554555667899999999999999999999999999999999999999999888777766
Q ss_pred HHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 319 VVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 319 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.... .....+..+++++++||.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 65443 3445677899999999999999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-58 Score=424.80 Aligned_cols=264 Identities=28% Similarity=0.536 Sum_probs=225.2
Q ss_pred cccccccCcccccc-ccccCceEEEEEEEC----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 75 EWEIDLSKLDMRNL-IAQGTYGSVYRGTYD----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 75 ~~~i~~~~~~~~~~-lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
.|-+..++|.+.+. ||+|+||.||+|.+. +..||||+++.... ....+.|.+|+++|++++|||||+
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~ 73 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVR 73 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 35566778888885 999999999999762 34799999963321 123467889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
++|++.++ .+|+||||+++|+|.+++... +..+++..+..++.||+.||+|||++||+
T Consensus 74 l~g~~~~~---------------------~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~ii 131 (285)
T d1u59a_ 74 LIGVCQAE---------------------ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 131 (285)
T ss_dssp EEEEEESS---------------------SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EeeeeccC---------------------eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99998632 348899999999999998543 45699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDM 305 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 305 (390)
||||||+|||++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||+| |..
T Consensus 132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence 99999999999999999999999998654332 12234568999999999999999999999999999999998 899
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
||.+.+..++...+ ..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+..+..
T Consensus 212 Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 212 PYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp TTTTCCTHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 99998877776554 5677888999999999999999999999999999999999998875433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=421.43 Aligned_cols=259 Identities=30% Similarity=0.628 Sum_probs=223.9
Q ss_pred ccccccCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 76 WEIDLSKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 76 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
|+|+.++|++.+.||+|+||.||+|+++|+.||||+++... ..+.+.+|++++++++||||++++|++.
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 70 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIV 70 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 99999999999999999999999999999999999996321 1256789999999999999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+. .+..|+||||+++|+|.+++.++....+++..++.++.||+.||.|||+.+|+||||||
T Consensus 71 ~~-------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp 131 (262)
T d1byga_ 71 EE-------------------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131 (262)
T ss_dssp CC---------------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ec-------------------CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccch
Confidence 43 22348899999999999999766555699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
+|||++.++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus 132 ~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 132 RNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp GGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred HhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999999854332 234568899999999998999999999999999999998 788999888888
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
+...+ ..+.++++|..+|+++.+||.+||..||.+|||+.+|++.|+.+.+.+
T Consensus 209 ~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 209 VVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp HHHHH-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHH-HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 77665 567788899999999999999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-58 Score=427.17 Aligned_cols=261 Identities=29% Similarity=0.599 Sum_probs=214.3
Q ss_pred cccccCccccccccccCceEEEEEEEC--Cc---eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYD--NQ---EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
+++.++|++.++||+|+||.||+|++. ++ .||||.+..... ....+.|.+|+++|++++|||||+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~ 93 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--------EKQRRDFLSEASIMGQFDHPNVIHLE 93 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--------HHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 567788999999999999999999873 32 588888753211 12345788999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
|++.+.. .+++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus 94 g~~~~~~--------------------~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHr 152 (299)
T d1jpaa_ 94 GVVTKST--------------------PVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 152 (299)
T ss_dssp EEECSSS--------------------SCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeCC--------------------EEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccC
Confidence 9997544 347899999999999988653 3469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCC-----CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPR-----DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDM 305 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 305 (390)
||||+|||++.++.+||+|||+|+....... ......+|+.|+|||++.+..++.++|||||||++|||+| |..
T Consensus 153 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp CCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence 9999999999999999999999986543221 1223457899999999999999999999999999999998 899
Q ss_pred CCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 306 PYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 306 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
||.+.+..++...+ ..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+++..+
T Consensus 233 Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 233 PYWDMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 99999988877665 45677788899999999999999999999999999999999988653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=414.32 Aligned_cols=255 Identities=26% Similarity=0.547 Sum_probs=223.7
Q ss_pred ccccCccccccccccCceEEEEEEEC-CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD-NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
++.++|++.++||+|+||.||+|++. ++.||||+++.+... .+.|.+|+.++++++||||++++|++.+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~ 70 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----------HHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----------HHHHHHHHHHHHhcCCCceeeEEEEEee
Confidence 45689999999999999999999985 568999999743321 2468899999999999999999999975
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ..++||||+.+|+|.+++... ...+++..++.++.||++||.|||++||+||||||+
T Consensus 71 ~~--------------------~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~ 129 (258)
T d1k2pa_ 71 QR--------------------PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 129 (258)
T ss_dssp SS--------------------SEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGG
T ss_pred CC--------------------ceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccce
Confidence 43 448899999999999998654 356899999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~ 314 (390)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 130 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 130 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp GEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred eEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 9999999999999999997544332 23345678999999999999999999999999999999998 899999999888
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+...+ ..+.++..|..+|+++.+||.+||+.||++|||+.+|++.|.++
T Consensus 210 ~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 210 TAEHI-AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHH-HhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 87766 45678889999999999999999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=421.81 Aligned_cols=250 Identities=24% Similarity=0.440 Sum_probs=215.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.+.||+|+||.||+|++ +++.||||+++..... ..+.+.+|+++|++++|||||++++++.+..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---------ELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---------GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---------HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4589999999999999999998 5789999999743221 1256789999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.+|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 83 --------------------~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NI 141 (288)
T d2jfla1 83 --------------------NLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141 (288)
T ss_dssp --------------------EEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred --------------------eEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhe
Confidence 347899999999999998653 35699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ-----GKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
|++.++.+||+|||+|+............+||+.|+|||++. +..|+.++|||||||++|||++|..||.+.+..
T Consensus 142 ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp EECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred eECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 999999999999999976543333344578999999999984 456899999999999999999999999999988
Q ss_pred hHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNL-RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+....+..... ....+..+|+++.+||.+||+.||++|||+.|++++
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 88888776543 234567889999999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=426.70 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=222.8
Q ss_pred ccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEe
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASV 155 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 155 (390)
|.+++|++++.||+|+||.||+|++ +|+.||||+++.. ..........+.+|+.+|++++||||+++++++.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~------~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE------VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchh------hccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 5678999999999999999999987 6889999999621 1112223466789999999999999999999998
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+...+ |+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 76 ~~~~~--------------------~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP 133 (337)
T d1o6la_ 76 THDRL--------------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133 (337)
T ss_dssp CSSEE--------------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred ccccc--------------------ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCH
Confidence 65544 7899999999999999654 4699999999999999999999999999999999
Q ss_pred CCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 236 ENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 236 ~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
+|||++.+|++||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..++
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH
Confidence 99999999999999999998655545555667899999999999999999999999999999999999999999999888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 316 SSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
...+.... +.+|..+++++.+||.+||++||.+||+ +.+++++
T Consensus 214 ~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 214 FELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 88776654 5678899999999999999999999994 8888863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=424.03 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=216.0
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEec
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVG 156 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 156 (390)
..++|++.+.||+|+||.||+|++ +|+.||||+++.. ........+.+.+|+++|++++||||+++++++.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~------~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR------HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehH------HccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 347899999999999999999988 5789999998621 11222234678899999999999999999999986
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... .|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+
T Consensus 80 ~~~--------------------~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~ 137 (288)
T d1uu3a_ 80 DEK--------------------LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 137 (288)
T ss_dssp SSE--------------------EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCE--------------------EEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcc
Confidence 544 47899999999999998653 56999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|||++.++.+||+|||+|+..... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+
T Consensus 138 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp GEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 999999999999999999865432 223345679999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 315 VSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+...+.... ..+|..+++++++||.+||+.||++|||++|+++.
T Consensus 218 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 218 IFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 888776553 45788899999999999999999999999997543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=417.14 Aligned_cols=261 Identities=29% Similarity=0.574 Sum_probs=215.9
Q ss_pred cccccccCccccccccccCceEEEEEEEC-----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccce
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYD-----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTK 149 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 149 (390)
+|+|+.++|++.+.||+|+||.||+|.+. +..||||.++... .....+.+.+|+.+|++++||||++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~~E~~~l~~l~HpnIv~ 72 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--------SDSVREKFLQEALTMRQFDHPHIVK 72 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--------SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence 59999999999999999999999999873 2358888875321 1233467889999999999999999
Q ss_pred EEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 036382 150 FVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIV 229 (390)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ii 229 (390)
++|++.+ +..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 73 l~~~~~~---------------------~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~ii 130 (273)
T d1mp8a_ 73 LIGVITE---------------------NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFV 130 (273)
T ss_dssp EEEEECS---------------------SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEec---------------------CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCee
Confidence 9999853 2348899999999999988653 45699999999999999999999999999
Q ss_pred ccCCCCCCEEECCCCcEEEeecccceeccCCC-CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 036382 230 HRDVKTENMLLDSQRTLKIADFGVARVEAQNP-RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPY 307 (390)
Q Consensus 230 HrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf 307 (390)
||||||+|||++.++.+||+|||+|+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||
T Consensus 131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~ 210 (273)
T d1mp8a_ 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210 (273)
T ss_dssp CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence 99999999999999999999999998654322 22344568999999999999999999999999999999998 89999
Q ss_pred CCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 308 PDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
.+.+..++...+. .+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 211 ~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 211 QGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999888887764 556678899999999999999999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-57 Score=418.03 Aligned_cols=248 Identities=29% Similarity=0.544 Sum_probs=211.6
Q ss_pred ccccccCceEEEEEEEC----CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 87 NLIAQGTYGSVYRGTYD----NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 87 ~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
++||+|+||.||+|.+. ++.||||+++... ......+.|.+|+++|++++|||||+++|++.++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~----- 80 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-------NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE----- 80 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-----
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-----
Confidence 46999999999999762 3579999996321 1223356789999999999999999999998532
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ----------------~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~ 142 (277)
T d1xbba_ 81 ----------------SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 142 (277)
T ss_dssp ----------------SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred ----------------CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc
Confidence 34789999999999999954 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 036382 243 QRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSA 318 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (390)
++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...
T Consensus 143 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~ 222 (277)
T d1xbba_ 143 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222 (277)
T ss_dssp TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred cCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH
Confidence 99999999999986543221 1233568999999999999999999999999999999998 8999999988877655
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 319 VVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 319 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
+ ..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 223 i-~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 223 L-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp H-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred H-HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 5 566788899999999999999999999999999999999998875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=420.32 Aligned_cols=250 Identities=28% Similarity=0.401 Sum_probs=207.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|++ +|+.||||+++.... ....+.+.+|+++|++++|||||++++++.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--------VDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--------chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 36799999999999999999987 588999999964321 11235688999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. .|+||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 76 ~~--------------------~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~N 133 (271)
T d1nvra_ 76 NI--------------------QYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133 (271)
T ss_dssp TE--------------------EEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ce--------------------eEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHH
Confidence 43 4789999999999999843 4579999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
||++.++.+||+|||+|+...... ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 134 ILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp EEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred EEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999998654322 23455789999999999988876 578999999999999999999997765444
Q ss_pred HHH-HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSS-AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
... ...........+..+++++.+||.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333 333333333344678999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=416.14 Aligned_cols=261 Identities=27% Similarity=0.559 Sum_probs=215.1
Q ss_pred cccccCccccccccccCceEEEEEEECC------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTYDN------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKF 150 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 150 (390)
||+++.|++.++||+|+||.||+|.+.+ ..||||+++.... ......|.+|++++++++|||||++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------EKQRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--------hHHHHHHHHHHHHHHhcCCCCEeee
Confidence 6778899999999999999999998732 3699999863221 1223568899999999999999999
Q ss_pred EEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 036382 151 VGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVH 230 (390)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiH 230 (390)
+|++.+.. ..++||||+.+|+|.+++... ...+++..+..++.||+.||+|||+++|+|
T Consensus 75 ~g~~~~~~--------------------~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH 133 (283)
T d1mqba_ 75 EGVISKYK--------------------PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133 (283)
T ss_dssp EEEECSSS--------------------SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eEEEecCC--------------------ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccccccc
Confidence 99997543 347899999999999988653 456999999999999999999999999999
Q ss_pred cCCCCCCEEECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-
Q 036382 231 RDVKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMP- 306 (390)
Q Consensus 231 rDlkp~NILl~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P- 306 (390)
|||||+||||+.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 9999999999999999999999998654322 122345689999999999999999999999999999999996555
Q ss_pred CCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 307 YPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 307 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
|...+..++.. .+..+.+++.|..+|.++.+||.+||+.||++|||+.+|++.|+++..+
T Consensus 214 ~~~~~~~~~~~-~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 214 YWELSNHEVMK-AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTCCHHHHHH-HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cccCCHHHHHH-HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 55556655554 4567788889999999999999999999999999999999999988653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=417.81 Aligned_cols=266 Identities=29% Similarity=0.553 Sum_probs=219.3
Q ss_pred CcccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCC
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHP 145 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 145 (390)
..|+|+.++|++.++||+|+||.||+|.+. ++.||||+++... .......+.+|+.++.++ +|+
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~~e~~~l~~~~~h~ 77 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--------THSEHRALMSELKILIHIGHHL 77 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--------CcHHHHHHHHHHHHHHhhcCCC
Confidence 579999999999999999999999999862 3579999986321 112235567788888777 789
Q ss_pred ccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHHHHH
Q 036382 146 NVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKIVIQ 211 (390)
Q Consensus 146 nIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ 211 (390)
||+++++++... ....++||||+++|+|.+++.... ...+++..+..
T Consensus 78 ~iv~~~~~~~~~-------------------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (299)
T d1ywna1 78 NVVNLLGACTKP-------------------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138 (299)
T ss_dssp TBCCEEEEECST-------------------TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHH
T ss_pred eEEEeeeeeccC-------------------CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHH
Confidence 999999988643 234588999999999999996543 23589999999
Q ss_pred HHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchh
Q 036382 212 LALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCD 289 (390)
Q Consensus 212 i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D 289 (390)
++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|
T Consensus 139 ~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 218 (299)
T d1ywna1 139 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccc
Confidence 999999999999999999999999999999999999999999986443322 233467999999999999999999999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 290 VYSFGICLWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 290 iwSlG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
||||||++|||++| ..||.+.+..+.....+..+.++..|..+|+++.+||.+||+.||++|||+.+|+++|+.+-.
T Consensus 219 iwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred eeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999986 568988877777777778888899999999999999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-56 Score=418.58 Aligned_cols=249 Identities=24% Similarity=0.424 Sum_probs=201.3
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+.|++.+.||+|+||+||+|++ +++.||||+++.... ......+.+|+.+|++++|||||++++++.+..
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--------EGKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh--------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999988 578999999974321 112355779999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.+|+||||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 81 --------------------~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni 138 (307)
T d1a06a_ 81 --------------------HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138 (307)
T ss_dssp --------------------EEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred --------------------EEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence 44789999999999999954 45799999999999999999999999999999999999
Q ss_pred EEC---CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLD---SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|+. .++.+||+|||+|+..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.
T Consensus 139 l~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 139 LYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp EESSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 995 4789999999999855432 233456899999999999999999999999999999999999999999988888
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+........ .+..+|+++.+||.+||++||++|||+.|++++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 888876655443 446789999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-56 Score=419.09 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=214.2
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
.|+..+.||+|+||.||+|++ +|+.||||+++.... ......+.+.+|+.+|++++|||||++++++.+...
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 89 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc------cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence 489999999999999999987 578999999974321 122334678899999999999999999999986543
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENML 239 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NIL 239 (390)
.|+||||+.+|+|..++.. +..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 90 --------------------~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NIL 147 (309)
T d1u5ra_ 90 --------------------AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147 (309)
T ss_dssp --------------------EEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred --------------------EEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEE
Confidence 4789999999999876643 357999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 240 LDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG---KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 240 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
++.++.+||+|||+|..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~ 223 (309)
T d1u5ra_ 148 LSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (309)
T ss_dssp EETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ECCCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999975432 234689999999999864 45899999999999999999999999999888888
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..+.........+..+|+++.+||.+||+.||.+|||+.++++
T Consensus 224 ~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 8887776666667779999999999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=409.09 Aligned_cols=249 Identities=27% Similarity=0.499 Sum_probs=206.5
Q ss_pred ccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 83 LDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 83 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
|++.++||+|+||+||+|.+ +++.||+|++..... .....+.+.+|+++|++++|||||++++++.+...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-
Confidence 57788999999999999988 467899999863221 11224678899999999999999999999864211
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCCE
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKK--IVHRDVKTENM 238 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--iiHrDlkp~NI 238 (390)
....+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 83 ---------------~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 83 ---------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145 (270)
T ss_dssp ---------------SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred ---------------cCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhc
Confidence 234568999999999999999654 46999999999999999999999999 99999999999
Q ss_pred EEC-CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLD-SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++ .++.+||+|||+|+..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......+.
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~ 222 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred eeeCCCCCEEEeecCcceeccCC--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH
Confidence 996 4789999999999754322 2335689999999999876 59999999999999999999999998765555444
Q ss_pred HHHHcC-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQN-LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
..+..+ ..+..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 444443 334466778999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=409.60 Aligned_cols=259 Identities=28% Similarity=0.514 Sum_probs=215.9
Q ss_pred ccccCccccccccccCceEEEEEEEC---C--ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTYD---N--QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
|+.++|++.+.||+|+||.||+|++. + ..||||+++.... ......+.|.+|+.+|++++||||++++|
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~------~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL------SQPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc------CCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45678999999999999999999863 2 3689998863221 12233467899999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++.+. ..++||||+++|+|.+++..+ ...+++..+..++.||+.||.|||++||+|||
T Consensus 79 ~~~~~---------------------~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrD 136 (273)
T d1u46a_ 79 VVLTP---------------------PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 136 (273)
T ss_dssp EECSS---------------------SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEeec---------------------chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeee
Confidence 98642 237899999999999988654 34699999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC---CCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR---DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYP 308 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~ 308 (390)
|||+|||++.++.+||+|||+++....... ......+|..|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986543322 1223457889999999999999999999999999999998 899999
Q ss_pred CCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 309 DLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+.+..+....+...+.+++.+..+|+++.+||.+||..||++|||+.+|++.|+..
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999889889999999999999999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=421.49 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=211.0
Q ss_pred cccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGAS 154 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 154 (390)
++..++|++.+.||+|+||+||+|++ +|+.||+|+++..... .....+.+|+.+|++++|||||+++++|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--------THHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45568999999999999999999998 5789999999743211 1235678999999999999999999999
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS-KKIVHRDV 233 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~iiHrDl 233 (390)
.+..+ .|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+ +||+||||
T Consensus 74 ~~~~~--------------------~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDi 131 (322)
T d1s9ja_ 74 YSDGE--------------------ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131 (322)
T ss_dssp ECSSE--------------------EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCC
T ss_pred EECCE--------------------EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcccc
Confidence 86544 48899999999999999654 469999999999999999999997 49999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
||+|||++.++.+||+|||+|+..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..
T Consensus 132 KP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 132 KPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred CHHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999999854332 234568999999999999999999999999999999999999999765432
Q ss_pred hHHH-----------------------------------------HHHHcCCCCCCC-CCCcHHHHHHHHHhhhhCCCCC
Q 036382 314 DVSS-----------------------------------------AVVRQNLRPEIP-RCCPSSLANIMRKCWDANAEKR 351 (390)
Q Consensus 314 ~~~~-----------------------------------------~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~R 351 (390)
+... ........+..+ ..++.++.+||.+||..||.+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 2110 000111112222 2357899999999999999999
Q ss_pred CCHHHHHH--HHHHhHhcC
Q 036382 352 PEMGEVVK--MLEAIDTSK 368 (390)
Q Consensus 352 pt~~~ll~--~L~~~~~~~ 368 (390)
||++|+++ .++......
T Consensus 290 ~ta~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 290 ADLKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp CCHHHHHTSHHHHHHHHSC
T ss_pred cCHHHHhhCHhhCcCCccc
Confidence 99999998 466655443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-55 Score=412.50 Aligned_cols=262 Identities=28% Similarity=0.527 Sum_probs=224.3
Q ss_pred cccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV 147 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 147 (390)
.|+++.++|++.+.||+|+||.||+|++. ++.||||+++... .......|.+|+.++++++||||
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~E~~il~~l~h~ni 78 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--------SADMQADFQREAALMAEFDNPNI 78 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--------CHHHHHHHHHHHHHHHTCCCTTB
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--------ChHHHHHHHHHHHHHHhcCCCCc
Confidence 47888899999999999999999999874 3689999986322 12235678899999999999999
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----------------------cCCCC
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----------------------RKKLA 205 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~ 205 (390)
+++++++.+... .++||||+.+|+|.+++.... ...++
T Consensus 79 v~~~~~~~~~~~--------------------~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 138 (301)
T d1lufa_ 79 VKLLGVCAVGKP--------------------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138 (301)
T ss_dssp CCEEEEECSSSS--------------------CEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred ccceeeeccCCc--------------------eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCC
Confidence 999999976544 378999999999999996422 23489
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCC--CCCCCCCCCCCccccccccCCCC
Q 036382 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQN--PRDMTGETGTLGYMAPEVLQGKP 283 (390)
Q Consensus 206 ~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~ 283 (390)
+..+..|+.|++.||+|||+++||||||||+|||++.++.+||+|||+|+..... ........+|+.|+|||.+.+..
T Consensus 139 ~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 9999999999999999999999999999999999999999999999999754322 12233467899999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCC-CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 284 YNRRCDVYSFGICLWEIYCCD-MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 284 ~~~~~DiwSlG~il~ell~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
|+.++|||||||++|||++|. +||.+.+..+....+. .+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+
T Consensus 219 ~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 219 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999999999999985 6899998888887764 45577889999999999999999999999999999999999
Q ss_pred HhH
Q 036382 363 AID 365 (390)
Q Consensus 363 ~~~ 365 (390)
++.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=413.00 Aligned_cols=270 Identities=29% Similarity=0.531 Sum_probs=233.2
Q ss_pred CCCCCcccccccCccccccccccCceEEEEEEE-------CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc
Q 036382 70 QRPKEEWEIDLSKLDMRNLIAQGTYGSVYRGTY-------DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL 142 (390)
Q Consensus 70 ~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 142 (390)
......|+++.++|++.++||+|+||.||+|++ +++.||||+++.... ......+.+|+.+++++
T Consensus 12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~E~~~~~~l 83 (311)
T d1t46a_ 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYL 83 (311)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHH
T ss_pred CCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--------HHHHHHHHHHHHHHHhc
Confidence 334668999999999999999999999999986 335899999973221 12245688999999999
Q ss_pred -CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc----------------cCCCC
Q 036382 143 -DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR----------------RKKLA 205 (390)
Q Consensus 143 -~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~ 205 (390)
+|||||++++++.+... .++||||+++|+|.+++.+.. ...++
T Consensus 84 ~~HpnIv~~~g~~~~~~~--------------------~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~ 143 (311)
T d1t46a_ 84 GNHMNIVNLLGACTIGGP--------------------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143 (311)
T ss_dssp CCCTTBCCEEEEECSSSS--------------------CEEEEECCTTEEHHHHHHHTTTTC--------------CCCC
T ss_pred cCCCCEEEEEEEEeeCCE--------------------EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCC
Confidence 79999999999976543 478999999999999996542 23589
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCC
Q 036382 206 LKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKP 283 (390)
Q Consensus 206 ~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 283 (390)
+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......++|+.|+|||++.+..
T Consensus 144 ~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 99999999999999999999999999999999999999999999999998654432 2233457899999999999999
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 284 YNRRCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 284 ~~~~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
++.++|||||||++|||+| |.+||...+..+.+..++..+.++..|..+|+++.+||.+||+.||++|||+.+|++.|+
T Consensus 224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999999999999999998 667777877777788888889999999999999999999999999999999999999999
Q ss_pred HhHhc
Q 036382 363 AIDTS 367 (390)
Q Consensus 363 ~~~~~ 367 (390)
++-+.
T Consensus 304 ~~i~~ 308 (311)
T d1t46a_ 304 KQISE 308 (311)
T ss_dssp HHHHH
T ss_pred Hhhcc
Confidence 87544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-55 Score=413.25 Aligned_cols=248 Identities=24% Similarity=0.407 Sum_probs=217.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||+||+|++ +|+.||||+++.. ........+.+.+|+.+++.++|||||++++++.+.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~------~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE------IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchH------HccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 57899999999999999999987 5889999998621 111222346788999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. ..|+||||+.||+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 77 ~--------------------~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N 134 (316)
T d1fota_ 77 Q--------------------QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134 (316)
T ss_dssp S--------------------EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred C--------------------eeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchh
Confidence 4 44789999999999999854 4568999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.+|.+||+|||+|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+...
T Consensus 135 ILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 135 ILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp EEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred eeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 99999999999999999865433 345789999999999999999999999999999999999999999999999888
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVKM 360 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~ 360 (390)
.+.... ..+|..+|+++.++|.+||.+||.+|+ |+++++++
T Consensus 212 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 212 KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 887664 456788999999999999999999996 89999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.6e-55 Score=402.13 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=223.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGT 157 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 157 (390)
++|++.+.||+|+||+||+|++ +|+.||||+++................+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999988 67899999998665544444555666778899999999996 99999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.+ .|+||||+++|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 83 ~~--------------------~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N 140 (277)
T d1phka_ 83 TF--------------------FFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140 (277)
T ss_dssp SE--------------------EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cc--------------------eEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccce
Confidence 44 4789999999999999965 3479999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQ------GKPYNRRCDVYSFGICLWEIYCCDMPYPDLS 311 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 311 (390)
||++.++.+||+|||+++..... .......||+.|+|||.+. ...++.++||||+||++|+|++|+.||.+.+
T Consensus 141 ill~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 141 ILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 99999999999999999865543 3345578999999999985 3457889999999999999999999999999
Q ss_pred hhhHHHHHHHcCCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 312 FADVSSAVVRQNLRPEI--PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 312 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+....+......... ...+|+++++||.+||+.||.+|||+.+|+++
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 88888888777654433 34789999999999999999999999998763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=407.92 Aligned_cols=265 Identities=31% Similarity=0.581 Sum_probs=223.2
Q ss_pred CCcccccccCccccccccccCceEEEEEEECC---------ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-
Q 036382 73 KEEWEIDLSKLDMRNLIAQGTYGSVYRGTYDN---------QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL- 142 (390)
Q Consensus 73 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 142 (390)
...|+|+.++|++++.||+|+||.||+|++.+ ..||||+++.... ......+.+|+..++++
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~e~~~l~~~~ 76 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--------EKDLSDLISEMEMMKMIG 76 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--------HHHHHHHHHHHHHHHHHC
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--------hHHHHHHHHHHHHHHHhc
Confidence 34599999999999999999999999997622 3799999863221 12245678899999888
Q ss_pred CCCccceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------------cCCCCHHH
Q 036382 143 DHPNVTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------------RKKLALKI 208 (390)
Q Consensus 143 ~hpnIv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~ 208 (390)
+|||||+++++|.+... .++||||+.+|+|.+++.... ...+++..
T Consensus 77 ~HpnIv~~~~~~~~~~~--------------------~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 136 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGP--------------------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136 (299)
T ss_dssp CCTTBCCEEEEECSSSS--------------------CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHH
T ss_pred CCCeEEecccccccCCe--------------------EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHH
Confidence 89999999999986543 478999999999999996543 24589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCC--CCCCCCCCCCccccccccCCCCCCC
Q 036382 209 VIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNP--RDMTGETGTLGYMAPEVLQGKPYNR 286 (390)
Q Consensus 209 ~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 286 (390)
+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..|+.
T Consensus 137 ~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~ 216 (299)
T d1fgka_ 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCc
Confidence 99999999999999999999999999999999999999999999998654332 2233456899999999999999999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 036382 287 RCDVYSFGICLWEIYC-CDMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAID 365 (390)
Q Consensus 287 ~~DiwSlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~ 365 (390)
++|||||||++|||++ |.+||.+.+..++...+ ..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 217 k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 217 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 9999999999999998 78999988887776554 567888999999999999999999999999999999999999986
Q ss_pred h
Q 036382 366 T 366 (390)
Q Consensus 366 ~ 366 (390)
.
T Consensus 296 a 296 (299)
T d1fgka_ 296 A 296 (299)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-55 Score=418.88 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=216.7
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||.||+|++ +|+.||||++.... . ...+.+.+|+.+|++++|||||++++++.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----E----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----H----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----h----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 57899999999999999999987 58899999986321 1 1235688999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. .+|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++|||||||||+|
T Consensus 96 ~--------------------~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~N 154 (350)
T d1koaa2 96 N--------------------EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154 (350)
T ss_dssp T--------------------EEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred C--------------------EEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhH
Confidence 4 448899999999999998543 3469999999999999999999999999999999999
Q ss_pred EEECC--CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLDS--QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~--~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||++. ++.+||+|||+|+..... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.
T Consensus 155 Ill~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 233 (350)
T d1koaa2 155 IMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233 (350)
T ss_dssp EEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 99964 588999999999865433 233446799999999999999999999999999999999999999999999998
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+........ ....+++++++||.+||+.||++|||+.|++++
T Consensus 234 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 888877665433 235689999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=407.66 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=217.0
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +|+.||||+++......... ....+.+.+|+.+|++++|||||++++++.+..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh---hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999997 58899999996433221111 112356889999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
. .|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 87 ~--------------------~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni 144 (293)
T d1jksa_ 87 D--------------------VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144 (293)
T ss_dssp E--------------------EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred E--------------------EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence 4 47899999999999999654 4699999999999999999999999999999999999
Q ss_pred EECCCC----cEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 239 LLDSQR----TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 239 Ll~~~~----~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|++.++ .+||+|||+|..... ........+|+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+
T Consensus 145 ll~~~~~~~~~vkl~DfG~a~~~~~-~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 145 MLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp EESCSSSSSCCEEECCCTTCEECTT-SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEecCCCcccceEecchhhhhhcCC-CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 998776 599999999986543 234455789999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 315 VSSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 315 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
....+........ .+..+|+++.+||.+||+.||++|||++++++
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8887766554432 34678999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.2e-55 Score=403.13 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=216.9
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +|+.||||+++.... ........+.+|+++++.++||||+++++++....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT------TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc------cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 5799999999999999999987 588999999974321 12233467889999999999999999999987543
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.. ....|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 81 ~~----------------~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NI 142 (277)
T d1o6ya_ 81 PA----------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 142 (277)
T ss_dssp SS----------------SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CC----------------CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccc
Confidence 21 23468999999999999998554 4699999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
|++.++..+|+|||.+....... ......+||+.|+|||++.+..++.++|||||||++|||+||.+||.+.+..+.
T Consensus 143 ll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 222 (277)
T d1o6ya_ 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222 (277)
T ss_dssp EEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH
Confidence 99999999999999987543221 233446799999999999999999999999999999999999999999998888
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhH
Q 036382 316 SSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRP-EMGEVVKMLEAID 365 (390)
Q Consensus 316 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~ 365 (390)
...++.....+. .+..+|+++.+||.+||++||.+|| |++++++.|.++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 877777655442 4567899999999999999999999 8999999998874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-55 Score=417.10 Aligned_cols=250 Identities=19% Similarity=0.322 Sum_probs=216.7
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||.||+|.+ +|+.||||+++... . .....+.+|+.+|++++|||||++++++.+.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----P----LDKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----H----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----h----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 46799999999999999999987 58899999986321 1 1135678999999999999999999999854
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
. .+|+||||+++|+|.+++.+. ..++++..++.|+.||+.||.|||++||+||||||+|
T Consensus 99 ~--------------------~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N 157 (352)
T d1koba_ 99 Y--------------------EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157 (352)
T ss_dssp S--------------------EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred C--------------------EEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence 4 447899999999999987543 4469999999999999999999999999999999999
Q ss_pred EEEC--CCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLD--SQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~--~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||++ .++.+||+|||+|...... .......+|+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.
T Consensus 158 ILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 158 IMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9997 5689999999999865433 233446799999999999999999999999999999999999999999999998
Q ss_pred HHHHHHcCCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 316 SSAVVRQNLRP--EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
...+....... ..+..+|+++.+||.+||+.||.+|||+.+++++
T Consensus 237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 88887765543 3456789999999999999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-55 Score=410.37 Aligned_cols=256 Identities=24% Similarity=0.550 Sum_probs=215.7
Q ss_pred ccCccccccccccCceEEEEEEEC--Cc----eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTYD--NQ----EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.++|+++++||+|+||.||+|.+. |+ .||||.++... .....+.|.+|+.++++++|||||+++|+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 79 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLLGI 79 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--------CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 357999999999999999999873 33 58888876321 11224568899999999999999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+. ..+++|||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 80 ~~~~---------------------~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl 137 (317)
T d1xkka_ 80 CLTS---------------------TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137 (317)
T ss_dssp EESS---------------------SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EecC---------------------CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcc
Confidence 9743 346899999999999988654 457999999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCC--CCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRD--MTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYC-CDMPYPDL 310 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~Pf~~~ 310 (390)
||+|||++.++.+||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.
T Consensus 138 Kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp CGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred hhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999865433222 233468999999999999999999999999999999998 89999988
Q ss_pred ChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 036382 311 SFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDT 366 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~ 366 (390)
+..++... +..+.+++.|..+|+++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 218 ~~~~~~~~-i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 218 PASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CGGGHHHH-HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHH-HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 87776654 45677888899999999999999999999999999999999998854
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=412.53 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=215.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHH-hcCCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQ-KLDHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~ 156 (390)
+++|++.+.||+|+||+||+|++ +|+.||||+++.. ........+.+..|..++. .++|||||++++++.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~------~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchh------hccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc
Confidence 36899999999999999999988 6889999999621 1111122344556666654 6899999999999986
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
... .|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 75 ~~~--------------------~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~ 132 (320)
T d1xjda_ 75 KEN--------------------LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 132 (320)
T ss_dssp SSE--------------------EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred CCc--------------------eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCccc
Confidence 544 47899999999999999653 46999999999999999999999999999999999
Q ss_pred CEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 237 NMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 237 NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|||++.++++||+|||+++............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++.
T Consensus 133 NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 133 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999986655555566678999999999999999999999999999999999999999999998888
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 036382 317 SAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMG-EVVK 359 (390)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll~ 359 (390)
..+... .+.+|..+|+++.+||.+||..||.+|||+. +|++
T Consensus 213 ~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 213 HSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 877655 4567888999999999999999999999995 6764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-54 Score=413.24 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=217.0
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++++.||+|+||.||+|++ +|+.||||+++.. ........+.+.+|+.+|+.++|||||++++++.+.
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~------~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ------KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchH------HccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 57899999999999999999988 5889999998621 112222345688999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. .++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++|||||||||+|
T Consensus 114 ~~--------------------~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~N 171 (350)
T d1rdqe_ 114 SN--------------------LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp SE--------------------EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cc--------------------cccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHH
Confidence 43 47899999999999999654 469999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.+|++||+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+......
T Consensus 172 ILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 172 LLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp EEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 99999999999999999865432 345689999999999999999999999999999999999999999999888888
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 036382 318 AVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVK 359 (390)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~ 359 (390)
.+.... +..|..+++++.+||++||..||.+|+ |+++|++
T Consensus 249 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 249 KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 877654 456788999999999999999999994 8999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=407.65 Aligned_cols=262 Identities=30% Similarity=0.541 Sum_probs=225.9
Q ss_pred CcccccccCccccccccccCceEEEEEEEC-------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCc
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTYD-------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPN 146 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 146 (390)
++|+|+.++|++.+.||+|+||.||+|.+. ++.||||+++... .......|.+|+.++++++|||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--------~~~~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--------SMRERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--------CHHHHHHHHHHHHHGGGCCCTT
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--------ChHHHHHHHHHHHHHHHcCCCC
Confidence 479999999999999999999999999873 4689999986321 1122356889999999999999
Q ss_pred cceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhc--------cCCCCHHHHHHHHHHHHH
Q 036382 147 VTKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNR--------RKKLALKIVIQLALDLSR 218 (390)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~ 218 (390)
|++++|++..... .++||||+.+|+|.+++.... ...+++..+..++.|++.
T Consensus 85 Iv~~~~~~~~~~~--------------------~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~ 144 (308)
T d1p4oa_ 85 VVRLLGVVSQGQP--------------------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144 (308)
T ss_dssp BCCEEEEECSSSS--------------------CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred EeeeeeEEecCCc--------------------eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHH
Confidence 9999999975443 478999999999999986432 134789999999999999
Q ss_pred HHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCC--CCCCCCCCCccccccccCCCCCCCchhHHHHHHH
Q 036382 219 GLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPR--DMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGIC 296 (390)
Q Consensus 219 ~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 296 (390)
||.|||+++|+||||||+|||++.++++||+|||+|+....... ......+|+.|+|||.+.+..++.++|||||||+
T Consensus 145 gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 145 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp HHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence 99999999999999999999999999999999999985443222 2233468999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 036382 297 LWEIYCC-DMPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAI 364 (390)
Q Consensus 297 l~ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~ 364 (390)
+|||++| .+||.+.+..+....+. .+.+++.|..+|+.+.+||.+||+.||++|||+.+|++.|++.
T Consensus 225 l~El~t~~~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999998 58899999988887765 4557778899999999999999999999999999999998775
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.9e-54 Score=411.23 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=206.9
Q ss_pred cccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHH---HHHHHHHhcCCCccceEEEE
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQ---QEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpnIv~~~~~ 153 (390)
.+++|++.++||+|+||.||+|++ +|+.||||+++.. ..........+. +|+.+++.++|||||+++++
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~------~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~ 75 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK------RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchH------HcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE
Confidence 568999999999999999999988 5889999998521 111111122233 44667777889999999999
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
+.+.. ..|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||
T Consensus 76 ~~~~~--------------------~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDl 133 (364)
T d1omwa3 76 FHTPD--------------------KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133 (364)
T ss_dssp EECSS--------------------EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEECC--------------------EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceee
Confidence 98654 347899999999999999654 56899999999999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||+|||++.+|.+||+|||+|+..... .....+||+.|+|||++.. ..|+.++|||||||++|||++|..||.+.+.
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999865432 3345689999999999964 5789999999999999999999999987655
Q ss_pred hhHHHHHH-HcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 036382 313 ADVSSAVV-RQNLRPEIPRCCPSSLANIMRKCWDANAEKRPE-----MGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~ 360 (390)
.+...... ........|..+|+++.+||.+||..||++||| +++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 212 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 44332221 233455677889999999999999999999999 6888753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=405.48 Aligned_cols=263 Identities=28% Similarity=0.538 Sum_probs=220.8
Q ss_pred cccccCccccccccccCceEEEEEEE--CCc--eEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEE
Q 036382 77 EIDLSKLDMRNLIAQGTYGSVYRGTY--DNQ--EVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFV 151 (390)
Q Consensus 77 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~ 151 (390)
.|+.++|++.++||+|+||.||+|++ +|. .||||.++... .....+.+.+|+++|+++ +|||||+++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~~HpnIv~~~ 77 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--------SKDDHRDFAGELEVLCKLGHHPNIINLL 77 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--------ChHHHHHHHHHHHHHHhccCCCCEeeEE
Confidence 46778999999999999999999987 444 46777765221 112245688999999999 799999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhh--------------ccCCCCHHHHHHHHHHHH
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRN--------------RRKKLALKIVIQLALDLS 217 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~ 217 (390)
|++.+... .++||||+++|+|.++|.++ ....+++..+..++.||+
T Consensus 78 ~~~~~~~~--------------------~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia 137 (309)
T d1fvra_ 78 GACEHRGY--------------------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137 (309)
T ss_dssp EEEEETTE--------------------EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHH
T ss_pred EEEecCCe--------------------eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHH
Confidence 99986543 47899999999999999643 236799999999999999
Q ss_pred HHHHHHHhCCCcccCCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHH
Q 036382 218 RGLSYLHSKKIVHRDVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICL 297 (390)
Q Consensus 218 ~~L~yLH~~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 297 (390)
.||.|||+++|+||||||+|||++.++.+||+|||+|+..... .......+|..|+|||.+.+..++.++|||||||++
T Consensus 138 ~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 138 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 9999999999999999999999999999999999999754332 222345689999999999999999999999999999
Q ss_pred HHHHhCC-CCCCCCChhhHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcCC
Q 036382 298 WEIYCCD-MPYPDLSFADVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSKG 369 (390)
Q Consensus 298 ~ell~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~ 369 (390)
|||++|. +||.+.+..++...+ ..+.+++.|..+|+++.+||.+||+.||++|||+.+|++.|+++...+.
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHG-GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhcCCCCCCCCCHHHHHHHH-HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 9999965 679888888877665 4567888899999999999999999999999999999999999875443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=399.00 Aligned_cols=255 Identities=32% Similarity=0.555 Sum_probs=210.8
Q ss_pred cccccccccCceEEEEEEECC-----ceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 84 DMRNLIAQGTYGSVYRGTYDN-----QEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
.+.++||+|+||+||+|++.. ..||||.++... .....+.|.+|+++|++++||||++++|++...
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~- 100 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS- 100 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-
Confidence 446789999999999998732 258999986221 122346789999999999999999999998643
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||
T Consensus 101 ------------------~~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NI 161 (311)
T d1r0pa_ 101 ------------------EGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 161 (311)
T ss_dssp ------------------TTEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ------------------CCceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhE
Confidence 23458899999999999998643 45688899999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-Chh
Q 036382 239 LLDSQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDL-SFA 313 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~ 313 (390)
|+++++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|..||... +..
T Consensus 162 Ll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~ 241 (311)
T d1r0pa_ 162 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241 (311)
T ss_dssp EECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred eECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 99999999999999998644322 1223356899999999999999999999999999999999987776544 444
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhc
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTS 367 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~ 367 (390)
+.... +..+.++..|..+|+++.+||.+||+.||++|||+.||++.|+.+..+
T Consensus 242 ~~~~~-i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 242 DITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHH-HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 44444 456678888999999999999999999999999999999999999765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=396.30 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=202.8
Q ss_pred ccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccccc
Q 036382 85 MRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNLKI 162 (390)
Q Consensus 85 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 162 (390)
.+++||+|+||+||+|++ +|+.||||+++.... ..........+.+|+.++++++|||||++++++.+..++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~-- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR----SEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI-- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC--
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhh----hhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce--
Confidence 357899999999999987 588999999964321 111122335678999999999999999999999865444
Q ss_pred CCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCEEECC
Q 036382 163 PSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENMLLDS 242 (390)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NILl~~ 242 (390)
|+||||+.++++..+. ..+..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ------------------~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~ 135 (299)
T d1ua2a_ 76 ------------------SLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 135 (299)
T ss_dssp ------------------EEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred ------------------eehhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC
Confidence 7899999987776655 33467999999999999999999999999999999999999999
Q ss_pred CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 036382 243 QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSSAVVR 321 (390)
Q Consensus 243 ~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (390)
++.+||+|||+|+............+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..+..
T Consensus 136 ~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 136 NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp TCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence 999999999999866555555556789999999999865 4689999999999999999999999999988887776653
Q ss_pred cCCCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 322 QNLRPE--------------------------IPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 322 ~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
....+. ....+++++.+||.+||+.||++|||+.|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 216 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 211110 012457899999999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=399.96 Aligned_cols=248 Identities=16% Similarity=0.269 Sum_probs=214.4
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||+||+|.+ +++.||||+++... .. ...+.+|+++|+.++|||||++++++.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD----QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH----HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------cc----HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 47899999999999999999987 57899999997321 11 24577999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. +|+||||++||+|.+++.+. +..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 74 ~~--------------------~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~N 132 (321)
T d1tkia_ 74 EE--------------------LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132 (321)
T ss_dssp TE--------------------EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CE--------------------EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccc
Confidence 44 48899999999999999543 3469999999999999999999999999999999999
Q ss_pred EEECCC--CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhH
Q 036382 238 MLLDSQ--RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADV 315 (390)
Q Consensus 238 ILl~~~--~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 315 (390)
||++.+ ..+||+|||+++..... .......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+.
T Consensus 133 Ill~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~ 211 (321)
T d1tkia_ 133 IIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred eeecCCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999854 58999999999865432 223345789999999999999999999999999999999999999999999998
Q ss_pred HHHHHHcCCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNLRPE--IPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+....+..+ .+..+++++.+||.+||..||.+|||+.++++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 888877655433 23468999999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=393.19 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=209.8
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.+.||+|+||.||+|++ +|+.||||+++... ........+.+|+++|++++|||||++++++.+.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 73 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-------cChHHHHHHHHHHHHHHhCCCCcEEEeccccccc
Confidence 46899999999999999999988 58899999996322 1112235688999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.+ +|+||||+.+ ++.+++.......+++..+..++.||+.||+|||++|||||||||+|
T Consensus 74 ~~--------------------~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN 132 (298)
T d1gz8a_ 74 NK--------------------LYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132 (298)
T ss_dssp TE--------------------EEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred cc--------------------eeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence 44 4789999965 56666655556779999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
||++.++.+||+|||+|+.............||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+..
T Consensus 133 Il~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 133 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp EEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence 9999999999999999987665555566678999999999987765 578999999999999999999999998877776
Q ss_pred HHHHHcCCCC----------------CC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 317 SAVVRQNLRP----------------EI-----------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 317 ~~~~~~~~~~----------------~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
..+......+ .. ...++.++.+||.+||..||.+|||+.|++++
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 6554321110 00 12457889999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=400.61 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=202.8
Q ss_pred ccCccccc-cccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEe
Q 036382 80 LSKLDMRN-LIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASV 155 (390)
Q Consensus 80 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 155 (390)
.++|++.+ .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.++ +|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 56898875 599999999999987 5789999998621 3456899987655 8999999999986
Q ss_pred cccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 156 GTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
+... ....+|+||||++||+|.+++.++....+++..++.|+.||+.||.|||++||+||||||
T Consensus 76 ~~~~----------------~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp 139 (335)
T d2ozaa1 76 NLYA----------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 139 (335)
T ss_dssp EEET----------------TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred eccc----------------CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Confidence 4211 134458999999999999999765556799999999999999999999999999999999
Q ss_pred CCEEECC---CCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 236 ENMLLDS---QRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 236 ~NILl~~---~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
+|||++. .+.+||+|||+|+..... ......+||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+.
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 9999985 467999999999865443 334557899999999999999999999999999999999999999987665
Q ss_pred hhHHHHHHHcCCCC--CCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNLRP--EIP----RCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~~~--~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+....... .+| ..+|+++.+||.+||+.||++|||+.+++++
T Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp C--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 55444333222111 222 2478999999999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=385.97 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=208.8
Q ss_pred cCccccccccccCceEEEEEEEC---CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc---CCCccceEEEEE
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYD---NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL---DHPNVTKFVGAS 154 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~ 154 (390)
++|++++.||+|+||+||+|++. ++.||||+++........ ...+.+|+.+++.| +||||++++++|
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-------HHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 68999999999999999999873 457999998643221111 12344677776665 899999999998
Q ss_pred ecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 036382 155 VGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVK 234 (390)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlk 234 (390)
.....- .....+++|||+.++.+.... ......+++..++.++.|++.||+|||++||+|||||
T Consensus 80 ~~~~~~---------------~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiK 143 (305)
T d1blxa_ 80 TVSRTD---------------RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 143 (305)
T ss_dssp EEEECS---------------SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred cccccc---------------cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCC
Confidence 643211 234568999999887665443 3455679999999999999999999999999999999
Q ss_pred CCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhh
Q 036382 235 TENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFAD 314 (390)
Q Consensus 235 p~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 314 (390)
|+|||++.++.+||+|||++..... ........||+.|+|||++.+.+|+.++||||+||++|||++|.+||.+.+..+
T Consensus 144 p~NILi~~~~~~kl~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 222 (305)
T d1blxa_ 144 PQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222 (305)
T ss_dssp GGGEEECTTCCEEECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccEEEEcCCCCeeecchhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999999999999999875433 233456789999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHcCCC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 036382 315 VSSAVVRQNLR-------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAID 365 (390)
Q Consensus 315 ~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~ 365 (390)
.+..+...... ...+..+++++.+||.+||+.||++|||+.|++++ |+++.
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 77766532110 01234578899999999999999999999999874 55443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-51 Score=383.56 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=203.9
Q ss_pred ccCccccccccccCceEEEEEEE-CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
+++|++.++||+|+||+||+|++ +|+.||||+++..... ......+.+|+.+|++++||||+++++++.+..
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-------hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 46899999999999999999988 5789999999643211 112356789999999999999999999998654
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
. .+++|||+.++.+..+.. ....+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 74 ~--------------------~~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI 131 (286)
T d1ob3a_ 74 R--------------------LVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (286)
T ss_dssp C--------------------EEEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred c--------------------eeEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence 4 478999998776666653 346799999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 239 LLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 239 Ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
|++.++.+||+|||.|..............+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred eEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999999866544444455678999999999875 457999999999999999999999999988777766
Q ss_pred HHHHcCCC---------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 318 AVVRQNLR---------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 318 ~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
.+...... ...+..+++++.+||++||+.||++|||+.|+++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 65431110 0123456889999999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=387.62 Aligned_cols=260 Identities=32% Similarity=0.479 Sum_probs=205.8
Q ss_pred cCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSNL 160 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 160 (390)
++|.+.+.||+|+||.||+|+++|+.||||+++.. ... ......|+..+++++||||+++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-------~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~- 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EER---SWFREAEIYQTVMLRHENILGFIAADNKDNG- 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-------GHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-------chh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-
Confidence 46889999999999999999999999999998621 111 1122245555567899999999999976532
Q ss_pred ccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccC
Q 036382 161 KIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS--------KKIVHRD 232 (390)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~--------~~iiHrD 232 (390)
.....|+||||+++|+|.++|.+. .+++..++.++.|++.||.|||+ +||+|||
T Consensus 72 ---------------~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrD 133 (303)
T d1vjya_ 72 ---------------TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp ---------------SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred ---------------cceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccc
Confidence 123468999999999999999653 59999999999999999999996 5999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCCC----CCCCCCCCCccccccccCCCC------CCCchhHHHHHHHHHHHHh
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNPR----DMTGETGTLGYMAPEVLQGKP------YNRRCDVYSFGICLWEIYC 302 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~ell~ 302 (390)
|||+||||+.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+|
T Consensus 134 lKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t 213 (303)
T d1vjya_ 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh
Confidence 999999999999999999999986543321 233467999999999987643 5678999999999999999
Q ss_pred CCCCCCC---------------CChhhHHHHHHHcCCCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 036382 303 CDMPYPD---------------LSFADVSSAVVRQNLRPEIPRC-----CPSSLANIMRKCWDANAEKRPEMGEVVKMLE 362 (390)
Q Consensus 303 g~~Pf~~---------------~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~ 362 (390)
|..||.. ..............+++.+|.. ++..+.+||.+||+.||++|||+.+|++.|+
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 9877632 1233344444455666665543 2356999999999999999999999999999
Q ss_pred HhHhcCC
Q 036382 363 AIDTSKG 369 (390)
Q Consensus 363 ~~~~~~~ 369 (390)
.+...++
T Consensus 294 ~i~~~~~ 300 (303)
T d1vjya_ 294 QLSQQEG 300 (303)
T ss_dssp HHHHHHC
T ss_pred HHHHhcC
Confidence 9986654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=380.91 Aligned_cols=245 Identities=23% Similarity=0.386 Sum_probs=200.6
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC--CCccceEEEEEec
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD--HPNVTKFVGASVG 156 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~ 156 (390)
++|++.+.||+|+||.||+|++ +|+.||||+++.......... .....+.+|+.++++++ |||||++++++.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~---~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh---hHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 4799999999999999999988 588999999864321111000 00123568999999996 8999999999986
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCC-CCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPG-GNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKT 235 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp 235 (390)
... .++||||+.+ +++.+++.+. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 81 ~~~--------------------~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp 138 (273)
T d1xwsa_ 81 PDS--------------------FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138 (273)
T ss_dssp SSE--------------------EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCe--------------------EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcc
Confidence 543 4789999976 6888888543 5699999999999999999999999999999999
Q ss_pred CCEEECCC-CcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 036382 236 ENMLLDSQ-RTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPY-NRRCDVYSFGICLWEIYCCDMPYPDLSFA 313 (390)
Q Consensus 236 ~NILl~~~-~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 313 (390)
+|||++.+ +.+||+|||+|+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+
T Consensus 139 ~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-- 214 (273)
T d1xwsa_ 139 ENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-- 214 (273)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred cceEEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--
Confidence 99999855 79999999999865432 3455789999999999987665 577999999999999999999997532
Q ss_pred hHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 314 DVSSAVVRQNLRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+... ...++..+|+++.+||.+||+.||++|||++|++++
T Consensus 215 ----~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 ----EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 23333 345677899999999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=383.37 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=209.2
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|++ .++|++.++||+|+||+||+|.+ +|+.||||+++.... .....+.+.+|+.+|++++|||||+++
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~Ei~il~~l~hpniv~l~ 83 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMRHENVIGLL 83 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-------SHHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-------ChHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence 45777 47899999999999999999987 589999999963211 122346778999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
++|....... .....|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~~--------------~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHr 145 (346)
T d1cm8a_ 84 DVFTPDETLD--------------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHR 145 (346)
T ss_dssp EEECSCSSTT--------------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EEeccCcccc--------------ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCccc
Confidence 9998665432 244569999999 5678877643 469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||||+|||++.++.+||+|||+|+.... ..+...+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.
T Consensus 146 DiKp~NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 146 DLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCcchhhcccccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 9999999999999999999999986543 2455789999999999876 45789999999999999999999999988
Q ss_pred ChhhHHHHHHHcCCC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH-
Q 036382 311 SFADVSSAVVRQNLR-----------------------------PEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM- 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~- 360 (390)
+..+....+...... ......+++++.+||.+||..||.+|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 766655443321111 01234568899999999999999999999999985
Q ss_pred -HHHhH
Q 036382 361 -LEAID 365 (390)
Q Consensus 361 -L~~~~ 365 (390)
|+.+.
T Consensus 303 ~f~~~~ 308 (346)
T d1cm8a_ 303 YFESLH 308 (346)
T ss_dssp GGTTTC
T ss_pred hhCcCC
Confidence 55544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=379.42 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=203.4
Q ss_pred cccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEE
Q 036382 75 EWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVG 152 (390)
Q Consensus 75 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 152 (390)
.|++. ++|++++.||+|+||+||+|++ +|+.||||+++... .....+.+.+|+++|+.++||||+++++
T Consensus 3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~~Ei~il~~l~hp~iv~~~~ 73 (345)
T d1pmea_ 3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--------HQTYCQRTLREIKILLRFRHENIIGIND 73 (345)
T ss_dssp CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--------CHHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--------ChHHHHHHHHHHHHHHHcCCCCCCcEEE
Confidence 35554 4699999999999999999987 58999999986321 1223456789999999999999999999
Q ss_pred EEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccC
Q 036382 153 ASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRD 232 (390)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrD 232 (390)
++...... ....+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++||||||
T Consensus 74 ~~~~~~~~----------------~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRD 134 (345)
T d1pmea_ 74 IIRAPTIE----------------QMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRD 134 (345)
T ss_dssp EECCSSTT----------------TCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEeecccc----------------ccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 98754322 1222455667779999999954 3599999999999999999999999999999
Q ss_pred CCCCCEEECCCCcEEEeecccceeccCCC---CCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 233 VKTENMLLDSQRTLKIADFGVARVEAQNP---RDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 233 lkp~NILl~~~~~~kL~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
|||+|||++.++.+||+|||+|....... ......+||+.|+|||++.. ..++.++||||+||++|+|++|..||.
T Consensus 135 IKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 99999999999999999999997543321 22345679999999999854 567899999999999999999999998
Q ss_pred CCChhhHHHHHHHcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 309 DLSFADVSSAVVRQNLRP-----------------------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
+.+..+...........+ .....+++++.+||.+||+.||.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 877665554443211000 012346788999999999999999999999997
Q ss_pred H
Q 036382 360 M 360 (390)
Q Consensus 360 ~ 360 (390)
+
T Consensus 295 h 295 (345)
T d1pmea_ 295 H 295 (345)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=372.14 Aligned_cols=260 Identities=23% Similarity=0.297 Sum_probs=201.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
.++|++.+.||+|+||+||+|++ +|+.||||+++...... .....+.+|+.+|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-------GFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-------HHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 57899999999999999999997 58899999986432211 1124567899999999999999999999765
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
...+. ......|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 82 ~~~~~------------~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~N 147 (318)
T d3blha1 82 ASPYN------------RCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147 (318)
T ss_dssp ---------------------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ccccc------------ccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchh
Confidence 43322 1245679999999877665443 344579999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCC----CCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNP----RDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLSF 312 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 312 (390)
||++.++.+||+|||++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 148 ILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 999999999999999997544221 122335799999999998765 689999999999999999999999998887
Q ss_pred hhHHHHHHHcCC--CCCCCC----------------------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 313 ADVSSAVVRQNL--RPEIPR----------------------------CCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 313 ~~~~~~~~~~~~--~~~~~~----------------------------~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
.+....+..... .+.... ..++++.+||.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 776655543211 111100 125678899999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=377.39 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=204.1
Q ss_pred CccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecccc
Q 036382 82 KLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTSN 159 (390)
Q Consensus 82 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 159 (390)
+|+..++||+|+||+||+|++ +|+.||||+++.... .+.+|+++|++++||||++++++|.....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 689999999999999999998 588999999974332 12379999999999999999999864321
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLI-RNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
. ......|+||||+.++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 88 ~--------------~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NI 153 (350)
T d1q5ka_ 88 K--------------KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153 (350)
T ss_dssp C--------------CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred c--------------CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceE
Confidence 1 12345689999998654433332 13355799999999999999999999999999999999999
Q ss_pred EECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHH
Q 036382 239 LLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQG-KPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVS 316 (390)
Q Consensus 239 Ll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 316 (390)
|++.++ .+||+|||++...... .......||+.|+|||.+.+ ..++.++||||+||++|||++|..||...+..+.+
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred EEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence 999875 8999999999865433 33445689999999998865 57899999999999999999999999988877766
Q ss_pred HHHHHcCC---------------CC------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhH
Q 036382 317 SAVVRQNL---------------RP------------EIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKM--LEAID 365 (390)
Q Consensus 317 ~~~~~~~~---------------~~------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~ 365 (390)
..+..... .. .....+++++.+||.+||..||++|||+.|++++ ++.+.
T Consensus 233 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 65543100 00 1123468899999999999999999999999863 55543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-49 Score=370.31 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=202.1
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEeccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGTS 158 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 158 (390)
++|++.+.||+|+||.||+|++ +|+.||||+++.... ...+..|+++++.++|+|++..++.+...
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~- 74 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE- 74 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----------SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----------CHHHHHHHHHHHHccCCCcccEEEEEEec-
Confidence 5799999999999999999997 578999999874322 12467899999999888766665555332
Q ss_pred ccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCCE
Q 036382 159 NLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTENM 238 (390)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~NI 238 (390)
....++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+||
T Consensus 75 ------------------~~~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NI 134 (299)
T d1ckia_ 75 ------------------GDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134 (299)
T ss_dssp ------------------TTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ------------------CCEEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhc
Confidence 34457899999 5677776654 345799999999999999999999999999999999999
Q ss_pred EECC---CCcEEEeecccceeccCCC-------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 239 LLDS---QRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 239 Ll~~---~~~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
|++. +..+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 135 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp EECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 9864 4579999999998654321 12334579999999999999999999999999999999999999998
Q ss_pred CCChhhHHHHHH---HcC---CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 309 DLSFADVSSAVV---RQN---LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 309 ~~~~~~~~~~~~---~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
..........+. ... ..+..+..+|+++.+||.+||+.||++||++.++.+.|+.+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp CCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 765544332221 111 112245678999999999999999999999999999999886543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=364.88 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=207.3
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++++.||+|+||+||+|++ +++.||||+++..... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 73 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-------hHHHHHHHHHHHHHHhcCcCCEEeeccccccc
Confidence 36899999999999999999998 5789999999744321 11246788999999999999999999999865
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
.. .++|++++.+++|..++. ....+++..++.++.|++.||+|||++||+||||||+|
T Consensus 74 ~~--------------------~~iv~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~N 131 (292)
T d1unla_ 74 KK--------------------LTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp SE--------------------EEEEEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cc--------------------eeEEeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcc
Confidence 44 478999999998888774 34578999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCC-CCCChhhH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKP-YNRRCDVYSFGICLWEIYCCDMPY-PDLSFADV 315 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf-~~~~~~~~ 315 (390)
||++.++.+||+|||.|+.............+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+.
T Consensus 132 Ili~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp EEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred cccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH
Confidence 9999999999999999987665555555567888999999987665 689999999999999999999986 44455554
Q ss_pred HHHHHHcCC---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 036382 316 SSAVVRQNL---------------------------RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVK 359 (390)
Q Consensus 316 ~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~ 359 (390)
...+..... ....+..+++++.+||++||+.||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 444432111 11123356789999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=378.89 Aligned_cols=255 Identities=20% Similarity=0.361 Sum_probs=208.2
Q ss_pred ccccCccccccccccCceEEEEEEE-----CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC-CccceEE
Q 036382 78 IDLSKLDMRNLIAQGTYGSVYRGTY-----DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-PNVTKFV 151 (390)
Q Consensus 78 i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~ 151 (390)
+.+++|++.+.||+|+||+||+|.. +|+.||||+++....... ....+.+.+|++++++++| |||++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-----AKTTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-----ESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-----hHHHHHHHHHHHHHHhccCCCeEEEee
Confidence 5678999999999999999999976 468999999863221000 0112456789999999966 8999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++.+... .+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 96 ~~~~~~~~--------------------~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHr 153 (322)
T d1vzoa_ 96 YAFQTETK--------------------LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153 (322)
T ss_dssp EEEEETTE--------------------EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eeeccCCc--------------------eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEec
Confidence 99986544 47899999999999999654 468899999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCC-CCCCCCCCCCCccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQN-PRDMTGETGTLGYMAPEVLQGK--PYNRRCDVYSFGICLWEIYCCDMPYP 308 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~ 308 (390)
||||+|||++.++.+||+|||+|+..... ........|++.|+|||.+.+. .++.++|||||||+||+|++|..||.
T Consensus 154 DiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999754332 2233446799999999999764 46789999999999999999999998
Q ss_pred CCChhhHHHHHHHc--CCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 036382 309 DLSFADVSSAVVRQ--NLRPEIPRCCPSSLANIMRKCWDANAEKRP-----EMGEVVK 359 (390)
Q Consensus 309 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~ 359 (390)
+....+....+... ...+.+|..+++++.+||.+||..||.+|| |++|+++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 87655554444332 234567788999999999999999999999 5788876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=376.24 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=207.1
Q ss_pred CcccccccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEE
Q 036382 74 EEWEIDLSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFV 151 (390)
Q Consensus 74 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 151 (390)
..|++ .++|++.++||+|+||+||+|++ +|+.||||+++.... .......+.+|+++|+.++|||||+++
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~Ei~il~~l~h~~iv~~~ 83 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-------SIIHAKRTYRELRLLKHMKHENVIGLL 83 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-------ChHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 35777 47899999999999999999987 589999999973321 112235678999999999999999999
Q ss_pred EEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 036382 152 GASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHR 231 (390)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHr 231 (390)
+++...... .....+++|+|+.+|+|.+++.. .++++..++.++.||+.||+|||++||+||
T Consensus 84 ~~~~~~~~~---------------~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHr 145 (348)
T d2gfsa1 84 DVFTPARSL---------------EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHR 145 (348)
T ss_dssp EEECSCSST---------------TTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred EEEeecccc---------------ccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCccc
Confidence 998754322 22334567788889999999843 469999999999999999999999999999
Q ss_pred CCCCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 036382 232 DVKTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDL 310 (390)
Q Consensus 232 Dlkp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~ 310 (390)
||||+|||++.++.+|++|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 146 DiKp~NILi~~~~~~kl~dfg~a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 146 DLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CCCGGGEEECTTCCEEECCC----CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCccccccccccccccccchhcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999975432 23456799999999987665 4689999999999999999999999988
Q ss_pred ChhhHHHHHHHcCCCC---------------------CC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 036382 311 SFADVSSAVVRQNLRP---------------------EI--------PRCCPSSLANIMRKCWDANAEKRPEMGEVVKM 360 (390)
Q Consensus 311 ~~~~~~~~~~~~~~~~---------------------~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~ 360 (390)
+.......+......+ .. ...+++++.+||.+||..||.+|||+.|++++
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 8776665554322111 00 13468899999999999999999999999973
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-48 Score=360.74 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=208.6
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCC-CccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDH-PNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~ 156 (390)
.++|++.+.||+|+||.||+|++ +|+.||||+++.... ...+.+|+++++.++| +|++.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----------APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----------cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 46899999999999999999987 578999999864321 1346689999999965 899999998864
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
. ...++||||+ +++|.+++... +..+++..+..++.|++.||+|||++||+||||||+
T Consensus 73 ~--------------------~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~ 130 (293)
T d1csna_ 73 G--------------------LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130 (293)
T ss_dssp T--------------------TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred C--------------------CccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCcc
Confidence 4 3458899998 68999988543 456999999999999999999999999999999999
Q ss_pred CEEECC-----CCcEEEeecccceeccCCC-------CCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 036382 237 NMLLDS-----QRTLKIADFGVARVEAQNP-------RDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCD 304 (390)
Q Consensus 237 NILl~~-----~~~~kL~DfG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 304 (390)
|||++. ++.+||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||++|.
T Consensus 131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~ 210 (293)
T d1csna_ 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210 (293)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC
Confidence 999964 5789999999998654321 1233457999999999999999999999999999999999999
Q ss_pred CCCCCCChh---hHHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhcC
Q 036382 305 MPYPDLSFA---DVSSAVVRQNL---RPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVVKMLEAIDTSK 368 (390)
Q Consensus 305 ~Pf~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~ 368 (390)
.||.+.... +....+..... ....+..+|+++.+++..||..+|++||+++.+.+.|+++....
T Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 999865433 22322222211 12234678999999999999999999999999999999876443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-48 Score=367.81 Aligned_cols=244 Identities=20% Similarity=0.337 Sum_probs=197.5
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhc-CCCccceEEEEEec
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKL-DHPNVTKFVGASVG 156 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 156 (390)
.++|+++++||+|+||+||+|++ +|+.||||+++... .+.+.+|+++|+++ .||||+++++++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 46899999999999999999998 58899999986321 24577899999999 59999999999875
Q ss_pred ccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 036382 157 TSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTE 236 (390)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~ 236 (390)
.. ....++||||+.+++|..+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 102 ~~------------------~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~ 158 (328)
T d3bqca1 102 PV------------------SRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 158 (328)
T ss_dssp TT------------------TCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cC------------------CCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhccccccccccc
Confidence 42 23458999999999987653 35999999999999999999999999999999999
Q ss_pred CEEECCCC-cEEEeecccceeccCCCCCCCCCCCCCccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC-hh
Q 036382 237 NMLLDSQR-TLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGK-PYNRRCDVYSFGICLWEIYCCDMPYPDLS-FA 313 (390)
Q Consensus 237 NILl~~~~-~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~ 313 (390)
|||++.++ .+||+|||+|+..... .......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.... ..
T Consensus 159 NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 159 NVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp GEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 99998765 6999999999865432 334556899999999998765 57999999999999999999999996643 22
Q ss_pred hHHHHHHH-------------cC----------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 036382 314 DVSSAVVR-------------QN----------------------LRPEIPRCCPSSLANIMRKCWDANAEKRPEMGEVV 358 (390)
Q Consensus 314 ~~~~~~~~-------------~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll 358 (390)
+....+.. .. ........+++++.+||++||..||++|||++|++
T Consensus 238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 22211110 00 01111234678999999999999999999999998
Q ss_pred H
Q 036382 359 K 359 (390)
Q Consensus 359 ~ 359 (390)
+
T Consensus 318 ~ 318 (328)
T d3bqca1 318 E 318 (328)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=373.27 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=195.9
Q ss_pred ccCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCccceEEEEEecc
Q 036382 80 LSKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNVTKFVGASVGT 157 (390)
Q Consensus 80 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 157 (390)
+++|++.++||+|+||+||+|.+ +|+.||||+++.... .......+.+|+.++++++||||++++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~ 88 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecc
Confidence 36799999999999999999998 589999999973321 122345678999999999999999999998754
Q ss_pred cccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCC
Q 036382 158 SNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDVKTEN 237 (390)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDlkp~N 237 (390)
... .....+|+||||+.++ |.+.+ ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~--------------~~~~~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~N 149 (355)
T d2b1pa1 89 KTL--------------EEFQDVYLVMELMDAN-LCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_dssp CST--------------TTCCEEEEEEECCSEE-HHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ccc--------------ccCceeEEEEeccchH-HHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccc
Confidence 322 1346779999999765 55544 2358999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChhhHHH
Q 036382 238 MLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFADVSS 317 (390)
Q Consensus 238 ILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 317 (390)
||++.++.+|++|||+++.... .......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......
T Consensus 150 il~~~~~~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~ 228 (355)
T d2b1pa1 150 IVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_dssp EEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccccccceeeechhhhhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence 9999999999999999875543 233455679999999999999999999999999999999999999999887666655
Q ss_pred HHHHcCCCC--------------------CC--------------C------CCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 036382 318 AVVRQNLRP--------------------EI--------------P------RCCPSSLANIMRKCWDANAEKRPEMGEV 357 (390)
Q Consensus 318 ~~~~~~~~~--------------------~~--------------~------~~~~~~l~~li~~cl~~dP~~Rpt~~~l 357 (390)
.+......+ .. + ...++++.+||++||..||++|||++||
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 443211100 00 0 0135678999999999999999999999
Q ss_pred HHH
Q 036382 358 VKM 360 (390)
Q Consensus 358 l~~ 360 (390)
+++
T Consensus 309 L~H 311 (355)
T d2b1pa1 309 LQH 311 (355)
T ss_dssp HTS
T ss_pred hcC
Confidence 865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-42 Score=327.62 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=189.2
Q ss_pred cCccccccccccCceEEEEEEE--CCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-----------CCcc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTY--DNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-----------HPNV 147 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI 147 (390)
.+|+++++||+|+||+||+|++ +|+.||||+++.. ....+.+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 4699999999999999999987 6899999999621 112345678888888775 5789
Q ss_pred ceEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCC-CHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-
Q 036382 148 TKFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGG-NLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHS- 225 (390)
Q Consensus 148 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~- 225 (390)
+++++++...... ..+++|++...+ .............+++..+..++.||+.||.|||+
T Consensus 83 v~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~ 144 (362)
T d1q8ya_ 83 LKLLDHFNHKGPN------------------GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR 144 (362)
T ss_dssp CCCCEEEEEEETT------------------EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEeeecccc------------------ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh
Confidence 9999887644322 224566655444 44444445556779999999999999999999998
Q ss_pred CCCcccCCCCCCEEECCCCc------EEEeecccceeccCCCCCCCCCCCCCccccccccCCCCCCCchhHHHHHHHHHH
Q 036382 226 KKIVHRDVKTENMLLDSQRT------LKIADFGVARVEAQNPRDMTGETGTLGYMAPEVLQGKPYNRRCDVYSFGICLWE 299 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~------~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 299 (390)
.||+||||||+|||++.++. ++++|||.+...... ....+||+.|+|||++.+..++.++|+||+||++++
T Consensus 145 ~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 221 (362)
T d1q8ya_ 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221 (362)
T ss_dssp TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred cCcccccCChhHeeeeccCcccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHH
Confidence 89999999999999987653 999999999754332 345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh------hhHHHHHHHc--------------------------C--------------CCCCCCCCCc
Q 036382 300 IYCCDMPYPDLSF------ADVSSAVVRQ--------------------------N--------------LRPEIPRCCP 333 (390)
Q Consensus 300 ll~g~~Pf~~~~~------~~~~~~~~~~--------------------------~--------------~~~~~~~~~~ 333 (390)
|++|+.||..... .+........ . .....+...+
T Consensus 222 l~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (362)
T d1q8ya_ 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301 (362)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred HHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccC
Confidence 9999999965321 1111111100 0 0001122345
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHh
Q 036382 334 SSLANIMRKCWDANAEKRPEMGEVVKM--LEAI 364 (390)
Q Consensus 334 ~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~ 364 (390)
+++.+||.+||..||.+|||+.|++++ +++.
T Consensus 302 ~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 789999999999999999999999874 5433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=7.5e-26 Score=196.17 Aligned_cols=171 Identities=18% Similarity=0.164 Sum_probs=120.9
Q ss_pred cccccccccCceEEEEEEE-CCceEEEEEeccCCCCccc---------hHHHHHHHHHHHHHHHHHHhcCCCccceEEEE
Q 036382 84 DMRNLIAQGTYGSVYRGTY-DNQEVAVKLLDWGEDGMAT---------TAETAALRSSFQQEVAVWQKLDHPNVTKFVGA 153 (390)
Q Consensus 84 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 153 (390)
.+.++||+|+||.||+|.+ +|+.||||+++.+...... ............+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999987 6889999998643221110 01112223445678999999999999988866
Q ss_pred EecccccccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 036382 154 SVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSKKIVHRDV 233 (390)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~iiHrDl 233 (390)
.. .+++|||+.++.+. .++......++.|++.+|.|||++||+||||
T Consensus 83 ~~------------------------~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDi 129 (191)
T d1zara2 83 EG------------------------NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDL 129 (191)
T ss_dssp ET------------------------TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cC------------------------CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccC
Confidence 31 16899999886542 2455556789999999999999999999999
Q ss_pred CCCCEEECCCCcEEEeecccceeccCCCCCCCCCCCCCccccccc-----cCCCCCCCchhHHHHHHH
Q 036382 234 KTENMLLDSQRTLKIADFGVARVEAQNPRDMTGETGTLGYMAPEV-----LQGKPYNRRCDVYSFGIC 296 (390)
Q Consensus 234 kp~NILl~~~~~~kL~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~~DiwSlG~i 296 (390)
||+|||++++ .++|+|||.|.....+. ...|....+ ...+.|+..+|+||+.--
T Consensus 130 KP~NILv~~~-~~~liDFG~a~~~~~~~--------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 130 SQYNVLVSEE-GIWIIDFPQSVEVGEEG--------WREILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp STTSEEEETT-EEEECCCTTCEETTSTT--------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ChhheeeeCC-CEEEEECCCcccCCCCC--------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9999999865 58999999997543221 111221110 113568889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=8.8e-08 Score=84.61 Aligned_cols=140 Identities=14% Similarity=0.090 Sum_probs=90.8
Q ss_pred cCccccccccccCceEEEEEEECCceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcC-CCccceEEEEEecccc
Q 036382 81 SKLDMRNLIAQGTYGSVYRGTYDNQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLD-HPNVTKFVGASVGTSN 159 (390)
Q Consensus 81 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 159 (390)
+.|++.+..+.++.+.||+...+++.++||+........ ...+.+|..+++.+. +=-+-+++.+..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~---------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--- 81 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---------TYDVEREKDMMLWLEGKLPVPKVLHFERH--- 81 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS---------TTCHHHHHHHHHHHTTTSCCCCEEEEEEE---
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc---------hhhHHHHHHHHHHHhccCCCCcEEEEEec---
Confidence 456666666556668999998888889999875322111 123567888877773 2224455555442
Q ss_pred cccCCcccccCCCCCCCCCceEEEEecCCCCCHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-------------
Q 036382 160 LKIPSKTASVDGNAAVPARACCVVVEYLPGGNLKQYLIRNRRKKLALKIVIQLALDLSRGLSYLHSK------------- 226 (390)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------- 226 (390)
.+..++||++++|.++.+.... ......++.+++..+..||+.
T Consensus 82 -----------------~~~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~ 137 (263)
T d1j7la_ 82 -----------------DGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp -----------------TTEEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHH
T ss_pred -----------------CCceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhh
Confidence 2345889999999888654311 111223344455555555531
Q ss_pred ----------------------------------------------CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 ----------------------------------------------KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ----------------------------------------------~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.++|+|+.|.|||+++++...|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 158999999999998777677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=1.5e-05 Score=69.41 Aligned_cols=29 Identities=24% Similarity=0.358 Sum_probs=25.6
Q ss_pred CcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 228 IVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 228 iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 69999999999998877778999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=0.00011 Score=68.35 Aligned_cols=30 Identities=20% Similarity=0.313 Sum_probs=25.8
Q ss_pred CCcccCCCCCCEEECCCCcEEEeecccceec
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARVE 257 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~~ 257 (390)
.++|+|+.|.|||++.++ ++|+||-+|...
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 589999999999998664 899999988743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.0021 Score=57.69 Aligned_cols=28 Identities=25% Similarity=0.268 Sum_probs=23.4
Q ss_pred CCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 227 KIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 227 ~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
++||+|+.+.|||++. + ..++||+.++.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 6899999999999974 3 45899998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.81 E-value=0.0017 Score=57.86 Aligned_cols=31 Identities=19% Similarity=0.285 Sum_probs=27.7
Q ss_pred CCCcccCCCCCCEEECCCCcEEEeeccccee
Q 036382 226 KKIVHRDVKTENMLLDSQRTLKIADFGVARV 256 (390)
Q Consensus 226 ~~iiHrDlkp~NILl~~~~~~kL~DfG~a~~ 256 (390)
.|+||+|+.++||+++.+...-|.||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999888889999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.44 E-value=0.0046 Score=56.94 Aligned_cols=78 Identities=21% Similarity=0.316 Sum_probs=47.8
Q ss_pred cccCccccccccccCceEEEEEEEC---------CceEEEEEeccCCCCccchHHHHHHHHHHHHHHHHHHhcCCCcc-c
Q 036382 79 DLSKLDMRNLIAQGTYGSVYRGTYD---------NQEVAVKLLDWGEDGMATTAETAALRSSFQQEVAVWQKLDHPNV-T 148 (390)
Q Consensus 79 ~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v 148 (390)
+.+++++. .|+.|-.-.+|+.... .+.|.+++.- +. ... ....+|..+++.+.-.++ .
T Consensus 41 ~~~~l~v~-~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~---~~~-------idr~~E~~i~~~ls~~gl~P 108 (395)
T d1nw1a_ 41 PLEHLRIS-RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP---ETE-------SHLVAESVIFTLLSERHLGP 108 (395)
T ss_dssp CGGGEEEE-EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC---CCH-------HHHHHHHHHHHHHHHTTSSS
T ss_pred CccceEEE-EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc---chh-------hHHHHHHHHHHHHHhCCCCC
Confidence 34455553 5777888999998763 2457777753 11 111 123468888888743344 4
Q ss_pred eEEEEEecccccccCCcccccCCCCCCCCCceEEEEecCCCCCH
Q 036382 149 KFVGASVGTSNLKIPSKTASVDGNAAVPARACCVVVEYLPGGNL 192 (390)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 192 (390)
++++++.+ .+|+||++|.+|
T Consensus 109 kll~~~~~------------------------g~I~efi~g~~l 128 (395)
T d1nw1a_ 109 KLYGIFSG------------------------GRLEEYIPSRPL 128 (395)
T ss_dssp CEEEEETT------------------------EEEECCCCEEEC
T ss_pred eEEEEcCC------------------------ceEEEEeccccC
Confidence 77777632 568999887543
|